data_2mj6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mj6 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 . . . . . 0 CA--C 1.544 0.713 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -36.4 78.01 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.347 -0.846 . . . . 0.0 112.588 -174.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.2 m -61.76 -21.41 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -68.72 -43.54 75.77 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.465 1.029 . . . . 0.0 112.231 174.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.74 -42.56 73.77 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.395 -0.815 . . . . 0.0 111.263 -171.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -65.7 -29.54 70.1 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.705 1.202 . . . . 0.0 112.81 171.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.59 -38.77 77.46 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.678 -1.264 . . . . 0.0 112.421 170.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.56 -36.28 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 O-C-N 121.289 -0.882 . . . . 0.0 111.305 172.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -58.83 -44.74 90.96 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.315 -0.865 . . . . 0.0 111.293 171.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.3 mp -70.01 -35.88 74.7 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-O 117.225 -1.369 . . . . 0.0 113.293 173.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.19 -34.73 66.53 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 121.284 1.856 . . . . 0.0 110.602 169.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.5 m -70.17 -38.89 75.53 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.709 0.803 . . . . 0.0 112.927 172.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.4 mm -74.42 -33.96 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 120.563 1.528 . . . . 0.0 111.507 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.9 t -66.13 -43.77 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 117.577 -1.201 . . . . 0.0 110.323 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -52.59 -43.01 65.05 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.666 1.575 . . . . 0.0 112.034 170.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.8 t -61.75 -31.08 71.24 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.317 0.647 . . . . 0.0 112.301 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -79.91 -36.49 36.35 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.993 1.317 . . . . 0.0 113.306 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 71.0 mt -66.27 -35.17 79.7 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.69 1.132 . . . . 0.0 111.685 175.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.4 mt -74.56 -35.21 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.417 1.087 . . . . 0.0 111.04 169.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.69 -38.33 50.69 Favored Glycine 0 C--N 1.339 0.724 0 C-N-CA 125.798 1.666 . . . . 0.0 114.99 -172.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.5 t -152.84 -26.52 0.15 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.82 4.66 42.21 Favored Glycine 0 N--CA 1.476 1.358 0 N-CA-C 116.512 1.365 . . . . 0.0 116.512 174.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.8 p -155.85 141.38 17.78 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.241 1.416 . . . . 0.0 111.131 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 80.4 t -93.74 144.09 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.247 1.419 . . . . 0.0 109.64 175.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -125.07 158.09 34.64 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.622 1.169 . . . . 0.0 110.302 171.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -56.9 -37.17 71.05 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.223 -0.923 . . . . 0.0 112.632 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -69.88 -19.07 63.44 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -77.11 -39.88 47.9 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.783 0.72 . . . . 0.0 111.91 171.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.2 mt -85.64 -27.45 25.4 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -173.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -57.82 -24.18 56.15 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 119.812 1.187 . . . . 0.0 113.58 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -83.58 -3.28 57.54 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.087 1.355 . . . . 0.0 114.122 175.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -118.6 -19.31 8.79 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.449 1.1 . . . . 0.0 113.561 -169.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.578 0 C-N-CA 124.062 0.945 . . . . 0.0 110.995 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.467 0.375 0 CA-C-O 119.35 -0.357 . . . . 0.0 110.65 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -131.47 132.03 43.96 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.438 0.695 . . . . 0.0 111.495 -170.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.08 147.41 31.24 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.212 -0.93 . . . . 0.0 110.924 169.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.3 t -138.43 141.18 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.266 1.427 . . . . 0.0 110.848 -171.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.35 131.18 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.998 1.319 . . . . 0.0 113.828 -171.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -130.72 76.43 1.72 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.967 1.707 . . . . 0.0 109.481 169.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.4 mt -94.31 131.0 32.21 Favored Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 123.715 0.806 . . . . 0.0 108.985 172.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -64.64 136.78 51.41 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.195 1.93 . . . . 0.0 111.544 175.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.97 -0.99 87.9 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.704 1.145 . . . . 0.0 115.851 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -138.32 156.56 73.53 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-N 119.322 1.561 . . . . 0.0 112.582 175.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.19 153.57 66.83 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.811 2.341 . . . . 0.0 113.064 -174.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.1 p -59.2 132.93 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.254 1.022 . . . . 0.0 111.531 172.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 95.5 t -111.32 141.64 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.492 1.517 . . . . 0.0 109.194 170.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -134.84 119.67 18.4 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.215 1.406 . . . . 0.0 109.428 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.2 t -94.87 155.24 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.287 1.835 . . . . 0.0 111.353 -174.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.67 -95.22 0.99 Allowed Glycine 0 CA--C 1.53 1.023 0 O-C-N 121.151 -0.968 . . . . 0.0 112.836 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.6 m -153.0 152.81 31.81 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.537 -0.978 . . . . 0.0 110.26 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -67.19 130.07 93.73 Favored Pre-proline 0 CA--C 1.547 0.865 0 O-C-N 120.72 -1.238 . . . . 0.0 110.883 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.54 158.77 25.46 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.179 3.253 . . . . 0.0 114.621 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.7 t -88.49 -34.02 17.6 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -169.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.15 -36.57 1.86 Allowed Glycine 0 N--CA 1.477 1.411 0 C-N-CA 125.153 1.358 . . . . 0.0 112.355 -174.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -78.43 63.07 3.2 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.236 1.414 . . . . 0.0 110.522 169.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.4 m -139.84 154.36 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.648 1.579 . . . . 0.0 112.351 -176.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.4 mt -89.04 147.5 24.23 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 127.677 2.391 . . . . 0.0 109.128 170.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -127.09 116.95 21.48 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 118.672 0.669 . . . . 0.0 112.206 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.89 150.78 19.98 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.12 1.343 . . . . 0.0 110.001 169.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -156.11 137.04 13.54 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.573 1.686 . . . . 0.0 113.137 -171.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.61 161.98 37.8 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.033 1.333 . . . . 0.0 113.6 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 74.9 m -114.42 128.26 56.25 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.155 1.382 . . . . 0.0 108.319 172.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.08 176.91 44.2 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 122.033 0.796 . . . . 0.0 114.64 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -83.51 -9.56 58.89 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -169.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -102.3 5.91 40.19 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 120.733 1.606 . . . . 0.0 112.194 169.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.12 17.48 34.56 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.247 1.879 . . . . 0.0 114.362 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -83.93 173.22 11.38 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.19 1.796 . . . . 0.0 113.357 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.4 m -129.23 136.55 50.26 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.97 1.308 . . . . 0.0 110.25 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.2 t -119.29 139.7 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.023 1.729 . . . . 0.0 109.575 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.4 tt -132.84 149.11 52.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.467 1.107 . . . . 0.0 109.817 175.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 86.0 t -133.23 139.87 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.509 1.523 . . . . 0.0 109.397 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -131.74 137.73 48.34 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.988 0.899 . . . . 0.0 112.825 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -137.04 150.48 69.62 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 126.564 1.946 . . . . 0.0 111.031 -173.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -64.17 137.93 59.08 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.801 2.334 . . . . 0.0 112.582 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 125.92 1.688 . . . . 0.0 112.409 177.605 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 . . . . . 0 CA--C 1.544 0.745 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -28.46 69.31 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -171.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.3 m -60.4 -21.1 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 170.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -69.2 -45.56 69.62 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 119.466 1.03 . . . . 0.0 112.391 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 mp -70.0 -40.17 75.43 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.552 -0.718 . . . . 0.0 111.617 -170.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -65.02 -34.2 77.87 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.722 1.209 . . . . 0.0 112.519 170.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.92 -38.92 89.94 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 120.604 -1.31 . . . . 0.0 112.361 171.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 94.3 t -68.11 -37.82 78.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 O-C-N 121.294 -0.879 . . . . 0.0 111.533 172.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -59.53 -44.59 93.15 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.318 -0.864 . . . . 0.0 111.057 172.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.5 mp -69.52 -34.32 74.1 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 117.448 -1.263 . . . . 0.0 113.044 174.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.16 -34.44 68.44 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 121.172 1.805 . . . . 0.0 110.534 169.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.3 m -72.63 -38.65 67.66 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.353 1.061 . . . . 0.0 113.636 171.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.1 mm -72.79 -34.2 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 120.915 1.689 . . . . 0.0 110.97 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.2 t -67.18 -47.19 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.795 1.238 . . . . 0.0 109.63 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -53.11 -44.0 67.32 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 120.821 1.646 . . . . 0.0 111.976 170.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.2 m -59.97 -30.43 69.1 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.744 -0.598 . . . . 0.0 112.486 175.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.2 tpt180 -80.92 -35.22 32.7 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.685 1.594 . . . . 0.0 113.526 171.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.7 mt -66.11 -33.8 76.61 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.988 1.267 . . . . 0.0 111.588 174.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 90.7 mt -75.08 -35.69 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.791 1.236 . . . . 0.0 110.811 169.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.89 -38.05 49.7 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 125.5 1.524 . . . . 0.0 114.807 -172.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.1 t -152.58 -26.97 0.16 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.93 1.06 39.2 Favored Glycine 0 N--CA 1.477 1.43 0 N-CA-C 116.774 1.47 . . . . 0.0 116.774 174.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.9 m -147.8 139.0 23.52 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.098 1.759 . . . . 0.0 109.33 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.46 147.05 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.737 1.215 . . . . 0.0 109.955 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -132.32 157.42 44.5 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.782 1.233 . . . . 0.0 110.472 -174.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -55.66 -38.28 69.38 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.758 -0.589 . . . . 0.0 112.268 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -70.45 -20.18 62.91 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.794 1.238 . . . . 0.0 113.721 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -78.99 -41.81 28.11 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.833 0.742 . . . . 0.0 111.067 169.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.3 mt -81.67 -30.34 32.74 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -170.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -56.3 -26.91 53.75 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 173.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -84.18 -3.35 58.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.325 1.05 . . . . 0.0 113.723 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.6 mm-40 -120.71 -13.73 8.67 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.617 1.167 . . . . 0.0 113.535 -169.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.47 0.544 0 C-N-CA 123.405 0.682 . . . . 0.0 112.66 -176.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -132.71 124.34 27.98 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.55 1.54 . . . . 0.0 109.169 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.13 142.63 29.57 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.443 1.02 . . . . 0.0 109.579 169.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 63.1 t -137.84 141.16 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.646 1.178 . . . . 0.0 109.476 -171.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -122.97 134.07 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -169.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -129.67 81.79 2.04 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.467 1.907 . . . . 0.0 109.631 170.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.5 mt -98.34 125.18 44.22 Favored Pre-proline 0 N--CA 1.48 1.063 0 C-N-CA 123.775 0.83 . . . . 0.0 108.979 169.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.87 133.4 53.51 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.384 2.056 . . . . 0.0 112.291 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.25 3.42 87.2 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-O 118.273 -1.293 . . . . 0.0 115.977 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -138.8 163.39 46.95 Favored Pre-proline 0 N--CA 1.475 0.78 0 CA-C-N 119.717 1.759 . . . . 0.0 114.075 173.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -60.62 140.78 92.86 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.579 2.853 . . . . 0.0 114.204 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.2 t -60.23 131.31 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.332 1.053 . . . . 0.0 110.024 169.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 70.1 t -110.38 141.41 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.095 1.358 . . . . 0.0 109.562 172.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -138.17 114.42 10.23 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.999 1.319 . . . . 0.0 109.191 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.3 t -89.97 155.53 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.941 1.696 . . . . 0.0 111.312 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.83 -102.83 1.58 Allowed Glycine 0 CA--C 1.532 1.107 0 O-C-N 121.343 -0.848 . . . . 0.0 112.736 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.3 m -146.12 150.05 35.18 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.516 1.126 . . . . 0.0 110.17 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -67.59 129.74 93.39 Favored Pre-proline 0 CA--C 1.548 0.898 0 O-C-N 120.861 -1.15 . . . . 0.0 111.002 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.86 155.0 23.32 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.952 3.102 . . . . 0.0 114.314 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.9 t -83.66 -26.95 29.44 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -171.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.25 -33.9 3.36 Favored Glycine 0 N--CA 1.476 1.32 0 C-N-CA 125.572 1.558 . . . . 0.0 112.64 -175.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -79.18 60.23 2.98 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.775 1.63 . . . . 0.0 111.216 169.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.3 m -136.68 158.99 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 126.078 1.751 . . . . 0.0 112.29 -173.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.9 mt -99.77 126.96 45.93 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.854 2.462 . . . . 0.0 110.382 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -111.33 110.1 20.41 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -169.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.38 145.88 18.29 Favored Glycine 0 N--CA 1.471 0.998 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 169.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -154.46 137.4 15.44 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 120.145 1.972 . . . . 0.0 113.654 -169.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.26 163.65 34.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.56 1.144 . . . . 0.0 113.95 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 62.1 m -117.11 130.52 56.69 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.411 1.485 . . . . 0.0 108.578 172.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.31 174.7 37.08 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.092 0.853 . . . . 0.0 114.638 -177.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -81.45 -10.82 59.42 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 -169.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -99.61 5.49 45.91 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.714 1.597 . . . . 0.0 111.983 169.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.37 17.62 33.49 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 126.259 1.885 . . . . 0.0 114.268 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.3 pm0 -84.08 175.51 9.46 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.839 1.656 . . . . 0.0 113.459 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.5 m -133.2 133.88 43.34 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.073 1.349 . . . . 0.0 110.41 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 67.3 t -114.26 141.18 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.168 1.787 . . . . 0.0 110.029 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.7 tp -129.23 146.77 51.07 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.388 1.475 . . . . 0.0 109.524 174.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.6 t -124.4 137.7 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 127.596 2.358 . . . . 0.0 107.719 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -135.35 138.13 43.06 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.017 0.527 . . . . 0.0 111.724 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -148.83 154.25 39.97 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 172.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -59.82 137.64 77.84 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.779 2.319 . . . . 0.0 113.404 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 . . . . . 0 C--O 1.255 1.354 0 C-N-CA 125.888 1.675 . . . . 0.0 112.241 178.542 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 . . . . . 0 CA--C 1.545 0.761 0 CA-C-O 119.711 -0.185 . . . . 0.0 111.325 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -37.15 79.78 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.057 -1.027 . . . . 0.0 111.822 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.9 t -58.24 -31.43 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.337 1.455 . . . . 0.0 113.085 173.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -71.12 -39.64 71.92 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.235 -0.916 . . . . 0.0 112.957 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -77.86 -36.31 50.01 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.271 -0.893 . . . . 0.0 111.918 -172.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -64.34 -28.0 69.4 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.337 -0.852 . . . . 0.0 112.705 170.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.68 -36.6 84.11 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.608 -1.307 . . . . 0.0 111.981 170.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.3 t -71.33 -35.79 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.567 1.147 . . . . 0.0 111.174 173.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.2 tpp85 -60.82 -46.36 90.82 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.011 -1.055 . . . . 0.0 111.473 171.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.3 mp -69.76 -33.25 72.16 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 117.352 -1.308 . . . . 0.0 112.418 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.58 -33.05 69.53 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 121.269 1.849 . . . . 0.0 110.785 169.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.3 m -73.79 -38.61 64.58 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.303 1.041 . . . . 0.0 113.33 171.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.7 mm -73.31 -36.7 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 121.072 1.76 . . . . 0.0 110.84 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.6 t -62.2 -49.93 82.03 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 CA-C-O 117.558 -1.21 . . . . 0.0 109.466 173.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -54.05 -43.52 70.28 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 120.803 1.638 . . . . 0.0 112.377 173.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.0 m -59.33 -36.84 76.41 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.756 -0.59 . . . . 0.0 111.912 176.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -74.55 -36.49 63.11 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.36 1.464 . . . . 0.0 113.271 172.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.2 mt -67.27 -30.57 70.48 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.864 1.211 . . . . 0.0 112.034 175.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.4 mt -76.05 -37.31 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.869 1.268 . . . . 0.0 110.936 169.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.58 -39.52 55.95 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.383 1.468 . . . . 0.0 114.456 -173.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.8 t -148.83 -27.61 0.3 Allowed 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.69 14.23 35.3 Favored Glycine 0 N--CA 1.479 1.535 0 N-CA-C 116.061 1.184 . . . . 0.0 116.061 175.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.1 m -156.67 145.83 20.36 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.945 1.698 . . . . 0.0 109.694 172.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.0 p -120.69 143.64 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.521 1.528 . . . . 0.0 110.359 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -128.8 156.25 43.88 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.371 1.068 . . . . 0.0 111.395 -169.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -54.2 -39.09 66.36 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.671 -0.643 . . . . 0.0 112.299 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -71.1 -21.07 62.27 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.246 1.418 . . . . 0.0 113.638 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -80.98 -37.23 29.62 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.869 0.759 . . . . 0.0 111.39 169.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.6 mt -82.16 -32.3 30.06 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.984 1.314 . . . . 0.0 113.733 -171.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -58.31 -22.94 54.93 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 173.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -85.11 -1.14 56.53 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.556 1.142 . . . . 0.0 113.913 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -116.56 -21.28 9.24 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.841 1.257 . . . . 0.0 112.998 -174.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.474 0.738 0 C-N-CA 123.623 0.769 . . . . 0.0 111.781 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 119.362 -0.351 . . . . 0.0 111.571 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -126.99 131.36 51.06 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.147 0.579 . . . . 0.0 112.501 -169.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.29 144.47 37.38 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.394 -0.816 . . . . 0.0 109.637 169.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.0 t -139.85 138.72 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.264 1.026 . . . . 0.0 110.389 -169.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -119.29 132.93 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -169.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -130.02 83.31 2.12 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.977 1.711 . . . . 0.0 109.45 172.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.5 mt -100.18 132.12 23.13 Favored Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 124.048 0.939 . . . . 0.0 109.271 173.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.52 134.18 37.43 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.352 2.035 . . . . 0.0 111.658 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.48 0.24 82.41 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.774 1.178 . . . . 0.0 115.565 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -135.31 158.12 75.23 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 119.027 1.414 . . . . 0.0 112.087 172.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.2 155.74 66.88 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.621 2.214 . . . . 0.0 112.786 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.2 p -57.66 139.82 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.637 1.175 . . . . 0.0 111.588 171.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 85.1 t -119.24 139.26 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.466 1.507 . . . . 0.0 108.806 172.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -133.5 121.82 22.73 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.001 1.32 . . . . 0.0 109.564 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.8 t -95.02 151.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.618 1.567 . . . . 0.0 111.116 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.17 -102.62 2.3 Favored Glycine 0 CA--C 1.533 1.213 0 O-C-N 121.462 -0.773 . . . . 0.0 112.522 172.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 94.5 m -143.97 141.65 30.3 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.599 1.159 . . . . 0.0 109.896 174.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -65.45 125.9 90.45 Favored Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 120.73 -1.231 . . . . 0.0 111.127 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.63 153.57 34.34 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.712 2.942 . . . . 0.0 114.911 -172.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.3 t -82.22 -24.0 35.1 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -169.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.64 -35.05 3.71 Favored Glycine 0 N--CA 1.478 1.487 0 C-N-CA 125.394 1.473 . . . . 0.0 112.618 -174.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -77.9 59.56 2.13 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.027 1.731 . . . . 0.0 110.672 169.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.0 m -135.55 157.29 39.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 126.292 1.837 . . . . 0.0 112.046 -173.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.6 mt -90.78 144.65 25.5 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.704 1.602 . . . . 0.0 109.125 170.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -125.49 122.13 35.73 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.532 0.733 . . . . 0.0 112.102 -177.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.42 148.08 16.44 Favored Glycine 0 N--CA 1.47 0.942 0 C-N-CA 126.033 1.778 . . . . 0.0 109.563 169.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -152.42 141.55 21.34 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.094 1.447 . . . . 0.0 112.876 -169.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.75 162.03 40.03 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.015 1.326 . . . . 0.0 113.228 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 70.1 m -113.11 127.44 56.2 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.951 1.301 . . . . 0.0 108.697 171.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.19 172.35 43.37 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.379 0.99 . . . . 0.0 114.06 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -82.93 -11.78 57.88 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 -169.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -92.94 2.91 56.55 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.837 1.653 . . . . 0.0 111.848 169.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.86 14.68 39.14 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 126.735 2.112 . . . . 0.0 114.369 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.5 pm0 -81.89 173.76 11.94 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.861 1.665 . . . . 0.0 113.794 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.0 m -127.84 138.92 52.87 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.452 1.501 . . . . 0.0 110.348 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.4 t -121.52 139.29 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.425 1.49 . . . . 0.0 109.487 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.2 tp -126.78 148.08 49.95 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.48 1.512 . . . . 0.0 109.935 174.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.38 136.17 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.462 1.505 . . . . 0.0 108.203 174.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -130.19 131.74 45.73 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.845 0.831 . . . . 0.0 112.142 -177.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -126.14 151.54 72.05 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 126.264 1.825 . . . . 0.0 111.552 -178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -61.11 136.15 63.18 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 122.655 2.237 . . . . 0.0 112.023 170.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 . . . . . 0 C--O 1.252 1.213 0 C-N-CA 125.211 1.404 . . . . 0.0 113.252 -177.597 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.406 HH21 ' CD ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER -61.62 -36.43 80.71 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 121.118 -0.989 . . . . 0.0 112.839 -174.351 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.9 m -60.07 -23.06 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 174.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -71.16 -39.95 71.59 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.217 0.917 . . . . 0.0 111.735 175.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.0 mt -71.84 -41.63 67.91 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.053 0.941 . . . . 0.0 111.541 -172.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.406 ' CD ' HH21 ' A' ' 14' ' ' ARG . 4.9 pt-20 -66.68 -33.24 75.2 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.88 0.872 . . . . 0.0 112.516 169.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.8 -37.88 89.02 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 120.28 1.4 . . . . 0.0 112.161 171.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.9 t -69.1 -37.78 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.193 0.997 . . . . 0.0 111.712 172.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -60.87 -43.44 98.42 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.004 -1.06 . . . . 0.0 111.336 172.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -69.79 -34.43 73.71 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 117.468 -1.254 . . . . 0.0 112.585 173.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.27 -33.05 68.99 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 121.175 1.807 . . . . 0.0 110.486 169.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.8 m -73.61 -38.89 64.94 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.401 1.08 . . . . 0.0 113.74 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.1 mm -72.47 -36.12 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 121.221 1.828 . . . . 0.0 110.626 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.66 -48.4 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 117.549 -1.215 . . . . 0.0 109.664 174.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -53.62 -44.27 69.37 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.836 1.653 . . . . 0.0 112.1 172.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.2 m -58.85 -34.48 71.62 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.786 -0.571 . . . . 0.0 112.113 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -77.78 -35.67 51.34 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.482 1.513 . . . . 0.0 113.63 172.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 56.0 mt -66.77 -33.05 74.77 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 120.127 1.33 . . . . 0.0 111.56 175.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 90.8 mt -72.75 -36.98 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 124.821 1.248 . . . . 0.0 110.672 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.2 -39.7 51.88 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.506 1.527 . . . . 0.0 114.673 -173.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.6 t -151.45 -27.25 0.19 Allowed 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.86 2.42 49.24 Favored Glycine 0 N--CA 1.48 1.629 0 N-CA-C 116.436 1.334 . . . . 0.0 116.436 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.9 m -143.81 136.5 27.19 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.254 1.821 . . . . 0.0 109.115 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 p -113.31 145.9 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.597 1.159 . . . . 0.0 110.216 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -132.92 157.4 45.2 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.634 1.174 . . . . 0.0 111.073 -170.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.55 -40.75 65.79 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.797 -0.565 . . . . 0.0 112.368 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.95 -17.82 62.05 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.394 1.078 . . . . 0.0 113.756 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -81.67 -36.86 28.29 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.032 0.833 . . . . 0.0 111.52 169.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 64.3 mt -85.68 -31.75 22.34 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.742 1.617 . . . . 0.0 114.374 -171.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -60.66 -19.17 57.61 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -85.62 -5.29 59.29 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.06 1.344 . . . . 0.0 114.131 173.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -116.1 -18.2 10.67 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.719 1.208 . . . . 0.0 113.482 -169.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.475 0.785 0 C-N-CA 124.004 0.922 . . . . 0.0 113.008 -178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -129.04 130.89 47.16 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.649 1.58 . . . . 0.0 111.44 -173.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -106.02 142.73 35.23 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.48 -0.762 . . . . 0.0 109.442 169.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.5 t -138.14 139.54 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.492 1.117 . . . . 0.0 110.354 -170.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.58 133.24 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -169.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.6 mmt85 -132.58 79.06 1.83 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.884 1.674 . . . . 0.0 109.664 171.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.5 mt -96.37 132.16 27.11 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 124.188 0.995 . . . . 0.0 109.329 172.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.59 131.02 26.49 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.174 1.916 . . . . 0.0 111.499 175.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.2 2.6 80.11 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 116.201 1.241 . . . . 0.0 116.201 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -137.99 155.83 74.4 Favored Pre-proline 0 N--CA 1.475 0.81 0 CA-C-N 119.246 1.523 . . . . 0.0 111.907 172.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.91 151.41 78.14 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.682 2.255 . . . . 0.0 113.044 -173.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 p -59.15 131.67 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.403 1.081 . . . . 0.0 111.249 172.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.3 t -109.53 138.25 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.313 1.445 . . . . 0.0 109.099 170.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -132.72 116.3 16.43 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.247 1.419 . . . . 0.0 108.804 176.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.6 t -93.12 152.02 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.439 1.495 . . . . 0.0 111.186 -175.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.25 -97.44 1.42 Allowed Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.694 -0.629 . . . . 0.0 111.558 176.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.2 m -146.53 149.7 34.11 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.42 1.088 . . . . 0.0 109.604 177.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.2 tttp -70.47 127.33 92.15 Favored Pre-proline 0 CA--C 1.547 0.84 0 O-C-N 120.628 -1.295 . . . . 0.0 110.485 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.64 154.83 39.82 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 124.026 3.151 . . . . 0.0 114.739 -173.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.1 t -83.19 -23.25 32.93 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -169.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.37 -35.45 3.61 Favored Glycine 0 N--CA 1.475 1.261 0 C-N-CA 125.545 1.545 . . . . 0.0 113.026 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -78.43 59.25 2.33 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.87 1.668 . . . . 0.0 111.267 169.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.0 m -132.93 158.2 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.949 1.7 . . . . 0.0 112.299 -174.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.4 mt -89.73 144.04 26.31 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 126.505 1.922 . . . . 0.0 109.425 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -123.29 114.03 19.68 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.074 0.549 . . . . 0.0 112.376 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.31 144.16 17.13 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 169.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -153.73 138.31 16.88 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 120.504 2.152 . . . . 0.0 113.559 -169.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.05 166.26 26.63 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.022 1.329 . . . . 0.0 113.782 -176.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.0 m -120.03 130.56 54.77 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.62 1.568 . . . . 0.0 108.454 173.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.93 177.29 39.94 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.11 0.862 . . . . 0.0 114.346 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -84.36 -14.09 50.49 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -169.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -93.76 4.52 53.81 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.871 1.669 . . . . 0.0 112.124 169.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.92 15.98 43.37 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.583 2.039 . . . . 0.0 114.106 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.9 pm0 -79.8 172.64 13.51 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.522 1.529 . . . . 0.0 113.573 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.5 m -130.22 137.36 50.0 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.37 1.468 . . . . 0.0 109.834 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.3 t -120.28 138.01 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.731 1.612 . . . . 0.0 109.605 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 15.6 tp -128.35 149.47 50.5 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.33 1.452 . . . . 0.0 109.539 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 75.2 t -132.09 133.73 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.246 1.818 . . . . 0.0 107.871 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -133.69 137.46 45.32 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.226 0.536 . . . . 0.0 112.395 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -151.95 155.03 33.41 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 123.835 0.854 . . . . 0.0 112.624 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -60.14 138.82 84.0 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.118 2.546 . . . . 0.0 113.906 -173.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 . . . . . 0 C--O 1.252 1.204 0 C-N-CA 126.162 1.785 . . . . 0.0 112.746 -178.598 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 . . . . . 0 CA--C 1.547 0.833 0 N-CA-C 111.35 0.13 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -35.2 73.49 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 121.228 -0.92 . . . . 0.0 113.006 -174.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.6 m -62.96 -20.71 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -69.73 -45.4 68.24 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 119.196 0.907 . . . . 0.0 112.07 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.92 -42.68 72.98 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.319 -0.863 . . . . 0.0 111.623 -170.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -60.74 -35.8 77.29 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.504 1.122 . . . . 0.0 112.168 171.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.2 -39.94 74.89 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 120.887 -1.133 . . . . 0.0 112.67 174.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.3 t -63.85 -40.79 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.961 0.905 . . . . 0.0 110.946 172.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.4 tmm_? -63.41 -40.17 96.49 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.245 -0.91 . . . . 0.0 112.0 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 mp -63.24 -34.37 77.51 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 117.276 -1.345 . . . . 0.0 112.423 170.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.71 -32.57 67.53 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 121.173 1.806 . . . . 0.0 111.339 169.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.0 m -75.08 -35.08 61.84 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 170.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.1 mm -70.57 -36.48 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 119.929 1.24 . . . . 0.0 110.709 176.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.8 t -66.99 -46.43 84.83 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.419 0 C-N-CA 125.681 1.592 . . . . 0.0 110.402 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -52.53 -42.54 64.47 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.742 1.61 . . . . 0.0 111.847 170.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.7 m -61.0 -29.31 69.62 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 175.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -83.22 -33.9 26.0 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.862 1.665 . . . . 0.0 113.679 171.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.8 mt -66.06 -35.81 81.52 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 120.033 1.288 . . . . 0.0 111.568 173.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 88.6 mt -73.19 -35.42 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.502 1.121 . . . . 0.0 110.662 169.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.14 -38.6 54.57 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 125.596 1.57 . . . . 0.0 114.752 -172.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.1 t -154.48 -26.99 0.12 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.17 4.03 38.48 Favored Glycine 0 N--CA 1.479 1.556 0 N-CA-C 116.721 1.448 . . . . 0.0 116.721 175.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.9 p -158.21 140.5 14.27 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.42 1.488 . . . . 0.0 111.488 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 81.0 t -94.43 143.69 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.29 1.436 . . . . 0.0 110.556 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -124.43 157.46 35.13 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.018 1.327 . . . . 0.0 110.427 171.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -53.87 -38.35 64.63 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.394 -0.816 . . . . 0.0 112.734 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -66.97 -22.44 65.93 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.169 1.388 . . . . 0.0 113.676 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -78.12 -37.64 45.72 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.288 0.495 . . . . 0.0 111.943 171.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.2 mt -88.04 -27.73 21.82 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 -173.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.0 ptt85 -58.16 -27.53 63.9 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -88.81 5.91 41.43 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 173.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -128.08 -8.97 5.38 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 120.572 -1.33 . . . . 0.0 113.966 -170.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.474 0.773 0 C-N-CA 124.784 1.233 . . . . 0.0 112.091 174.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.466 0.352 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -130.27 127.33 39.33 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.195 0.598 . . . . 0.0 111.812 -170.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -103.45 145.95 29.23 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.182 -0.949 . . . . 0.0 109.864 169.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.6 t -139.61 139.27 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 O-C-N 121.085 -1.009 . . . . 0.0 111.505 -170.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.2 mm -111.81 132.28 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.468 1.507 . . . . 0.0 113.519 -172.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.5 tpt85 -140.8 46.49 1.77 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.324 1.849 . . . . 0.0 110.423 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.2 mt -66.67 127.46 93.42 Favored Pre-proline 0 N--CA 1.481 1.083 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.054 170.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -58.63 135.41 67.19 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.978 2.452 . . . . 0.0 112.741 173.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.93 1.25 88.92 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-O 118.506 -1.163 . . . . 0.0 115.506 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -135.62 162.43 57.13 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 119.461 1.63 . . . . 0.0 113.921 173.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -61.92 142.85 94.53 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.603 2.869 . . . . 0.0 114.596 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.1 p -68.45 130.4 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.685 0.794 . . . . 0.0 110.285 169.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.8 p -123.39 147.31 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.036 1.334 . . . . 0.0 110.972 171.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -135.86 119.37 16.97 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.938 1.695 . . . . 0.0 108.948 -170.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 50.7 t -90.25 155.28 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 126.05 1.74 . . . . 0.0 111.701 -173.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.58 -88.95 1.03 Allowed Glycine 0 CA--C 1.533 1.192 0 O-C-N 121.429 -0.794 . . . . 0.0 112.761 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 85.3 m -154.25 154.2 33.04 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.164 1.386 . . . . 0.0 109.479 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -73.37 125.24 90.89 Favored Pre-proline 0 CA--C 1.547 0.839 0 O-C-N 120.561 -1.337 . . . . 0.0 110.779 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.84 155.19 43.68 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 124.036 3.157 . . . . 0.0 114.529 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.4 t -83.84 -27.98 28.35 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -169.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.73 -34.64 2.82 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 125.27 1.414 . . . . 0.0 113.36 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -79.1 60.48 2.99 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.877 1.671 . . . . 0.0 111.185 169.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.7 m -136.87 156.45 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.736 1.614 . . . . 0.0 112.525 -171.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 29.2 mt -94.36 133.55 37.81 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.309 2.243 . . . . 0.0 109.481 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -118.03 113.47 21.69 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -173.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -88.79 148.91 20.63 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.174 1.369 . . . . 0.0 110.616 169.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 68.5 mtt85 -145.92 159.38 43.3 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 119.23 1.515 . . . . 0.0 112.408 -175.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -164.82 167.23 19.01 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.499 1.12 . . . . 0.0 113.657 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.2 m -119.59 134.12 55.36 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.079 1.752 . . . . 0.0 108.002 169.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -97.49 177.73 32.25 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-O 122.025 0.792 . . . . 0.0 114.966 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -81.33 -12.13 59.12 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -169.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -101.78 4.98 40.97 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.656 1.571 . . . . 0.0 112.099 169.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.03 17.13 33.23 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 126.214 1.864 . . . . 0.0 114.384 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.1 pm0 -78.61 173.14 12.74 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.704 1.602 . . . . 0.0 113.726 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 95.5 m -130.75 135.14 47.5 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.453 1.101 . . . . 0.0 109.366 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 74.5 t -120.17 143.79 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.491 1.516 . . . . 0.0 110.822 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.6 tp -134.08 151.15 51.27 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.853 1.661 . . . . 0.0 109.151 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.2 t -140.86 139.38 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.884 1.673 . . . . 0.0 108.154 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -134.11 134.89 42.78 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.69 0.757 . . . . 0.0 112.304 -176.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -129.81 147.23 64.59 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 126.033 1.733 . . . . 0.0 111.194 -176.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -61.06 133.07 45.05 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.428 2.085 . . . . 0.0 111.394 171.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 . . . . . 0 C--O 1.253 1.263 0 C-N-CA 124.741 1.217 . . . . 0.0 112.358 -179.962 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.424 HH21 ' CD ' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -62.06 -36.9 83.03 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 120.91 -1.119 . . . . 0.0 112.787 -174.095 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.4 m -60.57 -24.37 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.434 0.693 . . . . 0.0 112.832 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -70.99 -38.7 72.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.122 0.874 . . . . 0.0 111.383 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.1 mt -71.63 -42.12 67.99 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.014 0.926 . . . . 0.0 111.717 -172.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.424 ' CD ' HH21 ' A' ' 14' ' ' ARG . 4.1 pt-20 -66.31 -32.61 74.12 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.091 0.956 . . . . 0.0 112.506 169.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.8 -37.78 88.76 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.749 -1.219 . . . . 0.0 112.299 170.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.8 t -69.63 -36.34 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.368 1.067 . . . . 0.0 111.748 172.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -60.37 -44.88 95.19 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.784 -1.197 . . . . 0.0 111.132 170.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.7 mp -67.55 -34.06 76.31 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-O 117.469 -1.253 . . . . 0.0 112.624 173.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.83 -34.56 69.81 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 121.167 1.803 . . . . 0.0 110.808 169.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.0 m -72.3 -38.32 68.76 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.177 0.991 . . . . 0.0 113.253 170.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.1 mm -72.91 -35.73 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 120.88 1.673 . . . . 0.0 111.112 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.0 t -66.73 -48.5 79.85 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.519 0 CA-C-O 117.387 -1.292 . . . . 0.0 109.221 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -53.25 -42.98 66.99 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 120.997 1.726 . . . . 0.0 112.273 171.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.6 m -60.52 -33.01 72.01 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.713 -0.617 . . . . 0.0 112.291 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -78.88 -35.11 44.18 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.669 1.587 . . . . 0.0 113.323 172.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.3 mt -66.46 -32.4 73.74 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.713 1.142 . . . . 0.0 111.723 174.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 92.2 mt -76.41 -35.92 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.908 1.283 . . . . 0.0 111.054 169.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.14 -38.57 46.92 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 125.474 1.511 . . . . 0.0 114.875 -172.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.5 t -151.34 -28.32 0.19 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 177.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.67 8.53 34.68 Favored Glycine 0 N--CA 1.475 1.278 0 N-CA-C 116.748 1.459 . . . . 0.0 116.748 174.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.2 m -157.14 145.25 19.31 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.55 1.54 . . . . 0.0 110.234 171.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.6 p -112.45 144.36 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.794 1.238 . . . . 0.0 110.634 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -129.68 159.9 35.03 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.023 1.329 . . . . 0.0 110.325 -173.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -52.97 -38.4 62.11 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -174.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -73.4 -15.73 61.35 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -87.33 -18.82 29.23 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.162 0.892 . . . . 0.0 112.617 171.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 76.5 mt -99.29 -32.49 11.16 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.91 1.684 . . . . 0.0 113.789 -176.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -61.19 -21.06 63.46 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 119.721 1.146 . . . . 0.0 114.082 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -83.77 -1.44 54.24 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.087 1.355 . . . . 0.0 113.558 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -118.41 -21.63 7.97 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.688 1.195 . . . . 0.0 113.611 -169.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.475 0.823 0 C-N-CA 124.09 0.956 . . . . 0.0 112.576 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.2 tpt85 . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -130.69 135.31 47.71 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.919 1.688 . . . . 0.0 111.314 -174.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -113.77 142.47 46.01 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 119.201 0.91 . . . . 0.0 109.928 168.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.9 t -140.25 138.32 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.536 1.134 . . . . 0.0 110.009 -169.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -124.24 136.68 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -172.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -131.16 89.23 2.7 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.955 1.702 . . . . 0.0 109.084 169.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.8 mt -101.35 134.88 20.03 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 124.696 1.198 . . . . 0.0 109.507 173.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.19 132.15 32.98 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.172 1.914 . . . . 0.0 111.671 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.01 -0.93 79.75 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.8 1.191 . . . . 0.0 115.79 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -137.55 155.82 75.15 Favored Pre-proline 0 N--CA 1.476 0.827 0 CA-C-N 119.336 1.568 . . . . 0.0 112.276 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.27 148.62 68.62 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.724 2.283 . . . . 0.0 112.618 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.2 p -55.66 135.92 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.282 1.033 . . . . 0.0 111.243 170.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.69 145.81 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.781 1.232 . . . . 0.0 110.904 170.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -132.92 125.54 30.09 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.294 1.437 . . . . 0.0 110.059 -174.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.6 t -95.96 149.17 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.818 1.647 . . . . 0.0 110.382 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.03 -98.94 1.36 Allowed Glycine 0 CA--C 1.532 1.113 0 O-C-N 121.486 -0.759 . . . . 0.0 112.116 175.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.4 m -153.83 146.07 23.84 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.665 1.232 . . . . 0.0 110.832 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -68.31 125.22 91.36 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 121.049 -1.032 . . . . 0.0 111.444 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -81.72 162.8 18.83 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.122 3.214 . . . . 0.0 115.053 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.6 t -102.85 -31.8 10.1 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 116.793 2.146 . . . . 0.0 116.793 -168.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.49 -29.93 1.17 Allowed Glycine 0 N--CA 1.478 1.464 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.0 p30 -85.46 55.97 3.75 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 122.557 1.17 . . . . 0.0 110.157 169.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.9 m -133.74 157.12 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.561 1.544 . . . . 0.0 111.195 -177.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 67.9 mt -87.88 153.08 21.6 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.707 2.003 . . . . 0.0 109.005 169.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -128.84 115.01 17.25 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.124 0.42 . . . . 0.0 111.26 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.83 141.27 15.46 Favored Glycine 0 N--CA 1.468 0.786 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 169.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -149.36 145.26 26.91 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 119.768 1.784 . . . . 0.0 112.953 -169.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.03 160.88 43.03 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.172 0.989 . . . . 0.0 113.521 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.6 m -113.36 125.95 54.83 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.099 1.36 . . . . 0.0 109.063 171.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.58 178.58 45.79 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.215 0.912 . . . . 0.0 115.001 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -84.21 -11.91 55.72 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 -169.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -96.93 3.39 52.11 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 120.573 1.533 . . . . 0.0 111.803 169.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.65 18.83 29.04 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 126.418 1.961 . . . . 0.0 114.379 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.8 pm0 -84.28 171.86 12.35 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.642 1.577 . . . . 0.0 114.558 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 90.9 m -125.7 133.27 52.19 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.962 1.305 . . . . 0.0 110.198 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.1 t -117.26 142.13 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.705 1.602 . . . . 0.0 109.805 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.5 tp -134.03 148.17 51.05 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.066 1.346 . . . . 0.0 110.878 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.4 t -134.12 135.76 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.92 2.088 . . . . 0.0 108.029 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -138.52 137.81 37.44 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.988 0.813 . . . . 0.0 112.958 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -153.17 153.96 30.22 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.215 1.006 . . . . 0.0 113.344 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -63.77 141.87 80.52 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.102 2.535 . . . . 0.0 114.452 -171.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 . . . . . 0 C--O 1.253 1.263 0 C-N-CA 127.109 2.163 . . . . 0.0 113.45 -173.755 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 . . . . . 0 CA--C 1.543 0.706 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.46 -38.26 77.16 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 121.273 -0.892 . . . . 0.0 112.689 -173.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.7 m -61.19 -22.33 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 123.864 0.727 . . . . 0.0 112.711 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -68.85 -43.65 75.01 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 119.258 0.935 . . . . 0.0 112.369 175.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.66 -41.55 71.94 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.335 -0.853 . . . . 0.0 111.466 -171.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -64.34 -32.51 74.15 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.531 1.133 . . . . 0.0 112.519 171.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.19 -39.33 82.51 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.707 -1.246 . . . . 0.0 112.468 171.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.1 t -65.32 -41.12 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.783 0.833 . . . . 0.0 111.116 172.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -57.85 -42.01 83.55 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.42 -0.8 . . . . 0.0 111.844 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.46 -33.8 73.44 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 117.583 -1.198 . . . . 0.0 113.31 173.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.97 -33.87 65.18 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 120.856 1.662 . . . . 0.0 111.24 169.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.6 m -73.06 -37.64 66.75 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 170.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.6 mm -72.05 -33.71 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 120.975 1.716 . . . . 0.0 110.792 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.4 t -69.25 -46.73 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.599 1.16 . . . . 0.0 109.748 175.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -53.44 -42.99 67.69 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.693 1.588 . . . . 0.0 112.044 170.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.8 m -60.43 -29.81 69.23 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.779 -0.576 . . . . 0.0 112.27 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -82.2 -35.17 28.57 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.81 1.644 . . . . 0.0 113.514 172.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.7 mt -65.87 -34.92 79.26 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.897 1.226 . . . . 0.0 111.578 174.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 91.8 mt -73.75 -36.32 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.731 1.212 . . . . 0.0 110.828 169.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.08 -37.73 55.68 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 125.557 1.551 . . . . 0.0 114.682 -172.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.5 t -154.23 -26.96 0.13 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.4 9.46 35.95 Favored Glycine 0 N--CA 1.478 1.463 0 N-CA-C 116.565 1.386 . . . . 0.0 116.565 175.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.3 m -158.79 142.73 15.35 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.788 1.635 . . . . 0.0 110.095 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -107.38 146.73 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.733 1.213 . . . . 0.0 110.676 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -130.1 160.2 34.46 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.473 1.509 . . . . 0.0 109.965 -177.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -54.61 -37.5 65.66 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.647 -0.658 . . . . 0.0 112.724 -175.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -66.21 -21.87 66.32 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.706 1.202 . . . . 0.0 113.561 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -92.66 5.92 49.28 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.751 1.22 . . . . 0.0 112.964 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.5 mt -127.65 -26.49 2.97 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.7 ptt85 -62.83 -23.09 67.11 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 120.219 -1.55 . . . . 0.0 114.565 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.94 -5.09 57.09 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.686 1.594 . . . . 0.0 112.611 173.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -107.72 -22.89 12.31 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.263 1.825 . . . . 0.0 111.561 -169.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.47 0.531 0 C-N-CA 124.691 1.197 . . . . 0.0 111.36 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.467 0.388 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.557 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -131.69 133.26 44.67 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.195 0.598 . . . . 0.0 112.07 -170.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.46 141.72 39.9 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.535 -0.728 . . . . 0.0 109.587 169.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.9 t -137.55 141.68 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.655 1.182 . . . . 0.0 110.191 -171.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.91 132.01 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -169.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -130.93 77.3 1.78 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.906 1.682 . . . . 0.0 109.857 171.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.4 mt -95.49 127.98 39.89 Favored Pre-proline 0 N--CA 1.478 0.97 0 O-C-N 121.262 -0.899 . . . . 0.0 109.159 171.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.91 134.17 58.45 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.46 2.107 . . . . 0.0 112.682 173.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.07 0.12 87.29 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 124.838 1.209 . . . . 0.0 116.017 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -137.1 157.21 74.93 Favored Pre-proline 0 CA--C 1.548 0.883 0 CA-C-N 119.232 1.516 . . . . 0.0 112.154 173.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -70.12 151.03 66.82 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.783 2.322 . . . . 0.0 113.057 -174.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.9 p -58.29 132.48 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.296 1.038 . . . . 0.0 111.467 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 86.6 t -110.94 142.01 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.593 1.557 . . . . 0.0 109.096 170.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -135.63 118.0 15.7 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.12 1.368 . . . . 0.0 109.115 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.7 t -92.57 153.7 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.286 1.834 . . . . 0.0 111.169 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.48 -101.71 1.42 Allowed Glycine 0 CA--C 1.533 1.157 0 O-C-N 121.321 -0.862 . . . . 0.0 112.472 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.4 m -144.29 147.89 34.11 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.388 1.075 . . . . 0.0 109.946 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -70.37 125.64 92.06 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 120.687 -1.258 . . . . 0.0 111.031 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -77.42 155.15 32.11 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 124.052 3.168 . . . . 0.0 114.824 -174.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.5 t -85.19 -31.35 23.26 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -169.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 133.51 -36.74 2.09 Favored Glycine 0 N--CA 1.478 1.467 0 C-N-CA 125.05 1.309 . . . . 0.0 112.321 -173.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -78.8 63.13 3.47 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.464 1.506 . . . . 0.0 110.101 169.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.98 151.83 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.506 1.523 . . . . 0.0 111.976 -176.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.9 mt -85.78 141.39 29.71 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.952 2.101 . . . . 0.0 109.122 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -121.43 110.35 15.96 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.366 0.53 . . . . 0.0 112.129 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.14 143.16 17.25 Favored Glycine 0 N--CA 1.467 0.755 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 169.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -153.68 134.83 14.02 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.886 1.843 . . . . 0.0 113.003 -169.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -142.63 161.44 38.08 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.503 1.121 . . . . 0.0 113.704 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.5 m -112.45 127.98 56.19 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.853 1.261 . . . . 0.0 108.72 171.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.18 174.51 40.42 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.206 0.908 . . . . 0.0 114.986 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -79.88 -11.41 59.81 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 -169.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -101.07 4.88 42.65 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 120.744 1.611 . . . . 0.0 112.355 169.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.67 17.4 30.9 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 126.031 1.777 . . . . 0.0 114.355 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.2 pm0 -83.79 172.98 11.67 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.792 1.637 . . . . 0.0 113.791 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.6 m -126.86 131.43 51.19 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.27 1.428 . . . . 0.0 109.681 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.1 t -113.68 141.02 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.624 1.57 . . . . 0.0 110.067 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.6 tp -129.89 148.23 51.74 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.087 1.355 . . . . 0.0 109.864 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.8 t -133.37 136.79 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.08 1.752 . . . . 0.0 108.317 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -131.68 131.99 43.57 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.783 0.801 . . . . 0.0 111.934 -176.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -131.84 148.31 69.41 Favored Pre-proline 0 N--CA 1.473 0.691 0 C-N-CA 126.163 1.785 . . . . 0.0 111.065 -173.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -61.39 134.91 54.38 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.87 2.38 . . . . 0.0 112.529 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 125.744 1.618 . . . . 0.0 112.438 177.479 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 . . . . . 0 N--CA 1.473 0.687 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -31.34 71.84 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -173.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.6 m -68.07 -21.46 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 172.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -71.17 -42.9 68.49 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 120.699 -1.251 . . . . 0.0 112.209 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.88 -39.1 76.49 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.386 -0.821 . . . . 0.0 111.301 -171.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.07 -28.83 65.75 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.721 1.208 . . . . 0.0 112.818 173.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.98 -39.76 87.26 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.764 -1.21 . . . . 0.0 111.381 169.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.4 t -67.92 -36.1 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.107 0.963 . . . . 0.0 111.538 174.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -59.26 -46.28 88.94 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.224 -0.923 . . . . 0.0 111.095 170.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.2 mp -69.07 -35.44 76.52 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 117.093 -1.432 . . . . 0.0 113.099 175.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.07 -38.69 68.38 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 121.066 1.757 . . . . 0.0 110.235 169.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.7 m -67.95 -38.82 83.26 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.152 0.981 . . . . 0.0 113.523 172.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.9 mm -72.35 -35.11 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 120.72 1.6 . . . . 0.0 110.748 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.2 t -68.82 -43.82 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.374 1.469 . . . . 0.0 110.235 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -56.54 -40.03 74.43 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 121.126 1.784 . . . . 0.0 112.34 169.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -62.79 -23.96 67.5 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 174.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -85.84 -36.86 19.75 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.295 1.838 . . . . 0.0 112.987 171.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.5 mt -68.92 -40.29 79.15 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 120.093 1.315 . . . . 0.0 111.984 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 86.2 mt -69.37 -32.18 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.457 1.503 . . . . 0.0 110.958 174.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.95 -75.34 0.77 Allowed Glycine 0 C--N 1.338 0.694 0 C-N-CA 125.36 1.457 . . . . 0.0 111.359 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.6 t -118.5 -26.73 6.12 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -170.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.61 0.74 46.41 Favored Glycine 0 N--CA 1.475 1.252 0 N-CA-C 116.972 1.549 . . . . 0.0 116.972 171.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.7 m -147.79 134.64 20.11 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.097 1.759 . . . . 0.0 109.956 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.5 p -104.86 147.92 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.04 1.336 . . . . 0.0 110.918 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -133.05 160.74 36.28 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.302 1.441 . . . . 0.0 110.702 -175.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -58.0 -37.7 74.74 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.745 -0.597 . . . . 0.0 111.899 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.73 -23.5 63.4 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.069 0.948 . . . . 0.0 113.187 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -77.79 -27.39 50.16 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.799 0.727 . . . . 0.0 112.16 174.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 72.3 mt -97.7 -28.1 14.05 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.587 1.555 . . . . 0.0 114.687 -173.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.2 ptt85 -62.03 -23.36 66.41 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 119.974 1.261 . . . . 0.0 113.702 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -88.23 5.97 39.08 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.314 1.446 . . . . 0.0 114.456 171.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -119.09 -15.04 9.29 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.947 1.249 . . . . 0.0 113.061 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.472 0.669 0 C-N-CA 123.74 0.816 . . . . 0.0 112.202 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 . . . . . 0 N--CA 1.475 0.79 0 CA-C-O 119.548 -0.263 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -132.58 131.72 41.77 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.008 1.323 . . . . 0.0 111.742 -176.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -104.81 144.6 31.54 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 119.784 1.174 . . . . 0.0 110.659 169.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 37.4 t -140.8 141.18 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.445 1.098 . . . . 0.0 111.821 -169.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 mm -118.06 140.16 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.801 1.24 . . . . 0.0 114.13 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -139.89 72.69 1.4 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 128.098 2.559 . . . . 0.0 109.537 169.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.0 mt -91.73 127.77 48.83 Favored Pre-proline 0 N--CA 1.484 1.241 0 O-C-N 121.009 -1.057 . . . . 0.0 109.898 172.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -60.77 136.41 66.22 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.995 2.463 . . . . 0.0 112.9 171.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.23 2.11 89.34 Favored Glycine 0 CA--C 1.536 1.367 0 N-CA-C 115.912 1.125 . . . . 0.0 115.912 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -139.79 157.35 69.95 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 118.901 1.351 . . . . 0.0 111.877 174.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.01 143.78 73.62 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.426 2.084 . . . . 0.0 112.956 -176.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.57 135.5 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.256 1.422 . . . . 0.0 110.945 172.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.2 p -129.37 142.65 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.798 0.839 . . . . 0.0 111.891 171.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -140.11 123.47 16.98 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.409 1.083 . . . . 0.0 110.099 -173.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.5 t -95.5 155.2 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 127.015 2.126 . . . . 0.0 111.128 -172.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.26 -96.56 1.12 Allowed Glycine 0 CA--C 1.53 1.009 0 O-C-N 121.087 -1.008 . . . . 0.0 112.536 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.0 m -155.97 155.39 32.68 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.174 0.99 . . . . 0.0 110.211 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -68.96 132.17 90.55 Favored Pre-proline 0 CA--C 1.546 0.803 0 O-C-N 120.93 -1.106 . . . . 0.0 110.425 171.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.65 160.76 34.51 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 124.18 3.253 . . . . 0.0 114.121 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.6 t -85.7 -28.36 24.72 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -173.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.68 -32.83 3.24 Favored Glycine 0 N--CA 1.478 1.44 0 C-N-CA 125.644 1.592 . . . . 0.0 112.709 -176.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -77.44 60.2 2.02 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.403 1.881 . . . . 0.0 111.114 169.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.0 m -138.51 155.05 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.273 1.429 . . . . 0.0 113.177 -172.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.5 mt -91.03 142.4 27.81 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 128.029 2.532 . . . . 0.0 109.092 171.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -126.42 112.62 15.83 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.753 0.706 . . . . 0.0 111.311 -176.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.53 149.88 19.44 Favored Glycine 0 N--CA 1.469 0.871 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 169.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -147.19 148.56 31.63 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 118.656 1.228 . . . . 0.0 112.099 -169.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.3 166.33 33.76 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.412 1.085 . . . . 0.0 112.865 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.6 m -132.49 123.11 25.97 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.325 1.45 . . . . 0.0 109.634 172.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.62 176.43 42.44 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.0 1.286 . . . . 0.0 113.651 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -49.13 -45.0 42.97 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 126.347 1.859 . . . . 0.0 111.775 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -83.39 3.58 31.22 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 -170.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.65 25.38 13.6 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.666 0.651 . . . . 0.0 113.298 173.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.39 -166.01 1.49 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.656 1.182 . . . . 0.0 113.914 -174.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 16.6 m -147.39 120.27 8.72 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.318 -1.489 . . . . 0.0 111.611 173.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 37.1 t -96.64 142.25 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 126.246 1.819 . . . . 0.0 108.998 169.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.5 tp -129.91 146.74 51.62 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.356 1.463 . . . . 0.0 108.975 169.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 p -133.86 142.07 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.02 1.328 . . . . 0.0 109.663 172.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -137.08 134.39 36.44 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.162 0.506 . . . . 0.0 111.825 -170.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -131.72 152.8 81.0 Favored Pre-proline 0 N--CA 1.473 0.714 0 C-N-CA 124.954 1.301 . . . . 0.0 112.524 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -56.91 137.56 82.26 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 122.641 2.227 . . . . 0.0 112.933 170.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 . . . . . 0 C--O 1.252 1.223 0 C-N-CA 125.798 1.639 . . . . 0.0 112.279 177.522 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -59.9 -32.44 70.76 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -172.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.3 m -64.94 -21.81 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 174.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -67.94 -43.22 79.6 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 120.878 -1.139 . . . . 0.0 112.837 176.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mp -70.62 -41.68 71.92 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.444 -0.785 . . . . 0.0 111.816 -171.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.15 -30.92 71.97 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.364 1.066 . . . . 0.0 112.64 172.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.41 -36.97 79.88 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.925 -1.109 . . . . 0.0 112.447 171.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.4 t -69.87 -36.23 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 124.175 0.99 . . . . 0.0 111.376 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -58.37 -46.07 87.02 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.314 -0.866 . . . . 0.0 111.23 171.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.1 mp -70.05 -34.13 72.83 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-O 117.321 -1.323 . . . . 0.0 113.195 173.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.18 -34.86 68.9 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 121.365 1.893 . . . . 0.0 110.586 169.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.1 m -71.23 -41.53 70.03 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.301 1.04 . . . . 0.0 112.806 171.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.4 mm -70.66 -35.08 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 120.623 1.556 . . . . 0.0 111.201 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.3 t -65.11 -47.44 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.026 1.33 . . . . 0.0 109.99 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -52.97 -42.64 65.71 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.607 1.549 . . . . 0.0 112.124 171.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.3 t -59.33 -38.12 79.51 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.788 -0.57 . . . . 0.0 111.95 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.2 tpt180 -72.47 -37.25 68.52 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.47 1.108 . . . . 0.0 113.367 172.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.6 mt -67.31 -32.35 73.27 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.877 1.217 . . . . 0.0 112.182 176.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 89.8 mt -74.15 -37.86 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 124.523 1.129 . . . . 0.0 110.826 169.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.1 -38.58 54.89 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 125.862 1.696 . . . . 0.0 114.52 -172.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.1 t -150.17 -30.52 0.21 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.29 4.47 35.24 Favored Glycine 0 N--CA 1.475 1.283 0 N-CA-C 117.105 1.602 . . . . 0.0 117.105 176.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.8 p -152.92 141.57 20.92 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.45 1.5 . . . . 0.0 111.34 177.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.5 t -99.67 139.19 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.124 1.37 . . . . 0.0 110.383 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -123.07 155.08 37.62 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.918 1.287 . . . . 0.0 109.806 174.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -54.76 -38.3 67.04 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.296 -0.878 . . . . 0.0 113.317 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -67.38 -17.69 64.83 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -85.11 -22.26 28.96 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 118.539 -0.743 . . . . 0.0 112.648 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.1 mt -97.6 -31.37 12.34 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.34 1.427 . . . . 0.0 114.439 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -58.88 -24.28 62.01 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -93.76 7.54 44.48 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.101 1.361 . . . . 0.0 113.456 174.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -127.62 -16.05 4.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.681 1.592 . . . . 0.0 113.246 -174.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.479 0.978 0 CA-C-N 119.125 0.875 . . . . 0.0 110.906 169.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.537 0 CA-C-O 119.245 -0.407 . . . . 0.0 111.77 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -130.64 126.89 37.77 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.296 0.638 . . . . 0.0 111.107 -170.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.71 148.69 27.15 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.98 -1.075 . . . . 0.0 110.127 169.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.2 t -141.0 140.81 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.897 1.279 . . . . 0.0 110.717 -171.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -118.55 133.44 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.986 1.314 . . . . 0.0 113.576 -170.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -131.88 79.61 1.88 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.738 1.615 . . . . 0.0 109.381 169.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.5 mt -96.91 123.65 52.78 Favored Pre-proline 0 N--CA 1.479 0.991 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 173.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.86 132.51 50.22 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.407 2.071 . . . . 0.0 112.501 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.53 2.57 87.09 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.906 1.241 . . . . 0.0 115.776 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -135.92 162.11 58.71 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-N 119.806 1.803 . . . . 0.0 114.084 171.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -62.94 143.64 91.64 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.481 2.787 . . . . 0.0 114.136 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 p -58.0 133.84 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.775 0.83 . . . . 0.0 110.631 169.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 71.4 t -114.01 141.71 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.765 1.226 . . . . 0.0 109.313 172.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -134.87 119.55 18.22 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.988 1.315 . . . . 0.0 109.554 177.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.4 t -90.39 152.51 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.366 1.466 . . . . 0.0 111.085 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.08 -105.48 2.24 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 121.368 -0.833 . . . . 0.0 112.621 170.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.8 m -145.02 148.87 34.21 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.544 1.137 . . . . 0.0 110.052 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -67.95 128.62 93.34 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 120.598 -1.314 . . . . 0.0 111.298 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -80.18 152.94 21.42 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.264 3.309 . . . . 0.0 114.922 -177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.7 t -82.9 -31.36 27.89 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -169.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.31 -35.03 2.42 Favored Glycine 0 N--CA 1.479 1.544 0 C-N-CA 125.246 1.403 . . . . 0.0 112.458 -174.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -79.44 61.14 3.4 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.306 1.442 . . . . 0.0 109.922 169.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.2 m -138.84 156.33 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.934 1.693 . . . . 0.0 111.398 -175.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.5 mt -91.72 138.61 31.42 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 127.734 2.414 . . . . 0.0 108.869 173.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -119.19 113.25 20.59 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.271 0.487 . . . . 0.0 111.741 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.68 144.68 17.47 Favored Glycine 0 N--CA 1.467 0.722 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 169.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -152.99 138.9 18.06 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.07 1.935 . . . . 0.0 112.853 -169.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.91 164.72 30.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.675 1.19 . . . . 0.0 114.043 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.3 m -119.74 125.21 48.07 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.223 1.409 . . . . 0.0 109.273 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.05 173.95 43.5 Favored Glycine 0 CA--C 1.54 1.653 0 C-N-CA 124.488 1.042 . . . . 0.0 115.26 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -81.59 -12.28 58.81 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -169.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -95.04 2.52 55.28 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 120.333 1.424 . . . . 0.0 112.161 169.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.93 15.03 46.99 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 126.783 2.135 . . . . 0.0 115.077 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 20.4 pm0 -78.68 172.4 13.76 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.992 1.717 . . . . 0.0 113.253 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.6 m -129.49 138.27 51.29 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.597 1.559 . . . . 0.0 110.342 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 88.6 t -122.52 140.27 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.471 1.508 . . . . 0.0 109.957 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.5 tp -128.79 148.35 50.86 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.181 1.392 . . . . 0.0 109.674 173.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.7 t -134.25 136.77 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.79 1.636 . . . . 0.0 108.275 176.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -131.01 129.98 42.75 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 122.031 0.919 . . . . 0.0 111.907 -176.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -130.44 142.25 44.79 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 126.661 1.984 . . . . 0.0 110.501 -171.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -61.89 133.67 45.91 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.435 2.09 . . . . 0.0 112.004 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 70.0 ttp85 . . . . . 0 C--O 1.252 1.211 0 C-N-CA 125.133 1.373 . . . . 0.0 112.33 -179.902 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 . . . . . 0 CA--C 1.546 0.805 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -59.48 -37.9 79.44 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.755 0.822 . . . . 0.0 112.889 -172.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.9 m -60.46 -22.65 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.666 0.786 . . . . 0.0 112.027 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -65.39 -42.94 92.11 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.251 0.932 . . . . 0.0 112.13 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.1 mp -73.86 -41.15 62.63 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.315 -0.866 . . . . 0.0 111.404 -170.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -67.73 -29.19 68.37 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.202 1.001 . . . . 0.0 112.799 171.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.06 -37.76 84.6 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 120.607 -1.308 . . . . 0.0 112.292 169.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.6 t -69.01 -36.15 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.002 0.921 . . . . 0.0 111.417 172.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -60.24 -44.57 95.12 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.12 -0.987 . . . . 0.0 111.421 171.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.0 mp -69.97 -34.18 73.04 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-O 117.343 -1.313 . . . . 0.0 112.673 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.95 -33.44 68.83 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 121.144 1.793 . . . . 0.0 110.883 169.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.1 m -72.25 -38.66 68.85 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.27 1.028 . . . . 0.0 113.432 171.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -74.11 -34.86 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 120.99 1.723 . . . . 0.0 111.073 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.5 t -64.86 -48.3 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.83 1.252 . . . . 0.0 109.62 173.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -54.12 -43.49 70.53 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.764 1.62 . . . . 0.0 112.086 172.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.2 m -59.45 -31.48 69.35 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.636 -0.665 . . . . 0.0 112.407 175.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -80.19 -35.19 36.74 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.715 1.606 . . . . 0.0 113.381 172.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 67.1 mt -66.59 -33.5 75.79 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 120.058 1.299 . . . . 0.0 111.643 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 91.1 mt -73.82 -36.46 46.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.904 1.281 . . . . 0.0 110.777 169.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.99 -38.72 55.62 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 125.632 1.587 . . . . 0.0 114.826 -173.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.2 t -152.5 -26.39 0.17 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.51 11.19 39.15 Favored Glycine 0 N--CA 1.48 1.581 0 N-CA-C 116.234 1.254 . . . . 0.0 116.234 175.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.8 m -157.69 143.4 17.27 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.886 1.674 . . . . 0.0 109.492 173.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.83 145.74 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.135 1.374 . . . . 0.0 109.858 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -130.49 158.77 39.01 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.723 1.209 . . . . 0.0 110.754 -172.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -56.11 -38.72 71.15 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.776 -0.577 . . . . 0.0 112.313 -177.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -70.96 -18.32 62.63 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -78.46 -38.28 41.52 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.211 0.914 . . . . 0.0 111.088 169.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 58.4 mt -87.35 -28.5 22.18 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -169.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -59.73 -21.14 60.28 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 172.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -83.56 -7.68 59.47 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.829 1.251 . . . . 0.0 114.032 174.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -115.46 -14.2 11.57 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.785 1.234 . . . . 0.0 113.302 -169.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.471 0.577 0 C-N-CA 123.486 0.714 . . . . 0.0 111.812 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -130.34 133.98 46.84 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.533 1.533 . . . . 0.0 110.877 -174.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.78 141.75 40.33 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.137 -0.977 . . . . 0.0 109.79 169.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.6 t -136.62 142.39 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.526 1.13 . . . . 0.0 111.024 -173.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.15 134.68 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.89 1.276 . . . . 0.0 114.226 -169.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -138.75 77.99 1.65 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.109 1.764 . . . . 0.0 109.679 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.0 mt -95.89 132.32 27.35 Favored Pre-proline 0 N--CA 1.478 0.947 0 C-N-CA 124.982 1.313 . . . . 0.0 109.523 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.1 134.66 37.58 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.196 1.931 . . . . 0.0 111.545 174.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.82 1.26 85.28 Favored Glycine 0 CA--C 1.536 1.36 0 N-CA-C 116.043 1.177 . . . . 0.0 116.043 177.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -138.78 156.9 72.64 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-N 119.073 1.437 . . . . 0.0 111.954 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.39 150.33 75.79 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.705 2.27 . . . . 0.0 112.969 -174.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 50.7 t -60.44 131.88 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.278 1.031 . . . . 0.0 110.358 173.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 72.4 t -112.62 140.25 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.454 1.502 . . . . 0.0 109.469 173.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -135.07 118.15 16.44 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.037 1.335 . . . . 0.0 109.421 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.7 t -94.62 151.77 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.881 1.672 . . . . 0.0 111.032 -177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.66 -93.5 1.03 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 121.283 -0.886 . . . . 0.0 112.317 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 m -154.74 152.58 30.06 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.669 -0.901 . . . . 0.0 110.463 175.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -69.17 129.4 92.02 Favored Pre-proline 0 CA--C 1.547 0.863 0 O-C-N 120.928 -1.108 . . . . 0.0 110.722 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -78.6 158.71 28.63 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 124.3 3.333 . . . . 0.0 114.602 -176.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.3 t -83.29 -25.19 31.8 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -171.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.59 -34.17 3.71 Favored Glycine 0 N--CA 1.478 1.442 0 C-N-CA 125.713 1.625 . . . . 0.0 112.804 -175.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -79.03 61.36 3.18 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.738 1.615 . . . . 0.0 111.261 169.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.9 m -136.93 158.95 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 126.343 1.857 . . . . 0.0 112.526 -173.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 27.9 mt -92.77 139.41 30.58 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.826 2.051 . . . . 0.0 108.799 172.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -127.55 113.56 16.28 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.101 0.961 . . . . 0.0 110.506 -175.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -97.75 145.4 17.79 Favored Glycine 0 N--CA 1.467 0.727 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -148.01 139.31 23.52 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.763 1.282 . . . . 0.0 112.682 -169.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.24 162.39 36.48 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.609 1.164 . . . . 0.0 113.181 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 74.5 m -114.16 124.65 52.59 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.19 1.396 . . . . 0.0 108.423 172.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.54 173.31 45.63 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-O 122.166 0.87 . . . . 0.0 114.424 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -79.63 -17.35 54.0 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -169.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -92.84 4.81 53.17 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.646 1.566 . . . . 0.0 112.543 169.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.37 16.96 32.93 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 126.136 1.827 . . . . 0.0 114.308 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.9 pm0 -82.92 171.55 13.75 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.471 1.508 . . . . 0.0 114.206 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.5 m -123.14 132.99 54.29 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.66 1.584 . . . . 0.0 109.203 175.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.4 t -127.51 140.68 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.629 1.171 . . . . 0.0 110.155 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.5 tp -133.42 147.66 51.74 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.293 1.037 . . . . 0.0 110.76 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.09 143.28 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.816 1.246 . . . . 0.0 109.565 170.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -137.37 137.5 38.93 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -173.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -132.13 151.27 78.11 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 125.793 1.637 . . . . 0.0 112.432 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -58.68 135.86 70.09 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.405 2.07 . . . . 0.0 111.996 169.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 . . . . . 0 C--O 1.253 1.285 0 C-N-CA 124.938 1.295 . . . . 0.0 112.179 178.614 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 . . . . . 0 CA--C 1.545 0.75 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -37.98 77.68 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 121.294 -0.879 . . . . 0.0 112.732 -173.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 m -62.52 -21.74 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -70.44 -44.06 68.63 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 119.132 0.878 . . . . 0.0 112.146 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.57 -42.26 71.33 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.083 -1.011 . . . . 0.0 111.367 -172.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -63.27 -32.73 74.22 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.395 1.078 . . . . 0.0 112.449 171.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.09 84.04 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.752 -1.217 . . . . 0.0 112.308 171.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.6 t -64.79 -40.33 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.802 0.841 . . . . 0.0 111.071 174.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -57.07 -44.72 83.34 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.536 -0.728 . . . . 0.0 112.145 171.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.9 mp -68.45 -33.91 75.02 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 116.871 -1.538 . . . . 0.0 112.943 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.11 -39.53 69.46 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 121.252 1.842 . . . . 0.0 110.308 169.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.6 m -70.09 -38.25 75.64 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 172.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.9 mm -70.42 -34.21 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 121.181 1.81 . . . . 0.0 110.813 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.2 t -66.57 -48.51 80.17 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 C-N-CA 124.945 1.298 . . . . 0.0 110.092 173.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -54.86 -39.52 68.72 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 121.408 1.913 . . . . 0.0 112.802 171.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.4 m -61.84 -29.08 69.93 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.984 0.514 . . . . 0.0 112.066 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -82.68 -36.78 25.61 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.063 1.745 . . . . 0.0 113.438 171.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.61 -34.2 77.35 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.055 1.298 . . . . 0.0 111.566 175.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 92.0 mt -76.56 -36.7 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 124.618 1.167 . . . . 0.0 110.714 169.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.36 -37.85 53.63 Favored Glycine 0 C--N 1.341 0.849 0 C-N-CA 125.822 1.677 . . . . 0.0 114.698 -171.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.2 t -148.66 -30.44 0.27 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 175.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.78 12.07 27.05 Favored Glycine 0 N--CA 1.473 1.141 0 N-CA-C 116.703 1.441 . . . . 0.0 116.703 174.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.4 m -157.84 143.2 16.93 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.364 1.466 . . . . 0.0 109.736 170.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.2 p -112.36 141.45 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.384 1.474 . . . . 0.0 110.616 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -131.74 159.79 37.42 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.535 1.534 . . . . 0.0 110.45 -172.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -56.2 -38.54 71.14 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.38 -0.825 . . . . 0.0 113.056 -175.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -69.87 -21.77 63.3 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -77.23 -35.52 55.42 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.476 0.58 . . . . 0.0 111.78 169.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 58.8 mt -86.61 -29.19 22.76 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -174.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -61.15 -22.72 64.96 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -91.97 -0.19 57.48 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.271 1.029 . . . . 0.0 113.457 172.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -117.03 -17.37 10.36 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.178 1.391 . . . . 0.0 113.496 -173.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 123.892 0.877 . . . . 0.0 111.08 170.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.468 0.437 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.328 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -129.9 132.97 46.58 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.955 0.502 . . . . 0.0 112.324 -170.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -111.52 141.24 45.35 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.636 -0.665 . . . . 0.0 109.555 168.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.0 t -138.89 138.23 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.681 1.192 . . . . 0.0 109.339 -169.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -120.62 132.83 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -169.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -129.75 84.11 2.19 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.263 1.825 . . . . 0.0 109.254 173.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.1 mt -99.06 134.37 21.44 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 124.208 1.003 . . . . 0.0 108.85 173.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.36 136.35 43.13 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.238 1.959 . . . . 0.0 111.514 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.76 0.28 83.98 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.638 1.113 . . . . 0.0 115.702 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -136.15 157.99 74.58 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 118.95 1.375 . . . . 0.0 112.564 175.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.59 151.75 64.54 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.676 2.251 . . . . 0.0 113.285 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.3 p -54.86 140.87 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.408 1.483 . . . . 0.0 112.328 172.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 85.0 t -116.18 140.81 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 125.864 1.666 . . . . 0.0 108.76 170.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -134.67 119.5 18.38 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.721 1.208 . . . . 0.0 110.12 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.1 t -93.77 154.99 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.716 2.006 . . . . 0.0 110.963 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.81 -105.13 1.67 Allowed Glycine 0 CA--C 1.533 1.203 0 O-C-N 121.216 -0.927 . . . . 0.0 111.521 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.2 t -153.87 161.04 42.35 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.033 0.917 . . . . 0.0 112.089 169.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -71.89 126.38 91.39 Favored Pre-proline 0 CA--C 1.548 0.878 0 O-C-N 120.902 -1.123 . . . . 0.0 111.85 -171.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.54 155.68 24.6 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 124.069 3.18 . . . . 0.0 114.856 -175.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.2 t -83.51 -20.46 33.89 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 115.81 1.781 . . . . 0.0 115.81 -169.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.39 -30.5 6.2 Favored Glycine 0 N--CA 1.479 1.559 0 C-N-CA 125.361 1.457 . . . . 0.0 113.12 -173.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -82.13 60.11 4.75 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.424 1.489 . . . . 0.0 109.351 168.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.4 m -140.94 152.98 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 126.458 1.903 . . . . 0.0 110.381 -175.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.7 mt -79.59 146.43 32.57 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.023 1.729 . . . . 0.0 108.942 169.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -126.75 106.39 9.34 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.877 0.762 . . . . 0.0 109.979 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -88.82 149.4 20.93 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 169.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 33.2 ttt-85 -148.07 143.69 27.36 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.217 1.509 . . . . 0.0 112.013 -170.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -152.66 167.72 27.98 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.373 1.069 . . . . 0.0 113.251 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.0 m -134.09 128.1 33.51 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.708 1.603 . . . . 0.0 109.601 171.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.42 -175.09 49.87 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.6 1.572 . . . . 0.0 114.934 177.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -58.74 -45.38 89.8 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.256 1.422 . . . . 0.0 112.107 177.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -77.71 2.57 16.43 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -172.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.26 23.0 28.11 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.0 1.286 . . . . 0.0 113.465 172.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.11 -163.15 0.95 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.266 1.426 . . . . 0.0 114.111 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.1 m -146.15 128.68 16.03 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.336 -1.478 . . . . 0.0 111.361 175.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.3 t -105.2 142.51 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 126.195 1.798 . . . . 0.0 109.208 169.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.8 tp -129.15 141.49 51.16 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.083 1.353 . . . . 0.0 109.382 169.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.18 136.81 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.524 1.53 . . . . 0.0 108.461 173.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -131.67 130.97 42.74 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.682 0.753 . . . . 0.0 112.048 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -133.54 142.36 43.66 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 125.066 1.346 . . . . 0.0 112.058 -169.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -59.24 130.41 35.96 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.184 2.59 . . . . 0.0 112.533 177.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 67.9 ttp85 . . . . . 0 C--O 1.253 1.258 0 C-N-CA 125.231 1.412 . . . . 0.0 112.356 178.458 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.75 -35.93 81.37 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 117.556 -1.211 . . . . 0.0 113.068 -174.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.8 m -59.9 -25.66 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 119.002 0.819 . . . . 0.0 112.756 172.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -77.45 -35.56 53.83 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.554 0.615 . . . . 0.0 112.56 176.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.8 mt -69.25 -39.87 78.19 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.405 -0.809 . . . . 0.0 110.976 -175.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -68.23 -30.47 69.53 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.041 0.936 . . . . 0.0 112.688 169.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.65 -38.64 89.92 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 120.227 1.376 . . . . 0.0 112.098 170.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.4 t -67.95 -39.74 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.182 0.993 . . . . 0.0 111.429 172.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -58.79 -44.91 90.85 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.211 -0.931 . . . . 0.0 111.277 172.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.2 mp -68.79 -34.9 76.32 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-O 117.13 -1.414 . . . . 0.0 112.678 174.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.38 -34.17 68.58 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 121.504 1.956 . . . . 0.0 110.511 169.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.3 m -72.72 -40.21 66.33 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.256 1.022 . . . . 0.0 113.736 170.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.1 mm -67.8 -37.38 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 120.983 1.719 . . . . 0.0 110.799 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.2 t -64.46 -45.58 95.36 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.376 0 C-N-CA 125.326 1.45 . . . . 0.0 110.241 176.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -51.97 -42.72 63.15 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 120.683 1.583 . . . . 0.0 112.345 171.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 56.5 m -62.05 -31.33 71.73 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.416 -0.803 . . . . 0.0 112.541 175.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -77.92 -37.08 48.58 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.877 1.271 . . . . 0.0 113.181 172.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.8 mt -67.42 -32.84 73.99 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.833 1.197 . . . . 0.0 111.916 176.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.8 mt -73.6 -36.93 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.585 1.154 . . . . 0.0 110.708 169.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.98 -39.17 55.02 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 125.689 1.614 . . . . 0.0 114.689 -172.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.0 t -151.48 -27.05 0.19 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.92 3.86 54.64 Favored Glycine 0 N--CA 1.479 1.54 0 N-CA-C 116.127 1.211 . . . . 0.0 116.127 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.6 m -142.26 132.9 25.38 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.756 1.622 . . . . 0.0 109.874 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.9 t -97.21 140.34 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.5 0.72 . . . . 0.0 109.423 170.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -127.11 156.68 41.35 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.76 1.224 . . . . 0.0 110.611 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -55.74 -36.89 67.76 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 121.303 -0.873 . . . . 0.0 112.557 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -67.55 -21.91 65.43 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.152 1.381 . . . . 0.0 113.73 177.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -78.44 -37.49 43.58 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.395 0.543 . . . . 0.0 111.863 171.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 18.9 mt -88.92 -30.29 18.95 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -172.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -55.89 -27.82 53.78 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -89.3 2.95 53.61 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.928 1.291 . . . . 0.0 114.382 176.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -121.6 -13.81 8.29 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.782 1.233 . . . . 0.0 113.446 -172.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -174.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 111.341 0.126 . . . . 0.0 111.341 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -130.97 120.95 24.27 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.121 1.768 . . . . 0.0 109.262 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.32 143.68 27.84 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.05 -1.032 . . . . 0.0 109.037 168.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.0 t -139.01 139.41 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.15 0.98 . . . . 0.0 110.774 -169.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 mm -114.02 134.03 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.541 1.536 . . . . 0.0 113.815 -169.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -133.67 70.96 1.45 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.232 1.813 . . . . 0.0 109.547 169.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.9 mt -88.08 128.93 51.91 Favored Pre-proline 0 N--CA 1.478 0.97 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.36 134.13 35.0 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.193 1.929 . . . . 0.0 111.287 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.92 3.3 85.68 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 118.533 -1.148 . . . . 0.0 115.962 176.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -137.49 162.9 52.29 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 119.539 1.669 . . . . 0.0 113.944 173.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -59.38 141.52 97.73 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.524 2.816 . . . . 0.0 114.454 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.59 130.18 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.182 0.993 . . . . 0.0 110.311 170.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.6 t -109.94 139.57 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.929 1.292 . . . . 0.0 109.275 172.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -134.41 112.72 11.19 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.838 1.255 . . . . 0.0 108.86 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.6 t -86.56 151.89 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.373 1.469 . . . . 0.0 110.947 -177.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.2 -96.91 1.38 Allowed Glycine 0 CA--C 1.531 1.059 0 O-C-N 121.608 -0.682 . . . . 0.0 112.025 175.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.1 m -150.0 157.41 43.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.52 1.128 . . . . 0.0 110.025 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -69.75 133.99 88.32 Favored Pre-proline 0 CA--C 1.546 0.796 0 O-C-N 120.791 -1.193 . . . . 0.0 110.654 169.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.63 156.01 31.68 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 124.194 3.263 . . . . 0.0 114.342 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.1 t -82.78 -26.32 31.93 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -175.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.02 -35.01 3.38 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 125.629 1.585 . . . . 0.0 113.055 -177.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -77.95 58.59 1.96 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.05 1.74 . . . . 0.0 111.404 169.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.1 m -131.5 159.93 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.549 1.54 . . . . 0.0 113.013 -172.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.1 mt -99.91 119.64 38.53 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 127.562 2.345 . . . . 0.0 110.335 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -106.09 108.3 19.74 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -170.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.55 145.54 17.79 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 169.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.1 ttt-85 -156.93 125.45 5.73 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 120.762 2.281 . . . . 0.0 113.967 -169.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.81 167.39 21.25 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.8 1.24 . . . . 0.0 114.044 -173.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 63.2 m -119.47 132.28 55.76 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.563 1.545 . . . . 0.0 108.15 174.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.59 -179.64 42.08 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 121.881 0.712 . . . . 0.0 114.634 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -86.99 -18.35 30.88 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -169.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -93.11 5.19 52.36 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.398 1.454 . . . . 0.0 112.163 169.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.89 16.12 49.46 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 126.661 2.077 . . . . 0.0 114.113 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.6 pm0 -76.98 178.24 7.11 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.955 1.702 . . . . 0.0 113.087 175.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.8 m -141.19 142.24 34.02 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.417 -1.427 . . . . 0.0 109.93 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 76.9 t -127.54 139.36 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.706 1.602 . . . . 0.0 109.721 -174.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.2 tp -129.1 148.22 51.03 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.154 1.382 . . . . 0.0 109.476 175.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.5 t -127.49 134.72 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.979 2.112 . . . . 0.0 107.414 175.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -135.78 137.21 41.4 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.2 0.6 . . . . 0.0 111.373 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -153.25 155.13 31.59 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 123.827 0.851 . . . . 0.0 112.796 174.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -58.85 134.72 62.14 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.795 2.33 . . . . 0.0 113.53 -176.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 . . . . . 0 C--O 1.253 1.27 0 C-N-CA 125.995 1.718 . . . . 0.0 112.265 176.492 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 . . . . . 0 N--CA 1.475 0.784 0 CA-C-O 120.733 0.301 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.64 -35.15 70.13 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.629 1.172 . . . . 0.0 113.007 -175.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.64 -21.4 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -70.56 -43.23 69.9 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 120.905 -1.122 . . . . 0.0 112.446 177.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.03 -42.08 76.85 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.446 -0.784 . . . . 0.0 111.599 -171.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -62.45 -32.97 73.93 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.719 1.208 . . . . 0.0 112.397 172.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.69 -39.17 80.67 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.6 -1.312 . . . . 0.0 112.412 172.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.74 -38.16 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 O-C-N 121.327 -0.858 . . . . 0.0 111.295 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -58.01 -46.76 84.74 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.39 -0.819 . . . . 0.0 111.195 171.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.1 mp -69.71 -33.59 72.73 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 117.387 -1.292 . . . . 0.0 113.057 175.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.34 -34.17 68.49 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 121.301 1.864 . . . . 0.0 110.455 169.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.2 m -73.56 -39.05 64.99 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.598 1.159 . . . . 0.0 113.535 171.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.7 mm -73.74 -34.2 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 120.724 1.602 . . . . 0.0 111.02 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.4 t -64.79 -48.86 82.73 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-O 117.544 -1.217 . . . . 0.0 109.411 172.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -53.49 -44.21 68.85 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 120.931 1.696 . . . . 0.0 112.177 171.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.8 m -58.74 -35.22 72.38 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.676 -0.64 . . . . 0.0 112.021 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -75.41 -37.05 60.68 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.483 1.513 . . . . 0.0 113.414 171.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.0 mt -66.21 -31.94 73.07 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 120.033 1.288 . . . . 0.0 111.966 175.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 93.1 mt -75.68 -39.45 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 124.685 1.194 . . . . 0.0 110.803 169.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.63 -38.08 61.56 Favored Glycine 0 C--N 1.34 0.775 0 C-N-CA 125.437 1.494 . . . . 0.0 114.114 -171.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.3 t -148.6 -29.69 0.28 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.3 12.18 31.85 Favored Glycine 0 N--CA 1.477 1.386 0 N-CA-C 116.425 1.33 . . . . 0.0 116.425 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.5 m -157.98 146.87 19.32 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.959 1.704 . . . . 0.0 109.611 171.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.4 p -119.34 142.17 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.635 1.574 . . . . 0.0 110.43 -175.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -133.02 157.44 45.22 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.3 1.04 . . . . 0.0 111.032 -169.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -54.98 -39.32 68.88 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -70.95 -19.73 62.53 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.526 1.131 . . . . 0.0 113.318 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -78.98 -43.44 24.43 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.162 0.892 . . . . 0.0 109.908 169.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.7 mt -79.87 -27.16 40.11 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -169.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -57.6 -24.21 55.12 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 170.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -84.14 -3.75 58.33 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.507 1.123 . . . . 0.0 113.882 173.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.2 mm-40 -115.97 -16.02 11.14 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.795 1.238 . . . . 0.0 113.167 -173.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt . . . . . 0 N--CA 1.472 0.666 0 CA-C-N 118.888 0.767 . . . . 0.0 110.937 173.469 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.471 0.62 0 CA-C-O 119.177 -0.44 . . . . 0.0 111.815 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -127.56 128.95 46.47 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.022 0.529 . . . . 0.0 111.932 -169.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -104.04 143.47 32.85 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.353 -0.842 . . . . 0.0 109.965 169.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.5 t -140.06 140.11 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.093 0.957 . . . . 0.0 110.625 -171.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -115.14 132.03 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.067 1.347 . . . . 0.0 113.63 -169.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.6 mmt85 -130.86 74.93 1.63 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.594 1.557 . . . . 0.0 109.673 171.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.5 mt -93.12 131.22 33.58 Favored Pre-proline 0 N--CA 1.479 1.003 0 O-C-N 121.396 -0.815 . . . . 0.0 108.856 172.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.46 136.7 44.08 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.231 1.954 . . . . 0.0 111.459 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.07 -0.13 83.68 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.746 1.165 . . . . 0.0 115.587 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -137.06 157.55 74.35 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 119.015 1.407 . . . . 0.0 112.218 173.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.2 153.02 62.28 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.848 2.366 . . . . 0.0 112.852 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.6 p -55.95 136.95 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.672 1.189 . . . . 0.0 111.935 172.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 99.2 t -115.8 141.13 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.888 1.675 . . . . 0.0 108.082 169.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -139.93 123.13 16.89 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.442 1.097 . . . . 0.0 110.646 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.7 t -95.97 154.97 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 126.596 1.959 . . . . 0.0 111.149 -172.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.36 -95.11 1.3 Allowed Glycine 0 CA--C 1.532 1.115 0 O-C-N 121.327 -0.858 . . . . 0.0 112.485 174.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 60.5 m -152.36 149.84 29.06 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.478 1.111 . . . . 0.0 110.057 174.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -69.38 125.28 91.86 Favored Pre-proline 0 CA--C 1.546 0.822 0 O-C-N 120.636 -1.29 . . . . 0.0 111.262 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.37 153.74 31.36 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.969 3.112 . . . . 0.0 114.623 -175.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 t -83.14 -31.08 27.39 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -169.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.26 -33.77 2.73 Favored Glycine 0 N--CA 1.478 1.466 0 C-N-CA 125.193 1.377 . . . . 0.0 112.978 -174.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -78.09 57.51 1.82 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.97 1.708 . . . . 0.0 110.511 169.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.8 m -137.4 154.43 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.274 1.83 . . . . 0.0 111.526 -172.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.7 mt -87.98 140.19 29.75 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 127.097 2.159 . . . . 0.0 109.187 173.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -121.36 112.58 18.75 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.424 0.556 . . . . 0.0 111.785 -176.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.6 143.14 16.41 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 169.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -151.66 131.46 13.25 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.646 1.723 . . . . 0.0 112.339 -170.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -143.58 168.18 20.48 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.729 1.211 . . . . 0.0 113.655 -174.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.7 m -120.03 131.85 55.27 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.422 1.489 . . . . 0.0 108.882 176.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.56 173.2 32.21 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.616 1.103 . . . . 0.0 114.688 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -81.43 -12.59 58.88 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -169.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -95.81 5.11 52.11 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 120.76 1.618 . . . . 0.0 111.58 169.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.36 17.32 40.05 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 126.766 2.127 . . . . 0.0 114.213 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.6 pm0 -82.93 175.26 10.2 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.911 1.684 . . . . 0.0 113.869 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.5 m -128.26 138.38 52.4 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.084 1.353 . . . . 0.0 109.956 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.2 t -120.98 141.13 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.365 1.466 . . . . 0.0 110.355 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.0 tp -128.56 147.18 50.69 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.219 1.407 . . . . 0.0 109.812 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.4 t -131.59 137.39 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.339 1.456 . . . . 0.0 108.426 173.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -130.22 127.39 39.52 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.989 0.9 . . . . 0.0 111.76 -176.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -125.35 143.77 45.6 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.44 1.896 . . . . 0.0 110.694 -173.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -61.22 132.55 41.96 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.426 2.084 . . . . 0.0 111.609 174.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 . . . . . 0 C--O 1.254 1.314 0 C-N-CA 124.688 1.195 . . . . 0.0 112.522 -178.539 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -57.33 -37.0 71.85 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.714 -0.616 . . . . 0.0 112.455 -173.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.2 m -68.48 -24.06 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.817 1.247 . . . . 0.0 112.968 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.17 -43.93 73.23 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.336 0.971 . . . . 0.0 112.115 177.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.26 -39.9 71.31 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.516 -0.74 . . . . 0.0 111.294 -169.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -69.84 -31.14 68.84 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.709 1.203 . . . . 0.0 112.686 173.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.95 -38.98 83.46 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.908 -1.12 . . . . 0.0 112.18 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.0 t -67.15 -39.42 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 O-C-N 121.29 -0.881 . . . . 0.0 111.414 172.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -57.24 -44.87 84.23 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.589 -0.694 . . . . 0.0 111.023 171.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -71.38 -36.24 71.36 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 116.176 -1.869 . . . . 0.0 113.257 175.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.3 -39.76 67.28 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 121.976 2.171 . . . . 0.0 109.8 169.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.0 m -64.83 -40.36 95.06 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 118.051 -0.976 . . . . 0.0 113.334 173.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.8 mm -75.49 -28.63 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 120.584 1.538 . . . . 0.0 111.552 178.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.3 t -65.14 -49.21 80.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 O-C-N 120.926 -1.109 . . . . 0.0 108.978 170.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -56.77 -42.28 79.13 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 120.444 1.475 . . . . 0.0 113.191 174.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.0 p -64.94 -23.42 67.22 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.998 0.817 . . . . 0.0 112.29 177.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -83.79 -35.15 24.52 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.471 1.908 . . . . 0.0 113.411 169.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.5 mt -64.38 -38.68 91.89 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 120.527 1.512 . . . . 0.0 111.386 172.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 89.3 mt -72.42 -35.58 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 124.491 1.117 . . . . 0.0 110.891 170.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.5 -38.48 51.92 Favored Glycine 0 C--N 1.34 0.75 0 C-N-CA 125.657 1.599 . . . . 0.0 114.473 -171.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.0 t -152.18 -26.87 0.17 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 177.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.35 6.59 33.46 Favored Glycine 0 N--CA 1.477 1.381 0 N-CA-C 116.954 1.542 . . . . 0.0 116.954 173.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 t -161.07 150.0 16.46 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.546 1.538 . . . . 0.0 109.881 170.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -115.9 147.15 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 126.046 1.738 . . . . 0.0 110.826 -178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -126.27 159.02 34.22 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.498 1.519 . . . . 0.0 110.352 -173.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -54.75 -38.48 67.24 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.862 -0.524 . . . . 0.0 112.413 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -69.36 -21.72 63.79 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -79.91 -31.92 40.16 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.769 0.713 . . . . 0.0 111.756 172.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 89.4 mt -86.54 -33.91 20.13 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.988 1.315 . . . . 0.0 114.19 -174.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -58.55 -20.88 50.33 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 175.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -80.38 -14.97 57.89 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 175.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -100.84 -44.36 5.8 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.921 0.888 . . . . 0.0 112.674 -169.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt . . . . . 0 N--CA 1.487 1.406 0 N-CA-C 117.832 2.53 . . . . 0.0 117.832 174.996 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.468 0.461 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -131.77 127.43 36.7 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.786 0.434 . . . . 0.0 111.17 -170.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -104.69 145.67 30.02 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.368 0.985 . . . . 0.0 109.675 169.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.2 t -139.99 141.4 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.331 1.052 . . . . 0.0 110.738 -170.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 mm -111.42 126.38 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.614 1.566 . . . . 0.0 112.669 -172.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -125.94 63.3 1.23 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.518 1.927 . . . . 0.0 109.703 170.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.9 mt -79.74 126.83 79.55 Favored Pre-proline 0 N--CA 1.481 1.084 0 CA-C-O 118.34 -0.838 . . . . 0.0 108.989 169.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -58.38 139.43 90.56 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.947 2.431 . . . . 0.0 113.082 173.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.78 0.0 87.22 Favored Glycine 0 CA--C 1.537 1.409 0 N-CA-C 116.042 1.177 . . . . 0.0 116.042 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -138.13 158.71 70.56 Favored Pre-proline 0 CA--C 1.549 0.935 0 CA-C-N 119.23 1.515 . . . . 0.0 112.685 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.98 149.85 59.83 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.846 2.364 . . . . 0.0 113.481 -174.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 81.3 t -64.09 130.82 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.5 1.52 . . . . 0.0 111.172 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.5 t -106.09 142.43 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.569 1.548 . . . . 0.0 108.202 170.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -135.57 113.97 11.59 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.797 1.239 . . . . 0.0 109.208 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.0 t -84.22 151.63 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.715 1.606 . . . . 0.0 110.975 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.51 -99.23 1.2 Allowed Glycine 0 CA--C 1.534 1.232 0 O-C-N 121.321 -0.862 . . . . 0.0 112.985 175.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -148.74 158.12 43.92 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.73 1.212 . . . . 0.0 109.979 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -71.27 130.28 88.03 Favored Pre-proline 0 CA--C 1.549 0.938 0 O-C-N 120.627 -1.295 . . . . 0.0 110.636 170.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.9 157.07 34.87 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.272 3.315 . . . . 0.0 114.103 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.7 t -83.63 -32.25 25.79 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -171.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.96 -33.19 2.64 Favored Glycine 0 N--CA 1.476 1.336 0 C-N-CA 125.41 1.481 . . . . 0.0 113.261 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -78.3 58.99 2.21 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.096 1.758 . . . . 0.0 111.229 169.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.0 m -136.94 155.23 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.372 1.469 . . . . 0.0 112.706 -171.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.8 mt -91.7 138.88 31.2 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 128.284 2.633 . . . . 0.0 109.546 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -121.62 103.8 9.17 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.787 0.721 . . . . 0.0 111.877 -175.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -83.75 150.97 27.21 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 169.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.8 ttt-85 -148.88 153.84 38.61 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 118.845 1.322 . . . . 0.0 111.478 -172.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -161.76 167.26 25.28 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.554 1.142 . . . . 0.0 112.922 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 97.2 m -131.51 110.98 11.37 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.507 1.523 . . . . 0.0 109.572 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.45 163.27 54.39 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.162 0.887 . . . . 0.0 114.88 -177.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -68.35 -8.22 38.11 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.632 1.973 . . . . 0.0 115.34 -174.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -102.9 4.05 37.17 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.258 1.39 . . . . 0.0 113.084 169.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.68 20.79 15.91 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.902 1.239 . . . . 0.0 114.484 172.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.64 -170.54 3.06 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.912 1.285 . . . . 0.0 113.874 -177.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.0 m -147.24 123.21 10.71 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 120.705 -1.247 . . . . 0.0 111.883 172.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.7 t -94.27 146.03 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.448 1.499 . . . . 0.0 110.866 171.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.6 tp -130.18 145.27 51.71 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.689 1.596 . . . . 0.0 108.364 169.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.16 139.4 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.179 1.392 . . . . 0.0 108.576 171.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -132.18 129.37 39.67 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.914 0.886 . . . . 0.0 111.014 -175.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -131.8 140.26 37.69 Favored Pre-proline 0 N--CA 1.473 0.677 0 C-N-CA 126.138 1.775 . . . . 0.0 111.042 -170.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -62.17 136.53 60.92 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.176 1.917 . . . . 0.0 112.099 174.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 . . . . . 0 C--O 1.253 1.252 0 C-N-CA 124.458 1.103 . . . . 0.0 111.8 173.225 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 . . . . . 0 N--CA 1.469 0.516 0 CA-C-O 119.753 -0.165 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.416 HH21 ' CD ' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -58.86 -39.95 82.84 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 118.383 -0.818 . . . . 0.0 111.751 -178.026 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.5 t -56.65 -31.61 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.201 1.4 . . . . 0.0 112.512 174.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -77.26 -33.67 55.91 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 176.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.4 mp -74.11 -38.92 63.7 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 120.929 -1.107 . . . . 0.0 111.24 -178.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.416 ' CD ' HH21 ' A' ' 14' ' ' ARG . 6.7 pt-20 -65.21 -27.25 68.55 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 170.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.39 -36.68 83.47 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 120.69 -1.256 . . . . 0.0 112.308 169.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.1 t -70.81 -36.28 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 124.445 1.098 . . . . 0.0 111.342 172.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -60.49 -45.0 95.36 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.112 -0.992 . . . . 0.0 111.449 171.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.1 mp -70.28 -33.38 71.5 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-O 117.147 -1.406 . . . . 0.0 112.494 174.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.29 -33.93 69.99 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 121.475 1.943 . . . . 0.0 110.805 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.7 m -72.05 -38.88 69.42 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.101 0.96 . . . . 0.0 113.236 171.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.0 mm -73.82 -34.85 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 120.721 1.6 . . . . 0.0 110.933 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.1 t -62.67 -48.2 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 117.452 -1.261 . . . . 0.0 110.033 172.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -54.1 -42.36 69.31 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 120.994 1.725 . . . . 0.0 112.173 171.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.2 m -60.28 -33.04 71.77 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.702 -0.624 . . . . 0.0 112.142 175.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -76.71 -37.22 56.45 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.065 1.346 . . . . 0.0 113.31 171.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.1 mt -65.06 -31.19 72.29 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.674 1.125 . . . . 0.0 112.133 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 89.7 mt -76.52 -36.78 28.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 125.156 1.382 . . . . 0.0 111.248 169.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.18 -39.43 31.92 Favored Glycine 0 N--CA 1.469 0.845 0 C-N-CA 126.08 1.8 . . . . 0.0 115.547 -171.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.9 t -151.08 -23.95 0.21 Allowed 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.0 6.04 54.34 Favored Glycine 0 N--CA 1.468 0.828 0 N-CA-C 117.271 1.668 . . . . 0.0 117.271 169.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.0 m -158.5 149.88 20.91 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.418 1.487 . . . . 0.0 110.343 170.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 p -103.51 145.11 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.448 1.099 . . . . 0.0 113.0 -173.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -116.6 152.9 33.23 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.675 1.59 . . . . 0.0 110.792 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -57.4 -35.67 70.33 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.888 -1.133 . . . . 0.0 111.885 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -70.42 -19.18 63.01 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.93 1.292 . . . . 0.0 112.738 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -83.62 -32.95 25.43 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.904 0.775 . . . . 0.0 112.179 169.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.3 mt -86.63 -34.65 19.76 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.451 1.5 . . . . 0.0 114.005 -172.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -60.48 -20.51 60.26 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -84.82 -3.41 58.63 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.23 1.412 . . . . 0.0 113.591 175.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -114.35 -26.49 7.96 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.942 1.297 . . . . 0.0 113.202 -172.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt . . . . . 0 N--CA 1.472 0.666 0 C-N-CA 124.017 0.927 . . . . 0.0 112.829 -178.265 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 111.143 0.053 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -133.83 129.88 37.14 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.246 1.419 . . . . 0.0 110.932 -175.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.12 136.17 47.42 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 120.195 1.361 . . . . 0.0 109.302 168.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.3 t -126.45 143.08 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.054 1.341 . . . . 0.0 110.767 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.3 mm -120.57 134.07 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.542 1.537 . . . . 0.0 113.418 -169.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -113.53 3.49 15.76 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 116.277 1.955 . . . . 0.0 116.277 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.6 mt -40.04 124.72 1.64 Allowed Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 125.739 1.616 . . . . 0.0 113.544 -172.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -60.7 140.64 91.92 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.147 2.564 . . . . 0.0 113.742 173.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.0 -1.38 86.85 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.811 1.196 . . . . 0.0 115.476 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -131.49 160.84 65.49 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 125.001 1.32 . . . . 0.0 111.298 172.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -62.26 161.89 25.38 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.461 2.107 . . . . 0.0 112.145 176.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.1 t -72.11 142.9 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 169.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 87.6 t -113.94 138.52 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 169.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -124.51 118.55 26.86 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.036 1.334 . . . . 0.0 108.708 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.3 t -94.22 154.34 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.043 1.337 . . . . 0.0 110.811 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.36 -109.14 2.7 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.0 t -154.69 162.14 41.25 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.736 0.768 . . . . 0.0 111.332 169.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.5 tttp -61.63 141.86 94.67 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.74 1.216 . . . . 0.0 111.565 -176.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -65.36 -167.48 0.1 Allowed 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 124.342 3.361 . . . . 0.0 115.89 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 t -119.61 -24.58 6.2 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 117.571 2.434 . . . . 0.0 117.571 -169.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.57 -10.04 21.76 Favored Glycine 0 N--CA 1.484 1.862 0 CA-C-N 119.472 1.033 . . . . 0.0 114.556 -173.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -134.45 83.8 2.06 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.829 2.452 . . . . 0.0 110.278 170.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.3 m -139.54 147.15 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.896 1.278 . . . . 0.0 111.621 -176.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.5 mt -72.33 148.95 44.86 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.05 1.34 . . . . 0.0 107.55 169.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -133.15 113.7 13.02 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.588 0.755 . . . . 0.0 109.201 -178.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -99.42 147.82 18.48 Favored Glycine 0 N--CA 1.468 0.788 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 169.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 74.2 ttt-85 -150.05 146.51 27.0 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 118.466 1.133 . . . . 0.0 112.84 -169.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.53 155.59 33.67 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.793 0.837 . . . . 0.0 112.955 -178.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.1 m -113.72 129.9 56.51 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.276 1.43 . . . . 0.0 109.475 169.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.03 -160.51 36.12 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 124.182 0.896 . . . . 0.0 115.055 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -99.51 -15.15 18.77 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -169.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -91.57 -1.82 57.36 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 120.338 1.426 . . . . 0.0 111.998 168.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.01 20.07 26.97 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 126.303 1.906 . . . . 0.0 113.651 -174.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.0 pm0 -80.66 163.5 23.55 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.841 1.656 . . . . 0.0 113.988 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.9 m -128.51 140.37 51.84 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.125 0.97 . . . . 0.0 110.507 173.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.8 t -131.79 143.2 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.157 1.783 . . . . 0.0 109.363 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.3 tp -130.15 147.58 51.9 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.46 1.504 . . . . 0.0 111.569 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 76.2 t -122.44 138.34 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 126.887 2.075 . . . . 0.0 108.401 171.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -137.06 134.51 36.6 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.741 0.701 . . . . 0.0 112.652 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.0 152.27 33.72 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 176.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -58.27 128.02 27.02 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.548 2.832 . . . . 0.0 113.431 -175.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 125.156 1.382 . . . . 0.0 112.131 179.396 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 . . . . . 0 CA--C 1.541 0.605 0 CA-C-O 119.695 -0.193 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.408 HH21 ' CD ' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -58.39 -36.1 73.04 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 118.365 -0.826 . . . . 0.0 112.042 176.744 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.8 t -57.25 -28.47 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.911 1.684 . . . . 0.0 113.408 171.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -76.85 -38.51 53.6 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.181 -0.949 . . . . 0.0 112.278 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.5 mp -70.6 -36.75 73.71 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.324 -0.86 . . . . 0.0 111.349 -174.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.408 ' CD ' HH21 ' A' ' 14' ' ' ARG . 8.3 pt-20 -67.08 -32.07 72.99 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.7 0.8 . . . . 0.0 112.581 170.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.06 -40.74 87.14 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.637 -1.289 . . . . 0.0 112.125 171.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.5 t -63.45 -43.55 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.822 0.849 . . . . 0.0 110.932 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -57.27 -41.13 79.1 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.741 -0.599 . . . . 0.0 111.51 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 mp -67.63 -34.84 77.76 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 117.315 -1.326 . . . . 0.0 113.326 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.74 -33.92 67.03 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 120.991 1.723 . . . . 0.0 111.249 169.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 m -73.92 -37.56 64.58 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 170.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.3 mm -69.58 -36.57 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 120.618 1.554 . . . . 0.0 110.4 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.13 -46.93 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.915 1.286 . . . . 0.0 109.624 176.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -52.89 -43.63 66.32 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 120.62 1.555 . . . . 0.0 111.963 170.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.9 m -59.96 -32.41 70.79 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.791 0.436 . . . . 0.0 111.986 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -79.07 -36.62 40.59 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.594 1.558 . . . . 0.0 113.712 172.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.0 mt -66.34 -34.26 77.57 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 120.195 1.361 . . . . 0.0 111.43 175.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.3 mt -73.06 -36.74 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.386 1.074 . . . . 0.0 110.491 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.75 -38.81 60.75 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 125.695 1.617 . . . . 0.0 114.428 -173.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.5 t -152.24 -26.52 0.17 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 178.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.51 3.35 53.24 Favored Glycine 0 N--CA 1.481 1.694 0 N-CA-C 116.156 1.223 . . . . 0.0 116.156 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.5 m -143.66 135.3 26.25 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.214 1.806 . . . . 0.0 108.974 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 p -107.01 145.5 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.668 0.787 . . . . 0.0 109.634 172.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -133.59 156.91 46.98 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.666 1.186 . . . . 0.0 110.187 -175.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -56.3 -37.58 70.08 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.804 -0.56 . . . . 0.0 111.907 -177.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -70.03 -22.06 63.13 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -77.6 -37.89 49.38 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.497 0.59 . . . . 0.0 111.738 170.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 60.6 mt -87.71 -27.05 22.63 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 -173.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -56.49 -27.74 57.94 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 175.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -90.5 4.34 51.41 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.623 1.169 . . . . 0.0 114.12 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -123.09 -10.57 8.12 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 119.814 1.188 . . . . 0.0 113.943 -170.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.829 0 C-N-CA 125.274 1.429 . . . . 0.0 114.547 -175.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 119.974 -0.06 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -131.74 116.93 17.92 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.733 1.613 . . . . 0.0 109.457 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.15 145.08 25.66 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.012 -1.055 . . . . 0.0 108.69 168.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.2 t -139.89 134.76 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 120.682 -1.261 . . . . 0.0 110.931 -169.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mm -116.07 139.16 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.087 1.355 . . . . 0.0 114.641 -170.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -144.87 73.3 1.36 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.076 1.75 . . . . 0.0 109.628 169.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.0 mt -83.35 121.76 76.91 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-N 114.386 -1.279 . . . . 0.0 107.682 169.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.22 132.68 50.48 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.073 1.849 . . . . 0.0 112.214 174.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.05 0.18 83.41 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.869 1.223 . . . . 0.0 116.016 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -139.87 165.57 30.01 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 119.79 1.795 . . . . 0.0 113.872 173.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -60.74 140.95 93.48 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.609 2.873 . . . . 0.0 115.644 -173.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.6 t -69.98 116.03 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.509 1.124 . . . . 0.0 108.946 169.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.87 143.98 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.195 1.398 . . . . 0.0 109.765 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -139.16 110.91 7.16 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.792 1.237 . . . . 0.0 108.881 -170.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.1 t -80.93 153.8 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.745 1.618 . . . . 0.0 111.466 -172.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.42 -87.54 1.12 Allowed Glycine 0 CA--C 1.533 1.157 0 O-C-N 121.487 -0.758 . . . . 0.0 113.263 172.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.1 m -157.68 160.76 38.31 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.014 1.326 . . . . 0.0 109.889 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.8 tptt -73.94 131.9 80.82 Favored Pre-proline 0 CA--C 1.548 0.879 0 O-C-N 120.778 -1.201 . . . . 0.0 110.581 171.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.65 156.49 40.13 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 124.223 3.282 . . . . 0.0 114.349 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.6 t -83.91 -33.24 24.77 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -173.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.62 -40.82 1.45 Allowed Glycine 0 N--CA 1.474 1.209 0 C-N-CA 124.983 1.278 . . . . 0.0 113.472 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -78.44 58.8 2.24 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.527 1.531 . . . . 0.0 111.767 171.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.8 m -127.13 156.76 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.244 1.418 . . . . 0.0 113.298 -173.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.0 mt -97.25 112.94 24.52 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 127.761 2.424 . . . . 0.0 110.789 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -98.45 100.57 11.84 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.172 0.989 . . . . 0.0 113.034 -171.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -85.68 152.83 26.62 Favored Glycine 0 N--CA 1.473 1.134 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 169.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -149.66 154.77 39.13 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.544 1.672 . . . . 0.0 112.211 -169.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -163.35 167.94 21.1 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.298 1.039 . . . . 0.0 113.372 176.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 62.3 m -124.75 132.93 53.32 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.121 1.768 . . . . 0.0 107.814 171.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.84 -179.31 38.96 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 123.52 0.581 . . . . 0.0 114.432 -178.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -88.51 -10.02 50.41 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -169.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -99.73 7.09 45.37 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.791 1.632 . . . . 0.0 111.138 169.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.43 18.04 40.22 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 127.033 2.254 . . . . 0.0 114.099 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.9 pm0 -79.14 176.05 10.03 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.525 1.53 . . . . 0.0 113.584 178.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.6 m -136.48 139.53 42.39 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.491 1.116 . . . . 0.0 109.534 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.4 t -129.68 143.42 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.539 1.536 . . . . 0.0 110.541 -174.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.0 tp -134.25 150.42 51.02 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.564 1.546 . . . . 0.0 109.136 173.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 37.7 t -126.42 138.39 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 126.194 1.798 . . . . 0.0 108.574 171.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -135.98 138.69 42.53 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.487 0.715 . . . . 0.0 111.438 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -154.5 156.62 31.79 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.289 1.436 . . . . 0.0 112.521 173.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -59.13 138.64 86.34 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.415 2.076 . . . . 0.0 113.828 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 . . . . . 0 C--O 1.255 1.344 0 C-N-CA 125.801 1.64 . . . . 0.0 112.19 172.87 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 . . . . . 0 CA--C 1.543 0.692 0 CA-C-O 120.303 0.097 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.403 HH21 ' CD ' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -61.93 -35.0 77.11 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 118.38 -0.819 . . . . 0.0 113.006 -175.621 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.0 m -63.99 -19.82 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 174.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.96 -44.82 68.71 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.672 1.124 . . . . 0.0 112.326 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -69.52 -41.33 76.16 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.278 -0.889 . . . . 0.0 111.491 -171.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.403 ' CD ' HH21 ' A' ' 14' ' ' ARG . 8.6 pt-20 -64.64 -33.6 76.31 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.65 1.18 . . . . 0.0 112.635 171.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.52 -37.76 85.73 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.736 -1.228 . . . . 0.0 112.384 172.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.0 t -68.85 -37.64 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 124.023 0.929 . . . . 0.0 111.37 172.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -59.4 -43.9 92.91 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.175 -0.953 . . . . 0.0 111.744 170.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.7 mp -68.98 -34.95 76.15 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 120.382 1.446 . . . . 0.0 112.806 173.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.26 -34.43 68.63 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 121.158 1.799 . . . . 0.0 110.584 169.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.5 m -71.52 -40.16 70.28 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.084 0.954 . . . . 0.0 113.177 172.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.8 mm -72.04 -35.48 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 120.69 1.587 . . . . 0.0 111.108 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.21 -45.69 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.696 1.198 . . . . 0.0 109.547 174.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -53.75 -43.11 68.88 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 120.78 1.627 . . . . 0.0 112.12 171.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.6 t -59.15 -39.55 82.79 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.964 -0.46 . . . . 0.0 111.826 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -68.55 -38.34 80.7 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.666 1.186 . . . . 0.0 113.088 171.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.0 mt -67.72 -38.46 83.61 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.747 1.158 . . . . 0.0 112.084 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.09 -37.36 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.49 1.116 . . . . 0.0 111.348 172.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.39 -64.19 3.08 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 124.837 1.208 . . . . 0.0 111.083 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.1 t -126.81 -27.6 3.05 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -174.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.48 3.05 53.51 Favored Glycine 0 N--CA 1.475 1.267 0 N-CA-C 116.81 1.484 . . . . 0.0 116.81 172.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.4 m -146.73 136.94 23.6 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.633 1.573 . . . . 0.0 109.713 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 p -104.76 146.69 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.505 1.122 . . . . 0.0 110.688 176.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -133.65 159.18 41.28 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.877 1.271 . . . . 0.0 110.352 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -55.79 -38.58 70.11 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -71.04 -17.18 62.63 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -80.62 -32.14 36.37 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.349 0.977 . . . . 0.0 112.041 170.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.3 mt -90.98 -30.45 16.82 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.237 1.415 . . . . 0.0 114.489 -172.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.9 ptt85 -59.0 -23.93 62.32 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 119.398 0.999 . . . . 0.0 113.491 174.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -82.02 -6.95 59.55 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 175.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -113.4 -20.11 11.45 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -169.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 N--CA 1.467 0.414 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -172.851 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -133.63 123.14 24.52 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.582 1.553 . . . . 0.0 109.193 -176.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.4 138.57 35.44 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.229 0.922 . . . . 0.0 109.166 169.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.8 t -132.89 140.36 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.033 1.333 . . . . 0.0 109.692 -173.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.24 131.9 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -169.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -128.77 78.43 1.85 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.5 1.92 . . . . 0.0 109.848 170.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.8 mt -96.9 125.59 45.8 Favored Pre-proline 0 N--CA 1.481 1.104 0 O-C-N 121.128 -0.982 . . . . 0.0 109.047 170.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.91 134.86 62.91 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.549 2.166 . . . . 0.0 112.484 172.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.9 0.31 85.81 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 124.711 1.148 . . . . 0.0 115.942 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -139.74 156.39 70.98 Favored Pre-proline 0 N--CA 1.476 0.827 0 CA-C-N 119.407 1.604 . . . . 0.0 112.506 174.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -69.75 149.79 67.39 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.699 2.266 . . . . 0.0 112.983 -173.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.0 t -57.02 132.8 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.934 1.294 . . . . 0.0 110.783 175.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.1 t -111.74 141.92 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.154 1.382 . . . . 0.0 109.41 170.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -136.5 117.77 14.57 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.132 1.373 . . . . 0.0 109.223 176.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.8 t -91.94 159.55 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.02 1.728 . . . . 0.0 111.156 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.41 -104.64 1.62 Allowed Glycine 0 CA--C 1.531 1.067 0 O-C-N 120.959 -1.088 . . . . 0.0 112.026 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.5 t -154.74 160.58 41.42 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.553 0.692 . . . . 0.0 111.516 169.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -74.16 125.94 89.6 Favored Pre-proline 0 CA--C 1.546 0.807 0 O-C-N 120.698 -1.251 . . . . 0.0 111.703 -170.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -76.65 154.19 34.7 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.834 3.023 . . . . 0.0 114.728 -177.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.1 t -84.4 -30.13 25.62 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -171.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.29 -35.38 2.44 Favored Glycine 0 N--CA 1.479 1.534 0 C-N-CA 124.738 1.161 . . . . 0.0 113.816 -175.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -78.18 58.64 2.08 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.922 1.689 . . . . 0.0 110.816 169.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.6 m -138.95 155.33 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 125.946 1.698 . . . . 0.0 111.863 -171.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.1 mt -74.44 164.79 26.18 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.881 1.672 . . . . 0.0 109.873 169.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -149.32 93.14 2.03 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.729 0.812 . . . . 0.0 110.223 -173.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -85.58 148.56 22.88 Favored Glycine 0 N--CA 1.471 1.007 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 169.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -151.44 150.14 30.08 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.636 1.718 . . . . 0.0 113.207 -169.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -157.51 157.18 33.34 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.316 1.046 . . . . 0.0 113.638 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 85.5 m -109.52 125.86 52.93 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.107 1.363 . . . . 0.0 107.871 169.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.18 173.42 42.74 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 122.385 0.991 . . . . 0.0 114.807 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -80.47 -8.03 59.39 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 -169.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -103.39 6.38 37.72 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.935 1.698 . . . . 0.0 111.648 168.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.1 18.71 30.7 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.264 1.887 . . . . 0.0 114.273 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.7 pm0 -85.28 176.18 8.48 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.613 1.565 . . . . 0.0 113.759 177.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.8 m -132.59 134.18 44.59 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.124 1.37 . . . . 0.0 110.444 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.7 t -118.89 144.28 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.066 1.746 . . . . 0.0 110.115 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.6 tp -133.6 143.75 48.83 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.469 1.108 . . . . 0.0 110.557 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.7 t -114.76 135.66 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 127.797 2.439 . . . . 0.0 108.207 171.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -136.71 144.18 43.76 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.839 0.828 . . . . 0.0 111.145 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.2 152.45 20.18 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 176.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -58.11 142.36 96.97 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.678 2.919 . . . . 0.0 114.316 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 . . . . . 0 C--O 1.253 1.284 0 C-N-CA 125.715 1.606 . . . . 0.0 112.68 172.47 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 . . . . . 0 N--CA 1.475 0.817 0 CA-C-O 120.813 0.339 . . . . 0.0 111.737 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -31.47 71.49 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 121.008 -1.057 . . . . 0.0 113.795 -174.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.2 m -65.79 -21.4 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 172.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -69.97 -43.03 72.34 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 120.905 -1.122 . . . . 0.0 112.5 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.26 -40.82 77.6 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.387 -0.821 . . . . 0.0 111.523 -171.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.4 -30.23 70.56 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.538 1.135 . . . . 0.0 112.62 173.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.43 -37.64 80.45 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.881 -1.137 . . . . 0.0 111.918 171.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.0 t -68.71 -37.0 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 O-C-N 121.43 -0.794 . . . . 0.0 111.302 172.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -59.36 -46.48 88.51 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.2 -0.937 . . . . 0.0 111.602 171.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -69.18 -34.14 74.47 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 117.398 -1.287 . . . . 0.0 112.844 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.16 -34.08 68.07 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 121.079 1.763 . . . . 0.0 110.578 169.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.9 m -73.0 -38.46 66.61 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.552 1.141 . . . . 0.0 113.642 171.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.6 mm -70.89 -37.04 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 120.701 1.591 . . . . 0.0 110.814 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.3 t -66.42 -48.31 81.17 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 C-N-CA 124.792 1.237 . . . . 0.0 109.609 175.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -53.61 -43.06 68.35 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 120.593 1.542 . . . . 0.0 112.154 171.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.2 m -59.64 -32.47 70.47 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.807 -0.558 . . . . 0.0 112.107 176.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -79.72 -36.39 37.49 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.634 1.574 . . . . 0.0 113.555 172.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 78.5 mt -65.62 -33.22 75.38 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 120.063 1.301 . . . . 0.0 111.707 174.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.32 -37.57 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.312 1.045 . . . . 0.0 110.894 169.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.39 -37.53 62.75 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 125.637 1.589 . . . . 0.0 114.272 -172.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.3 t -151.46 -27.45 0.19 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 177.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.15 8.69 33.3 Favored Glycine 0 N--CA 1.477 1.411 0 N-CA-C 116.703 1.441 . . . . 0.0 116.703 175.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.7 p -158.82 136.94 10.58 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.517 1.527 . . . . 0.0 109.985 176.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.45 145.95 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.272 1.029 . . . . 0.0 110.327 176.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -127.56 159.41 34.71 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.598 1.559 . . . . 0.0 109.666 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -53.44 -38.95 64.02 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -175.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -70.24 -15.96 62.98 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -89.27 -3.71 58.42 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.785 0.834 . . . . 0.0 112.494 170.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.1 mt -116.19 -33.88 4.86 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.022 1.329 . . . . 0.0 113.634 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.3 ptt85 -64.42 -21.66 66.71 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 119.66 1.118 . . . . 0.0 113.471 178.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -89.02 2.8 53.47 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.209 1.404 . . . . 0.0 113.984 171.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -121.33 -13.38 8.47 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.357 1.463 . . . . 0.0 112.742 -174.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 N--CA 1.472 0.629 0 CA-C-N 118.715 0.689 . . . . 0.0 110.938 171.319 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -136.45 144.89 44.66 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.177 1.391 . . . . 0.0 112.246 -173.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -120.58 149.45 42.43 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.907 0.883 . . . . 0.0 110.87 169.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.9 t -141.16 140.77 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 120.838 -1.163 . . . . 0.0 110.582 -173.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -113.97 136.17 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -170.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -138.72 74.54 1.48 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.218 1.807 . . . . 0.0 109.469 175.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.8 mt -91.69 126.44 53.95 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-N 114.392 -1.277 . . . . 0.0 109.331 171.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -57.87 137.15 79.58 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.027 2.485 . . . . 0.0 112.932 173.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.61 -1.1 88.32 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.604 1.097 . . . . 0.0 115.413 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -136.25 158.27 73.93 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 119.009 1.404 . . . . 0.0 112.164 175.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.46 152.42 60.27 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.72 2.28 . . . . 0.0 112.774 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.1 p -62.44 135.89 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.693 1.197 . . . . 0.0 111.822 171.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.1 p -122.24 147.17 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.818 1.247 . . . . 0.0 110.752 169.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -127.07 124.34 39.04 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.313 1.445 . . . . 0.0 109.727 -173.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.2 t -103.8 149.1 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 127.81 2.444 . . . . 0.0 109.792 -169.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.96 -94.53 1.0 Allowed Glycine 0 CA--C 1.532 1.114 0 O-C-N 120.727 -1.233 . . . . 0.0 111.678 -175.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 m -155.4 157.64 37.37 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.551 1.14 . . . . 0.0 109.879 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -71.51 128.48 89.88 Favored Pre-proline 0 CA--C 1.55 0.943 0 O-C-N 120.569 -1.332 . . . . 0.0 112.19 177.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -77.94 155.53 30.3 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 124.397 3.398 . . . . 0.0 114.736 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.0 t -84.45 -20.3 31.98 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -170.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.21 -31.6 5.76 Favored Glycine 0 N--CA 1.478 1.458 0 C-N-CA 125.782 1.658 . . . . 0.0 113.413 -176.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -78.46 60.1 2.54 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.033 1.733 . . . . 0.0 110.365 169.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.57 154.08 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 126.19 1.796 . . . . 0.0 111.502 -170.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 25.0 mt -86.93 138.23 31.71 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.946 2.098 . . . . 0.0 108.963 173.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -121.57 111.15 16.88 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.151 0.887 . . . . 0.0 111.619 -174.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.56 144.28 16.99 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 169.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -151.35 135.76 16.92 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 119.247 1.523 . . . . 0.0 112.548 -169.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.1 165.01 29.5 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.392 1.077 . . . . 0.0 113.779 -176.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.7 m -117.44 129.76 56.04 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.401 1.481 . . . . 0.0 108.613 173.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.11 173.52 36.21 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.2 0.905 . . . . 0.0 114.603 -178.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -81.86 -9.25 59.66 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 -169.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -99.01 5.02 47.32 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 120.752 1.614 . . . . 0.0 111.506 168.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.38 16.77 36.23 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.562 2.029 . . . . 0.0 114.157 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.7 pm0 -83.58 173.29 11.54 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.66 1.584 . . . . 0.0 113.837 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.1 m -126.75 137.48 53.24 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.452 1.501 . . . . 0.0 110.14 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.7 t -124.17 141.4 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.606 1.562 . . . . 0.0 110.303 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.6 tp -130.49 146.02 51.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.798 1.239 . . . . 0.0 110.209 175.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.9 t -130.63 138.85 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.039 1.736 . . . . 0.0 108.789 176.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -134.53 131.52 38.08 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.394 0.616 . . . . 0.0 112.576 -175.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -123.33 148.68 55.86 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 125.031 1.332 . . . . 0.0 112.446 175.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -57.42 134.27 62.47 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.545 2.163 . . . . 0.0 112.101 170.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 . . . . . 0 C--O 1.254 1.315 0 C-N-CA 124.957 1.303 . . . . 0.0 112.63 -178.776 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 . . . . . 0 CA--C 1.542 0.651 0 CA-C-O 118.821 -0.609 . . . . 0.0 111.791 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -57.75 -41.34 81.71 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.259 0.936 . . . . 0.0 111.134 175.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.1 t -59.94 -29.02 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.34 1.856 . . . . 0.0 112.667 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -70.52 -40.52 73.45 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.31 -0.868 . . . . 0.0 112.674 173.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.7 mp -75.6 -36.96 60.16 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.026 -1.046 . . . . 0.0 111.818 -171.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -64.54 -27.48 68.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.548 0.739 . . . . 0.0 112.784 169.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.2 -37.75 78.27 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.713 -1.242 . . . . 0.0 112.076 169.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.6 t -68.12 -36.4 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 O-C-N 121.267 -0.895 . . . . 0.0 111.315 173.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -58.71 -44.49 90.38 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.321 -0.862 . . . . 0.0 111.526 170.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.6 mp -69.62 -35.8 75.59 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-O 116.597 -1.668 . . . . 0.0 113.101 173.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.64 -37.11 67.79 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 121.8 2.091 . . . . 0.0 110.391 169.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.6 m -69.16 -39.57 78.68 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.162 0.985 . . . . 0.0 113.334 172.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.9 mm -71.1 -34.76 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 120.606 1.548 . . . . 0.0 110.549 176.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.83 -51.04 76.9 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 C-N-CA 125.667 1.587 . . . . 0.0 110.328 174.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -54.66 -40.12 68.73 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 121.086 1.766 . . . . 0.0 112.745 172.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.1 m -62.68 -28.97 70.3 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.883 0.473 . . . . 0.0 112.103 175.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -83.23 -37.06 24.08 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.123 1.769 . . . . 0.0 113.482 172.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.7 mt -66.39 -35.98 81.7 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.989 1.268 . . . . 0.0 111.807 175.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.7 mt -74.33 -36.34 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 124.845 1.258 . . . . 0.0 110.879 169.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.87 -39.0 40.14 Favored Glycine 0 C--N 1.34 0.786 0 C-N-CA 125.523 1.535 . . . . 0.0 114.775 -170.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.8 t -150.07 -27.31 0.25 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 176.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.94 11.83 36.16 Favored Glycine 0 N--CA 1.475 1.25 0 N-CA-C 116.515 1.366 . . . . 0.0 116.515 174.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.9 m -155.29 140.05 17.11 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.256 1.422 . . . . 0.0 110.871 172.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 80.5 t -99.84 143.68 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.037 1.735 . . . . 0.0 109.212 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -127.77 156.69 42.06 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.549 1.14 . . . . 0.0 111.2 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -54.85 -38.23 67.2 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.211 -0.93 . . . . 0.0 112.241 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.29 -20.58 64.77 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.199 1.4 . . . . 0.0 113.692 177.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -82.99 -35.3 25.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.565 0.62 . . . . 0.0 112.345 172.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.4 mt -84.11 -32.23 24.83 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -175.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -58.66 -21.87 55.41 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 175.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -82.54 -5.19 58.61 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 174.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -109.16 -44.54 3.93 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.678 1.191 . . . . 0.0 112.452 -174.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 pt . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 117.354 2.353 . . . . 0.0 117.354 175.165 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.47 0.541 0 CA-C-O 119.039 -0.505 . . . . 0.0 112.058 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -130.86 129.6 42.52 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 122.995 0.518 . . . . 0.0 111.367 -170.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.47 144.24 32.51 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 118.902 0.773 . . . . 0.0 109.607 169.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.3 t -140.53 140.58 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.841 1.257 . . . . 0.0 110.328 -169.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -128.95 141.1 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -169.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -138.75 88.22 2.28 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.376 1.87 . . . . 0.0 108.314 169.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.1 mt -104.65 126.75 30.49 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 124.132 0.973 . . . . 0.0 109.364 173.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.15 133.83 57.96 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.542 2.162 . . . . 0.0 113.235 174.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.0 1.11 89.79 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.043 1.306 . . . . 0.0 116.207 175.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -134.12 158.17 75.95 Favored Pre-proline 0 N--CA 1.476 0.829 0 CA-C-N 119.247 1.523 . . . . 0.0 112.19 173.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.65 143.19 61.24 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.518 2.145 . . . . 0.0 112.702 -177.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 p -52.34 137.41 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.857 1.663 . . . . 0.0 112.451 171.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.7 t -119.78 134.03 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.287 1.835 . . . . 0.0 109.352 172.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -141.16 115.9 9.67 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.594 1.158 . . . . 0.0 109.283 176.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.7 t -93.23 155.1 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.682 1.993 . . . . 0.0 111.494 -169.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.74 -97.17 1.21 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 121.269 -0.895 . . . . 0.0 113.409 172.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.8 m -153.71 154.86 34.88 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.471 1.109 . . . . 0.0 110.346 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -70.67 127.99 91.38 Favored Pre-proline 0 CA--C 1.548 0.882 0 O-C-N 120.69 -1.256 . . . . 0.0 110.951 175.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.55 158.76 28.79 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 124.283 3.322 . . . . 0.0 114.664 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.8 t -85.57 -29.77 23.88 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -169.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.48 -35.48 2.33 Favored Glycine 0 N--CA 1.476 1.365 0 C-N-CA 125.484 1.516 . . . . 0.0 112.449 -175.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -78.9 61.86 3.22 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.489 1.515 . . . . 0.0 110.589 169.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.3 m -137.47 155.48 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.53 1.532 . . . . 0.0 112.535 -177.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.0 mt -91.99 127.93 37.65 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 128.417 2.687 . . . . 0.0 109.243 176.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -114.52 108.13 16.44 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.766 0.712 . . . . 0.0 111.649 -173.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.51 146.78 18.73 Favored Glycine 0 N--CA 1.469 0.856 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 169.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -152.37 132.92 13.85 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 119.377 1.589 . . . . 0.0 112.644 -169.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.28 168.45 21.04 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 42.6 m -135.43 118.01 15.93 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.927 1.691 . . . . 0.0 109.417 -177.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.48 172.15 52.57 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.454 1.026 . . . . 0.0 113.055 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -49.19 -43.96 42.68 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 126.324 1.85 . . . . 0.0 111.472 175.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -81.06 2.17 28.33 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -172.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.39 22.97 27.85 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.387 0.994 . . . . 0.0 113.139 172.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.42 -166.78 1.54 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.322 1.449 . . . . 0.0 113.285 -178.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.7 m -146.85 123.55 11.19 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 120.377 -1.452 . . . . 0.0 111.904 172.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.2 t -97.69 143.0 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.708 2.003 . . . . 0.0 109.988 170.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.1 tp -131.28 144.9 51.63 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.395 1.478 . . . . 0.0 109.134 169.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.7 t -125.76 137.42 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.318 1.447 . . . . 0.0 108.544 172.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -131.67 126.36 34.41 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.689 0.757 . . . . 0.0 111.284 -175.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -129.49 144.59 53.47 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 126.564 1.946 . . . . 0.0 110.813 -170.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.92 133.42 38.67 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.377 2.051 . . . . 0.0 112.188 178.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.2 ttp85 . . . . . 0 C--O 1.253 1.265 0 C-N-CA 125.138 1.375 . . . . 0.0 112.231 178.479 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 . . . . . 0 CA--C 1.545 0.787 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.97 -31.66 72.04 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 121.011 -1.056 . . . . 0.0 113.724 -172.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.6 m -60.57 -20.58 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 172.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -70.24 -45.13 67.12 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.181 0.901 . . . . 0.0 112.454 174.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -70.9 -41.33 71.42 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.209 -0.932 . . . . 0.0 111.303 -170.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -63.62 -33.13 74.94 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.909 0.883 . . . . 0.0 112.562 170.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.24 -37.02 84.51 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.72 -1.238 . . . . 0.0 111.829 172.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.7 t -69.27 -38.58 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 O-C-N 121.236 -0.915 . . . . 0.0 111.529 172.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.9 tpp85 -58.11 -46.14 86.06 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.156 -0.965 . . . . 0.0 111.009 171.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -69.95 -34.79 73.87 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 116.759 -1.591 . . . . 0.0 112.616 175.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.78 -37.99 69.31 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 121.589 1.995 . . . . 0.0 109.735 169.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.8 m -70.23 -38.26 75.18 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.115 0.966 . . . . 0.0 113.483 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.0 mm -71.55 -34.86 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 120.854 1.661 . . . . 0.0 110.489 176.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.1 t -63.21 -50.5 78.84 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 C-N-CA 125.4 1.48 . . . . 0.0 109.59 172.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -55.08 -40.51 70.45 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 121.307 1.867 . . . . 0.0 113.34 172.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.4 m -59.32 -34.01 71.81 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.085 -0.384 . . . . 0.0 111.682 174.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -79.41 -35.7 40.19 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.825 1.65 . . . . 0.0 113.937 172.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.96 -33.71 76.43 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 120.161 1.346 . . . . 0.0 111.576 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 87.6 mt -75.04 -37.4 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 124.849 1.259 . . . . 0.0 110.585 169.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.23 -39.48 62.3 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 125.637 1.589 . . . . 0.0 114.181 -173.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.3 t -151.49 -27.75 0.19 Allowed 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.22 0.27 38.14 Favored Glycine 0 N--CA 1.481 1.655 0 N-CA-C 116.757 1.463 . . . . 0.0 116.757 175.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.1 m -144.09 136.01 26.26 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.35 1.86 . . . . 0.0 109.01 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.9 p -114.41 143.18 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.335 1.054 . . . . 0.0 110.224 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -128.41 158.46 38.25 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.748 1.219 . . . . 0.0 110.872 -170.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -51.9 -37.95 54.38 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.722 0.809 . . . . 0.0 113.07 -177.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -70.31 -20.05 63.03 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.637 1.575 . . . . 0.0 114.236 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -80.55 -36.96 32.29 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.997 0.817 . . . . 0.0 111.491 171.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.5 mt -87.48 -33.06 19.14 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.74 1.616 . . . . 0.0 113.951 -170.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.6 ptt85 -55.15 -22.37 16.81 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 172.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -84.35 -12.25 54.87 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 176.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -110.55 -21.63 12.05 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 119.957 1.253 . . . . 0.0 114.038 -170.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -132.52 130.08 39.93 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.042 1.337 . . . . 0.0 111.498 -174.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.71 142.76 34.89 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 168.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.5 t -138.33 140.5 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 O-C-N 121.085 -1.009 . . . . 0.0 110.975 -169.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 mm -114.17 134.28 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.748 1.619 . . . . 0.0 113.628 -172.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -136.64 69.13 1.42 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.594 1.958 . . . . 0.0 109.589 170.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 30.8 mt -89.93 128.18 51.0 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 123.971 0.909 . . . . 0.0 109.383 171.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -61.46 132.56 41.38 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.35 2.033 . . . . 0.0 112.713 173.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.35 2.89 87.33 Favored Glycine 0 CA--C 1.537 1.412 0 N-CA-C 116.079 1.192 . . . . 0.0 116.079 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -136.13 155.12 77.72 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-N 119.152 1.476 . . . . 0.0 112.008 172.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.05 147.45 67.49 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.722 2.281 . . . . 0.0 113.14 -171.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 p -58.33 130.2 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.641 1.176 . . . . 0.0 111.651 174.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.1 t -109.88 139.28 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.753 1.621 . . . . 0.0 108.937 171.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -135.47 108.5 7.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.767 1.227 . . . . 0.0 108.511 177.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.6 t -80.8 149.3 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.111 1.364 . . . . 0.0 110.985 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.14 -93.59 1.43 Allowed Glycine 0 CA--C 1.533 1.196 0 O-C-N 121.654 -0.654 . . . . 0.0 112.128 174.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.1 m -149.35 158.4 44.14 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.048 1.339 . . . . 0.0 109.146 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -76.69 128.27 82.25 Favored Pre-proline 0 CA--C 1.548 0.892 0 O-C-N 120.548 -1.345 . . . . 0.0 110.896 173.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -75.83 155.45 39.16 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.285 3.323 . . . . 0.0 114.89 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.7 t -86.18 -31.79 21.58 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -169.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.36 -41.17 1.42 Allowed Glycine 0 N--CA 1.474 1.201 0 C-N-CA 124.991 1.282 . . . . 0.0 112.583 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -78.49 64.13 3.48 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.059 1.343 . . . . 0.0 111.047 169.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.0 158.17 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.443 1.497 . . . . 0.0 112.406 -178.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.4 mt -99.83 126.7 45.97 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.612 2.365 . . . . 0.0 110.056 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -109.2 109.58 20.56 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -170.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.26 146.7 18.24 Favored Glycine 0 N--CA 1.475 1.24 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 169.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 68.8 ttt-85 -154.2 132.84 12.16 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 120.812 2.306 . . . . 0.0 114.101 -169.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -143.32 173.59 11.47 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.196 1.398 . . . . 0.0 113.597 -177.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -143.73 119.26 10.35 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.597 1.559 . . . . 0.0 110.409 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.26 175.14 54.62 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.521 1.534 . . . . 0.0 115.513 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -68.02 -9.92 49.58 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.11 2.164 . . . . 0.0 115.373 -174.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -97.47 3.81 50.69 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 120.309 1.413 . . . . 0.0 113.452 169.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.57 23.47 26.13 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.971 1.272 . . . . 0.0 114.238 173.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.14 -164.4 1.11 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.297 1.439 . . . . 0.0 114.527 -172.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.4 m -146.91 121.57 9.83 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.334 -1.479 . . . . 0.0 111.833 173.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.7 t -98.14 139.55 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.841 1.656 . . . . 0.0 109.456 169.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.6 tp -129.01 146.9 50.86 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.216 1.406 . . . . 0.0 109.302 171.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.9 t -125.6 134.81 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.005 1.322 . . . . 0.0 108.268 171.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -132.94 131.33 40.7 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.278 1.031 . . . . 0.0 111.359 -176.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -148.51 152.98 39.44 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.352 1.061 . . . . 0.0 112.398 177.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -62.65 135.93 55.43 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.893 2.395 . . . . 0.0 113.86 -170.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 . . . . . 0 C--O 1.254 1.324 0 C-N-CA 127.369 2.268 . . . . 0.0 112.34 179.82 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.808 0 CA-C-O 121.114 0.286 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.0 m -66.0 157.96 29.51 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.869 1.268 . . . . 0.0 113.67 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -141.11 155.17 46.16 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.212 1.405 . . . . 0.0 112.991 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.9 m -107.83 157.1 18.45 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.157 1.783 . . . . 0.0 110.442 174.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.9 mmt-85 -144.65 165.04 29.17 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 127.681 2.392 . . . . 0.0 110.177 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.4 m -109.91 102.94 11.66 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.484 1.114 . . . . 0.0 111.067 -174.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.2 mm -73.73 160.54 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 125.592 1.557 . . . . 0.0 110.894 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.6 t -111.94 141.91 44.99 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.937 1.295 . . . . 0.0 112.3 177.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.1 m -127.78 26.94 5.81 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.428 1.891 . . . . 0.0 110.475 169.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.1 p -136.27 -70.95 0.46 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.85 1.66 . . . . 0.0 109.292 -172.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.97 -43.58 78.68 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.211 1.404 . . . . 0.0 111.936 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -73.54 -25.27 60.32 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.836 -0.54 . . . . 0.0 112.44 174.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -74.19 -47.93 32.4 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.966 -1.084 . . . . 0.0 111.837 174.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -36.4 78.01 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.347 -0.846 . . . . 0.0 112.588 -174.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.2 m -61.76 -21.41 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -68.72 -43.54 75.77 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.465 1.029 . . . . 0.0 112.231 174.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.74 -42.56 73.77 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.395 -0.815 . . . . 0.0 111.263 -171.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -65.7 -29.54 70.1 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.705 1.202 . . . . 0.0 112.81 171.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.59 -38.77 77.46 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.678 -1.264 . . . . 0.0 112.421 170.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.56 -36.28 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 O-C-N 121.289 -0.882 . . . . 0.0 111.305 172.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -58.83 -44.74 90.96 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.315 -0.865 . . . . 0.0 111.293 171.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.3 mp -70.01 -35.88 74.7 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-O 117.225 -1.369 . . . . 0.0 113.293 173.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.19 -34.73 66.53 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 121.284 1.856 . . . . 0.0 110.602 169.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.5 m -70.17 -38.89 75.53 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.709 0.803 . . . . 0.0 112.927 172.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.4 mm -74.42 -33.96 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 120.563 1.528 . . . . 0.0 111.507 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.9 t -66.13 -43.77 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 117.577 -1.201 . . . . 0.0 110.323 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -52.59 -43.01 65.05 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.666 1.575 . . . . 0.0 112.034 170.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.8 t -61.75 -31.08 71.24 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.317 0.647 . . . . 0.0 112.301 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -79.91 -36.49 36.35 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.993 1.317 . . . . 0.0 113.306 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 71.0 mt -66.27 -35.17 79.7 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.69 1.132 . . . . 0.0 111.685 175.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.4 mt -74.56 -35.21 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.417 1.087 . . . . 0.0 111.04 169.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.69 -38.33 50.69 Favored Glycine 0 C--N 1.339 0.724 0 C-N-CA 125.798 1.666 . . . . 0.0 114.99 -172.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.5 t -152.84 -26.52 0.15 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.82 4.66 42.21 Favored Glycine 0 N--CA 1.476 1.358 0 N-CA-C 116.512 1.365 . . . . 0.0 116.512 174.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.8 p -155.85 141.38 17.78 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.241 1.416 . . . . 0.0 111.131 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 80.4 t -93.74 144.09 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.247 1.419 . . . . 0.0 109.64 175.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -125.07 158.09 34.64 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.622 1.169 . . . . 0.0 110.302 171.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -56.9 -37.17 71.05 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.223 -0.923 . . . . 0.0 112.632 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -69.88 -19.07 63.44 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -77.11 -39.88 47.9 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.783 0.72 . . . . 0.0 111.91 171.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.2 mt -85.64 -27.45 25.4 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -173.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -57.82 -24.18 56.15 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 119.812 1.187 . . . . 0.0 113.58 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -83.58 -3.28 57.54 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.087 1.355 . . . . 0.0 114.122 175.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -118.6 -19.31 8.79 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.449 1.1 . . . . 0.0 113.561 -169.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -50.64 -64.09 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.062 0.945 . . . . 0.0 110.995 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 62.58 -13.4 0.07 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 128.265 2.626 . . . . 0.0 116.953 170.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -142.89 -31.47 0.5 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.707 1.603 . . . . 0.0 112.502 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.28 158.65 15.48 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.62 -53.49 13.52 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.218 1.407 . . . . 0.0 110.65 169.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -131.47 132.03 43.96 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.438 0.695 . . . . 0.0 111.495 -170.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.08 147.41 31.24 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.212 -0.93 . . . . 0.0 110.924 169.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.3 t -138.43 141.18 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.266 1.427 . . . . 0.0 110.848 -171.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.35 131.18 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.998 1.319 . . . . 0.0 113.828 -171.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -130.72 76.43 1.72 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.967 1.707 . . . . 0.0 109.481 169.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.4 mt -94.31 131.0 32.21 Favored Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 123.715 0.806 . . . . 0.0 108.985 172.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -64.64 136.78 51.41 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.195 1.93 . . . . 0.0 111.544 175.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.97 -0.99 87.9 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.704 1.145 . . . . 0.0 115.851 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -138.32 156.56 73.53 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-N 119.322 1.561 . . . . 0.0 112.582 175.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.19 153.57 66.83 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.811 2.341 . . . . 0.0 113.064 -174.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.1 p -59.2 132.93 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.254 1.022 . . . . 0.0 111.531 172.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 95.5 t -111.32 141.64 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.492 1.517 . . . . 0.0 109.194 170.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -134.84 119.67 18.4 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.215 1.406 . . . . 0.0 109.428 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.2 t -94.87 155.24 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.287 1.835 . . . . 0.0 111.353 -174.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.67 -95.22 0.99 Allowed Glycine 0 CA--C 1.53 1.023 0 O-C-N 121.151 -0.968 . . . . 0.0 112.836 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.6 m -153.0 152.81 31.81 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.537 -0.978 . . . . 0.0 110.26 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -67.19 130.07 93.73 Favored Pre-proline 0 CA--C 1.547 0.865 0 O-C-N 120.72 -1.238 . . . . 0.0 110.883 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.54 158.77 25.46 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.179 3.253 . . . . 0.0 114.621 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.7 t -88.49 -34.02 17.6 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -169.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.15 -36.57 1.86 Allowed Glycine 0 N--CA 1.477 1.411 0 C-N-CA 125.153 1.358 . . . . 0.0 112.355 -174.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -78.43 63.07 3.2 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.236 1.414 . . . . 0.0 110.522 169.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.4 m -139.84 154.36 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.648 1.579 . . . . 0.0 112.351 -176.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.4 mt -89.04 147.5 24.23 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 127.677 2.391 . . . . 0.0 109.128 170.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -127.09 116.95 21.48 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 118.672 0.669 . . . . 0.0 112.206 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.89 150.78 19.98 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.12 1.343 . . . . 0.0 110.001 169.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -156.11 137.04 13.54 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.573 1.686 . . . . 0.0 113.137 -171.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.61 161.98 37.8 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.033 1.333 . . . . 0.0 113.6 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 74.9 m -114.42 128.26 56.25 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.155 1.382 . . . . 0.0 108.319 172.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.08 176.91 44.2 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 122.033 0.796 . . . . 0.0 114.64 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -83.51 -9.56 58.89 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -169.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -102.3 5.91 40.19 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 120.733 1.606 . . . . 0.0 112.194 169.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.12 17.48 34.56 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.247 1.879 . . . . 0.0 114.362 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -83.93 173.22 11.38 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.19 1.796 . . . . 0.0 113.357 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.4 m -129.23 136.55 50.26 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.97 1.308 . . . . 0.0 110.25 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.2 t -119.29 139.7 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.023 1.729 . . . . 0.0 109.575 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.4 tt -132.84 149.11 52.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.467 1.107 . . . . 0.0 109.817 175.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 86.0 t -133.23 139.87 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.509 1.523 . . . . 0.0 109.397 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -131.74 137.73 48.34 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.988 0.899 . . . . 0.0 112.825 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -137.04 150.48 69.62 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 126.564 1.946 . . . . 0.0 111.031 -173.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -64.17 137.93 59.08 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.801 2.334 . . . . 0.0 112.582 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 125.92 1.688 . . . . 0.0 112.409 177.605 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.736 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.9 m -71.26 -29.63 65.32 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -174.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -44.43 132.31 6.1 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.757 1.623 . . . . 0.0 113.985 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.4 t -160.82 148.55 15.82 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.139 1.775 . . . . 0.0 110.531 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -144.2 156.61 44.38 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.987 2.115 . . . . 0.0 110.761 -174.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.9 t -144.49 144.3 31.29 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.668 1.187 . . . . 0.0 111.671 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 55.0 mt -81.38 138.82 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.909 0.884 . . . . 0.0 111.368 -170.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.3 m -76.34 42.62 0.28 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.045 1.738 . . . . 0.0 113.754 178.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.9 m -62.59 42.34 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 130.273 3.429 . . . . 0.0 117.213 -169.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.4 p -137.01 -64.6 0.57 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 127.372 2.269 . . . . 0.0 107.335 169.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.87 -47.26 60.23 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.045 1.338 . . . . 0.0 112.411 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -69.94 -26.43 64.12 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.475 0.71 . . . . 0.0 111.654 174.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -71.18 -54.09 12.22 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.059 -1.026 . . . . 0.0 111.554 173.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -28.46 69.31 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -171.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.3 m -60.4 -21.1 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 170.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -69.2 -45.56 69.62 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 119.466 1.03 . . . . 0.0 112.391 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 mp -70.0 -40.17 75.43 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.552 -0.718 . . . . 0.0 111.617 -170.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -65.02 -34.2 77.87 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.722 1.209 . . . . 0.0 112.519 170.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.92 -38.92 89.94 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 120.604 -1.31 . . . . 0.0 112.361 171.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 94.3 t -68.11 -37.82 78.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 O-C-N 121.294 -0.879 . . . . 0.0 111.533 172.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -59.53 -44.59 93.15 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.318 -0.864 . . . . 0.0 111.057 172.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.5 mp -69.52 -34.32 74.1 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 117.448 -1.263 . . . . 0.0 113.044 174.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.16 -34.44 68.44 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 121.172 1.805 . . . . 0.0 110.534 169.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.3 m -72.63 -38.65 67.66 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.353 1.061 . . . . 0.0 113.636 171.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.1 mm -72.79 -34.2 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 120.915 1.689 . . . . 0.0 110.97 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.2 t -67.18 -47.19 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.795 1.238 . . . . 0.0 109.63 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -53.11 -44.0 67.32 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 120.821 1.646 . . . . 0.0 111.976 170.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.2 m -59.97 -30.43 69.1 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.744 -0.598 . . . . 0.0 112.486 175.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.2 tpt180 -80.92 -35.22 32.7 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.685 1.594 . . . . 0.0 113.526 171.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.7 mt -66.11 -33.8 76.61 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.988 1.267 . . . . 0.0 111.588 174.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 90.7 mt -75.08 -35.69 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.791 1.236 . . . . 0.0 110.811 169.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.89 -38.05 49.7 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 125.5 1.524 . . . . 0.0 114.807 -172.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.1 t -152.58 -26.97 0.16 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.93 1.06 39.2 Favored Glycine 0 N--CA 1.477 1.43 0 N-CA-C 116.774 1.47 . . . . 0.0 116.774 174.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.9 m -147.8 139.0 23.52 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.098 1.759 . . . . 0.0 109.33 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.46 147.05 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.737 1.215 . . . . 0.0 109.955 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -132.32 157.42 44.5 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.782 1.233 . . . . 0.0 110.472 -174.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -55.66 -38.28 69.38 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.758 -0.589 . . . . 0.0 112.268 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -70.45 -20.18 62.91 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.794 1.238 . . . . 0.0 113.721 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -78.99 -41.81 28.11 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.833 0.742 . . . . 0.0 111.067 169.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.3 mt -81.67 -30.34 32.74 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -170.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -56.3 -26.91 53.75 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 173.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -84.18 -3.35 58.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.325 1.05 . . . . 0.0 113.723 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.6 mm-40 -120.71 -13.73 8.67 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.617 1.167 . . . . 0.0 113.535 -169.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.82 -60.81 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.405 0.682 . . . . 0.0 112.66 -176.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.259 21.7 mmt85 62.71 -19.33 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 128.148 2.579 . . . . 0.0 117.869 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -148.97 -33.9 0.21 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.843 1.257 . . . . 0.0 113.121 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.23 151.47 45.31 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.458 1.103 . . . . 0.0 111.582 174.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.06 -45.53 13.91 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.849 -0.532 . . . . 0.0 110.3 172.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -132.71 124.34 27.98 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.55 1.54 . . . . 0.0 109.169 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.13 142.63 29.57 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.443 1.02 . . . . 0.0 109.579 169.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 63.1 t -137.84 141.16 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.646 1.178 . . . . 0.0 109.476 -171.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -122.97 134.07 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -169.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -129.67 81.79 2.04 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.467 1.907 . . . . 0.0 109.631 170.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.5 mt -98.34 125.18 44.22 Favored Pre-proline 0 N--CA 1.48 1.063 0 C-N-CA 123.775 0.83 . . . . 0.0 108.979 169.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.87 133.4 53.51 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.384 2.056 . . . . 0.0 112.291 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.25 3.42 87.2 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-O 118.273 -1.293 . . . . 0.0 115.977 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -138.8 163.39 46.95 Favored Pre-proline 0 N--CA 1.475 0.78 0 CA-C-N 119.717 1.759 . . . . 0.0 114.075 173.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -60.62 140.78 92.86 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.579 2.853 . . . . 0.0 114.204 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.2 t -60.23 131.31 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.332 1.053 . . . . 0.0 110.024 169.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 70.1 t -110.38 141.41 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.095 1.358 . . . . 0.0 109.562 172.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -138.17 114.42 10.23 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.999 1.319 . . . . 0.0 109.191 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.3 t -89.97 155.53 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.941 1.696 . . . . 0.0 111.312 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.83 -102.83 1.58 Allowed Glycine 0 CA--C 1.532 1.107 0 O-C-N 121.343 -0.848 . . . . 0.0 112.736 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.3 m -146.12 150.05 35.18 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.516 1.126 . . . . 0.0 110.17 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -67.59 129.74 93.39 Favored Pre-proline 0 CA--C 1.548 0.898 0 O-C-N 120.861 -1.15 . . . . 0.0 111.002 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.86 155.0 23.32 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.952 3.102 . . . . 0.0 114.314 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.9 t -83.66 -26.95 29.44 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -171.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.25 -33.9 3.36 Favored Glycine 0 N--CA 1.476 1.32 0 C-N-CA 125.572 1.558 . . . . 0.0 112.64 -175.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -79.18 60.23 2.98 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.775 1.63 . . . . 0.0 111.216 169.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.3 m -136.68 158.99 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 126.078 1.751 . . . . 0.0 112.29 -173.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.9 mt -99.77 126.96 45.93 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.854 2.462 . . . . 0.0 110.382 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -111.33 110.1 20.41 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -169.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.38 145.88 18.29 Favored Glycine 0 N--CA 1.471 0.998 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 169.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -154.46 137.4 15.44 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 120.145 1.972 . . . . 0.0 113.654 -169.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.26 163.65 34.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.56 1.144 . . . . 0.0 113.95 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 62.1 m -117.11 130.52 56.69 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.411 1.485 . . . . 0.0 108.578 172.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.31 174.7 37.08 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.092 0.853 . . . . 0.0 114.638 -177.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -81.45 -10.82 59.42 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 -169.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -99.61 5.49 45.91 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.714 1.597 . . . . 0.0 111.983 169.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.37 17.62 33.49 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 126.259 1.885 . . . . 0.0 114.268 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.3 pm0 -84.08 175.51 9.46 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.839 1.656 . . . . 0.0 113.459 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.5 m -133.2 133.88 43.34 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.073 1.349 . . . . 0.0 110.41 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 67.3 t -114.26 141.18 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.168 1.787 . . . . 0.0 110.029 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.7 tp -129.23 146.77 51.07 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.388 1.475 . . . . 0.0 109.524 174.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.6 t -124.4 137.7 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 127.596 2.358 . . . . 0.0 107.719 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -135.35 138.13 43.06 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.017 0.527 . . . . 0.0 111.724 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -148.83 154.25 39.97 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 172.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -59.82 137.64 77.84 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.779 2.319 . . . . 0.0 113.404 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 . . . . . 0 C--O 1.255 1.354 0 C-N-CA 125.888 1.675 . . . . 0.0 112.241 178.542 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 112.325 -0.31 . . . . 0.0 112.325 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.4 m -153.74 157.42 39.44 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.264 1.426 . . . . 0.0 112.076 174.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -64.38 159.23 21.66 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -174.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.4 m -59.54 145.09 45.48 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.822 1.649 . . . . 0.0 112.724 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 -77.2 127.81 33.27 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.162 0.985 . . . . 0.0 112.305 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.9 m -56.27 140.13 45.84 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.909 1.284 . . . . 0.0 111.888 176.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.1 mt -58.4 138.52 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.486 1.115 . . . . 0.0 109.959 178.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 t -83.69 37.33 0.58 Allowed 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 -169.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.0 m -66.58 47.25 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.839 2.456 . . . . 0.0 113.675 171.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.6 p -138.34 -64.15 0.53 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 128.896 2.878 . . . . 0.0 107.024 171.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.85 -47.77 50.68 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.974 1.31 . . . . 0.0 112.504 174.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.6 tp60 -68.81 -28.26 66.59 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.9 -1.125 . . . . 0.0 111.286 174.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -71.46 -51.28 24.63 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.738 -0.601 . . . . 0.0 111.325 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -37.15 79.78 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.057 -1.027 . . . . 0.0 111.822 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.9 t -58.24 -31.43 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.337 1.455 . . . . 0.0 113.085 173.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -71.12 -39.64 71.92 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.235 -0.916 . . . . 0.0 112.957 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -77.86 -36.31 50.01 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.271 -0.893 . . . . 0.0 111.918 -172.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -64.34 -28.0 69.4 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.337 -0.852 . . . . 0.0 112.705 170.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.68 -36.6 84.11 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.608 -1.307 . . . . 0.0 111.981 170.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.3 t -71.33 -35.79 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.567 1.147 . . . . 0.0 111.174 173.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.2 tpp85 -60.82 -46.36 90.82 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.011 -1.055 . . . . 0.0 111.473 171.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.3 mp -69.76 -33.25 72.16 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 117.352 -1.308 . . . . 0.0 112.418 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.58 -33.05 69.53 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 121.269 1.849 . . . . 0.0 110.785 169.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.3 m -73.79 -38.61 64.58 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.303 1.041 . . . . 0.0 113.33 171.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.7 mm -73.31 -36.7 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 121.072 1.76 . . . . 0.0 110.84 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.6 t -62.2 -49.93 82.03 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 CA-C-O 117.558 -1.21 . . . . 0.0 109.466 173.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -54.05 -43.52 70.28 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 120.803 1.638 . . . . 0.0 112.377 173.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.0 m -59.33 -36.84 76.41 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.756 -0.59 . . . . 0.0 111.912 176.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -74.55 -36.49 63.11 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.36 1.464 . . . . 0.0 113.271 172.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.2 mt -67.27 -30.57 70.48 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.864 1.211 . . . . 0.0 112.034 175.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.4 mt -76.05 -37.31 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.869 1.268 . . . . 0.0 110.936 169.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.58 -39.52 55.95 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.383 1.468 . . . . 0.0 114.456 -173.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.8 t -148.83 -27.61 0.3 Allowed 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.69 14.23 35.3 Favored Glycine 0 N--CA 1.479 1.535 0 N-CA-C 116.061 1.184 . . . . 0.0 116.061 175.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.1 m -156.67 145.83 20.36 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.945 1.698 . . . . 0.0 109.694 172.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.0 p -120.69 143.64 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.521 1.528 . . . . 0.0 110.359 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -128.8 156.25 43.88 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.371 1.068 . . . . 0.0 111.395 -169.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -54.2 -39.09 66.36 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.671 -0.643 . . . . 0.0 112.299 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -71.1 -21.07 62.27 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.246 1.418 . . . . 0.0 113.638 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -80.98 -37.23 29.62 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.869 0.759 . . . . 0.0 111.39 169.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.6 mt -82.16 -32.3 30.06 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.984 1.314 . . . . 0.0 113.733 -171.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -58.31 -22.94 54.93 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 173.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -85.11 -1.14 56.53 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.556 1.142 . . . . 0.0 113.913 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -116.56 -21.28 9.24 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.841 1.257 . . . . 0.0 112.998 -174.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -53.53 -62.0 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.623 0.769 . . . . 0.0 111.781 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 64.42 -12.4 0.11 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.648 2.379 . . . . 0.0 117.114 170.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -151.94 -31.37 0.15 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.278 1.031 . . . . 0.0 112.491 171.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.37 154.89 32.32 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.6 -56.57 5.61 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.023 1.329 . . . . 0.0 111.571 171.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -126.99 131.36 51.06 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.147 0.579 . . . . 0.0 112.501 -169.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.29 144.47 37.38 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.394 -0.816 . . . . 0.0 109.637 169.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.0 t -139.85 138.72 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.264 1.026 . . . . 0.0 110.389 -169.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -119.29 132.93 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -169.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -130.02 83.31 2.12 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.977 1.711 . . . . 0.0 109.45 172.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.5 mt -100.18 132.12 23.13 Favored Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 124.048 0.939 . . . . 0.0 109.271 173.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.52 134.18 37.43 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.352 2.035 . . . . 0.0 111.658 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.48 0.24 82.41 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.774 1.178 . . . . 0.0 115.565 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -135.31 158.12 75.23 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 119.027 1.414 . . . . 0.0 112.087 172.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.2 155.74 66.88 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.621 2.214 . . . . 0.0 112.786 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.2 p -57.66 139.82 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.637 1.175 . . . . 0.0 111.588 171.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 85.1 t -119.24 139.26 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.466 1.507 . . . . 0.0 108.806 172.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -133.5 121.82 22.73 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.001 1.32 . . . . 0.0 109.564 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.8 t -95.02 151.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.618 1.567 . . . . 0.0 111.116 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.17 -102.62 2.3 Favored Glycine 0 CA--C 1.533 1.213 0 O-C-N 121.462 -0.773 . . . . 0.0 112.522 172.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 94.5 m -143.97 141.65 30.3 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.599 1.159 . . . . 0.0 109.896 174.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -65.45 125.9 90.45 Favored Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 120.73 -1.231 . . . . 0.0 111.127 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.63 153.57 34.34 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.712 2.942 . . . . 0.0 114.911 -172.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.3 t -82.22 -24.0 35.1 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -169.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.64 -35.05 3.71 Favored Glycine 0 N--CA 1.478 1.487 0 C-N-CA 125.394 1.473 . . . . 0.0 112.618 -174.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -77.9 59.56 2.13 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.027 1.731 . . . . 0.0 110.672 169.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.0 m -135.55 157.29 39.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 126.292 1.837 . . . . 0.0 112.046 -173.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.6 mt -90.78 144.65 25.5 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.704 1.602 . . . . 0.0 109.125 170.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -125.49 122.13 35.73 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.532 0.733 . . . . 0.0 112.102 -177.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.42 148.08 16.44 Favored Glycine 0 N--CA 1.47 0.942 0 C-N-CA 126.033 1.778 . . . . 0.0 109.563 169.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -152.42 141.55 21.34 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.094 1.447 . . . . 0.0 112.876 -169.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.75 162.03 40.03 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.015 1.326 . . . . 0.0 113.228 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 70.1 m -113.11 127.44 56.2 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.951 1.301 . . . . 0.0 108.697 171.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.19 172.35 43.37 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.379 0.99 . . . . 0.0 114.06 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -82.93 -11.78 57.88 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 -169.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -92.94 2.91 56.55 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.837 1.653 . . . . 0.0 111.848 169.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.86 14.68 39.14 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 126.735 2.112 . . . . 0.0 114.369 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.5 pm0 -81.89 173.76 11.94 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.861 1.665 . . . . 0.0 113.794 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.0 m -127.84 138.92 52.87 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.452 1.501 . . . . 0.0 110.348 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.4 t -121.52 139.29 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.425 1.49 . . . . 0.0 109.487 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.2 tp -126.78 148.08 49.95 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.48 1.512 . . . . 0.0 109.935 174.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.38 136.17 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.462 1.505 . . . . 0.0 108.203 174.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -130.19 131.74 45.73 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.845 0.831 . . . . 0.0 112.142 -177.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -126.14 151.54 72.05 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 126.264 1.825 . . . . 0.0 111.552 -178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -61.11 136.15 63.18 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 122.655 2.237 . . . . 0.0 112.023 170.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 . . . . . 0 C--O 1.252 1.213 0 C-N-CA 125.211 1.404 . . . . 0.0 113.252 -177.597 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.762 0 N-CA-C 112.115 -0.394 . . . . 0.0 112.115 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.6 p -98.7 18.14 17.6 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.066 1.746 . . . . 0.0 114.106 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -152.92 167.64 28.45 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.08 1.752 . . . . 0.0 111.069 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.5 m -103.02 130.65 50.2 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.217 1.007 . . . . 0.0 110.9 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -56.5 -33.21 65.79 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.752 1.221 . . . . 0.0 114.047 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.3 t -113.33 175.53 5.41 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.002 1.721 . . . . 0.0 111.908 171.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.0 mt -117.05 136.67 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.668 1.587 . . . . 0.0 107.69 176.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 64.1 p -86.8 30.32 0.75 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -169.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 p -68.72 51.59 0.08 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 128.571 2.749 . . . . 0.0 114.163 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.7 p -137.55 -66.48 0.5 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 130.007 3.323 . . . . 0.0 106.561 169.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.15 -46.48 61.41 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.428 1.491 . . . . 0.0 113.048 174.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.6 tp60 -74.16 -19.23 60.63 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.687 0.795 . . . . 0.0 111.703 175.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -77.78 -49.05 15.14 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 120.79 -1.194 . . . . 0.0 112.162 172.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.406 HH21 ' CD ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER -61.62 -36.43 80.71 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 121.118 -0.989 . . . . 0.0 112.839 -174.351 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.9 m -60.07 -23.06 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 174.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -71.16 -39.95 71.59 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.217 0.917 . . . . 0.0 111.735 175.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.0 mt -71.84 -41.63 67.91 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.053 0.941 . . . . 0.0 111.541 -172.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.406 ' CD ' HH21 ' A' ' 14' ' ' ARG . 4.9 pt-20 -66.68 -33.24 75.2 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.88 0.872 . . . . 0.0 112.516 169.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.8 -37.88 89.02 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 120.28 1.4 . . . . 0.0 112.161 171.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.9 t -69.1 -37.78 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.193 0.997 . . . . 0.0 111.712 172.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -60.87 -43.44 98.42 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.004 -1.06 . . . . 0.0 111.336 172.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -69.79 -34.43 73.71 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 117.468 -1.254 . . . . 0.0 112.585 173.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.27 -33.05 68.99 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 121.175 1.807 . . . . 0.0 110.486 169.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.8 m -73.61 -38.89 64.94 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.401 1.08 . . . . 0.0 113.74 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.1 mm -72.47 -36.12 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 121.221 1.828 . . . . 0.0 110.626 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.66 -48.4 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 117.549 -1.215 . . . . 0.0 109.664 174.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -53.62 -44.27 69.37 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.836 1.653 . . . . 0.0 112.1 172.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.2 m -58.85 -34.48 71.62 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.786 -0.571 . . . . 0.0 112.113 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -77.78 -35.67 51.34 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.482 1.513 . . . . 0.0 113.63 172.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 56.0 mt -66.77 -33.05 74.77 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 120.127 1.33 . . . . 0.0 111.56 175.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 90.8 mt -72.75 -36.98 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 124.821 1.248 . . . . 0.0 110.672 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.2 -39.7 51.88 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.506 1.527 . . . . 0.0 114.673 -173.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.6 t -151.45 -27.25 0.19 Allowed 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.86 2.42 49.24 Favored Glycine 0 N--CA 1.48 1.629 0 N-CA-C 116.436 1.334 . . . . 0.0 116.436 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.9 m -143.81 136.5 27.19 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.254 1.821 . . . . 0.0 109.115 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 p -113.31 145.9 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.597 1.159 . . . . 0.0 110.216 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -132.92 157.4 45.2 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.634 1.174 . . . . 0.0 111.073 -170.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.55 -40.75 65.79 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.797 -0.565 . . . . 0.0 112.368 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.95 -17.82 62.05 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.394 1.078 . . . . 0.0 113.756 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -81.67 -36.86 28.29 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.032 0.833 . . . . 0.0 111.52 169.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 64.3 mt -85.68 -31.75 22.34 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.742 1.617 . . . . 0.0 114.374 -171.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -60.66 -19.17 57.61 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -85.62 -5.29 59.29 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.06 1.344 . . . . 0.0 114.131 173.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -116.1 -18.2 10.67 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.719 1.208 . . . . 0.0 113.482 -169.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -51.01 -57.05 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.004 0.922 . . . . 0.0 113.008 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.28 20.9 mmt85 62.6 -15.02 0.06 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 118.824 2.898 . . . . 0.0 118.824 175.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -155.52 -28.15 0.1 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.787 0.835 . . . . 0.0 113.023 173.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.61 159.44 29.21 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -82.13 -49.69 9.88 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.967 0.907 . . . . 0.0 111.853 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -129.04 130.89 47.16 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.649 1.58 . . . . 0.0 111.44 -173.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -106.02 142.73 35.23 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.48 -0.762 . . . . 0.0 109.442 169.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.5 t -138.14 139.54 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.492 1.117 . . . . 0.0 110.354 -170.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.58 133.24 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -169.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.6 mmt85 -132.58 79.06 1.83 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.884 1.674 . . . . 0.0 109.664 171.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.5 mt -96.37 132.16 27.11 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 124.188 0.995 . . . . 0.0 109.329 172.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.59 131.02 26.49 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.174 1.916 . . . . 0.0 111.499 175.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.2 2.6 80.11 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 116.201 1.241 . . . . 0.0 116.201 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -137.99 155.83 74.4 Favored Pre-proline 0 N--CA 1.475 0.81 0 CA-C-N 119.246 1.523 . . . . 0.0 111.907 172.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.91 151.41 78.14 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.682 2.255 . . . . 0.0 113.044 -173.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 p -59.15 131.67 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.403 1.081 . . . . 0.0 111.249 172.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.3 t -109.53 138.25 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.313 1.445 . . . . 0.0 109.099 170.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -132.72 116.3 16.43 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.247 1.419 . . . . 0.0 108.804 176.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.6 t -93.12 152.02 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.439 1.495 . . . . 0.0 111.186 -175.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.25 -97.44 1.42 Allowed Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.694 -0.629 . . . . 0.0 111.558 176.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.2 m -146.53 149.7 34.11 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.42 1.088 . . . . 0.0 109.604 177.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.2 tttp -70.47 127.33 92.15 Favored Pre-proline 0 CA--C 1.547 0.84 0 O-C-N 120.628 -1.295 . . . . 0.0 110.485 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.64 154.83 39.82 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 124.026 3.151 . . . . 0.0 114.739 -173.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.1 t -83.19 -23.25 32.93 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -169.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.37 -35.45 3.61 Favored Glycine 0 N--CA 1.475 1.261 0 C-N-CA 125.545 1.545 . . . . 0.0 113.026 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -78.43 59.25 2.33 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.87 1.668 . . . . 0.0 111.267 169.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.0 m -132.93 158.2 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.949 1.7 . . . . 0.0 112.299 -174.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.4 mt -89.73 144.04 26.31 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 126.505 1.922 . . . . 0.0 109.425 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -123.29 114.03 19.68 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.074 0.549 . . . . 0.0 112.376 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.31 144.16 17.13 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 169.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -153.73 138.31 16.88 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 120.504 2.152 . . . . 0.0 113.559 -169.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.05 166.26 26.63 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.022 1.329 . . . . 0.0 113.782 -176.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.0 m -120.03 130.56 54.77 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.62 1.568 . . . . 0.0 108.454 173.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.93 177.29 39.94 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.11 0.862 . . . . 0.0 114.346 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -84.36 -14.09 50.49 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -169.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -93.76 4.52 53.81 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.871 1.669 . . . . 0.0 112.124 169.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.92 15.98 43.37 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.583 2.039 . . . . 0.0 114.106 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.9 pm0 -79.8 172.64 13.51 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.522 1.529 . . . . 0.0 113.573 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.5 m -130.22 137.36 50.0 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.37 1.468 . . . . 0.0 109.834 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.3 t -120.28 138.01 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.731 1.612 . . . . 0.0 109.605 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 15.6 tp -128.35 149.47 50.5 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.33 1.452 . . . . 0.0 109.539 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 75.2 t -132.09 133.73 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.246 1.818 . . . . 0.0 107.871 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -133.69 137.46 45.32 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.226 0.536 . . . . 0.0 112.395 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -151.95 155.03 33.41 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 123.835 0.854 . . . . 0.0 112.624 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -60.14 138.82 84.0 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.118 2.546 . . . . 0.0 113.906 -173.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 . . . . . 0 C--O 1.252 1.204 0 C-N-CA 126.162 1.785 . . . . 0.0 112.746 -178.598 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.4 t -150.07 149.61 30.55 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.184 1.393 . . . . 0.0 111.398 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -135.64 146.78 48.2 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.557 1.543 . . . . 0.0 111.656 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.2 m -52.11 136.86 28.93 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.089 1.356 . . . . 0.0 112.743 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -67.14 165.48 15.88 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.828 1.651 . . . . 0.0 114.251 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.6 m -66.02 148.74 51.34 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.763 1.225 . . . . 0.0 109.443 169.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.6 mt -133.19 140.14 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.495 1.118 . . . . 0.0 108.225 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.9 m -90.84 38.39 0.95 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -169.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 m -63.1 34.05 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 129.24 3.016 . . . . 0.0 117.512 -170.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.0 p -134.35 -63.66 0.71 Allowed 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 127.448 2.299 . . . . 0.0 107.719 169.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.95 -43.43 71.61 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.531 1.532 . . . . 0.0 112.934 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -77.84 -24.54 48.61 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.51 0.724 . . . . 0.0 111.799 173.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -71.79 -50.44 29.82 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 121.095 -1.003 . . . . 0.0 111.35 174.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -35.2 73.49 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 121.228 -0.92 . . . . 0.0 113.006 -174.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.6 m -62.96 -20.71 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -69.73 -45.4 68.24 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 119.196 0.907 . . . . 0.0 112.07 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.92 -42.68 72.98 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.319 -0.863 . . . . 0.0 111.623 -170.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -60.74 -35.8 77.29 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.504 1.122 . . . . 0.0 112.168 171.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.2 -39.94 74.89 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 120.887 -1.133 . . . . 0.0 112.67 174.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.3 t -63.85 -40.79 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.961 0.905 . . . . 0.0 110.946 172.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.4 tmm_? -63.41 -40.17 96.49 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.245 -0.91 . . . . 0.0 112.0 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 mp -63.24 -34.37 77.51 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 117.276 -1.345 . . . . 0.0 112.423 170.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.71 -32.57 67.53 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 121.173 1.806 . . . . 0.0 111.339 169.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.0 m -75.08 -35.08 61.84 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 170.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.1 mm -70.57 -36.48 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 119.929 1.24 . . . . 0.0 110.709 176.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.8 t -66.99 -46.43 84.83 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.419 0 C-N-CA 125.681 1.592 . . . . 0.0 110.402 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -52.53 -42.54 64.47 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.742 1.61 . . . . 0.0 111.847 170.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.7 m -61.0 -29.31 69.62 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 175.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -83.22 -33.9 26.0 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.862 1.665 . . . . 0.0 113.679 171.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.8 mt -66.06 -35.81 81.52 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 120.033 1.288 . . . . 0.0 111.568 173.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 88.6 mt -73.19 -35.42 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.502 1.121 . . . . 0.0 110.662 169.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.14 -38.6 54.57 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 125.596 1.57 . . . . 0.0 114.752 -172.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.1 t -154.48 -26.99 0.12 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.17 4.03 38.48 Favored Glycine 0 N--CA 1.479 1.556 0 N-CA-C 116.721 1.448 . . . . 0.0 116.721 175.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.9 p -158.21 140.5 14.27 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.42 1.488 . . . . 0.0 111.488 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 81.0 t -94.43 143.69 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.29 1.436 . . . . 0.0 110.556 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -124.43 157.46 35.13 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.018 1.327 . . . . 0.0 110.427 171.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -53.87 -38.35 64.63 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.394 -0.816 . . . . 0.0 112.734 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -66.97 -22.44 65.93 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.169 1.388 . . . . 0.0 113.676 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -78.12 -37.64 45.72 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.288 0.495 . . . . 0.0 111.943 171.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.2 mt -88.04 -27.73 21.82 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 -173.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.0 ptt85 -58.16 -27.53 63.9 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -88.81 5.91 41.43 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 173.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -128.08 -8.97 5.38 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 120.572 -1.33 . . . . 0.0 113.966 -170.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -53.01 -61.66 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.784 1.233 . . . . 0.0 112.091 174.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.269 23.7 mmt85 64.92 -17.22 0.09 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 117.82 2.526 . . . . 0.0 117.82 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -143.45 -28.23 0.54 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.591 1.157 . . . . 0.0 113.974 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.3 153.9 17.76 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.429 1.092 . . . . 0.0 113.805 -171.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.72 -53.55 21.43 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.271 1.028 . . . . 0.0 109.64 169.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -130.27 127.33 39.33 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.195 0.598 . . . . 0.0 111.812 -170.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -103.45 145.95 29.23 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.182 -0.949 . . . . 0.0 109.864 169.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.6 t -139.61 139.27 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 O-C-N 121.085 -1.009 . . . . 0.0 111.505 -170.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.2 mm -111.81 132.28 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.468 1.507 . . . . 0.0 113.519 -172.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.5 tpt85 -140.8 46.49 1.77 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.324 1.849 . . . . 0.0 110.423 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.2 mt -66.67 127.46 93.42 Favored Pre-proline 0 N--CA 1.481 1.083 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.054 170.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -58.63 135.41 67.19 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.978 2.452 . . . . 0.0 112.741 173.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.93 1.25 88.92 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-O 118.506 -1.163 . . . . 0.0 115.506 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -135.62 162.43 57.13 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 119.461 1.63 . . . . 0.0 113.921 173.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -61.92 142.85 94.53 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.603 2.869 . . . . 0.0 114.596 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.1 p -68.45 130.4 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.685 0.794 . . . . 0.0 110.285 169.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.8 p -123.39 147.31 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.036 1.334 . . . . 0.0 110.972 171.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -135.86 119.37 16.97 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.938 1.695 . . . . 0.0 108.948 -170.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 50.7 t -90.25 155.28 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 126.05 1.74 . . . . 0.0 111.701 -173.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.58 -88.95 1.03 Allowed Glycine 0 CA--C 1.533 1.192 0 O-C-N 121.429 -0.794 . . . . 0.0 112.761 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 85.3 m -154.25 154.2 33.04 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.164 1.386 . . . . 0.0 109.479 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -73.37 125.24 90.89 Favored Pre-proline 0 CA--C 1.547 0.839 0 O-C-N 120.561 -1.337 . . . . 0.0 110.779 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.84 155.19 43.68 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 124.036 3.157 . . . . 0.0 114.529 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.4 t -83.84 -27.98 28.35 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -169.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.73 -34.64 2.82 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 125.27 1.414 . . . . 0.0 113.36 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -79.1 60.48 2.99 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.877 1.671 . . . . 0.0 111.185 169.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.7 m -136.87 156.45 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.736 1.614 . . . . 0.0 112.525 -171.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 29.2 mt -94.36 133.55 37.81 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.309 2.243 . . . . 0.0 109.481 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -118.03 113.47 21.69 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -173.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -88.79 148.91 20.63 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.174 1.369 . . . . 0.0 110.616 169.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 68.5 mtt85 -145.92 159.38 43.3 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 119.23 1.515 . . . . 0.0 112.408 -175.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -164.82 167.23 19.01 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.499 1.12 . . . . 0.0 113.657 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.2 m -119.59 134.12 55.36 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.079 1.752 . . . . 0.0 108.002 169.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -97.49 177.73 32.25 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-O 122.025 0.792 . . . . 0.0 114.966 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -81.33 -12.13 59.12 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -169.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -101.78 4.98 40.97 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.656 1.571 . . . . 0.0 112.099 169.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.03 17.13 33.23 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 126.214 1.864 . . . . 0.0 114.384 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.1 pm0 -78.61 173.14 12.74 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.704 1.602 . . . . 0.0 113.726 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 95.5 m -130.75 135.14 47.5 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.453 1.101 . . . . 0.0 109.366 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 74.5 t -120.17 143.79 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.491 1.516 . . . . 0.0 110.822 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.6 tp -134.08 151.15 51.27 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.853 1.661 . . . . 0.0 109.151 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.2 t -140.86 139.38 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.884 1.673 . . . . 0.0 108.154 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -134.11 134.89 42.78 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.69 0.757 . . . . 0.0 112.304 -176.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -129.81 147.23 64.59 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 126.033 1.733 . . . . 0.0 111.194 -176.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -61.06 133.07 45.05 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.428 2.085 . . . . 0.0 111.394 171.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 . . . . . 0 C--O 1.253 1.263 0 C-N-CA 124.741 1.217 . . . . 0.0 112.358 -179.962 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.767 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -77.56 165.44 24.31 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.929 1.292 . . . . 0.0 113.208 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.62 173.48 7.07 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.673 1.189 . . . . 0.0 113.687 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.8 p -65.37 152.4 43.94 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.311 1.044 . . . . 0.0 113.669 -175.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -114.41 -25.91 8.19 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.508 1.523 . . . . 0.0 113.696 177.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.2 t -93.5 -176.6 4.15 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.358 1.463 . . . . 0.0 112.24 175.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.7 mp -108.54 141.04 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.975 2.11 . . . . 0.0 108.916 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.4 t -52.89 145.95 11.69 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.478 0.711 . . . . 0.0 112.475 173.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.7 m -107.44 4.17 25.95 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.627 1.171 . . . . 0.0 113.462 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.6 p -120.1 -72.99 0.66 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.617 1.567 . . . . 0.0 110.524 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.12 -36.83 72.27 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.764 0.826 . . . . 0.0 112.511 -171.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.3 tp60 -85.8 -18.03 34.09 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.555 0.742 . . . . 0.0 112.029 175.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -80.94 -48.82 11.79 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.884 -1.135 . . . . 0.0 112.049 174.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.424 HH21 ' CD ' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -62.06 -36.9 83.03 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 120.91 -1.119 . . . . 0.0 112.787 -174.095 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.4 m -60.57 -24.37 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.434 0.693 . . . . 0.0 112.832 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -70.99 -38.7 72.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.122 0.874 . . . . 0.0 111.383 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.1 mt -71.63 -42.12 67.99 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.014 0.926 . . . . 0.0 111.717 -172.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.424 ' CD ' HH21 ' A' ' 14' ' ' ARG . 4.1 pt-20 -66.31 -32.61 74.12 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.091 0.956 . . . . 0.0 112.506 169.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.8 -37.78 88.76 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.749 -1.219 . . . . 0.0 112.299 170.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.8 t -69.63 -36.34 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.368 1.067 . . . . 0.0 111.748 172.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -60.37 -44.88 95.19 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.784 -1.197 . . . . 0.0 111.132 170.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.7 mp -67.55 -34.06 76.31 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-O 117.469 -1.253 . . . . 0.0 112.624 173.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.83 -34.56 69.81 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 121.167 1.803 . . . . 0.0 110.808 169.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.0 m -72.3 -38.32 68.76 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.177 0.991 . . . . 0.0 113.253 170.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.1 mm -72.91 -35.73 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 120.88 1.673 . . . . 0.0 111.112 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.0 t -66.73 -48.5 79.85 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.519 0 CA-C-O 117.387 -1.292 . . . . 0.0 109.221 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -53.25 -42.98 66.99 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 120.997 1.726 . . . . 0.0 112.273 171.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.6 m -60.52 -33.01 72.01 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.713 -0.617 . . . . 0.0 112.291 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -78.88 -35.11 44.18 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.669 1.587 . . . . 0.0 113.323 172.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.3 mt -66.46 -32.4 73.74 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.713 1.142 . . . . 0.0 111.723 174.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 92.2 mt -76.41 -35.92 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.908 1.283 . . . . 0.0 111.054 169.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.14 -38.57 46.92 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 125.474 1.511 . . . . 0.0 114.875 -172.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.5 t -151.34 -28.32 0.19 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 177.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.67 8.53 34.68 Favored Glycine 0 N--CA 1.475 1.278 0 N-CA-C 116.748 1.459 . . . . 0.0 116.748 174.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.2 m -157.14 145.25 19.31 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.55 1.54 . . . . 0.0 110.234 171.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.6 p -112.45 144.36 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.794 1.238 . . . . 0.0 110.634 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -129.68 159.9 35.03 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.023 1.329 . . . . 0.0 110.325 -173.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -52.97 -38.4 62.11 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -174.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -73.4 -15.73 61.35 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -87.33 -18.82 29.23 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.162 0.892 . . . . 0.0 112.617 171.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 76.5 mt -99.29 -32.49 11.16 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.91 1.684 . . . . 0.0 113.789 -176.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -61.19 -21.06 63.46 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 119.721 1.146 . . . . 0.0 114.082 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -83.77 -1.44 54.24 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.087 1.355 . . . . 0.0 113.558 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -118.41 -21.63 7.97 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.688 1.195 . . . . 0.0 113.611 -169.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -51.06 -59.65 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.09 0.956 . . . . 0.0 112.576 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 63.25 -19.7 0.05 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 118.098 2.629 . . . . 0.0 118.098 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -155.54 -26.07 0.11 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.66 160.81 23.64 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.866 0.867 . . . . 0.0 113.235 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.2 tpt85 -83.86 -48.35 10.12 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.768 0.827 . . . . 0.0 112.534 -177.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -130.69 135.31 47.71 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.919 1.688 . . . . 0.0 111.314 -174.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -113.77 142.47 46.01 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 119.201 0.91 . . . . 0.0 109.928 168.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.9 t -140.25 138.32 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.536 1.134 . . . . 0.0 110.009 -169.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -124.24 136.68 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -172.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -131.16 89.23 2.7 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.955 1.702 . . . . 0.0 109.084 169.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.8 mt -101.35 134.88 20.03 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 124.696 1.198 . . . . 0.0 109.507 173.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.19 132.15 32.98 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.172 1.914 . . . . 0.0 111.671 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.01 -0.93 79.75 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.8 1.191 . . . . 0.0 115.79 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -137.55 155.82 75.15 Favored Pre-proline 0 N--CA 1.476 0.827 0 CA-C-N 119.336 1.568 . . . . 0.0 112.276 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.27 148.62 68.62 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.724 2.283 . . . . 0.0 112.618 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.2 p -55.66 135.92 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.282 1.033 . . . . 0.0 111.243 170.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.69 145.81 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.781 1.232 . . . . 0.0 110.904 170.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -132.92 125.54 30.09 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.294 1.437 . . . . 0.0 110.059 -174.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.6 t -95.96 149.17 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.818 1.647 . . . . 0.0 110.382 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.03 -98.94 1.36 Allowed Glycine 0 CA--C 1.532 1.113 0 O-C-N 121.486 -0.759 . . . . 0.0 112.116 175.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.4 m -153.83 146.07 23.84 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.665 1.232 . . . . 0.0 110.832 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -68.31 125.22 91.36 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 121.049 -1.032 . . . . 0.0 111.444 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -81.72 162.8 18.83 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.122 3.214 . . . . 0.0 115.053 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.6 t -102.85 -31.8 10.1 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 116.793 2.146 . . . . 0.0 116.793 -168.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.49 -29.93 1.17 Allowed Glycine 0 N--CA 1.478 1.464 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.0 p30 -85.46 55.97 3.75 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 122.557 1.17 . . . . 0.0 110.157 169.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.9 m -133.74 157.12 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.561 1.544 . . . . 0.0 111.195 -177.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 67.9 mt -87.88 153.08 21.6 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.707 2.003 . . . . 0.0 109.005 169.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -128.84 115.01 17.25 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.124 0.42 . . . . 0.0 111.26 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.83 141.27 15.46 Favored Glycine 0 N--CA 1.468 0.786 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 169.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -149.36 145.26 26.91 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 119.768 1.784 . . . . 0.0 112.953 -169.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.03 160.88 43.03 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.172 0.989 . . . . 0.0 113.521 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.6 m -113.36 125.95 54.83 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.099 1.36 . . . . 0.0 109.063 171.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.58 178.58 45.79 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.215 0.912 . . . . 0.0 115.001 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -84.21 -11.91 55.72 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 -169.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -96.93 3.39 52.11 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 120.573 1.533 . . . . 0.0 111.803 169.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.65 18.83 29.04 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 126.418 1.961 . . . . 0.0 114.379 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.8 pm0 -84.28 171.86 12.35 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.642 1.577 . . . . 0.0 114.558 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 90.9 m -125.7 133.27 52.19 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.962 1.305 . . . . 0.0 110.198 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.1 t -117.26 142.13 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.705 1.602 . . . . 0.0 109.805 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.5 tp -134.03 148.17 51.05 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.066 1.346 . . . . 0.0 110.878 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.4 t -134.12 135.76 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.92 2.088 . . . . 0.0 108.029 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -138.52 137.81 37.44 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.988 0.813 . . . . 0.0 112.958 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -153.17 153.96 30.22 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.215 1.006 . . . . 0.0 113.344 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -63.77 141.87 80.52 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.102 2.535 . . . . 0.0 114.452 -171.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 . . . . . 0 C--O 1.253 1.263 0 C-N-CA 127.109 2.163 . . . . 0.0 113.45 -173.755 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.897 0 N-CA-C 111.614 -0.595 . . . . 0.0 111.614 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.0 m 61.38 0.04 0.41 Allowed 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 118.37 2.73 . . . . 0.0 118.37 171.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -144.66 128.87 17.72 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.745 1.218 . . . . 0.0 111.594 -177.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.5 p -71.06 160.12 33.47 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.846 1.258 . . . . 0.0 113.36 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -115.82 -9.57 11.84 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -170.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.8 m 55.0 64.1 1.91 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.327 1.451 . . . . 0.0 112.085 -175.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.8 mt -129.02 140.52 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 126.733 2.013 . . . . 0.0 107.641 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.6 p -81.58 31.94 0.35 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 116.288 1.958 . . . . 0.0 116.288 -169.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.3 m -68.04 49.22 0.06 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 128.626 2.77 . . . . 0.0 114.89 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.4 p -139.19 -66.2 0.47 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 128.562 2.745 . . . . 0.0 106.965 169.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.48 -44.94 66.67 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.53 1.532 . . . . 0.0 112.942 175.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -76.78 -21.43 55.17 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.565 -0.709 . . . . 0.0 112.171 174.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -73.51 -50.52 21.06 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.01 -1.056 . . . . 0.0 111.662 173.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.46 -38.26 77.16 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 121.273 -0.892 . . . . 0.0 112.689 -173.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.7 m -61.19 -22.33 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 123.864 0.727 . . . . 0.0 112.711 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -68.85 -43.65 75.01 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 119.258 0.935 . . . . 0.0 112.369 175.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.66 -41.55 71.94 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.335 -0.853 . . . . 0.0 111.466 -171.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -64.34 -32.51 74.15 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.531 1.133 . . . . 0.0 112.519 171.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.19 -39.33 82.51 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.707 -1.246 . . . . 0.0 112.468 171.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.1 t -65.32 -41.12 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.783 0.833 . . . . 0.0 111.116 172.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -57.85 -42.01 83.55 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.42 -0.8 . . . . 0.0 111.844 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.46 -33.8 73.44 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 117.583 -1.198 . . . . 0.0 113.31 173.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.97 -33.87 65.18 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 120.856 1.662 . . . . 0.0 111.24 169.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.6 m -73.06 -37.64 66.75 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 170.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.6 mm -72.05 -33.71 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 120.975 1.716 . . . . 0.0 110.792 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.4 t -69.25 -46.73 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.599 1.16 . . . . 0.0 109.748 175.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -53.44 -42.99 67.69 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.693 1.588 . . . . 0.0 112.044 170.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.8 m -60.43 -29.81 69.23 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.779 -0.576 . . . . 0.0 112.27 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -82.2 -35.17 28.57 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.81 1.644 . . . . 0.0 113.514 172.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.7 mt -65.87 -34.92 79.26 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.897 1.226 . . . . 0.0 111.578 174.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 91.8 mt -73.75 -36.32 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.731 1.212 . . . . 0.0 110.828 169.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.08 -37.73 55.68 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 125.557 1.551 . . . . 0.0 114.682 -172.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.5 t -154.23 -26.96 0.13 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.4 9.46 35.95 Favored Glycine 0 N--CA 1.478 1.463 0 N-CA-C 116.565 1.386 . . . . 0.0 116.565 175.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.3 m -158.79 142.73 15.35 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.788 1.635 . . . . 0.0 110.095 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -107.38 146.73 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.733 1.213 . . . . 0.0 110.676 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -130.1 160.2 34.46 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.473 1.509 . . . . 0.0 109.965 -177.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -54.61 -37.5 65.66 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.647 -0.658 . . . . 0.0 112.724 -175.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -66.21 -21.87 66.32 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.706 1.202 . . . . 0.0 113.561 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -92.66 5.92 49.28 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.751 1.22 . . . . 0.0 112.964 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.5 mt -127.65 -26.49 2.97 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.7 ptt85 -62.83 -23.09 67.11 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 120.219 -1.55 . . . . 0.0 114.565 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.94 -5.09 57.09 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.686 1.594 . . . . 0.0 112.611 173.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -107.72 -22.89 12.31 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.263 1.825 . . . . 0.0 111.561 -169.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -53.15 -64.91 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.691 1.197 . . . . 0.0 111.36 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 64.8 -12.62 0.12 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.566 2.346 . . . . 0.0 116.686 171.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -153.15 -28.06 0.14 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.96 0.904 . . . . 0.0 112.977 176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.61 154.27 23.84 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 175.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.02 -54.84 13.0 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.839 1.256 . . . . 0.0 110.557 169.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -131.69 133.26 44.67 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.195 0.598 . . . . 0.0 112.07 -170.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.46 141.72 39.9 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.535 -0.728 . . . . 0.0 109.587 169.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.9 t -137.55 141.68 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.655 1.182 . . . . 0.0 110.191 -171.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.91 132.01 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -169.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -130.93 77.3 1.78 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.906 1.682 . . . . 0.0 109.857 171.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.4 mt -95.49 127.98 39.89 Favored Pre-proline 0 N--CA 1.478 0.97 0 O-C-N 121.262 -0.899 . . . . 0.0 109.159 171.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.91 134.17 58.45 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.46 2.107 . . . . 0.0 112.682 173.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.07 0.12 87.29 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 124.838 1.209 . . . . 0.0 116.017 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -137.1 157.21 74.93 Favored Pre-proline 0 CA--C 1.548 0.883 0 CA-C-N 119.232 1.516 . . . . 0.0 112.154 173.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -70.12 151.03 66.82 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.783 2.322 . . . . 0.0 113.057 -174.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.9 p -58.29 132.48 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.296 1.038 . . . . 0.0 111.467 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 86.6 t -110.94 142.01 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.593 1.557 . . . . 0.0 109.096 170.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -135.63 118.0 15.7 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.12 1.368 . . . . 0.0 109.115 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.7 t -92.57 153.7 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.286 1.834 . . . . 0.0 111.169 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.48 -101.71 1.42 Allowed Glycine 0 CA--C 1.533 1.157 0 O-C-N 121.321 -0.862 . . . . 0.0 112.472 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.4 m -144.29 147.89 34.11 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.388 1.075 . . . . 0.0 109.946 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -70.37 125.64 92.06 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 120.687 -1.258 . . . . 0.0 111.031 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -77.42 155.15 32.11 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 124.052 3.168 . . . . 0.0 114.824 -174.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.5 t -85.19 -31.35 23.26 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -169.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 133.51 -36.74 2.09 Favored Glycine 0 N--CA 1.478 1.467 0 C-N-CA 125.05 1.309 . . . . 0.0 112.321 -173.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -78.8 63.13 3.47 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.464 1.506 . . . . 0.0 110.101 169.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.98 151.83 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.506 1.523 . . . . 0.0 111.976 -176.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.9 mt -85.78 141.39 29.71 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.952 2.101 . . . . 0.0 109.122 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -121.43 110.35 15.96 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.366 0.53 . . . . 0.0 112.129 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.14 143.16 17.25 Favored Glycine 0 N--CA 1.467 0.755 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 169.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -153.68 134.83 14.02 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.886 1.843 . . . . 0.0 113.003 -169.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -142.63 161.44 38.08 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.503 1.121 . . . . 0.0 113.704 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.5 m -112.45 127.98 56.19 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.853 1.261 . . . . 0.0 108.72 171.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.18 174.51 40.42 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.206 0.908 . . . . 0.0 114.986 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -79.88 -11.41 59.81 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 -169.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -101.07 4.88 42.65 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 120.744 1.611 . . . . 0.0 112.355 169.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.67 17.4 30.9 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 126.031 1.777 . . . . 0.0 114.355 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.2 pm0 -83.79 172.98 11.67 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.792 1.637 . . . . 0.0 113.791 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.6 m -126.86 131.43 51.19 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.27 1.428 . . . . 0.0 109.681 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.1 t -113.68 141.02 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.624 1.57 . . . . 0.0 110.067 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.6 tp -129.89 148.23 51.74 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.087 1.355 . . . . 0.0 109.864 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.8 t -133.37 136.79 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.08 1.752 . . . . 0.0 108.317 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -131.68 131.99 43.57 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.783 0.801 . . . . 0.0 111.934 -176.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -131.84 148.31 69.41 Favored Pre-proline 0 N--CA 1.473 0.691 0 C-N-CA 126.163 1.785 . . . . 0.0 111.065 -173.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -61.39 134.91 54.38 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.87 2.38 . . . . 0.0 112.529 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 125.744 1.618 . . . . 0.0 112.438 177.479 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.686 0 N-CA-C 112.205 -0.358 . . . . 0.0 112.205 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.9 t -84.22 166.91 17.14 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.499 1.119 . . . . 0.0 112.966 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.97 156.13 25.41 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.562 1.145 . . . . 0.0 112.75 173.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.1 m -163.71 119.98 1.7 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.407 1.483 . . . . 0.0 109.466 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -49.6 129.25 19.11 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.99 1.316 . . . . 0.0 113.753 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.1 t -80.52 170.34 16.48 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.716 1.206 . . . . 0.0 113.549 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 68.3 mt -126.09 135.08 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 126.727 2.011 . . . . 0.0 108.583 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -124.3 138.36 54.39 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -169.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.1 m -62.43 24.52 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 128.628 2.771 . . . . 0.0 116.796 174.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.7 p -117.04 -64.53 1.3 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 127.821 2.448 . . . . 0.0 109.634 169.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.09 -35.03 66.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.447 1.099 . . . . 0.0 113.213 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -87.72 -16.99 32.71 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.692 -0.63 . . . . 0.0 112.246 174.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -79.75 -45.41 18.92 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.844 -1.16 . . . . 0.0 112.055 173.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -31.34 71.84 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -173.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.6 m -68.07 -21.46 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 172.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -71.17 -42.9 68.49 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 120.699 -1.251 . . . . 0.0 112.209 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.88 -39.1 76.49 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.386 -0.821 . . . . 0.0 111.301 -171.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.07 -28.83 65.75 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.721 1.208 . . . . 0.0 112.818 173.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.98 -39.76 87.26 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.764 -1.21 . . . . 0.0 111.381 169.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.4 t -67.92 -36.1 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.107 0.963 . . . . 0.0 111.538 174.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -59.26 -46.28 88.94 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.224 -0.923 . . . . 0.0 111.095 170.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.2 mp -69.07 -35.44 76.52 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 117.093 -1.432 . . . . 0.0 113.099 175.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.07 -38.69 68.38 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 121.066 1.757 . . . . 0.0 110.235 169.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.7 m -67.95 -38.82 83.26 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.152 0.981 . . . . 0.0 113.523 172.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.9 mm -72.35 -35.11 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 120.72 1.6 . . . . 0.0 110.748 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.2 t -68.82 -43.82 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.374 1.469 . . . . 0.0 110.235 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -56.54 -40.03 74.43 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 121.126 1.784 . . . . 0.0 112.34 169.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -62.79 -23.96 67.5 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 174.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -85.84 -36.86 19.75 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.295 1.838 . . . . 0.0 112.987 171.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.5 mt -68.92 -40.29 79.15 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 120.093 1.315 . . . . 0.0 111.984 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 86.2 mt -69.37 -32.18 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.457 1.503 . . . . 0.0 110.958 174.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.95 -75.34 0.77 Allowed Glycine 0 C--N 1.338 0.694 0 C-N-CA 125.36 1.457 . . . . 0.0 111.359 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.6 t -118.5 -26.73 6.12 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -170.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.61 0.74 46.41 Favored Glycine 0 N--CA 1.475 1.252 0 N-CA-C 116.972 1.549 . . . . 0.0 116.972 171.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.7 m -147.79 134.64 20.11 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.097 1.759 . . . . 0.0 109.956 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.5 p -104.86 147.92 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.04 1.336 . . . . 0.0 110.918 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -133.05 160.74 36.28 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.302 1.441 . . . . 0.0 110.702 -175.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -58.0 -37.7 74.74 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.745 -0.597 . . . . 0.0 111.899 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.73 -23.5 63.4 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.069 0.948 . . . . 0.0 113.187 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -77.79 -27.39 50.16 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.799 0.727 . . . . 0.0 112.16 174.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 72.3 mt -97.7 -28.1 14.05 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.587 1.555 . . . . 0.0 114.687 -173.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.2 ptt85 -62.03 -23.36 66.41 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 119.974 1.261 . . . . 0.0 113.702 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -88.23 5.97 39.08 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.314 1.446 . . . . 0.0 114.456 171.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -119.09 -15.04 9.29 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.947 1.249 . . . . 0.0 113.061 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -54.29 -59.01 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.74 0.816 . . . . 0.0 112.202 177.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.255 20.9 mmt85 65.53 -12.53 0.15 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 117.832 2.53 . . . . 0.0 117.832 174.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -164.56 -29.35 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.898 1.279 . . . . 0.0 112.602 169.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.22 153.09 43.43 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.057 0.943 . . . . 0.0 112.824 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -76.04 -53.36 8.47 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.159 0.583 . . . . 0.0 111.703 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -132.58 131.72 41.77 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.008 1.323 . . . . 0.0 111.742 -176.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -104.81 144.6 31.54 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 119.784 1.174 . . . . 0.0 110.659 169.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 37.4 t -140.8 141.18 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.445 1.098 . . . . 0.0 111.821 -169.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 mm -118.06 140.16 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.801 1.24 . . . . 0.0 114.13 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -139.89 72.69 1.4 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 128.098 2.559 . . . . 0.0 109.537 169.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.0 mt -91.73 127.77 48.83 Favored Pre-proline 0 N--CA 1.484 1.241 0 O-C-N 121.009 -1.057 . . . . 0.0 109.898 172.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -60.77 136.41 66.22 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.995 2.463 . . . . 0.0 112.9 171.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.23 2.11 89.34 Favored Glycine 0 CA--C 1.536 1.367 0 N-CA-C 115.912 1.125 . . . . 0.0 115.912 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -139.79 157.35 69.95 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 118.901 1.351 . . . . 0.0 111.877 174.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.01 143.78 73.62 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.426 2.084 . . . . 0.0 112.956 -176.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.57 135.5 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.256 1.422 . . . . 0.0 110.945 172.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.2 p -129.37 142.65 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.798 0.839 . . . . 0.0 111.891 171.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -140.11 123.47 16.98 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.409 1.083 . . . . 0.0 110.099 -173.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.5 t -95.5 155.2 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 127.015 2.126 . . . . 0.0 111.128 -172.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.26 -96.56 1.12 Allowed Glycine 0 CA--C 1.53 1.009 0 O-C-N 121.087 -1.008 . . . . 0.0 112.536 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.0 m -155.97 155.39 32.68 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.174 0.99 . . . . 0.0 110.211 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -68.96 132.17 90.55 Favored Pre-proline 0 CA--C 1.546 0.803 0 O-C-N 120.93 -1.106 . . . . 0.0 110.425 171.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.65 160.76 34.51 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 124.18 3.253 . . . . 0.0 114.121 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.6 t -85.7 -28.36 24.72 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -173.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.68 -32.83 3.24 Favored Glycine 0 N--CA 1.478 1.44 0 C-N-CA 125.644 1.592 . . . . 0.0 112.709 -176.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -77.44 60.2 2.02 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.403 1.881 . . . . 0.0 111.114 169.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.0 m -138.51 155.05 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.273 1.429 . . . . 0.0 113.177 -172.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.5 mt -91.03 142.4 27.81 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 128.029 2.532 . . . . 0.0 109.092 171.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -126.42 112.62 15.83 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.753 0.706 . . . . 0.0 111.311 -176.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.53 149.88 19.44 Favored Glycine 0 N--CA 1.469 0.871 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 169.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -147.19 148.56 31.63 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 118.656 1.228 . . . . 0.0 112.099 -169.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.3 166.33 33.76 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.412 1.085 . . . . 0.0 112.865 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.6 m -132.49 123.11 25.97 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.325 1.45 . . . . 0.0 109.634 172.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.62 176.43 42.44 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.0 1.286 . . . . 0.0 113.651 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -49.13 -45.0 42.97 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 126.347 1.859 . . . . 0.0 111.775 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -83.39 3.58 31.22 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 -170.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.65 25.38 13.6 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.666 0.651 . . . . 0.0 113.298 173.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.39 -166.01 1.49 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.656 1.182 . . . . 0.0 113.914 -174.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 16.6 m -147.39 120.27 8.72 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.318 -1.489 . . . . 0.0 111.611 173.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 37.1 t -96.64 142.25 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 126.246 1.819 . . . . 0.0 108.998 169.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.5 tp -129.91 146.74 51.62 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.356 1.463 . . . . 0.0 108.975 169.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 p -133.86 142.07 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.02 1.328 . . . . 0.0 109.663 172.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -137.08 134.39 36.44 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.162 0.506 . . . . 0.0 111.825 -170.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -131.72 152.8 81.0 Favored Pre-proline 0 N--CA 1.473 0.714 0 C-N-CA 124.954 1.301 . . . . 0.0 112.524 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -56.91 137.56 82.26 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 122.641 2.227 . . . . 0.0 112.933 170.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 . . . . . 0 C--O 1.252 1.223 0 C-N-CA 125.798 1.639 . . . . 0.0 112.279 177.522 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.799 0 N-CA-C 111.984 -0.446 . . . . 0.0 111.984 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.7 m -59.66 142.59 52.65 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.912 1.285 . . . . 0.0 113.902 -175.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.23 159.87 28.2 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -177.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.2 m -66.73 136.57 55.7 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.013 1.325 . . . . 0.0 112.271 -176.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -59.15 112.02 1.55 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.01 1.324 . . . . 0.0 110.495 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.8 m -143.82 135.82 26.52 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.618 1.567 . . . . 0.0 110.164 -169.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.6 mt -114.35 128.2 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.644 1.177 . . . . 0.0 110.697 176.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 27.0 m -54.52 140.39 34.78 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.641 1.976 . . . . 0.0 115.307 -173.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 m -70.92 56.38 0.19 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.678 1.991 . . . . 0.0 112.769 170.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -141.6 -59.51 0.48 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 128.432 2.693 . . . . 0.0 108.281 172.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.97 -41.4 51.5 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.663 1.585 . . . . 0.0 112.303 171.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -83.29 -15.49 49.95 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -77.99 -50.5 12.01 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.72 -1.237 . . . . 0.0 112.107 173.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -59.9 -32.44 70.76 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -172.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.3 m -64.94 -21.81 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 174.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -67.94 -43.22 79.6 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 120.878 -1.139 . . . . 0.0 112.837 176.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mp -70.62 -41.68 71.92 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.444 -0.785 . . . . 0.0 111.816 -171.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.15 -30.92 71.97 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.364 1.066 . . . . 0.0 112.64 172.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.41 -36.97 79.88 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.925 -1.109 . . . . 0.0 112.447 171.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.4 t -69.87 -36.23 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 124.175 0.99 . . . . 0.0 111.376 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -58.37 -46.07 87.02 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.314 -0.866 . . . . 0.0 111.23 171.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.1 mp -70.05 -34.13 72.83 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-O 117.321 -1.323 . . . . 0.0 113.195 173.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.18 -34.86 68.9 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 121.365 1.893 . . . . 0.0 110.586 169.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.1 m -71.23 -41.53 70.03 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.301 1.04 . . . . 0.0 112.806 171.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.4 mm -70.66 -35.08 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 120.623 1.556 . . . . 0.0 111.201 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.3 t -65.11 -47.44 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.026 1.33 . . . . 0.0 109.99 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -52.97 -42.64 65.71 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.607 1.549 . . . . 0.0 112.124 171.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.3 t -59.33 -38.12 79.51 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.788 -0.57 . . . . 0.0 111.95 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.2 tpt180 -72.47 -37.25 68.52 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.47 1.108 . . . . 0.0 113.367 172.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.6 mt -67.31 -32.35 73.27 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.877 1.217 . . . . 0.0 112.182 176.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 89.8 mt -74.15 -37.86 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 124.523 1.129 . . . . 0.0 110.826 169.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.1 -38.58 54.89 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 125.862 1.696 . . . . 0.0 114.52 -172.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.1 t -150.17 -30.52 0.21 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.29 4.47 35.24 Favored Glycine 0 N--CA 1.475 1.283 0 N-CA-C 117.105 1.602 . . . . 0.0 117.105 176.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.8 p -152.92 141.57 20.92 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.45 1.5 . . . . 0.0 111.34 177.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.5 t -99.67 139.19 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.124 1.37 . . . . 0.0 110.383 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -123.07 155.08 37.62 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.918 1.287 . . . . 0.0 109.806 174.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -54.76 -38.3 67.04 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.296 -0.878 . . . . 0.0 113.317 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -67.38 -17.69 64.83 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -85.11 -22.26 28.96 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 118.539 -0.743 . . . . 0.0 112.648 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.1 mt -97.6 -31.37 12.34 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.34 1.427 . . . . 0.0 114.439 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -58.88 -24.28 62.01 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -93.76 7.54 44.48 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.101 1.361 . . . . 0.0 113.456 174.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -127.62 -16.05 4.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.681 1.592 . . . . 0.0 113.246 -174.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -50.27 -66.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.125 0.875 . . . . 0.0 110.906 169.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 64.19 -16.25 0.08 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 128.255 2.622 . . . . 0.0 117.025 174.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -147.24 1.98 0.75 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.632 1.173 . . . . 0.0 114.042 -174.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.41 150.6 48.86 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.457 1.503 . . . . 0.0 113.094 -172.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.66 -56.15 10.49 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.017 1.327 . . . . 0.0 111.77 174.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -130.64 126.89 37.77 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.296 0.638 . . . . 0.0 111.107 -170.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.71 148.69 27.15 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.98 -1.075 . . . . 0.0 110.127 169.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.2 t -141.0 140.81 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.897 1.279 . . . . 0.0 110.717 -171.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -118.55 133.44 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.986 1.314 . . . . 0.0 113.576 -170.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -131.88 79.61 1.88 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.738 1.615 . . . . 0.0 109.381 169.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.5 mt -96.91 123.65 52.78 Favored Pre-proline 0 N--CA 1.479 0.991 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 173.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.86 132.51 50.22 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.407 2.071 . . . . 0.0 112.501 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.53 2.57 87.09 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.906 1.241 . . . . 0.0 115.776 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -135.92 162.11 58.71 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-N 119.806 1.803 . . . . 0.0 114.084 171.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -62.94 143.64 91.64 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.481 2.787 . . . . 0.0 114.136 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 p -58.0 133.84 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.775 0.83 . . . . 0.0 110.631 169.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 71.4 t -114.01 141.71 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.765 1.226 . . . . 0.0 109.313 172.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -134.87 119.55 18.22 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.988 1.315 . . . . 0.0 109.554 177.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.4 t -90.39 152.51 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.366 1.466 . . . . 0.0 111.085 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.08 -105.48 2.24 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 121.368 -0.833 . . . . 0.0 112.621 170.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.8 m -145.02 148.87 34.21 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.544 1.137 . . . . 0.0 110.052 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -67.95 128.62 93.34 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 120.598 -1.314 . . . . 0.0 111.298 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -80.18 152.94 21.42 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.264 3.309 . . . . 0.0 114.922 -177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.7 t -82.9 -31.36 27.89 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -169.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.31 -35.03 2.42 Favored Glycine 0 N--CA 1.479 1.544 0 C-N-CA 125.246 1.403 . . . . 0.0 112.458 -174.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -79.44 61.14 3.4 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.306 1.442 . . . . 0.0 109.922 169.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.2 m -138.84 156.33 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.934 1.693 . . . . 0.0 111.398 -175.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.5 mt -91.72 138.61 31.42 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 127.734 2.414 . . . . 0.0 108.869 173.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -119.19 113.25 20.59 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.271 0.487 . . . . 0.0 111.741 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.68 144.68 17.47 Favored Glycine 0 N--CA 1.467 0.722 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 169.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -152.99 138.9 18.06 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.07 1.935 . . . . 0.0 112.853 -169.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.91 164.72 30.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.675 1.19 . . . . 0.0 114.043 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.3 m -119.74 125.21 48.07 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.223 1.409 . . . . 0.0 109.273 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.05 173.95 43.5 Favored Glycine 0 CA--C 1.54 1.653 0 C-N-CA 124.488 1.042 . . . . 0.0 115.26 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -81.59 -12.28 58.81 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -169.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -95.04 2.52 55.28 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 120.333 1.424 . . . . 0.0 112.161 169.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.93 15.03 46.99 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 126.783 2.135 . . . . 0.0 115.077 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 20.4 pm0 -78.68 172.4 13.76 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.992 1.717 . . . . 0.0 113.253 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.6 m -129.49 138.27 51.29 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.597 1.559 . . . . 0.0 110.342 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 88.6 t -122.52 140.27 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.471 1.508 . . . . 0.0 109.957 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.5 tp -128.79 148.35 50.86 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.181 1.392 . . . . 0.0 109.674 173.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.7 t -134.25 136.77 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.79 1.636 . . . . 0.0 108.275 176.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -131.01 129.98 42.75 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 122.031 0.919 . . . . 0.0 111.907 -176.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -130.44 142.25 44.79 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 126.661 1.984 . . . . 0.0 110.501 -171.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -61.89 133.67 45.91 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.435 2.09 . . . . 0.0 112.004 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 70.0 ttp85 . . . . . 0 C--O 1.252 1.211 0 C-N-CA 125.133 1.373 . . . . 0.0 112.33 -179.902 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.761 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.1 p -69.05 161.02 29.91 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.787 1.235 . . . . 0.0 114.295 -178.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -128.86 153.1 47.79 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.719 1.608 . . . . 0.0 112.238 -178.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 90.6 m -154.19 146.03 23.45 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.151 1.381 . . . . 0.0 110.669 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.51 136.55 38.34 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.812 1.245 . . . . 0.0 111.554 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.4 m -69.8 117.93 12.02 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.94 0.896 . . . . 0.0 110.328 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.5 mt -75.51 135.61 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-O 122.011 0.91 . . . . 0.0 111.516 -169.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.1 m -89.07 41.84 1.05 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.096 1.759 . . . . 0.0 113.668 -175.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.1 m -62.42 32.64 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 129.472 3.109 . . . . 0.0 117.636 -170.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.3 p -132.16 -64.5 0.77 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.28 2.232 . . . . 0.0 107.633 169.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.28 -43.43 70.46 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.473 1.509 . . . . 0.0 113.291 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -77.63 -22.9 50.01 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.026 0.93 . . . . 0.0 112.129 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -71.8 -50.62 28.12 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.299 -0.876 . . . . 0.0 111.632 173.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -59.48 -37.9 79.44 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.755 0.822 . . . . 0.0 112.889 -172.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.9 m -60.46 -22.65 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.666 0.786 . . . . 0.0 112.027 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -65.39 -42.94 92.11 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.251 0.932 . . . . 0.0 112.13 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.1 mp -73.86 -41.15 62.63 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.315 -0.866 . . . . 0.0 111.404 -170.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -67.73 -29.19 68.37 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.202 1.001 . . . . 0.0 112.799 171.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.06 -37.76 84.6 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 120.607 -1.308 . . . . 0.0 112.292 169.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.6 t -69.01 -36.15 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.002 0.921 . . . . 0.0 111.417 172.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -60.24 -44.57 95.12 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.12 -0.987 . . . . 0.0 111.421 171.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.0 mp -69.97 -34.18 73.04 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-O 117.343 -1.313 . . . . 0.0 112.673 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.95 -33.44 68.83 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 121.144 1.793 . . . . 0.0 110.883 169.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.1 m -72.25 -38.66 68.85 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.27 1.028 . . . . 0.0 113.432 171.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -74.11 -34.86 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 120.99 1.723 . . . . 0.0 111.073 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.5 t -64.86 -48.3 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.83 1.252 . . . . 0.0 109.62 173.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -54.12 -43.49 70.53 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.764 1.62 . . . . 0.0 112.086 172.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.2 m -59.45 -31.48 69.35 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.636 -0.665 . . . . 0.0 112.407 175.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -80.19 -35.19 36.74 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.715 1.606 . . . . 0.0 113.381 172.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 67.1 mt -66.59 -33.5 75.79 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 120.058 1.299 . . . . 0.0 111.643 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 91.1 mt -73.82 -36.46 46.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.904 1.281 . . . . 0.0 110.777 169.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.99 -38.72 55.62 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 125.632 1.587 . . . . 0.0 114.826 -173.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.2 t -152.5 -26.39 0.17 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.51 11.19 39.15 Favored Glycine 0 N--CA 1.48 1.581 0 N-CA-C 116.234 1.254 . . . . 0.0 116.234 175.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.8 m -157.69 143.4 17.27 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.886 1.674 . . . . 0.0 109.492 173.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.83 145.74 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.135 1.374 . . . . 0.0 109.858 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -130.49 158.77 39.01 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.723 1.209 . . . . 0.0 110.754 -172.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -56.11 -38.72 71.15 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.776 -0.577 . . . . 0.0 112.313 -177.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -70.96 -18.32 62.63 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -78.46 -38.28 41.52 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.211 0.914 . . . . 0.0 111.088 169.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 58.4 mt -87.35 -28.5 22.18 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -169.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -59.73 -21.14 60.28 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 172.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -83.56 -7.68 59.47 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.829 1.251 . . . . 0.0 114.032 174.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -115.46 -14.2 11.57 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.785 1.234 . . . . 0.0 113.302 -169.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -55.06 -58.73 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.486 0.714 . . . . 0.0 111.812 175.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.261 26.6 mmm180 64.2 -13.53 0.1 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 127.902 2.481 . . . . 0.0 117.659 172.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -159.89 -29.31 0.06 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.968 1.307 . . . . 0.0 113.168 169.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.38 159.17 33.7 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.325 1.05 . . . . 0.0 113.343 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -80.7 -54.04 5.98 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.535 0.734 . . . . 0.0 112.649 -176.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -130.34 133.98 46.84 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.533 1.533 . . . . 0.0 110.877 -174.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.78 141.75 40.33 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.137 -0.977 . . . . 0.0 109.79 169.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.6 t -136.62 142.39 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.526 1.13 . . . . 0.0 111.024 -173.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.15 134.68 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.89 1.276 . . . . 0.0 114.226 -169.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -138.75 77.99 1.65 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.109 1.764 . . . . 0.0 109.679 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.0 mt -95.89 132.32 27.35 Favored Pre-proline 0 N--CA 1.478 0.947 0 C-N-CA 124.982 1.313 . . . . 0.0 109.523 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.1 134.66 37.58 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.196 1.931 . . . . 0.0 111.545 174.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.82 1.26 85.28 Favored Glycine 0 CA--C 1.536 1.36 0 N-CA-C 116.043 1.177 . . . . 0.0 116.043 177.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -138.78 156.9 72.64 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-N 119.073 1.437 . . . . 0.0 111.954 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.39 150.33 75.79 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.705 2.27 . . . . 0.0 112.969 -174.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 50.7 t -60.44 131.88 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.278 1.031 . . . . 0.0 110.358 173.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 72.4 t -112.62 140.25 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.454 1.502 . . . . 0.0 109.469 173.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -135.07 118.15 16.44 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.037 1.335 . . . . 0.0 109.421 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.7 t -94.62 151.77 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.881 1.672 . . . . 0.0 111.032 -177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.66 -93.5 1.03 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 121.283 -0.886 . . . . 0.0 112.317 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 m -154.74 152.58 30.06 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.669 -0.901 . . . . 0.0 110.463 175.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -69.17 129.4 92.02 Favored Pre-proline 0 CA--C 1.547 0.863 0 O-C-N 120.928 -1.108 . . . . 0.0 110.722 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -78.6 158.71 28.63 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 124.3 3.333 . . . . 0.0 114.602 -176.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.3 t -83.29 -25.19 31.8 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -171.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.59 -34.17 3.71 Favored Glycine 0 N--CA 1.478 1.442 0 C-N-CA 125.713 1.625 . . . . 0.0 112.804 -175.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -79.03 61.36 3.18 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.738 1.615 . . . . 0.0 111.261 169.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.9 m -136.93 158.95 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 126.343 1.857 . . . . 0.0 112.526 -173.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 27.9 mt -92.77 139.41 30.58 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.826 2.051 . . . . 0.0 108.799 172.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -127.55 113.56 16.28 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.101 0.961 . . . . 0.0 110.506 -175.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -97.75 145.4 17.79 Favored Glycine 0 N--CA 1.467 0.727 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -148.01 139.31 23.52 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.763 1.282 . . . . 0.0 112.682 -169.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.24 162.39 36.48 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.609 1.164 . . . . 0.0 113.181 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 74.5 m -114.16 124.65 52.59 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.19 1.396 . . . . 0.0 108.423 172.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.54 173.31 45.63 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-O 122.166 0.87 . . . . 0.0 114.424 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -79.63 -17.35 54.0 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -169.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -92.84 4.81 53.17 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.646 1.566 . . . . 0.0 112.543 169.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.37 16.96 32.93 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 126.136 1.827 . . . . 0.0 114.308 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.9 pm0 -82.92 171.55 13.75 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.471 1.508 . . . . 0.0 114.206 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.5 m -123.14 132.99 54.29 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.66 1.584 . . . . 0.0 109.203 175.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.4 t -127.51 140.68 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.629 1.171 . . . . 0.0 110.155 -176.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.5 tp -133.42 147.66 51.74 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.293 1.037 . . . . 0.0 110.76 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.09 143.28 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.816 1.246 . . . . 0.0 109.565 170.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -137.37 137.5 38.93 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -173.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -132.13 151.27 78.11 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 125.793 1.637 . . . . 0.0 112.432 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -58.68 135.86 70.09 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.405 2.07 . . . . 0.0 111.996 169.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 . . . . . 0 C--O 1.253 1.285 0 C-N-CA 124.938 1.295 . . . . 0.0 112.179 178.614 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.734 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.1 p -76.05 159.85 30.38 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.689 1.196 . . . . 0.0 113.103 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -147.74 149.07 31.71 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.954 1.302 . . . . 0.0 111.845 -177.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.7 m -59.4 150.63 25.87 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.518 1.527 . . . . 0.0 112.834 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -101.21 -28.2 12.79 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -176.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.9 m -78.85 128.2 33.03 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.978 1.311 . . . . 0.0 110.958 -176.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.3 mm -93.72 146.8 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.582 1.153 . . . . 0.0 110.504 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.5 m -75.75 34.83 0.12 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.004 1.722 . . . . 0.0 115.625 -172.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.4 m -70.17 51.71 0.12 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 128.269 2.628 . . . . 0.0 115.009 -173.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -140.09 -68.67 0.41 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 128.437 2.695 . . . . 0.0 106.939 169.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.75 -43.74 68.22 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.623 1.569 . . . . 0.0 112.677 176.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -77.41 -21.11 53.61 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.637 -0.665 . . . . 0.0 112.33 175.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -73.72 -51.12 17.62 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 121.166 -0.959 . . . . 0.0 111.583 173.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -37.98 77.68 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 121.294 -0.879 . . . . 0.0 112.732 -173.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 m -62.52 -21.74 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -70.44 -44.06 68.63 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 119.132 0.878 . . . . 0.0 112.146 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.57 -42.26 71.33 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.083 -1.011 . . . . 0.0 111.367 -172.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -63.27 -32.73 74.22 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.395 1.078 . . . . 0.0 112.449 171.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.09 84.04 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.752 -1.217 . . . . 0.0 112.308 171.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.6 t -64.79 -40.33 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.802 0.841 . . . . 0.0 111.071 174.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -57.07 -44.72 83.34 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.536 -0.728 . . . . 0.0 112.145 171.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.9 mp -68.45 -33.91 75.02 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 116.871 -1.538 . . . . 0.0 112.943 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.11 -39.53 69.46 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 121.252 1.842 . . . . 0.0 110.308 169.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.6 m -70.09 -38.25 75.64 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 172.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.9 mm -70.42 -34.21 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 121.181 1.81 . . . . 0.0 110.813 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.2 t -66.57 -48.51 80.17 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 C-N-CA 124.945 1.298 . . . . 0.0 110.092 173.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -54.86 -39.52 68.72 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 121.408 1.913 . . . . 0.0 112.802 171.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.4 m -61.84 -29.08 69.93 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.984 0.514 . . . . 0.0 112.066 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -82.68 -36.78 25.61 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.063 1.745 . . . . 0.0 113.438 171.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.61 -34.2 77.35 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.055 1.298 . . . . 0.0 111.566 175.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 92.0 mt -76.56 -36.7 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 124.618 1.167 . . . . 0.0 110.714 169.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.36 -37.85 53.63 Favored Glycine 0 C--N 1.341 0.849 0 C-N-CA 125.822 1.677 . . . . 0.0 114.698 -171.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.2 t -148.66 -30.44 0.27 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 175.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.78 12.07 27.05 Favored Glycine 0 N--CA 1.473 1.141 0 N-CA-C 116.703 1.441 . . . . 0.0 116.703 174.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.4 m -157.84 143.2 16.93 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.364 1.466 . . . . 0.0 109.736 170.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.2 p -112.36 141.45 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.384 1.474 . . . . 0.0 110.616 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -131.74 159.79 37.42 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.535 1.534 . . . . 0.0 110.45 -172.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -56.2 -38.54 71.14 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.38 -0.825 . . . . 0.0 113.056 -175.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -69.87 -21.77 63.3 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -77.23 -35.52 55.42 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.476 0.58 . . . . 0.0 111.78 169.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 58.8 mt -86.61 -29.19 22.76 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -174.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -61.15 -22.72 64.96 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -91.97 -0.19 57.48 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.271 1.029 . . . . 0.0 113.457 172.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -117.03 -17.37 10.36 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.178 1.391 . . . . 0.0 113.496 -173.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -48.75 -57.33 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.892 0.877 . . . . 0.0 111.08 170.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 63.26 -15.22 0.07 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 128.053 2.541 . . . . 0.0 117.499 173.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -155.73 -25.4 0.11 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.27 156.34 23.16 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.345 1.058 . . . . 0.0 112.937 177.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.78 -57.81 5.08 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.857 1.263 . . . . 0.0 111.328 170.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -129.9 132.97 46.58 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.955 0.502 . . . . 0.0 112.324 -170.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -111.52 141.24 45.35 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.636 -0.665 . . . . 0.0 109.555 168.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.0 t -138.89 138.23 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.681 1.192 . . . . 0.0 109.339 -169.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -120.62 132.83 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -169.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -129.75 84.11 2.19 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.263 1.825 . . . . 0.0 109.254 173.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.1 mt -99.06 134.37 21.44 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 124.208 1.003 . . . . 0.0 108.85 173.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.36 136.35 43.13 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.238 1.959 . . . . 0.0 111.514 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.76 0.28 83.98 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.638 1.113 . . . . 0.0 115.702 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -136.15 157.99 74.58 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 118.95 1.375 . . . . 0.0 112.564 175.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.59 151.75 64.54 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.676 2.251 . . . . 0.0 113.285 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.3 p -54.86 140.87 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.408 1.483 . . . . 0.0 112.328 172.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 85.0 t -116.18 140.81 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 125.864 1.666 . . . . 0.0 108.76 170.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -134.67 119.5 18.38 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.721 1.208 . . . . 0.0 110.12 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.1 t -93.77 154.99 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.716 2.006 . . . . 0.0 110.963 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.81 -105.13 1.67 Allowed Glycine 0 CA--C 1.533 1.203 0 O-C-N 121.216 -0.927 . . . . 0.0 111.521 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.2 t -153.87 161.04 42.35 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.033 0.917 . . . . 0.0 112.089 169.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -71.89 126.38 91.39 Favored Pre-proline 0 CA--C 1.548 0.878 0 O-C-N 120.902 -1.123 . . . . 0.0 111.85 -171.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.54 155.68 24.6 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 124.069 3.18 . . . . 0.0 114.856 -175.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.2 t -83.51 -20.46 33.89 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 115.81 1.781 . . . . 0.0 115.81 -169.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.39 -30.5 6.2 Favored Glycine 0 N--CA 1.479 1.559 0 C-N-CA 125.361 1.457 . . . . 0.0 113.12 -173.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -82.13 60.11 4.75 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.424 1.489 . . . . 0.0 109.351 168.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.4 m -140.94 152.98 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 126.458 1.903 . . . . 0.0 110.381 -175.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.7 mt -79.59 146.43 32.57 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.023 1.729 . . . . 0.0 108.942 169.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -126.75 106.39 9.34 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.877 0.762 . . . . 0.0 109.979 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -88.82 149.4 20.93 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 169.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 33.2 ttt-85 -148.07 143.69 27.36 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.217 1.509 . . . . 0.0 112.013 -170.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -152.66 167.72 27.98 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.373 1.069 . . . . 0.0 113.251 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.0 m -134.09 128.1 33.51 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.708 1.603 . . . . 0.0 109.601 171.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.42 -175.09 49.87 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.6 1.572 . . . . 0.0 114.934 177.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -58.74 -45.38 89.8 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.256 1.422 . . . . 0.0 112.107 177.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -77.71 2.57 16.43 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -172.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.26 23.0 28.11 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.0 1.286 . . . . 0.0 113.465 172.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.11 -163.15 0.95 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.266 1.426 . . . . 0.0 114.111 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.1 m -146.15 128.68 16.03 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.336 -1.478 . . . . 0.0 111.361 175.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.3 t -105.2 142.51 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 126.195 1.798 . . . . 0.0 109.208 169.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.8 tp -129.15 141.49 51.16 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.083 1.353 . . . . 0.0 109.382 169.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.18 136.81 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.524 1.53 . . . . 0.0 108.461 173.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -131.67 130.97 42.74 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.682 0.753 . . . . 0.0 112.048 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -133.54 142.36 43.66 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 125.066 1.346 . . . . 0.0 112.058 -169.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -59.24 130.41 35.96 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.184 2.59 . . . . 0.0 112.533 177.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 67.9 ttp85 . . . . . 0 C--O 1.253 1.258 0 C-N-CA 125.231 1.412 . . . . 0.0 112.356 178.458 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.775 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.6 m 52.18 63.42 2.25 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.777 1.631 . . . . 0.0 113.17 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -136.27 144.49 44.81 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.322 1.449 . . . . 0.0 112.331 -177.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.8 m -61.82 143.2 56.68 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.968 1.307 . . . . 0.0 113.39 -173.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -45.6 151.78 0.38 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.603 2.361 . . . . 0.0 114.618 173.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.8 t -143.24 150.0 38.71 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.36 1.464 . . . . 0.0 111.389 174.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.8 mt -133.64 139.28 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.375 1.87 . . . . 0.0 108.742 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 94.7 p -64.21 166.63 7.65 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -176.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.7 m -127.51 30.12 5.4 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.823 1.649 . . . . 0.0 111.234 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.2 p -133.61 -74.43 0.49 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.582 1.553 . . . . 0.0 109.325 -175.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.64 -46.19 66.76 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.333 1.053 . . . . 0.0 112.018 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -72.58 -23.03 60.9 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.852 -0.53 . . . . 0.0 112.324 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -74.92 -50.47 16.72 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.966 -1.084 . . . . 0.0 111.564 172.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.75 -35.93 81.37 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 117.556 -1.211 . . . . 0.0 113.068 -174.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.8 m -59.9 -25.66 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 119.002 0.819 . . . . 0.0 112.756 172.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -77.45 -35.56 53.83 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.554 0.615 . . . . 0.0 112.56 176.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.8 mt -69.25 -39.87 78.19 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.405 -0.809 . . . . 0.0 110.976 -175.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -68.23 -30.47 69.53 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.041 0.936 . . . . 0.0 112.688 169.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.65 -38.64 89.92 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 120.227 1.376 . . . . 0.0 112.098 170.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.4 t -67.95 -39.74 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.182 0.993 . . . . 0.0 111.429 172.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -58.79 -44.91 90.85 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.211 -0.931 . . . . 0.0 111.277 172.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.2 mp -68.79 -34.9 76.32 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-O 117.13 -1.414 . . . . 0.0 112.678 174.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.38 -34.17 68.58 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 121.504 1.956 . . . . 0.0 110.511 169.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.3 m -72.72 -40.21 66.33 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.256 1.022 . . . . 0.0 113.736 170.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.1 mm -67.8 -37.38 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 120.983 1.719 . . . . 0.0 110.799 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.2 t -64.46 -45.58 95.36 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.376 0 C-N-CA 125.326 1.45 . . . . 0.0 110.241 176.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -51.97 -42.72 63.15 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 120.683 1.583 . . . . 0.0 112.345 171.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 56.5 m -62.05 -31.33 71.73 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.416 -0.803 . . . . 0.0 112.541 175.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -77.92 -37.08 48.58 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.877 1.271 . . . . 0.0 113.181 172.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.8 mt -67.42 -32.84 73.99 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.833 1.197 . . . . 0.0 111.916 176.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.8 mt -73.6 -36.93 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.585 1.154 . . . . 0.0 110.708 169.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.98 -39.17 55.02 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 125.689 1.614 . . . . 0.0 114.689 -172.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.0 t -151.48 -27.05 0.19 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.92 3.86 54.64 Favored Glycine 0 N--CA 1.479 1.54 0 N-CA-C 116.127 1.211 . . . . 0.0 116.127 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.6 m -142.26 132.9 25.38 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.756 1.622 . . . . 0.0 109.874 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.9 t -97.21 140.34 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.5 0.72 . . . . 0.0 109.423 170.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -127.11 156.68 41.35 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.76 1.224 . . . . 0.0 110.611 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -55.74 -36.89 67.76 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 121.303 -0.873 . . . . 0.0 112.557 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -67.55 -21.91 65.43 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.152 1.381 . . . . 0.0 113.73 177.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -78.44 -37.49 43.58 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.395 0.543 . . . . 0.0 111.863 171.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 18.9 mt -88.92 -30.29 18.95 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -172.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -55.89 -27.82 53.78 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -89.3 2.95 53.61 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.928 1.291 . . . . 0.0 114.382 176.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -121.6 -13.81 8.29 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.782 1.233 . . . . 0.0 113.446 -172.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -56.0 -49.29 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -174.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.499 0.0 OUTLIER 67.18 -18.54 0.13 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 129.535 3.134 . . . . 0.0 118.216 178.572 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -160.0 -43.66 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.022 1.329 . . . . 0.0 110.226 169.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -41.45 112.63 0.33 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.287 2.235 . . . . 0.0 111.579 177.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -63.56 -42.18 98.36 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 121.712 -0.617 . . . . 0.0 111.341 -172.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -130.97 120.95 24.27 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.121 1.768 . . . . 0.0 109.262 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.32 143.68 27.84 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.05 -1.032 . . . . 0.0 109.037 168.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.0 t -139.01 139.41 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.15 0.98 . . . . 0.0 110.774 -169.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 mm -114.02 134.03 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.541 1.536 . . . . 0.0 113.815 -169.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -133.67 70.96 1.45 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.232 1.813 . . . . 0.0 109.547 169.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.9 mt -88.08 128.93 51.91 Favored Pre-proline 0 N--CA 1.478 0.97 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.36 134.13 35.0 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.193 1.929 . . . . 0.0 111.287 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.92 3.3 85.68 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 118.533 -1.148 . . . . 0.0 115.962 176.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -137.49 162.9 52.29 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 119.539 1.669 . . . . 0.0 113.944 173.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -59.38 141.52 97.73 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.524 2.816 . . . . 0.0 114.454 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.59 130.18 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.182 0.993 . . . . 0.0 110.311 170.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.6 t -109.94 139.57 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.929 1.292 . . . . 0.0 109.275 172.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -134.41 112.72 11.19 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.838 1.255 . . . . 0.0 108.86 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.6 t -86.56 151.89 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.373 1.469 . . . . 0.0 110.947 -177.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.2 -96.91 1.38 Allowed Glycine 0 CA--C 1.531 1.059 0 O-C-N 121.608 -0.682 . . . . 0.0 112.025 175.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.1 m -150.0 157.41 43.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.52 1.128 . . . . 0.0 110.025 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -69.75 133.99 88.32 Favored Pre-proline 0 CA--C 1.546 0.796 0 O-C-N 120.791 -1.193 . . . . 0.0 110.654 169.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.63 156.01 31.68 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 124.194 3.263 . . . . 0.0 114.342 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.1 t -82.78 -26.32 31.93 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -175.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.02 -35.01 3.38 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 125.629 1.585 . . . . 0.0 113.055 -177.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -77.95 58.59 1.96 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.05 1.74 . . . . 0.0 111.404 169.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.1 m -131.5 159.93 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.549 1.54 . . . . 0.0 113.013 -172.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.1 mt -99.91 119.64 38.53 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 127.562 2.345 . . . . 0.0 110.335 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -106.09 108.3 19.74 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -170.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.55 145.54 17.79 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 169.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.1 ttt-85 -156.93 125.45 5.73 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 120.762 2.281 . . . . 0.0 113.967 -169.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.81 167.39 21.25 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.8 1.24 . . . . 0.0 114.044 -173.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 63.2 m -119.47 132.28 55.76 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.563 1.545 . . . . 0.0 108.15 174.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.59 -179.64 42.08 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 121.881 0.712 . . . . 0.0 114.634 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -86.99 -18.35 30.88 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -169.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -93.11 5.19 52.36 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.398 1.454 . . . . 0.0 112.163 169.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.89 16.12 49.46 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 126.661 2.077 . . . . 0.0 114.113 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.6 pm0 -76.98 178.24 7.11 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.955 1.702 . . . . 0.0 113.087 175.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.8 m -141.19 142.24 34.02 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.417 -1.427 . . . . 0.0 109.93 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 76.9 t -127.54 139.36 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.706 1.602 . . . . 0.0 109.721 -174.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.2 tp -129.1 148.22 51.03 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.154 1.382 . . . . 0.0 109.476 175.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.5 t -127.49 134.72 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.979 2.112 . . . . 0.0 107.414 175.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -135.78 137.21 41.4 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.2 0.6 . . . . 0.0 111.373 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -153.25 155.13 31.59 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 123.827 0.851 . . . . 0.0 112.796 174.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -58.85 134.72 62.14 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.795 2.33 . . . . 0.0 113.53 -176.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 . . . . . 0 C--O 1.253 1.27 0 C-N-CA 125.995 1.718 . . . . 0.0 112.265 176.492 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.784 0 CA-C-O 121.149 0.305 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.8 m -86.02 165.19 16.88 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.828 1.251 . . . . 0.0 112.727 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -111.37 143.29 42.41 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.488 1.515 . . . . 0.0 109.888 169.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.0 p -83.41 170.55 14.38 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.59 -1.319 . . . . 0.0 113.57 -174.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -110.77 -2.67 16.1 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -169.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . 0.276 3.6 t 49.42 -174.6 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 127.917 2.487 . . . . 0.0 114.417 -170.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.7 mm -66.78 154.27 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 O-C-N 120.419 -1.426 . . . . 0.0 111.189 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.1 m -70.33 105.92 3.18 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.156 0.982 . . . . 0.0 112.275 -177.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.6 p -68.39 55.01 0.08 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 127.357 2.263 . . . . 0.0 113.933 170.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.7 p -141.48 -64.55 0.44 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 129.435 3.094 . . . . 0.0 107.182 170.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.7 -39.48 70.16 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.455 1.502 . . . . 0.0 113.129 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -86.11 -17.75 34.2 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.623 -0.673 . . . . 0.0 112.596 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -76.5 -49.0 17.63 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 120.855 -1.153 . . . . 0.0 111.776 173.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.64 -35.15 70.13 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.629 1.172 . . . . 0.0 113.007 -175.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.64 -21.4 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -70.56 -43.23 69.9 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 120.905 -1.122 . . . . 0.0 112.446 177.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.03 -42.08 76.85 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.446 -0.784 . . . . 0.0 111.599 -171.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -62.45 -32.97 73.93 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.719 1.208 . . . . 0.0 112.397 172.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.69 -39.17 80.67 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.6 -1.312 . . . . 0.0 112.412 172.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.74 -38.16 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 O-C-N 121.327 -0.858 . . . . 0.0 111.295 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -58.01 -46.76 84.74 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.39 -0.819 . . . . 0.0 111.195 171.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.1 mp -69.71 -33.59 72.73 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 117.387 -1.292 . . . . 0.0 113.057 175.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.34 -34.17 68.49 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 121.301 1.864 . . . . 0.0 110.455 169.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.2 m -73.56 -39.05 64.99 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.598 1.159 . . . . 0.0 113.535 171.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.7 mm -73.74 -34.2 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 120.724 1.602 . . . . 0.0 111.02 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.4 t -64.79 -48.86 82.73 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-O 117.544 -1.217 . . . . 0.0 109.411 172.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -53.49 -44.21 68.85 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 120.931 1.696 . . . . 0.0 112.177 171.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.8 m -58.74 -35.22 72.38 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.676 -0.64 . . . . 0.0 112.021 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -75.41 -37.05 60.68 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.483 1.513 . . . . 0.0 113.414 171.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.0 mt -66.21 -31.94 73.07 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 120.033 1.288 . . . . 0.0 111.966 175.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 93.1 mt -75.68 -39.45 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 124.685 1.194 . . . . 0.0 110.803 169.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.63 -38.08 61.56 Favored Glycine 0 C--N 1.34 0.775 0 C-N-CA 125.437 1.494 . . . . 0.0 114.114 -171.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.3 t -148.6 -29.69 0.28 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.3 12.18 31.85 Favored Glycine 0 N--CA 1.477 1.386 0 N-CA-C 116.425 1.33 . . . . 0.0 116.425 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.5 m -157.98 146.87 19.32 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.959 1.704 . . . . 0.0 109.611 171.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.4 p -119.34 142.17 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.635 1.574 . . . . 0.0 110.43 -175.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -133.02 157.44 45.22 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.3 1.04 . . . . 0.0 111.032 -169.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -54.98 -39.32 68.88 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -70.95 -19.73 62.53 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.526 1.131 . . . . 0.0 113.318 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -78.98 -43.44 24.43 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.162 0.892 . . . . 0.0 109.908 169.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.7 mt -79.87 -27.16 40.11 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -169.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -57.6 -24.21 55.12 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 170.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -84.14 -3.75 58.33 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.507 1.123 . . . . 0.0 113.882 173.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.2 mm-40 -115.97 -16.02 11.14 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.795 1.238 . . . . 0.0 113.167 -173.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt -58.17 -66.22 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 118.888 0.767 . . . . 0.0 110.937 173.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 66.15 -15.08 0.13 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 127.462 2.305 . . . . 0.0 116.521 172.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -156.16 -26.73 0.1 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.759 1.224 . . . . 0.0 114.079 175.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.97 154.0 25.95 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.007 0.923 . . . . 0.0 111.974 174.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.04 -60.29 2.46 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.412 1.085 . . . . 0.0 111.815 175.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -127.56 128.95 46.47 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.022 0.529 . . . . 0.0 111.932 -169.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -104.04 143.47 32.85 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.353 -0.842 . . . . 0.0 109.965 169.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.5 t -140.06 140.11 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.093 0.957 . . . . 0.0 110.625 -171.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -115.14 132.03 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.067 1.347 . . . . 0.0 113.63 -169.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.6 mmt85 -130.86 74.93 1.63 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.594 1.557 . . . . 0.0 109.673 171.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.5 mt -93.12 131.22 33.58 Favored Pre-proline 0 N--CA 1.479 1.003 0 O-C-N 121.396 -0.815 . . . . 0.0 108.856 172.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.46 136.7 44.08 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.231 1.954 . . . . 0.0 111.459 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.07 -0.13 83.68 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.746 1.165 . . . . 0.0 115.587 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -137.06 157.55 74.35 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 119.015 1.407 . . . . 0.0 112.218 173.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.2 153.02 62.28 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.848 2.366 . . . . 0.0 112.852 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.6 p -55.95 136.95 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.672 1.189 . . . . 0.0 111.935 172.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 99.2 t -115.8 141.13 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.888 1.675 . . . . 0.0 108.082 169.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -139.93 123.13 16.89 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.442 1.097 . . . . 0.0 110.646 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.7 t -95.97 154.97 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 126.596 1.959 . . . . 0.0 111.149 -172.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.36 -95.11 1.3 Allowed Glycine 0 CA--C 1.532 1.115 0 O-C-N 121.327 -0.858 . . . . 0.0 112.485 174.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 60.5 m -152.36 149.84 29.06 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.478 1.111 . . . . 0.0 110.057 174.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -69.38 125.28 91.86 Favored Pre-proline 0 CA--C 1.546 0.822 0 O-C-N 120.636 -1.29 . . . . 0.0 111.262 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.37 153.74 31.36 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.969 3.112 . . . . 0.0 114.623 -175.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 t -83.14 -31.08 27.39 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -169.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.26 -33.77 2.73 Favored Glycine 0 N--CA 1.478 1.466 0 C-N-CA 125.193 1.377 . . . . 0.0 112.978 -174.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -78.09 57.51 1.82 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.97 1.708 . . . . 0.0 110.511 169.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.8 m -137.4 154.43 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.274 1.83 . . . . 0.0 111.526 -172.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.7 mt -87.98 140.19 29.75 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 127.097 2.159 . . . . 0.0 109.187 173.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -121.36 112.58 18.75 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.424 0.556 . . . . 0.0 111.785 -176.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.6 143.14 16.41 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 169.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -151.66 131.46 13.25 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.646 1.723 . . . . 0.0 112.339 -170.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -143.58 168.18 20.48 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.729 1.211 . . . . 0.0 113.655 -174.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.7 m -120.03 131.85 55.27 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.422 1.489 . . . . 0.0 108.882 176.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.56 173.2 32.21 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.616 1.103 . . . . 0.0 114.688 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -81.43 -12.59 58.88 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -169.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -95.81 5.11 52.11 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 120.76 1.618 . . . . 0.0 111.58 169.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.36 17.32 40.05 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 126.766 2.127 . . . . 0.0 114.213 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.6 pm0 -82.93 175.26 10.2 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.911 1.684 . . . . 0.0 113.869 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.5 m -128.26 138.38 52.4 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.084 1.353 . . . . 0.0 109.956 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.2 t -120.98 141.13 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.365 1.466 . . . . 0.0 110.355 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.0 tp -128.56 147.18 50.69 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.219 1.407 . . . . 0.0 109.812 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.4 t -131.59 137.39 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.339 1.456 . . . . 0.0 108.426 173.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -130.22 127.39 39.52 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.989 0.9 . . . . 0.0 111.76 -176.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -125.35 143.77 45.6 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.44 1.896 . . . . 0.0 110.694 -173.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -61.22 132.55 41.96 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.426 2.084 . . . . 0.0 111.609 174.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 . . . . . 0 C--O 1.254 1.314 0 C-N-CA 124.688 1.195 . . . . 0.0 112.522 -178.539 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 112.069 -0.412 . . . . 0.0 112.069 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.3 m -94.45 -13.48 26.16 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -175.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.76 149.68 48.8 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.541 1.136 . . . . 0.0 112.875 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.7 m -153.95 154.77 34.4 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.913 1.685 . . . . 0.0 110.381 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -86.43 121.76 29.43 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.987 0.915 . . . . 0.0 111.581 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.9 m -65.6 145.8 55.61 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.4 1.08 . . . . 0.0 111.142 171.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 55.1 mt -128.14 133.35 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.574 1.55 . . . . 0.0 108.536 175.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.2 m -122.46 129.72 52.32 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.824 0.85 . . . . 0.0 112.869 -170.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.1 p -70.57 58.62 0.19 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.522 1.929 . . . . 0.0 114.063 173.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.3 p -141.82 -64.75 0.43 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 129.128 2.971 . . . . 0.0 107.273 169.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.4 -43.04 67.57 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.359 1.464 . . . . 0.0 112.836 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -79.51 -21.62 45.05 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.547 -0.721 . . . . 0.0 112.603 174.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -72.82 -45.2 59.73 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.722 -1.236 . . . . 0.0 111.734 173.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -57.33 -37.0 71.85 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.714 -0.616 . . . . 0.0 112.455 -173.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.2 m -68.48 -24.06 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.817 1.247 . . . . 0.0 112.968 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.17 -43.93 73.23 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.336 0.971 . . . . 0.0 112.115 177.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.26 -39.9 71.31 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.516 -0.74 . . . . 0.0 111.294 -169.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -69.84 -31.14 68.84 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.709 1.203 . . . . 0.0 112.686 173.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.95 -38.98 83.46 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.908 -1.12 . . . . 0.0 112.18 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.0 t -67.15 -39.42 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 O-C-N 121.29 -0.881 . . . . 0.0 111.414 172.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -57.24 -44.87 84.23 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.589 -0.694 . . . . 0.0 111.023 171.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -71.38 -36.24 71.36 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 116.176 -1.869 . . . . 0.0 113.257 175.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.3 -39.76 67.28 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 121.976 2.171 . . . . 0.0 109.8 169.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.0 m -64.83 -40.36 95.06 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 118.051 -0.976 . . . . 0.0 113.334 173.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.8 mm -75.49 -28.63 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 120.584 1.538 . . . . 0.0 111.552 178.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.3 t -65.14 -49.21 80.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 O-C-N 120.926 -1.109 . . . . 0.0 108.978 170.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -56.77 -42.28 79.13 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 120.444 1.475 . . . . 0.0 113.191 174.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.0 p -64.94 -23.42 67.22 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.998 0.817 . . . . 0.0 112.29 177.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -83.79 -35.15 24.52 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.471 1.908 . . . . 0.0 113.411 169.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.5 mt -64.38 -38.68 91.89 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 120.527 1.512 . . . . 0.0 111.386 172.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 89.3 mt -72.42 -35.58 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 124.491 1.117 . . . . 0.0 110.891 170.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.5 -38.48 51.92 Favored Glycine 0 C--N 1.34 0.75 0 C-N-CA 125.657 1.599 . . . . 0.0 114.473 -171.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.0 t -152.18 -26.87 0.17 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 177.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.35 6.59 33.46 Favored Glycine 0 N--CA 1.477 1.381 0 N-CA-C 116.954 1.542 . . . . 0.0 116.954 173.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 t -161.07 150.0 16.46 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.546 1.538 . . . . 0.0 109.881 170.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -115.9 147.15 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 126.046 1.738 . . . . 0.0 110.826 -178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -126.27 159.02 34.22 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.498 1.519 . . . . 0.0 110.352 -173.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -54.75 -38.48 67.24 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.862 -0.524 . . . . 0.0 112.413 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -69.36 -21.72 63.79 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -79.91 -31.92 40.16 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.769 0.713 . . . . 0.0 111.756 172.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 89.4 mt -86.54 -33.91 20.13 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.988 1.315 . . . . 0.0 114.19 -174.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -58.55 -20.88 50.33 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 175.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -80.38 -14.97 57.89 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 175.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.402 ' C ' ' H ' ' A' ' 46' ' ' ARG . 33.9 mm-40 -100.84 -44.36 5.8 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.921 0.888 . . . . 0.0 112.674 -169.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt -40.03 -36.9 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 117.832 2.53 . . . . 0.0 117.832 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.402 ' H ' ' C ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER 43.36 -3.11 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.293 1 C-N-CA 132.021 4.128 . . . . 0.0 119.112 175.677 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -179.95 -35.38 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 128.242 2.617 . . . . 0.0 111.988 -169.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.85 139.56 55.2 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.315 0.646 . . . . 0.0 109.928 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.22 -58.62 5.51 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.628 0.771 . . . . 0.0 112.706 -171.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -131.77 127.43 36.7 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.786 0.434 . . . . 0.0 111.17 -170.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -104.69 145.67 30.02 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.368 0.985 . . . . 0.0 109.675 169.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.2 t -139.99 141.4 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.331 1.052 . . . . 0.0 110.738 -170.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 mm -111.42 126.38 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.614 1.566 . . . . 0.0 112.669 -172.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -125.94 63.3 1.23 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.518 1.927 . . . . 0.0 109.703 170.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.9 mt -79.74 126.83 79.55 Favored Pre-proline 0 N--CA 1.481 1.084 0 CA-C-O 118.34 -0.838 . . . . 0.0 108.989 169.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -58.38 139.43 90.56 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.947 2.431 . . . . 0.0 113.082 173.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.78 0.0 87.22 Favored Glycine 0 CA--C 1.537 1.409 0 N-CA-C 116.042 1.177 . . . . 0.0 116.042 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -138.13 158.71 70.56 Favored Pre-proline 0 CA--C 1.549 0.935 0 CA-C-N 119.23 1.515 . . . . 0.0 112.685 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.98 149.85 59.83 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.846 2.364 . . . . 0.0 113.481 -174.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 81.3 t -64.09 130.82 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.5 1.52 . . . . 0.0 111.172 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.5 t -106.09 142.43 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.569 1.548 . . . . 0.0 108.202 170.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -135.57 113.97 11.59 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.797 1.239 . . . . 0.0 109.208 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.0 t -84.22 151.63 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.715 1.606 . . . . 0.0 110.975 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.51 -99.23 1.2 Allowed Glycine 0 CA--C 1.534 1.232 0 O-C-N 121.321 -0.862 . . . . 0.0 112.985 175.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -148.74 158.12 43.92 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.73 1.212 . . . . 0.0 109.979 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -71.27 130.28 88.03 Favored Pre-proline 0 CA--C 1.549 0.938 0 O-C-N 120.627 -1.295 . . . . 0.0 110.636 170.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.9 157.07 34.87 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.272 3.315 . . . . 0.0 114.103 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.7 t -83.63 -32.25 25.79 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -171.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.96 -33.19 2.64 Favored Glycine 0 N--CA 1.476 1.336 0 C-N-CA 125.41 1.481 . . . . 0.0 113.261 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -78.3 58.99 2.21 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.096 1.758 . . . . 0.0 111.229 169.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.0 m -136.94 155.23 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.372 1.469 . . . . 0.0 112.706 -171.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.8 mt -91.7 138.88 31.2 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 128.284 2.633 . . . . 0.0 109.546 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -121.62 103.8 9.17 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.787 0.721 . . . . 0.0 111.877 -175.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -83.75 150.97 27.21 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 169.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.8 ttt-85 -148.88 153.84 38.61 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 118.845 1.322 . . . . 0.0 111.478 -172.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -161.76 167.26 25.28 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.554 1.142 . . . . 0.0 112.922 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 97.2 m -131.51 110.98 11.37 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.507 1.523 . . . . 0.0 109.572 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.45 163.27 54.39 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.162 0.887 . . . . 0.0 114.88 -177.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -68.35 -8.22 38.11 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.632 1.973 . . . . 0.0 115.34 -174.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -102.9 4.05 37.17 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.258 1.39 . . . . 0.0 113.084 169.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.68 20.79 15.91 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.902 1.239 . . . . 0.0 114.484 172.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.64 -170.54 3.06 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.912 1.285 . . . . 0.0 113.874 -177.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.0 m -147.24 123.21 10.71 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 120.705 -1.247 . . . . 0.0 111.883 172.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.7 t -94.27 146.03 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.448 1.499 . . . . 0.0 110.866 171.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.6 tp -130.18 145.27 51.71 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.689 1.596 . . . . 0.0 108.364 169.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.16 139.4 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.179 1.392 . . . . 0.0 108.576 171.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -132.18 129.37 39.67 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.914 0.886 . . . . 0.0 111.014 -175.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -131.8 140.26 37.69 Favored Pre-proline 0 N--CA 1.473 0.677 0 C-N-CA 126.138 1.775 . . . . 0.0 111.042 -170.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -62.17 136.53 60.92 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.176 1.917 . . . . 0.0 112.099 174.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 . . . . . 0 C--O 1.253 1.252 0 C-N-CA 124.458 1.103 . . . . 0.0 111.8 173.225 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.747 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m 57.73 37.94 27.34 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.795 1.638 . . . . 0.0 114.461 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -92.52 44.66 1.17 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.595 1.558 . . . . 0.0 112.588 -175.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.8 m -59.53 143.47 50.07 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.514 1.926 . . . . 0.0 113.303 -174.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.19 156.8 43.66 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.471 1.509 . . . . 0.0 113.01 175.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.1 t -152.09 158.62 43.24 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.704 1.602 . . . . 0.0 110.972 174.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.2 mt -79.8 120.89 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 O-C-N 121.498 -0.751 . . . . 0.0 109.85 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.1 m -47.56 125.55 8.55 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.28 1.832 . . . . 0.0 115.44 -171.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.8 m -70.77 63.04 0.28 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.635 1.574 . . . . 0.0 112.47 170.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.6 p -142.18 -83.16 0.19 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.95 2.5 . . . . 0.0 108.419 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.92 -46.83 67.29 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.595 1.158 . . . . 0.0 111.967 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -66.65 -28.25 68.33 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.578 -0.701 . . . . 0.0 112.155 175.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -71.02 -56.7 5.61 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.345 0.658 . . . . 0.0 111.191 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.416 HH21 ' CD ' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -58.86 -39.95 82.84 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 118.383 -0.818 . . . . 0.0 111.751 -178.026 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.5 t -56.65 -31.61 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.201 1.4 . . . . 0.0 112.512 174.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -77.26 -33.67 55.91 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 176.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.4 mp -74.11 -38.92 63.7 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 120.929 -1.107 . . . . 0.0 111.24 -178.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.416 ' CD ' HH21 ' A' ' 14' ' ' ARG . 6.7 pt-20 -65.21 -27.25 68.55 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 170.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.39 -36.68 83.47 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 120.69 -1.256 . . . . 0.0 112.308 169.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.1 t -70.81 -36.28 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 124.445 1.098 . . . . 0.0 111.342 172.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -60.49 -45.0 95.36 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.112 -0.992 . . . . 0.0 111.449 171.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.1 mp -70.28 -33.38 71.5 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-O 117.147 -1.406 . . . . 0.0 112.494 174.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.29 -33.93 69.99 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 121.475 1.943 . . . . 0.0 110.805 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.7 m -72.05 -38.88 69.42 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.101 0.96 . . . . 0.0 113.236 171.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.0 mm -73.82 -34.85 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 120.721 1.6 . . . . 0.0 110.933 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.1 t -62.67 -48.2 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 117.452 -1.261 . . . . 0.0 110.033 172.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -54.1 -42.36 69.31 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 120.994 1.725 . . . . 0.0 112.173 171.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.2 m -60.28 -33.04 71.77 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.702 -0.624 . . . . 0.0 112.142 175.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -76.71 -37.22 56.45 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.065 1.346 . . . . 0.0 113.31 171.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.1 mt -65.06 -31.19 72.29 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.674 1.125 . . . . 0.0 112.133 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 89.7 mt -76.52 -36.78 28.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 125.156 1.382 . . . . 0.0 111.248 169.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.18 -39.43 31.92 Favored Glycine 0 N--CA 1.469 0.845 0 C-N-CA 126.08 1.8 . . . . 0.0 115.547 -171.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.9 t -151.08 -23.95 0.21 Allowed 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.0 6.04 54.34 Favored Glycine 0 N--CA 1.468 0.828 0 N-CA-C 117.271 1.668 . . . . 0.0 117.271 169.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.0 m -158.5 149.88 20.91 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.418 1.487 . . . . 0.0 110.343 170.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 p -103.51 145.11 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.448 1.099 . . . . 0.0 113.0 -173.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -116.6 152.9 33.23 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.675 1.59 . . . . 0.0 110.792 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -57.4 -35.67 70.33 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.888 -1.133 . . . . 0.0 111.885 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -70.42 -19.18 63.01 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.93 1.292 . . . . 0.0 112.738 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -83.62 -32.95 25.43 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.904 0.775 . . . . 0.0 112.179 169.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.3 mt -86.63 -34.65 19.76 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.451 1.5 . . . . 0.0 114.005 -172.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -60.48 -20.51 60.26 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -84.82 -3.41 58.63 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.23 1.412 . . . . 0.0 113.591 175.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -114.35 -26.49 7.96 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.942 1.297 . . . . 0.0 113.202 -172.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -52.5 -60.5 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.017 0.927 . . . . 0.0 112.829 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 62.53 -23.29 0.05 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 128.086 2.554 . . . . 0.0 117.556 -177.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -153.38 -27.77 0.14 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -172.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.53 146.43 51.85 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.51 1.124 . . . . 0.0 111.156 169.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -77.94 -48.39 16.4 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.594 0.358 . . . . 0.0 111.143 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -133.83 129.88 37.14 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.246 1.419 . . . . 0.0 110.932 -175.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.12 136.17 47.42 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 120.195 1.361 . . . . 0.0 109.302 168.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.3 t -126.45 143.08 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.054 1.341 . . . . 0.0 110.767 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.3 mm -120.57 134.07 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.542 1.537 . . . . 0.0 113.418 -169.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -113.53 3.49 15.76 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 116.277 1.955 . . . . 0.0 116.277 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.6 mt -40.04 124.72 1.64 Allowed Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 125.739 1.616 . . . . 0.0 113.544 -172.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -60.7 140.64 91.92 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.147 2.564 . . . . 0.0 113.742 173.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.0 -1.38 86.85 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.811 1.196 . . . . 0.0 115.476 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -131.49 160.84 65.49 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 125.001 1.32 . . . . 0.0 111.298 172.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -62.26 161.89 25.38 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.461 2.107 . . . . 0.0 112.145 176.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.1 t -72.11 142.9 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 169.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 87.6 t -113.94 138.52 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 169.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -124.51 118.55 26.86 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.036 1.334 . . . . 0.0 108.708 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.3 t -94.22 154.34 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.043 1.337 . . . . 0.0 110.811 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.36 -109.14 2.7 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.0 t -154.69 162.14 41.25 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.736 0.768 . . . . 0.0 111.332 169.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.5 tttp -61.63 141.86 94.67 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.74 1.216 . . . . 0.0 111.565 -176.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -65.36 -167.48 0.1 Allowed 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 124.342 3.361 . . . . 0.0 115.89 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 t -119.61 -24.58 6.2 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 117.571 2.434 . . . . 0.0 117.571 -169.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.57 -10.04 21.76 Favored Glycine 0 N--CA 1.484 1.862 0 CA-C-N 119.472 1.033 . . . . 0.0 114.556 -173.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -134.45 83.8 2.06 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.829 2.452 . . . . 0.0 110.278 170.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.3 m -139.54 147.15 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.896 1.278 . . . . 0.0 111.621 -176.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.5 mt -72.33 148.95 44.86 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.05 1.34 . . . . 0.0 107.55 169.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -133.15 113.7 13.02 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.588 0.755 . . . . 0.0 109.201 -178.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -99.42 147.82 18.48 Favored Glycine 0 N--CA 1.468 0.788 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 169.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 74.2 ttt-85 -150.05 146.51 27.0 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 118.466 1.133 . . . . 0.0 112.84 -169.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.53 155.59 33.67 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.793 0.837 . . . . 0.0 112.955 -178.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.1 m -113.72 129.9 56.51 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.276 1.43 . . . . 0.0 109.475 169.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.03 -160.51 36.12 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 124.182 0.896 . . . . 0.0 115.055 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -99.51 -15.15 18.77 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -169.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -91.57 -1.82 57.36 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 120.338 1.426 . . . . 0.0 111.998 168.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.01 20.07 26.97 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 126.303 1.906 . . . . 0.0 113.651 -174.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.0 pm0 -80.66 163.5 23.55 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.841 1.656 . . . . 0.0 113.988 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.9 m -128.51 140.37 51.84 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.125 0.97 . . . . 0.0 110.507 173.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.8 t -131.79 143.2 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.157 1.783 . . . . 0.0 109.363 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.3 tp -130.15 147.58 51.9 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.46 1.504 . . . . 0.0 111.569 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 76.2 t -122.44 138.34 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 126.887 2.075 . . . . 0.0 108.401 171.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -137.06 134.51 36.6 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.741 0.701 . . . . 0.0 112.652 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.0 152.27 33.72 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 176.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -58.27 128.02 27.02 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.548 2.832 . . . . 0.0 113.431 -175.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 125.156 1.382 . . . . 0.0 112.131 179.396 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.855 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.5 p -75.0 -38.77 61.52 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -174.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -77.76 167.22 21.9 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -172.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.4 t -146.44 159.71 43.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.676 1.59 . . . . 0.0 111.081 169.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 68.7 mmt-85 -112.92 -152.9 0.51 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.864 1.666 . . . . 0.0 112.002 -175.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.1 t -169.18 111.62 0.5 Allowed 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 123.057 1.408 . . . . 0.0 111.845 170.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mp -85.87 144.77 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 124.556 1.142 . . . . 0.0 109.917 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 64.5 m -94.24 49.52 1.31 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.39 1.476 . . . . 0.0 112.121 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.4 m -56.11 18.96 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 130.326 3.45 . . . . 0.0 118.831 -169.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.4 p -124.29 -62.71 1.25 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.822 2.049 . . . . 0.0 108.714 169.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.13 -45.45 73.58 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.289 1.436 . . . . 0.0 112.288 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.4 tp60 -68.54 -34.78 76.46 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.634 -0.666 . . . . 0.0 111.101 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -70.51 -52.71 19.97 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.608 0.363 . . . . 0.0 110.807 -176.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.408 HH21 ' CD ' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -58.39 -36.1 73.04 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 118.365 -0.826 . . . . 0.0 112.042 176.744 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.8 t -57.25 -28.47 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.911 1.684 . . . . 0.0 113.408 171.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -76.85 -38.51 53.6 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.181 -0.949 . . . . 0.0 112.278 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.5 mp -70.6 -36.75 73.71 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.324 -0.86 . . . . 0.0 111.349 -174.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.408 ' CD ' HH21 ' A' ' 14' ' ' ARG . 8.3 pt-20 -67.08 -32.07 72.99 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.7 0.8 . . . . 0.0 112.581 170.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.06 -40.74 87.14 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.637 -1.289 . . . . 0.0 112.125 171.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.5 t -63.45 -43.55 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.822 0.849 . . . . 0.0 110.932 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -57.27 -41.13 79.1 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.741 -0.599 . . . . 0.0 111.51 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 mp -67.63 -34.84 77.76 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 117.315 -1.326 . . . . 0.0 113.326 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.74 -33.92 67.03 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 120.991 1.723 . . . . 0.0 111.249 169.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 m -73.92 -37.56 64.58 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 170.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.3 mm -69.58 -36.57 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 120.618 1.554 . . . . 0.0 110.4 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.13 -46.93 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.915 1.286 . . . . 0.0 109.624 176.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -52.89 -43.63 66.32 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 120.62 1.555 . . . . 0.0 111.963 170.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.9 m -59.96 -32.41 70.79 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.791 0.436 . . . . 0.0 111.986 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -79.07 -36.62 40.59 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.594 1.558 . . . . 0.0 113.712 172.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.0 mt -66.34 -34.26 77.57 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 120.195 1.361 . . . . 0.0 111.43 175.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.3 mt -73.06 -36.74 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.386 1.074 . . . . 0.0 110.491 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.75 -38.81 60.75 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 125.695 1.617 . . . . 0.0 114.428 -173.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.5 t -152.24 -26.52 0.17 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 178.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.51 3.35 53.24 Favored Glycine 0 N--CA 1.481 1.694 0 N-CA-C 116.156 1.223 . . . . 0.0 116.156 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.5 m -143.66 135.3 26.25 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.214 1.806 . . . . 0.0 108.974 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 p -107.01 145.5 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.668 0.787 . . . . 0.0 109.634 172.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -133.59 156.91 46.98 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.666 1.186 . . . . 0.0 110.187 -175.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -56.3 -37.58 70.08 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.804 -0.56 . . . . 0.0 111.907 -177.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -70.03 -22.06 63.13 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -77.6 -37.89 49.38 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.497 0.59 . . . . 0.0 111.738 170.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 60.6 mt -87.71 -27.05 22.63 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 -173.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -56.49 -27.74 57.94 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 175.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -90.5 4.34 51.41 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.623 1.169 . . . . 0.0 114.12 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -123.09 -10.57 8.12 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 119.814 1.188 . . . . 0.0 113.943 -170.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.27 -45.18 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.274 1.429 . . . . 0.0 114.547 -175.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.3 73.4 mtt85 75.15 -24.84 0.21 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 129.056 2.942 . . . . 0.0 117.273 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -160.1 -42.72 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.628 1.571 . . . . 0.0 109.487 169.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -38.69 130.13 1.42 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 128.34 2.656 . . . . 0.0 112.905 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -47.65 60.08 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.596 -0.69 . . . . 0.0 110.867 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -131.74 116.93 17.92 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.733 1.613 . . . . 0.0 109.457 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.15 145.08 25.66 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.012 -1.055 . . . . 0.0 108.69 168.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.2 t -139.89 134.76 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 120.682 -1.261 . . . . 0.0 110.931 -169.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mm -116.07 139.16 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.087 1.355 . . . . 0.0 114.641 -170.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -144.87 73.3 1.36 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.076 1.75 . . . . 0.0 109.628 169.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.0 mt -83.35 121.76 76.91 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-N 114.386 -1.279 . . . . 0.0 107.682 169.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.22 132.68 50.48 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.073 1.849 . . . . 0.0 112.214 174.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.05 0.18 83.41 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.869 1.223 . . . . 0.0 116.016 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -139.87 165.57 30.01 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 119.79 1.795 . . . . 0.0 113.872 173.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -60.74 140.95 93.48 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.609 2.873 . . . . 0.0 115.644 -173.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.6 t -69.98 116.03 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.509 1.124 . . . . 0.0 108.946 169.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.87 143.98 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.195 1.398 . . . . 0.0 109.765 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -139.16 110.91 7.16 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.792 1.237 . . . . 0.0 108.881 -170.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.1 t -80.93 153.8 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.745 1.618 . . . . 0.0 111.466 -172.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.42 -87.54 1.12 Allowed Glycine 0 CA--C 1.533 1.157 0 O-C-N 121.487 -0.758 . . . . 0.0 113.263 172.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.1 m -157.68 160.76 38.31 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.014 1.326 . . . . 0.0 109.889 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.8 tptt -73.94 131.9 80.82 Favored Pre-proline 0 CA--C 1.548 0.879 0 O-C-N 120.778 -1.201 . . . . 0.0 110.581 171.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.65 156.49 40.13 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 124.223 3.282 . . . . 0.0 114.349 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.6 t -83.91 -33.24 24.77 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -173.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.62 -40.82 1.45 Allowed Glycine 0 N--CA 1.474 1.209 0 C-N-CA 124.983 1.278 . . . . 0.0 113.472 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -78.44 58.8 2.24 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.527 1.531 . . . . 0.0 111.767 171.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.8 m -127.13 156.76 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.244 1.418 . . . . 0.0 113.298 -173.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.0 mt -97.25 112.94 24.52 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 127.761 2.424 . . . . 0.0 110.789 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -98.45 100.57 11.84 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.172 0.989 . . . . 0.0 113.034 -171.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -85.68 152.83 26.62 Favored Glycine 0 N--CA 1.473 1.134 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 169.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -149.66 154.77 39.13 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.544 1.672 . . . . 0.0 112.211 -169.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -163.35 167.94 21.1 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.298 1.039 . . . . 0.0 113.372 176.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 62.3 m -124.75 132.93 53.32 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.121 1.768 . . . . 0.0 107.814 171.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.84 -179.31 38.96 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 123.52 0.581 . . . . 0.0 114.432 -178.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -88.51 -10.02 50.41 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -169.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -99.73 7.09 45.37 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.791 1.632 . . . . 0.0 111.138 169.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.43 18.04 40.22 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 127.033 2.254 . . . . 0.0 114.099 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.9 pm0 -79.14 176.05 10.03 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.525 1.53 . . . . 0.0 113.584 178.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.6 m -136.48 139.53 42.39 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.491 1.116 . . . . 0.0 109.534 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.4 t -129.68 143.42 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.539 1.536 . . . . 0.0 110.541 -174.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.0 tp -134.25 150.42 51.02 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.564 1.546 . . . . 0.0 109.136 173.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 37.7 t -126.42 138.39 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 126.194 1.798 . . . . 0.0 108.574 171.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -135.98 138.69 42.53 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.487 0.715 . . . . 0.0 111.438 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -154.5 156.62 31.79 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.289 1.436 . . . . 0.0 112.521 173.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -59.13 138.64 86.34 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.415 2.076 . . . . 0.0 113.828 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 . . . . . 0 C--O 1.255 1.344 0 C-N-CA 125.801 1.64 . . . . 0.0 112.19 172.87 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.68 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m -137.13 160.36 39.22 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.204 1.401 . . . . 0.0 112.576 -174.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -60.75 163.36 5.67 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.409 1.084 . . . . 0.0 113.17 174.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.1 m -158.49 162.74 37.51 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.42 1.888 . . . . 0.0 109.025 -173.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -98.91 128.6 45.13 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.807 0.843 . . . . 0.0 111.526 172.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.8 m -82.47 135.21 35.18 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 171.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.7 mt -143.92 159.98 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 125.962 1.705 . . . . 0.0 108.098 -176.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.8 m -96.39 118.87 33.81 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.156 -0.965 . . . . 0.0 112.342 -178.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.7 m -67.79 57.68 0.06 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.497 2.319 . . . . 0.0 113.419 172.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.8 p -141.17 -64.11 0.45 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 129.265 3.026 . . . . 0.0 106.444 169.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.58 -44.44 64.47 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.493 1.517 . . . . 0.0 112.389 172.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -72.34 -27.73 62.6 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.431 -0.793 . . . . 0.0 112.356 174.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -70.68 -48.96 52.09 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.337 -0.852 . . . . 0.0 110.862 176.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.403 HH21 ' CD ' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -61.93 -35.0 77.11 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 118.38 -0.819 . . . . 0.0 113.006 -175.621 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.0 m -63.99 -19.82 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 174.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.96 -44.82 68.71 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.672 1.124 . . . . 0.0 112.326 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -69.52 -41.33 76.16 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.278 -0.889 . . . . 0.0 111.491 -171.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.403 ' CD ' HH21 ' A' ' 14' ' ' ARG . 8.6 pt-20 -64.64 -33.6 76.31 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.65 1.18 . . . . 0.0 112.635 171.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.52 -37.76 85.73 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.736 -1.228 . . . . 0.0 112.384 172.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.0 t -68.85 -37.64 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 124.023 0.929 . . . . 0.0 111.37 172.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -59.4 -43.9 92.91 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.175 -0.953 . . . . 0.0 111.744 170.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.7 mp -68.98 -34.95 76.15 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 120.382 1.446 . . . . 0.0 112.806 173.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.26 -34.43 68.63 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 121.158 1.799 . . . . 0.0 110.584 169.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.5 m -71.52 -40.16 70.28 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.084 0.954 . . . . 0.0 113.177 172.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.8 mm -72.04 -35.48 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 120.69 1.587 . . . . 0.0 111.108 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.21 -45.69 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.696 1.198 . . . . 0.0 109.547 174.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -53.75 -43.11 68.88 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 120.78 1.627 . . . . 0.0 112.12 171.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.6 t -59.15 -39.55 82.79 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.964 -0.46 . . . . 0.0 111.826 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -68.55 -38.34 80.7 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.666 1.186 . . . . 0.0 113.088 171.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.0 mt -67.72 -38.46 83.61 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.747 1.158 . . . . 0.0 112.084 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.09 -37.36 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.49 1.116 . . . . 0.0 111.348 172.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.39 -64.19 3.08 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 124.837 1.208 . . . . 0.0 111.083 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.1 t -126.81 -27.6 3.05 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -174.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.48 3.05 53.51 Favored Glycine 0 N--CA 1.475 1.267 0 N-CA-C 116.81 1.484 . . . . 0.0 116.81 172.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.4 m -146.73 136.94 23.6 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.633 1.573 . . . . 0.0 109.713 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 p -104.76 146.69 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.505 1.122 . . . . 0.0 110.688 176.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -133.65 159.18 41.28 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.877 1.271 . . . . 0.0 110.352 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -55.79 -38.58 70.11 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -71.04 -17.18 62.63 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -80.62 -32.14 36.37 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.349 0.977 . . . . 0.0 112.041 170.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.3 mt -90.98 -30.45 16.82 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.237 1.415 . . . . 0.0 114.489 -172.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.9 ptt85 -59.0 -23.93 62.32 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 119.398 0.999 . . . . 0.0 113.491 174.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -82.02 -6.95 59.55 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 175.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -113.4 -20.11 11.45 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -169.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.1 pt -56.92 -63.11 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -172.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 63.9 -19.56 0.06 Allowed 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 117.696 2.48 . . . . 0.0 117.696 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -148.25 -35.47 0.21 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.216 1.406 . . . . 0.0 112.803 -178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.35 145.66 53.97 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.867 1.267 . . . . 0.0 110.585 172.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.52 -42.83 16.41 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.561 0.345 . . . . 0.0 111.51 176.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -133.63 123.14 24.52 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.582 1.553 . . . . 0.0 109.193 -176.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.4 138.57 35.44 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.229 0.922 . . . . 0.0 109.166 169.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.8 t -132.89 140.36 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.033 1.333 . . . . 0.0 109.692 -173.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.24 131.9 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -169.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -128.77 78.43 1.85 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.5 1.92 . . . . 0.0 109.848 170.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.8 mt -96.9 125.59 45.8 Favored Pre-proline 0 N--CA 1.481 1.104 0 O-C-N 121.128 -0.982 . . . . 0.0 109.047 170.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.91 134.86 62.91 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.549 2.166 . . . . 0.0 112.484 172.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.9 0.31 85.81 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 124.711 1.148 . . . . 0.0 115.942 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -139.74 156.39 70.98 Favored Pre-proline 0 N--CA 1.476 0.827 0 CA-C-N 119.407 1.604 . . . . 0.0 112.506 174.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -69.75 149.79 67.39 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.699 2.266 . . . . 0.0 112.983 -173.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.0 t -57.02 132.8 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.934 1.294 . . . . 0.0 110.783 175.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.1 t -111.74 141.92 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.154 1.382 . . . . 0.0 109.41 170.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -136.5 117.77 14.57 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.132 1.373 . . . . 0.0 109.223 176.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.8 t -91.94 159.55 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.02 1.728 . . . . 0.0 111.156 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.41 -104.64 1.62 Allowed Glycine 0 CA--C 1.531 1.067 0 O-C-N 120.959 -1.088 . . . . 0.0 112.026 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.5 t -154.74 160.58 41.42 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.553 0.692 . . . . 0.0 111.516 169.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -74.16 125.94 89.6 Favored Pre-proline 0 CA--C 1.546 0.807 0 O-C-N 120.698 -1.251 . . . . 0.0 111.703 -170.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -76.65 154.19 34.7 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.834 3.023 . . . . 0.0 114.728 -177.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.1 t -84.4 -30.13 25.62 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -171.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.29 -35.38 2.44 Favored Glycine 0 N--CA 1.479 1.534 0 C-N-CA 124.738 1.161 . . . . 0.0 113.816 -175.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -78.18 58.64 2.08 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.922 1.689 . . . . 0.0 110.816 169.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.6 m -138.95 155.33 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 125.946 1.698 . . . . 0.0 111.863 -171.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.1 mt -74.44 164.79 26.18 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.881 1.672 . . . . 0.0 109.873 169.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -149.32 93.14 2.03 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.729 0.812 . . . . 0.0 110.223 -173.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -85.58 148.56 22.88 Favored Glycine 0 N--CA 1.471 1.007 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 169.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -151.44 150.14 30.08 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.636 1.718 . . . . 0.0 113.207 -169.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -157.51 157.18 33.34 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.316 1.046 . . . . 0.0 113.638 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 85.5 m -109.52 125.86 52.93 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.107 1.363 . . . . 0.0 107.871 169.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.18 173.42 42.74 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 122.385 0.991 . . . . 0.0 114.807 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -80.47 -8.03 59.39 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 -169.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -103.39 6.38 37.72 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.935 1.698 . . . . 0.0 111.648 168.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.1 18.71 30.7 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.264 1.887 . . . . 0.0 114.273 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.7 pm0 -85.28 176.18 8.48 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.613 1.565 . . . . 0.0 113.759 177.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.8 m -132.59 134.18 44.59 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.124 1.37 . . . . 0.0 110.444 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.7 t -118.89 144.28 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.066 1.746 . . . . 0.0 110.115 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.6 tp -133.6 143.75 48.83 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.469 1.108 . . . . 0.0 110.557 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.7 t -114.76 135.66 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 127.797 2.439 . . . . 0.0 108.207 171.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -136.71 144.18 43.76 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.839 0.828 . . . . 0.0 111.145 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.2 152.45 20.18 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 176.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -58.11 142.36 96.97 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.678 2.919 . . . . 0.0 114.316 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 . . . . . 0 C--O 1.253 1.284 0 C-N-CA 125.715 1.606 . . . . 0.0 112.68 172.47 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.85 0 N-CA-C 112.354 -0.299 . . . . 0.0 112.354 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.0 m 56.4 49.98 14.0 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.466 1.507 . . . . 0.0 112.913 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -81.57 142.72 32.56 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.076 0.951 . . . . 0.0 111.26 177.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.7 m 53.14 56.83 6.96 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.811 1.244 . . . . 0.0 112.121 -172.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.5 mmm-85 -133.89 150.14 51.34 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 127.164 2.186 . . . . 0.0 110.386 176.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 73.4 m -136.32 132.34 35.53 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.932 1.293 . . . . 0.0 110.684 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.0 mm -124.62 140.53 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.919 1.688 . . . . 0.0 109.266 173.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 27.9 t -52.38 146.17 10.0 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.645 1.178 . . . . 0.0 113.751 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 m -118.58 25.71 10.07 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.126 1.77 . . . . 0.0 111.106 171.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.7 p -139.14 -72.35 0.39 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.902 1.681 . . . . 0.0 108.798 -175.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.65 -38.68 73.86 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.432 1.493 . . . . 0.0 113.009 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -84.44 -20.0 32.5 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.679 -0.638 . . . . 0.0 112.698 174.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -77.14 -48.04 18.77 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.876 -1.14 . . . . 0.0 111.737 172.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -31.47 71.49 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 121.008 -1.057 . . . . 0.0 113.795 -174.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.2 m -65.79 -21.4 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 172.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -69.97 -43.03 72.34 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 120.905 -1.122 . . . . 0.0 112.5 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.26 -40.82 77.6 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.387 -0.821 . . . . 0.0 111.523 -171.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.4 -30.23 70.56 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.538 1.135 . . . . 0.0 112.62 173.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.43 -37.64 80.45 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.881 -1.137 . . . . 0.0 111.918 171.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.0 t -68.71 -37.0 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 O-C-N 121.43 -0.794 . . . . 0.0 111.302 172.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -59.36 -46.48 88.51 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.2 -0.937 . . . . 0.0 111.602 171.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -69.18 -34.14 74.47 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 117.398 -1.287 . . . . 0.0 112.844 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.16 -34.08 68.07 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 121.079 1.763 . . . . 0.0 110.578 169.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.9 m -73.0 -38.46 66.61 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.552 1.141 . . . . 0.0 113.642 171.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.6 mm -70.89 -37.04 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 120.701 1.591 . . . . 0.0 110.814 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.3 t -66.42 -48.31 81.17 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 C-N-CA 124.792 1.237 . . . . 0.0 109.609 175.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -53.61 -43.06 68.35 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 120.593 1.542 . . . . 0.0 112.154 171.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.2 m -59.64 -32.47 70.47 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.807 -0.558 . . . . 0.0 112.107 176.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -79.72 -36.39 37.49 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.634 1.574 . . . . 0.0 113.555 172.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 78.5 mt -65.62 -33.22 75.38 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 120.063 1.301 . . . . 0.0 111.707 174.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.32 -37.57 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.312 1.045 . . . . 0.0 110.894 169.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.39 -37.53 62.75 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 125.637 1.589 . . . . 0.0 114.272 -172.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.3 t -151.46 -27.45 0.19 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 177.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.15 8.69 33.3 Favored Glycine 0 N--CA 1.477 1.411 0 N-CA-C 116.703 1.441 . . . . 0.0 116.703 175.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.7 p -158.82 136.94 10.58 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.517 1.527 . . . . 0.0 109.985 176.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.45 145.95 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.272 1.029 . . . . 0.0 110.327 176.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -127.56 159.41 34.71 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.598 1.559 . . . . 0.0 109.666 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -53.44 -38.95 64.02 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -175.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -70.24 -15.96 62.98 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -89.27 -3.71 58.42 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.785 0.834 . . . . 0.0 112.494 170.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.1 mt -116.19 -33.88 4.86 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.022 1.329 . . . . 0.0 113.634 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.3 ptt85 -64.42 -21.66 66.71 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 119.66 1.118 . . . . 0.0 113.471 178.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -89.02 2.8 53.47 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.209 1.404 . . . . 0.0 113.984 171.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -121.33 -13.38 8.47 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.357 1.463 . . . . 0.0 112.742 -174.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.1 pt -56.49 -63.36 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 118.715 0.689 . . . . 0.0 110.938 171.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 66.07 -13.47 0.16 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 127.907 2.483 . . . . 0.0 116.7 170.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -154.88 -31.84 0.1 Allowed 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 169.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.14 155.85 39.81 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.608 0.763 . . . . 0.0 111.291 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -76.66 -49.61 15.74 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.957 -0.464 . . . . 0.0 111.589 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -136.45 144.89 44.66 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.177 1.391 . . . . 0.0 112.246 -173.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -120.58 149.45 42.43 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.907 0.883 . . . . 0.0 110.87 169.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.9 t -141.16 140.77 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 120.838 -1.163 . . . . 0.0 110.582 -173.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -113.97 136.17 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -170.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -138.72 74.54 1.48 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.218 1.807 . . . . 0.0 109.469 175.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.8 mt -91.69 126.44 53.95 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-N 114.392 -1.277 . . . . 0.0 109.331 171.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -57.87 137.15 79.58 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.027 2.485 . . . . 0.0 112.932 173.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.61 -1.1 88.32 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.604 1.097 . . . . 0.0 115.413 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -136.25 158.27 73.93 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 119.009 1.404 . . . . 0.0 112.164 175.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.46 152.42 60.27 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.72 2.28 . . . . 0.0 112.774 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.1 p -62.44 135.89 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.693 1.197 . . . . 0.0 111.822 171.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.1 p -122.24 147.17 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.818 1.247 . . . . 0.0 110.752 169.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -127.07 124.34 39.04 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.313 1.445 . . . . 0.0 109.727 -173.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.2 t -103.8 149.1 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 127.81 2.444 . . . . 0.0 109.792 -169.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.96 -94.53 1.0 Allowed Glycine 0 CA--C 1.532 1.114 0 O-C-N 120.727 -1.233 . . . . 0.0 111.678 -175.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 m -155.4 157.64 37.37 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.551 1.14 . . . . 0.0 109.879 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -71.51 128.48 89.88 Favored Pre-proline 0 CA--C 1.55 0.943 0 O-C-N 120.569 -1.332 . . . . 0.0 112.19 177.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -77.94 155.53 30.3 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 124.397 3.398 . . . . 0.0 114.736 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.0 t -84.45 -20.3 31.98 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -170.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.21 -31.6 5.76 Favored Glycine 0 N--CA 1.478 1.458 0 C-N-CA 125.782 1.658 . . . . 0.0 113.413 -176.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -78.46 60.1 2.54 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.033 1.733 . . . . 0.0 110.365 169.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.57 154.08 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 126.19 1.796 . . . . 0.0 111.502 -170.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 25.0 mt -86.93 138.23 31.71 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.946 2.098 . . . . 0.0 108.963 173.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -121.57 111.15 16.88 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.151 0.887 . . . . 0.0 111.619 -174.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.56 144.28 16.99 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 169.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -151.35 135.76 16.92 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 119.247 1.523 . . . . 0.0 112.548 -169.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.1 165.01 29.5 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.392 1.077 . . . . 0.0 113.779 -176.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.7 m -117.44 129.76 56.04 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.401 1.481 . . . . 0.0 108.613 173.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.11 173.52 36.21 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.2 0.905 . . . . 0.0 114.603 -178.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -81.86 -9.25 59.66 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 -169.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -99.01 5.02 47.32 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 120.752 1.614 . . . . 0.0 111.506 168.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.38 16.77 36.23 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.562 2.029 . . . . 0.0 114.157 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.7 pm0 -83.58 173.29 11.54 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.66 1.584 . . . . 0.0 113.837 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.1 m -126.75 137.48 53.24 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.452 1.501 . . . . 0.0 110.14 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.7 t -124.17 141.4 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.606 1.562 . . . . 0.0 110.303 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.6 tp -130.49 146.02 51.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.798 1.239 . . . . 0.0 110.209 175.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.9 t -130.63 138.85 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.039 1.736 . . . . 0.0 108.789 176.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -134.53 131.52 38.08 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.394 0.616 . . . . 0.0 112.576 -175.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -123.33 148.68 55.86 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 125.031 1.332 . . . . 0.0 112.446 175.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -57.42 134.27 62.47 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.545 2.163 . . . . 0.0 112.101 170.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 . . . . . 0 C--O 1.254 1.315 0 C-N-CA 124.957 1.303 . . . . 0.0 112.63 -178.776 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.699 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.9 p -151.73 162.6 40.75 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.591 1.557 . . . . 0.0 111.854 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -57.9 107.57 0.48 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.183 1.393 . . . . 0.0 111.795 -176.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.1 m -135.63 137.12 41.55 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.971 1.308 . . . . 0.0 111.407 -169.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.73 156.63 37.92 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.151 1.38 . . . . 0.0 112.167 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.6 t -156.28 166.23 34.05 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.542 1.537 . . . . 0.0 110.716 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.9 mm -100.57 129.46 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.324 1.049 . . . . 0.0 110.577 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.5 t -58.08 142.53 46.63 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.664 1.186 . . . . 0.0 113.918 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.0 m -127.38 31.95 5.12 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.791 2.037 . . . . 0.0 109.861 169.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.8 p -141.3 -75.03 0.31 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.234 1.813 . . . . 0.0 109.47 -171.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.69 -45.53 82.44 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.292 1.437 . . . . 0.0 111.732 173.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.2 tp60 -67.85 -32.7 73.41 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.652 -0.655 . . . . 0.0 112.175 173.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -72.2 -47.28 51.77 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.515 -0.741 . . . . 0.0 111.791 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -57.75 -41.34 81.71 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.259 0.936 . . . . 0.0 111.134 175.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.1 t -59.94 -29.02 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.34 1.856 . . . . 0.0 112.667 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -70.52 -40.52 73.45 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.31 -0.868 . . . . 0.0 112.674 173.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.7 mp -75.6 -36.96 60.16 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.026 -1.046 . . . . 0.0 111.818 -171.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -64.54 -27.48 68.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.548 0.739 . . . . 0.0 112.784 169.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.2 -37.75 78.27 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.713 -1.242 . . . . 0.0 112.076 169.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.6 t -68.12 -36.4 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 O-C-N 121.267 -0.895 . . . . 0.0 111.315 173.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -58.71 -44.49 90.38 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.321 -0.862 . . . . 0.0 111.526 170.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.6 mp -69.62 -35.8 75.59 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-O 116.597 -1.668 . . . . 0.0 113.101 173.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.64 -37.11 67.79 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 121.8 2.091 . . . . 0.0 110.391 169.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.6 m -69.16 -39.57 78.68 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.162 0.985 . . . . 0.0 113.334 172.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.9 mm -71.1 -34.76 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 120.606 1.548 . . . . 0.0 110.549 176.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.83 -51.04 76.9 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 C-N-CA 125.667 1.587 . . . . 0.0 110.328 174.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -54.66 -40.12 68.73 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 121.086 1.766 . . . . 0.0 112.745 172.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.1 m -62.68 -28.97 70.3 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.883 0.473 . . . . 0.0 112.103 175.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -83.23 -37.06 24.08 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.123 1.769 . . . . 0.0 113.482 172.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.7 mt -66.39 -35.98 81.7 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.989 1.268 . . . . 0.0 111.807 175.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.7 mt -74.33 -36.34 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 124.845 1.258 . . . . 0.0 110.879 169.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.87 -39.0 40.14 Favored Glycine 0 C--N 1.34 0.786 0 C-N-CA 125.523 1.535 . . . . 0.0 114.775 -170.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.8 t -150.07 -27.31 0.25 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 176.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.94 11.83 36.16 Favored Glycine 0 N--CA 1.475 1.25 0 N-CA-C 116.515 1.366 . . . . 0.0 116.515 174.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.9 m -155.29 140.05 17.11 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.256 1.422 . . . . 0.0 110.871 172.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 80.5 t -99.84 143.68 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.037 1.735 . . . . 0.0 109.212 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -127.77 156.69 42.06 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.549 1.14 . . . . 0.0 111.2 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -54.85 -38.23 67.2 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.211 -0.93 . . . . 0.0 112.241 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.29 -20.58 64.77 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.199 1.4 . . . . 0.0 113.692 177.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -82.99 -35.3 25.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.565 0.62 . . . . 0.0 112.345 172.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.4 mt -84.11 -32.23 24.83 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -175.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -58.66 -21.87 55.41 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 175.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -82.54 -5.19 58.61 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 174.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -109.16 -44.54 3.93 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.678 1.191 . . . . 0.0 112.452 -174.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.455 ' C ' ' H ' ' A' ' 47' ' ' ASP . 1.3 pt -39.74 -42.59 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 117.354 2.353 . . . . 0.0 117.354 175.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 38.19 -3.83 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 1 C-N-CA 133.88 4.872 . . . . 0.0 118.794 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' A' ' 45' ' ' ILE . 36.6 t70 -169.05 -33.86 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 128.531 2.732 . . . . 0.0 112.716 -170.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.41 145.74 43.48 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.808 0.843 . . . . 0.0 110.7 172.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.08 -59.8 3.16 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.263 1.025 . . . . 0.0 112.058 -176.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -130.86 129.6 42.52 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 122.995 0.518 . . . . 0.0 111.367 -170.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.47 144.24 32.51 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 118.902 0.773 . . . . 0.0 109.607 169.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.3 t -140.53 140.58 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.841 1.257 . . . . 0.0 110.328 -169.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -128.95 141.1 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -169.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -138.75 88.22 2.28 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.376 1.87 . . . . 0.0 108.314 169.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.1 mt -104.65 126.75 30.49 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 124.132 0.973 . . . . 0.0 109.364 173.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.15 133.83 57.96 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.542 2.162 . . . . 0.0 113.235 174.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.0 1.11 89.79 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.043 1.306 . . . . 0.0 116.207 175.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -134.12 158.17 75.95 Favored Pre-proline 0 N--CA 1.476 0.829 0 CA-C-N 119.247 1.523 . . . . 0.0 112.19 173.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.65 143.19 61.24 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.518 2.145 . . . . 0.0 112.702 -177.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 p -52.34 137.41 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.857 1.663 . . . . 0.0 112.451 171.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.7 t -119.78 134.03 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.287 1.835 . . . . 0.0 109.352 172.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -141.16 115.9 9.67 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.594 1.158 . . . . 0.0 109.283 176.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.7 t -93.23 155.1 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.682 1.993 . . . . 0.0 111.494 -169.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.74 -97.17 1.21 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 121.269 -0.895 . . . . 0.0 113.409 172.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.8 m -153.71 154.86 34.88 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.471 1.109 . . . . 0.0 110.346 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -70.67 127.99 91.38 Favored Pre-proline 0 CA--C 1.548 0.882 0 O-C-N 120.69 -1.256 . . . . 0.0 110.951 175.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.55 158.76 28.79 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 124.283 3.322 . . . . 0.0 114.664 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.8 t -85.57 -29.77 23.88 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -169.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.48 -35.48 2.33 Favored Glycine 0 N--CA 1.476 1.365 0 C-N-CA 125.484 1.516 . . . . 0.0 112.449 -175.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -78.9 61.86 3.22 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.489 1.515 . . . . 0.0 110.589 169.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.3 m -137.47 155.48 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.53 1.532 . . . . 0.0 112.535 -177.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.0 mt -91.99 127.93 37.65 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 128.417 2.687 . . . . 0.0 109.243 176.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -114.52 108.13 16.44 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.766 0.712 . . . . 0.0 111.649 -173.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.51 146.78 18.73 Favored Glycine 0 N--CA 1.469 0.856 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 169.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -152.37 132.92 13.85 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 119.377 1.589 . . . . 0.0 112.644 -169.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.28 168.45 21.04 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 42.6 m -135.43 118.01 15.93 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.927 1.691 . . . . 0.0 109.417 -177.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.48 172.15 52.57 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.454 1.026 . . . . 0.0 113.055 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -49.19 -43.96 42.68 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 126.324 1.85 . . . . 0.0 111.472 175.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -81.06 2.17 28.33 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -172.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.39 22.97 27.85 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.387 0.994 . . . . 0.0 113.139 172.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.42 -166.78 1.54 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.322 1.449 . . . . 0.0 113.285 -178.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.7 m -146.85 123.55 11.19 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 120.377 -1.452 . . . . 0.0 111.904 172.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.2 t -97.69 143.0 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.708 2.003 . . . . 0.0 109.988 170.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.1 tp -131.28 144.9 51.63 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.395 1.478 . . . . 0.0 109.134 169.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.7 t -125.76 137.42 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.318 1.447 . . . . 0.0 108.544 172.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -131.67 126.36 34.41 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.689 0.757 . . . . 0.0 111.284 -175.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -129.49 144.59 53.47 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 126.564 1.946 . . . . 0.0 110.813 -170.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.92 133.42 38.67 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.377 2.051 . . . . 0.0 112.188 178.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.2 ttp85 . . . . . 0 C--O 1.253 1.265 0 C-N-CA 125.138 1.375 . . . . 0.0 112.231 178.479 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.772 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.1 p -77.01 168.85 19.39 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.991 1.316 . . . . 0.0 112.631 174.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -149.06 144.34 26.63 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.339 1.055 . . . . 0.0 111.397 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.1 p -78.95 118.28 20.81 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.365 1.066 . . . . 0.0 112.174 177.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.86 166.68 32.06 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 126.429 1.892 . . . . 0.0 112.532 178.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.3 m -68.55 143.65 54.84 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.516 1.127 . . . . 0.0 110.74 171.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 68.3 mt -134.38 145.67 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.274 1.429 . . . . 0.0 108.242 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.1 p -82.32 34.19 0.42 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 -172.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.2 m -63.58 32.23 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 130.02 3.328 . . . . 0.0 117.315 -172.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 27.2 p -129.42 -65.42 0.85 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.219 2.208 . . . . 0.0 107.92 169.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.05 -44.28 76.75 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.339 1.456 . . . . 0.0 112.76 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -78.03 -22.09 49.72 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.76 0.824 . . . . 0.0 111.839 174.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -74.17 -53.22 10.31 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 120.803 -1.186 . . . . 0.0 111.68 173.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.97 -31.66 72.04 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 121.011 -1.056 . . . . 0.0 113.724 -172.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.6 m -60.57 -20.58 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 172.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -70.24 -45.13 67.12 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.181 0.901 . . . . 0.0 112.454 174.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -70.9 -41.33 71.42 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.209 -0.932 . . . . 0.0 111.303 -170.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -63.62 -33.13 74.94 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.909 0.883 . . . . 0.0 112.562 170.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.24 -37.02 84.51 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.72 -1.238 . . . . 0.0 111.829 172.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.7 t -69.27 -38.58 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 O-C-N 121.236 -0.915 . . . . 0.0 111.529 172.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.9 tpp85 -58.11 -46.14 86.06 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.156 -0.965 . . . . 0.0 111.009 171.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -69.95 -34.79 73.87 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 116.759 -1.591 . . . . 0.0 112.616 175.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.78 -37.99 69.31 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 121.589 1.995 . . . . 0.0 109.735 169.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.8 m -70.23 -38.26 75.18 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.115 0.966 . . . . 0.0 113.483 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.0 mm -71.55 -34.86 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 120.854 1.661 . . . . 0.0 110.489 176.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.1 t -63.21 -50.5 78.84 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 C-N-CA 125.4 1.48 . . . . 0.0 109.59 172.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -55.08 -40.51 70.45 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 121.307 1.867 . . . . 0.0 113.34 172.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.4 m -59.32 -34.01 71.81 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.085 -0.384 . . . . 0.0 111.682 174.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -79.41 -35.7 40.19 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.825 1.65 . . . . 0.0 113.937 172.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.96 -33.71 76.43 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 120.161 1.346 . . . . 0.0 111.576 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 87.6 mt -75.04 -37.4 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 124.849 1.259 . . . . 0.0 110.585 169.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.23 -39.48 62.3 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 125.637 1.589 . . . . 0.0 114.181 -173.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.3 t -151.49 -27.75 0.19 Allowed 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.22 0.27 38.14 Favored Glycine 0 N--CA 1.481 1.655 0 N-CA-C 116.757 1.463 . . . . 0.0 116.757 175.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.1 m -144.09 136.01 26.26 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.35 1.86 . . . . 0.0 109.01 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.9 p -114.41 143.18 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.335 1.054 . . . . 0.0 110.224 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -128.41 158.46 38.25 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.748 1.219 . . . . 0.0 110.872 -170.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -51.9 -37.95 54.38 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.722 0.809 . . . . 0.0 113.07 -177.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -70.31 -20.05 63.03 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.637 1.575 . . . . 0.0 114.236 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -80.55 -36.96 32.29 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.997 0.817 . . . . 0.0 111.491 171.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.5 mt -87.48 -33.06 19.14 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.74 1.616 . . . . 0.0 113.951 -170.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.6 ptt85 -55.15 -22.37 16.81 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 172.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -84.35 -12.25 54.87 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 176.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -110.55 -21.63 12.05 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 119.957 1.253 . . . . 0.0 114.038 -170.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -60.44 -31.64 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.15 -5.61 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.209 1 C-N-CA 132.424 4.29 . . . . 0.0 117.806 177.629 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -173.92 -47.04 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 128.851 2.86 . . . . 0.0 109.398 -174.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.99 130.69 30.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.813 1.245 . . . . 0.0 110.977 -176.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -59.05 -54.69 44.21 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -169.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -132.52 130.08 39.93 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.042 1.337 . . . . 0.0 111.498 -174.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.71 142.76 34.89 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 168.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.5 t -138.33 140.5 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 O-C-N 121.085 -1.009 . . . . 0.0 110.975 -169.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 mm -114.17 134.28 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.748 1.619 . . . . 0.0 113.628 -172.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -136.64 69.13 1.42 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.594 1.958 . . . . 0.0 109.589 170.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 30.8 mt -89.93 128.18 51.0 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 123.971 0.909 . . . . 0.0 109.383 171.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -61.46 132.56 41.38 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.35 2.033 . . . . 0.0 112.713 173.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.35 2.89 87.33 Favored Glycine 0 CA--C 1.537 1.412 0 N-CA-C 116.079 1.192 . . . . 0.0 116.079 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -136.13 155.12 77.72 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-N 119.152 1.476 . . . . 0.0 112.008 172.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.05 147.45 67.49 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.722 2.281 . . . . 0.0 113.14 -171.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 p -58.33 130.2 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.641 1.176 . . . . 0.0 111.651 174.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.1 t -109.88 139.28 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.753 1.621 . . . . 0.0 108.937 171.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -135.47 108.5 7.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.767 1.227 . . . . 0.0 108.511 177.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.6 t -80.8 149.3 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.111 1.364 . . . . 0.0 110.985 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.14 -93.59 1.43 Allowed Glycine 0 CA--C 1.533 1.196 0 O-C-N 121.654 -0.654 . . . . 0.0 112.128 174.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.1 m -149.35 158.4 44.14 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.048 1.339 . . . . 0.0 109.146 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -76.69 128.27 82.25 Favored Pre-proline 0 CA--C 1.548 0.892 0 O-C-N 120.548 -1.345 . . . . 0.0 110.896 173.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -75.83 155.45 39.16 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.285 3.323 . . . . 0.0 114.89 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.7 t -86.18 -31.79 21.58 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -169.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.36 -41.17 1.42 Allowed Glycine 0 N--CA 1.474 1.201 0 C-N-CA 124.991 1.282 . . . . 0.0 112.583 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -78.49 64.13 3.48 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.059 1.343 . . . . 0.0 111.047 169.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.0 158.17 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.443 1.497 . . . . 0.0 112.406 -178.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.4 mt -99.83 126.7 45.97 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.612 2.365 . . . . 0.0 110.056 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -109.2 109.58 20.56 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -170.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.26 146.7 18.24 Favored Glycine 0 N--CA 1.475 1.24 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 169.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 68.8 ttt-85 -154.2 132.84 12.16 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 120.812 2.306 . . . . 0.0 114.101 -169.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -143.32 173.59 11.47 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.196 1.398 . . . . 0.0 113.597 -177.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -143.73 119.26 10.35 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.597 1.559 . . . . 0.0 110.409 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.26 175.14 54.62 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.521 1.534 . . . . 0.0 115.513 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -68.02 -9.92 49.58 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.11 2.164 . . . . 0.0 115.373 -174.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -97.47 3.81 50.69 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 120.309 1.413 . . . . 0.0 113.452 169.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.57 23.47 26.13 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.971 1.272 . . . . 0.0 114.238 173.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.14 -164.4 1.11 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.297 1.439 . . . . 0.0 114.527 -172.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.4 m -146.91 121.57 9.83 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.334 -1.479 . . . . 0.0 111.833 173.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.7 t -98.14 139.55 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.841 1.656 . . . . 0.0 109.456 169.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.6 tp -129.01 146.9 50.86 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.216 1.406 . . . . 0.0 109.302 171.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.9 t -125.6 134.81 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.005 1.322 . . . . 0.0 108.268 171.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -132.94 131.33 40.7 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.278 1.031 . . . . 0.0 111.359 -176.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -148.51 152.98 39.44 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.352 1.061 . . . . 0.0 112.398 177.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -62.65 135.93 55.43 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.893 2.395 . . . . 0.0 113.86 -170.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 . . . . . 0 C--O 1.254 1.324 0 C-N-CA 127.369 2.268 . . . . 0.0 112.34 179.82 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 . . . . . 0 CA--C 1.544 0.713 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -36.4 78.01 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.347 -0.846 . . . . 0.0 112.588 -174.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.2 m -61.76 -21.41 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -68.72 -43.54 75.77 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.465 1.029 . . . . 0.0 112.231 174.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.74 -42.56 73.77 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.395 -0.815 . . . . 0.0 111.263 -171.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -65.7 -29.54 70.1 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.705 1.202 . . . . 0.0 112.81 171.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.59 -38.77 77.46 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.678 -1.264 . . . . 0.0 112.421 170.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.56 -36.28 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 O-C-N 121.289 -0.882 . . . . 0.0 111.305 172.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -58.83 -44.74 90.96 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.315 -0.865 . . . . 0.0 111.293 171.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.3 mp -70.01 -35.88 74.7 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-O 117.225 -1.369 . . . . 0.0 113.293 173.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.19 -34.73 66.53 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 121.284 1.856 . . . . 0.0 110.602 169.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.5 m -70.17 -38.89 75.53 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.709 0.803 . . . . 0.0 112.927 172.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.4 mm -74.42 -33.96 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 120.563 1.528 . . . . 0.0 111.507 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.9 t -66.13 -43.77 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 117.577 -1.201 . . . . 0.0 110.323 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -52.59 -43.01 65.05 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.666 1.575 . . . . 0.0 112.034 170.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.8 t -61.75 -31.08 71.24 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.317 0.647 . . . . 0.0 112.301 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -79.91 -36.49 36.35 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.993 1.317 . . . . 0.0 113.306 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 71.0 mt -66.27 -35.17 79.7 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.69 1.132 . . . . 0.0 111.685 175.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.4 mt -74.56 -35.21 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.417 1.087 . . . . 0.0 111.04 169.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.69 -38.33 50.69 Favored Glycine 0 C--N 1.339 0.724 0 C-N-CA 125.798 1.666 . . . . 0.0 114.99 -172.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.5 t -152.84 -26.52 0.15 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.82 4.66 42.21 Favored Glycine 0 N--CA 1.476 1.358 0 N-CA-C 116.512 1.365 . . . . 0.0 116.512 174.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.8 p -155.85 141.38 17.78 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.241 1.416 . . . . 0.0 111.131 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 80.4 t -93.74 144.09 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.247 1.419 . . . . 0.0 109.64 175.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -125.07 158.09 34.64 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.622 1.169 . . . . 0.0 110.302 171.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -56.9 -37.17 71.05 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.223 -0.923 . . . . 0.0 112.632 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -69.88 -19.07 63.44 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -77.11 -39.88 47.9 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.783 0.72 . . . . 0.0 111.91 171.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.2 mt -85.64 -27.45 25.4 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -173.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -57.82 -24.18 56.15 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 119.812 1.187 . . . . 0.0 113.58 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -83.58 -3.28 57.54 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.087 1.355 . . . . 0.0 114.122 175.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -118.6 -19.31 8.79 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.449 1.1 . . . . 0.0 113.561 -169.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.578 0 C-N-CA 124.062 0.945 . . . . 0.0 110.995 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.467 0.375 0 CA-C-O 119.35 -0.357 . . . . 0.0 110.65 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -131.47 132.03 43.96 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.438 0.695 . . . . 0.0 111.495 -170.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.08 147.41 31.24 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.212 -0.93 . . . . 0.0 110.924 169.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.3 t -138.43 141.18 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.266 1.427 . . . . 0.0 110.848 -171.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.35 131.18 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.998 1.319 . . . . 0.0 113.828 -171.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -130.72 76.43 1.72 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.967 1.707 . . . . 0.0 109.481 169.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.4 mt -94.31 131.0 32.21 Favored Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 123.715 0.806 . . . . 0.0 108.985 172.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -64.64 136.78 51.41 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.195 1.93 . . . . 0.0 111.544 175.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.97 -0.99 87.9 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.704 1.145 . . . . 0.0 115.851 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -138.32 156.56 73.53 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-N 119.322 1.561 . . . . 0.0 112.582 175.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.19 153.57 66.83 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.811 2.341 . . . . 0.0 113.064 -174.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.1 p -59.2 132.93 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.254 1.022 . . . . 0.0 111.531 172.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 95.5 t -111.32 141.64 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.492 1.517 . . . . 0.0 109.194 170.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -134.84 119.67 18.4 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.215 1.406 . . . . 0.0 109.428 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.2 t -94.87 155.24 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.287 1.835 . . . . 0.0 111.353 -174.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.67 -95.22 0.99 Allowed Glycine 0 CA--C 1.53 1.023 0 O-C-N 121.151 -0.968 . . . . 0.0 112.836 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.6 m -153.0 152.81 31.81 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.537 -0.978 . . . . 0.0 110.26 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -67.19 130.07 93.73 Favored Pre-proline 0 CA--C 1.547 0.865 0 O-C-N 120.72 -1.238 . . . . 0.0 110.883 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.458 ' CB ' HG11 ' A' ' 71' ' ' VAL . 73.1 Cg_endo -79.54 158.77 25.46 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.179 3.253 . . . . 0.0 114.621 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.7 t -88.49 -34.02 17.6 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -169.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.15 -36.57 1.86 Allowed Glycine 0 N--CA 1.477 1.411 0 C-N-CA 125.153 1.358 . . . . 0.0 112.355 -174.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -78.43 63.07 3.2 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.236 1.414 . . . . 0.0 110.522 169.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.458 HG11 ' CB ' ' A' ' 67' ' ' PRO . 30.4 m -139.84 154.36 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.648 1.579 . . . . 0.0 112.351 -176.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.4 mt -89.04 147.5 24.23 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 127.677 2.391 . . . . 0.0 109.128 170.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -127.09 116.95 21.48 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 118.672 0.669 . . . . 0.0 112.206 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.89 150.78 19.98 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.12 1.343 . . . . 0.0 110.001 169.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -156.11 137.04 13.54 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.573 1.686 . . . . 0.0 113.137 -171.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.61 161.98 37.8 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.033 1.333 . . . . 0.0 113.6 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 74.9 m -114.42 128.26 56.25 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.155 1.382 . . . . 0.0 108.319 172.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.08 176.91 44.2 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 122.033 0.796 . . . . 0.0 114.64 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -83.51 -9.56 58.89 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -169.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -102.3 5.91 40.19 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 120.733 1.606 . . . . 0.0 112.194 169.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.12 17.48 34.56 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.247 1.879 . . . . 0.0 114.362 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -83.93 173.22 11.38 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.19 1.796 . . . . 0.0 113.357 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.4 m -129.23 136.55 50.26 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.97 1.308 . . . . 0.0 110.25 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.2 t -119.29 139.7 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.023 1.729 . . . . 0.0 109.575 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.4 tt -132.84 149.11 52.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.467 1.107 . . . . 0.0 109.817 175.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 86.0 t -133.23 139.87 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.509 1.523 . . . . 0.0 109.397 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -131.74 137.73 48.34 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.988 0.899 . . . . 0.0 112.825 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -137.04 150.48 69.62 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 126.564 1.946 . . . . 0.0 111.031 -173.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -64.17 137.93 59.08 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.801 2.334 . . . . 0.0 112.582 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 125.92 1.688 . . . . 0.0 112.409 177.605 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 . . . . . 0 CA--C 1.544 0.745 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -28.46 69.31 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -171.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.3 m -60.4 -21.1 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 170.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -69.2 -45.56 69.62 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 119.466 1.03 . . . . 0.0 112.391 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 mp -70.0 -40.17 75.43 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.552 -0.718 . . . . 0.0 111.617 -170.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -65.02 -34.2 77.87 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.722 1.209 . . . . 0.0 112.519 170.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.92 -38.92 89.94 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 120.604 -1.31 . . . . 0.0 112.361 171.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 94.3 t -68.11 -37.82 78.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 O-C-N 121.294 -0.879 . . . . 0.0 111.533 172.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -59.53 -44.59 93.15 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.318 -0.864 . . . . 0.0 111.057 172.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.5 mp -69.52 -34.32 74.1 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 117.448 -1.263 . . . . 0.0 113.044 174.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.16 -34.44 68.44 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 121.172 1.805 . . . . 0.0 110.534 169.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.3 m -72.63 -38.65 67.66 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.353 1.061 . . . . 0.0 113.636 171.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.1 mm -72.79 -34.2 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 120.915 1.689 . . . . 0.0 110.97 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.2 t -67.18 -47.19 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.795 1.238 . . . . 0.0 109.63 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -53.11 -44.0 67.32 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 120.821 1.646 . . . . 0.0 111.976 170.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.2 m -59.97 -30.43 69.1 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.744 -0.598 . . . . 0.0 112.486 175.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.2 tpt180 -80.92 -35.22 32.7 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.685 1.594 . . . . 0.0 113.526 171.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.7 mt -66.11 -33.8 76.61 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.988 1.267 . . . . 0.0 111.588 174.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 90.7 mt -75.08 -35.69 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.791 1.236 . . . . 0.0 110.811 169.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.89 -38.05 49.7 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 125.5 1.524 . . . . 0.0 114.807 -172.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.1 t -152.58 -26.97 0.16 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.93 1.06 39.2 Favored Glycine 0 N--CA 1.477 1.43 0 N-CA-C 116.774 1.47 . . . . 0.0 116.774 174.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.9 m -147.8 139.0 23.52 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.098 1.759 . . . . 0.0 109.33 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.46 147.05 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.737 1.215 . . . . 0.0 109.955 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -132.32 157.42 44.5 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.782 1.233 . . . . 0.0 110.472 -174.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -55.66 -38.28 69.38 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.758 -0.589 . . . . 0.0 112.268 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -70.45 -20.18 62.91 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.794 1.238 . . . . 0.0 113.721 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -78.99 -41.81 28.11 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.833 0.742 . . . . 0.0 111.067 169.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.3 mt -81.67 -30.34 32.74 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -170.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -56.3 -26.91 53.75 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 173.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -84.18 -3.35 58.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.325 1.05 . . . . 0.0 113.723 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.6 mm-40 -120.71 -13.73 8.67 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.617 1.167 . . . . 0.0 113.535 -169.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.47 0.544 0 C-N-CA 123.405 0.682 . . . . 0.0 112.66 -176.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -132.71 124.34 27.98 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.55 1.54 . . . . 0.0 109.169 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.13 142.63 29.57 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.443 1.02 . . . . 0.0 109.579 169.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 63.1 t -137.84 141.16 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.646 1.178 . . . . 0.0 109.476 -171.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -122.97 134.07 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -169.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -129.67 81.79 2.04 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.467 1.907 . . . . 0.0 109.631 170.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.5 mt -98.34 125.18 44.22 Favored Pre-proline 0 N--CA 1.48 1.063 0 C-N-CA 123.775 0.83 . . . . 0.0 108.979 169.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.87 133.4 53.51 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.384 2.056 . . . . 0.0 112.291 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.25 3.42 87.2 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-O 118.273 -1.293 . . . . 0.0 115.977 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -138.8 163.39 46.95 Favored Pre-proline 0 N--CA 1.475 0.78 0 CA-C-N 119.717 1.759 . . . . 0.0 114.075 173.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -60.62 140.78 92.86 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.579 2.853 . . . . 0.0 114.204 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.2 t -60.23 131.31 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.332 1.053 . . . . 0.0 110.024 169.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 70.1 t -110.38 141.41 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.095 1.358 . . . . 0.0 109.562 172.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -138.17 114.42 10.23 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.999 1.319 . . . . 0.0 109.191 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.3 t -89.97 155.53 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.941 1.696 . . . . 0.0 111.312 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.83 -102.83 1.58 Allowed Glycine 0 CA--C 1.532 1.107 0 O-C-N 121.343 -0.848 . . . . 0.0 112.736 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.3 m -146.12 150.05 35.18 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.516 1.126 . . . . 0.0 110.17 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -67.59 129.74 93.39 Favored Pre-proline 0 CA--C 1.548 0.898 0 O-C-N 120.861 -1.15 . . . . 0.0 111.002 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.413 ' CB ' HG11 ' A' ' 71' ' ' VAL . 73.8 Cg_endo -79.86 155.0 23.32 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.952 3.102 . . . . 0.0 114.314 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.4 HG23 ' H ' ' A' ' 70' ' ' ASP . 13.9 t -83.66 -26.95 29.44 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -171.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.25 -33.9 3.36 Favored Glycine 0 N--CA 1.476 1.32 0 C-N-CA 125.572 1.558 . . . . 0.0 112.64 -175.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.4 ' H ' HG23 ' A' ' 68' ' ' THR . 23.8 m-20 -79.18 60.23 2.98 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.775 1.63 . . . . 0.0 111.216 169.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.413 HG11 ' CB ' ' A' ' 67' ' ' PRO . 34.3 m -136.68 158.99 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 126.078 1.751 . . . . 0.0 112.29 -173.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.9 mt -99.77 126.96 45.93 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.854 2.462 . . . . 0.0 110.382 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -111.33 110.1 20.41 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -169.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.38 145.88 18.29 Favored Glycine 0 N--CA 1.471 0.998 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 169.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -154.46 137.4 15.44 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 120.145 1.972 . . . . 0.0 113.654 -169.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.26 163.65 34.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.56 1.144 . . . . 0.0 113.95 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 62.1 m -117.11 130.52 56.69 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.411 1.485 . . . . 0.0 108.578 172.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.31 174.7 37.08 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.092 0.853 . . . . 0.0 114.638 -177.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -81.45 -10.82 59.42 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 -169.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -99.61 5.49 45.91 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.714 1.597 . . . . 0.0 111.983 169.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.37 17.62 33.49 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 126.259 1.885 . . . . 0.0 114.268 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.3 pm0 -84.08 175.51 9.46 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.839 1.656 . . . . 0.0 113.459 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.5 m -133.2 133.88 43.34 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.073 1.349 . . . . 0.0 110.41 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 67.3 t -114.26 141.18 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.168 1.787 . . . . 0.0 110.029 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.7 tp -129.23 146.77 51.07 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.388 1.475 . . . . 0.0 109.524 174.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.6 t -124.4 137.7 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 127.596 2.358 . . . . 0.0 107.719 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -135.35 138.13 43.06 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.017 0.527 . . . . 0.0 111.724 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -148.83 154.25 39.97 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 172.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -59.82 137.64 77.84 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.779 2.319 . . . . 0.0 113.404 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 . . . . . 0 C--O 1.255 1.354 0 C-N-CA 125.888 1.675 . . . . 0.0 112.241 178.542 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 . . . . . 0 CA--C 1.545 0.761 0 CA-C-O 119.711 -0.185 . . . . 0.0 111.325 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -37.15 79.78 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.057 -1.027 . . . . 0.0 111.822 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.9 t -58.24 -31.43 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.337 1.455 . . . . 0.0 113.085 173.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -71.12 -39.64 71.92 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.235 -0.916 . . . . 0.0 112.957 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -77.86 -36.31 50.01 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.271 -0.893 . . . . 0.0 111.918 -172.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -64.34 -28.0 69.4 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.337 -0.852 . . . . 0.0 112.705 170.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.68 -36.6 84.11 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.608 -1.307 . . . . 0.0 111.981 170.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.3 t -71.33 -35.79 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.567 1.147 . . . . 0.0 111.174 173.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.2 tpp85 -60.82 -46.36 90.82 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.011 -1.055 . . . . 0.0 111.473 171.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.3 mp -69.76 -33.25 72.16 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 117.352 -1.308 . . . . 0.0 112.418 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.58 -33.05 69.53 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 121.269 1.849 . . . . 0.0 110.785 169.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.3 m -73.79 -38.61 64.58 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.303 1.041 . . . . 0.0 113.33 171.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.7 mm -73.31 -36.7 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 121.072 1.76 . . . . 0.0 110.84 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.6 t -62.2 -49.93 82.03 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 CA-C-O 117.558 -1.21 . . . . 0.0 109.466 173.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -54.05 -43.52 70.28 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 120.803 1.638 . . . . 0.0 112.377 173.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.0 m -59.33 -36.84 76.41 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.756 -0.59 . . . . 0.0 111.912 176.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -74.55 -36.49 63.11 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.36 1.464 . . . . 0.0 113.271 172.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.2 mt -67.27 -30.57 70.48 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.864 1.211 . . . . 0.0 112.034 175.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.4 mt -76.05 -37.31 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.869 1.268 . . . . 0.0 110.936 169.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.58 -39.52 55.95 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.383 1.468 . . . . 0.0 114.456 -173.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.8 t -148.83 -27.61 0.3 Allowed 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.69 14.23 35.3 Favored Glycine 0 N--CA 1.479 1.535 0 N-CA-C 116.061 1.184 . . . . 0.0 116.061 175.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.1 m -156.67 145.83 20.36 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.945 1.698 . . . . 0.0 109.694 172.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.0 p -120.69 143.64 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.521 1.528 . . . . 0.0 110.359 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -128.8 156.25 43.88 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.371 1.068 . . . . 0.0 111.395 -169.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -54.2 -39.09 66.36 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.671 -0.643 . . . . 0.0 112.299 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -71.1 -21.07 62.27 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.246 1.418 . . . . 0.0 113.638 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -80.98 -37.23 29.62 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.869 0.759 . . . . 0.0 111.39 169.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.6 mt -82.16 -32.3 30.06 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.984 1.314 . . . . 0.0 113.733 -171.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -58.31 -22.94 54.93 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 173.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -85.11 -1.14 56.53 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.556 1.142 . . . . 0.0 113.913 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -116.56 -21.28 9.24 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.841 1.257 . . . . 0.0 112.998 -174.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.474 0.738 0 C-N-CA 123.623 0.769 . . . . 0.0 111.781 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 119.362 -0.351 . . . . 0.0 111.571 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -126.99 131.36 51.06 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.147 0.579 . . . . 0.0 112.501 -169.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.29 144.47 37.38 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.394 -0.816 . . . . 0.0 109.637 169.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.0 t -139.85 138.72 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.264 1.026 . . . . 0.0 110.389 -169.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.448 HD13 ' HA ' ' A' ' 53' ' ' ILE . 0.4 OUTLIER -119.29 132.93 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -169.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -130.02 83.31 2.12 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.977 1.711 . . . . 0.0 109.45 172.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.5 mt -100.18 132.12 23.13 Favored Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 124.048 0.939 . . . . 0.0 109.271 173.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.52 134.18 37.43 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.352 2.035 . . . . 0.0 111.658 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.48 0.24 82.41 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.774 1.178 . . . . 0.0 115.565 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -135.31 158.12 75.23 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 119.027 1.414 . . . . 0.0 112.087 172.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.2 155.74 66.88 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.621 2.214 . . . . 0.0 112.786 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.2 p -57.66 139.82 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.637 1.175 . . . . 0.0 111.588 171.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 85.1 t -119.24 139.26 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.466 1.507 . . . . 0.0 108.806 172.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -133.5 121.82 22.73 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.001 1.32 . . . . 0.0 109.564 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.8 t -95.02 151.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.618 1.567 . . . . 0.0 111.116 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.17 -102.62 2.3 Favored Glycine 0 CA--C 1.533 1.213 0 O-C-N 121.462 -0.773 . . . . 0.0 112.522 172.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 94.5 m -143.97 141.65 30.3 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.599 1.159 . . . . 0.0 109.896 174.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -65.45 125.9 90.45 Favored Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 120.73 -1.231 . . . . 0.0 111.127 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.437 ' CB ' HG11 ' A' ' 71' ' ' VAL . 60.5 Cg_endo -76.63 153.57 34.34 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.712 2.942 . . . . 0.0 114.911 -172.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 70' ' ' ASP . 11.3 t -82.22 -24.0 35.1 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -169.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.64 -35.05 3.71 Favored Glycine 0 N--CA 1.478 1.487 0 C-N-CA 125.394 1.473 . . . . 0.0 112.618 -174.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.411 ' H ' HG23 ' A' ' 68' ' ' THR . 18.9 m-20 -77.9 59.56 2.13 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.027 1.731 . . . . 0.0 110.672 169.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.437 HG11 ' CB ' ' A' ' 67' ' ' PRO . 28.0 m -135.55 157.29 39.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 126.292 1.837 . . . . 0.0 112.046 -173.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.6 mt -90.78 144.65 25.5 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.704 1.602 . . . . 0.0 109.125 170.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -125.49 122.13 35.73 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.532 0.733 . . . . 0.0 112.102 -177.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.42 148.08 16.44 Favored Glycine 0 N--CA 1.47 0.942 0 C-N-CA 126.033 1.778 . . . . 0.0 109.563 169.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -152.42 141.55 21.34 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.094 1.447 . . . . 0.0 112.876 -169.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.75 162.03 40.03 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.015 1.326 . . . . 0.0 113.228 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 70.1 m -113.11 127.44 56.2 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.951 1.301 . . . . 0.0 108.697 171.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.19 172.35 43.37 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.379 0.99 . . . . 0.0 114.06 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -82.93 -11.78 57.88 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 -169.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -92.94 2.91 56.55 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.837 1.653 . . . . 0.0 111.848 169.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.86 14.68 39.14 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 126.735 2.112 . . . . 0.0 114.369 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.5 pm0 -81.89 173.76 11.94 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.861 1.665 . . . . 0.0 113.794 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.0 m -127.84 138.92 52.87 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.452 1.501 . . . . 0.0 110.348 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.4 t -121.52 139.29 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.425 1.49 . . . . 0.0 109.487 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.2 tp -126.78 148.08 49.95 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.48 1.512 . . . . 0.0 109.935 174.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.38 136.17 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.462 1.505 . . . . 0.0 108.203 174.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -130.19 131.74 45.73 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.845 0.831 . . . . 0.0 112.142 -177.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -126.14 151.54 72.05 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 126.264 1.825 . . . . 0.0 111.552 -178.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -61.11 136.15 63.18 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 122.655 2.237 . . . . 0.0 112.023 170.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 . . . . . 0 C--O 1.252 1.213 0 C-N-CA 125.211 1.404 . . . . 0.0 113.252 -177.597 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.62 -36.43 80.71 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 121.118 -0.989 . . . . 0.0 112.839 -174.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.9 m -60.07 -23.06 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 174.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -71.16 -39.95 71.59 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.217 0.917 . . . . 0.0 111.735 175.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.0 mt -71.84 -41.63 67.91 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.053 0.941 . . . . 0.0 111.541 -172.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -66.68 -33.24 75.2 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.88 0.872 . . . . 0.0 112.516 169.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.8 -37.88 89.02 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 120.28 1.4 . . . . 0.0 112.161 171.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.9 t -69.1 -37.78 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.193 0.997 . . . . 0.0 111.712 172.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -60.87 -43.44 98.42 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.004 -1.06 . . . . 0.0 111.336 172.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -69.79 -34.43 73.71 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 117.468 -1.254 . . . . 0.0 112.585 173.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.27 -33.05 68.99 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 121.175 1.807 . . . . 0.0 110.486 169.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.8 m -73.61 -38.89 64.94 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.401 1.08 . . . . 0.0 113.74 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.1 mm -72.47 -36.12 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 121.221 1.828 . . . . 0.0 110.626 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.413 HG21 HD11 ' A' ' 53' ' ' ILE . 94.7 t -64.66 -48.4 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 117.549 -1.215 . . . . 0.0 109.664 174.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -53.62 -44.27 69.37 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.836 1.653 . . . . 0.0 112.1 172.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.2 m -58.85 -34.48 71.62 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.786 -0.571 . . . . 0.0 112.113 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -77.78 -35.67 51.34 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.482 1.513 . . . . 0.0 113.63 172.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 56.0 mt -66.77 -33.05 74.77 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 120.127 1.33 . . . . 0.0 111.56 175.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 90.8 mt -72.75 -36.98 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 124.821 1.248 . . . . 0.0 110.672 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.2 -39.7 51.88 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.506 1.527 . . . . 0.0 114.673 -173.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.6 t -151.45 -27.25 0.19 Allowed 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.86 2.42 49.24 Favored Glycine 0 N--CA 1.48 1.629 0 N-CA-C 116.436 1.334 . . . . 0.0 116.436 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.9 m -143.81 136.5 27.19 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.254 1.821 . . . . 0.0 109.115 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 p -113.31 145.9 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.597 1.159 . . . . 0.0 110.216 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -132.92 157.4 45.2 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.634 1.174 . . . . 0.0 111.073 -170.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.55 -40.75 65.79 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.797 -0.565 . . . . 0.0 112.368 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.95 -17.82 62.05 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.394 1.078 . . . . 0.0 113.756 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -81.67 -36.86 28.29 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.032 0.833 . . . . 0.0 111.52 169.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 64.3 mt -85.68 -31.75 22.34 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.742 1.617 . . . . 0.0 114.374 -171.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -60.66 -19.17 57.61 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -85.62 -5.29 59.29 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.06 1.344 . . . . 0.0 114.131 173.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -116.1 -18.2 10.67 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.719 1.208 . . . . 0.0 113.482 -169.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.475 0.785 0 C-N-CA 124.004 0.922 . . . . 0.0 113.008 -178.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -129.04 130.89 47.16 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.649 1.58 . . . . 0.0 111.44 -173.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -106.02 142.73 35.23 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.48 -0.762 . . . . 0.0 109.442 169.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.5 t -138.14 139.54 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.492 1.117 . . . . 0.0 110.354 -170.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.413 HD11 HG21 ' A' ' 26' ' ' VAL . 0.8 OUTLIER -120.58 133.24 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -169.72 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.6 mmt85 -132.58 79.06 1.83 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.884 1.674 . . . . 0.0 109.664 171.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.5 mt -96.37 132.16 27.11 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 124.188 0.995 . . . . 0.0 109.329 172.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.59 131.02 26.49 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.174 1.916 . . . . 0.0 111.499 175.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.2 2.6 80.11 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 116.201 1.241 . . . . 0.0 116.201 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -137.99 155.83 74.4 Favored Pre-proline 0 N--CA 1.475 0.81 0 CA-C-N 119.246 1.523 . . . . 0.0 111.907 172.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.91 151.41 78.14 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.682 2.255 . . . . 0.0 113.044 -173.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 p -59.15 131.67 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.403 1.081 . . . . 0.0 111.249 172.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.3 t -109.53 138.25 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.313 1.445 . . . . 0.0 109.099 170.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -132.72 116.3 16.43 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.247 1.419 . . . . 0.0 108.804 176.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.6 t -93.12 152.02 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.439 1.495 . . . . 0.0 111.186 -175.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.25 -97.44 1.42 Allowed Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.694 -0.629 . . . . 0.0 111.558 176.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.2 m -146.53 149.7 34.11 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.42 1.088 . . . . 0.0 109.604 177.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.2 tttp -70.47 127.33 92.15 Favored Pre-proline 0 CA--C 1.547 0.84 0 O-C-N 120.628 -1.295 . . . . 0.0 110.485 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.64 154.83 39.82 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 124.026 3.151 . . . . 0.0 114.739 -173.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.1 t -83.19 -23.25 32.93 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -169.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.37 -35.45 3.61 Favored Glycine 0 N--CA 1.475 1.261 0 C-N-CA 125.545 1.545 . . . . 0.0 113.026 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -78.43 59.25 2.33 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.87 1.668 . . . . 0.0 111.267 169.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.0 m -132.93 158.2 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.949 1.7 . . . . 0.0 112.299 -174.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.4 mt -89.73 144.04 26.31 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 126.505 1.922 . . . . 0.0 109.425 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -123.29 114.03 19.68 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.074 0.549 . . . . 0.0 112.376 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.31 144.16 17.13 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 169.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -153.73 138.31 16.88 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 120.504 2.152 . . . . 0.0 113.559 -169.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.05 166.26 26.63 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.022 1.329 . . . . 0.0 113.782 -176.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.0 m -120.03 130.56 54.77 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.62 1.568 . . . . 0.0 108.454 173.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.93 177.29 39.94 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.11 0.862 . . . . 0.0 114.346 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -84.36 -14.09 50.49 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -169.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -93.76 4.52 53.81 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.871 1.669 . . . . 0.0 112.124 169.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.92 15.98 43.37 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.583 2.039 . . . . 0.0 114.106 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.9 pm0 -79.8 172.64 13.51 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.522 1.529 . . . . 0.0 113.573 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.5 m -130.22 137.36 50.0 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.37 1.468 . . . . 0.0 109.834 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.3 t -120.28 138.01 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.731 1.612 . . . . 0.0 109.605 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 15.6 tp -128.35 149.47 50.5 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.33 1.452 . . . . 0.0 109.539 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 75.2 t -132.09 133.73 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.246 1.818 . . . . 0.0 107.871 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -133.69 137.46 45.32 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.226 0.536 . . . . 0.0 112.395 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -151.95 155.03 33.41 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 123.835 0.854 . . . . 0.0 112.624 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -60.14 138.82 84.0 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.118 2.546 . . . . 0.0 113.906 -173.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 . . . . . 0 C--O 1.252 1.204 0 C-N-CA 126.162 1.785 . . . . 0.0 112.746 -178.598 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 . . . . . 0 CA--C 1.547 0.833 0 N-CA-C 111.35 0.13 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -35.2 73.49 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 121.228 -0.92 . . . . 0.0 113.006 -174.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.6 m -62.96 -20.71 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -69.73 -45.4 68.24 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 119.196 0.907 . . . . 0.0 112.07 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.92 -42.68 72.98 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.319 -0.863 . . . . 0.0 111.623 -170.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -60.74 -35.8 77.29 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.504 1.122 . . . . 0.0 112.168 171.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.2 -39.94 74.89 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 120.887 -1.133 . . . . 0.0 112.67 174.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.3 t -63.85 -40.79 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.961 0.905 . . . . 0.0 110.946 172.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.4 tmm_? -63.41 -40.17 96.49 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.245 -0.91 . . . . 0.0 112.0 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 mp -63.24 -34.37 77.51 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 117.276 -1.345 . . . . 0.0 112.423 170.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.71 -32.57 67.53 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 121.173 1.806 . . . . 0.0 111.339 169.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.0 m -75.08 -35.08 61.84 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 170.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.1 mm -70.57 -36.48 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 119.929 1.24 . . . . 0.0 110.709 176.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.8 t -66.99 -46.43 84.83 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.419 0 C-N-CA 125.681 1.592 . . . . 0.0 110.402 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -52.53 -42.54 64.47 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.742 1.61 . . . . 0.0 111.847 170.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.7 m -61.0 -29.31 69.62 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 175.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -83.22 -33.9 26.0 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.862 1.665 . . . . 0.0 113.679 171.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.8 mt -66.06 -35.81 81.52 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 120.033 1.288 . . . . 0.0 111.568 173.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 88.6 mt -73.19 -35.42 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.502 1.121 . . . . 0.0 110.662 169.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.14 -38.6 54.57 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 125.596 1.57 . . . . 0.0 114.752 -172.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.1 t -154.48 -26.99 0.12 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.17 4.03 38.48 Favored Glycine 0 N--CA 1.479 1.556 0 N-CA-C 116.721 1.448 . . . . 0.0 116.721 175.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.9 p -158.21 140.5 14.27 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.42 1.488 . . . . 0.0 111.488 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 81.0 t -94.43 143.69 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.29 1.436 . . . . 0.0 110.556 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -124.43 157.46 35.13 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.018 1.327 . . . . 0.0 110.427 171.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -53.87 -38.35 64.63 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.394 -0.816 . . . . 0.0 112.734 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -66.97 -22.44 65.93 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.169 1.388 . . . . 0.0 113.676 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -78.12 -37.64 45.72 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.288 0.495 . . . . 0.0 111.943 171.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.2 mt -88.04 -27.73 21.82 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 -173.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.0 ptt85 -58.16 -27.53 63.9 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -88.81 5.91 41.43 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 173.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -128.08 -8.97 5.38 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 120.572 -1.33 . . . . 0.0 113.966 -170.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.474 0.773 0 C-N-CA 124.784 1.233 . . . . 0.0 112.091 174.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.466 0.352 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -130.27 127.33 39.33 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.195 0.598 . . . . 0.0 111.812 -170.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -103.45 145.95 29.23 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.182 -0.949 . . . . 0.0 109.864 169.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.6 t -139.61 139.27 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 O-C-N 121.085 -1.009 . . . . 0.0 111.505 -170.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.2 mm -111.81 132.28 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.468 1.507 . . . . 0.0 113.519 -172.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.5 tpt85 -140.8 46.49 1.77 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.324 1.849 . . . . 0.0 110.423 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.2 mt -66.67 127.46 93.42 Favored Pre-proline 0 N--CA 1.481 1.083 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.054 170.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -58.63 135.41 67.19 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.978 2.452 . . . . 0.0 112.741 173.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.93 1.25 88.92 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-O 118.506 -1.163 . . . . 0.0 115.506 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -135.62 162.43 57.13 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 119.461 1.63 . . . . 0.0 113.921 173.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -61.92 142.85 94.53 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.603 2.869 . . . . 0.0 114.596 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.1 p -68.45 130.4 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.685 0.794 . . . . 0.0 110.285 169.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.8 p -123.39 147.31 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.036 1.334 . . . . 0.0 110.972 171.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -135.86 119.37 16.97 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.938 1.695 . . . . 0.0 108.948 -170.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 50.7 t -90.25 155.28 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 126.05 1.74 . . . . 0.0 111.701 -173.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.58 -88.95 1.03 Allowed Glycine 0 CA--C 1.533 1.192 0 O-C-N 121.429 -0.794 . . . . 0.0 112.761 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 85.3 m -154.25 154.2 33.04 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.164 1.386 . . . . 0.0 109.479 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -73.37 125.24 90.89 Favored Pre-proline 0 CA--C 1.547 0.839 0 O-C-N 120.561 -1.337 . . . . 0.0 110.779 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.84 155.19 43.68 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 124.036 3.157 . . . . 0.0 114.529 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.4 t -83.84 -27.98 28.35 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -169.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.73 -34.64 2.82 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 125.27 1.414 . . . . 0.0 113.36 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -79.1 60.48 2.99 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.877 1.671 . . . . 0.0 111.185 169.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.7 m -136.87 156.45 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.736 1.614 . . . . 0.0 112.525 -171.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 29.2 mt -94.36 133.55 37.81 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.309 2.243 . . . . 0.0 109.481 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -118.03 113.47 21.69 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -173.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -88.79 148.91 20.63 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.174 1.369 . . . . 0.0 110.616 169.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 68.5 mtt85 -145.92 159.38 43.3 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 119.23 1.515 . . . . 0.0 112.408 -175.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -164.82 167.23 19.01 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.499 1.12 . . . . 0.0 113.657 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.2 m -119.59 134.12 55.36 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.079 1.752 . . . . 0.0 108.002 169.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -97.49 177.73 32.25 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-O 122.025 0.792 . . . . 0.0 114.966 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -81.33 -12.13 59.12 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -169.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -101.78 4.98 40.97 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.656 1.571 . . . . 0.0 112.099 169.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.03 17.13 33.23 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 126.214 1.864 . . . . 0.0 114.384 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.1 pm0 -78.61 173.14 12.74 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.704 1.602 . . . . 0.0 113.726 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 95.5 m -130.75 135.14 47.5 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.453 1.101 . . . . 0.0 109.366 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 74.5 t -120.17 143.79 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.491 1.516 . . . . 0.0 110.822 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.6 tp -134.08 151.15 51.27 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.853 1.661 . . . . 0.0 109.151 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.2 t -140.86 139.38 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.884 1.673 . . . . 0.0 108.154 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -134.11 134.89 42.78 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.69 0.757 . . . . 0.0 112.304 -176.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -129.81 147.23 64.59 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 126.033 1.733 . . . . 0.0 111.194 -176.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -61.06 133.07 45.05 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.428 2.085 . . . . 0.0 111.394 171.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 . . . . . 0 C--O 1.253 1.263 0 C-N-CA 124.741 1.217 . . . . 0.0 112.358 -179.962 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.416 HH21 ' CD ' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -62.06 -36.9 83.03 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 120.91 -1.119 . . . . 0.0 112.787 -174.095 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.4 m -60.57 -24.37 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.434 0.693 . . . . 0.0 112.832 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -70.99 -38.7 72.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.122 0.874 . . . . 0.0 111.383 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.1 mt -71.63 -42.12 67.99 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.014 0.926 . . . . 0.0 111.717 -172.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.416 ' CD ' HH21 ' A' ' 14' ' ' ARG . 4.1 pt-20 -66.31 -32.61 74.12 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.091 0.956 . . . . 0.0 112.506 169.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.8 -37.78 88.76 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.749 -1.219 . . . . 0.0 112.299 170.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.8 t -69.63 -36.34 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.368 1.067 . . . . 0.0 111.748 172.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -60.37 -44.88 95.19 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.784 -1.197 . . . . 0.0 111.132 170.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.7 mp -67.55 -34.06 76.31 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-O 117.469 -1.253 . . . . 0.0 112.624 173.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.83 -34.56 69.81 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 121.167 1.803 . . . . 0.0 110.808 169.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.0 m -72.3 -38.32 68.76 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.177 0.991 . . . . 0.0 113.253 170.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.1 mm -72.91 -35.73 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 120.88 1.673 . . . . 0.0 111.112 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.0 t -66.73 -48.5 79.85 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.519 0 CA-C-O 117.387 -1.292 . . . . 0.0 109.221 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -53.25 -42.98 66.99 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 120.997 1.726 . . . . 0.0 112.273 171.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.6 m -60.52 -33.01 72.01 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.713 -0.617 . . . . 0.0 112.291 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -78.88 -35.11 44.18 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.669 1.587 . . . . 0.0 113.323 172.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.3 mt -66.46 -32.4 73.74 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.713 1.142 . . . . 0.0 111.723 174.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 92.2 mt -76.41 -35.92 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.908 1.283 . . . . 0.0 111.054 169.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.14 -38.57 46.92 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 125.474 1.511 . . . . 0.0 114.875 -172.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.5 t -151.34 -28.32 0.19 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 177.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.67 8.53 34.68 Favored Glycine 0 N--CA 1.475 1.278 0 N-CA-C 116.748 1.459 . . . . 0.0 116.748 174.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.2 m -157.14 145.25 19.31 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.55 1.54 . . . . 0.0 110.234 171.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.6 p -112.45 144.36 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.794 1.238 . . . . 0.0 110.634 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -129.68 159.9 35.03 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.023 1.329 . . . . 0.0 110.325 -173.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -52.97 -38.4 62.11 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -174.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -73.4 -15.73 61.35 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -87.33 -18.82 29.23 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.162 0.892 . . . . 0.0 112.617 171.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 76.5 mt -99.29 -32.49 11.16 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.91 1.684 . . . . 0.0 113.789 -176.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -61.19 -21.06 63.46 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 119.721 1.146 . . . . 0.0 114.082 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -83.77 -1.44 54.24 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.087 1.355 . . . . 0.0 113.558 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -118.41 -21.63 7.97 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.688 1.195 . . . . 0.0 113.611 -169.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.475 0.823 0 C-N-CA 124.09 0.956 . . . . 0.0 112.576 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.2 tpt85 . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -130.69 135.31 47.71 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.919 1.688 . . . . 0.0 111.314 -174.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -113.77 142.47 46.01 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 119.201 0.91 . . . . 0.0 109.928 168.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.9 t -140.25 138.32 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.536 1.134 . . . . 0.0 110.009 -169.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.408 ' HA ' HD13 ' A' ' 53' ' ' ILE . 0.4 OUTLIER -124.24 136.68 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -172.44 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -131.16 89.23 2.7 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.955 1.702 . . . . 0.0 109.084 169.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.8 mt -101.35 134.88 20.03 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 124.696 1.198 . . . . 0.0 109.507 173.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.19 132.15 32.98 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.172 1.914 . . . . 0.0 111.671 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.01 -0.93 79.75 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.8 1.191 . . . . 0.0 115.79 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -137.55 155.82 75.15 Favored Pre-proline 0 N--CA 1.476 0.827 0 CA-C-N 119.336 1.568 . . . . 0.0 112.276 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.27 148.62 68.62 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.724 2.283 . . . . 0.0 112.618 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.2 p -55.66 135.92 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.282 1.033 . . . . 0.0 111.243 170.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.69 145.81 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.781 1.232 . . . . 0.0 110.904 170.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -132.92 125.54 30.09 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.294 1.437 . . . . 0.0 110.059 -174.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.6 t -95.96 149.17 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.818 1.647 . . . . 0.0 110.382 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.03 -98.94 1.36 Allowed Glycine 0 CA--C 1.532 1.113 0 O-C-N 121.486 -0.759 . . . . 0.0 112.116 175.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.4 m -153.83 146.07 23.84 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.665 1.232 . . . . 0.0 110.832 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -68.31 125.22 91.36 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 121.049 -1.032 . . . . 0.0 111.444 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.511 ' HB2' HG11 ' A' ' 71' ' ' VAL . 95.8 Cg_endo -81.72 162.8 18.83 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.122 3.214 . . . . 0.0 115.053 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.6 t -102.85 -31.8 10.1 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 116.793 2.146 . . . . 0.0 116.793 -168.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.49 -29.93 1.17 Allowed Glycine 0 N--CA 1.478 1.464 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.0 p30 -85.46 55.97 3.75 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 122.557 1.17 . . . . 0.0 110.157 169.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.511 HG11 ' HB2' ' A' ' 67' ' ' PRO . 27.9 m -133.74 157.12 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.561 1.544 . . . . 0.0 111.195 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 67.9 mt -87.88 153.08 21.6 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.707 2.003 . . . . 0.0 109.005 169.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -128.84 115.01 17.25 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.124 0.42 . . . . 0.0 111.26 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.83 141.27 15.46 Favored Glycine 0 N--CA 1.468 0.786 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 169.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -149.36 145.26 26.91 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 119.768 1.784 . . . . 0.0 112.953 -169.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.03 160.88 43.03 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.172 0.989 . . . . 0.0 113.521 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.6 m -113.36 125.95 54.83 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.099 1.36 . . . . 0.0 109.063 171.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.58 178.58 45.79 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.215 0.912 . . . . 0.0 115.001 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -84.21 -11.91 55.72 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 -169.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -96.93 3.39 52.11 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 120.573 1.533 . . . . 0.0 111.803 169.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.65 18.83 29.04 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 126.418 1.961 . . . . 0.0 114.379 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.8 pm0 -84.28 171.86 12.35 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.642 1.577 . . . . 0.0 114.558 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 90.9 m -125.7 133.27 52.19 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.962 1.305 . . . . 0.0 110.198 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.1 t -117.26 142.13 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.705 1.602 . . . . 0.0 109.805 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.5 tp -134.03 148.17 51.05 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.066 1.346 . . . . 0.0 110.878 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.4 t -134.12 135.76 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.92 2.088 . . . . 0.0 108.029 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -138.52 137.81 37.44 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.988 0.813 . . . . 0.0 112.958 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -153.17 153.96 30.22 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.215 1.006 . . . . 0.0 113.344 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -63.77 141.87 80.52 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.102 2.535 . . . . 0.0 114.452 -171.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 . . . . . 0 C--O 1.253 1.263 0 C-N-CA 127.109 2.163 . . . . 0.0 113.45 -173.755 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 . . . . . 0 CA--C 1.543 0.706 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.46 -38.26 77.16 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 121.273 -0.892 . . . . 0.0 112.689 -173.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.7 m -61.19 -22.33 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 123.864 0.727 . . . . 0.0 112.711 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -68.85 -43.65 75.01 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 119.258 0.935 . . . . 0.0 112.369 175.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.66 -41.55 71.94 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.335 -0.853 . . . . 0.0 111.466 -171.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -64.34 -32.51 74.15 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.531 1.133 . . . . 0.0 112.519 171.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.19 -39.33 82.51 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.707 -1.246 . . . . 0.0 112.468 171.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.1 t -65.32 -41.12 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.783 0.833 . . . . 0.0 111.116 172.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -57.85 -42.01 83.55 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.42 -0.8 . . . . 0.0 111.844 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.46 -33.8 73.44 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 117.583 -1.198 . . . . 0.0 113.31 173.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.97 -33.87 65.18 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 120.856 1.662 . . . . 0.0 111.24 169.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.6 m -73.06 -37.64 66.75 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 170.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.6 mm -72.05 -33.71 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 120.975 1.716 . . . . 0.0 110.792 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.406 HG21 HD11 ' A' ' 53' ' ' ILE . 93.4 t -69.25 -46.73 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.599 1.16 . . . . 0.0 109.748 175.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -53.44 -42.99 67.69 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.693 1.588 . . . . 0.0 112.044 170.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.8 m -60.43 -29.81 69.23 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.779 -0.576 . . . . 0.0 112.27 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -82.2 -35.17 28.57 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.81 1.644 . . . . 0.0 113.514 172.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.7 mt -65.87 -34.92 79.26 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.897 1.226 . . . . 0.0 111.578 174.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 91.8 mt -73.75 -36.32 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.731 1.212 . . . . 0.0 110.828 169.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.08 -37.73 55.68 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 125.557 1.551 . . . . 0.0 114.682 -172.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.5 t -154.23 -26.96 0.13 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.4 9.46 35.95 Favored Glycine 0 N--CA 1.478 1.463 0 N-CA-C 116.565 1.386 . . . . 0.0 116.565 175.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.3 m -158.79 142.73 15.35 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.788 1.635 . . . . 0.0 110.095 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -107.38 146.73 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.733 1.213 . . . . 0.0 110.676 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -130.1 160.2 34.46 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.473 1.509 . . . . 0.0 109.965 -177.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -54.61 -37.5 65.66 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.647 -0.658 . . . . 0.0 112.724 -175.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -66.21 -21.87 66.32 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.706 1.202 . . . . 0.0 113.561 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -92.66 5.92 49.28 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.751 1.22 . . . . 0.0 112.964 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.5 mt -127.65 -26.49 2.97 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.7 ptt85 -62.83 -23.09 67.11 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 120.219 -1.55 . . . . 0.0 114.565 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.94 -5.09 57.09 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.686 1.594 . . . . 0.0 112.611 173.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -107.72 -22.89 12.31 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.263 1.825 . . . . 0.0 111.561 -169.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.47 0.531 0 C-N-CA 124.691 1.197 . . . . 0.0 111.36 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.467 0.388 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.557 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -131.69 133.26 44.67 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.195 0.598 . . . . 0.0 112.07 -170.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.46 141.72 39.9 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.535 -0.728 . . . . 0.0 109.587 169.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.9 t -137.55 141.68 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.655 1.182 . . . . 0.0 110.191 -171.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.406 HD11 HG21 ' A' ' 26' ' ' VAL . 0.8 OUTLIER -119.91 132.01 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -169.845 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -130.93 77.3 1.78 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.906 1.682 . . . . 0.0 109.857 171.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.4 mt -95.49 127.98 39.89 Favored Pre-proline 0 N--CA 1.478 0.97 0 O-C-N 121.262 -0.899 . . . . 0.0 109.159 171.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.91 134.17 58.45 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.46 2.107 . . . . 0.0 112.682 173.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.07 0.12 87.29 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 124.838 1.209 . . . . 0.0 116.017 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -137.1 157.21 74.93 Favored Pre-proline 0 CA--C 1.548 0.883 0 CA-C-N 119.232 1.516 . . . . 0.0 112.154 173.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -70.12 151.03 66.82 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.783 2.322 . . . . 0.0 113.057 -174.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.9 p -58.29 132.48 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.296 1.038 . . . . 0.0 111.467 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 86.6 t -110.94 142.01 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.593 1.557 . . . . 0.0 109.096 170.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -135.63 118.0 15.7 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.12 1.368 . . . . 0.0 109.115 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.7 t -92.57 153.7 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.286 1.834 . . . . 0.0 111.169 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.48 -101.71 1.42 Allowed Glycine 0 CA--C 1.533 1.157 0 O-C-N 121.321 -0.862 . . . . 0.0 112.472 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.4 m -144.29 147.89 34.11 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.388 1.075 . . . . 0.0 109.946 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -70.37 125.64 92.06 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 120.687 -1.258 . . . . 0.0 111.031 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.419 ' CB ' HG11 ' A' ' 71' ' ' VAL . 62.2 Cg_endo -77.42 155.15 32.11 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 124.052 3.168 . . . . 0.0 114.824 -174.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.5 t -85.19 -31.35 23.26 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -169.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 133.51 -36.74 2.09 Favored Glycine 0 N--CA 1.478 1.467 0 C-N-CA 125.05 1.309 . . . . 0.0 112.321 -173.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -78.8 63.13 3.47 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.464 1.506 . . . . 0.0 110.101 169.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.419 HG11 ' CB ' ' A' ' 67' ' ' PRO . 27.7 m -138.98 151.83 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.506 1.523 . . . . 0.0 111.976 -176.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.9 mt -85.78 141.39 29.71 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.952 2.101 . . . . 0.0 109.122 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -121.43 110.35 15.96 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.366 0.53 . . . . 0.0 112.129 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.14 143.16 17.25 Favored Glycine 0 N--CA 1.467 0.755 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 169.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -153.68 134.83 14.02 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.886 1.843 . . . . 0.0 113.003 -169.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -142.63 161.44 38.08 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.503 1.121 . . . . 0.0 113.704 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.5 m -112.45 127.98 56.19 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.853 1.261 . . . . 0.0 108.72 171.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.18 174.51 40.42 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.206 0.908 . . . . 0.0 114.986 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -79.88 -11.41 59.81 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 -169.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -101.07 4.88 42.65 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 120.744 1.611 . . . . 0.0 112.355 169.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.67 17.4 30.9 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 126.031 1.777 . . . . 0.0 114.355 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.2 pm0 -83.79 172.98 11.67 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.792 1.637 . . . . 0.0 113.791 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.6 m -126.86 131.43 51.19 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.27 1.428 . . . . 0.0 109.681 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.1 t -113.68 141.02 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.624 1.57 . . . . 0.0 110.067 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.6 tp -129.89 148.23 51.74 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.087 1.355 . . . . 0.0 109.864 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.8 t -133.37 136.79 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.08 1.752 . . . . 0.0 108.317 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -131.68 131.99 43.57 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.783 0.801 . . . . 0.0 111.934 -176.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -131.84 148.31 69.41 Favored Pre-proline 0 N--CA 1.473 0.691 0 C-N-CA 126.163 1.785 . . . . 0.0 111.065 -173.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -61.39 134.91 54.38 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.87 2.38 . . . . 0.0 112.529 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 125.744 1.618 . . . . 0.0 112.438 177.479 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 . . . . . 0 N--CA 1.473 0.687 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -31.34 71.84 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -173.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.6 m -68.07 -21.46 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 172.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -71.17 -42.9 68.49 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 120.699 -1.251 . . . . 0.0 112.209 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.88 -39.1 76.49 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.386 -0.821 . . . . 0.0 111.301 -171.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.07 -28.83 65.75 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.721 1.208 . . . . 0.0 112.818 173.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.98 -39.76 87.26 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.764 -1.21 . . . . 0.0 111.381 169.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.4 t -67.92 -36.1 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.107 0.963 . . . . 0.0 111.538 174.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -59.26 -46.28 88.94 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.224 -0.923 . . . . 0.0 111.095 170.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.2 mp -69.07 -35.44 76.52 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 117.093 -1.432 . . . . 0.0 113.099 175.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.07 -38.69 68.38 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 121.066 1.757 . . . . 0.0 110.235 169.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.7 m -67.95 -38.82 83.26 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.152 0.981 . . . . 0.0 113.523 172.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.9 mm -72.35 -35.11 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 120.72 1.6 . . . . 0.0 110.748 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.2 t -68.82 -43.82 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.374 1.469 . . . . 0.0 110.235 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -56.54 -40.03 74.43 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 121.126 1.784 . . . . 0.0 112.34 169.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -62.79 -23.96 67.5 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 174.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -85.84 -36.86 19.75 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.295 1.838 . . . . 0.0 112.987 171.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.5 mt -68.92 -40.29 79.15 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 120.093 1.315 . . . . 0.0 111.984 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 86.2 mt -69.37 -32.18 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.457 1.503 . . . . 0.0 110.958 174.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.95 -75.34 0.77 Allowed Glycine 0 C--N 1.338 0.694 0 C-N-CA 125.36 1.457 . . . . 0.0 111.359 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.6 t -118.5 -26.73 6.12 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -170.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.61 0.74 46.41 Favored Glycine 0 N--CA 1.475 1.252 0 N-CA-C 116.972 1.549 . . . . 0.0 116.972 171.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.7 m -147.79 134.64 20.11 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.097 1.759 . . . . 0.0 109.956 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.5 p -104.86 147.92 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.04 1.336 . . . . 0.0 110.918 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -133.05 160.74 36.28 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.302 1.441 . . . . 0.0 110.702 -175.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -58.0 -37.7 74.74 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.745 -0.597 . . . . 0.0 111.899 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.73 -23.5 63.4 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.069 0.948 . . . . 0.0 113.187 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -77.79 -27.39 50.16 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.799 0.727 . . . . 0.0 112.16 174.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 72.3 mt -97.7 -28.1 14.05 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.587 1.555 . . . . 0.0 114.687 -173.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.2 ptt85 -62.03 -23.36 66.41 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 119.974 1.261 . . . . 0.0 113.702 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -88.23 5.97 39.08 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.314 1.446 . . . . 0.0 114.456 171.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -119.09 -15.04 9.29 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.947 1.249 . . . . 0.0 113.061 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.472 0.669 0 C-N-CA 123.74 0.816 . . . . 0.0 112.202 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 . . . . . 0 N--CA 1.475 0.79 0 CA-C-O 119.548 -0.263 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -132.58 131.72 41.77 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.008 1.323 . . . . 0.0 111.742 -176.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -104.81 144.6 31.54 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 119.784 1.174 . . . . 0.0 110.659 169.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 37.4 t -140.8 141.18 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.445 1.098 . . . . 0.0 111.821 -169.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 mm -118.06 140.16 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.801 1.24 . . . . 0.0 114.13 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -139.89 72.69 1.4 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 128.098 2.559 . . . . 0.0 109.537 169.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.0 mt -91.73 127.77 48.83 Favored Pre-proline 0 N--CA 1.484 1.241 0 O-C-N 121.009 -1.057 . . . . 0.0 109.898 172.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -60.77 136.41 66.22 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.995 2.463 . . . . 0.0 112.9 171.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.23 2.11 89.34 Favored Glycine 0 CA--C 1.536 1.367 0 N-CA-C 115.912 1.125 . . . . 0.0 115.912 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -139.79 157.35 69.95 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 118.901 1.351 . . . . 0.0 111.877 174.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.01 143.78 73.62 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.426 2.084 . . . . 0.0 112.956 -176.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.57 135.5 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.256 1.422 . . . . 0.0 110.945 172.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.2 p -129.37 142.65 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.798 0.839 . . . . 0.0 111.891 171.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -140.11 123.47 16.98 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.409 1.083 . . . . 0.0 110.099 -173.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.5 t -95.5 155.2 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 127.015 2.126 . . . . 0.0 111.128 -172.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.26 -96.56 1.12 Allowed Glycine 0 CA--C 1.53 1.009 0 O-C-N 121.087 -1.008 . . . . 0.0 112.536 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.0 m -155.97 155.39 32.68 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.174 0.99 . . . . 0.0 110.211 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -68.96 132.17 90.55 Favored Pre-proline 0 CA--C 1.546 0.803 0 O-C-N 120.93 -1.106 . . . . 0.0 110.425 171.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.65 160.76 34.51 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 124.18 3.253 . . . . 0.0 114.121 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.6 t -85.7 -28.36 24.72 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -173.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.68 -32.83 3.24 Favored Glycine 0 N--CA 1.478 1.44 0 C-N-CA 125.644 1.592 . . . . 0.0 112.709 -176.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -77.44 60.2 2.02 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.403 1.881 . . . . 0.0 111.114 169.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.0 m -138.51 155.05 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.273 1.429 . . . . 0.0 113.177 -172.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.5 mt -91.03 142.4 27.81 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 128.029 2.532 . . . . 0.0 109.092 171.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -126.42 112.62 15.83 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.753 0.706 . . . . 0.0 111.311 -176.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.53 149.88 19.44 Favored Glycine 0 N--CA 1.469 0.871 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 169.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -147.19 148.56 31.63 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 118.656 1.228 . . . . 0.0 112.099 -169.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.3 166.33 33.76 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.412 1.085 . . . . 0.0 112.865 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.6 m -132.49 123.11 25.97 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.325 1.45 . . . . 0.0 109.634 172.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.62 176.43 42.44 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.0 1.286 . . . . 0.0 113.651 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -49.13 -45.0 42.97 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 126.347 1.859 . . . . 0.0 111.775 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -83.39 3.58 31.22 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 -170.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.65 25.38 13.6 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.666 0.651 . . . . 0.0 113.298 173.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.39 -166.01 1.49 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.656 1.182 . . . . 0.0 113.914 -174.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 16.6 m -147.39 120.27 8.72 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.318 -1.489 . . . . 0.0 111.611 173.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 37.1 t -96.64 142.25 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 126.246 1.819 . . . . 0.0 108.998 169.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.5 tp -129.91 146.74 51.62 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.356 1.463 . . . . 0.0 108.975 169.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 p -133.86 142.07 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.02 1.328 . . . . 0.0 109.663 172.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -137.08 134.39 36.44 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.162 0.506 . . . . 0.0 111.825 -170.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -131.72 152.8 81.0 Favored Pre-proline 0 N--CA 1.473 0.714 0 C-N-CA 124.954 1.301 . . . . 0.0 112.524 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -56.91 137.56 82.26 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 122.641 2.227 . . . . 0.0 112.933 170.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 . . . . . 0 C--O 1.252 1.223 0 C-N-CA 125.798 1.639 . . . . 0.0 112.279 177.522 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -59.9 -32.44 70.76 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -172.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.3 m -64.94 -21.81 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 174.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -67.94 -43.22 79.6 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 120.878 -1.139 . . . . 0.0 112.837 176.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mp -70.62 -41.68 71.92 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.444 -0.785 . . . . 0.0 111.816 -171.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.15 -30.92 71.97 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.364 1.066 . . . . 0.0 112.64 172.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.41 -36.97 79.88 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.925 -1.109 . . . . 0.0 112.447 171.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.4 t -69.87 -36.23 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 124.175 0.99 . . . . 0.0 111.376 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -58.37 -46.07 87.02 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.314 -0.866 . . . . 0.0 111.23 171.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.1 mp -70.05 -34.13 72.83 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-O 117.321 -1.323 . . . . 0.0 113.195 173.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.18 -34.86 68.9 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 121.365 1.893 . . . . 0.0 110.586 169.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.1 m -71.23 -41.53 70.03 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.301 1.04 . . . . 0.0 112.806 171.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.4 mm -70.66 -35.08 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 120.623 1.556 . . . . 0.0 111.201 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.3 t -65.11 -47.44 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.026 1.33 . . . . 0.0 109.99 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -52.97 -42.64 65.71 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.607 1.549 . . . . 0.0 112.124 171.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.3 t -59.33 -38.12 79.51 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.788 -0.57 . . . . 0.0 111.95 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.404 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . 18.2 tpt180 -72.47 -37.25 68.52 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.47 1.108 . . . . 0.0 113.367 172.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.6 mt -67.31 -32.35 73.27 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.877 1.217 . . . . 0.0 112.182 176.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 89.8 mt -74.15 -37.86 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 124.523 1.129 . . . . 0.0 110.826 169.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.1 -38.58 54.89 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 125.862 1.696 . . . . 0.0 114.52 -172.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.1 t -150.17 -30.52 0.21 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.29 4.47 35.24 Favored Glycine 0 N--CA 1.475 1.283 0 N-CA-C 117.105 1.602 . . . . 0.0 117.105 176.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.8 p -152.92 141.57 20.92 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.45 1.5 . . . . 0.0 111.34 177.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.5 t -99.67 139.19 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.124 1.37 . . . . 0.0 110.383 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -123.07 155.08 37.62 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.918 1.287 . . . . 0.0 109.806 174.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -54.76 -38.3 67.04 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.296 -0.878 . . . . 0.0 113.317 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -67.38 -17.69 64.83 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.404 ' CE2' ' HB2' ' A' ' 29' ' ' ARG . 91.3 t80 -85.11 -22.26 28.96 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 118.539 -0.743 . . . . 0.0 112.648 171.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.1 mt -97.6 -31.37 12.34 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.34 1.427 . . . . 0.0 114.439 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -58.88 -24.28 62.01 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -93.76 7.54 44.48 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.101 1.361 . . . . 0.0 113.456 174.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -127.62 -16.05 4.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.681 1.592 . . . . 0.0 113.246 -174.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.479 0.978 0 CA-C-N 119.125 0.875 . . . . 0.0 110.906 169.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.537 0 CA-C-O 119.245 -0.407 . . . . 0.0 111.77 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -130.64 126.89 37.77 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.296 0.638 . . . . 0.0 111.107 -170.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.71 148.69 27.15 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.98 -1.075 . . . . 0.0 110.127 169.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.2 t -141.0 140.81 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.897 1.279 . . . . 0.0 110.717 -171.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 53' ' ' ILE . 0.6 OUTLIER -118.55 133.44 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.986 1.314 . . . . 0.0 113.576 -170.051 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -131.88 79.61 1.88 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.738 1.615 . . . . 0.0 109.381 169.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.5 mt -96.91 123.65 52.78 Favored Pre-proline 0 N--CA 1.479 0.991 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 173.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.86 132.51 50.22 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.407 2.071 . . . . 0.0 112.501 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.53 2.57 87.09 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.906 1.241 . . . . 0.0 115.776 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -135.92 162.11 58.71 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-N 119.806 1.803 . . . . 0.0 114.084 171.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -62.94 143.64 91.64 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.481 2.787 . . . . 0.0 114.136 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 p -58.0 133.84 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.775 0.83 . . . . 0.0 110.631 169.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 71.4 t -114.01 141.71 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.765 1.226 . . . . 0.0 109.313 172.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -134.87 119.55 18.22 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.988 1.315 . . . . 0.0 109.554 177.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.4 t -90.39 152.51 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.366 1.466 . . . . 0.0 111.085 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.08 -105.48 2.24 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 121.368 -0.833 . . . . 0.0 112.621 170.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.8 m -145.02 148.87 34.21 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.544 1.137 . . . . 0.0 110.052 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -67.95 128.62 93.34 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 120.598 -1.314 . . . . 0.0 111.298 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.447 ' CB ' HG11 ' A' ' 71' ' ' VAL . 73.7 Cg_endo -80.18 152.94 21.42 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.264 3.309 . . . . 0.0 114.922 -177.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.7 t -82.9 -31.36 27.89 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -169.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.31 -35.03 2.42 Favored Glycine 0 N--CA 1.479 1.544 0 C-N-CA 125.246 1.403 . . . . 0.0 112.458 -174.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -79.44 61.14 3.4 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.306 1.442 . . . . 0.0 109.922 169.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.447 HG11 ' CB ' ' A' ' 67' ' ' PRO . 32.2 m -138.84 156.33 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.934 1.693 . . . . 0.0 111.398 -175.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.5 mt -91.72 138.61 31.42 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 127.734 2.414 . . . . 0.0 108.869 173.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -119.19 113.25 20.59 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.271 0.487 . . . . 0.0 111.741 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.68 144.68 17.47 Favored Glycine 0 N--CA 1.467 0.722 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 169.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -152.99 138.9 18.06 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.07 1.935 . . . . 0.0 112.853 -169.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.91 164.72 30.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.675 1.19 . . . . 0.0 114.043 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.3 m -119.74 125.21 48.07 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.223 1.409 . . . . 0.0 109.273 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.05 173.95 43.5 Favored Glycine 0 CA--C 1.54 1.653 0 C-N-CA 124.488 1.042 . . . . 0.0 115.26 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -81.59 -12.28 58.81 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -169.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -95.04 2.52 55.28 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 120.333 1.424 . . . . 0.0 112.161 169.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.93 15.03 46.99 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 126.783 2.135 . . . . 0.0 115.077 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 20.4 pm0 -78.68 172.4 13.76 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.992 1.717 . . . . 0.0 113.253 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.6 m -129.49 138.27 51.29 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.597 1.559 . . . . 0.0 110.342 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 88.6 t -122.52 140.27 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.471 1.508 . . . . 0.0 109.957 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.5 tp -128.79 148.35 50.86 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.181 1.392 . . . . 0.0 109.674 173.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.7 t -134.25 136.77 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.79 1.636 . . . . 0.0 108.275 176.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -131.01 129.98 42.75 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 122.031 0.919 . . . . 0.0 111.907 -176.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -130.44 142.25 44.79 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 126.661 1.984 . . . . 0.0 110.501 -171.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -61.89 133.67 45.91 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.435 2.09 . . . . 0.0 112.004 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 70.0 ttp85 . . . . . 0 C--O 1.252 1.211 0 C-N-CA 125.133 1.373 . . . . 0.0 112.33 -179.902 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 . . . . . 0 CA--C 1.546 0.805 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -59.48 -37.9 79.44 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.755 0.822 . . . . 0.0 112.889 -172.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.9 m -60.46 -22.65 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.666 0.786 . . . . 0.0 112.027 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -65.39 -42.94 92.11 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.251 0.932 . . . . 0.0 112.13 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.1 mp -73.86 -41.15 62.63 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.315 -0.866 . . . . 0.0 111.404 -170.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -67.73 -29.19 68.37 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.202 1.001 . . . . 0.0 112.799 171.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.06 -37.76 84.6 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 120.607 -1.308 . . . . 0.0 112.292 169.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.6 t -69.01 -36.15 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.002 0.921 . . . . 0.0 111.417 172.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -60.24 -44.57 95.12 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.12 -0.987 . . . . 0.0 111.421 171.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.0 mp -69.97 -34.18 73.04 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-O 117.343 -1.313 . . . . 0.0 112.673 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.434 ' HA ' HG21 ' A' ' 84' ' ' VAL . . . -57.95 -33.44 68.83 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 121.144 1.793 . . . . 0.0 110.883 169.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.1 m -72.25 -38.66 68.85 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.27 1.028 . . . . 0.0 113.432 171.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -74.11 -34.86 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 120.99 1.723 . . . . 0.0 111.073 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.471 HG21 HD11 ' A' ' 53' ' ' ILE . 97.5 t -64.86 -48.3 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.83 1.252 . . . . 0.0 109.62 173.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -54.12 -43.49 70.53 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.764 1.62 . . . . 0.0 112.086 172.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.2 m -59.45 -31.48 69.35 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.636 -0.665 . . . . 0.0 112.407 175.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -80.19 -35.19 36.74 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.715 1.606 . . . . 0.0 113.381 172.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 67.1 mt -66.59 -33.5 75.79 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 120.058 1.299 . . . . 0.0 111.643 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 91.1 mt -73.82 -36.46 46.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.904 1.281 . . . . 0.0 110.777 169.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.99 -38.72 55.62 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 125.632 1.587 . . . . 0.0 114.826 -173.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.2 t -152.5 -26.39 0.17 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.51 11.19 39.15 Favored Glycine 0 N--CA 1.48 1.581 0 N-CA-C 116.234 1.254 . . . . 0.0 116.234 175.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.8 m -157.69 143.4 17.27 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.886 1.674 . . . . 0.0 109.492 173.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.83 145.74 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.135 1.374 . . . . 0.0 109.858 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -130.49 158.77 39.01 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.723 1.209 . . . . 0.0 110.754 -172.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -56.11 -38.72 71.15 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.776 -0.577 . . . . 0.0 112.313 -177.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -70.96 -18.32 62.63 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -78.46 -38.28 41.52 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.211 0.914 . . . . 0.0 111.088 169.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 58.4 mt -87.35 -28.5 22.18 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -169.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -59.73 -21.14 60.28 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 172.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -83.56 -7.68 59.47 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.829 1.251 . . . . 0.0 114.032 174.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -115.46 -14.2 11.57 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.785 1.234 . . . . 0.0 113.302 -169.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.471 0.577 0 C-N-CA 123.486 0.714 . . . . 0.0 111.812 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -130.34 133.98 46.84 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.533 1.533 . . . . 0.0 110.877 -174.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.78 141.75 40.33 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.137 -0.977 . . . . 0.0 109.79 169.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.6 t -136.62 142.39 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.526 1.13 . . . . 0.0 111.024 -173.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.471 HD11 HG21 ' A' ' 26' ' ' VAL . 0.6 OUTLIER -124.15 134.68 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.89 1.276 . . . . 0.0 114.226 -169.742 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -138.75 77.99 1.65 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.109 1.764 . . . . 0.0 109.679 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.0 mt -95.89 132.32 27.35 Favored Pre-proline 0 N--CA 1.478 0.947 0 C-N-CA 124.982 1.313 . . . . 0.0 109.523 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.1 134.66 37.58 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.196 1.931 . . . . 0.0 111.545 174.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.82 1.26 85.28 Favored Glycine 0 CA--C 1.536 1.36 0 N-CA-C 116.043 1.177 . . . . 0.0 116.043 177.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -138.78 156.9 72.64 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-N 119.073 1.437 . . . . 0.0 111.954 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.39 150.33 75.79 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.705 2.27 . . . . 0.0 112.969 -174.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 50.7 t -60.44 131.88 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.278 1.031 . . . . 0.0 110.358 173.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 72.4 t -112.62 140.25 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.454 1.502 . . . . 0.0 109.469 173.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -135.07 118.15 16.44 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.037 1.335 . . . . 0.0 109.421 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.7 t -94.62 151.77 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.881 1.672 . . . . 0.0 111.032 -177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.66 -93.5 1.03 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 121.283 -0.886 . . . . 0.0 112.317 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 m -154.74 152.58 30.06 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.669 -0.901 . . . . 0.0 110.463 175.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -69.17 129.4 92.02 Favored Pre-proline 0 CA--C 1.547 0.863 0 O-C-N 120.928 -1.108 . . . . 0.0 110.722 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.43 ' CB ' HG11 ' A' ' 71' ' ' VAL . 75.3 Cg_endo -78.6 158.71 28.63 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 124.3 3.333 . . . . 0.0 114.602 -176.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.3 t -83.29 -25.19 31.8 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -171.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.59 -34.17 3.71 Favored Glycine 0 N--CA 1.478 1.442 0 C-N-CA 125.713 1.625 . . . . 0.0 112.804 -175.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -79.03 61.36 3.18 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.738 1.615 . . . . 0.0 111.261 169.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.43 HG11 ' CB ' ' A' ' 67' ' ' PRO . 29.9 m -136.93 158.95 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 126.343 1.857 . . . . 0.0 112.526 -173.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 27.9 mt -92.77 139.41 30.58 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.826 2.051 . . . . 0.0 108.799 172.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -127.55 113.56 16.28 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.101 0.961 . . . . 0.0 110.506 -175.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -97.75 145.4 17.79 Favored Glycine 0 N--CA 1.467 0.727 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -148.01 139.31 23.52 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.763 1.282 . . . . 0.0 112.682 -169.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.24 162.39 36.48 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.609 1.164 . . . . 0.0 113.181 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 74.5 m -114.16 124.65 52.59 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.19 1.396 . . . . 0.0 108.423 172.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.54 173.31 45.63 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-O 122.166 0.87 . . . . 0.0 114.424 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -79.63 -17.35 54.0 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -169.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -92.84 4.81 53.17 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.646 1.566 . . . . 0.0 112.543 169.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.37 16.96 32.93 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 126.136 1.827 . . . . 0.0 114.308 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.9 pm0 -82.92 171.55 13.75 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.471 1.508 . . . . 0.0 114.206 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.5 m -123.14 132.99 54.29 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.66 1.584 . . . . 0.0 109.203 175.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.434 HG21 ' HA ' ' A' ' 23' ' ' ALA . 17.4 t -127.51 140.68 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.629 1.171 . . . . 0.0 110.155 -176.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.5 tp -133.42 147.66 51.74 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.293 1.037 . . . . 0.0 110.76 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.09 143.28 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.816 1.246 . . . . 0.0 109.565 170.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -137.37 137.5 38.93 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -173.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -132.13 151.27 78.11 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 125.793 1.637 . . . . 0.0 112.432 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -58.68 135.86 70.09 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.405 2.07 . . . . 0.0 111.996 169.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 . . . . . 0 C--O 1.253 1.285 0 C-N-CA 124.938 1.295 . . . . 0.0 112.179 178.614 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 . . . . . 0 CA--C 1.545 0.75 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -37.98 77.68 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 121.294 -0.879 . . . . 0.0 112.732 -173.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 m -62.52 -21.74 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -70.44 -44.06 68.63 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 119.132 0.878 . . . . 0.0 112.146 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.57 -42.26 71.33 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.083 -1.011 . . . . 0.0 111.367 -172.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -63.27 -32.73 74.22 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.395 1.078 . . . . 0.0 112.449 171.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.09 84.04 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.752 -1.217 . . . . 0.0 112.308 171.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.6 t -64.79 -40.33 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.802 0.841 . . . . 0.0 111.071 174.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -57.07 -44.72 83.34 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.536 -0.728 . . . . 0.0 112.145 171.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.9 mp -68.45 -33.91 75.02 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 116.871 -1.538 . . . . 0.0 112.943 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.11 -39.53 69.46 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 121.252 1.842 . . . . 0.0 110.308 169.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.6 m -70.09 -38.25 75.64 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 172.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.9 mm -70.42 -34.21 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 121.181 1.81 . . . . 0.0 110.813 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.2 t -66.57 -48.51 80.17 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 C-N-CA 124.945 1.298 . . . . 0.0 110.092 173.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -54.86 -39.52 68.72 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 121.408 1.913 . . . . 0.0 112.802 171.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.4 m -61.84 -29.08 69.93 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.984 0.514 . . . . 0.0 112.066 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -82.68 -36.78 25.61 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.063 1.745 . . . . 0.0 113.438 171.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.61 -34.2 77.35 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.055 1.298 . . . . 0.0 111.566 175.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 92.0 mt -76.56 -36.7 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 124.618 1.167 . . . . 0.0 110.714 169.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.36 -37.85 53.63 Favored Glycine 0 C--N 1.341 0.849 0 C-N-CA 125.822 1.677 . . . . 0.0 114.698 -171.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.2 t -148.66 -30.44 0.27 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 175.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.78 12.07 27.05 Favored Glycine 0 N--CA 1.473 1.141 0 N-CA-C 116.703 1.441 . . . . 0.0 116.703 174.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.4 m -157.84 143.2 16.93 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.364 1.466 . . . . 0.0 109.736 170.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.2 p -112.36 141.45 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.384 1.474 . . . . 0.0 110.616 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -131.74 159.79 37.42 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.535 1.534 . . . . 0.0 110.45 -172.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -56.2 -38.54 71.14 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.38 -0.825 . . . . 0.0 113.056 -175.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -69.87 -21.77 63.3 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -77.23 -35.52 55.42 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.476 0.58 . . . . 0.0 111.78 169.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 58.8 mt -86.61 -29.19 22.76 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -174.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -61.15 -22.72 64.96 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -91.97 -0.19 57.48 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.271 1.029 . . . . 0.0 113.457 172.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -117.03 -17.37 10.36 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.178 1.391 . . . . 0.0 113.496 -173.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 123.892 0.877 . . . . 0.0 111.08 170.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.468 0.437 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.328 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -129.9 132.97 46.58 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.955 0.502 . . . . 0.0 112.324 -170.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -111.52 141.24 45.35 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.636 -0.665 . . . . 0.0 109.555 168.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.0 t -138.89 138.23 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.681 1.192 . . . . 0.0 109.339 -169.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 53' ' ' ILE . 0.3 OUTLIER -120.62 132.83 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -169.879 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -129.75 84.11 2.19 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.263 1.825 . . . . 0.0 109.254 173.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.1 mt -99.06 134.37 21.44 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 124.208 1.003 . . . . 0.0 108.85 173.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.36 136.35 43.13 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.238 1.959 . . . . 0.0 111.514 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.76 0.28 83.98 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.638 1.113 . . . . 0.0 115.702 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -136.15 157.99 74.58 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 118.95 1.375 . . . . 0.0 112.564 175.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.59 151.75 64.54 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.676 2.251 . . . . 0.0 113.285 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.3 p -54.86 140.87 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.408 1.483 . . . . 0.0 112.328 172.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 85.0 t -116.18 140.81 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 125.864 1.666 . . . . 0.0 108.76 170.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -134.67 119.5 18.38 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.721 1.208 . . . . 0.0 110.12 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.1 t -93.77 154.99 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.716 2.006 . . . . 0.0 110.963 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.81 -105.13 1.67 Allowed Glycine 0 CA--C 1.533 1.203 0 O-C-N 121.216 -0.927 . . . . 0.0 111.521 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.2 t -153.87 161.04 42.35 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.033 0.917 . . . . 0.0 112.089 169.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -71.89 126.38 91.39 Favored Pre-proline 0 CA--C 1.548 0.878 0 O-C-N 120.902 -1.123 . . . . 0.0 111.85 -171.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.444 ' CB ' HG11 ' A' ' 71' ' ' VAL . 73.6 Cg_endo -79.54 155.68 24.6 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 124.069 3.18 . . . . 0.0 114.856 -175.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.431 HG23 ' H ' ' A' ' 70' ' ' ASP . 7.2 t -83.51 -20.46 33.89 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 115.81 1.781 . . . . 0.0 115.81 -169.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.39 -30.5 6.2 Favored Glycine 0 N--CA 1.479 1.559 0 C-N-CA 125.361 1.457 . . . . 0.0 113.12 -173.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.431 ' H ' HG23 ' A' ' 68' ' ' THR . 20.6 m-20 -82.13 60.11 4.75 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.424 1.489 . . . . 0.0 109.351 168.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.444 HG11 ' CB ' ' A' ' 67' ' ' PRO . 34.4 m -140.94 152.98 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 126.458 1.903 . . . . 0.0 110.381 -175.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.7 mt -79.59 146.43 32.57 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.023 1.729 . . . . 0.0 108.942 169.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -126.75 106.39 9.34 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.877 0.762 . . . . 0.0 109.979 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -88.82 149.4 20.93 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 169.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 33.2 ttt-85 -148.07 143.69 27.36 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.217 1.509 . . . . 0.0 112.013 -170.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -152.66 167.72 27.98 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.373 1.069 . . . . 0.0 113.251 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.0 m -134.09 128.1 33.51 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.708 1.603 . . . . 0.0 109.601 171.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.42 -175.09 49.87 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.6 1.572 . . . . 0.0 114.934 177.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -58.74 -45.38 89.8 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.256 1.422 . . . . 0.0 112.107 177.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -77.71 2.57 16.43 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -172.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.26 23.0 28.11 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.0 1.286 . . . . 0.0 113.465 172.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.11 -163.15 0.95 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.266 1.426 . . . . 0.0 114.111 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.1 m -146.15 128.68 16.03 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.336 -1.478 . . . . 0.0 111.361 175.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.3 t -105.2 142.51 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 126.195 1.798 . . . . 0.0 109.208 169.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.8 tp -129.15 141.49 51.16 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.083 1.353 . . . . 0.0 109.382 169.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.18 136.81 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.524 1.53 . . . . 0.0 108.461 173.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -131.67 130.97 42.74 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.682 0.753 . . . . 0.0 112.048 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -133.54 142.36 43.66 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 125.066 1.346 . . . . 0.0 112.058 -169.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -59.24 130.41 35.96 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.184 2.59 . . . . 0.0 112.533 177.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 67.9 ttp85 . . . . . 0 C--O 1.253 1.258 0 C-N-CA 125.231 1.412 . . . . 0.0 112.356 178.458 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.406 HH21 ' CD ' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -62.75 -35.93 81.37 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 117.556 -1.211 . . . . 0.0 113.068 -174.583 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.8 m -59.9 -25.66 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 119.002 0.819 . . . . 0.0 112.756 172.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -77.45 -35.56 53.83 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.554 0.615 . . . . 0.0 112.56 176.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.8 mt -69.25 -39.87 78.19 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.405 -0.809 . . . . 0.0 110.976 -175.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.406 ' CD ' HH21 ' A' ' 14' ' ' ARG . 6.0 pt-20 -68.23 -30.47 69.53 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.041 0.936 . . . . 0.0 112.688 169.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.65 -38.64 89.92 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 120.227 1.376 . . . . 0.0 112.098 170.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.4 t -67.95 -39.74 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.182 0.993 . . . . 0.0 111.429 172.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -58.79 -44.91 90.85 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.211 -0.931 . . . . 0.0 111.277 172.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.2 mp -68.79 -34.9 76.32 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-O 117.13 -1.414 . . . . 0.0 112.678 174.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.38 -34.17 68.58 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 121.504 1.956 . . . . 0.0 110.511 169.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.3 m -72.72 -40.21 66.33 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.256 1.022 . . . . 0.0 113.736 170.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.1 mm -67.8 -37.38 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 120.983 1.719 . . . . 0.0 110.799 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.443 HG13 HG21 ' A' ' 36' ' ' VAL . 57.2 t -64.46 -45.58 95.36 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.376 0 C-N-CA 125.326 1.45 . . . . 0.0 110.241 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -51.97 -42.72 63.15 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 120.683 1.583 . . . . 0.0 112.345 171.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 56.5 m -62.05 -31.33 71.73 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.416 -0.803 . . . . 0.0 112.541 175.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -77.92 -37.08 48.58 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.877 1.271 . . . . 0.0 113.181 172.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.8 mt -67.42 -32.84 73.99 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.833 1.197 . . . . 0.0 111.916 176.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.8 mt -73.6 -36.93 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.585 1.154 . . . . 0.0 110.708 169.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.98 -39.17 55.02 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 125.689 1.614 . . . . 0.0 114.689 -172.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.0 t -151.48 -27.05 0.19 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.92 3.86 54.64 Favored Glycine 0 N--CA 1.479 1.54 0 N-CA-C 116.127 1.211 . . . . 0.0 116.127 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.6 m -142.26 132.9 25.38 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.756 1.622 . . . . 0.0 109.874 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.443 HG21 HG13 ' A' ' 26' ' ' VAL . 89.9 t -97.21 140.34 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.5 0.72 . . . . 0.0 109.423 170.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -127.11 156.68 41.35 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.76 1.224 . . . . 0.0 110.611 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -55.74 -36.89 67.76 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 121.303 -0.873 . . . . 0.0 112.557 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -67.55 -21.91 65.43 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.152 1.381 . . . . 0.0 113.73 177.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -78.44 -37.49 43.58 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.395 0.543 . . . . 0.0 111.863 171.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 18.9 mt -88.92 -30.29 18.95 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -172.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -55.89 -27.82 53.78 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -89.3 2.95 53.61 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.928 1.291 . . . . 0.0 114.382 176.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -121.6 -13.81 8.29 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.782 1.233 . . . . 0.0 113.446 -172.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -174.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 111.341 0.126 . . . . 0.0 111.341 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -130.97 120.95 24.27 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.121 1.768 . . . . 0.0 109.262 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.32 143.68 27.84 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.05 -1.032 . . . . 0.0 109.037 168.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.0 t -139.01 139.41 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.15 0.98 . . . . 0.0 110.774 -169.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 mm -114.02 134.03 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.541 1.536 . . . . 0.0 113.815 -169.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -133.67 70.96 1.45 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.232 1.813 . . . . 0.0 109.547 169.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.9 mt -88.08 128.93 51.91 Favored Pre-proline 0 N--CA 1.478 0.97 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.36 134.13 35.0 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.193 1.929 . . . . 0.0 111.287 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.92 3.3 85.68 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 118.533 -1.148 . . . . 0.0 115.962 176.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -137.49 162.9 52.29 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 119.539 1.669 . . . . 0.0 113.944 173.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -59.38 141.52 97.73 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.524 2.816 . . . . 0.0 114.454 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.59 130.18 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.182 0.993 . . . . 0.0 110.311 170.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.6 t -109.94 139.57 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.929 1.292 . . . . 0.0 109.275 172.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -134.41 112.72 11.19 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.838 1.255 . . . . 0.0 108.86 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.6 t -86.56 151.89 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.373 1.469 . . . . 0.0 110.947 -177.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.2 -96.91 1.38 Allowed Glycine 0 CA--C 1.531 1.059 0 O-C-N 121.608 -0.682 . . . . 0.0 112.025 175.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.1 m -150.0 157.41 43.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.52 1.128 . . . . 0.0 110.025 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -69.75 133.99 88.32 Favored Pre-proline 0 CA--C 1.546 0.796 0 O-C-N 120.791 -1.193 . . . . 0.0 110.654 169.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.63 156.01 31.68 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 124.194 3.263 . . . . 0.0 114.342 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.1 t -82.78 -26.32 31.93 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -175.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.02 -35.01 3.38 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 125.629 1.585 . . . . 0.0 113.055 -177.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -77.95 58.59 1.96 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.05 1.74 . . . . 0.0 111.404 169.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.1 m -131.5 159.93 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.549 1.54 . . . . 0.0 113.013 -172.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.1 mt -99.91 119.64 38.53 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 127.562 2.345 . . . . 0.0 110.335 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -106.09 108.3 19.74 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -170.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.55 145.54 17.79 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 169.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.1 ttt-85 -156.93 125.45 5.73 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 120.762 2.281 . . . . 0.0 113.967 -169.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.81 167.39 21.25 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.8 1.24 . . . . 0.0 114.044 -173.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 63.2 m -119.47 132.28 55.76 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.563 1.545 . . . . 0.0 108.15 174.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.59 -179.64 42.08 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 121.881 0.712 . . . . 0.0 114.634 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -86.99 -18.35 30.88 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -169.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -93.11 5.19 52.36 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.398 1.454 . . . . 0.0 112.163 169.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.89 16.12 49.46 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 126.661 2.077 . . . . 0.0 114.113 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.6 pm0 -76.98 178.24 7.11 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.955 1.702 . . . . 0.0 113.087 175.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.8 m -141.19 142.24 34.02 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.417 -1.427 . . . . 0.0 109.93 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 76.9 t -127.54 139.36 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.706 1.602 . . . . 0.0 109.721 -174.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.2 tp -129.1 148.22 51.03 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.154 1.382 . . . . 0.0 109.476 175.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.5 t -127.49 134.72 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.979 2.112 . . . . 0.0 107.414 175.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -135.78 137.21 41.4 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.2 0.6 . . . . 0.0 111.373 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -153.25 155.13 31.59 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 123.827 0.851 . . . . 0.0 112.796 174.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -58.85 134.72 62.14 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.795 2.33 . . . . 0.0 113.53 -176.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 . . . . . 0 C--O 1.253 1.27 0 C-N-CA 125.995 1.718 . . . . 0.0 112.265 176.492 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 . . . . . 0 N--CA 1.475 0.784 0 CA-C-O 120.733 0.301 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.64 -35.15 70.13 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.629 1.172 . . . . 0.0 113.007 -175.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.64 -21.4 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -70.56 -43.23 69.9 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 120.905 -1.122 . . . . 0.0 112.446 177.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.03 -42.08 76.85 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.446 -0.784 . . . . 0.0 111.599 -171.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -62.45 -32.97 73.93 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.719 1.208 . . . . 0.0 112.397 172.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.69 -39.17 80.67 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.6 -1.312 . . . . 0.0 112.412 172.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.74 -38.16 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 O-C-N 121.327 -0.858 . . . . 0.0 111.295 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -58.01 -46.76 84.74 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.39 -0.819 . . . . 0.0 111.195 171.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.1 mp -69.71 -33.59 72.73 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 117.387 -1.292 . . . . 0.0 113.057 175.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.34 -34.17 68.49 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 121.301 1.864 . . . . 0.0 110.455 169.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.2 m -73.56 -39.05 64.99 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.598 1.159 . . . . 0.0 113.535 171.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.7 mm -73.74 -34.2 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 120.724 1.602 . . . . 0.0 111.02 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.4 t -64.79 -48.86 82.73 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-O 117.544 -1.217 . . . . 0.0 109.411 172.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -53.49 -44.21 68.85 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 120.931 1.696 . . . . 0.0 112.177 171.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.8 m -58.74 -35.22 72.38 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.676 -0.64 . . . . 0.0 112.021 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -75.41 -37.05 60.68 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.483 1.513 . . . . 0.0 113.414 171.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.0 mt -66.21 -31.94 73.07 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 120.033 1.288 . . . . 0.0 111.966 175.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 93.1 mt -75.68 -39.45 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 124.685 1.194 . . . . 0.0 110.803 169.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.63 -38.08 61.56 Favored Glycine 0 C--N 1.34 0.775 0 C-N-CA 125.437 1.494 . . . . 0.0 114.114 -171.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.3 t -148.6 -29.69 0.28 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.3 12.18 31.85 Favored Glycine 0 N--CA 1.477 1.386 0 N-CA-C 116.425 1.33 . . . . 0.0 116.425 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.5 m -157.98 146.87 19.32 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.959 1.704 . . . . 0.0 109.611 171.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.4 p -119.34 142.17 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.635 1.574 . . . . 0.0 110.43 -175.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -133.02 157.44 45.22 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.3 1.04 . . . . 0.0 111.032 -169.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -54.98 -39.32 68.88 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -70.95 -19.73 62.53 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.526 1.131 . . . . 0.0 113.318 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -78.98 -43.44 24.43 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.162 0.892 . . . . 0.0 109.908 169.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.7 mt -79.87 -27.16 40.11 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -169.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -57.6 -24.21 55.12 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 170.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -84.14 -3.75 58.33 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.507 1.123 . . . . 0.0 113.882 173.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.2 mm-40 -115.97 -16.02 11.14 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.795 1.238 . . . . 0.0 113.167 -173.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt . . . . . 0 N--CA 1.472 0.666 0 CA-C-N 118.888 0.767 . . . . 0.0 110.937 173.469 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.471 0.62 0 CA-C-O 119.177 -0.44 . . . . 0.0 111.815 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -127.56 128.95 46.47 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.022 0.529 . . . . 0.0 111.932 -169.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -104.04 143.47 32.85 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.353 -0.842 . . . . 0.0 109.965 169.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.5 t -140.06 140.11 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.093 0.957 . . . . 0.0 110.625 -171.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 53' ' ' ILE . 0.7 OUTLIER -115.14 132.03 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.067 1.347 . . . . 0.0 113.63 -169.812 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.6 mmt85 -130.86 74.93 1.63 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.594 1.557 . . . . 0.0 109.673 171.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.5 mt -93.12 131.22 33.58 Favored Pre-proline 0 N--CA 1.479 1.003 0 O-C-N 121.396 -0.815 . . . . 0.0 108.856 172.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.46 136.7 44.08 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.231 1.954 . . . . 0.0 111.459 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.07 -0.13 83.68 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.746 1.165 . . . . 0.0 115.587 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -137.06 157.55 74.35 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 119.015 1.407 . . . . 0.0 112.218 173.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.2 153.02 62.28 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.848 2.366 . . . . 0.0 112.852 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.6 p -55.95 136.95 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.672 1.189 . . . . 0.0 111.935 172.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 99.2 t -115.8 141.13 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.888 1.675 . . . . 0.0 108.082 169.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -139.93 123.13 16.89 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.442 1.097 . . . . 0.0 110.646 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.7 t -95.97 154.97 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 126.596 1.959 . . . . 0.0 111.149 -172.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.36 -95.11 1.3 Allowed Glycine 0 CA--C 1.532 1.115 0 O-C-N 121.327 -0.858 . . . . 0.0 112.485 174.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 60.5 m -152.36 149.84 29.06 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.478 1.111 . . . . 0.0 110.057 174.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -69.38 125.28 91.86 Favored Pre-proline 0 CA--C 1.546 0.822 0 O-C-N 120.636 -1.29 . . . . 0.0 111.262 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.415 ' HB2' HG11 ' A' ' 71' ' ' VAL . 61.1 Cg_endo -77.37 153.74 31.36 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.969 3.112 . . . . 0.0 114.623 -175.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 t -83.14 -31.08 27.39 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -169.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.26 -33.77 2.73 Favored Glycine 0 N--CA 1.478 1.466 0 C-N-CA 125.193 1.377 . . . . 0.0 112.978 -174.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -78.09 57.51 1.82 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.97 1.708 . . . . 0.0 110.511 169.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.415 HG11 ' HB2' ' A' ' 67' ' ' PRO . 35.8 m -137.4 154.43 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.274 1.83 . . . . 0.0 111.526 -172.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.7 mt -87.98 140.19 29.75 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 127.097 2.159 . . . . 0.0 109.187 173.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -121.36 112.58 18.75 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.424 0.556 . . . . 0.0 111.785 -176.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.6 143.14 16.41 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 169.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -151.66 131.46 13.25 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.646 1.723 . . . . 0.0 112.339 -170.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -143.58 168.18 20.48 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.729 1.211 . . . . 0.0 113.655 -174.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.7 m -120.03 131.85 55.27 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.422 1.489 . . . . 0.0 108.882 176.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.56 173.2 32.21 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.616 1.103 . . . . 0.0 114.688 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -81.43 -12.59 58.88 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -169.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -95.81 5.11 52.11 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 120.76 1.618 . . . . 0.0 111.58 169.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.36 17.32 40.05 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 126.766 2.127 . . . . 0.0 114.213 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.6 pm0 -82.93 175.26 10.2 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.911 1.684 . . . . 0.0 113.869 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.5 m -128.26 138.38 52.4 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.084 1.353 . . . . 0.0 109.956 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.2 t -120.98 141.13 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.365 1.466 . . . . 0.0 110.355 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.0 tp -128.56 147.18 50.69 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.219 1.407 . . . . 0.0 109.812 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.4 t -131.59 137.39 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.339 1.456 . . . . 0.0 108.426 173.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -130.22 127.39 39.52 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.989 0.9 . . . . 0.0 111.76 -176.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -125.35 143.77 45.6 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.44 1.896 . . . . 0.0 110.694 -173.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -61.22 132.55 41.96 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.426 2.084 . . . . 0.0 111.609 174.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 . . . . . 0 C--O 1.254 1.314 0 C-N-CA 124.688 1.195 . . . . 0.0 112.522 -178.539 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -57.33 -37.0 71.85 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.714 -0.616 . . . . 0.0 112.455 -173.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.2 m -68.48 -24.06 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.817 1.247 . . . . 0.0 112.968 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.17 -43.93 73.23 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.336 0.971 . . . . 0.0 112.115 177.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.26 -39.9 71.31 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.516 -0.74 . . . . 0.0 111.294 -169.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -69.84 -31.14 68.84 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.709 1.203 . . . . 0.0 112.686 173.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.95 -38.98 83.46 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.908 -1.12 . . . . 0.0 112.18 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.0 t -67.15 -39.42 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 O-C-N 121.29 -0.881 . . . . 0.0 111.414 172.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -57.24 -44.87 84.23 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.589 -0.694 . . . . 0.0 111.023 171.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -71.38 -36.24 71.36 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 116.176 -1.869 . . . . 0.0 113.257 175.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.3 -39.76 67.28 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 121.976 2.171 . . . . 0.0 109.8 169.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.0 m -64.83 -40.36 95.06 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 118.051 -0.976 . . . . 0.0 113.334 173.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.8 mm -75.49 -28.63 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 120.584 1.538 . . . . 0.0 111.552 178.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.3 t -65.14 -49.21 80.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 O-C-N 120.926 -1.109 . . . . 0.0 108.978 170.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -56.77 -42.28 79.13 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 120.444 1.475 . . . . 0.0 113.191 174.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.0 p -64.94 -23.42 67.22 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.998 0.817 . . . . 0.0 112.29 177.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -83.79 -35.15 24.52 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.471 1.908 . . . . 0.0 113.411 169.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.5 mt -64.38 -38.68 91.89 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 120.527 1.512 . . . . 0.0 111.386 172.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 89.3 mt -72.42 -35.58 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 124.491 1.117 . . . . 0.0 110.891 170.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.5 -38.48 51.92 Favored Glycine 0 C--N 1.34 0.75 0 C-N-CA 125.657 1.599 . . . . 0.0 114.473 -171.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.0 t -152.18 -26.87 0.17 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 177.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.35 6.59 33.46 Favored Glycine 0 N--CA 1.477 1.381 0 N-CA-C 116.954 1.542 . . . . 0.0 116.954 173.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 t -161.07 150.0 16.46 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.546 1.538 . . . . 0.0 109.881 170.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -115.9 147.15 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 126.046 1.738 . . . . 0.0 110.826 -178.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -126.27 159.02 34.22 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.498 1.519 . . . . 0.0 110.352 -173.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -54.75 -38.48 67.24 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.862 -0.524 . . . . 0.0 112.413 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -69.36 -21.72 63.79 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -79.91 -31.92 40.16 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.769 0.713 . . . . 0.0 111.756 172.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 89.4 mt -86.54 -33.91 20.13 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.988 1.315 . . . . 0.0 114.19 -174.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -58.55 -20.88 50.33 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 175.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -80.38 -14.97 57.89 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 175.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -100.84 -44.36 5.8 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.921 0.888 . . . . 0.0 112.674 -169.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt . . . . . 0 N--CA 1.487 1.406 0 N-CA-C 117.832 2.53 . . . . 0.0 117.832 174.996 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.468 0.461 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -131.77 127.43 36.7 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.786 0.434 . . . . 0.0 111.17 -170.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -104.69 145.67 30.02 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.368 0.985 . . . . 0.0 109.675 169.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.2 t -139.99 141.4 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.331 1.052 . . . . 0.0 110.738 -170.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 mm -111.42 126.38 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.614 1.566 . . . . 0.0 112.669 -172.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -125.94 63.3 1.23 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.518 1.927 . . . . 0.0 109.703 170.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.9 mt -79.74 126.83 79.55 Favored Pre-proline 0 N--CA 1.481 1.084 0 CA-C-O 118.34 -0.838 . . . . 0.0 108.989 169.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -58.38 139.43 90.56 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.947 2.431 . . . . 0.0 113.082 173.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.78 0.0 87.22 Favored Glycine 0 CA--C 1.537 1.409 0 N-CA-C 116.042 1.177 . . . . 0.0 116.042 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -138.13 158.71 70.56 Favored Pre-proline 0 CA--C 1.549 0.935 0 CA-C-N 119.23 1.515 . . . . 0.0 112.685 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.98 149.85 59.83 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.846 2.364 . . . . 0.0 113.481 -174.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 81.3 t -64.09 130.82 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.5 1.52 . . . . 0.0 111.172 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.5 t -106.09 142.43 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.569 1.548 . . . . 0.0 108.202 170.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -135.57 113.97 11.59 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.797 1.239 . . . . 0.0 109.208 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.0 t -84.22 151.63 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.715 1.606 . . . . 0.0 110.975 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.51 -99.23 1.2 Allowed Glycine 0 CA--C 1.534 1.232 0 O-C-N 121.321 -0.862 . . . . 0.0 112.985 175.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -148.74 158.12 43.92 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.73 1.212 . . . . 0.0 109.979 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -71.27 130.28 88.03 Favored Pre-proline 0 CA--C 1.549 0.938 0 O-C-N 120.627 -1.295 . . . . 0.0 110.636 170.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.9 157.07 34.87 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.272 3.315 . . . . 0.0 114.103 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.7 t -83.63 -32.25 25.79 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -171.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.96 -33.19 2.64 Favored Glycine 0 N--CA 1.476 1.336 0 C-N-CA 125.41 1.481 . . . . 0.0 113.261 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -78.3 58.99 2.21 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.096 1.758 . . . . 0.0 111.229 169.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.0 m -136.94 155.23 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.372 1.469 . . . . 0.0 112.706 -171.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.8 mt -91.7 138.88 31.2 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 128.284 2.633 . . . . 0.0 109.546 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -121.62 103.8 9.17 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.787 0.721 . . . . 0.0 111.877 -175.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -83.75 150.97 27.21 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 169.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.8 ttt-85 -148.88 153.84 38.61 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 118.845 1.322 . . . . 0.0 111.478 -172.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -161.76 167.26 25.28 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.554 1.142 . . . . 0.0 112.922 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 97.2 m -131.51 110.98 11.37 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.507 1.523 . . . . 0.0 109.572 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.45 163.27 54.39 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.162 0.887 . . . . 0.0 114.88 -177.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -68.35 -8.22 38.11 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.632 1.973 . . . . 0.0 115.34 -174.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -102.9 4.05 37.17 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.258 1.39 . . . . 0.0 113.084 169.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.68 20.79 15.91 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.902 1.239 . . . . 0.0 114.484 172.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.64 -170.54 3.06 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.912 1.285 . . . . 0.0 113.874 -177.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.0 m -147.24 123.21 10.71 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 120.705 -1.247 . . . . 0.0 111.883 172.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.7 t -94.27 146.03 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.448 1.499 . . . . 0.0 110.866 171.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.6 tp -130.18 145.27 51.71 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.689 1.596 . . . . 0.0 108.364 169.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.16 139.4 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.179 1.392 . . . . 0.0 108.576 171.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -132.18 129.37 39.67 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.914 0.886 . . . . 0.0 111.014 -175.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -131.8 140.26 37.69 Favored Pre-proline 0 N--CA 1.473 0.677 0 C-N-CA 126.138 1.775 . . . . 0.0 111.042 -170.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -62.17 136.53 60.92 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.176 1.917 . . . . 0.0 112.099 174.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 . . . . . 0 C--O 1.253 1.252 0 C-N-CA 124.458 1.103 . . . . 0.0 111.8 173.225 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 . . . . . 0 N--CA 1.469 0.516 0 CA-C-O 119.753 -0.165 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.403 HH21 ' CD ' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -58.86 -39.95 82.84 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 118.383 -0.818 . . . . 0.0 111.751 -178.026 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.5 t -56.65 -31.61 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.201 1.4 . . . . 0.0 112.512 174.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -77.26 -33.67 55.91 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 176.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.4 mp -74.11 -38.92 63.7 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 120.929 -1.107 . . . . 0.0 111.24 -178.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.403 ' CD ' HH21 ' A' ' 14' ' ' ARG . 6.7 pt-20 -65.21 -27.25 68.55 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 170.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.39 -36.68 83.47 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 120.69 -1.256 . . . . 0.0 112.308 169.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.1 t -70.81 -36.28 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 124.445 1.098 . . . . 0.0 111.342 172.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -60.49 -45.0 95.36 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.112 -0.992 . . . . 0.0 111.449 171.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.1 mp -70.28 -33.38 71.5 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-O 117.147 -1.406 . . . . 0.0 112.494 174.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.29 -33.93 69.99 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 121.475 1.943 . . . . 0.0 110.805 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.7 m -72.05 -38.88 69.42 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.101 0.96 . . . . 0.0 113.236 171.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.0 mm -73.82 -34.85 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 120.721 1.6 . . . . 0.0 110.933 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.1 t -62.67 -48.2 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 117.452 -1.261 . . . . 0.0 110.033 172.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -54.1 -42.36 69.31 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 120.994 1.725 . . . . 0.0 112.173 171.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.2 m -60.28 -33.04 71.77 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.702 -0.624 . . . . 0.0 112.142 175.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -76.71 -37.22 56.45 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.065 1.346 . . . . 0.0 113.31 171.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.1 mt -65.06 -31.19 72.29 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.674 1.125 . . . . 0.0 112.133 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 89.7 mt -76.52 -36.78 28.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 125.156 1.382 . . . . 0.0 111.248 169.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.18 -39.43 31.92 Favored Glycine 0 N--CA 1.469 0.845 0 C-N-CA 126.08 1.8 . . . . 0.0 115.547 -171.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.9 t -151.08 -23.95 0.21 Allowed 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.0 6.04 54.34 Favored Glycine 0 N--CA 1.468 0.828 0 N-CA-C 117.271 1.668 . . . . 0.0 117.271 169.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.0 m -158.5 149.88 20.91 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.418 1.487 . . . . 0.0 110.343 170.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 p -103.51 145.11 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.448 1.099 . . . . 0.0 113.0 -173.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -116.6 152.9 33.23 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.675 1.59 . . . . 0.0 110.792 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -57.4 -35.67 70.33 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.888 -1.133 . . . . 0.0 111.885 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -70.42 -19.18 63.01 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.93 1.292 . . . . 0.0 112.738 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -83.62 -32.95 25.43 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.904 0.775 . . . . 0.0 112.179 169.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.3 mt -86.63 -34.65 19.76 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.451 1.5 . . . . 0.0 114.005 -172.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -60.48 -20.51 60.26 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -84.82 -3.41 58.63 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.23 1.412 . . . . 0.0 113.591 175.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -114.35 -26.49 7.96 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.942 1.297 . . . . 0.0 113.202 -172.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt . . . . . 0 N--CA 1.472 0.666 0 C-N-CA 124.017 0.927 . . . . 0.0 112.829 -178.265 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 111.143 0.053 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -133.83 129.88 37.14 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.246 1.419 . . . . 0.0 110.932 -175.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.12 136.17 47.42 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 120.195 1.361 . . . . 0.0 109.302 168.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.3 t -126.45 143.08 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.054 1.341 . . . . 0.0 110.767 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.471 ' HB ' ' H ' ' A' ' 61' ' ' VAL . 20.3 mm -120.57 134.07 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.542 1.537 . . . . 0.0 113.418 -169.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -113.53 3.49 15.76 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 116.277 1.955 . . . . 0.0 116.277 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.6 mt -40.04 124.72 1.64 Allowed Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 125.739 1.616 . . . . 0.0 113.544 -172.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -60.7 140.64 91.92 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.147 2.564 . . . . 0.0 113.742 173.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.0 -1.38 86.85 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.811 1.196 . . . . 0.0 115.476 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -131.49 160.84 65.49 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 125.001 1.32 . . . . 0.0 111.298 172.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -62.26 161.89 25.38 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.461 2.107 . . . . 0.0 112.145 176.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.1 t -72.11 142.9 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 169.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.471 ' H ' ' HB ' ' A' ' 53' ' ' ILE . 87.6 t -113.94 138.52 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 169.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -124.51 118.55 26.86 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.036 1.334 . . . . 0.0 108.708 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.3 t -94.22 154.34 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.043 1.337 . . . . 0.0 110.811 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.36 -109.14 2.7 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.0 t -154.69 162.14 41.25 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.736 0.768 . . . . 0.0 111.332 169.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.5 tttp -61.63 141.86 94.67 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.74 1.216 . . . . 0.0 111.565 -176.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -65.36 -167.48 0.1 Allowed 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 124.342 3.361 . . . . 0.0 115.89 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 t -119.61 -24.58 6.2 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 117.571 2.434 . . . . 0.0 117.571 -169.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.57 -10.04 21.76 Favored Glycine 0 N--CA 1.484 1.862 0 CA-C-N 119.472 1.033 . . . . 0.0 114.556 -173.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -134.45 83.8 2.06 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.829 2.452 . . . . 0.0 110.278 170.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.3 m -139.54 147.15 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.896 1.278 . . . . 0.0 111.621 -176.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.5 mt -72.33 148.95 44.86 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.05 1.34 . . . . 0.0 107.55 169.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -133.15 113.7 13.02 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.588 0.755 . . . . 0.0 109.201 -178.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -99.42 147.82 18.48 Favored Glycine 0 N--CA 1.468 0.788 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 169.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 74.2 ttt-85 -150.05 146.51 27.0 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 118.466 1.133 . . . . 0.0 112.84 -169.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.53 155.59 33.67 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.793 0.837 . . . . 0.0 112.955 -178.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.1 m -113.72 129.9 56.51 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.276 1.43 . . . . 0.0 109.475 169.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.03 -160.51 36.12 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 124.182 0.896 . . . . 0.0 115.055 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -99.51 -15.15 18.77 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -169.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -91.57 -1.82 57.36 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 120.338 1.426 . . . . 0.0 111.998 168.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.01 20.07 26.97 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 126.303 1.906 . . . . 0.0 113.651 -174.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.0 pm0 -80.66 163.5 23.55 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.841 1.656 . . . . 0.0 113.988 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.9 m -128.51 140.37 51.84 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.125 0.97 . . . . 0.0 110.507 173.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.8 t -131.79 143.2 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.157 1.783 . . . . 0.0 109.363 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.3 tp -130.15 147.58 51.9 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.46 1.504 . . . . 0.0 111.569 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 76.2 t -122.44 138.34 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 126.887 2.075 . . . . 0.0 108.401 171.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -137.06 134.51 36.6 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.741 0.701 . . . . 0.0 112.652 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.0 152.27 33.72 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 176.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -58.27 128.02 27.02 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.548 2.832 . . . . 0.0 113.431 -175.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 125.156 1.382 . . . . 0.0 112.131 179.396 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 . . . . . 0 CA--C 1.541 0.605 0 CA-C-O 119.695 -0.193 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.4 HH21 ' CD ' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -58.39 -36.1 73.04 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 118.365 -0.826 . . . . 0.0 112.042 176.744 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.8 t -57.25 -28.47 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.911 1.684 . . . . 0.0 113.408 171.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -76.85 -38.51 53.6 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.181 -0.949 . . . . 0.0 112.278 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.5 mp -70.6 -36.75 73.71 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.324 -0.86 . . . . 0.0 111.349 -174.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.4 ' CD ' HH21 ' A' ' 14' ' ' ARG . 8.3 pt-20 -67.08 -32.07 72.99 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.7 0.8 . . . . 0.0 112.581 170.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.06 -40.74 87.14 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.637 -1.289 . . . . 0.0 112.125 171.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.5 t -63.45 -43.55 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.822 0.849 . . . . 0.0 110.932 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -57.27 -41.13 79.1 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.741 -0.599 . . . . 0.0 111.51 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 mp -67.63 -34.84 77.76 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 117.315 -1.326 . . . . 0.0 113.326 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.74 -33.92 67.03 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 120.991 1.723 . . . . 0.0 111.249 169.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 m -73.92 -37.56 64.58 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 170.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.3 mm -69.58 -36.57 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 120.618 1.554 . . . . 0.0 110.4 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.13 -46.93 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.915 1.286 . . . . 0.0 109.624 176.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -52.89 -43.63 66.32 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 120.62 1.555 . . . . 0.0 111.963 170.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.9 m -59.96 -32.41 70.79 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.791 0.436 . . . . 0.0 111.986 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -79.07 -36.62 40.59 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.594 1.558 . . . . 0.0 113.712 172.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.0 mt -66.34 -34.26 77.57 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 120.195 1.361 . . . . 0.0 111.43 175.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.3 mt -73.06 -36.74 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.386 1.074 . . . . 0.0 110.491 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.75 -38.81 60.75 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 125.695 1.617 . . . . 0.0 114.428 -173.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.5 t -152.24 -26.52 0.17 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 178.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.51 3.35 53.24 Favored Glycine 0 N--CA 1.481 1.694 0 N-CA-C 116.156 1.223 . . . . 0.0 116.156 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.5 m -143.66 135.3 26.25 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.214 1.806 . . . . 0.0 108.974 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 p -107.01 145.5 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.668 0.787 . . . . 0.0 109.634 172.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -133.59 156.91 46.98 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.666 1.186 . . . . 0.0 110.187 -175.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -56.3 -37.58 70.08 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.804 -0.56 . . . . 0.0 111.907 -177.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -70.03 -22.06 63.13 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -77.6 -37.89 49.38 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.497 0.59 . . . . 0.0 111.738 170.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 60.6 mt -87.71 -27.05 22.63 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 -173.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -56.49 -27.74 57.94 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 175.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -90.5 4.34 51.41 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.623 1.169 . . . . 0.0 114.12 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -123.09 -10.57 8.12 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 119.814 1.188 . . . . 0.0 113.943 -170.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.829 0 C-N-CA 125.274 1.429 . . . . 0.0 114.547 -175.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 119.974 -0.06 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -131.74 116.93 17.92 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.733 1.613 . . . . 0.0 109.457 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.15 145.08 25.66 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.012 -1.055 . . . . 0.0 108.69 168.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.2 t -139.89 134.76 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 120.682 -1.261 . . . . 0.0 110.931 -169.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mm -116.07 139.16 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.087 1.355 . . . . 0.0 114.641 -170.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -144.87 73.3 1.36 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.076 1.75 . . . . 0.0 109.628 169.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.0 mt -83.35 121.76 76.91 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-N 114.386 -1.279 . . . . 0.0 107.682 169.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.22 132.68 50.48 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.073 1.849 . . . . 0.0 112.214 174.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.05 0.18 83.41 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.869 1.223 . . . . 0.0 116.016 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -139.87 165.57 30.01 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 119.79 1.795 . . . . 0.0 113.872 173.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -60.74 140.95 93.48 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.609 2.873 . . . . 0.0 115.644 -173.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.6 t -69.98 116.03 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.509 1.124 . . . . 0.0 108.946 169.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.87 143.98 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.195 1.398 . . . . 0.0 109.765 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -139.16 110.91 7.16 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.792 1.237 . . . . 0.0 108.881 -170.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.1 t -80.93 153.8 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.745 1.618 . . . . 0.0 111.466 -172.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.42 -87.54 1.12 Allowed Glycine 0 CA--C 1.533 1.157 0 O-C-N 121.487 -0.758 . . . . 0.0 113.263 172.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.1 m -157.68 160.76 38.31 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.014 1.326 . . . . 0.0 109.889 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.8 tptt -73.94 131.9 80.82 Favored Pre-proline 0 CA--C 1.548 0.879 0 O-C-N 120.778 -1.201 . . . . 0.0 110.581 171.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.65 156.49 40.13 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 124.223 3.282 . . . . 0.0 114.349 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.6 t -83.91 -33.24 24.77 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -173.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.62 -40.82 1.45 Allowed Glycine 0 N--CA 1.474 1.209 0 C-N-CA 124.983 1.278 . . . . 0.0 113.472 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -78.44 58.8 2.24 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.527 1.531 . . . . 0.0 111.767 171.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.8 m -127.13 156.76 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.244 1.418 . . . . 0.0 113.298 -173.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.0 mt -97.25 112.94 24.52 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 127.761 2.424 . . . . 0.0 110.789 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -98.45 100.57 11.84 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.172 0.989 . . . . 0.0 113.034 -171.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -85.68 152.83 26.62 Favored Glycine 0 N--CA 1.473 1.134 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 169.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -149.66 154.77 39.13 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.544 1.672 . . . . 0.0 112.211 -169.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -163.35 167.94 21.1 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.298 1.039 . . . . 0.0 113.372 176.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 62.3 m -124.75 132.93 53.32 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.121 1.768 . . . . 0.0 107.814 171.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.84 -179.31 38.96 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 123.52 0.581 . . . . 0.0 114.432 -178.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -88.51 -10.02 50.41 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -169.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -99.73 7.09 45.37 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.791 1.632 . . . . 0.0 111.138 169.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.43 18.04 40.22 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 127.033 2.254 . . . . 0.0 114.099 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.9 pm0 -79.14 176.05 10.03 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.525 1.53 . . . . 0.0 113.584 178.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.6 m -136.48 139.53 42.39 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.491 1.116 . . . . 0.0 109.534 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.4 t -129.68 143.42 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.539 1.536 . . . . 0.0 110.541 -174.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.0 tp -134.25 150.42 51.02 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.564 1.546 . . . . 0.0 109.136 173.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 37.7 t -126.42 138.39 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 126.194 1.798 . . . . 0.0 108.574 171.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -135.98 138.69 42.53 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.487 0.715 . . . . 0.0 111.438 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -154.5 156.62 31.79 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.289 1.436 . . . . 0.0 112.521 173.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -59.13 138.64 86.34 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.415 2.076 . . . . 0.0 113.828 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 . . . . . 0 C--O 1.255 1.344 0 C-N-CA 125.801 1.64 . . . . 0.0 112.19 172.87 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 . . . . . 0 CA--C 1.543 0.692 0 CA-C-O 120.303 0.097 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -35.0 77.11 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 118.38 -0.819 . . . . 0.0 113.006 -175.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.0 m -63.99 -19.82 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 174.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.96 -44.82 68.71 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.672 1.124 . . . . 0.0 112.326 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -69.52 -41.33 76.16 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.278 -0.889 . . . . 0.0 111.491 -171.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -64.64 -33.6 76.31 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.65 1.18 . . . . 0.0 112.635 171.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.52 -37.76 85.73 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.736 -1.228 . . . . 0.0 112.384 172.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.0 t -68.85 -37.64 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 124.023 0.929 . . . . 0.0 111.37 172.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -59.4 -43.9 92.91 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.175 -0.953 . . . . 0.0 111.744 170.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.7 mp -68.98 -34.95 76.15 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 120.382 1.446 . . . . 0.0 112.806 173.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.26 -34.43 68.63 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 121.158 1.799 . . . . 0.0 110.584 169.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.5 m -71.52 -40.16 70.28 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.084 0.954 . . . . 0.0 113.177 172.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.8 mm -72.04 -35.48 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 120.69 1.587 . . . . 0.0 111.108 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.21 -45.69 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.696 1.198 . . . . 0.0 109.547 174.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -53.75 -43.11 68.88 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 120.78 1.627 . . . . 0.0 112.12 171.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.6 t -59.15 -39.55 82.79 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.964 -0.46 . . . . 0.0 111.826 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -68.55 -38.34 80.7 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.666 1.186 . . . . 0.0 113.088 171.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.0 mt -67.72 -38.46 83.61 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.747 1.158 . . . . 0.0 112.084 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.09 -37.36 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.49 1.116 . . . . 0.0 111.348 172.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.39 -64.19 3.08 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 124.837 1.208 . . . . 0.0 111.083 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.1 t -126.81 -27.6 3.05 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -174.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.48 3.05 53.51 Favored Glycine 0 N--CA 1.475 1.267 0 N-CA-C 116.81 1.484 . . . . 0.0 116.81 172.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.4 m -146.73 136.94 23.6 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.633 1.573 . . . . 0.0 109.713 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 p -104.76 146.69 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.505 1.122 . . . . 0.0 110.688 176.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -133.65 159.18 41.28 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.877 1.271 . . . . 0.0 110.352 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -55.79 -38.58 70.11 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -71.04 -17.18 62.63 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -80.62 -32.14 36.37 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.349 0.977 . . . . 0.0 112.041 170.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.3 mt -90.98 -30.45 16.82 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.237 1.415 . . . . 0.0 114.489 -172.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.9 ptt85 -59.0 -23.93 62.32 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 119.398 0.999 . . . . 0.0 113.491 174.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -82.02 -6.95 59.55 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 175.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -113.4 -20.11 11.45 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -169.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 N--CA 1.467 0.414 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -172.851 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -133.63 123.14 24.52 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.582 1.553 . . . . 0.0 109.193 -176.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.4 138.57 35.44 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.229 0.922 . . . . 0.0 109.166 169.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.8 t -132.89 140.36 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.033 1.333 . . . . 0.0 109.692 -173.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.24 131.9 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -169.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -128.77 78.43 1.85 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.5 1.92 . . . . 0.0 109.848 170.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.8 mt -96.9 125.59 45.8 Favored Pre-proline 0 N--CA 1.481 1.104 0 O-C-N 121.128 -0.982 . . . . 0.0 109.047 170.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.91 134.86 62.91 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.549 2.166 . . . . 0.0 112.484 172.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.9 0.31 85.81 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 124.711 1.148 . . . . 0.0 115.942 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -139.74 156.39 70.98 Favored Pre-proline 0 N--CA 1.476 0.827 0 CA-C-N 119.407 1.604 . . . . 0.0 112.506 174.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -69.75 149.79 67.39 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.699 2.266 . . . . 0.0 112.983 -173.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.0 t -57.02 132.8 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.934 1.294 . . . . 0.0 110.783 175.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.1 t -111.74 141.92 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.154 1.382 . . . . 0.0 109.41 170.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -136.5 117.77 14.57 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.132 1.373 . . . . 0.0 109.223 176.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.8 t -91.94 159.55 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.02 1.728 . . . . 0.0 111.156 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.41 -104.64 1.62 Allowed Glycine 0 CA--C 1.531 1.067 0 O-C-N 120.959 -1.088 . . . . 0.0 112.026 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.5 t -154.74 160.58 41.42 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.553 0.692 . . . . 0.0 111.516 169.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -74.16 125.94 89.6 Favored Pre-proline 0 CA--C 1.546 0.807 0 O-C-N 120.698 -1.251 . . . . 0.0 111.703 -170.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.402 ' HB2' HG11 ' A' ' 71' ' ' VAL . 71.1 Cg_endo -76.65 154.19 34.7 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.834 3.023 . . . . 0.0 114.728 -177.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.1 t -84.4 -30.13 25.62 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -171.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.29 -35.38 2.44 Favored Glycine 0 N--CA 1.479 1.534 0 C-N-CA 124.738 1.161 . . . . 0.0 113.816 -175.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -78.18 58.64 2.08 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.922 1.689 . . . . 0.0 110.816 169.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.402 HG11 ' HB2' ' A' ' 67' ' ' PRO . 33.6 m -138.95 155.33 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 125.946 1.698 . . . . 0.0 111.863 -171.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.1 mt -74.44 164.79 26.18 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.881 1.672 . . . . 0.0 109.873 169.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -149.32 93.14 2.03 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.729 0.812 . . . . 0.0 110.223 -173.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -85.58 148.56 22.88 Favored Glycine 0 N--CA 1.471 1.007 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 169.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -151.44 150.14 30.08 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.636 1.718 . . . . 0.0 113.207 -169.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -157.51 157.18 33.34 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.316 1.046 . . . . 0.0 113.638 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 85.5 m -109.52 125.86 52.93 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.107 1.363 . . . . 0.0 107.871 169.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.18 173.42 42.74 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 122.385 0.991 . . . . 0.0 114.807 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -80.47 -8.03 59.39 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 -169.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -103.39 6.38 37.72 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.935 1.698 . . . . 0.0 111.648 168.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.1 18.71 30.7 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.264 1.887 . . . . 0.0 114.273 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.7 pm0 -85.28 176.18 8.48 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.613 1.565 . . . . 0.0 113.759 177.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.8 m -132.59 134.18 44.59 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.124 1.37 . . . . 0.0 110.444 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.7 t -118.89 144.28 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.066 1.746 . . . . 0.0 110.115 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.6 tp -133.6 143.75 48.83 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.469 1.108 . . . . 0.0 110.557 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.7 t -114.76 135.66 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 127.797 2.439 . . . . 0.0 108.207 171.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -136.71 144.18 43.76 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.839 0.828 . . . . 0.0 111.145 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.2 152.45 20.18 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 176.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -58.11 142.36 96.97 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.678 2.919 . . . . 0.0 114.316 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 . . . . . 0 C--O 1.253 1.284 0 C-N-CA 125.715 1.606 . . . . 0.0 112.68 172.47 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 . . . . . 0 N--CA 1.475 0.817 0 CA-C-O 120.813 0.339 . . . . 0.0 111.737 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -31.47 71.49 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 121.008 -1.057 . . . . 0.0 113.795 -174.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.2 m -65.79 -21.4 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 172.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -69.97 -43.03 72.34 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 120.905 -1.122 . . . . 0.0 112.5 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.26 -40.82 77.6 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.387 -0.821 . . . . 0.0 111.523 -171.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.4 -30.23 70.56 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.538 1.135 . . . . 0.0 112.62 173.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.43 -37.64 80.45 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.881 -1.137 . . . . 0.0 111.918 171.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.0 t -68.71 -37.0 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 O-C-N 121.43 -0.794 . . . . 0.0 111.302 172.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -59.36 -46.48 88.51 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.2 -0.937 . . . . 0.0 111.602 171.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -69.18 -34.14 74.47 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 117.398 -1.287 . . . . 0.0 112.844 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.16 -34.08 68.07 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 121.079 1.763 . . . . 0.0 110.578 169.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.9 m -73.0 -38.46 66.61 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.552 1.141 . . . . 0.0 113.642 171.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.6 mm -70.89 -37.04 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 120.701 1.591 . . . . 0.0 110.814 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.3 t -66.42 -48.31 81.17 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 C-N-CA 124.792 1.237 . . . . 0.0 109.609 175.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -53.61 -43.06 68.35 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 120.593 1.542 . . . . 0.0 112.154 171.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.2 m -59.64 -32.47 70.47 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.807 -0.558 . . . . 0.0 112.107 176.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -79.72 -36.39 37.49 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.634 1.574 . . . . 0.0 113.555 172.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 78.5 mt -65.62 -33.22 75.38 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 120.063 1.301 . . . . 0.0 111.707 174.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.32 -37.57 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.312 1.045 . . . . 0.0 110.894 169.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.39 -37.53 62.75 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 125.637 1.589 . . . . 0.0 114.272 -172.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.3 t -151.46 -27.45 0.19 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 177.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.15 8.69 33.3 Favored Glycine 0 N--CA 1.477 1.411 0 N-CA-C 116.703 1.441 . . . . 0.0 116.703 175.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.7 p -158.82 136.94 10.58 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.517 1.527 . . . . 0.0 109.985 176.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.45 145.95 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.272 1.029 . . . . 0.0 110.327 176.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -127.56 159.41 34.71 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.598 1.559 . . . . 0.0 109.666 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -53.44 -38.95 64.02 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -175.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -70.24 -15.96 62.98 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -89.27 -3.71 58.42 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.785 0.834 . . . . 0.0 112.494 170.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.1 mt -116.19 -33.88 4.86 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.022 1.329 . . . . 0.0 113.634 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.3 ptt85 -64.42 -21.66 66.71 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 119.66 1.118 . . . . 0.0 113.471 178.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -89.02 2.8 53.47 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.209 1.404 . . . . 0.0 113.984 171.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -121.33 -13.38 8.47 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.357 1.463 . . . . 0.0 112.742 -174.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 N--CA 1.472 0.629 0 CA-C-N 118.715 0.689 . . . . 0.0 110.938 171.319 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -136.45 144.89 44.66 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.177 1.391 . . . . 0.0 112.246 -173.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -120.58 149.45 42.43 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.907 0.883 . . . . 0.0 110.87 169.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.9 t -141.16 140.77 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 120.838 -1.163 . . . . 0.0 110.582 -173.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -113.97 136.17 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -170.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -138.72 74.54 1.48 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.218 1.807 . . . . 0.0 109.469 175.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.8 mt -91.69 126.44 53.95 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-N 114.392 -1.277 . . . . 0.0 109.331 171.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -57.87 137.15 79.58 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.027 2.485 . . . . 0.0 112.932 173.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.61 -1.1 88.32 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.604 1.097 . . . . 0.0 115.413 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -136.25 158.27 73.93 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 119.009 1.404 . . . . 0.0 112.164 175.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.46 152.42 60.27 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.72 2.28 . . . . 0.0 112.774 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.1 p -62.44 135.89 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.693 1.197 . . . . 0.0 111.822 171.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.1 p -122.24 147.17 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.818 1.247 . . . . 0.0 110.752 169.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -127.07 124.34 39.04 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.313 1.445 . . . . 0.0 109.727 -173.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.2 t -103.8 149.1 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 127.81 2.444 . . . . 0.0 109.792 -169.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.96 -94.53 1.0 Allowed Glycine 0 CA--C 1.532 1.114 0 O-C-N 120.727 -1.233 . . . . 0.0 111.678 -175.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 m -155.4 157.64 37.37 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.551 1.14 . . . . 0.0 109.879 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -71.51 128.48 89.88 Favored Pre-proline 0 CA--C 1.55 0.943 0 O-C-N 120.569 -1.332 . . . . 0.0 112.19 177.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -77.94 155.53 30.3 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 124.397 3.398 . . . . 0.0 114.736 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.0 t -84.45 -20.3 31.98 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -170.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.21 -31.6 5.76 Favored Glycine 0 N--CA 1.478 1.458 0 C-N-CA 125.782 1.658 . . . . 0.0 113.413 -176.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -78.46 60.1 2.54 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.033 1.733 . . . . 0.0 110.365 169.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.57 154.08 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 126.19 1.796 . . . . 0.0 111.502 -170.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 25.0 mt -86.93 138.23 31.71 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.946 2.098 . . . . 0.0 108.963 173.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -121.57 111.15 16.88 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.151 0.887 . . . . 0.0 111.619 -174.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.56 144.28 16.99 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 169.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -151.35 135.76 16.92 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 119.247 1.523 . . . . 0.0 112.548 -169.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.1 165.01 29.5 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.392 1.077 . . . . 0.0 113.779 -176.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.7 m -117.44 129.76 56.04 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.401 1.481 . . . . 0.0 108.613 173.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.11 173.52 36.21 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.2 0.905 . . . . 0.0 114.603 -178.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -81.86 -9.25 59.66 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 -169.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -99.01 5.02 47.32 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 120.752 1.614 . . . . 0.0 111.506 168.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.38 16.77 36.23 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.562 2.029 . . . . 0.0 114.157 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.7 pm0 -83.58 173.29 11.54 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.66 1.584 . . . . 0.0 113.837 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.1 m -126.75 137.48 53.24 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.452 1.501 . . . . 0.0 110.14 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.7 t -124.17 141.4 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.606 1.562 . . . . 0.0 110.303 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.6 tp -130.49 146.02 51.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.798 1.239 . . . . 0.0 110.209 175.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.9 t -130.63 138.85 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.039 1.736 . . . . 0.0 108.789 176.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -134.53 131.52 38.08 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.394 0.616 . . . . 0.0 112.576 -175.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -123.33 148.68 55.86 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 125.031 1.332 . . . . 0.0 112.446 175.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -57.42 134.27 62.47 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.545 2.163 . . . . 0.0 112.101 170.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 . . . . . 0 C--O 1.254 1.315 0 C-N-CA 124.957 1.303 . . . . 0.0 112.63 -178.776 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 . . . . . 0 CA--C 1.542 0.651 0 CA-C-O 118.821 -0.609 . . . . 0.0 111.791 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -57.75 -41.34 81.71 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.259 0.936 . . . . 0.0 111.134 175.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.1 t -59.94 -29.02 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.34 1.856 . . . . 0.0 112.667 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -70.52 -40.52 73.45 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.31 -0.868 . . . . 0.0 112.674 173.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.7 mp -75.6 -36.96 60.16 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.026 -1.046 . . . . 0.0 111.818 -171.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -64.54 -27.48 68.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.548 0.739 . . . . 0.0 112.784 169.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.2 -37.75 78.27 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.713 -1.242 . . . . 0.0 112.076 169.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.6 t -68.12 -36.4 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 O-C-N 121.267 -0.895 . . . . 0.0 111.315 173.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -58.71 -44.49 90.38 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.321 -0.862 . . . . 0.0 111.526 170.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.6 mp -69.62 -35.8 75.59 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-O 116.597 -1.668 . . . . 0.0 113.101 173.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.64 -37.11 67.79 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 121.8 2.091 . . . . 0.0 110.391 169.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.6 m -69.16 -39.57 78.68 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.162 0.985 . . . . 0.0 113.334 172.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.9 mm -71.1 -34.76 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 120.606 1.548 . . . . 0.0 110.549 176.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.83 -51.04 76.9 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 C-N-CA 125.667 1.587 . . . . 0.0 110.328 174.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -54.66 -40.12 68.73 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 121.086 1.766 . . . . 0.0 112.745 172.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.1 m -62.68 -28.97 70.3 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.883 0.473 . . . . 0.0 112.103 175.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -83.23 -37.06 24.08 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.123 1.769 . . . . 0.0 113.482 172.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.7 mt -66.39 -35.98 81.7 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.989 1.268 . . . . 0.0 111.807 175.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.7 mt -74.33 -36.34 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 124.845 1.258 . . . . 0.0 110.879 169.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.87 -39.0 40.14 Favored Glycine 0 C--N 1.34 0.786 0 C-N-CA 125.523 1.535 . . . . 0.0 114.775 -170.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.8 t -150.07 -27.31 0.25 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 176.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.94 11.83 36.16 Favored Glycine 0 N--CA 1.475 1.25 0 N-CA-C 116.515 1.366 . . . . 0.0 116.515 174.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.9 m -155.29 140.05 17.11 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.256 1.422 . . . . 0.0 110.871 172.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 80.5 t -99.84 143.68 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.037 1.735 . . . . 0.0 109.212 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -127.77 156.69 42.06 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.549 1.14 . . . . 0.0 111.2 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -54.85 -38.23 67.2 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.211 -0.93 . . . . 0.0 112.241 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.29 -20.58 64.77 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.199 1.4 . . . . 0.0 113.692 177.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -82.99 -35.3 25.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.565 0.62 . . . . 0.0 112.345 172.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.4 mt -84.11 -32.23 24.83 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -175.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -58.66 -21.87 55.41 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 175.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -82.54 -5.19 58.61 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 174.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -109.16 -44.54 3.93 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.678 1.191 . . . . 0.0 112.452 -174.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 pt . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 117.354 2.353 . . . . 0.0 117.354 175.165 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.47 0.541 0 CA-C-O 119.039 -0.505 . . . . 0.0 112.058 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -130.86 129.6 42.52 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 122.995 0.518 . . . . 0.0 111.367 -170.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.47 144.24 32.51 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 118.902 0.773 . . . . 0.0 109.607 169.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.3 t -140.53 140.58 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.841 1.257 . . . . 0.0 110.328 -169.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -128.95 141.1 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -169.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -138.75 88.22 2.28 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.376 1.87 . . . . 0.0 108.314 169.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.1 mt -104.65 126.75 30.49 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 124.132 0.973 . . . . 0.0 109.364 173.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.15 133.83 57.96 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.542 2.162 . . . . 0.0 113.235 174.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.0 1.11 89.79 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.043 1.306 . . . . 0.0 116.207 175.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -134.12 158.17 75.95 Favored Pre-proline 0 N--CA 1.476 0.829 0 CA-C-N 119.247 1.523 . . . . 0.0 112.19 173.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.65 143.19 61.24 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.518 2.145 . . . . 0.0 112.702 -177.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 p -52.34 137.41 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.857 1.663 . . . . 0.0 112.451 171.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.7 t -119.78 134.03 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.287 1.835 . . . . 0.0 109.352 172.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -141.16 115.9 9.67 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.594 1.158 . . . . 0.0 109.283 176.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.7 t -93.23 155.1 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.682 1.993 . . . . 0.0 111.494 -169.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.74 -97.17 1.21 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 121.269 -0.895 . . . . 0.0 113.409 172.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.8 m -153.71 154.86 34.88 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.471 1.109 . . . . 0.0 110.346 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -70.67 127.99 91.38 Favored Pre-proline 0 CA--C 1.548 0.882 0 O-C-N 120.69 -1.256 . . . . 0.0 110.951 175.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.426 ' CB ' HG11 ' A' ' 71' ' ' VAL . 73.8 Cg_endo -78.55 158.76 28.79 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 124.283 3.322 . . . . 0.0 114.664 -178.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.8 t -85.57 -29.77 23.88 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -169.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.48 -35.48 2.33 Favored Glycine 0 N--CA 1.476 1.365 0 C-N-CA 125.484 1.516 . . . . 0.0 112.449 -175.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -78.9 61.86 3.22 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.489 1.515 . . . . 0.0 110.589 169.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.426 HG11 ' CB ' ' A' ' 67' ' ' PRO . 30.3 m -137.47 155.48 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.53 1.532 . . . . 0.0 112.535 -177.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.0 mt -91.99 127.93 37.65 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 128.417 2.687 . . . . 0.0 109.243 176.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -114.52 108.13 16.44 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.766 0.712 . . . . 0.0 111.649 -173.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.51 146.78 18.73 Favored Glycine 0 N--CA 1.469 0.856 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 169.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -152.37 132.92 13.85 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 119.377 1.589 . . . . 0.0 112.644 -169.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.28 168.45 21.04 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 42.6 m -135.43 118.01 15.93 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.927 1.691 . . . . 0.0 109.417 -177.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.48 172.15 52.57 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.454 1.026 . . . . 0.0 113.055 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -49.19 -43.96 42.68 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 126.324 1.85 . . . . 0.0 111.472 175.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -81.06 2.17 28.33 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -172.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.39 22.97 27.85 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.387 0.994 . . . . 0.0 113.139 172.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.42 -166.78 1.54 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.322 1.449 . . . . 0.0 113.285 -178.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.7 m -146.85 123.55 11.19 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 120.377 -1.452 . . . . 0.0 111.904 172.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.2 t -97.69 143.0 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.708 2.003 . . . . 0.0 109.988 170.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.1 tp -131.28 144.9 51.63 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.395 1.478 . . . . 0.0 109.134 169.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.7 t -125.76 137.42 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.318 1.447 . . . . 0.0 108.544 172.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -131.67 126.36 34.41 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.689 0.757 . . . . 0.0 111.284 -175.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -129.49 144.59 53.47 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 126.564 1.946 . . . . 0.0 110.813 -170.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.92 133.42 38.67 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.377 2.051 . . . . 0.0 112.188 178.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.2 ttp85 . . . . . 0 C--O 1.253 1.265 0 C-N-CA 125.138 1.375 . . . . 0.0 112.231 178.479 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 . . . . . 0 CA--C 1.545 0.787 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.97 -31.66 72.04 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 121.011 -1.056 . . . . 0.0 113.724 -172.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.6 m -60.57 -20.58 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 172.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -70.24 -45.13 67.12 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.181 0.901 . . . . 0.0 112.454 174.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -70.9 -41.33 71.42 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.209 -0.932 . . . . 0.0 111.303 -170.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -63.62 -33.13 74.94 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.909 0.883 . . . . 0.0 112.562 170.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.24 -37.02 84.51 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.72 -1.238 . . . . 0.0 111.829 172.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.7 t -69.27 -38.58 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 O-C-N 121.236 -0.915 . . . . 0.0 111.529 172.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.9 tpp85 -58.11 -46.14 86.06 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.156 -0.965 . . . . 0.0 111.009 171.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -69.95 -34.79 73.87 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 116.759 -1.591 . . . . 0.0 112.616 175.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.78 -37.99 69.31 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 121.589 1.995 . . . . 0.0 109.735 169.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.8 m -70.23 -38.26 75.18 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.115 0.966 . . . . 0.0 113.483 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.0 mm -71.55 -34.86 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 120.854 1.661 . . . . 0.0 110.489 176.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.1 t -63.21 -50.5 78.84 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 C-N-CA 125.4 1.48 . . . . 0.0 109.59 172.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -55.08 -40.51 70.45 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 121.307 1.867 . . . . 0.0 113.34 172.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.4 m -59.32 -34.01 71.81 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.085 -0.384 . . . . 0.0 111.682 174.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -79.41 -35.7 40.19 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.825 1.65 . . . . 0.0 113.937 172.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.96 -33.71 76.43 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 120.161 1.346 . . . . 0.0 111.576 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 87.6 mt -75.04 -37.4 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 124.849 1.259 . . . . 0.0 110.585 169.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.23 -39.48 62.3 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 125.637 1.589 . . . . 0.0 114.181 -173.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.3 t -151.49 -27.75 0.19 Allowed 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.22 0.27 38.14 Favored Glycine 0 N--CA 1.481 1.655 0 N-CA-C 116.757 1.463 . . . . 0.0 116.757 175.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.1 m -144.09 136.01 26.26 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.35 1.86 . . . . 0.0 109.01 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.9 p -114.41 143.18 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.335 1.054 . . . . 0.0 110.224 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -128.41 158.46 38.25 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.748 1.219 . . . . 0.0 110.872 -170.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -51.9 -37.95 54.38 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.722 0.809 . . . . 0.0 113.07 -177.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -70.31 -20.05 63.03 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.637 1.575 . . . . 0.0 114.236 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -80.55 -36.96 32.29 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.997 0.817 . . . . 0.0 111.491 171.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.5 mt -87.48 -33.06 19.14 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.74 1.616 . . . . 0.0 113.951 -170.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.6 ptt85 -55.15 -22.37 16.81 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 172.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -84.35 -12.25 54.87 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 176.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -110.55 -21.63 12.05 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 119.957 1.253 . . . . 0.0 114.038 -170.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -132.52 130.08 39.93 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.042 1.337 . . . . 0.0 111.498 -174.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.405 ' H ' ' HB ' ' A' ' 63' ' ' VAL . . . -105.71 142.76 34.89 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 168.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.5 t -138.33 140.5 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 O-C-N 121.085 -1.009 . . . . 0.0 110.975 -169.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 mm -114.17 134.28 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.748 1.619 . . . . 0.0 113.628 -172.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -136.64 69.13 1.42 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.594 1.958 . . . . 0.0 109.589 170.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 30.8 mt -89.93 128.18 51.0 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 123.971 0.909 . . . . 0.0 109.383 171.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -61.46 132.56 41.38 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.35 2.033 . . . . 0.0 112.713 173.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.35 2.89 87.33 Favored Glycine 0 CA--C 1.537 1.412 0 N-CA-C 116.079 1.192 . . . . 0.0 116.079 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -136.13 155.12 77.72 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-N 119.152 1.476 . . . . 0.0 112.008 172.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.05 147.45 67.49 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.722 2.281 . . . . 0.0 113.14 -171.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 p -58.33 130.2 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.641 1.176 . . . . 0.0 111.651 174.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.1 t -109.88 139.28 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.753 1.621 . . . . 0.0 108.937 171.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -135.47 108.5 7.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.767 1.227 . . . . 0.0 108.511 177.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.405 ' HB ' ' H ' ' A' ' 51' ' ' ALA . 27.6 t -80.8 149.3 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.111 1.364 . . . . 0.0 110.985 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.14 -93.59 1.43 Allowed Glycine 0 CA--C 1.533 1.196 0 O-C-N 121.654 -0.654 . . . . 0.0 112.128 174.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.1 m -149.35 158.4 44.14 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.048 1.339 . . . . 0.0 109.146 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -76.69 128.27 82.25 Favored Pre-proline 0 CA--C 1.548 0.892 0 O-C-N 120.548 -1.345 . . . . 0.0 110.896 173.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -75.83 155.45 39.16 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.285 3.323 . . . . 0.0 114.89 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.7 t -86.18 -31.79 21.58 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -169.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.36 -41.17 1.42 Allowed Glycine 0 N--CA 1.474 1.201 0 C-N-CA 124.991 1.282 . . . . 0.0 112.583 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -78.49 64.13 3.48 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.059 1.343 . . . . 0.0 111.047 169.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.0 158.17 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.443 1.497 . . . . 0.0 112.406 -178.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.4 mt -99.83 126.7 45.97 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.612 2.365 . . . . 0.0 110.056 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -109.2 109.58 20.56 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -170.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.26 146.7 18.24 Favored Glycine 0 N--CA 1.475 1.24 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 169.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 68.8 ttt-85 -154.2 132.84 12.16 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 120.812 2.306 . . . . 0.0 114.101 -169.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -143.32 173.59 11.47 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.196 1.398 . . . . 0.0 113.597 -177.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -143.73 119.26 10.35 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.597 1.559 . . . . 0.0 110.409 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.26 175.14 54.62 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.521 1.534 . . . . 0.0 115.513 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -68.02 -9.92 49.58 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.11 2.164 . . . . 0.0 115.373 -174.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -97.47 3.81 50.69 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 120.309 1.413 . . . . 0.0 113.452 169.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.57 23.47 26.13 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.971 1.272 . . . . 0.0 114.238 173.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.14 -164.4 1.11 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.297 1.439 . . . . 0.0 114.527 -172.031 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.4 m -146.91 121.57 9.83 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.334 -1.479 . . . . 0.0 111.833 173.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.7 t -98.14 139.55 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.841 1.656 . . . . 0.0 109.456 169.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.6 tp -129.01 146.9 50.86 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.216 1.406 . . . . 0.0 109.302 171.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.9 t -125.6 134.81 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.005 1.322 . . . . 0.0 108.268 171.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -132.94 131.33 40.7 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.278 1.031 . . . . 0.0 111.359 -176.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -148.51 152.98 39.44 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.352 1.061 . . . . 0.0 112.398 177.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -62.65 135.93 55.43 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.893 2.395 . . . . 0.0 113.86 -170.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 . . . . . 0 C--O 1.254 1.324 0 C-N-CA 127.369 2.268 . . . . 0.0 112.34 179.82 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.808 0 CA-C-O 121.114 0.286 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.0 m -66.0 157.96 29.51 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.869 1.268 . . . . 0.0 113.67 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -141.11 155.17 46.16 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.212 1.405 . . . . 0.0 112.991 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.9 m -107.83 157.1 18.45 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.157 1.783 . . . . 0.0 110.442 174.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.9 mmt-85 -144.65 165.04 29.17 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 127.681 2.392 . . . . 0.0 110.177 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.4 m -109.91 102.94 11.66 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.484 1.114 . . . . 0.0 111.067 -174.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.2 mm -73.73 160.54 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 125.592 1.557 . . . . 0.0 110.894 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.6 t -111.94 141.91 44.99 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.937 1.295 . . . . 0.0 112.3 177.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.1 m -127.78 26.94 5.81 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.428 1.891 . . . . 0.0 110.475 169.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.1 p -136.27 -70.95 0.46 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.85 1.66 . . . . 0.0 109.292 -172.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.97 -43.58 78.68 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.211 1.404 . . . . 0.0 111.936 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -73.54 -25.27 60.32 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.836 -0.54 . . . . 0.0 112.44 174.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -74.19 -47.93 32.4 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.966 -1.084 . . . . 0.0 111.837 174.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -36.4 78.01 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.347 -0.846 . . . . 0.0 112.588 -174.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.2 m -61.76 -21.41 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -68.72 -43.54 75.77 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.465 1.029 . . . . 0.0 112.231 174.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.74 -42.56 73.77 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.395 -0.815 . . . . 0.0 111.263 -171.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -65.7 -29.54 70.1 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.705 1.202 . . . . 0.0 112.81 171.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.59 -38.77 77.46 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.678 -1.264 . . . . 0.0 112.421 170.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.56 -36.28 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 O-C-N 121.289 -0.882 . . . . 0.0 111.305 172.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -58.83 -44.74 90.96 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.315 -0.865 . . . . 0.0 111.293 171.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.3 mp -70.01 -35.88 74.7 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-O 117.225 -1.369 . . . . 0.0 113.293 173.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.19 -34.73 66.53 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 121.284 1.856 . . . . 0.0 110.602 169.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.5 m -70.17 -38.89 75.53 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.709 0.803 . . . . 0.0 112.927 172.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.4 mm -74.42 -33.96 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 120.563 1.528 . . . . 0.0 111.507 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.9 t -66.13 -43.77 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 117.577 -1.201 . . . . 0.0 110.323 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -52.59 -43.01 65.05 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.666 1.575 . . . . 0.0 112.034 170.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.8 t -61.75 -31.08 71.24 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.317 0.647 . . . . 0.0 112.301 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -79.91 -36.49 36.35 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.993 1.317 . . . . 0.0 113.306 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 71.0 mt -66.27 -35.17 79.7 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.69 1.132 . . . . 0.0 111.685 175.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.4 mt -74.56 -35.21 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.417 1.087 . . . . 0.0 111.04 169.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.69 -38.33 50.69 Favored Glycine 0 C--N 1.339 0.724 0 C-N-CA 125.798 1.666 . . . . 0.0 114.99 -172.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.5 t -152.84 -26.52 0.15 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.82 4.66 42.21 Favored Glycine 0 N--CA 1.476 1.358 0 N-CA-C 116.512 1.365 . . . . 0.0 116.512 174.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.8 p -155.85 141.38 17.78 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.241 1.416 . . . . 0.0 111.131 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 80.4 t -93.74 144.09 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.247 1.419 . . . . 0.0 109.64 175.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -125.07 158.09 34.64 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.622 1.169 . . . . 0.0 110.302 171.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -56.9 -37.17 71.05 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.223 -0.923 . . . . 0.0 112.632 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -69.88 -19.07 63.44 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -77.11 -39.88 47.9 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.783 0.72 . . . . 0.0 111.91 171.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.2 mt -85.64 -27.45 25.4 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -173.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -57.82 -24.18 56.15 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 119.812 1.187 . . . . 0.0 113.58 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -83.58 -3.28 57.54 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.087 1.355 . . . . 0.0 114.122 175.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -118.6 -19.31 8.79 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.449 1.1 . . . . 0.0 113.561 -169.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -50.64 -64.09 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.062 0.945 . . . . 0.0 110.995 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 62.58 -13.4 0.07 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 128.265 2.626 . . . . 0.0 116.953 170.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -142.89 -31.47 0.5 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.707 1.603 . . . . 0.0 112.502 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.28 158.65 15.48 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.62 -53.49 13.52 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.218 1.407 . . . . 0.0 110.65 169.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -131.47 132.03 43.96 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.438 0.695 . . . . 0.0 111.495 -170.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.08 147.41 31.24 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.212 -0.93 . . . . 0.0 110.924 169.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.3 t -138.43 141.18 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.266 1.427 . . . . 0.0 110.848 -171.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.35 131.18 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.998 1.319 . . . . 0.0 113.828 -171.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -130.72 76.43 1.72 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.967 1.707 . . . . 0.0 109.481 169.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.4 mt -94.31 131.0 32.21 Favored Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 123.715 0.806 . . . . 0.0 108.985 172.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -64.64 136.78 51.41 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.195 1.93 . . . . 0.0 111.544 175.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.97 -0.99 87.9 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.704 1.145 . . . . 0.0 115.851 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -138.32 156.56 73.53 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-N 119.322 1.561 . . . . 0.0 112.582 175.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.19 153.57 66.83 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.811 2.341 . . . . 0.0 113.064 -174.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.1 p -59.2 132.93 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.254 1.022 . . . . 0.0 111.531 172.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 95.5 t -111.32 141.64 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.492 1.517 . . . . 0.0 109.194 170.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -134.84 119.67 18.4 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.215 1.406 . . . . 0.0 109.428 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.2 t -94.87 155.24 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.287 1.835 . . . . 0.0 111.353 -174.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.67 -95.22 0.99 Allowed Glycine 0 CA--C 1.53 1.023 0 O-C-N 121.151 -0.968 . . . . 0.0 112.836 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.6 m -153.0 152.81 31.81 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.537 -0.978 . . . . 0.0 110.26 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -67.19 130.07 93.73 Favored Pre-proline 0 CA--C 1.547 0.865 0 O-C-N 120.72 -1.238 . . . . 0.0 110.883 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.458 ' CB ' HG11 ' A' ' 71' ' ' VAL . 73.1 Cg_endo -79.54 158.77 25.46 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.179 3.253 . . . . 0.0 114.621 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.7 t -88.49 -34.02 17.6 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -169.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.15 -36.57 1.86 Allowed Glycine 0 N--CA 1.477 1.411 0 C-N-CA 125.153 1.358 . . . . 0.0 112.355 -174.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -78.43 63.07 3.2 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.236 1.414 . . . . 0.0 110.522 169.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.458 HG11 ' CB ' ' A' ' 67' ' ' PRO . 30.4 m -139.84 154.36 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.648 1.579 . . . . 0.0 112.351 -176.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.4 mt -89.04 147.5 24.23 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 127.677 2.391 . . . . 0.0 109.128 170.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -127.09 116.95 21.48 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 118.672 0.669 . . . . 0.0 112.206 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.89 150.78 19.98 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.12 1.343 . . . . 0.0 110.001 169.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -156.11 137.04 13.54 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.573 1.686 . . . . 0.0 113.137 -171.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.61 161.98 37.8 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.033 1.333 . . . . 0.0 113.6 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 74.9 m -114.42 128.26 56.25 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.155 1.382 . . . . 0.0 108.319 172.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.08 176.91 44.2 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 122.033 0.796 . . . . 0.0 114.64 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -83.51 -9.56 58.89 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -169.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -102.3 5.91 40.19 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 120.733 1.606 . . . . 0.0 112.194 169.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.12 17.48 34.56 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.247 1.879 . . . . 0.0 114.362 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -83.93 173.22 11.38 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.19 1.796 . . . . 0.0 113.357 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.4 m -129.23 136.55 50.26 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.97 1.308 . . . . 0.0 110.25 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.2 t -119.29 139.7 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.023 1.729 . . . . 0.0 109.575 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.4 tt -132.84 149.11 52.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.467 1.107 . . . . 0.0 109.817 175.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 86.0 t -133.23 139.87 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.509 1.523 . . . . 0.0 109.397 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -131.74 137.73 48.34 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.988 0.899 . . . . 0.0 112.825 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -137.04 150.48 69.62 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 126.564 1.946 . . . . 0.0 111.031 -173.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -64.17 137.93 59.08 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.801 2.334 . . . . 0.0 112.582 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 125.92 1.688 . . . . 0.0 112.409 177.605 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.736 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.9 m -71.26 -29.63 65.32 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -174.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -44.43 132.31 6.1 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.757 1.623 . . . . 0.0 113.985 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.4 t -160.82 148.55 15.82 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.139 1.775 . . . . 0.0 110.531 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -144.2 156.61 44.38 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.987 2.115 . . . . 0.0 110.761 -174.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.9 t -144.49 144.3 31.29 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.668 1.187 . . . . 0.0 111.671 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 55.0 mt -81.38 138.82 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.909 0.884 . . . . 0.0 111.368 -170.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.3 m -76.34 42.62 0.28 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.045 1.738 . . . . 0.0 113.754 178.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.9 m -62.59 42.34 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 130.273 3.429 . . . . 0.0 117.213 -169.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.4 p -137.01 -64.6 0.57 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 127.372 2.269 . . . . 0.0 107.335 169.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.87 -47.26 60.23 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.045 1.338 . . . . 0.0 112.411 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -69.94 -26.43 64.12 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.475 0.71 . . . . 0.0 111.654 174.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -71.18 -54.09 12.22 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.059 -1.026 . . . . 0.0 111.554 173.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -28.46 69.31 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -171.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.3 m -60.4 -21.1 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 170.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -69.2 -45.56 69.62 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 119.466 1.03 . . . . 0.0 112.391 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 mp -70.0 -40.17 75.43 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.552 -0.718 . . . . 0.0 111.617 -170.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -65.02 -34.2 77.87 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.722 1.209 . . . . 0.0 112.519 170.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.92 -38.92 89.94 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 120.604 -1.31 . . . . 0.0 112.361 171.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 94.3 t -68.11 -37.82 78.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 O-C-N 121.294 -0.879 . . . . 0.0 111.533 172.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -59.53 -44.59 93.15 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.318 -0.864 . . . . 0.0 111.057 172.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.5 mp -69.52 -34.32 74.1 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 117.448 -1.263 . . . . 0.0 113.044 174.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.16 -34.44 68.44 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 121.172 1.805 . . . . 0.0 110.534 169.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.3 m -72.63 -38.65 67.66 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.353 1.061 . . . . 0.0 113.636 171.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.1 mm -72.79 -34.2 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 120.915 1.689 . . . . 0.0 110.97 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.2 t -67.18 -47.19 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.795 1.238 . . . . 0.0 109.63 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -53.11 -44.0 67.32 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 120.821 1.646 . . . . 0.0 111.976 170.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.2 m -59.97 -30.43 69.1 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.744 -0.598 . . . . 0.0 112.486 175.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.2 tpt180 -80.92 -35.22 32.7 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.685 1.594 . . . . 0.0 113.526 171.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.7 mt -66.11 -33.8 76.61 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.988 1.267 . . . . 0.0 111.588 174.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 90.7 mt -75.08 -35.69 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.791 1.236 . . . . 0.0 110.811 169.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.89 -38.05 49.7 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 125.5 1.524 . . . . 0.0 114.807 -172.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.1 t -152.58 -26.97 0.16 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.93 1.06 39.2 Favored Glycine 0 N--CA 1.477 1.43 0 N-CA-C 116.774 1.47 . . . . 0.0 116.774 174.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.9 m -147.8 139.0 23.52 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.098 1.759 . . . . 0.0 109.33 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.46 147.05 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.737 1.215 . . . . 0.0 109.955 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -132.32 157.42 44.5 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.782 1.233 . . . . 0.0 110.472 -174.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -55.66 -38.28 69.38 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.758 -0.589 . . . . 0.0 112.268 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -70.45 -20.18 62.91 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.794 1.238 . . . . 0.0 113.721 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -78.99 -41.81 28.11 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.833 0.742 . . . . 0.0 111.067 169.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.3 mt -81.67 -30.34 32.74 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -170.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -56.3 -26.91 53.75 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 173.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -84.18 -3.35 58.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.325 1.05 . . . . 0.0 113.723 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.6 mm-40 -120.71 -13.73 8.67 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.617 1.167 . . . . 0.0 113.535 -169.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.82 -60.81 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.405 0.682 . . . . 0.0 112.66 -176.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.259 21.7 mmt85 62.71 -19.33 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 128.148 2.579 . . . . 0.0 117.869 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -148.97 -33.9 0.21 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.843 1.257 . . . . 0.0 113.121 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.23 151.47 45.31 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.458 1.103 . . . . 0.0 111.582 174.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.06 -45.53 13.91 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.849 -0.532 . . . . 0.0 110.3 172.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -132.71 124.34 27.98 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.55 1.54 . . . . 0.0 109.169 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.13 142.63 29.57 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.443 1.02 . . . . 0.0 109.579 169.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 63.1 t -137.84 141.16 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.646 1.178 . . . . 0.0 109.476 -171.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -122.97 134.07 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -169.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -129.67 81.79 2.04 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.467 1.907 . . . . 0.0 109.631 170.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.5 mt -98.34 125.18 44.22 Favored Pre-proline 0 N--CA 1.48 1.063 0 C-N-CA 123.775 0.83 . . . . 0.0 108.979 169.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.87 133.4 53.51 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.384 2.056 . . . . 0.0 112.291 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.25 3.42 87.2 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-O 118.273 -1.293 . . . . 0.0 115.977 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -138.8 163.39 46.95 Favored Pre-proline 0 N--CA 1.475 0.78 0 CA-C-N 119.717 1.759 . . . . 0.0 114.075 173.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -60.62 140.78 92.86 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.579 2.853 . . . . 0.0 114.204 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.2 t -60.23 131.31 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.332 1.053 . . . . 0.0 110.024 169.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 70.1 t -110.38 141.41 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.095 1.358 . . . . 0.0 109.562 172.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -138.17 114.42 10.23 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.999 1.319 . . . . 0.0 109.191 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.3 t -89.97 155.53 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.941 1.696 . . . . 0.0 111.312 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.83 -102.83 1.58 Allowed Glycine 0 CA--C 1.532 1.107 0 O-C-N 121.343 -0.848 . . . . 0.0 112.736 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.3 m -146.12 150.05 35.18 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.516 1.126 . . . . 0.0 110.17 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -67.59 129.74 93.39 Favored Pre-proline 0 CA--C 1.548 0.898 0 O-C-N 120.861 -1.15 . . . . 0.0 111.002 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.413 ' CB ' HG11 ' A' ' 71' ' ' VAL . 73.8 Cg_endo -79.86 155.0 23.32 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.952 3.102 . . . . 0.0 114.314 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.4 HG23 ' H ' ' A' ' 70' ' ' ASP . 13.9 t -83.66 -26.95 29.44 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -171.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.25 -33.9 3.36 Favored Glycine 0 N--CA 1.476 1.32 0 C-N-CA 125.572 1.558 . . . . 0.0 112.64 -175.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.4 ' H ' HG23 ' A' ' 68' ' ' THR . 23.8 m-20 -79.18 60.23 2.98 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.775 1.63 . . . . 0.0 111.216 169.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.413 HG11 ' CB ' ' A' ' 67' ' ' PRO . 34.3 m -136.68 158.99 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 126.078 1.751 . . . . 0.0 112.29 -173.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.9 mt -99.77 126.96 45.93 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.854 2.462 . . . . 0.0 110.382 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -111.33 110.1 20.41 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -169.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.38 145.88 18.29 Favored Glycine 0 N--CA 1.471 0.998 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 169.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -154.46 137.4 15.44 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 120.145 1.972 . . . . 0.0 113.654 -169.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.26 163.65 34.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.56 1.144 . . . . 0.0 113.95 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 62.1 m -117.11 130.52 56.69 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.411 1.485 . . . . 0.0 108.578 172.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.31 174.7 37.08 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.092 0.853 . . . . 0.0 114.638 -177.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -81.45 -10.82 59.42 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 -169.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -99.61 5.49 45.91 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.714 1.597 . . . . 0.0 111.983 169.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.37 17.62 33.49 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 126.259 1.885 . . . . 0.0 114.268 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.3 pm0 -84.08 175.51 9.46 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.839 1.656 . . . . 0.0 113.459 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.5 m -133.2 133.88 43.34 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.073 1.349 . . . . 0.0 110.41 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 67.3 t -114.26 141.18 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.168 1.787 . . . . 0.0 110.029 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.7 tp -129.23 146.77 51.07 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.388 1.475 . . . . 0.0 109.524 174.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.6 t -124.4 137.7 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 127.596 2.358 . . . . 0.0 107.719 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -135.35 138.13 43.06 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.017 0.527 . . . . 0.0 111.724 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -148.83 154.25 39.97 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 172.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -59.82 137.64 77.84 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.779 2.319 . . . . 0.0 113.404 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 . . . . . 0 C--O 1.255 1.354 0 C-N-CA 125.888 1.675 . . . . 0.0 112.241 178.542 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 112.325 -0.31 . . . . 0.0 112.325 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.4 m -153.74 157.42 39.44 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.264 1.426 . . . . 0.0 112.076 174.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -64.38 159.23 21.66 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -174.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.4 m -59.54 145.09 45.48 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.822 1.649 . . . . 0.0 112.724 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 -77.2 127.81 33.27 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.162 0.985 . . . . 0.0 112.305 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.9 m -56.27 140.13 45.84 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.909 1.284 . . . . 0.0 111.888 176.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.1 mt -58.4 138.52 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.486 1.115 . . . . 0.0 109.959 178.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 t -83.69 37.33 0.58 Allowed 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 -169.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.0 m -66.58 47.25 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.839 2.456 . . . . 0.0 113.675 171.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.6 p -138.34 -64.15 0.53 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 128.896 2.878 . . . . 0.0 107.024 171.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.85 -47.77 50.68 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.974 1.31 . . . . 0.0 112.504 174.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.6 tp60 -68.81 -28.26 66.59 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.9 -1.125 . . . . 0.0 111.286 174.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -71.46 -51.28 24.63 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.738 -0.601 . . . . 0.0 111.325 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -37.15 79.78 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.057 -1.027 . . . . 0.0 111.822 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.9 t -58.24 -31.43 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.337 1.455 . . . . 0.0 113.085 173.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -71.12 -39.64 71.92 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.235 -0.916 . . . . 0.0 112.957 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -77.86 -36.31 50.01 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.271 -0.893 . . . . 0.0 111.918 -172.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -64.34 -28.0 69.4 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.337 -0.852 . . . . 0.0 112.705 170.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.68 -36.6 84.11 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.608 -1.307 . . . . 0.0 111.981 170.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.3 t -71.33 -35.79 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.567 1.147 . . . . 0.0 111.174 173.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.2 tpp85 -60.82 -46.36 90.82 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.011 -1.055 . . . . 0.0 111.473 171.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.3 mp -69.76 -33.25 72.16 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 117.352 -1.308 . . . . 0.0 112.418 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.58 -33.05 69.53 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 121.269 1.849 . . . . 0.0 110.785 169.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.3 m -73.79 -38.61 64.58 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.303 1.041 . . . . 0.0 113.33 171.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.7 mm -73.31 -36.7 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 121.072 1.76 . . . . 0.0 110.84 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.6 t -62.2 -49.93 82.03 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 CA-C-O 117.558 -1.21 . . . . 0.0 109.466 173.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -54.05 -43.52 70.28 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 120.803 1.638 . . . . 0.0 112.377 173.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.0 m -59.33 -36.84 76.41 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.756 -0.59 . . . . 0.0 111.912 176.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -74.55 -36.49 63.11 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.36 1.464 . . . . 0.0 113.271 172.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.2 mt -67.27 -30.57 70.48 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.864 1.211 . . . . 0.0 112.034 175.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.4 mt -76.05 -37.31 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.869 1.268 . . . . 0.0 110.936 169.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.58 -39.52 55.95 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.383 1.468 . . . . 0.0 114.456 -173.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.8 t -148.83 -27.61 0.3 Allowed 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.69 14.23 35.3 Favored Glycine 0 N--CA 1.479 1.535 0 N-CA-C 116.061 1.184 . . . . 0.0 116.061 175.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.1 m -156.67 145.83 20.36 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.945 1.698 . . . . 0.0 109.694 172.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.0 p -120.69 143.64 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.521 1.528 . . . . 0.0 110.359 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -128.8 156.25 43.88 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.371 1.068 . . . . 0.0 111.395 -169.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -54.2 -39.09 66.36 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.671 -0.643 . . . . 0.0 112.299 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -71.1 -21.07 62.27 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.246 1.418 . . . . 0.0 113.638 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -80.98 -37.23 29.62 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.869 0.759 . . . . 0.0 111.39 169.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.6 mt -82.16 -32.3 30.06 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.984 1.314 . . . . 0.0 113.733 -171.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -58.31 -22.94 54.93 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 173.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -85.11 -1.14 56.53 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.556 1.142 . . . . 0.0 113.913 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -116.56 -21.28 9.24 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.841 1.257 . . . . 0.0 112.998 -174.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -53.53 -62.0 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.623 0.769 . . . . 0.0 111.781 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 64.42 -12.4 0.11 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.648 2.379 . . . . 0.0 117.114 170.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -151.94 -31.37 0.15 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.278 1.031 . . . . 0.0 112.491 171.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.37 154.89 32.32 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.6 -56.57 5.61 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.023 1.329 . . . . 0.0 111.571 171.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -126.99 131.36 51.06 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.147 0.579 . . . . 0.0 112.501 -169.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.29 144.47 37.38 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.394 -0.816 . . . . 0.0 109.637 169.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.0 t -139.85 138.72 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.264 1.026 . . . . 0.0 110.389 -169.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.448 HD13 ' HA ' ' A' ' 53' ' ' ILE . 0.4 OUTLIER -119.29 132.93 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -169.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -130.02 83.31 2.12 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.977 1.711 . . . . 0.0 109.45 172.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.5 mt -100.18 132.12 23.13 Favored Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 124.048 0.939 . . . . 0.0 109.271 173.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.52 134.18 37.43 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.352 2.035 . . . . 0.0 111.658 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.48 0.24 82.41 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.774 1.178 . . . . 0.0 115.565 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -135.31 158.12 75.23 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 119.027 1.414 . . . . 0.0 112.087 172.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.2 155.74 66.88 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.621 2.214 . . . . 0.0 112.786 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.2 p -57.66 139.82 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.637 1.175 . . . . 0.0 111.588 171.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 85.1 t -119.24 139.26 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.466 1.507 . . . . 0.0 108.806 172.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -133.5 121.82 22.73 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.001 1.32 . . . . 0.0 109.564 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.8 t -95.02 151.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.618 1.567 . . . . 0.0 111.116 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.17 -102.62 2.3 Favored Glycine 0 CA--C 1.533 1.213 0 O-C-N 121.462 -0.773 . . . . 0.0 112.522 172.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 94.5 m -143.97 141.65 30.3 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.599 1.159 . . . . 0.0 109.896 174.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -65.45 125.9 90.45 Favored Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 120.73 -1.231 . . . . 0.0 111.127 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.437 ' CB ' HG11 ' A' ' 71' ' ' VAL . 60.5 Cg_endo -76.63 153.57 34.34 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.712 2.942 . . . . 0.0 114.911 -172.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 70' ' ' ASP . 11.3 t -82.22 -24.0 35.1 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -169.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.64 -35.05 3.71 Favored Glycine 0 N--CA 1.478 1.487 0 C-N-CA 125.394 1.473 . . . . 0.0 112.618 -174.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.411 ' H ' HG23 ' A' ' 68' ' ' THR . 18.9 m-20 -77.9 59.56 2.13 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.027 1.731 . . . . 0.0 110.672 169.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.437 HG11 ' CB ' ' A' ' 67' ' ' PRO . 28.0 m -135.55 157.29 39.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 126.292 1.837 . . . . 0.0 112.046 -173.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.6 mt -90.78 144.65 25.5 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.704 1.602 . . . . 0.0 109.125 170.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -125.49 122.13 35.73 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.532 0.733 . . . . 0.0 112.102 -177.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.42 148.08 16.44 Favored Glycine 0 N--CA 1.47 0.942 0 C-N-CA 126.033 1.778 . . . . 0.0 109.563 169.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -152.42 141.55 21.34 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.094 1.447 . . . . 0.0 112.876 -169.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.75 162.03 40.03 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.015 1.326 . . . . 0.0 113.228 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 70.1 m -113.11 127.44 56.2 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.951 1.301 . . . . 0.0 108.697 171.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.19 172.35 43.37 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.379 0.99 . . . . 0.0 114.06 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -82.93 -11.78 57.88 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 -169.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -92.94 2.91 56.55 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.837 1.653 . . . . 0.0 111.848 169.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.86 14.68 39.14 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 126.735 2.112 . . . . 0.0 114.369 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.5 pm0 -81.89 173.76 11.94 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.861 1.665 . . . . 0.0 113.794 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.0 m -127.84 138.92 52.87 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.452 1.501 . . . . 0.0 110.348 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.4 t -121.52 139.29 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.425 1.49 . . . . 0.0 109.487 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.2 tp -126.78 148.08 49.95 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.48 1.512 . . . . 0.0 109.935 174.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.38 136.17 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.462 1.505 . . . . 0.0 108.203 174.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -130.19 131.74 45.73 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.845 0.831 . . . . 0.0 112.142 -177.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -126.14 151.54 72.05 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 126.264 1.825 . . . . 0.0 111.552 -178.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -61.11 136.15 63.18 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 122.655 2.237 . . . . 0.0 112.023 170.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 . . . . . 0 C--O 1.252 1.213 0 C-N-CA 125.211 1.404 . . . . 0.0 113.252 -177.597 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.762 0 N-CA-C 112.115 -0.394 . . . . 0.0 112.115 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.6 p -98.7 18.14 17.6 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.066 1.746 . . . . 0.0 114.106 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -152.92 167.64 28.45 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.08 1.752 . . . . 0.0 111.069 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.5 m -103.02 130.65 50.2 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.217 1.007 . . . . 0.0 110.9 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -56.5 -33.21 65.79 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.752 1.221 . . . . 0.0 114.047 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.3 t -113.33 175.53 5.41 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.002 1.721 . . . . 0.0 111.908 171.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.0 mt -117.05 136.67 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.668 1.587 . . . . 0.0 107.69 176.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 64.1 p -86.8 30.32 0.75 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -169.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 p -68.72 51.59 0.08 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 128.571 2.749 . . . . 0.0 114.163 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.7 p -137.55 -66.48 0.5 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 130.007 3.323 . . . . 0.0 106.561 169.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.15 -46.48 61.41 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.428 1.491 . . . . 0.0 113.048 174.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.6 tp60 -74.16 -19.23 60.63 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.687 0.795 . . . . 0.0 111.703 175.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -77.78 -49.05 15.14 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 120.79 -1.194 . . . . 0.0 112.162 172.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.62 -36.43 80.71 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 121.118 -0.989 . . . . 0.0 112.839 -174.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.9 m -60.07 -23.06 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 174.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -71.16 -39.95 71.59 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.217 0.917 . . . . 0.0 111.735 175.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.0 mt -71.84 -41.63 67.91 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.053 0.941 . . . . 0.0 111.541 -172.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -66.68 -33.24 75.2 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.88 0.872 . . . . 0.0 112.516 169.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.8 -37.88 89.02 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 120.28 1.4 . . . . 0.0 112.161 171.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.9 t -69.1 -37.78 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.193 0.997 . . . . 0.0 111.712 172.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -60.87 -43.44 98.42 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.004 -1.06 . . . . 0.0 111.336 172.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -69.79 -34.43 73.71 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 117.468 -1.254 . . . . 0.0 112.585 173.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.27 -33.05 68.99 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 121.175 1.807 . . . . 0.0 110.486 169.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.8 m -73.61 -38.89 64.94 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.401 1.08 . . . . 0.0 113.74 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.1 mm -72.47 -36.12 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 121.221 1.828 . . . . 0.0 110.626 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.413 HG21 HD11 ' A' ' 53' ' ' ILE . 94.7 t -64.66 -48.4 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 117.549 -1.215 . . . . 0.0 109.664 174.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -53.62 -44.27 69.37 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.836 1.653 . . . . 0.0 112.1 172.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.2 m -58.85 -34.48 71.62 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.786 -0.571 . . . . 0.0 112.113 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -77.78 -35.67 51.34 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.482 1.513 . . . . 0.0 113.63 172.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 56.0 mt -66.77 -33.05 74.77 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 120.127 1.33 . . . . 0.0 111.56 175.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 90.8 mt -72.75 -36.98 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 124.821 1.248 . . . . 0.0 110.672 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.2 -39.7 51.88 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.506 1.527 . . . . 0.0 114.673 -173.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.6 t -151.45 -27.25 0.19 Allowed 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.86 2.42 49.24 Favored Glycine 0 N--CA 1.48 1.629 0 N-CA-C 116.436 1.334 . . . . 0.0 116.436 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.9 m -143.81 136.5 27.19 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.254 1.821 . . . . 0.0 109.115 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 p -113.31 145.9 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.597 1.159 . . . . 0.0 110.216 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -132.92 157.4 45.2 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.634 1.174 . . . . 0.0 111.073 -170.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.55 -40.75 65.79 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.797 -0.565 . . . . 0.0 112.368 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.95 -17.82 62.05 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.394 1.078 . . . . 0.0 113.756 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -81.67 -36.86 28.29 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.032 0.833 . . . . 0.0 111.52 169.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 64.3 mt -85.68 -31.75 22.34 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.742 1.617 . . . . 0.0 114.374 -171.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -60.66 -19.17 57.61 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -85.62 -5.29 59.29 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.06 1.344 . . . . 0.0 114.131 173.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -116.1 -18.2 10.67 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.719 1.208 . . . . 0.0 113.482 -169.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -51.01 -57.05 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.004 0.922 . . . . 0.0 113.008 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.28 20.9 mmt85 62.6 -15.02 0.06 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 118.824 2.898 . . . . 0.0 118.824 175.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -155.52 -28.15 0.1 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.787 0.835 . . . . 0.0 113.023 173.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.61 159.44 29.21 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -82.13 -49.69 9.88 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.967 0.907 . . . . 0.0 111.853 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -129.04 130.89 47.16 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.649 1.58 . . . . 0.0 111.44 -173.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -106.02 142.73 35.23 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.48 -0.762 . . . . 0.0 109.442 169.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.5 t -138.14 139.54 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.492 1.117 . . . . 0.0 110.354 -170.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.413 HD11 HG21 ' A' ' 26' ' ' VAL . 0.8 OUTLIER -120.58 133.24 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -169.72 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.6 mmt85 -132.58 79.06 1.83 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.884 1.674 . . . . 0.0 109.664 171.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.5 mt -96.37 132.16 27.11 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 124.188 0.995 . . . . 0.0 109.329 172.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.59 131.02 26.49 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.174 1.916 . . . . 0.0 111.499 175.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.2 2.6 80.11 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 116.201 1.241 . . . . 0.0 116.201 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -137.99 155.83 74.4 Favored Pre-proline 0 N--CA 1.475 0.81 0 CA-C-N 119.246 1.523 . . . . 0.0 111.907 172.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.91 151.41 78.14 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.682 2.255 . . . . 0.0 113.044 -173.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 p -59.15 131.67 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.403 1.081 . . . . 0.0 111.249 172.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.3 t -109.53 138.25 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.313 1.445 . . . . 0.0 109.099 170.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -132.72 116.3 16.43 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.247 1.419 . . . . 0.0 108.804 176.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.6 t -93.12 152.02 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.439 1.495 . . . . 0.0 111.186 -175.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.25 -97.44 1.42 Allowed Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.694 -0.629 . . . . 0.0 111.558 176.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.2 m -146.53 149.7 34.11 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.42 1.088 . . . . 0.0 109.604 177.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.2 tttp -70.47 127.33 92.15 Favored Pre-proline 0 CA--C 1.547 0.84 0 O-C-N 120.628 -1.295 . . . . 0.0 110.485 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.64 154.83 39.82 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 124.026 3.151 . . . . 0.0 114.739 -173.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.1 t -83.19 -23.25 32.93 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -169.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.37 -35.45 3.61 Favored Glycine 0 N--CA 1.475 1.261 0 C-N-CA 125.545 1.545 . . . . 0.0 113.026 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -78.43 59.25 2.33 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.87 1.668 . . . . 0.0 111.267 169.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.0 m -132.93 158.2 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.949 1.7 . . . . 0.0 112.299 -174.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.4 mt -89.73 144.04 26.31 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 126.505 1.922 . . . . 0.0 109.425 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -123.29 114.03 19.68 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.074 0.549 . . . . 0.0 112.376 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.31 144.16 17.13 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 169.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -153.73 138.31 16.88 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 120.504 2.152 . . . . 0.0 113.559 -169.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.05 166.26 26.63 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.022 1.329 . . . . 0.0 113.782 -176.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.0 m -120.03 130.56 54.77 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.62 1.568 . . . . 0.0 108.454 173.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.93 177.29 39.94 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.11 0.862 . . . . 0.0 114.346 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -84.36 -14.09 50.49 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -169.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -93.76 4.52 53.81 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.871 1.669 . . . . 0.0 112.124 169.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.92 15.98 43.37 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.583 2.039 . . . . 0.0 114.106 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.9 pm0 -79.8 172.64 13.51 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.522 1.529 . . . . 0.0 113.573 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.5 m -130.22 137.36 50.0 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.37 1.468 . . . . 0.0 109.834 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.3 t -120.28 138.01 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.731 1.612 . . . . 0.0 109.605 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 15.6 tp -128.35 149.47 50.5 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.33 1.452 . . . . 0.0 109.539 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 75.2 t -132.09 133.73 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.246 1.818 . . . . 0.0 107.871 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -133.69 137.46 45.32 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.226 0.536 . . . . 0.0 112.395 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -151.95 155.03 33.41 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 123.835 0.854 . . . . 0.0 112.624 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -60.14 138.82 84.0 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.118 2.546 . . . . 0.0 113.906 -173.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 . . . . . 0 C--O 1.252 1.204 0 C-N-CA 126.162 1.785 . . . . 0.0 112.746 -178.598 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.4 t -150.07 149.61 30.55 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.184 1.393 . . . . 0.0 111.398 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -135.64 146.78 48.2 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.557 1.543 . . . . 0.0 111.656 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.2 m -52.11 136.86 28.93 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.089 1.356 . . . . 0.0 112.743 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -67.14 165.48 15.88 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.828 1.651 . . . . 0.0 114.251 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.6 m -66.02 148.74 51.34 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.763 1.225 . . . . 0.0 109.443 169.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.6 mt -133.19 140.14 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.495 1.118 . . . . 0.0 108.225 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.9 m -90.84 38.39 0.95 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -169.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 m -63.1 34.05 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 129.24 3.016 . . . . 0.0 117.512 -170.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.0 p -134.35 -63.66 0.71 Allowed 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 127.448 2.299 . . . . 0.0 107.719 169.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.95 -43.43 71.61 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.531 1.532 . . . . 0.0 112.934 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -77.84 -24.54 48.61 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.51 0.724 . . . . 0.0 111.799 173.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -71.79 -50.44 29.82 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 121.095 -1.003 . . . . 0.0 111.35 174.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -35.2 73.49 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 121.228 -0.92 . . . . 0.0 113.006 -174.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.6 m -62.96 -20.71 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -69.73 -45.4 68.24 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 119.196 0.907 . . . . 0.0 112.07 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.92 -42.68 72.98 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.319 -0.863 . . . . 0.0 111.623 -170.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -60.74 -35.8 77.29 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.504 1.122 . . . . 0.0 112.168 171.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.2 -39.94 74.89 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 120.887 -1.133 . . . . 0.0 112.67 174.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.3 t -63.85 -40.79 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.961 0.905 . . . . 0.0 110.946 172.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.4 tmm_? -63.41 -40.17 96.49 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.245 -0.91 . . . . 0.0 112.0 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 mp -63.24 -34.37 77.51 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 117.276 -1.345 . . . . 0.0 112.423 170.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.71 -32.57 67.53 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 121.173 1.806 . . . . 0.0 111.339 169.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.0 m -75.08 -35.08 61.84 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 170.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.1 mm -70.57 -36.48 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 119.929 1.24 . . . . 0.0 110.709 176.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.8 t -66.99 -46.43 84.83 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.419 0 C-N-CA 125.681 1.592 . . . . 0.0 110.402 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -52.53 -42.54 64.47 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.742 1.61 . . . . 0.0 111.847 170.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.7 m -61.0 -29.31 69.62 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 175.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -83.22 -33.9 26.0 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.862 1.665 . . . . 0.0 113.679 171.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.8 mt -66.06 -35.81 81.52 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 120.033 1.288 . . . . 0.0 111.568 173.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 88.6 mt -73.19 -35.42 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.502 1.121 . . . . 0.0 110.662 169.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.14 -38.6 54.57 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 125.596 1.57 . . . . 0.0 114.752 -172.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.1 t -154.48 -26.99 0.12 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.17 4.03 38.48 Favored Glycine 0 N--CA 1.479 1.556 0 N-CA-C 116.721 1.448 . . . . 0.0 116.721 175.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.9 p -158.21 140.5 14.27 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.42 1.488 . . . . 0.0 111.488 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 81.0 t -94.43 143.69 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.29 1.436 . . . . 0.0 110.556 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -124.43 157.46 35.13 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.018 1.327 . . . . 0.0 110.427 171.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -53.87 -38.35 64.63 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.394 -0.816 . . . . 0.0 112.734 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -66.97 -22.44 65.93 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.169 1.388 . . . . 0.0 113.676 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -78.12 -37.64 45.72 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.288 0.495 . . . . 0.0 111.943 171.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.2 mt -88.04 -27.73 21.82 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 -173.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.0 ptt85 -58.16 -27.53 63.9 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -88.81 5.91 41.43 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 173.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -128.08 -8.97 5.38 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 120.572 -1.33 . . . . 0.0 113.966 -170.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -53.01 -61.66 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.784 1.233 . . . . 0.0 112.091 174.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.269 23.7 mmt85 64.92 -17.22 0.09 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 117.82 2.526 . . . . 0.0 117.82 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -143.45 -28.23 0.54 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.591 1.157 . . . . 0.0 113.974 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.3 153.9 17.76 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.429 1.092 . . . . 0.0 113.805 -171.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.72 -53.55 21.43 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.271 1.028 . . . . 0.0 109.64 169.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -130.27 127.33 39.33 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.195 0.598 . . . . 0.0 111.812 -170.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -103.45 145.95 29.23 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.182 -0.949 . . . . 0.0 109.864 169.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.6 t -139.61 139.27 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 O-C-N 121.085 -1.009 . . . . 0.0 111.505 -170.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.2 mm -111.81 132.28 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.468 1.507 . . . . 0.0 113.519 -172.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.5 tpt85 -140.8 46.49 1.77 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.324 1.849 . . . . 0.0 110.423 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.2 mt -66.67 127.46 93.42 Favored Pre-proline 0 N--CA 1.481 1.083 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.054 170.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -58.63 135.41 67.19 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.978 2.452 . . . . 0.0 112.741 173.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.93 1.25 88.92 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-O 118.506 -1.163 . . . . 0.0 115.506 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -135.62 162.43 57.13 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 119.461 1.63 . . . . 0.0 113.921 173.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -61.92 142.85 94.53 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.603 2.869 . . . . 0.0 114.596 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.1 p -68.45 130.4 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.685 0.794 . . . . 0.0 110.285 169.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.8 p -123.39 147.31 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.036 1.334 . . . . 0.0 110.972 171.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -135.86 119.37 16.97 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.938 1.695 . . . . 0.0 108.948 -170.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 50.7 t -90.25 155.28 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 126.05 1.74 . . . . 0.0 111.701 -173.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.58 -88.95 1.03 Allowed Glycine 0 CA--C 1.533 1.192 0 O-C-N 121.429 -0.794 . . . . 0.0 112.761 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 85.3 m -154.25 154.2 33.04 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.164 1.386 . . . . 0.0 109.479 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -73.37 125.24 90.89 Favored Pre-proline 0 CA--C 1.547 0.839 0 O-C-N 120.561 -1.337 . . . . 0.0 110.779 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.84 155.19 43.68 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 124.036 3.157 . . . . 0.0 114.529 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.4 t -83.84 -27.98 28.35 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -169.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.73 -34.64 2.82 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 125.27 1.414 . . . . 0.0 113.36 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -79.1 60.48 2.99 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.877 1.671 . . . . 0.0 111.185 169.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.7 m -136.87 156.45 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.736 1.614 . . . . 0.0 112.525 -171.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 29.2 mt -94.36 133.55 37.81 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.309 2.243 . . . . 0.0 109.481 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -118.03 113.47 21.69 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -173.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -88.79 148.91 20.63 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.174 1.369 . . . . 0.0 110.616 169.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 68.5 mtt85 -145.92 159.38 43.3 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 119.23 1.515 . . . . 0.0 112.408 -175.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -164.82 167.23 19.01 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.499 1.12 . . . . 0.0 113.657 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.2 m -119.59 134.12 55.36 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.079 1.752 . . . . 0.0 108.002 169.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -97.49 177.73 32.25 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-O 122.025 0.792 . . . . 0.0 114.966 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -81.33 -12.13 59.12 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -169.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -101.78 4.98 40.97 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.656 1.571 . . . . 0.0 112.099 169.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.03 17.13 33.23 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 126.214 1.864 . . . . 0.0 114.384 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.1 pm0 -78.61 173.14 12.74 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.704 1.602 . . . . 0.0 113.726 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 95.5 m -130.75 135.14 47.5 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.453 1.101 . . . . 0.0 109.366 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 74.5 t -120.17 143.79 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.491 1.516 . . . . 0.0 110.822 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.6 tp -134.08 151.15 51.27 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.853 1.661 . . . . 0.0 109.151 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.2 t -140.86 139.38 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.884 1.673 . . . . 0.0 108.154 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -134.11 134.89 42.78 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.69 0.757 . . . . 0.0 112.304 -176.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -129.81 147.23 64.59 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 126.033 1.733 . . . . 0.0 111.194 -176.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -61.06 133.07 45.05 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.428 2.085 . . . . 0.0 111.394 171.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 . . . . . 0 C--O 1.253 1.263 0 C-N-CA 124.741 1.217 . . . . 0.0 112.358 -179.962 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.767 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -77.56 165.44 24.31 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.929 1.292 . . . . 0.0 113.208 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.62 173.48 7.07 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.673 1.189 . . . . 0.0 113.687 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.8 p -65.37 152.4 43.94 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.311 1.044 . . . . 0.0 113.669 -175.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -114.41 -25.91 8.19 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.508 1.523 . . . . 0.0 113.696 177.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.2 t -93.5 -176.6 4.15 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.358 1.463 . . . . 0.0 112.24 175.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.7 mp -108.54 141.04 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.975 2.11 . . . . 0.0 108.916 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.4 t -52.89 145.95 11.69 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.478 0.711 . . . . 0.0 112.475 173.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.7 m -107.44 4.17 25.95 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.627 1.171 . . . . 0.0 113.462 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.6 p -120.1 -72.99 0.66 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.617 1.567 . . . . 0.0 110.524 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.12 -36.83 72.27 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.764 0.826 . . . . 0.0 112.511 -171.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.3 tp60 -85.8 -18.03 34.09 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.555 0.742 . . . . 0.0 112.029 175.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -80.94 -48.82 11.79 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.884 -1.135 . . . . 0.0 112.049 174.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.416 HH21 ' CD ' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -62.06 -36.9 83.03 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 120.91 -1.119 . . . . 0.0 112.787 -174.095 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.4 m -60.57 -24.37 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.434 0.693 . . . . 0.0 112.832 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -70.99 -38.7 72.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.122 0.874 . . . . 0.0 111.383 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.1 mt -71.63 -42.12 67.99 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.014 0.926 . . . . 0.0 111.717 -172.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.416 ' CD ' HH21 ' A' ' 14' ' ' ARG . 4.1 pt-20 -66.31 -32.61 74.12 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.091 0.956 . . . . 0.0 112.506 169.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.8 -37.78 88.76 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.749 -1.219 . . . . 0.0 112.299 170.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.8 t -69.63 -36.34 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.368 1.067 . . . . 0.0 111.748 172.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -60.37 -44.88 95.19 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.784 -1.197 . . . . 0.0 111.132 170.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.7 mp -67.55 -34.06 76.31 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-O 117.469 -1.253 . . . . 0.0 112.624 173.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.83 -34.56 69.81 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 121.167 1.803 . . . . 0.0 110.808 169.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.0 m -72.3 -38.32 68.76 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.177 0.991 . . . . 0.0 113.253 170.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.1 mm -72.91 -35.73 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 120.88 1.673 . . . . 0.0 111.112 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.0 t -66.73 -48.5 79.85 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.519 0 CA-C-O 117.387 -1.292 . . . . 0.0 109.221 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -53.25 -42.98 66.99 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 120.997 1.726 . . . . 0.0 112.273 171.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.6 m -60.52 -33.01 72.01 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.713 -0.617 . . . . 0.0 112.291 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -78.88 -35.11 44.18 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.669 1.587 . . . . 0.0 113.323 172.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.3 mt -66.46 -32.4 73.74 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.713 1.142 . . . . 0.0 111.723 174.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 92.2 mt -76.41 -35.92 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.908 1.283 . . . . 0.0 111.054 169.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.14 -38.57 46.92 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 125.474 1.511 . . . . 0.0 114.875 -172.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.5 t -151.34 -28.32 0.19 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 177.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.67 8.53 34.68 Favored Glycine 0 N--CA 1.475 1.278 0 N-CA-C 116.748 1.459 . . . . 0.0 116.748 174.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.2 m -157.14 145.25 19.31 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.55 1.54 . . . . 0.0 110.234 171.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.6 p -112.45 144.36 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.794 1.238 . . . . 0.0 110.634 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -129.68 159.9 35.03 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.023 1.329 . . . . 0.0 110.325 -173.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -52.97 -38.4 62.11 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -174.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -73.4 -15.73 61.35 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -87.33 -18.82 29.23 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.162 0.892 . . . . 0.0 112.617 171.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 76.5 mt -99.29 -32.49 11.16 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.91 1.684 . . . . 0.0 113.789 -176.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -61.19 -21.06 63.46 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 119.721 1.146 . . . . 0.0 114.082 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -83.77 -1.44 54.24 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.087 1.355 . . . . 0.0 113.558 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -118.41 -21.63 7.97 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.688 1.195 . . . . 0.0 113.611 -169.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -51.06 -59.65 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.09 0.956 . . . . 0.0 112.576 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 63.25 -19.7 0.05 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 118.098 2.629 . . . . 0.0 118.098 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -155.54 -26.07 0.11 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.66 160.81 23.64 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.866 0.867 . . . . 0.0 113.235 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.2 tpt85 -83.86 -48.35 10.12 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.768 0.827 . . . . 0.0 112.534 -177.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -130.69 135.31 47.71 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.919 1.688 . . . . 0.0 111.314 -174.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -113.77 142.47 46.01 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 119.201 0.91 . . . . 0.0 109.928 168.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.9 t -140.25 138.32 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.536 1.134 . . . . 0.0 110.009 -169.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.408 ' HA ' HD13 ' A' ' 53' ' ' ILE . 0.4 OUTLIER -124.24 136.68 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -172.44 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -131.16 89.23 2.7 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.955 1.702 . . . . 0.0 109.084 169.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.8 mt -101.35 134.88 20.03 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 124.696 1.198 . . . . 0.0 109.507 173.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.19 132.15 32.98 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.172 1.914 . . . . 0.0 111.671 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.01 -0.93 79.75 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.8 1.191 . . . . 0.0 115.79 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -137.55 155.82 75.15 Favored Pre-proline 0 N--CA 1.476 0.827 0 CA-C-N 119.336 1.568 . . . . 0.0 112.276 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.27 148.62 68.62 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.724 2.283 . . . . 0.0 112.618 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.2 p -55.66 135.92 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.282 1.033 . . . . 0.0 111.243 170.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.69 145.81 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.781 1.232 . . . . 0.0 110.904 170.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -132.92 125.54 30.09 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.294 1.437 . . . . 0.0 110.059 -174.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.6 t -95.96 149.17 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.818 1.647 . . . . 0.0 110.382 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.03 -98.94 1.36 Allowed Glycine 0 CA--C 1.532 1.113 0 O-C-N 121.486 -0.759 . . . . 0.0 112.116 175.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.4 m -153.83 146.07 23.84 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.665 1.232 . . . . 0.0 110.832 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -68.31 125.22 91.36 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 121.049 -1.032 . . . . 0.0 111.444 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.511 ' HB2' HG11 ' A' ' 71' ' ' VAL . 95.8 Cg_endo -81.72 162.8 18.83 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.122 3.214 . . . . 0.0 115.053 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.6 t -102.85 -31.8 10.1 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 116.793 2.146 . . . . 0.0 116.793 -168.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.49 -29.93 1.17 Allowed Glycine 0 N--CA 1.478 1.464 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.0 p30 -85.46 55.97 3.75 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 122.557 1.17 . . . . 0.0 110.157 169.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.511 HG11 ' HB2' ' A' ' 67' ' ' PRO . 27.9 m -133.74 157.12 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.561 1.544 . . . . 0.0 111.195 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 67.9 mt -87.88 153.08 21.6 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.707 2.003 . . . . 0.0 109.005 169.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -128.84 115.01 17.25 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.124 0.42 . . . . 0.0 111.26 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.83 141.27 15.46 Favored Glycine 0 N--CA 1.468 0.786 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 169.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -149.36 145.26 26.91 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 119.768 1.784 . . . . 0.0 112.953 -169.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.03 160.88 43.03 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.172 0.989 . . . . 0.0 113.521 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.6 m -113.36 125.95 54.83 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.099 1.36 . . . . 0.0 109.063 171.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.58 178.58 45.79 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.215 0.912 . . . . 0.0 115.001 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -84.21 -11.91 55.72 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 -169.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -96.93 3.39 52.11 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 120.573 1.533 . . . . 0.0 111.803 169.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.65 18.83 29.04 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 126.418 1.961 . . . . 0.0 114.379 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.8 pm0 -84.28 171.86 12.35 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.642 1.577 . . . . 0.0 114.558 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 90.9 m -125.7 133.27 52.19 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.962 1.305 . . . . 0.0 110.198 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.1 t -117.26 142.13 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.705 1.602 . . . . 0.0 109.805 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.5 tp -134.03 148.17 51.05 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.066 1.346 . . . . 0.0 110.878 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.4 t -134.12 135.76 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.92 2.088 . . . . 0.0 108.029 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -138.52 137.81 37.44 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.988 0.813 . . . . 0.0 112.958 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -153.17 153.96 30.22 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.215 1.006 . . . . 0.0 113.344 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -63.77 141.87 80.52 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.102 2.535 . . . . 0.0 114.452 -171.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 . . . . . 0 C--O 1.253 1.263 0 C-N-CA 127.109 2.163 . . . . 0.0 113.45 -173.755 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.897 0 N-CA-C 111.614 -0.595 . . . . 0.0 111.614 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.0 m 61.38 0.04 0.41 Allowed 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 118.37 2.73 . . . . 0.0 118.37 171.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -144.66 128.87 17.72 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.745 1.218 . . . . 0.0 111.594 -177.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.5 p -71.06 160.12 33.47 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.846 1.258 . . . . 0.0 113.36 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -115.82 -9.57 11.84 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -170.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.8 m 55.0 64.1 1.91 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.327 1.451 . . . . 0.0 112.085 -175.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.8 mt -129.02 140.52 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 126.733 2.013 . . . . 0.0 107.641 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.6 p -81.58 31.94 0.35 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 116.288 1.958 . . . . 0.0 116.288 -169.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.3 m -68.04 49.22 0.06 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 128.626 2.77 . . . . 0.0 114.89 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.4 p -139.19 -66.2 0.47 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 128.562 2.745 . . . . 0.0 106.965 169.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.48 -44.94 66.67 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.53 1.532 . . . . 0.0 112.942 175.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -76.78 -21.43 55.17 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.565 -0.709 . . . . 0.0 112.171 174.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -73.51 -50.52 21.06 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.01 -1.056 . . . . 0.0 111.662 173.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.46 -38.26 77.16 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 121.273 -0.892 . . . . 0.0 112.689 -173.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.7 m -61.19 -22.33 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 123.864 0.727 . . . . 0.0 112.711 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -68.85 -43.65 75.01 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 119.258 0.935 . . . . 0.0 112.369 175.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.66 -41.55 71.94 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.335 -0.853 . . . . 0.0 111.466 -171.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -64.34 -32.51 74.15 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.531 1.133 . . . . 0.0 112.519 171.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.19 -39.33 82.51 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.707 -1.246 . . . . 0.0 112.468 171.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.1 t -65.32 -41.12 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.783 0.833 . . . . 0.0 111.116 172.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -57.85 -42.01 83.55 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.42 -0.8 . . . . 0.0 111.844 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.46 -33.8 73.44 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 117.583 -1.198 . . . . 0.0 113.31 173.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.97 -33.87 65.18 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 120.856 1.662 . . . . 0.0 111.24 169.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.6 m -73.06 -37.64 66.75 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 170.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.6 mm -72.05 -33.71 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 120.975 1.716 . . . . 0.0 110.792 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.406 HG21 HD11 ' A' ' 53' ' ' ILE . 93.4 t -69.25 -46.73 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.599 1.16 . . . . 0.0 109.748 175.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -53.44 -42.99 67.69 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.693 1.588 . . . . 0.0 112.044 170.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.8 m -60.43 -29.81 69.23 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.779 -0.576 . . . . 0.0 112.27 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -82.2 -35.17 28.57 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.81 1.644 . . . . 0.0 113.514 172.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.7 mt -65.87 -34.92 79.26 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.897 1.226 . . . . 0.0 111.578 174.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 91.8 mt -73.75 -36.32 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.731 1.212 . . . . 0.0 110.828 169.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.08 -37.73 55.68 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 125.557 1.551 . . . . 0.0 114.682 -172.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.5 t -154.23 -26.96 0.13 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.4 9.46 35.95 Favored Glycine 0 N--CA 1.478 1.463 0 N-CA-C 116.565 1.386 . . . . 0.0 116.565 175.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.3 m -158.79 142.73 15.35 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.788 1.635 . . . . 0.0 110.095 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -107.38 146.73 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.733 1.213 . . . . 0.0 110.676 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -130.1 160.2 34.46 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.473 1.509 . . . . 0.0 109.965 -177.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -54.61 -37.5 65.66 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.647 -0.658 . . . . 0.0 112.724 -175.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -66.21 -21.87 66.32 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.706 1.202 . . . . 0.0 113.561 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -92.66 5.92 49.28 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.751 1.22 . . . . 0.0 112.964 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.5 mt -127.65 -26.49 2.97 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.7 ptt85 -62.83 -23.09 67.11 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 120.219 -1.55 . . . . 0.0 114.565 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.94 -5.09 57.09 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.686 1.594 . . . . 0.0 112.611 173.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -107.72 -22.89 12.31 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.263 1.825 . . . . 0.0 111.561 -169.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -53.15 -64.91 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.691 1.197 . . . . 0.0 111.36 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 64.8 -12.62 0.12 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.566 2.346 . . . . 0.0 116.686 171.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -153.15 -28.06 0.14 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.96 0.904 . . . . 0.0 112.977 176.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.61 154.27 23.84 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 175.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.02 -54.84 13.0 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.839 1.256 . . . . 0.0 110.557 169.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -131.69 133.26 44.67 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.195 0.598 . . . . 0.0 112.07 -170.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.46 141.72 39.9 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.535 -0.728 . . . . 0.0 109.587 169.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.9 t -137.55 141.68 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.655 1.182 . . . . 0.0 110.191 -171.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.406 HD11 HG21 ' A' ' 26' ' ' VAL . 0.8 OUTLIER -119.91 132.01 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -169.845 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -130.93 77.3 1.78 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.906 1.682 . . . . 0.0 109.857 171.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.4 mt -95.49 127.98 39.89 Favored Pre-proline 0 N--CA 1.478 0.97 0 O-C-N 121.262 -0.899 . . . . 0.0 109.159 171.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.91 134.17 58.45 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.46 2.107 . . . . 0.0 112.682 173.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.07 0.12 87.29 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 124.838 1.209 . . . . 0.0 116.017 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -137.1 157.21 74.93 Favored Pre-proline 0 CA--C 1.548 0.883 0 CA-C-N 119.232 1.516 . . . . 0.0 112.154 173.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -70.12 151.03 66.82 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.783 2.322 . . . . 0.0 113.057 -174.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.9 p -58.29 132.48 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.296 1.038 . . . . 0.0 111.467 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 86.6 t -110.94 142.01 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.593 1.557 . . . . 0.0 109.096 170.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -135.63 118.0 15.7 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.12 1.368 . . . . 0.0 109.115 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.7 t -92.57 153.7 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.286 1.834 . . . . 0.0 111.169 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.48 -101.71 1.42 Allowed Glycine 0 CA--C 1.533 1.157 0 O-C-N 121.321 -0.862 . . . . 0.0 112.472 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.4 m -144.29 147.89 34.11 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.388 1.075 . . . . 0.0 109.946 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -70.37 125.64 92.06 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 120.687 -1.258 . . . . 0.0 111.031 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.419 ' CB ' HG11 ' A' ' 71' ' ' VAL . 62.2 Cg_endo -77.42 155.15 32.11 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 124.052 3.168 . . . . 0.0 114.824 -174.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.5 t -85.19 -31.35 23.26 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -169.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 133.51 -36.74 2.09 Favored Glycine 0 N--CA 1.478 1.467 0 C-N-CA 125.05 1.309 . . . . 0.0 112.321 -173.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -78.8 63.13 3.47 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.464 1.506 . . . . 0.0 110.101 169.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.419 HG11 ' CB ' ' A' ' 67' ' ' PRO . 27.7 m -138.98 151.83 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.506 1.523 . . . . 0.0 111.976 -176.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.9 mt -85.78 141.39 29.71 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.952 2.101 . . . . 0.0 109.122 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -121.43 110.35 15.96 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.366 0.53 . . . . 0.0 112.129 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.14 143.16 17.25 Favored Glycine 0 N--CA 1.467 0.755 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 169.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -153.68 134.83 14.02 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.886 1.843 . . . . 0.0 113.003 -169.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -142.63 161.44 38.08 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.503 1.121 . . . . 0.0 113.704 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.5 m -112.45 127.98 56.19 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.853 1.261 . . . . 0.0 108.72 171.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.18 174.51 40.42 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.206 0.908 . . . . 0.0 114.986 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -79.88 -11.41 59.81 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 -169.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -101.07 4.88 42.65 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 120.744 1.611 . . . . 0.0 112.355 169.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.67 17.4 30.9 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 126.031 1.777 . . . . 0.0 114.355 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.2 pm0 -83.79 172.98 11.67 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.792 1.637 . . . . 0.0 113.791 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.6 m -126.86 131.43 51.19 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.27 1.428 . . . . 0.0 109.681 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.1 t -113.68 141.02 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.624 1.57 . . . . 0.0 110.067 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.6 tp -129.89 148.23 51.74 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.087 1.355 . . . . 0.0 109.864 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.8 t -133.37 136.79 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.08 1.752 . . . . 0.0 108.317 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -131.68 131.99 43.57 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.783 0.801 . . . . 0.0 111.934 -176.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -131.84 148.31 69.41 Favored Pre-proline 0 N--CA 1.473 0.691 0 C-N-CA 126.163 1.785 . . . . 0.0 111.065 -173.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -61.39 134.91 54.38 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.87 2.38 . . . . 0.0 112.529 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 125.744 1.618 . . . . 0.0 112.438 177.479 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.686 0 N-CA-C 112.205 -0.358 . . . . 0.0 112.205 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.9 t -84.22 166.91 17.14 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.499 1.119 . . . . 0.0 112.966 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.97 156.13 25.41 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.562 1.145 . . . . 0.0 112.75 173.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.1 m -163.71 119.98 1.7 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.407 1.483 . . . . 0.0 109.466 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -49.6 129.25 19.11 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.99 1.316 . . . . 0.0 113.753 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.1 t -80.52 170.34 16.48 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.716 1.206 . . . . 0.0 113.549 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 68.3 mt -126.09 135.08 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 126.727 2.011 . . . . 0.0 108.583 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -124.3 138.36 54.39 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -169.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.1 m -62.43 24.52 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 128.628 2.771 . . . . 0.0 116.796 174.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.7 p -117.04 -64.53 1.3 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 127.821 2.448 . . . . 0.0 109.634 169.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.09 -35.03 66.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.447 1.099 . . . . 0.0 113.213 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -87.72 -16.99 32.71 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.692 -0.63 . . . . 0.0 112.246 174.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -79.75 -45.41 18.92 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.844 -1.16 . . . . 0.0 112.055 173.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -31.34 71.84 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -173.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.6 m -68.07 -21.46 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 172.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -71.17 -42.9 68.49 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 120.699 -1.251 . . . . 0.0 112.209 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.88 -39.1 76.49 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.386 -0.821 . . . . 0.0 111.301 -171.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.07 -28.83 65.75 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.721 1.208 . . . . 0.0 112.818 173.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.98 -39.76 87.26 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.764 -1.21 . . . . 0.0 111.381 169.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.4 t -67.92 -36.1 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.107 0.963 . . . . 0.0 111.538 174.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -59.26 -46.28 88.94 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.224 -0.923 . . . . 0.0 111.095 170.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.2 mp -69.07 -35.44 76.52 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 117.093 -1.432 . . . . 0.0 113.099 175.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.07 -38.69 68.38 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 121.066 1.757 . . . . 0.0 110.235 169.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.7 m -67.95 -38.82 83.26 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.152 0.981 . . . . 0.0 113.523 172.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.9 mm -72.35 -35.11 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 120.72 1.6 . . . . 0.0 110.748 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.2 t -68.82 -43.82 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.374 1.469 . . . . 0.0 110.235 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -56.54 -40.03 74.43 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 121.126 1.784 . . . . 0.0 112.34 169.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -62.79 -23.96 67.5 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 174.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -85.84 -36.86 19.75 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.295 1.838 . . . . 0.0 112.987 171.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.5 mt -68.92 -40.29 79.15 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 120.093 1.315 . . . . 0.0 111.984 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 86.2 mt -69.37 -32.18 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.457 1.503 . . . . 0.0 110.958 174.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.95 -75.34 0.77 Allowed Glycine 0 C--N 1.338 0.694 0 C-N-CA 125.36 1.457 . . . . 0.0 111.359 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.6 t -118.5 -26.73 6.12 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -170.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.61 0.74 46.41 Favored Glycine 0 N--CA 1.475 1.252 0 N-CA-C 116.972 1.549 . . . . 0.0 116.972 171.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.7 m -147.79 134.64 20.11 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.097 1.759 . . . . 0.0 109.956 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.5 p -104.86 147.92 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.04 1.336 . . . . 0.0 110.918 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -133.05 160.74 36.28 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.302 1.441 . . . . 0.0 110.702 -175.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -58.0 -37.7 74.74 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.745 -0.597 . . . . 0.0 111.899 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.73 -23.5 63.4 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.069 0.948 . . . . 0.0 113.187 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -77.79 -27.39 50.16 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.799 0.727 . . . . 0.0 112.16 174.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 72.3 mt -97.7 -28.1 14.05 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.587 1.555 . . . . 0.0 114.687 -173.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.2 ptt85 -62.03 -23.36 66.41 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 119.974 1.261 . . . . 0.0 113.702 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -88.23 5.97 39.08 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.314 1.446 . . . . 0.0 114.456 171.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -119.09 -15.04 9.29 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.947 1.249 . . . . 0.0 113.061 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -54.29 -59.01 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.74 0.816 . . . . 0.0 112.202 177.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.255 20.9 mmt85 65.53 -12.53 0.15 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 117.832 2.53 . . . . 0.0 117.832 174.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -164.56 -29.35 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.898 1.279 . . . . 0.0 112.602 169.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.22 153.09 43.43 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.057 0.943 . . . . 0.0 112.824 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -76.04 -53.36 8.47 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.159 0.583 . . . . 0.0 111.703 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -132.58 131.72 41.77 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.008 1.323 . . . . 0.0 111.742 -176.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -104.81 144.6 31.54 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 119.784 1.174 . . . . 0.0 110.659 169.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 37.4 t -140.8 141.18 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.445 1.098 . . . . 0.0 111.821 -169.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 mm -118.06 140.16 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.801 1.24 . . . . 0.0 114.13 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -139.89 72.69 1.4 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 128.098 2.559 . . . . 0.0 109.537 169.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.0 mt -91.73 127.77 48.83 Favored Pre-proline 0 N--CA 1.484 1.241 0 O-C-N 121.009 -1.057 . . . . 0.0 109.898 172.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -60.77 136.41 66.22 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.995 2.463 . . . . 0.0 112.9 171.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.23 2.11 89.34 Favored Glycine 0 CA--C 1.536 1.367 0 N-CA-C 115.912 1.125 . . . . 0.0 115.912 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -139.79 157.35 69.95 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 118.901 1.351 . . . . 0.0 111.877 174.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.01 143.78 73.62 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.426 2.084 . . . . 0.0 112.956 -176.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.57 135.5 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.256 1.422 . . . . 0.0 110.945 172.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.2 p -129.37 142.65 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.798 0.839 . . . . 0.0 111.891 171.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -140.11 123.47 16.98 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.409 1.083 . . . . 0.0 110.099 -173.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.5 t -95.5 155.2 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 127.015 2.126 . . . . 0.0 111.128 -172.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.26 -96.56 1.12 Allowed Glycine 0 CA--C 1.53 1.009 0 O-C-N 121.087 -1.008 . . . . 0.0 112.536 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.0 m -155.97 155.39 32.68 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.174 0.99 . . . . 0.0 110.211 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -68.96 132.17 90.55 Favored Pre-proline 0 CA--C 1.546 0.803 0 O-C-N 120.93 -1.106 . . . . 0.0 110.425 171.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.65 160.76 34.51 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 124.18 3.253 . . . . 0.0 114.121 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.6 t -85.7 -28.36 24.72 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -173.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.68 -32.83 3.24 Favored Glycine 0 N--CA 1.478 1.44 0 C-N-CA 125.644 1.592 . . . . 0.0 112.709 -176.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -77.44 60.2 2.02 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.403 1.881 . . . . 0.0 111.114 169.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.0 m -138.51 155.05 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.273 1.429 . . . . 0.0 113.177 -172.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.5 mt -91.03 142.4 27.81 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 128.029 2.532 . . . . 0.0 109.092 171.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -126.42 112.62 15.83 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.753 0.706 . . . . 0.0 111.311 -176.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.53 149.88 19.44 Favored Glycine 0 N--CA 1.469 0.871 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 169.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -147.19 148.56 31.63 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 118.656 1.228 . . . . 0.0 112.099 -169.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.3 166.33 33.76 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.412 1.085 . . . . 0.0 112.865 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.6 m -132.49 123.11 25.97 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.325 1.45 . . . . 0.0 109.634 172.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.62 176.43 42.44 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.0 1.286 . . . . 0.0 113.651 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -49.13 -45.0 42.97 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 126.347 1.859 . . . . 0.0 111.775 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -83.39 3.58 31.22 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 -170.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.65 25.38 13.6 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.666 0.651 . . . . 0.0 113.298 173.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.39 -166.01 1.49 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.656 1.182 . . . . 0.0 113.914 -174.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 16.6 m -147.39 120.27 8.72 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.318 -1.489 . . . . 0.0 111.611 173.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 37.1 t -96.64 142.25 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 126.246 1.819 . . . . 0.0 108.998 169.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.5 tp -129.91 146.74 51.62 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.356 1.463 . . . . 0.0 108.975 169.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 p -133.86 142.07 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.02 1.328 . . . . 0.0 109.663 172.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -137.08 134.39 36.44 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.162 0.506 . . . . 0.0 111.825 -170.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -131.72 152.8 81.0 Favored Pre-proline 0 N--CA 1.473 0.714 0 C-N-CA 124.954 1.301 . . . . 0.0 112.524 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -56.91 137.56 82.26 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 122.641 2.227 . . . . 0.0 112.933 170.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 . . . . . 0 C--O 1.252 1.223 0 C-N-CA 125.798 1.639 . . . . 0.0 112.279 177.522 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.799 0 N-CA-C 111.984 -0.446 . . . . 0.0 111.984 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.7 m -59.66 142.59 52.65 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.912 1.285 . . . . 0.0 113.902 -175.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.23 159.87 28.2 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -177.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.2 m -66.73 136.57 55.7 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.013 1.325 . . . . 0.0 112.271 -176.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -59.15 112.02 1.55 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.01 1.324 . . . . 0.0 110.495 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.8 m -143.82 135.82 26.52 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.618 1.567 . . . . 0.0 110.164 -169.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.6 mt -114.35 128.2 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.644 1.177 . . . . 0.0 110.697 176.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 27.0 m -54.52 140.39 34.78 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.641 1.976 . . . . 0.0 115.307 -173.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 m -70.92 56.38 0.19 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.678 1.991 . . . . 0.0 112.769 170.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -141.6 -59.51 0.48 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 128.432 2.693 . . . . 0.0 108.281 172.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.97 -41.4 51.5 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.663 1.585 . . . . 0.0 112.303 171.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -83.29 -15.49 49.95 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -77.99 -50.5 12.01 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.72 -1.237 . . . . 0.0 112.107 173.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -59.9 -32.44 70.76 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -172.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.3 m -64.94 -21.81 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 174.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -67.94 -43.22 79.6 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 120.878 -1.139 . . . . 0.0 112.837 176.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mp -70.62 -41.68 71.92 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.444 -0.785 . . . . 0.0 111.816 -171.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.15 -30.92 71.97 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.364 1.066 . . . . 0.0 112.64 172.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.41 -36.97 79.88 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.925 -1.109 . . . . 0.0 112.447 171.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.4 t -69.87 -36.23 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 124.175 0.99 . . . . 0.0 111.376 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -58.37 -46.07 87.02 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.314 -0.866 . . . . 0.0 111.23 171.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.1 mp -70.05 -34.13 72.83 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-O 117.321 -1.323 . . . . 0.0 113.195 173.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.18 -34.86 68.9 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 121.365 1.893 . . . . 0.0 110.586 169.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.1 m -71.23 -41.53 70.03 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.301 1.04 . . . . 0.0 112.806 171.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.4 mm -70.66 -35.08 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 120.623 1.556 . . . . 0.0 111.201 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.3 t -65.11 -47.44 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.026 1.33 . . . . 0.0 109.99 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -52.97 -42.64 65.71 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.607 1.549 . . . . 0.0 112.124 171.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.3 t -59.33 -38.12 79.51 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.788 -0.57 . . . . 0.0 111.95 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.404 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . 18.2 tpt180 -72.47 -37.25 68.52 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.47 1.108 . . . . 0.0 113.367 172.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.6 mt -67.31 -32.35 73.27 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.877 1.217 . . . . 0.0 112.182 176.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 89.8 mt -74.15 -37.86 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 124.523 1.129 . . . . 0.0 110.826 169.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.1 -38.58 54.89 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 125.862 1.696 . . . . 0.0 114.52 -172.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.1 t -150.17 -30.52 0.21 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.29 4.47 35.24 Favored Glycine 0 N--CA 1.475 1.283 0 N-CA-C 117.105 1.602 . . . . 0.0 117.105 176.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.8 p -152.92 141.57 20.92 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.45 1.5 . . . . 0.0 111.34 177.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.5 t -99.67 139.19 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.124 1.37 . . . . 0.0 110.383 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -123.07 155.08 37.62 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.918 1.287 . . . . 0.0 109.806 174.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -54.76 -38.3 67.04 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.296 -0.878 . . . . 0.0 113.317 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -67.38 -17.69 64.83 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.404 ' CE2' ' HB2' ' A' ' 29' ' ' ARG . 91.3 t80 -85.11 -22.26 28.96 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 118.539 -0.743 . . . . 0.0 112.648 171.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.1 mt -97.6 -31.37 12.34 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.34 1.427 . . . . 0.0 114.439 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -58.88 -24.28 62.01 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -93.76 7.54 44.48 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.101 1.361 . . . . 0.0 113.456 174.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -127.62 -16.05 4.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.681 1.592 . . . . 0.0 113.246 -174.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -50.27 -66.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.125 0.875 . . . . 0.0 110.906 169.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 64.19 -16.25 0.08 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 128.255 2.622 . . . . 0.0 117.025 174.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -147.24 1.98 0.75 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.632 1.173 . . . . 0.0 114.042 -174.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.41 150.6 48.86 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.457 1.503 . . . . 0.0 113.094 -172.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.66 -56.15 10.49 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.017 1.327 . . . . 0.0 111.77 174.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -130.64 126.89 37.77 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.296 0.638 . . . . 0.0 111.107 -170.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.71 148.69 27.15 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.98 -1.075 . . . . 0.0 110.127 169.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.2 t -141.0 140.81 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.897 1.279 . . . . 0.0 110.717 -171.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 53' ' ' ILE . 0.6 OUTLIER -118.55 133.44 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.986 1.314 . . . . 0.0 113.576 -170.051 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -131.88 79.61 1.88 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.738 1.615 . . . . 0.0 109.381 169.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.5 mt -96.91 123.65 52.78 Favored Pre-proline 0 N--CA 1.479 0.991 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 173.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.86 132.51 50.22 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.407 2.071 . . . . 0.0 112.501 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.53 2.57 87.09 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.906 1.241 . . . . 0.0 115.776 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -135.92 162.11 58.71 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-N 119.806 1.803 . . . . 0.0 114.084 171.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -62.94 143.64 91.64 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.481 2.787 . . . . 0.0 114.136 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 p -58.0 133.84 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.775 0.83 . . . . 0.0 110.631 169.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 71.4 t -114.01 141.71 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.765 1.226 . . . . 0.0 109.313 172.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -134.87 119.55 18.22 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.988 1.315 . . . . 0.0 109.554 177.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.4 t -90.39 152.51 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.366 1.466 . . . . 0.0 111.085 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.08 -105.48 2.24 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 121.368 -0.833 . . . . 0.0 112.621 170.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.8 m -145.02 148.87 34.21 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.544 1.137 . . . . 0.0 110.052 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -67.95 128.62 93.34 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 120.598 -1.314 . . . . 0.0 111.298 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.447 ' CB ' HG11 ' A' ' 71' ' ' VAL . 73.7 Cg_endo -80.18 152.94 21.42 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.264 3.309 . . . . 0.0 114.922 -177.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.7 t -82.9 -31.36 27.89 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -169.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.31 -35.03 2.42 Favored Glycine 0 N--CA 1.479 1.544 0 C-N-CA 125.246 1.403 . . . . 0.0 112.458 -174.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -79.44 61.14 3.4 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.306 1.442 . . . . 0.0 109.922 169.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.447 HG11 ' CB ' ' A' ' 67' ' ' PRO . 32.2 m -138.84 156.33 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.934 1.693 . . . . 0.0 111.398 -175.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.5 mt -91.72 138.61 31.42 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 127.734 2.414 . . . . 0.0 108.869 173.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -119.19 113.25 20.59 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.271 0.487 . . . . 0.0 111.741 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.68 144.68 17.47 Favored Glycine 0 N--CA 1.467 0.722 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 169.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -152.99 138.9 18.06 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.07 1.935 . . . . 0.0 112.853 -169.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.91 164.72 30.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.675 1.19 . . . . 0.0 114.043 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.3 m -119.74 125.21 48.07 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.223 1.409 . . . . 0.0 109.273 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.05 173.95 43.5 Favored Glycine 0 CA--C 1.54 1.653 0 C-N-CA 124.488 1.042 . . . . 0.0 115.26 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -81.59 -12.28 58.81 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -169.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -95.04 2.52 55.28 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 120.333 1.424 . . . . 0.0 112.161 169.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.93 15.03 46.99 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 126.783 2.135 . . . . 0.0 115.077 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 20.4 pm0 -78.68 172.4 13.76 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.992 1.717 . . . . 0.0 113.253 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.6 m -129.49 138.27 51.29 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.597 1.559 . . . . 0.0 110.342 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 88.6 t -122.52 140.27 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.471 1.508 . . . . 0.0 109.957 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.5 tp -128.79 148.35 50.86 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.181 1.392 . . . . 0.0 109.674 173.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.7 t -134.25 136.77 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.79 1.636 . . . . 0.0 108.275 176.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -131.01 129.98 42.75 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 122.031 0.919 . . . . 0.0 111.907 -176.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -130.44 142.25 44.79 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 126.661 1.984 . . . . 0.0 110.501 -171.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -61.89 133.67 45.91 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.435 2.09 . . . . 0.0 112.004 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 70.0 ttp85 . . . . . 0 C--O 1.252 1.211 0 C-N-CA 125.133 1.373 . . . . 0.0 112.33 -179.902 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.761 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.1 p -69.05 161.02 29.91 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.787 1.235 . . . . 0.0 114.295 -178.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -128.86 153.1 47.79 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.719 1.608 . . . . 0.0 112.238 -178.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 90.6 m -154.19 146.03 23.45 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.151 1.381 . . . . 0.0 110.669 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.51 136.55 38.34 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.812 1.245 . . . . 0.0 111.554 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.4 m -69.8 117.93 12.02 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.94 0.896 . . . . 0.0 110.328 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.5 mt -75.51 135.61 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-O 122.011 0.91 . . . . 0.0 111.516 -169.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.1 m -89.07 41.84 1.05 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.096 1.759 . . . . 0.0 113.668 -175.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.1 m -62.42 32.64 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 129.472 3.109 . . . . 0.0 117.636 -170.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.3 p -132.16 -64.5 0.77 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.28 2.232 . . . . 0.0 107.633 169.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.28 -43.43 70.46 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.473 1.509 . . . . 0.0 113.291 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -77.63 -22.9 50.01 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.026 0.93 . . . . 0.0 112.129 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -71.8 -50.62 28.12 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.299 -0.876 . . . . 0.0 111.632 173.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -59.48 -37.9 79.44 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.755 0.822 . . . . 0.0 112.889 -172.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.9 m -60.46 -22.65 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.666 0.786 . . . . 0.0 112.027 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -65.39 -42.94 92.11 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.251 0.932 . . . . 0.0 112.13 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.1 mp -73.86 -41.15 62.63 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.315 -0.866 . . . . 0.0 111.404 -170.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -67.73 -29.19 68.37 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.202 1.001 . . . . 0.0 112.799 171.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.06 -37.76 84.6 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 120.607 -1.308 . . . . 0.0 112.292 169.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.6 t -69.01 -36.15 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.002 0.921 . . . . 0.0 111.417 172.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -60.24 -44.57 95.12 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.12 -0.987 . . . . 0.0 111.421 171.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.0 mp -69.97 -34.18 73.04 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-O 117.343 -1.313 . . . . 0.0 112.673 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.434 ' HA ' HG21 ' A' ' 84' ' ' VAL . . . -57.95 -33.44 68.83 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 121.144 1.793 . . . . 0.0 110.883 169.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.1 m -72.25 -38.66 68.85 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.27 1.028 . . . . 0.0 113.432 171.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -74.11 -34.86 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 120.99 1.723 . . . . 0.0 111.073 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.471 HG21 HD11 ' A' ' 53' ' ' ILE . 97.5 t -64.86 -48.3 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.83 1.252 . . . . 0.0 109.62 173.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -54.12 -43.49 70.53 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.764 1.62 . . . . 0.0 112.086 172.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.2 m -59.45 -31.48 69.35 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.636 -0.665 . . . . 0.0 112.407 175.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -80.19 -35.19 36.74 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.715 1.606 . . . . 0.0 113.381 172.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 67.1 mt -66.59 -33.5 75.79 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 120.058 1.299 . . . . 0.0 111.643 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 91.1 mt -73.82 -36.46 46.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.904 1.281 . . . . 0.0 110.777 169.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.99 -38.72 55.62 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 125.632 1.587 . . . . 0.0 114.826 -173.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.2 t -152.5 -26.39 0.17 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.51 11.19 39.15 Favored Glycine 0 N--CA 1.48 1.581 0 N-CA-C 116.234 1.254 . . . . 0.0 116.234 175.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.8 m -157.69 143.4 17.27 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.886 1.674 . . . . 0.0 109.492 173.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.83 145.74 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.135 1.374 . . . . 0.0 109.858 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -130.49 158.77 39.01 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.723 1.209 . . . . 0.0 110.754 -172.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -56.11 -38.72 71.15 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.776 -0.577 . . . . 0.0 112.313 -177.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -70.96 -18.32 62.63 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -78.46 -38.28 41.52 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.211 0.914 . . . . 0.0 111.088 169.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 58.4 mt -87.35 -28.5 22.18 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -169.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -59.73 -21.14 60.28 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 172.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -83.56 -7.68 59.47 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.829 1.251 . . . . 0.0 114.032 174.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -115.46 -14.2 11.57 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.785 1.234 . . . . 0.0 113.302 -169.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -55.06 -58.73 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.486 0.714 . . . . 0.0 111.812 175.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.261 26.6 mmm180 64.2 -13.53 0.1 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 127.902 2.481 . . . . 0.0 117.659 172.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -159.89 -29.31 0.06 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.968 1.307 . . . . 0.0 113.168 169.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.38 159.17 33.7 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.325 1.05 . . . . 0.0 113.343 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -80.7 -54.04 5.98 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.535 0.734 . . . . 0.0 112.649 -176.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -130.34 133.98 46.84 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.533 1.533 . . . . 0.0 110.877 -174.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.78 141.75 40.33 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.137 -0.977 . . . . 0.0 109.79 169.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.6 t -136.62 142.39 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.526 1.13 . . . . 0.0 111.024 -173.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.471 HD11 HG21 ' A' ' 26' ' ' VAL . 0.6 OUTLIER -124.15 134.68 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.89 1.276 . . . . 0.0 114.226 -169.742 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -138.75 77.99 1.65 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.109 1.764 . . . . 0.0 109.679 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.0 mt -95.89 132.32 27.35 Favored Pre-proline 0 N--CA 1.478 0.947 0 C-N-CA 124.982 1.313 . . . . 0.0 109.523 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.1 134.66 37.58 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.196 1.931 . . . . 0.0 111.545 174.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.82 1.26 85.28 Favored Glycine 0 CA--C 1.536 1.36 0 N-CA-C 116.043 1.177 . . . . 0.0 116.043 177.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -138.78 156.9 72.64 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-N 119.073 1.437 . . . . 0.0 111.954 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.39 150.33 75.79 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.705 2.27 . . . . 0.0 112.969 -174.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 50.7 t -60.44 131.88 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.278 1.031 . . . . 0.0 110.358 173.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 72.4 t -112.62 140.25 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.454 1.502 . . . . 0.0 109.469 173.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -135.07 118.15 16.44 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.037 1.335 . . . . 0.0 109.421 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.7 t -94.62 151.77 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.881 1.672 . . . . 0.0 111.032 -177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.66 -93.5 1.03 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 121.283 -0.886 . . . . 0.0 112.317 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 m -154.74 152.58 30.06 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.669 -0.901 . . . . 0.0 110.463 175.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -69.17 129.4 92.02 Favored Pre-proline 0 CA--C 1.547 0.863 0 O-C-N 120.928 -1.108 . . . . 0.0 110.722 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.43 ' CB ' HG11 ' A' ' 71' ' ' VAL . 75.3 Cg_endo -78.6 158.71 28.63 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 124.3 3.333 . . . . 0.0 114.602 -176.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.3 t -83.29 -25.19 31.8 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -171.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.59 -34.17 3.71 Favored Glycine 0 N--CA 1.478 1.442 0 C-N-CA 125.713 1.625 . . . . 0.0 112.804 -175.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -79.03 61.36 3.18 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.738 1.615 . . . . 0.0 111.261 169.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.43 HG11 ' CB ' ' A' ' 67' ' ' PRO . 29.9 m -136.93 158.95 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 126.343 1.857 . . . . 0.0 112.526 -173.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 27.9 mt -92.77 139.41 30.58 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.826 2.051 . . . . 0.0 108.799 172.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -127.55 113.56 16.28 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.101 0.961 . . . . 0.0 110.506 -175.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -97.75 145.4 17.79 Favored Glycine 0 N--CA 1.467 0.727 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -148.01 139.31 23.52 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.763 1.282 . . . . 0.0 112.682 -169.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.24 162.39 36.48 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.609 1.164 . . . . 0.0 113.181 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 74.5 m -114.16 124.65 52.59 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.19 1.396 . . . . 0.0 108.423 172.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.54 173.31 45.63 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-O 122.166 0.87 . . . . 0.0 114.424 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -79.63 -17.35 54.0 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -169.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -92.84 4.81 53.17 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.646 1.566 . . . . 0.0 112.543 169.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.37 16.96 32.93 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 126.136 1.827 . . . . 0.0 114.308 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.9 pm0 -82.92 171.55 13.75 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.471 1.508 . . . . 0.0 114.206 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.5 m -123.14 132.99 54.29 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.66 1.584 . . . . 0.0 109.203 175.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.434 HG21 ' HA ' ' A' ' 23' ' ' ALA . 17.4 t -127.51 140.68 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.629 1.171 . . . . 0.0 110.155 -176.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.5 tp -133.42 147.66 51.74 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.293 1.037 . . . . 0.0 110.76 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.09 143.28 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.816 1.246 . . . . 0.0 109.565 170.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -137.37 137.5 38.93 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -173.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -132.13 151.27 78.11 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 125.793 1.637 . . . . 0.0 112.432 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -58.68 135.86 70.09 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.405 2.07 . . . . 0.0 111.996 169.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 . . . . . 0 C--O 1.253 1.285 0 C-N-CA 124.938 1.295 . . . . 0.0 112.179 178.614 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.734 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.1 p -76.05 159.85 30.38 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.689 1.196 . . . . 0.0 113.103 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -147.74 149.07 31.71 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.954 1.302 . . . . 0.0 111.845 -177.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.7 m -59.4 150.63 25.87 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.518 1.527 . . . . 0.0 112.834 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -101.21 -28.2 12.79 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -176.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.9 m -78.85 128.2 33.03 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.978 1.311 . . . . 0.0 110.958 -176.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.3 mm -93.72 146.8 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.582 1.153 . . . . 0.0 110.504 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.5 m -75.75 34.83 0.12 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.004 1.722 . . . . 0.0 115.625 -172.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.4 m -70.17 51.71 0.12 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 128.269 2.628 . . . . 0.0 115.009 -173.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -140.09 -68.67 0.41 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 128.437 2.695 . . . . 0.0 106.939 169.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.75 -43.74 68.22 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.623 1.569 . . . . 0.0 112.677 176.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -77.41 -21.11 53.61 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.637 -0.665 . . . . 0.0 112.33 175.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -73.72 -51.12 17.62 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 121.166 -0.959 . . . . 0.0 111.583 173.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -37.98 77.68 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 121.294 -0.879 . . . . 0.0 112.732 -173.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 m -62.52 -21.74 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -70.44 -44.06 68.63 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 119.132 0.878 . . . . 0.0 112.146 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.57 -42.26 71.33 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.083 -1.011 . . . . 0.0 111.367 -172.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -63.27 -32.73 74.22 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.395 1.078 . . . . 0.0 112.449 171.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.09 84.04 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.752 -1.217 . . . . 0.0 112.308 171.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.6 t -64.79 -40.33 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.802 0.841 . . . . 0.0 111.071 174.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -57.07 -44.72 83.34 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.536 -0.728 . . . . 0.0 112.145 171.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.9 mp -68.45 -33.91 75.02 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 116.871 -1.538 . . . . 0.0 112.943 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.11 -39.53 69.46 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 121.252 1.842 . . . . 0.0 110.308 169.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.6 m -70.09 -38.25 75.64 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 172.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.9 mm -70.42 -34.21 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 121.181 1.81 . . . . 0.0 110.813 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.2 t -66.57 -48.51 80.17 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 C-N-CA 124.945 1.298 . . . . 0.0 110.092 173.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -54.86 -39.52 68.72 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 121.408 1.913 . . . . 0.0 112.802 171.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.4 m -61.84 -29.08 69.93 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.984 0.514 . . . . 0.0 112.066 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -82.68 -36.78 25.61 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.063 1.745 . . . . 0.0 113.438 171.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.61 -34.2 77.35 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.055 1.298 . . . . 0.0 111.566 175.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 92.0 mt -76.56 -36.7 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 124.618 1.167 . . . . 0.0 110.714 169.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.36 -37.85 53.63 Favored Glycine 0 C--N 1.341 0.849 0 C-N-CA 125.822 1.677 . . . . 0.0 114.698 -171.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.2 t -148.66 -30.44 0.27 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 175.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.78 12.07 27.05 Favored Glycine 0 N--CA 1.473 1.141 0 N-CA-C 116.703 1.441 . . . . 0.0 116.703 174.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.4 m -157.84 143.2 16.93 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.364 1.466 . . . . 0.0 109.736 170.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.2 p -112.36 141.45 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.384 1.474 . . . . 0.0 110.616 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -131.74 159.79 37.42 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.535 1.534 . . . . 0.0 110.45 -172.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -56.2 -38.54 71.14 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.38 -0.825 . . . . 0.0 113.056 -175.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -69.87 -21.77 63.3 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -77.23 -35.52 55.42 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.476 0.58 . . . . 0.0 111.78 169.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 58.8 mt -86.61 -29.19 22.76 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -174.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -61.15 -22.72 64.96 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -91.97 -0.19 57.48 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.271 1.029 . . . . 0.0 113.457 172.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -117.03 -17.37 10.36 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.178 1.391 . . . . 0.0 113.496 -173.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -48.75 -57.33 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.892 0.877 . . . . 0.0 111.08 170.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 63.26 -15.22 0.07 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 128.053 2.541 . . . . 0.0 117.499 173.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -155.73 -25.4 0.11 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.27 156.34 23.16 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.345 1.058 . . . . 0.0 112.937 177.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.78 -57.81 5.08 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.857 1.263 . . . . 0.0 111.328 170.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -129.9 132.97 46.58 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.955 0.502 . . . . 0.0 112.324 -170.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -111.52 141.24 45.35 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.636 -0.665 . . . . 0.0 109.555 168.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.0 t -138.89 138.23 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.681 1.192 . . . . 0.0 109.339 -169.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 53' ' ' ILE . 0.3 OUTLIER -120.62 132.83 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -169.879 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -129.75 84.11 2.19 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.263 1.825 . . . . 0.0 109.254 173.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.1 mt -99.06 134.37 21.44 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 124.208 1.003 . . . . 0.0 108.85 173.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.36 136.35 43.13 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.238 1.959 . . . . 0.0 111.514 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.76 0.28 83.98 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.638 1.113 . . . . 0.0 115.702 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -136.15 157.99 74.58 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 118.95 1.375 . . . . 0.0 112.564 175.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.59 151.75 64.54 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.676 2.251 . . . . 0.0 113.285 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.3 p -54.86 140.87 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.408 1.483 . . . . 0.0 112.328 172.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 85.0 t -116.18 140.81 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 125.864 1.666 . . . . 0.0 108.76 170.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -134.67 119.5 18.38 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.721 1.208 . . . . 0.0 110.12 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.1 t -93.77 154.99 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.716 2.006 . . . . 0.0 110.963 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.81 -105.13 1.67 Allowed Glycine 0 CA--C 1.533 1.203 0 O-C-N 121.216 -0.927 . . . . 0.0 111.521 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.2 t -153.87 161.04 42.35 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.033 0.917 . . . . 0.0 112.089 169.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -71.89 126.38 91.39 Favored Pre-proline 0 CA--C 1.548 0.878 0 O-C-N 120.902 -1.123 . . . . 0.0 111.85 -171.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.444 ' CB ' HG11 ' A' ' 71' ' ' VAL . 73.6 Cg_endo -79.54 155.68 24.6 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 124.069 3.18 . . . . 0.0 114.856 -175.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.431 HG23 ' H ' ' A' ' 70' ' ' ASP . 7.2 t -83.51 -20.46 33.89 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 115.81 1.781 . . . . 0.0 115.81 -169.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.39 -30.5 6.2 Favored Glycine 0 N--CA 1.479 1.559 0 C-N-CA 125.361 1.457 . . . . 0.0 113.12 -173.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.431 ' H ' HG23 ' A' ' 68' ' ' THR . 20.6 m-20 -82.13 60.11 4.75 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.424 1.489 . . . . 0.0 109.351 168.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.444 HG11 ' CB ' ' A' ' 67' ' ' PRO . 34.4 m -140.94 152.98 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 126.458 1.903 . . . . 0.0 110.381 -175.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.7 mt -79.59 146.43 32.57 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.023 1.729 . . . . 0.0 108.942 169.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -126.75 106.39 9.34 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.877 0.762 . . . . 0.0 109.979 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -88.82 149.4 20.93 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 169.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 33.2 ttt-85 -148.07 143.69 27.36 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.217 1.509 . . . . 0.0 112.013 -170.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -152.66 167.72 27.98 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.373 1.069 . . . . 0.0 113.251 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.0 m -134.09 128.1 33.51 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.708 1.603 . . . . 0.0 109.601 171.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.42 -175.09 49.87 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.6 1.572 . . . . 0.0 114.934 177.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -58.74 -45.38 89.8 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.256 1.422 . . . . 0.0 112.107 177.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -77.71 2.57 16.43 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -172.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.26 23.0 28.11 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.0 1.286 . . . . 0.0 113.465 172.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.11 -163.15 0.95 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.266 1.426 . . . . 0.0 114.111 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.1 m -146.15 128.68 16.03 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.336 -1.478 . . . . 0.0 111.361 175.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.3 t -105.2 142.51 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 126.195 1.798 . . . . 0.0 109.208 169.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.8 tp -129.15 141.49 51.16 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.083 1.353 . . . . 0.0 109.382 169.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.18 136.81 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.524 1.53 . . . . 0.0 108.461 173.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -131.67 130.97 42.74 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.682 0.753 . . . . 0.0 112.048 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -133.54 142.36 43.66 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 125.066 1.346 . . . . 0.0 112.058 -169.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -59.24 130.41 35.96 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.184 2.59 . . . . 0.0 112.533 177.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 67.9 ttp85 . . . . . 0 C--O 1.253 1.258 0 C-N-CA 125.231 1.412 . . . . 0.0 112.356 178.458 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.775 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.6 m 52.18 63.42 2.25 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.777 1.631 . . . . 0.0 113.17 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -136.27 144.49 44.81 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.322 1.449 . . . . 0.0 112.331 -177.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.8 m -61.82 143.2 56.68 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.968 1.307 . . . . 0.0 113.39 -173.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -45.6 151.78 0.38 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.603 2.361 . . . . 0.0 114.618 173.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.8 t -143.24 150.0 38.71 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.36 1.464 . . . . 0.0 111.389 174.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.8 mt -133.64 139.28 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.375 1.87 . . . . 0.0 108.742 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 94.7 p -64.21 166.63 7.65 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -176.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.7 m -127.51 30.12 5.4 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.823 1.649 . . . . 0.0 111.234 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.2 p -133.61 -74.43 0.49 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.582 1.553 . . . . 0.0 109.325 -175.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.64 -46.19 66.76 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.333 1.053 . . . . 0.0 112.018 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -72.58 -23.03 60.9 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.852 -0.53 . . . . 0.0 112.324 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -74.92 -50.47 16.72 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.966 -1.084 . . . . 0.0 111.564 172.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.406 HH21 ' CD ' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -62.75 -35.93 81.37 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 117.556 -1.211 . . . . 0.0 113.068 -174.583 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.8 m -59.9 -25.66 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 119.002 0.819 . . . . 0.0 112.756 172.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -77.45 -35.56 53.83 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.554 0.615 . . . . 0.0 112.56 176.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.8 mt -69.25 -39.87 78.19 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.405 -0.809 . . . . 0.0 110.976 -175.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.406 ' CD ' HH21 ' A' ' 14' ' ' ARG . 6.0 pt-20 -68.23 -30.47 69.53 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.041 0.936 . . . . 0.0 112.688 169.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.65 -38.64 89.92 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 120.227 1.376 . . . . 0.0 112.098 170.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.4 t -67.95 -39.74 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.182 0.993 . . . . 0.0 111.429 172.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -58.79 -44.91 90.85 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.211 -0.931 . . . . 0.0 111.277 172.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.2 mp -68.79 -34.9 76.32 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-O 117.13 -1.414 . . . . 0.0 112.678 174.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.38 -34.17 68.58 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 121.504 1.956 . . . . 0.0 110.511 169.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.3 m -72.72 -40.21 66.33 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.256 1.022 . . . . 0.0 113.736 170.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.1 mm -67.8 -37.38 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 120.983 1.719 . . . . 0.0 110.799 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.443 HG13 HG21 ' A' ' 36' ' ' VAL . 57.2 t -64.46 -45.58 95.36 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.376 0 C-N-CA 125.326 1.45 . . . . 0.0 110.241 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -51.97 -42.72 63.15 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 120.683 1.583 . . . . 0.0 112.345 171.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 56.5 m -62.05 -31.33 71.73 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.416 -0.803 . . . . 0.0 112.541 175.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -77.92 -37.08 48.58 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.877 1.271 . . . . 0.0 113.181 172.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.8 mt -67.42 -32.84 73.99 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.833 1.197 . . . . 0.0 111.916 176.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.8 mt -73.6 -36.93 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.585 1.154 . . . . 0.0 110.708 169.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.98 -39.17 55.02 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 125.689 1.614 . . . . 0.0 114.689 -172.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.0 t -151.48 -27.05 0.19 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.92 3.86 54.64 Favored Glycine 0 N--CA 1.479 1.54 0 N-CA-C 116.127 1.211 . . . . 0.0 116.127 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.6 m -142.26 132.9 25.38 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.756 1.622 . . . . 0.0 109.874 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.443 HG21 HG13 ' A' ' 26' ' ' VAL . 89.9 t -97.21 140.34 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.5 0.72 . . . . 0.0 109.423 170.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -127.11 156.68 41.35 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.76 1.224 . . . . 0.0 110.611 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -55.74 -36.89 67.76 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 121.303 -0.873 . . . . 0.0 112.557 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -67.55 -21.91 65.43 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.152 1.381 . . . . 0.0 113.73 177.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -78.44 -37.49 43.58 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.395 0.543 . . . . 0.0 111.863 171.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 18.9 mt -88.92 -30.29 18.95 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -172.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -55.89 -27.82 53.78 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -89.3 2.95 53.61 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.928 1.291 . . . . 0.0 114.382 176.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -121.6 -13.81 8.29 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.782 1.233 . . . . 0.0 113.446 -172.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -56.0 -49.29 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -174.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.499 0.0 OUTLIER 67.18 -18.54 0.13 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 129.535 3.134 . . . . 0.0 118.216 178.572 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -160.0 -43.66 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.022 1.329 . . . . 0.0 110.226 169.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.501 ' HB1' HG13 ' A' ' 86' ' ' VAL . . . -41.45 112.63 0.33 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.287 2.235 . . . . 0.0 111.579 177.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -63.56 -42.18 98.36 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 121.712 -0.617 . . . . 0.0 111.341 -172.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -130.97 120.95 24.27 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.121 1.768 . . . . 0.0 109.262 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.32 143.68 27.84 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.05 -1.032 . . . . 0.0 109.037 168.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.0 t -139.01 139.41 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.15 0.98 . . . . 0.0 110.774 -169.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 mm -114.02 134.03 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.541 1.536 . . . . 0.0 113.815 -169.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -133.67 70.96 1.45 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.232 1.813 . . . . 0.0 109.547 169.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.9 mt -88.08 128.93 51.91 Favored Pre-proline 0 N--CA 1.478 0.97 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.36 134.13 35.0 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.193 1.929 . . . . 0.0 111.287 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.92 3.3 85.68 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 118.533 -1.148 . . . . 0.0 115.962 176.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -137.49 162.9 52.29 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 119.539 1.669 . . . . 0.0 113.944 173.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -59.38 141.52 97.73 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.524 2.816 . . . . 0.0 114.454 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.59 130.18 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.182 0.993 . . . . 0.0 110.311 170.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.6 t -109.94 139.57 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.929 1.292 . . . . 0.0 109.275 172.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -134.41 112.72 11.19 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.838 1.255 . . . . 0.0 108.86 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.6 t -86.56 151.89 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.373 1.469 . . . . 0.0 110.947 -177.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.2 -96.91 1.38 Allowed Glycine 0 CA--C 1.531 1.059 0 O-C-N 121.608 -0.682 . . . . 0.0 112.025 175.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.1 m -150.0 157.41 43.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.52 1.128 . . . . 0.0 110.025 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -69.75 133.99 88.32 Favored Pre-proline 0 CA--C 1.546 0.796 0 O-C-N 120.791 -1.193 . . . . 0.0 110.654 169.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.63 156.01 31.68 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 124.194 3.263 . . . . 0.0 114.342 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.1 t -82.78 -26.32 31.93 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -175.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.02 -35.01 3.38 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 125.629 1.585 . . . . 0.0 113.055 -177.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -77.95 58.59 1.96 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.05 1.74 . . . . 0.0 111.404 169.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.1 m -131.5 159.93 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.549 1.54 . . . . 0.0 113.013 -172.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.1 mt -99.91 119.64 38.53 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 127.562 2.345 . . . . 0.0 110.335 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -106.09 108.3 19.74 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -170.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.55 145.54 17.79 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 169.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.1 ttt-85 -156.93 125.45 5.73 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 120.762 2.281 . . . . 0.0 113.967 -169.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.81 167.39 21.25 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.8 1.24 . . . . 0.0 114.044 -173.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 63.2 m -119.47 132.28 55.76 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.563 1.545 . . . . 0.0 108.15 174.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.59 -179.64 42.08 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 121.881 0.712 . . . . 0.0 114.634 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -86.99 -18.35 30.88 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -169.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -93.11 5.19 52.36 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.398 1.454 . . . . 0.0 112.163 169.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.89 16.12 49.46 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 126.661 2.077 . . . . 0.0 114.113 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.6 pm0 -76.98 178.24 7.11 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.955 1.702 . . . . 0.0 113.087 175.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.8 m -141.19 142.24 34.02 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.417 -1.427 . . . . 0.0 109.93 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 76.9 t -127.54 139.36 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.706 1.602 . . . . 0.0 109.721 -174.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.2 tp -129.1 148.22 51.03 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.154 1.382 . . . . 0.0 109.476 175.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.501 HG13 ' HB1' ' A' ' 48' ' ' ALA . 34.5 t -127.49 134.72 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.979 2.112 . . . . 0.0 107.414 175.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -135.78 137.21 41.4 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.2 0.6 . . . . 0.0 111.373 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -153.25 155.13 31.59 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 123.827 0.851 . . . . 0.0 112.796 174.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -58.85 134.72 62.14 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.795 2.33 . . . . 0.0 113.53 -176.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 . . . . . 0 C--O 1.253 1.27 0 C-N-CA 125.995 1.718 . . . . 0.0 112.265 176.492 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.784 0 CA-C-O 121.149 0.305 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.8 m -86.02 165.19 16.88 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.828 1.251 . . . . 0.0 112.727 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -111.37 143.29 42.41 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.488 1.515 . . . . 0.0 109.888 169.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.0 p -83.41 170.55 14.38 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.59 -1.319 . . . . 0.0 113.57 -174.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -110.77 -2.67 16.1 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -169.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . 0.276 3.6 t 49.42 -174.6 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 127.917 2.487 . . . . 0.0 114.417 -170.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.7 mm -66.78 154.27 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 O-C-N 120.419 -1.426 . . . . 0.0 111.189 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.1 m -70.33 105.92 3.18 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.156 0.982 . . . . 0.0 112.275 -177.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.6 p -68.39 55.01 0.08 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 127.357 2.263 . . . . 0.0 113.933 170.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.7 p -141.48 -64.55 0.44 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 129.435 3.094 . . . . 0.0 107.182 170.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.7 -39.48 70.16 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.455 1.502 . . . . 0.0 113.129 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -86.11 -17.75 34.2 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.623 -0.673 . . . . 0.0 112.596 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -76.5 -49.0 17.63 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 120.855 -1.153 . . . . 0.0 111.776 173.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.64 -35.15 70.13 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.629 1.172 . . . . 0.0 113.007 -175.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.64 -21.4 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -70.56 -43.23 69.9 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 120.905 -1.122 . . . . 0.0 112.446 177.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.03 -42.08 76.85 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.446 -0.784 . . . . 0.0 111.599 -171.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -62.45 -32.97 73.93 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.719 1.208 . . . . 0.0 112.397 172.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.69 -39.17 80.67 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.6 -1.312 . . . . 0.0 112.412 172.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.74 -38.16 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 O-C-N 121.327 -0.858 . . . . 0.0 111.295 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -58.01 -46.76 84.74 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.39 -0.819 . . . . 0.0 111.195 171.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.1 mp -69.71 -33.59 72.73 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 117.387 -1.292 . . . . 0.0 113.057 175.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.34 -34.17 68.49 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 121.301 1.864 . . . . 0.0 110.455 169.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.2 m -73.56 -39.05 64.99 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.598 1.159 . . . . 0.0 113.535 171.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.7 mm -73.74 -34.2 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 120.724 1.602 . . . . 0.0 111.02 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.4 t -64.79 -48.86 82.73 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-O 117.544 -1.217 . . . . 0.0 109.411 172.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -53.49 -44.21 68.85 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 120.931 1.696 . . . . 0.0 112.177 171.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.8 m -58.74 -35.22 72.38 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.676 -0.64 . . . . 0.0 112.021 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -75.41 -37.05 60.68 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.483 1.513 . . . . 0.0 113.414 171.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.0 mt -66.21 -31.94 73.07 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 120.033 1.288 . . . . 0.0 111.966 175.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 93.1 mt -75.68 -39.45 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 124.685 1.194 . . . . 0.0 110.803 169.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.63 -38.08 61.56 Favored Glycine 0 C--N 1.34 0.775 0 C-N-CA 125.437 1.494 . . . . 0.0 114.114 -171.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.3 t -148.6 -29.69 0.28 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.3 12.18 31.85 Favored Glycine 0 N--CA 1.477 1.386 0 N-CA-C 116.425 1.33 . . . . 0.0 116.425 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.5 m -157.98 146.87 19.32 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.959 1.704 . . . . 0.0 109.611 171.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.4 p -119.34 142.17 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.635 1.574 . . . . 0.0 110.43 -175.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -133.02 157.44 45.22 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.3 1.04 . . . . 0.0 111.032 -169.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -54.98 -39.32 68.88 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -70.95 -19.73 62.53 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.526 1.131 . . . . 0.0 113.318 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -78.98 -43.44 24.43 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.162 0.892 . . . . 0.0 109.908 169.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.7 mt -79.87 -27.16 40.11 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -169.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -57.6 -24.21 55.12 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 170.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -84.14 -3.75 58.33 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.507 1.123 . . . . 0.0 113.882 173.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.2 mm-40 -115.97 -16.02 11.14 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.795 1.238 . . . . 0.0 113.167 -173.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt -58.17 -66.22 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 118.888 0.767 . . . . 0.0 110.937 173.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 66.15 -15.08 0.13 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 127.462 2.305 . . . . 0.0 116.521 172.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -156.16 -26.73 0.1 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.759 1.224 . . . . 0.0 114.079 175.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.97 154.0 25.95 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.007 0.923 . . . . 0.0 111.974 174.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.04 -60.29 2.46 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.412 1.085 . . . . 0.0 111.815 175.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -127.56 128.95 46.47 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.022 0.529 . . . . 0.0 111.932 -169.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -104.04 143.47 32.85 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.353 -0.842 . . . . 0.0 109.965 169.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.5 t -140.06 140.11 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.093 0.957 . . . . 0.0 110.625 -171.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 53' ' ' ILE . 0.7 OUTLIER -115.14 132.03 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.067 1.347 . . . . 0.0 113.63 -169.812 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.6 mmt85 -130.86 74.93 1.63 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.594 1.557 . . . . 0.0 109.673 171.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.5 mt -93.12 131.22 33.58 Favored Pre-proline 0 N--CA 1.479 1.003 0 O-C-N 121.396 -0.815 . . . . 0.0 108.856 172.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.46 136.7 44.08 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.231 1.954 . . . . 0.0 111.459 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.07 -0.13 83.68 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.746 1.165 . . . . 0.0 115.587 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -137.06 157.55 74.35 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 119.015 1.407 . . . . 0.0 112.218 173.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.2 153.02 62.28 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.848 2.366 . . . . 0.0 112.852 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.6 p -55.95 136.95 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.672 1.189 . . . . 0.0 111.935 172.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 99.2 t -115.8 141.13 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.888 1.675 . . . . 0.0 108.082 169.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -139.93 123.13 16.89 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.442 1.097 . . . . 0.0 110.646 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.7 t -95.97 154.97 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 126.596 1.959 . . . . 0.0 111.149 -172.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.36 -95.11 1.3 Allowed Glycine 0 CA--C 1.532 1.115 0 O-C-N 121.327 -0.858 . . . . 0.0 112.485 174.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 60.5 m -152.36 149.84 29.06 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.478 1.111 . . . . 0.0 110.057 174.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -69.38 125.28 91.86 Favored Pre-proline 0 CA--C 1.546 0.822 0 O-C-N 120.636 -1.29 . . . . 0.0 111.262 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.415 ' HB2' HG11 ' A' ' 71' ' ' VAL . 61.1 Cg_endo -77.37 153.74 31.36 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.969 3.112 . . . . 0.0 114.623 -175.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 t -83.14 -31.08 27.39 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -169.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.26 -33.77 2.73 Favored Glycine 0 N--CA 1.478 1.466 0 C-N-CA 125.193 1.377 . . . . 0.0 112.978 -174.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -78.09 57.51 1.82 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.97 1.708 . . . . 0.0 110.511 169.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.415 HG11 ' HB2' ' A' ' 67' ' ' PRO . 35.8 m -137.4 154.43 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.274 1.83 . . . . 0.0 111.526 -172.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.7 mt -87.98 140.19 29.75 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 127.097 2.159 . . . . 0.0 109.187 173.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -121.36 112.58 18.75 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.424 0.556 . . . . 0.0 111.785 -176.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.6 143.14 16.41 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 169.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -151.66 131.46 13.25 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.646 1.723 . . . . 0.0 112.339 -170.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -143.58 168.18 20.48 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.729 1.211 . . . . 0.0 113.655 -174.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.7 m -120.03 131.85 55.27 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.422 1.489 . . . . 0.0 108.882 176.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.56 173.2 32.21 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.616 1.103 . . . . 0.0 114.688 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -81.43 -12.59 58.88 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -169.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -95.81 5.11 52.11 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 120.76 1.618 . . . . 0.0 111.58 169.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.36 17.32 40.05 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 126.766 2.127 . . . . 0.0 114.213 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.6 pm0 -82.93 175.26 10.2 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.911 1.684 . . . . 0.0 113.869 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.5 m -128.26 138.38 52.4 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.084 1.353 . . . . 0.0 109.956 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.2 t -120.98 141.13 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.365 1.466 . . . . 0.0 110.355 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.0 tp -128.56 147.18 50.69 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.219 1.407 . . . . 0.0 109.812 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.4 t -131.59 137.39 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.339 1.456 . . . . 0.0 108.426 173.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -130.22 127.39 39.52 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.989 0.9 . . . . 0.0 111.76 -176.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -125.35 143.77 45.6 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.44 1.896 . . . . 0.0 110.694 -173.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -61.22 132.55 41.96 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.426 2.084 . . . . 0.0 111.609 174.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 . . . . . 0 C--O 1.254 1.314 0 C-N-CA 124.688 1.195 . . . . 0.0 112.522 -178.539 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 112.069 -0.412 . . . . 0.0 112.069 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.3 m -94.45 -13.48 26.16 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -175.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.76 149.68 48.8 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.541 1.136 . . . . 0.0 112.875 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.7 m -153.95 154.77 34.4 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.913 1.685 . . . . 0.0 110.381 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -86.43 121.76 29.43 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.987 0.915 . . . . 0.0 111.581 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.9 m -65.6 145.8 55.61 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.4 1.08 . . . . 0.0 111.142 171.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 55.1 mt -128.14 133.35 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.574 1.55 . . . . 0.0 108.536 175.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.2 m -122.46 129.72 52.32 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.824 0.85 . . . . 0.0 112.869 -170.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.1 p -70.57 58.62 0.19 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.522 1.929 . . . . 0.0 114.063 173.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.3 p -141.82 -64.75 0.43 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 129.128 2.971 . . . . 0.0 107.273 169.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.4 -43.04 67.57 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.359 1.464 . . . . 0.0 112.836 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -79.51 -21.62 45.05 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.547 -0.721 . . . . 0.0 112.603 174.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -72.82 -45.2 59.73 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.722 -1.236 . . . . 0.0 111.734 173.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -57.33 -37.0 71.85 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.714 -0.616 . . . . 0.0 112.455 -173.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.2 m -68.48 -24.06 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.817 1.247 . . . . 0.0 112.968 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.17 -43.93 73.23 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.336 0.971 . . . . 0.0 112.115 177.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.26 -39.9 71.31 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.516 -0.74 . . . . 0.0 111.294 -169.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -69.84 -31.14 68.84 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.709 1.203 . . . . 0.0 112.686 173.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.95 -38.98 83.46 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.908 -1.12 . . . . 0.0 112.18 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.0 t -67.15 -39.42 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 O-C-N 121.29 -0.881 . . . . 0.0 111.414 172.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -57.24 -44.87 84.23 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.589 -0.694 . . . . 0.0 111.023 171.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -71.38 -36.24 71.36 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 116.176 -1.869 . . . . 0.0 113.257 175.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.3 -39.76 67.28 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 121.976 2.171 . . . . 0.0 109.8 169.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.0 m -64.83 -40.36 95.06 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 118.051 -0.976 . . . . 0.0 113.334 173.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.8 mm -75.49 -28.63 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 120.584 1.538 . . . . 0.0 111.552 178.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.3 t -65.14 -49.21 80.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 O-C-N 120.926 -1.109 . . . . 0.0 108.978 170.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -56.77 -42.28 79.13 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 120.444 1.475 . . . . 0.0 113.191 174.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.0 p -64.94 -23.42 67.22 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.998 0.817 . . . . 0.0 112.29 177.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -83.79 -35.15 24.52 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.471 1.908 . . . . 0.0 113.411 169.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.5 mt -64.38 -38.68 91.89 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 120.527 1.512 . . . . 0.0 111.386 172.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 89.3 mt -72.42 -35.58 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 124.491 1.117 . . . . 0.0 110.891 170.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.5 -38.48 51.92 Favored Glycine 0 C--N 1.34 0.75 0 C-N-CA 125.657 1.599 . . . . 0.0 114.473 -171.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.0 t -152.18 -26.87 0.17 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 177.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.35 6.59 33.46 Favored Glycine 0 N--CA 1.477 1.381 0 N-CA-C 116.954 1.542 . . . . 0.0 116.954 173.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 t -161.07 150.0 16.46 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.546 1.538 . . . . 0.0 109.881 170.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -115.9 147.15 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 126.046 1.738 . . . . 0.0 110.826 -178.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -126.27 159.02 34.22 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.498 1.519 . . . . 0.0 110.352 -173.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -54.75 -38.48 67.24 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.862 -0.524 . . . . 0.0 112.413 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -69.36 -21.72 63.79 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -79.91 -31.92 40.16 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.769 0.713 . . . . 0.0 111.756 172.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 89.4 mt -86.54 -33.91 20.13 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.988 1.315 . . . . 0.0 114.19 -174.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -58.55 -20.88 50.33 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 175.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -80.38 -14.97 57.89 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 175.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -100.84 -44.36 5.8 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.921 0.888 . . . . 0.0 112.674 -169.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt -40.03 -36.9 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 117.832 2.53 . . . . 0.0 117.832 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.36 -3.11 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.293 1 C-N-CA 132.021 4.128 . . . . 0.0 119.112 175.677 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -179.95 -35.38 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 128.242 2.617 . . . . 0.0 111.988 -169.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.85 139.56 55.2 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.315 0.646 . . . . 0.0 109.928 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.22 -58.62 5.51 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.628 0.771 . . . . 0.0 112.706 -171.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -131.77 127.43 36.7 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.786 0.434 . . . . 0.0 111.17 -170.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -104.69 145.67 30.02 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.368 0.985 . . . . 0.0 109.675 169.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.2 t -139.99 141.4 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.331 1.052 . . . . 0.0 110.738 -170.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 mm -111.42 126.38 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.614 1.566 . . . . 0.0 112.669 -172.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -125.94 63.3 1.23 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.518 1.927 . . . . 0.0 109.703 170.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.9 mt -79.74 126.83 79.55 Favored Pre-proline 0 N--CA 1.481 1.084 0 CA-C-O 118.34 -0.838 . . . . 0.0 108.989 169.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -58.38 139.43 90.56 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.947 2.431 . . . . 0.0 113.082 173.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.78 0.0 87.22 Favored Glycine 0 CA--C 1.537 1.409 0 N-CA-C 116.042 1.177 . . . . 0.0 116.042 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -138.13 158.71 70.56 Favored Pre-proline 0 CA--C 1.549 0.935 0 CA-C-N 119.23 1.515 . . . . 0.0 112.685 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.98 149.85 59.83 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.846 2.364 . . . . 0.0 113.481 -174.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 81.3 t -64.09 130.82 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.5 1.52 . . . . 0.0 111.172 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.5 t -106.09 142.43 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.569 1.548 . . . . 0.0 108.202 170.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -135.57 113.97 11.59 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.797 1.239 . . . . 0.0 109.208 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.0 t -84.22 151.63 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.715 1.606 . . . . 0.0 110.975 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.51 -99.23 1.2 Allowed Glycine 0 CA--C 1.534 1.232 0 O-C-N 121.321 -0.862 . . . . 0.0 112.985 175.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -148.74 158.12 43.92 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.73 1.212 . . . . 0.0 109.979 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -71.27 130.28 88.03 Favored Pre-proline 0 CA--C 1.549 0.938 0 O-C-N 120.627 -1.295 . . . . 0.0 110.636 170.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.9 157.07 34.87 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.272 3.315 . . . . 0.0 114.103 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.7 t -83.63 -32.25 25.79 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -171.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.96 -33.19 2.64 Favored Glycine 0 N--CA 1.476 1.336 0 C-N-CA 125.41 1.481 . . . . 0.0 113.261 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -78.3 58.99 2.21 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.096 1.758 . . . . 0.0 111.229 169.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.0 m -136.94 155.23 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.372 1.469 . . . . 0.0 112.706 -171.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.8 mt -91.7 138.88 31.2 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 128.284 2.633 . . . . 0.0 109.546 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -121.62 103.8 9.17 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.787 0.721 . . . . 0.0 111.877 -175.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -83.75 150.97 27.21 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 169.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.8 ttt-85 -148.88 153.84 38.61 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 118.845 1.322 . . . . 0.0 111.478 -172.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -161.76 167.26 25.28 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.554 1.142 . . . . 0.0 112.922 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 97.2 m -131.51 110.98 11.37 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.507 1.523 . . . . 0.0 109.572 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.45 163.27 54.39 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.162 0.887 . . . . 0.0 114.88 -177.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -68.35 -8.22 38.11 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.632 1.973 . . . . 0.0 115.34 -174.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -102.9 4.05 37.17 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.258 1.39 . . . . 0.0 113.084 169.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.68 20.79 15.91 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.902 1.239 . . . . 0.0 114.484 172.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.64 -170.54 3.06 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.912 1.285 . . . . 0.0 113.874 -177.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.0 m -147.24 123.21 10.71 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 120.705 -1.247 . . . . 0.0 111.883 172.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.7 t -94.27 146.03 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.448 1.499 . . . . 0.0 110.866 171.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.6 tp -130.18 145.27 51.71 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.689 1.596 . . . . 0.0 108.364 169.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.16 139.4 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.179 1.392 . . . . 0.0 108.576 171.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -132.18 129.37 39.67 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.914 0.886 . . . . 0.0 111.014 -175.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -131.8 140.26 37.69 Favored Pre-proline 0 N--CA 1.473 0.677 0 C-N-CA 126.138 1.775 . . . . 0.0 111.042 -170.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -62.17 136.53 60.92 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.176 1.917 . . . . 0.0 112.099 174.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 . . . . . 0 C--O 1.253 1.252 0 C-N-CA 124.458 1.103 . . . . 0.0 111.8 173.225 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.747 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m 57.73 37.94 27.34 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.795 1.638 . . . . 0.0 114.461 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -92.52 44.66 1.17 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.595 1.558 . . . . 0.0 112.588 -175.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.8 m -59.53 143.47 50.07 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.514 1.926 . . . . 0.0 113.303 -174.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.19 156.8 43.66 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.471 1.509 . . . . 0.0 113.01 175.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.1 t -152.09 158.62 43.24 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.704 1.602 . . . . 0.0 110.972 174.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.2 mt -79.8 120.89 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 O-C-N 121.498 -0.751 . . . . 0.0 109.85 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.1 m -47.56 125.55 8.55 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.28 1.832 . . . . 0.0 115.44 -171.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.8 m -70.77 63.04 0.28 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.635 1.574 . . . . 0.0 112.47 170.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.6 p -142.18 -83.16 0.19 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.95 2.5 . . . . 0.0 108.419 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.92 -46.83 67.29 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.595 1.158 . . . . 0.0 111.967 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -66.65 -28.25 68.33 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.578 -0.701 . . . . 0.0 112.155 175.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -71.02 -56.7 5.61 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.345 0.658 . . . . 0.0 111.191 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.403 HH21 ' CD ' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -58.86 -39.95 82.84 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 118.383 -0.818 . . . . 0.0 111.751 -178.026 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.5 t -56.65 -31.61 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.201 1.4 . . . . 0.0 112.512 174.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -77.26 -33.67 55.91 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 176.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.4 mp -74.11 -38.92 63.7 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 120.929 -1.107 . . . . 0.0 111.24 -178.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.403 ' CD ' HH21 ' A' ' 14' ' ' ARG . 6.7 pt-20 -65.21 -27.25 68.55 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 170.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.39 -36.68 83.47 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 120.69 -1.256 . . . . 0.0 112.308 169.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.1 t -70.81 -36.28 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 124.445 1.098 . . . . 0.0 111.342 172.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -60.49 -45.0 95.36 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.112 -0.992 . . . . 0.0 111.449 171.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.1 mp -70.28 -33.38 71.5 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-O 117.147 -1.406 . . . . 0.0 112.494 174.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.29 -33.93 69.99 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 121.475 1.943 . . . . 0.0 110.805 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.7 m -72.05 -38.88 69.42 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.101 0.96 . . . . 0.0 113.236 171.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.0 mm -73.82 -34.85 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 120.721 1.6 . . . . 0.0 110.933 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.1 t -62.67 -48.2 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 117.452 -1.261 . . . . 0.0 110.033 172.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -54.1 -42.36 69.31 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 120.994 1.725 . . . . 0.0 112.173 171.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.2 m -60.28 -33.04 71.77 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.702 -0.624 . . . . 0.0 112.142 175.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -76.71 -37.22 56.45 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.065 1.346 . . . . 0.0 113.31 171.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.1 mt -65.06 -31.19 72.29 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.674 1.125 . . . . 0.0 112.133 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 89.7 mt -76.52 -36.78 28.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 125.156 1.382 . . . . 0.0 111.248 169.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.18 -39.43 31.92 Favored Glycine 0 N--CA 1.469 0.845 0 C-N-CA 126.08 1.8 . . . . 0.0 115.547 -171.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.9 t -151.08 -23.95 0.21 Allowed 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.0 6.04 54.34 Favored Glycine 0 N--CA 1.468 0.828 0 N-CA-C 117.271 1.668 . . . . 0.0 117.271 169.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.0 m -158.5 149.88 20.91 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.418 1.487 . . . . 0.0 110.343 170.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 p -103.51 145.11 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.448 1.099 . . . . 0.0 113.0 -173.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -116.6 152.9 33.23 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.675 1.59 . . . . 0.0 110.792 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -57.4 -35.67 70.33 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.888 -1.133 . . . . 0.0 111.885 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -70.42 -19.18 63.01 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.93 1.292 . . . . 0.0 112.738 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -83.62 -32.95 25.43 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.904 0.775 . . . . 0.0 112.179 169.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.3 mt -86.63 -34.65 19.76 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.451 1.5 . . . . 0.0 114.005 -172.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -60.48 -20.51 60.26 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -84.82 -3.41 58.63 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.23 1.412 . . . . 0.0 113.591 175.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -114.35 -26.49 7.96 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.942 1.297 . . . . 0.0 113.202 -172.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.49 HG22 ' HB3' ' A' ' 48' ' ' ALA . 1.2 pt -52.5 -60.5 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.017 0.927 . . . . 0.0 112.829 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 62.53 -23.29 0.05 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 128.086 2.554 . . . . 0.0 117.556 -177.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -153.38 -27.77 0.14 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -172.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.49 ' HB3' HG22 ' A' ' 45' ' ' ILE . . . -69.53 146.43 51.85 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.51 1.124 . . . . 0.0 111.156 169.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -77.94 -48.39 16.4 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.594 0.358 . . . . 0.0 111.143 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -133.83 129.88 37.14 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.246 1.419 . . . . 0.0 110.932 -175.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.12 136.17 47.42 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 120.195 1.361 . . . . 0.0 109.302 168.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.3 t -126.45 143.08 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.054 1.341 . . . . 0.0 110.767 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.471 ' HB ' ' H ' ' A' ' 61' ' ' VAL . 20.3 mm -120.57 134.07 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.542 1.537 . . . . 0.0 113.418 -169.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -113.53 3.49 15.76 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 116.277 1.955 . . . . 0.0 116.277 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.6 mt -40.04 124.72 1.64 Allowed Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 125.739 1.616 . . . . 0.0 113.544 -172.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -60.7 140.64 91.92 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.147 2.564 . . . . 0.0 113.742 173.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.0 -1.38 86.85 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.811 1.196 . . . . 0.0 115.476 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -131.49 160.84 65.49 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 125.001 1.32 . . . . 0.0 111.298 172.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -62.26 161.89 25.38 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.461 2.107 . . . . 0.0 112.145 176.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.1 t -72.11 142.9 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 169.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.471 ' H ' ' HB ' ' A' ' 53' ' ' ILE . 87.6 t -113.94 138.52 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 169.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -124.51 118.55 26.86 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.036 1.334 . . . . 0.0 108.708 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.3 t -94.22 154.34 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.043 1.337 . . . . 0.0 110.811 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.36 -109.14 2.7 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.0 t -154.69 162.14 41.25 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.736 0.768 . . . . 0.0 111.332 169.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.5 tttp -61.63 141.86 94.67 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.74 1.216 . . . . 0.0 111.565 -176.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -65.36 -167.48 0.1 Allowed 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 124.342 3.361 . . . . 0.0 115.89 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 t -119.61 -24.58 6.2 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 117.571 2.434 . . . . 0.0 117.571 -169.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.57 -10.04 21.76 Favored Glycine 0 N--CA 1.484 1.862 0 CA-C-N 119.472 1.033 . . . . 0.0 114.556 -173.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -134.45 83.8 2.06 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.829 2.452 . . . . 0.0 110.278 170.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.3 m -139.54 147.15 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.896 1.278 . . . . 0.0 111.621 -176.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.5 mt -72.33 148.95 44.86 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.05 1.34 . . . . 0.0 107.55 169.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -133.15 113.7 13.02 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.588 0.755 . . . . 0.0 109.201 -178.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -99.42 147.82 18.48 Favored Glycine 0 N--CA 1.468 0.788 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 169.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 74.2 ttt-85 -150.05 146.51 27.0 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 118.466 1.133 . . . . 0.0 112.84 -169.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.53 155.59 33.67 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.793 0.837 . . . . 0.0 112.955 -178.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.1 m -113.72 129.9 56.51 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.276 1.43 . . . . 0.0 109.475 169.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.03 -160.51 36.12 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 124.182 0.896 . . . . 0.0 115.055 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -99.51 -15.15 18.77 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -169.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -91.57 -1.82 57.36 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 120.338 1.426 . . . . 0.0 111.998 168.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.01 20.07 26.97 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 126.303 1.906 . . . . 0.0 113.651 -174.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.0 pm0 -80.66 163.5 23.55 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.841 1.656 . . . . 0.0 113.988 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.9 m -128.51 140.37 51.84 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.125 0.97 . . . . 0.0 110.507 173.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.8 t -131.79 143.2 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.157 1.783 . . . . 0.0 109.363 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.3 tp -130.15 147.58 51.9 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.46 1.504 . . . . 0.0 111.569 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.484 HG13 ' HB1' ' A' ' 48' ' ' ALA . 76.2 t -122.44 138.34 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 126.887 2.075 . . . . 0.0 108.401 171.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -137.06 134.51 36.6 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.741 0.701 . . . . 0.0 112.652 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.0 152.27 33.72 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 176.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -58.27 128.02 27.02 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.548 2.832 . . . . 0.0 113.431 -175.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 125.156 1.382 . . . . 0.0 112.131 179.396 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.855 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.5 p -75.0 -38.77 61.52 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -174.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -77.76 167.22 21.9 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -172.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.4 t -146.44 159.71 43.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.676 1.59 . . . . 0.0 111.081 169.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 68.7 mmt-85 -112.92 -152.9 0.51 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.864 1.666 . . . . 0.0 112.002 -175.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.1 t -169.18 111.62 0.5 Allowed 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 123.057 1.408 . . . . 0.0 111.845 170.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mp -85.87 144.77 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 124.556 1.142 . . . . 0.0 109.917 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 64.5 m -94.24 49.52 1.31 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.39 1.476 . . . . 0.0 112.121 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.4 m -56.11 18.96 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 130.326 3.45 . . . . 0.0 118.831 -169.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.4 p -124.29 -62.71 1.25 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.822 2.049 . . . . 0.0 108.714 169.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.13 -45.45 73.58 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.289 1.436 . . . . 0.0 112.288 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.4 tp60 -68.54 -34.78 76.46 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.634 -0.666 . . . . 0.0 111.101 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -70.51 -52.71 19.97 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.608 0.363 . . . . 0.0 110.807 -176.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.4 HH21 ' CD ' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -58.39 -36.1 73.04 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 118.365 -0.826 . . . . 0.0 112.042 176.744 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.8 t -57.25 -28.47 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.911 1.684 . . . . 0.0 113.408 171.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -76.85 -38.51 53.6 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.181 -0.949 . . . . 0.0 112.278 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.5 mp -70.6 -36.75 73.71 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.324 -0.86 . . . . 0.0 111.349 -174.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.4 ' CD ' HH21 ' A' ' 14' ' ' ARG . 8.3 pt-20 -67.08 -32.07 72.99 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.7 0.8 . . . . 0.0 112.581 170.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.06 -40.74 87.14 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.637 -1.289 . . . . 0.0 112.125 171.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.5 t -63.45 -43.55 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.822 0.849 . . . . 0.0 110.932 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -57.27 -41.13 79.1 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.741 -0.599 . . . . 0.0 111.51 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 mp -67.63 -34.84 77.76 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 117.315 -1.326 . . . . 0.0 113.326 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.74 -33.92 67.03 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 120.991 1.723 . . . . 0.0 111.249 169.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 m -73.92 -37.56 64.58 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 170.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.3 mm -69.58 -36.57 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 120.618 1.554 . . . . 0.0 110.4 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.13 -46.93 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.915 1.286 . . . . 0.0 109.624 176.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -52.89 -43.63 66.32 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 120.62 1.555 . . . . 0.0 111.963 170.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.9 m -59.96 -32.41 70.79 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.791 0.436 . . . . 0.0 111.986 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -79.07 -36.62 40.59 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.594 1.558 . . . . 0.0 113.712 172.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.0 mt -66.34 -34.26 77.57 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 120.195 1.361 . . . . 0.0 111.43 175.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.3 mt -73.06 -36.74 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.386 1.074 . . . . 0.0 110.491 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.75 -38.81 60.75 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 125.695 1.617 . . . . 0.0 114.428 -173.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.5 t -152.24 -26.52 0.17 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 178.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.51 3.35 53.24 Favored Glycine 0 N--CA 1.481 1.694 0 N-CA-C 116.156 1.223 . . . . 0.0 116.156 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.5 m -143.66 135.3 26.25 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.214 1.806 . . . . 0.0 108.974 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 p -107.01 145.5 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.668 0.787 . . . . 0.0 109.634 172.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -133.59 156.91 46.98 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.666 1.186 . . . . 0.0 110.187 -175.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -56.3 -37.58 70.08 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.804 -0.56 . . . . 0.0 111.907 -177.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -70.03 -22.06 63.13 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -77.6 -37.89 49.38 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.497 0.59 . . . . 0.0 111.738 170.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 60.6 mt -87.71 -27.05 22.63 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 -173.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -56.49 -27.74 57.94 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 175.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -90.5 4.34 51.41 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.623 1.169 . . . . 0.0 114.12 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -123.09 -10.57 8.12 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 119.814 1.188 . . . . 0.0 113.943 -170.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.27 -45.18 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.274 1.429 . . . . 0.0 114.547 -175.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.3 73.4 mtt85 75.15 -24.84 0.21 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 129.056 2.942 . . . . 0.0 117.273 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -160.1 -42.72 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.628 1.571 . . . . 0.0 109.487 169.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.437 ' HB1' HG13 ' A' ' 86' ' ' VAL . . . -38.69 130.13 1.42 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 128.34 2.656 . . . . 0.0 112.905 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -47.65 60.08 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.596 -0.69 . . . . 0.0 110.867 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -131.74 116.93 17.92 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.733 1.613 . . . . 0.0 109.457 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.15 145.08 25.66 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.012 -1.055 . . . . 0.0 108.69 168.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.2 t -139.89 134.76 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 120.682 -1.261 . . . . 0.0 110.931 -169.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mm -116.07 139.16 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.087 1.355 . . . . 0.0 114.641 -170.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -144.87 73.3 1.36 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.076 1.75 . . . . 0.0 109.628 169.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.0 mt -83.35 121.76 76.91 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-N 114.386 -1.279 . . . . 0.0 107.682 169.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.22 132.68 50.48 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.073 1.849 . . . . 0.0 112.214 174.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.05 0.18 83.41 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.869 1.223 . . . . 0.0 116.016 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -139.87 165.57 30.01 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 119.79 1.795 . . . . 0.0 113.872 173.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -60.74 140.95 93.48 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.609 2.873 . . . . 0.0 115.644 -173.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.6 t -69.98 116.03 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.509 1.124 . . . . 0.0 108.946 169.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.87 143.98 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.195 1.398 . . . . 0.0 109.765 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -139.16 110.91 7.16 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.792 1.237 . . . . 0.0 108.881 -170.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.1 t -80.93 153.8 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.745 1.618 . . . . 0.0 111.466 -172.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.42 -87.54 1.12 Allowed Glycine 0 CA--C 1.533 1.157 0 O-C-N 121.487 -0.758 . . . . 0.0 113.263 172.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.1 m -157.68 160.76 38.31 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.014 1.326 . . . . 0.0 109.889 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.8 tptt -73.94 131.9 80.82 Favored Pre-proline 0 CA--C 1.548 0.879 0 O-C-N 120.778 -1.201 . . . . 0.0 110.581 171.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.65 156.49 40.13 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 124.223 3.282 . . . . 0.0 114.349 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.6 t -83.91 -33.24 24.77 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -173.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.62 -40.82 1.45 Allowed Glycine 0 N--CA 1.474 1.209 0 C-N-CA 124.983 1.278 . . . . 0.0 113.472 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -78.44 58.8 2.24 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.527 1.531 . . . . 0.0 111.767 171.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.8 m -127.13 156.76 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.244 1.418 . . . . 0.0 113.298 -173.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.0 mt -97.25 112.94 24.52 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 127.761 2.424 . . . . 0.0 110.789 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -98.45 100.57 11.84 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.172 0.989 . . . . 0.0 113.034 -171.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -85.68 152.83 26.62 Favored Glycine 0 N--CA 1.473 1.134 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 169.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -149.66 154.77 39.13 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.544 1.672 . . . . 0.0 112.211 -169.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -163.35 167.94 21.1 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.298 1.039 . . . . 0.0 113.372 176.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 62.3 m -124.75 132.93 53.32 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.121 1.768 . . . . 0.0 107.814 171.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.84 -179.31 38.96 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 123.52 0.581 . . . . 0.0 114.432 -178.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -88.51 -10.02 50.41 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -169.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -99.73 7.09 45.37 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.791 1.632 . . . . 0.0 111.138 169.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.43 18.04 40.22 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 127.033 2.254 . . . . 0.0 114.099 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.9 pm0 -79.14 176.05 10.03 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.525 1.53 . . . . 0.0 113.584 178.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.6 m -136.48 139.53 42.39 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.491 1.116 . . . . 0.0 109.534 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.4 t -129.68 143.42 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.539 1.536 . . . . 0.0 110.541 -174.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.0 tp -134.25 150.42 51.02 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.564 1.546 . . . . 0.0 109.136 173.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.437 HG13 ' HB1' ' A' ' 48' ' ' ALA . 37.7 t -126.42 138.39 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 126.194 1.798 . . . . 0.0 108.574 171.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -135.98 138.69 42.53 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.487 0.715 . . . . 0.0 111.438 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -154.5 156.62 31.79 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.289 1.436 . . . . 0.0 112.521 173.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -59.13 138.64 86.34 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.415 2.076 . . . . 0.0 113.828 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 . . . . . 0 C--O 1.255 1.344 0 C-N-CA 125.801 1.64 . . . . 0.0 112.19 172.87 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.68 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m -137.13 160.36 39.22 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.204 1.401 . . . . 0.0 112.576 -174.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -60.75 163.36 5.67 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.409 1.084 . . . . 0.0 113.17 174.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.1 m -158.49 162.74 37.51 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.42 1.888 . . . . 0.0 109.025 -173.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -98.91 128.6 45.13 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.807 0.843 . . . . 0.0 111.526 172.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.8 m -82.47 135.21 35.18 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 171.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.7 mt -143.92 159.98 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 125.962 1.705 . . . . 0.0 108.098 -176.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.8 m -96.39 118.87 33.81 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.156 -0.965 . . . . 0.0 112.342 -178.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.7 m -67.79 57.68 0.06 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.497 2.319 . . . . 0.0 113.419 172.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.8 p -141.17 -64.11 0.45 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 129.265 3.026 . . . . 0.0 106.444 169.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.58 -44.44 64.47 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.493 1.517 . . . . 0.0 112.389 172.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -72.34 -27.73 62.6 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.431 -0.793 . . . . 0.0 112.356 174.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -70.68 -48.96 52.09 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.337 -0.852 . . . . 0.0 110.862 176.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -35.0 77.11 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 118.38 -0.819 . . . . 0.0 113.006 -175.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.0 m -63.99 -19.82 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 174.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.96 -44.82 68.71 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.672 1.124 . . . . 0.0 112.326 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -69.52 -41.33 76.16 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.278 -0.889 . . . . 0.0 111.491 -171.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -64.64 -33.6 76.31 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.65 1.18 . . . . 0.0 112.635 171.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.52 -37.76 85.73 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.736 -1.228 . . . . 0.0 112.384 172.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.0 t -68.85 -37.64 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 124.023 0.929 . . . . 0.0 111.37 172.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -59.4 -43.9 92.91 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.175 -0.953 . . . . 0.0 111.744 170.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.7 mp -68.98 -34.95 76.15 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 120.382 1.446 . . . . 0.0 112.806 173.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.26 -34.43 68.63 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 121.158 1.799 . . . . 0.0 110.584 169.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.5 m -71.52 -40.16 70.28 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.084 0.954 . . . . 0.0 113.177 172.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.8 mm -72.04 -35.48 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 120.69 1.587 . . . . 0.0 111.108 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.21 -45.69 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.696 1.198 . . . . 0.0 109.547 174.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -53.75 -43.11 68.88 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 120.78 1.627 . . . . 0.0 112.12 171.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.6 t -59.15 -39.55 82.79 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.964 -0.46 . . . . 0.0 111.826 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -68.55 -38.34 80.7 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.666 1.186 . . . . 0.0 113.088 171.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.0 mt -67.72 -38.46 83.61 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.747 1.158 . . . . 0.0 112.084 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.09 -37.36 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.49 1.116 . . . . 0.0 111.348 172.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.39 -64.19 3.08 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 124.837 1.208 . . . . 0.0 111.083 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.1 t -126.81 -27.6 3.05 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -174.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.48 3.05 53.51 Favored Glycine 0 N--CA 1.475 1.267 0 N-CA-C 116.81 1.484 . . . . 0.0 116.81 172.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.4 m -146.73 136.94 23.6 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.633 1.573 . . . . 0.0 109.713 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 p -104.76 146.69 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.505 1.122 . . . . 0.0 110.688 176.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -133.65 159.18 41.28 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.877 1.271 . . . . 0.0 110.352 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -55.79 -38.58 70.11 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -71.04 -17.18 62.63 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -80.62 -32.14 36.37 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.349 0.977 . . . . 0.0 112.041 170.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.3 mt -90.98 -30.45 16.82 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.237 1.415 . . . . 0.0 114.489 -172.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.9 ptt85 -59.0 -23.93 62.32 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 119.398 0.999 . . . . 0.0 113.491 174.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -82.02 -6.95 59.55 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 175.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -113.4 -20.11 11.45 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -169.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.449 HG22 ' HB3' ' A' ' 48' ' ' ALA . 1.1 pt -56.92 -63.11 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -172.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 63.9 -19.56 0.06 Allowed 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 117.696 2.48 . . . . 0.0 117.696 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -148.25 -35.47 0.21 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.216 1.406 . . . . 0.0 112.803 -178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HB3' HG22 ' A' ' 45' ' ' ILE . . . -68.35 145.66 53.97 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.867 1.267 . . . . 0.0 110.585 172.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.52 -42.83 16.41 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.561 0.345 . . . . 0.0 111.51 176.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -133.63 123.14 24.52 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.582 1.553 . . . . 0.0 109.193 -176.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.4 138.57 35.44 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.229 0.922 . . . . 0.0 109.166 169.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.8 t -132.89 140.36 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.033 1.333 . . . . 0.0 109.692 -173.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.24 131.9 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -169.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -128.77 78.43 1.85 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.5 1.92 . . . . 0.0 109.848 170.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.8 mt -96.9 125.59 45.8 Favored Pre-proline 0 N--CA 1.481 1.104 0 O-C-N 121.128 -0.982 . . . . 0.0 109.047 170.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.91 134.86 62.91 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.549 2.166 . . . . 0.0 112.484 172.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.9 0.31 85.81 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 124.711 1.148 . . . . 0.0 115.942 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -139.74 156.39 70.98 Favored Pre-proline 0 N--CA 1.476 0.827 0 CA-C-N 119.407 1.604 . . . . 0.0 112.506 174.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -69.75 149.79 67.39 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.699 2.266 . . . . 0.0 112.983 -173.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.0 t -57.02 132.8 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.934 1.294 . . . . 0.0 110.783 175.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.1 t -111.74 141.92 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.154 1.382 . . . . 0.0 109.41 170.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -136.5 117.77 14.57 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.132 1.373 . . . . 0.0 109.223 176.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.8 t -91.94 159.55 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.02 1.728 . . . . 0.0 111.156 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.41 -104.64 1.62 Allowed Glycine 0 CA--C 1.531 1.067 0 O-C-N 120.959 -1.088 . . . . 0.0 112.026 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.5 t -154.74 160.58 41.42 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.553 0.692 . . . . 0.0 111.516 169.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -74.16 125.94 89.6 Favored Pre-proline 0 CA--C 1.546 0.807 0 O-C-N 120.698 -1.251 . . . . 0.0 111.703 -170.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.402 ' HB2' HG11 ' A' ' 71' ' ' VAL . 71.1 Cg_endo -76.65 154.19 34.7 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.834 3.023 . . . . 0.0 114.728 -177.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.1 t -84.4 -30.13 25.62 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -171.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.29 -35.38 2.44 Favored Glycine 0 N--CA 1.479 1.534 0 C-N-CA 124.738 1.161 . . . . 0.0 113.816 -175.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -78.18 58.64 2.08 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.922 1.689 . . . . 0.0 110.816 169.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.402 HG11 ' HB2' ' A' ' 67' ' ' PRO . 33.6 m -138.95 155.33 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 125.946 1.698 . . . . 0.0 111.863 -171.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.1 mt -74.44 164.79 26.18 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.881 1.672 . . . . 0.0 109.873 169.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -149.32 93.14 2.03 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.729 0.812 . . . . 0.0 110.223 -173.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -85.58 148.56 22.88 Favored Glycine 0 N--CA 1.471 1.007 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 169.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -151.44 150.14 30.08 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.636 1.718 . . . . 0.0 113.207 -169.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -157.51 157.18 33.34 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.316 1.046 . . . . 0.0 113.638 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 85.5 m -109.52 125.86 52.93 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.107 1.363 . . . . 0.0 107.871 169.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.18 173.42 42.74 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 122.385 0.991 . . . . 0.0 114.807 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -80.47 -8.03 59.39 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 -169.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -103.39 6.38 37.72 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.935 1.698 . . . . 0.0 111.648 168.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.1 18.71 30.7 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.264 1.887 . . . . 0.0 114.273 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.7 pm0 -85.28 176.18 8.48 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.613 1.565 . . . . 0.0 113.759 177.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.8 m -132.59 134.18 44.59 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.124 1.37 . . . . 0.0 110.444 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.7 t -118.89 144.28 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.066 1.746 . . . . 0.0 110.115 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.6 tp -133.6 143.75 48.83 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.469 1.108 . . . . 0.0 110.557 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.7 t -114.76 135.66 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 127.797 2.439 . . . . 0.0 108.207 171.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -136.71 144.18 43.76 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.839 0.828 . . . . 0.0 111.145 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.2 152.45 20.18 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 176.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -58.11 142.36 96.97 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.678 2.919 . . . . 0.0 114.316 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 . . . . . 0 C--O 1.253 1.284 0 C-N-CA 125.715 1.606 . . . . 0.0 112.68 172.47 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.85 0 N-CA-C 112.354 -0.299 . . . . 0.0 112.354 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.0 m 56.4 49.98 14.0 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.466 1.507 . . . . 0.0 112.913 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -81.57 142.72 32.56 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.076 0.951 . . . . 0.0 111.26 177.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.7 m 53.14 56.83 6.96 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.811 1.244 . . . . 0.0 112.121 -172.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.5 mmm-85 -133.89 150.14 51.34 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 127.164 2.186 . . . . 0.0 110.386 176.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 73.4 m -136.32 132.34 35.53 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.932 1.293 . . . . 0.0 110.684 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.0 mm -124.62 140.53 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.919 1.688 . . . . 0.0 109.266 173.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 27.9 t -52.38 146.17 10.0 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.645 1.178 . . . . 0.0 113.751 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 m -118.58 25.71 10.07 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.126 1.77 . . . . 0.0 111.106 171.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.7 p -139.14 -72.35 0.39 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.902 1.681 . . . . 0.0 108.798 -175.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.65 -38.68 73.86 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.432 1.493 . . . . 0.0 113.009 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -84.44 -20.0 32.5 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.679 -0.638 . . . . 0.0 112.698 174.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -77.14 -48.04 18.77 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.876 -1.14 . . . . 0.0 111.737 172.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -31.47 71.49 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 121.008 -1.057 . . . . 0.0 113.795 -174.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.2 m -65.79 -21.4 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 172.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -69.97 -43.03 72.34 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 120.905 -1.122 . . . . 0.0 112.5 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.26 -40.82 77.6 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.387 -0.821 . . . . 0.0 111.523 -171.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.4 -30.23 70.56 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.538 1.135 . . . . 0.0 112.62 173.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.43 -37.64 80.45 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.881 -1.137 . . . . 0.0 111.918 171.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.0 t -68.71 -37.0 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 O-C-N 121.43 -0.794 . . . . 0.0 111.302 172.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -59.36 -46.48 88.51 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.2 -0.937 . . . . 0.0 111.602 171.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -69.18 -34.14 74.47 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 117.398 -1.287 . . . . 0.0 112.844 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.16 -34.08 68.07 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 121.079 1.763 . . . . 0.0 110.578 169.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.9 m -73.0 -38.46 66.61 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.552 1.141 . . . . 0.0 113.642 171.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.6 mm -70.89 -37.04 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 120.701 1.591 . . . . 0.0 110.814 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.3 t -66.42 -48.31 81.17 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 C-N-CA 124.792 1.237 . . . . 0.0 109.609 175.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -53.61 -43.06 68.35 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 120.593 1.542 . . . . 0.0 112.154 171.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.2 m -59.64 -32.47 70.47 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.807 -0.558 . . . . 0.0 112.107 176.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -79.72 -36.39 37.49 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.634 1.574 . . . . 0.0 113.555 172.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 78.5 mt -65.62 -33.22 75.38 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 120.063 1.301 . . . . 0.0 111.707 174.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.32 -37.57 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.312 1.045 . . . . 0.0 110.894 169.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.39 -37.53 62.75 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 125.637 1.589 . . . . 0.0 114.272 -172.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.3 t -151.46 -27.45 0.19 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 177.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.15 8.69 33.3 Favored Glycine 0 N--CA 1.477 1.411 0 N-CA-C 116.703 1.441 . . . . 0.0 116.703 175.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.7 p -158.82 136.94 10.58 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.517 1.527 . . . . 0.0 109.985 176.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.45 145.95 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.272 1.029 . . . . 0.0 110.327 176.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -127.56 159.41 34.71 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.598 1.559 . . . . 0.0 109.666 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -53.44 -38.95 64.02 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -175.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -70.24 -15.96 62.98 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -89.27 -3.71 58.42 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.785 0.834 . . . . 0.0 112.494 170.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.1 mt -116.19 -33.88 4.86 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.022 1.329 . . . . 0.0 113.634 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.3 ptt85 -64.42 -21.66 66.71 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 119.66 1.118 . . . . 0.0 113.471 178.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -89.02 2.8 53.47 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.209 1.404 . . . . 0.0 113.984 171.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -121.33 -13.38 8.47 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.357 1.463 . . . . 0.0 112.742 -174.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.1 pt -56.49 -63.36 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 118.715 0.689 . . . . 0.0 110.938 171.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 66.07 -13.47 0.16 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 127.907 2.483 . . . . 0.0 116.7 170.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -154.88 -31.84 0.1 Allowed 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 169.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.14 155.85 39.81 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.608 0.763 . . . . 0.0 111.291 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -76.66 -49.61 15.74 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.957 -0.464 . . . . 0.0 111.589 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -136.45 144.89 44.66 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.177 1.391 . . . . 0.0 112.246 -173.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -120.58 149.45 42.43 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.907 0.883 . . . . 0.0 110.87 169.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.9 t -141.16 140.77 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 120.838 -1.163 . . . . 0.0 110.582 -173.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -113.97 136.17 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -170.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -138.72 74.54 1.48 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.218 1.807 . . . . 0.0 109.469 175.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.8 mt -91.69 126.44 53.95 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-N 114.392 -1.277 . . . . 0.0 109.331 171.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -57.87 137.15 79.58 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.027 2.485 . . . . 0.0 112.932 173.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.61 -1.1 88.32 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.604 1.097 . . . . 0.0 115.413 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -136.25 158.27 73.93 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 119.009 1.404 . . . . 0.0 112.164 175.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.46 152.42 60.27 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.72 2.28 . . . . 0.0 112.774 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.1 p -62.44 135.89 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.693 1.197 . . . . 0.0 111.822 171.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.1 p -122.24 147.17 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.818 1.247 . . . . 0.0 110.752 169.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -127.07 124.34 39.04 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.313 1.445 . . . . 0.0 109.727 -173.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.2 t -103.8 149.1 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 127.81 2.444 . . . . 0.0 109.792 -169.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.96 -94.53 1.0 Allowed Glycine 0 CA--C 1.532 1.114 0 O-C-N 120.727 -1.233 . . . . 0.0 111.678 -175.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 m -155.4 157.64 37.37 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.551 1.14 . . . . 0.0 109.879 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -71.51 128.48 89.88 Favored Pre-proline 0 CA--C 1.55 0.943 0 O-C-N 120.569 -1.332 . . . . 0.0 112.19 177.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -77.94 155.53 30.3 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 124.397 3.398 . . . . 0.0 114.736 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.0 t -84.45 -20.3 31.98 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -170.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.21 -31.6 5.76 Favored Glycine 0 N--CA 1.478 1.458 0 C-N-CA 125.782 1.658 . . . . 0.0 113.413 -176.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -78.46 60.1 2.54 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.033 1.733 . . . . 0.0 110.365 169.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.57 154.08 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 126.19 1.796 . . . . 0.0 111.502 -170.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 25.0 mt -86.93 138.23 31.71 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.946 2.098 . . . . 0.0 108.963 173.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -121.57 111.15 16.88 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.151 0.887 . . . . 0.0 111.619 -174.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.56 144.28 16.99 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 169.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -151.35 135.76 16.92 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 119.247 1.523 . . . . 0.0 112.548 -169.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.1 165.01 29.5 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.392 1.077 . . . . 0.0 113.779 -176.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.7 m -117.44 129.76 56.04 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.401 1.481 . . . . 0.0 108.613 173.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.11 173.52 36.21 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.2 0.905 . . . . 0.0 114.603 -178.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -81.86 -9.25 59.66 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 -169.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -99.01 5.02 47.32 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 120.752 1.614 . . . . 0.0 111.506 168.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.38 16.77 36.23 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.562 2.029 . . . . 0.0 114.157 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.7 pm0 -83.58 173.29 11.54 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.66 1.584 . . . . 0.0 113.837 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.1 m -126.75 137.48 53.24 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.452 1.501 . . . . 0.0 110.14 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.7 t -124.17 141.4 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.606 1.562 . . . . 0.0 110.303 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.6 tp -130.49 146.02 51.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.798 1.239 . . . . 0.0 110.209 175.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.9 t -130.63 138.85 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.039 1.736 . . . . 0.0 108.789 176.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -134.53 131.52 38.08 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.394 0.616 . . . . 0.0 112.576 -175.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -123.33 148.68 55.86 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 125.031 1.332 . . . . 0.0 112.446 175.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -57.42 134.27 62.47 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.545 2.163 . . . . 0.0 112.101 170.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 . . . . . 0 C--O 1.254 1.315 0 C-N-CA 124.957 1.303 . . . . 0.0 112.63 -178.776 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.699 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.9 p -151.73 162.6 40.75 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.591 1.557 . . . . 0.0 111.854 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -57.9 107.57 0.48 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.183 1.393 . . . . 0.0 111.795 -176.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.1 m -135.63 137.12 41.55 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.971 1.308 . . . . 0.0 111.407 -169.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.73 156.63 37.92 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.151 1.38 . . . . 0.0 112.167 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.6 t -156.28 166.23 34.05 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.542 1.537 . . . . 0.0 110.716 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.9 mm -100.57 129.46 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.324 1.049 . . . . 0.0 110.577 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.5 t -58.08 142.53 46.63 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.664 1.186 . . . . 0.0 113.918 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.0 m -127.38 31.95 5.12 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.791 2.037 . . . . 0.0 109.861 169.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.8 p -141.3 -75.03 0.31 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.234 1.813 . . . . 0.0 109.47 -171.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.69 -45.53 82.44 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.292 1.437 . . . . 0.0 111.732 173.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.2 tp60 -67.85 -32.7 73.41 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.652 -0.655 . . . . 0.0 112.175 173.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -72.2 -47.28 51.77 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.515 -0.741 . . . . 0.0 111.791 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -57.75 -41.34 81.71 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.259 0.936 . . . . 0.0 111.134 175.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.1 t -59.94 -29.02 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.34 1.856 . . . . 0.0 112.667 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -70.52 -40.52 73.45 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.31 -0.868 . . . . 0.0 112.674 173.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.7 mp -75.6 -36.96 60.16 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.026 -1.046 . . . . 0.0 111.818 -171.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -64.54 -27.48 68.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.548 0.739 . . . . 0.0 112.784 169.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.2 -37.75 78.27 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.713 -1.242 . . . . 0.0 112.076 169.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.6 t -68.12 -36.4 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 O-C-N 121.267 -0.895 . . . . 0.0 111.315 173.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -58.71 -44.49 90.38 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.321 -0.862 . . . . 0.0 111.526 170.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.6 mp -69.62 -35.8 75.59 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-O 116.597 -1.668 . . . . 0.0 113.101 173.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.64 -37.11 67.79 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 121.8 2.091 . . . . 0.0 110.391 169.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.6 m -69.16 -39.57 78.68 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.162 0.985 . . . . 0.0 113.334 172.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.9 mm -71.1 -34.76 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 120.606 1.548 . . . . 0.0 110.549 176.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.83 -51.04 76.9 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 C-N-CA 125.667 1.587 . . . . 0.0 110.328 174.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -54.66 -40.12 68.73 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 121.086 1.766 . . . . 0.0 112.745 172.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.1 m -62.68 -28.97 70.3 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.883 0.473 . . . . 0.0 112.103 175.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -83.23 -37.06 24.08 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.123 1.769 . . . . 0.0 113.482 172.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.7 mt -66.39 -35.98 81.7 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.989 1.268 . . . . 0.0 111.807 175.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.7 mt -74.33 -36.34 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 124.845 1.258 . . . . 0.0 110.879 169.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.87 -39.0 40.14 Favored Glycine 0 C--N 1.34 0.786 0 C-N-CA 125.523 1.535 . . . . 0.0 114.775 -170.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.8 t -150.07 -27.31 0.25 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 176.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.94 11.83 36.16 Favored Glycine 0 N--CA 1.475 1.25 0 N-CA-C 116.515 1.366 . . . . 0.0 116.515 174.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.9 m -155.29 140.05 17.11 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.256 1.422 . . . . 0.0 110.871 172.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 80.5 t -99.84 143.68 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.037 1.735 . . . . 0.0 109.212 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -127.77 156.69 42.06 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.549 1.14 . . . . 0.0 111.2 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -54.85 -38.23 67.2 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.211 -0.93 . . . . 0.0 112.241 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.29 -20.58 64.77 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.199 1.4 . . . . 0.0 113.692 177.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -82.99 -35.3 25.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.565 0.62 . . . . 0.0 112.345 172.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.4 mt -84.11 -32.23 24.83 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -175.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -58.66 -21.87 55.41 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 175.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -82.54 -5.19 58.61 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 174.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -109.16 -44.54 3.93 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.678 1.191 . . . . 0.0 112.452 -174.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 pt -39.74 -42.59 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 117.354 2.353 . . . . 0.0 117.354 175.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 38.19 -3.83 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 1 C-N-CA 133.88 4.872 . . . . 0.0 118.794 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -169.05 -33.86 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 128.531 2.732 . . . . 0.0 112.716 -170.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.41 145.74 43.48 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.808 0.843 . . . . 0.0 110.7 172.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.08 -59.8 3.16 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.263 1.025 . . . . 0.0 112.058 -176.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -130.86 129.6 42.52 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 122.995 0.518 . . . . 0.0 111.367 -170.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.47 144.24 32.51 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 118.902 0.773 . . . . 0.0 109.607 169.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.3 t -140.53 140.58 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.841 1.257 . . . . 0.0 110.328 -169.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -128.95 141.1 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -169.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -138.75 88.22 2.28 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.376 1.87 . . . . 0.0 108.314 169.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.1 mt -104.65 126.75 30.49 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 124.132 0.973 . . . . 0.0 109.364 173.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.15 133.83 57.96 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.542 2.162 . . . . 0.0 113.235 174.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.0 1.11 89.79 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.043 1.306 . . . . 0.0 116.207 175.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -134.12 158.17 75.95 Favored Pre-proline 0 N--CA 1.476 0.829 0 CA-C-N 119.247 1.523 . . . . 0.0 112.19 173.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.65 143.19 61.24 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.518 2.145 . . . . 0.0 112.702 -177.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 p -52.34 137.41 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.857 1.663 . . . . 0.0 112.451 171.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.7 t -119.78 134.03 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.287 1.835 . . . . 0.0 109.352 172.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -141.16 115.9 9.67 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.594 1.158 . . . . 0.0 109.283 176.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.7 t -93.23 155.1 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.682 1.993 . . . . 0.0 111.494 -169.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.74 -97.17 1.21 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 121.269 -0.895 . . . . 0.0 113.409 172.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.8 m -153.71 154.86 34.88 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.471 1.109 . . . . 0.0 110.346 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -70.67 127.99 91.38 Favored Pre-proline 0 CA--C 1.548 0.882 0 O-C-N 120.69 -1.256 . . . . 0.0 110.951 175.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.426 ' CB ' HG11 ' A' ' 71' ' ' VAL . 73.8 Cg_endo -78.55 158.76 28.79 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 124.283 3.322 . . . . 0.0 114.664 -178.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.8 t -85.57 -29.77 23.88 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -169.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.48 -35.48 2.33 Favored Glycine 0 N--CA 1.476 1.365 0 C-N-CA 125.484 1.516 . . . . 0.0 112.449 -175.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -78.9 61.86 3.22 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.489 1.515 . . . . 0.0 110.589 169.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.426 HG11 ' CB ' ' A' ' 67' ' ' PRO . 30.3 m -137.47 155.48 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.53 1.532 . . . . 0.0 112.535 -177.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.0 mt -91.99 127.93 37.65 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 128.417 2.687 . . . . 0.0 109.243 176.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -114.52 108.13 16.44 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.766 0.712 . . . . 0.0 111.649 -173.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.51 146.78 18.73 Favored Glycine 0 N--CA 1.469 0.856 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 169.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -152.37 132.92 13.85 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 119.377 1.589 . . . . 0.0 112.644 -169.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.28 168.45 21.04 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 42.6 m -135.43 118.01 15.93 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.927 1.691 . . . . 0.0 109.417 -177.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.48 172.15 52.57 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.454 1.026 . . . . 0.0 113.055 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -49.19 -43.96 42.68 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 126.324 1.85 . . . . 0.0 111.472 175.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -81.06 2.17 28.33 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -172.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.39 22.97 27.85 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.387 0.994 . . . . 0.0 113.139 172.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.42 -166.78 1.54 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.322 1.449 . . . . 0.0 113.285 -178.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.7 m -146.85 123.55 11.19 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 120.377 -1.452 . . . . 0.0 111.904 172.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.2 t -97.69 143.0 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.708 2.003 . . . . 0.0 109.988 170.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.1 tp -131.28 144.9 51.63 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.395 1.478 . . . . 0.0 109.134 169.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.7 t -125.76 137.42 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.318 1.447 . . . . 0.0 108.544 172.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -131.67 126.36 34.41 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.689 0.757 . . . . 0.0 111.284 -175.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -129.49 144.59 53.47 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 126.564 1.946 . . . . 0.0 110.813 -170.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.92 133.42 38.67 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.377 2.051 . . . . 0.0 112.188 178.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.2 ttp85 . . . . . 0 C--O 1.253 1.265 0 C-N-CA 125.138 1.375 . . . . 0.0 112.231 178.479 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.772 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.1 p -77.01 168.85 19.39 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.991 1.316 . . . . 0.0 112.631 174.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -149.06 144.34 26.63 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.339 1.055 . . . . 0.0 111.397 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.1 p -78.95 118.28 20.81 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.365 1.066 . . . . 0.0 112.174 177.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.86 166.68 32.06 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 126.429 1.892 . . . . 0.0 112.532 178.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.3 m -68.55 143.65 54.84 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.516 1.127 . . . . 0.0 110.74 171.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 68.3 mt -134.38 145.67 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.274 1.429 . . . . 0.0 108.242 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.1 p -82.32 34.19 0.42 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 -172.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.2 m -63.58 32.23 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 130.02 3.328 . . . . 0.0 117.315 -172.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 27.2 p -129.42 -65.42 0.85 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.219 2.208 . . . . 0.0 107.92 169.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.05 -44.28 76.75 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.339 1.456 . . . . 0.0 112.76 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -78.03 -22.09 49.72 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.76 0.824 . . . . 0.0 111.839 174.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -74.17 -53.22 10.31 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 120.803 -1.186 . . . . 0.0 111.68 173.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.97 -31.66 72.04 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 121.011 -1.056 . . . . 0.0 113.724 -172.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.6 m -60.57 -20.58 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 172.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -70.24 -45.13 67.12 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.181 0.901 . . . . 0.0 112.454 174.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -70.9 -41.33 71.42 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.209 -0.932 . . . . 0.0 111.303 -170.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -63.62 -33.13 74.94 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.909 0.883 . . . . 0.0 112.562 170.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.24 -37.02 84.51 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.72 -1.238 . . . . 0.0 111.829 172.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.7 t -69.27 -38.58 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 O-C-N 121.236 -0.915 . . . . 0.0 111.529 172.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.9 tpp85 -58.11 -46.14 86.06 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.156 -0.965 . . . . 0.0 111.009 171.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -69.95 -34.79 73.87 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 116.759 -1.591 . . . . 0.0 112.616 175.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.78 -37.99 69.31 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 121.589 1.995 . . . . 0.0 109.735 169.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.8 m -70.23 -38.26 75.18 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.115 0.966 . . . . 0.0 113.483 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.0 mm -71.55 -34.86 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 120.854 1.661 . . . . 0.0 110.489 176.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.1 t -63.21 -50.5 78.84 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 C-N-CA 125.4 1.48 . . . . 0.0 109.59 172.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -55.08 -40.51 70.45 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 121.307 1.867 . . . . 0.0 113.34 172.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.4 m -59.32 -34.01 71.81 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.085 -0.384 . . . . 0.0 111.682 174.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -79.41 -35.7 40.19 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.825 1.65 . . . . 0.0 113.937 172.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.96 -33.71 76.43 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 120.161 1.346 . . . . 0.0 111.576 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 87.6 mt -75.04 -37.4 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 124.849 1.259 . . . . 0.0 110.585 169.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.23 -39.48 62.3 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 125.637 1.589 . . . . 0.0 114.181 -173.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.3 t -151.49 -27.75 0.19 Allowed 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.22 0.27 38.14 Favored Glycine 0 N--CA 1.481 1.655 0 N-CA-C 116.757 1.463 . . . . 0.0 116.757 175.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.1 m -144.09 136.01 26.26 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.35 1.86 . . . . 0.0 109.01 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.9 p -114.41 143.18 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.335 1.054 . . . . 0.0 110.224 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -128.41 158.46 38.25 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.748 1.219 . . . . 0.0 110.872 -170.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -51.9 -37.95 54.38 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.722 0.809 . . . . 0.0 113.07 -177.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -70.31 -20.05 63.03 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.637 1.575 . . . . 0.0 114.236 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -80.55 -36.96 32.29 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.997 0.817 . . . . 0.0 111.491 171.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.5 mt -87.48 -33.06 19.14 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.74 1.616 . . . . 0.0 113.951 -170.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.6 ptt85 -55.15 -22.37 16.81 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 172.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -84.35 -12.25 54.87 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 176.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -110.55 -21.63 12.05 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 119.957 1.253 . . . . 0.0 114.038 -170.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -60.44 -31.64 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.15 -5.61 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.209 1 C-N-CA 132.424 4.29 . . . . 0.0 117.806 177.629 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -173.92 -47.04 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 128.851 2.86 . . . . 0.0 109.398 -174.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.99 130.69 30.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.813 1.245 . . . . 0.0 110.977 -176.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -59.05 -54.69 44.21 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -169.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -132.52 130.08 39.93 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.042 1.337 . . . . 0.0 111.498 -174.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.405 ' H ' ' HB ' ' A' ' 63' ' ' VAL . . . -105.71 142.76 34.89 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 168.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.5 t -138.33 140.5 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 O-C-N 121.085 -1.009 . . . . 0.0 110.975 -169.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 mm -114.17 134.28 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.748 1.619 . . . . 0.0 113.628 -172.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -136.64 69.13 1.42 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.594 1.958 . . . . 0.0 109.589 170.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 30.8 mt -89.93 128.18 51.0 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 123.971 0.909 . . . . 0.0 109.383 171.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -61.46 132.56 41.38 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.35 2.033 . . . . 0.0 112.713 173.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.35 2.89 87.33 Favored Glycine 0 CA--C 1.537 1.412 0 N-CA-C 116.079 1.192 . . . . 0.0 116.079 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -136.13 155.12 77.72 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-N 119.152 1.476 . . . . 0.0 112.008 172.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.05 147.45 67.49 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.722 2.281 . . . . 0.0 113.14 -171.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 p -58.33 130.2 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.641 1.176 . . . . 0.0 111.651 174.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.1 t -109.88 139.28 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.753 1.621 . . . . 0.0 108.937 171.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -135.47 108.5 7.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.767 1.227 . . . . 0.0 108.511 177.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.405 ' HB ' ' H ' ' A' ' 51' ' ' ALA . 27.6 t -80.8 149.3 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.111 1.364 . . . . 0.0 110.985 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.14 -93.59 1.43 Allowed Glycine 0 CA--C 1.533 1.196 0 O-C-N 121.654 -0.654 . . . . 0.0 112.128 174.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.1 m -149.35 158.4 44.14 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.048 1.339 . . . . 0.0 109.146 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -76.69 128.27 82.25 Favored Pre-proline 0 CA--C 1.548 0.892 0 O-C-N 120.548 -1.345 . . . . 0.0 110.896 173.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -75.83 155.45 39.16 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.285 3.323 . . . . 0.0 114.89 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.7 t -86.18 -31.79 21.58 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -169.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.36 -41.17 1.42 Allowed Glycine 0 N--CA 1.474 1.201 0 C-N-CA 124.991 1.282 . . . . 0.0 112.583 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -78.49 64.13 3.48 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.059 1.343 . . . . 0.0 111.047 169.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.0 158.17 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.443 1.497 . . . . 0.0 112.406 -178.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.4 mt -99.83 126.7 45.97 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.612 2.365 . . . . 0.0 110.056 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -109.2 109.58 20.56 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -170.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.26 146.7 18.24 Favored Glycine 0 N--CA 1.475 1.24 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 169.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 68.8 ttt-85 -154.2 132.84 12.16 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 120.812 2.306 . . . . 0.0 114.101 -169.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -143.32 173.59 11.47 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.196 1.398 . . . . 0.0 113.597 -177.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -143.73 119.26 10.35 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.597 1.559 . . . . 0.0 110.409 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.26 175.14 54.62 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.521 1.534 . . . . 0.0 115.513 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -68.02 -9.92 49.58 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.11 2.164 . . . . 0.0 115.373 -174.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -97.47 3.81 50.69 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 120.309 1.413 . . . . 0.0 113.452 169.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.57 23.47 26.13 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.971 1.272 . . . . 0.0 114.238 173.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.14 -164.4 1.11 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.297 1.439 . . . . 0.0 114.527 -172.031 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.4 m -146.91 121.57 9.83 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.334 -1.479 . . . . 0.0 111.833 173.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.7 t -98.14 139.55 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.841 1.656 . . . . 0.0 109.456 169.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.6 tp -129.01 146.9 50.86 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.216 1.406 . . . . 0.0 109.302 171.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.9 t -125.6 134.81 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.005 1.322 . . . . 0.0 108.268 171.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -132.94 131.33 40.7 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.278 1.031 . . . . 0.0 111.359 -176.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -148.51 152.98 39.44 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.352 1.061 . . . . 0.0 112.398 177.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -62.65 135.93 55.43 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.893 2.395 . . . . 0.0 113.86 -170.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 . . . . . 0 C--O 1.254 1.324 0 C-N-CA 127.369 2.268 . . . . 0.0 112.34 179.82 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 . . . . . 0 CA--C 1.544 0.713 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -36.4 78.01 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.347 -0.846 . . . . 0.0 112.588 -174.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.2 m -61.76 -21.41 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -68.72 -43.54 75.77 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.465 1.029 . . . . 0.0 112.231 174.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.74 -42.56 73.77 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.395 -0.815 . . . . 0.0 111.263 -171.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -65.7 -29.54 70.1 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.705 1.202 . . . . 0.0 112.81 171.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.59 -38.77 77.46 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.678 -1.264 . . . . 0.0 112.421 170.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.56 -36.28 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 O-C-N 121.289 -0.882 . . . . 0.0 111.305 172.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -58.83 -44.74 90.96 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.315 -0.865 . . . . 0.0 111.293 171.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.3 mp -70.01 -35.88 74.7 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-O 117.225 -1.369 . . . . 0.0 113.293 173.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.19 -34.73 66.53 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 121.284 1.856 . . . . 0.0 110.602 169.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.5 m -70.17 -38.89 75.53 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.709 0.803 . . . . 0.0 112.927 172.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.4 mm -74.42 -33.96 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 120.563 1.528 . . . . 0.0 111.507 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.9 t -66.13 -43.77 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 117.577 -1.201 . . . . 0.0 110.323 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -52.59 -43.01 65.05 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.666 1.575 . . . . 0.0 112.034 170.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.8 t -61.75 -31.08 71.24 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.317 0.647 . . . . 0.0 112.301 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -79.91 -36.49 36.35 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.993 1.317 . . . . 0.0 113.306 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 71.0 mt -66.27 -35.17 79.7 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.69 1.132 . . . . 0.0 111.685 175.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.4 mt -74.56 -35.21 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.417 1.087 . . . . 0.0 111.04 169.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.69 -38.33 50.69 Favored Glycine 0 C--N 1.339 0.724 0 C-N-CA 125.798 1.666 . . . . 0.0 114.99 -172.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.5 t -152.84 -26.52 0.15 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.82 4.66 42.21 Favored Glycine 0 N--CA 1.476 1.358 0 N-CA-C 116.512 1.365 . . . . 0.0 116.512 174.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.8 p -155.85 141.38 17.78 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.241 1.416 . . . . 0.0 111.131 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 80.4 t -93.74 144.09 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.247 1.419 . . . . 0.0 109.64 175.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -125.07 158.09 34.64 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.622 1.169 . . . . 0.0 110.302 171.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -56.9 -37.17 71.05 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.223 -0.923 . . . . 0.0 112.632 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -69.88 -19.07 63.44 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -77.11 -39.88 47.9 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.783 0.72 . . . . 0.0 111.91 171.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.2 mt -85.64 -27.45 25.4 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -173.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -57.82 -24.18 56.15 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 119.812 1.187 . . . . 0.0 113.58 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -83.58 -3.28 57.54 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.087 1.355 . . . . 0.0 114.122 175.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -118.6 -19.31 8.79 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.449 1.1 . . . . 0.0 113.561 -169.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.578 0 C-N-CA 124.062 0.945 . . . . 0.0 110.995 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.467 0.375 0 CA-C-O 119.35 -0.357 . . . . 0.0 110.65 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -131.47 132.03 43.96 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.438 0.695 . . . . 0.0 111.495 -170.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.08 147.41 31.24 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.212 -0.93 . . . . 0.0 110.924 169.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.3 t -138.43 141.18 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.266 1.427 . . . . 0.0 110.848 -171.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.35 131.18 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.998 1.319 . . . . 0.0 113.828 -171.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -130.72 76.43 1.72 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.967 1.707 . . . . 0.0 109.481 169.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.4 mt -94.31 131.0 32.21 Favored Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 123.715 0.806 . . . . 0.0 108.985 172.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -64.64 136.78 51.41 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.195 1.93 . . . . 0.0 111.544 175.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.97 -0.99 87.9 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.704 1.145 . . . . 0.0 115.851 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -138.32 156.56 73.53 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-N 119.322 1.561 . . . . 0.0 112.582 175.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.19 153.57 66.83 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.811 2.341 . . . . 0.0 113.064 -174.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.1 p -59.2 132.93 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.254 1.022 . . . . 0.0 111.531 172.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 95.5 t -111.32 141.64 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.492 1.517 . . . . 0.0 109.194 170.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -134.84 119.67 18.4 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.215 1.406 . . . . 0.0 109.428 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.2 t -94.87 155.24 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.287 1.835 . . . . 0.0 111.353 -174.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.67 -95.22 0.99 Allowed Glycine 0 CA--C 1.53 1.023 0 O-C-N 121.151 -0.968 . . . . 0.0 112.836 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.6 m -153.0 152.81 31.81 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.537 -0.978 . . . . 0.0 110.26 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -67.19 130.07 93.73 Favored Pre-proline 0 CA--C 1.547 0.865 0 O-C-N 120.72 -1.238 . . . . 0.0 110.883 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.458 ' CB ' HG11 ' A' ' 71' ' ' VAL . 73.1 Cg_endo -79.54 158.77 25.46 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.179 3.253 . . . . 0.0 114.621 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.7 t -88.49 -34.02 17.6 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -169.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.15 -36.57 1.86 Allowed Glycine 0 N--CA 1.477 1.411 0 C-N-CA 125.153 1.358 . . . . 0.0 112.355 -174.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -78.43 63.07 3.2 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.236 1.414 . . . . 0.0 110.522 169.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.458 HG11 ' CB ' ' A' ' 67' ' ' PRO . 30.4 m -139.84 154.36 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.648 1.579 . . . . 0.0 112.351 -176.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.4 mt -89.04 147.5 24.23 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 127.677 2.391 . . . . 0.0 109.128 170.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -127.09 116.95 21.48 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 118.672 0.669 . . . . 0.0 112.206 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.89 150.78 19.98 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.12 1.343 . . . . 0.0 110.001 169.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -156.11 137.04 13.54 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.573 1.686 . . . . 0.0 113.137 -171.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.61 161.98 37.8 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.033 1.333 . . . . 0.0 113.6 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 74.9 m -114.42 128.26 56.25 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.155 1.382 . . . . 0.0 108.319 172.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.08 176.91 44.2 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 122.033 0.796 . . . . 0.0 114.64 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -83.51 -9.56 58.89 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -169.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -102.3 5.91 40.19 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 120.733 1.606 . . . . 0.0 112.194 169.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.12 17.48 34.56 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.247 1.879 . . . . 0.0 114.362 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -83.93 173.22 11.38 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.19 1.796 . . . . 0.0 113.357 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.4 m -129.23 136.55 50.26 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.97 1.308 . . . . 0.0 110.25 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.2 t -119.29 139.7 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.023 1.729 . . . . 0.0 109.575 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.4 tt -132.84 149.11 52.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.467 1.107 . . . . 0.0 109.817 175.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 86.0 t -133.23 139.87 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.509 1.523 . . . . 0.0 109.397 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -131.74 137.73 48.34 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.988 0.899 . . . . 0.0 112.825 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -137.04 150.48 69.62 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 126.564 1.946 . . . . 0.0 111.031 -173.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -64.17 137.93 59.08 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.801 2.334 . . . . 0.0 112.582 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 125.92 1.688 . . . . 0.0 112.409 177.605 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 . . . . . 0 CA--C 1.544 0.745 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -28.46 69.31 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -171.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.3 m -60.4 -21.1 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 170.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -69.2 -45.56 69.62 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 119.466 1.03 . . . . 0.0 112.391 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 mp -70.0 -40.17 75.43 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.552 -0.718 . . . . 0.0 111.617 -170.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -65.02 -34.2 77.87 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.722 1.209 . . . . 0.0 112.519 170.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.92 -38.92 89.94 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 120.604 -1.31 . . . . 0.0 112.361 171.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 94.3 t -68.11 -37.82 78.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 O-C-N 121.294 -0.879 . . . . 0.0 111.533 172.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -59.53 -44.59 93.15 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.318 -0.864 . . . . 0.0 111.057 172.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.5 mp -69.52 -34.32 74.1 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 117.448 -1.263 . . . . 0.0 113.044 174.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.16 -34.44 68.44 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 121.172 1.805 . . . . 0.0 110.534 169.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.3 m -72.63 -38.65 67.66 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.353 1.061 . . . . 0.0 113.636 171.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.1 mm -72.79 -34.2 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 120.915 1.689 . . . . 0.0 110.97 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.2 t -67.18 -47.19 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.795 1.238 . . . . 0.0 109.63 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -53.11 -44.0 67.32 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 120.821 1.646 . . . . 0.0 111.976 170.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.2 m -59.97 -30.43 69.1 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.744 -0.598 . . . . 0.0 112.486 175.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.2 tpt180 -80.92 -35.22 32.7 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.685 1.594 . . . . 0.0 113.526 171.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.7 mt -66.11 -33.8 76.61 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.988 1.267 . . . . 0.0 111.588 174.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 90.7 mt -75.08 -35.69 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.791 1.236 . . . . 0.0 110.811 169.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.89 -38.05 49.7 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 125.5 1.524 . . . . 0.0 114.807 -172.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.1 t -152.58 -26.97 0.16 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.93 1.06 39.2 Favored Glycine 0 N--CA 1.477 1.43 0 N-CA-C 116.774 1.47 . . . . 0.0 116.774 174.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.9 m -147.8 139.0 23.52 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.098 1.759 . . . . 0.0 109.33 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.46 147.05 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.737 1.215 . . . . 0.0 109.955 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -132.32 157.42 44.5 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.782 1.233 . . . . 0.0 110.472 -174.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -55.66 -38.28 69.38 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.758 -0.589 . . . . 0.0 112.268 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -70.45 -20.18 62.91 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.794 1.238 . . . . 0.0 113.721 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -78.99 -41.81 28.11 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.833 0.742 . . . . 0.0 111.067 169.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.3 mt -81.67 -30.34 32.74 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -170.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -56.3 -26.91 53.75 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 173.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -84.18 -3.35 58.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.325 1.05 . . . . 0.0 113.723 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.6 mm-40 -120.71 -13.73 8.67 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.617 1.167 . . . . 0.0 113.535 -169.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.47 0.544 0 C-N-CA 123.405 0.682 . . . . 0.0 112.66 -176.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -132.71 124.34 27.98 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.55 1.54 . . . . 0.0 109.169 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.13 142.63 29.57 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.443 1.02 . . . . 0.0 109.579 169.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 63.1 t -137.84 141.16 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.646 1.178 . . . . 0.0 109.476 -171.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -122.97 134.07 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -169.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -129.67 81.79 2.04 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.467 1.907 . . . . 0.0 109.631 170.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.5 mt -98.34 125.18 44.22 Favored Pre-proline 0 N--CA 1.48 1.063 0 C-N-CA 123.775 0.83 . . . . 0.0 108.979 169.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.87 133.4 53.51 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.384 2.056 . . . . 0.0 112.291 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.25 3.42 87.2 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-O 118.273 -1.293 . . . . 0.0 115.977 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -138.8 163.39 46.95 Favored Pre-proline 0 N--CA 1.475 0.78 0 CA-C-N 119.717 1.759 . . . . 0.0 114.075 173.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -60.62 140.78 92.86 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.579 2.853 . . . . 0.0 114.204 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.2 t -60.23 131.31 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.332 1.053 . . . . 0.0 110.024 169.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 70.1 t -110.38 141.41 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.095 1.358 . . . . 0.0 109.562 172.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -138.17 114.42 10.23 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.999 1.319 . . . . 0.0 109.191 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.3 t -89.97 155.53 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.941 1.696 . . . . 0.0 111.312 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.83 -102.83 1.58 Allowed Glycine 0 CA--C 1.532 1.107 0 O-C-N 121.343 -0.848 . . . . 0.0 112.736 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.3 m -146.12 150.05 35.18 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.516 1.126 . . . . 0.0 110.17 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -67.59 129.74 93.39 Favored Pre-proline 0 CA--C 1.548 0.898 0 O-C-N 120.861 -1.15 . . . . 0.0 111.002 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.413 ' CB ' HG11 ' A' ' 71' ' ' VAL . 73.8 Cg_endo -79.86 155.0 23.32 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.952 3.102 . . . . 0.0 114.314 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.4 HG23 ' H ' ' A' ' 70' ' ' ASP . 13.9 t -83.66 -26.95 29.44 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -171.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.25 -33.9 3.36 Favored Glycine 0 N--CA 1.476 1.32 0 C-N-CA 125.572 1.558 . . . . 0.0 112.64 -175.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.4 ' H ' HG23 ' A' ' 68' ' ' THR . 23.8 m-20 -79.18 60.23 2.98 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.775 1.63 . . . . 0.0 111.216 169.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.413 HG11 ' CB ' ' A' ' 67' ' ' PRO . 34.3 m -136.68 158.99 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 126.078 1.751 . . . . 0.0 112.29 -173.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.9 mt -99.77 126.96 45.93 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.854 2.462 . . . . 0.0 110.382 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -111.33 110.1 20.41 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -169.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.38 145.88 18.29 Favored Glycine 0 N--CA 1.471 0.998 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 169.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -154.46 137.4 15.44 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 120.145 1.972 . . . . 0.0 113.654 -169.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.26 163.65 34.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.56 1.144 . . . . 0.0 113.95 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 62.1 m -117.11 130.52 56.69 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.411 1.485 . . . . 0.0 108.578 172.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.31 174.7 37.08 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.092 0.853 . . . . 0.0 114.638 -177.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -81.45 -10.82 59.42 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 -169.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -99.61 5.49 45.91 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.714 1.597 . . . . 0.0 111.983 169.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.37 17.62 33.49 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 126.259 1.885 . . . . 0.0 114.268 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.3 pm0 -84.08 175.51 9.46 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.839 1.656 . . . . 0.0 113.459 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.5 m -133.2 133.88 43.34 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.073 1.349 . . . . 0.0 110.41 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 67.3 t -114.26 141.18 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.168 1.787 . . . . 0.0 110.029 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.7 tp -129.23 146.77 51.07 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.388 1.475 . . . . 0.0 109.524 174.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.6 t -124.4 137.7 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 127.596 2.358 . . . . 0.0 107.719 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -135.35 138.13 43.06 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.017 0.527 . . . . 0.0 111.724 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -148.83 154.25 39.97 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 172.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -59.82 137.64 77.84 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.779 2.319 . . . . 0.0 113.404 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 . . . . . 0 C--O 1.255 1.354 0 C-N-CA 125.888 1.675 . . . . 0.0 112.241 178.542 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 . . . . . 0 CA--C 1.545 0.761 0 CA-C-O 119.711 -0.185 . . . . 0.0 111.325 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -37.15 79.78 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.057 -1.027 . . . . 0.0 111.822 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.9 t -58.24 -31.43 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.337 1.455 . . . . 0.0 113.085 173.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -71.12 -39.64 71.92 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.235 -0.916 . . . . 0.0 112.957 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -77.86 -36.31 50.01 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.271 -0.893 . . . . 0.0 111.918 -172.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -64.34 -28.0 69.4 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.337 -0.852 . . . . 0.0 112.705 170.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.68 -36.6 84.11 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.608 -1.307 . . . . 0.0 111.981 170.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.3 t -71.33 -35.79 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.567 1.147 . . . . 0.0 111.174 173.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.2 tpp85 -60.82 -46.36 90.82 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.011 -1.055 . . . . 0.0 111.473 171.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.3 mp -69.76 -33.25 72.16 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 117.352 -1.308 . . . . 0.0 112.418 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.58 -33.05 69.53 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 121.269 1.849 . . . . 0.0 110.785 169.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.3 m -73.79 -38.61 64.58 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.303 1.041 . . . . 0.0 113.33 171.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.7 mm -73.31 -36.7 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 121.072 1.76 . . . . 0.0 110.84 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.6 t -62.2 -49.93 82.03 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 CA-C-O 117.558 -1.21 . . . . 0.0 109.466 173.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -54.05 -43.52 70.28 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 120.803 1.638 . . . . 0.0 112.377 173.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.0 m -59.33 -36.84 76.41 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.756 -0.59 . . . . 0.0 111.912 176.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -74.55 -36.49 63.11 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.36 1.464 . . . . 0.0 113.271 172.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.2 mt -67.27 -30.57 70.48 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.864 1.211 . . . . 0.0 112.034 175.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.4 mt -76.05 -37.31 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.869 1.268 . . . . 0.0 110.936 169.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.58 -39.52 55.95 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.383 1.468 . . . . 0.0 114.456 -173.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.8 t -148.83 -27.61 0.3 Allowed 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.69 14.23 35.3 Favored Glycine 0 N--CA 1.479 1.535 0 N-CA-C 116.061 1.184 . . . . 0.0 116.061 175.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.1 m -156.67 145.83 20.36 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.945 1.698 . . . . 0.0 109.694 172.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.0 p -120.69 143.64 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.521 1.528 . . . . 0.0 110.359 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -128.8 156.25 43.88 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.371 1.068 . . . . 0.0 111.395 -169.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -54.2 -39.09 66.36 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.671 -0.643 . . . . 0.0 112.299 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -71.1 -21.07 62.27 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.246 1.418 . . . . 0.0 113.638 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -80.98 -37.23 29.62 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.869 0.759 . . . . 0.0 111.39 169.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.6 mt -82.16 -32.3 30.06 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.984 1.314 . . . . 0.0 113.733 -171.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -58.31 -22.94 54.93 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 173.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -85.11 -1.14 56.53 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.556 1.142 . . . . 0.0 113.913 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -116.56 -21.28 9.24 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.841 1.257 . . . . 0.0 112.998 -174.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.474 0.738 0 C-N-CA 123.623 0.769 . . . . 0.0 111.781 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 119.362 -0.351 . . . . 0.0 111.571 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -126.99 131.36 51.06 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.147 0.579 . . . . 0.0 112.501 -169.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.29 144.47 37.38 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.394 -0.816 . . . . 0.0 109.637 169.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.0 t -139.85 138.72 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.264 1.026 . . . . 0.0 110.389 -169.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.448 HD13 ' HA ' ' A' ' 53' ' ' ILE . 0.4 OUTLIER -119.29 132.93 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -169.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -130.02 83.31 2.12 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.977 1.711 . . . . 0.0 109.45 172.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.5 mt -100.18 132.12 23.13 Favored Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 124.048 0.939 . . . . 0.0 109.271 173.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.52 134.18 37.43 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.352 2.035 . . . . 0.0 111.658 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.48 0.24 82.41 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.774 1.178 . . . . 0.0 115.565 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -135.31 158.12 75.23 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 119.027 1.414 . . . . 0.0 112.087 172.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.2 155.74 66.88 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.621 2.214 . . . . 0.0 112.786 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.2 p -57.66 139.82 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.637 1.175 . . . . 0.0 111.588 171.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 85.1 t -119.24 139.26 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.466 1.507 . . . . 0.0 108.806 172.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -133.5 121.82 22.73 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.001 1.32 . . . . 0.0 109.564 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.8 t -95.02 151.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.618 1.567 . . . . 0.0 111.116 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.17 -102.62 2.3 Favored Glycine 0 CA--C 1.533 1.213 0 O-C-N 121.462 -0.773 . . . . 0.0 112.522 172.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 94.5 m -143.97 141.65 30.3 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.599 1.159 . . . . 0.0 109.896 174.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -65.45 125.9 90.45 Favored Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 120.73 -1.231 . . . . 0.0 111.127 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.437 ' CB ' HG11 ' A' ' 71' ' ' VAL . 60.5 Cg_endo -76.63 153.57 34.34 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.712 2.942 . . . . 0.0 114.911 -172.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 70' ' ' ASP . 11.3 t -82.22 -24.0 35.1 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -169.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.64 -35.05 3.71 Favored Glycine 0 N--CA 1.478 1.487 0 C-N-CA 125.394 1.473 . . . . 0.0 112.618 -174.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.411 ' H ' HG23 ' A' ' 68' ' ' THR . 18.9 m-20 -77.9 59.56 2.13 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.027 1.731 . . . . 0.0 110.672 169.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.437 HG11 ' CB ' ' A' ' 67' ' ' PRO . 28.0 m -135.55 157.29 39.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 126.292 1.837 . . . . 0.0 112.046 -173.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.6 mt -90.78 144.65 25.5 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.704 1.602 . . . . 0.0 109.125 170.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -125.49 122.13 35.73 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.532 0.733 . . . . 0.0 112.102 -177.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.42 148.08 16.44 Favored Glycine 0 N--CA 1.47 0.942 0 C-N-CA 126.033 1.778 . . . . 0.0 109.563 169.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -152.42 141.55 21.34 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.094 1.447 . . . . 0.0 112.876 -169.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.75 162.03 40.03 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.015 1.326 . . . . 0.0 113.228 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 70.1 m -113.11 127.44 56.2 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.951 1.301 . . . . 0.0 108.697 171.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.19 172.35 43.37 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.379 0.99 . . . . 0.0 114.06 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -82.93 -11.78 57.88 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 -169.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -92.94 2.91 56.55 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.837 1.653 . . . . 0.0 111.848 169.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.86 14.68 39.14 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 126.735 2.112 . . . . 0.0 114.369 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.5 pm0 -81.89 173.76 11.94 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.861 1.665 . . . . 0.0 113.794 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.0 m -127.84 138.92 52.87 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.452 1.501 . . . . 0.0 110.348 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.4 t -121.52 139.29 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.425 1.49 . . . . 0.0 109.487 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.2 tp -126.78 148.08 49.95 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.48 1.512 . . . . 0.0 109.935 174.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.38 136.17 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.462 1.505 . . . . 0.0 108.203 174.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -130.19 131.74 45.73 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.845 0.831 . . . . 0.0 112.142 -177.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -126.14 151.54 72.05 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 126.264 1.825 . . . . 0.0 111.552 -178.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -61.11 136.15 63.18 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 122.655 2.237 . . . . 0.0 112.023 170.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 . . . . . 0 C--O 1.252 1.213 0 C-N-CA 125.211 1.404 . . . . 0.0 113.252 -177.597 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.62 -36.43 80.71 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 121.118 -0.989 . . . . 0.0 112.839 -174.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.9 m -60.07 -23.06 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 174.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -71.16 -39.95 71.59 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.217 0.917 . . . . 0.0 111.735 175.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.0 mt -71.84 -41.63 67.91 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.053 0.941 . . . . 0.0 111.541 -172.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -66.68 -33.24 75.2 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.88 0.872 . . . . 0.0 112.516 169.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.8 -37.88 89.02 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 120.28 1.4 . . . . 0.0 112.161 171.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.9 t -69.1 -37.78 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.193 0.997 . . . . 0.0 111.712 172.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -60.87 -43.44 98.42 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.004 -1.06 . . . . 0.0 111.336 172.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -69.79 -34.43 73.71 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 117.468 -1.254 . . . . 0.0 112.585 173.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.27 -33.05 68.99 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 121.175 1.807 . . . . 0.0 110.486 169.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.8 m -73.61 -38.89 64.94 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.401 1.08 . . . . 0.0 113.74 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.1 mm -72.47 -36.12 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 121.221 1.828 . . . . 0.0 110.626 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.413 HG21 HD11 ' A' ' 53' ' ' ILE . 94.7 t -64.66 -48.4 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 117.549 -1.215 . . . . 0.0 109.664 174.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -53.62 -44.27 69.37 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.836 1.653 . . . . 0.0 112.1 172.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.2 m -58.85 -34.48 71.62 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.786 -0.571 . . . . 0.0 112.113 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -77.78 -35.67 51.34 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.482 1.513 . . . . 0.0 113.63 172.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 56.0 mt -66.77 -33.05 74.77 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 120.127 1.33 . . . . 0.0 111.56 175.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 90.8 mt -72.75 -36.98 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 124.821 1.248 . . . . 0.0 110.672 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.2 -39.7 51.88 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.506 1.527 . . . . 0.0 114.673 -173.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.6 t -151.45 -27.25 0.19 Allowed 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.86 2.42 49.24 Favored Glycine 0 N--CA 1.48 1.629 0 N-CA-C 116.436 1.334 . . . . 0.0 116.436 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.9 m -143.81 136.5 27.19 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.254 1.821 . . . . 0.0 109.115 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 p -113.31 145.9 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.597 1.159 . . . . 0.0 110.216 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -132.92 157.4 45.2 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.634 1.174 . . . . 0.0 111.073 -170.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.55 -40.75 65.79 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.797 -0.565 . . . . 0.0 112.368 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.95 -17.82 62.05 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.394 1.078 . . . . 0.0 113.756 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -81.67 -36.86 28.29 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.032 0.833 . . . . 0.0 111.52 169.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 64.3 mt -85.68 -31.75 22.34 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.742 1.617 . . . . 0.0 114.374 -171.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -60.66 -19.17 57.61 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -85.62 -5.29 59.29 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.06 1.344 . . . . 0.0 114.131 173.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -116.1 -18.2 10.67 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.719 1.208 . . . . 0.0 113.482 -169.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.475 0.785 0 C-N-CA 124.004 0.922 . . . . 0.0 113.008 -178.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -129.04 130.89 47.16 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.649 1.58 . . . . 0.0 111.44 -173.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -106.02 142.73 35.23 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.48 -0.762 . . . . 0.0 109.442 169.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.5 t -138.14 139.54 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.492 1.117 . . . . 0.0 110.354 -170.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.413 HD11 HG21 ' A' ' 26' ' ' VAL . 0.8 OUTLIER -120.58 133.24 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -169.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.6 mmt85 -132.58 79.06 1.83 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.884 1.674 . . . . 0.0 109.664 171.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.5 mt -96.37 132.16 27.11 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 124.188 0.995 . . . . 0.0 109.329 172.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.59 131.02 26.49 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.174 1.916 . . . . 0.0 111.499 175.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.2 2.6 80.11 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 116.201 1.241 . . . . 0.0 116.201 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -137.99 155.83 74.4 Favored Pre-proline 0 N--CA 1.475 0.81 0 CA-C-N 119.246 1.523 . . . . 0.0 111.907 172.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.91 151.41 78.14 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.682 2.255 . . . . 0.0 113.044 -173.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 p -59.15 131.67 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.403 1.081 . . . . 0.0 111.249 172.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.3 t -109.53 138.25 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.313 1.445 . . . . 0.0 109.099 170.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -132.72 116.3 16.43 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.247 1.419 . . . . 0.0 108.804 176.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.6 t -93.12 152.02 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.439 1.495 . . . . 0.0 111.186 -175.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.25 -97.44 1.42 Allowed Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.694 -0.629 . . . . 0.0 111.558 176.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.2 m -146.53 149.7 34.11 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.42 1.088 . . . . 0.0 109.604 177.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.2 tttp -70.47 127.33 92.15 Favored Pre-proline 0 CA--C 1.547 0.84 0 O-C-N 120.628 -1.295 . . . . 0.0 110.485 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.64 154.83 39.82 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 124.026 3.151 . . . . 0.0 114.739 -173.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.1 t -83.19 -23.25 32.93 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -169.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.37 -35.45 3.61 Favored Glycine 0 N--CA 1.475 1.261 0 C-N-CA 125.545 1.545 . . . . 0.0 113.026 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -78.43 59.25 2.33 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.87 1.668 . . . . 0.0 111.267 169.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.0 m -132.93 158.2 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.949 1.7 . . . . 0.0 112.299 -174.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.4 mt -89.73 144.04 26.31 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 126.505 1.922 . . . . 0.0 109.425 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -123.29 114.03 19.68 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.074 0.549 . . . . 0.0 112.376 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.31 144.16 17.13 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 169.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -153.73 138.31 16.88 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 120.504 2.152 . . . . 0.0 113.559 -169.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.05 166.26 26.63 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.022 1.329 . . . . 0.0 113.782 -176.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.0 m -120.03 130.56 54.77 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.62 1.568 . . . . 0.0 108.454 173.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.93 177.29 39.94 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.11 0.862 . . . . 0.0 114.346 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -84.36 -14.09 50.49 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -169.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -93.76 4.52 53.81 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.871 1.669 . . . . 0.0 112.124 169.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.92 15.98 43.37 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.583 2.039 . . . . 0.0 114.106 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.9 pm0 -79.8 172.64 13.51 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.522 1.529 . . . . 0.0 113.573 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.5 m -130.22 137.36 50.0 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.37 1.468 . . . . 0.0 109.834 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.3 t -120.28 138.01 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.731 1.612 . . . . 0.0 109.605 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 15.6 tp -128.35 149.47 50.5 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.33 1.452 . . . . 0.0 109.539 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 75.2 t -132.09 133.73 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.246 1.818 . . . . 0.0 107.871 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -133.69 137.46 45.32 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.226 0.536 . . . . 0.0 112.395 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -151.95 155.03 33.41 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 123.835 0.854 . . . . 0.0 112.624 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -60.14 138.82 84.0 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.118 2.546 . . . . 0.0 113.906 -173.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 . . . . . 0 C--O 1.252 1.204 0 C-N-CA 126.162 1.785 . . . . 0.0 112.746 -178.598 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 . . . . . 0 CA--C 1.547 0.833 0 N-CA-C 111.35 0.13 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -35.2 73.49 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 121.228 -0.92 . . . . 0.0 113.006 -174.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.6 m -62.96 -20.71 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -69.73 -45.4 68.24 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 119.196 0.907 . . . . 0.0 112.07 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.92 -42.68 72.98 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.319 -0.863 . . . . 0.0 111.623 -170.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -60.74 -35.8 77.29 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.504 1.122 . . . . 0.0 112.168 171.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.2 -39.94 74.89 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 120.887 -1.133 . . . . 0.0 112.67 174.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.3 t -63.85 -40.79 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.961 0.905 . . . . 0.0 110.946 172.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.4 tmm_? -63.41 -40.17 96.49 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.245 -0.91 . . . . 0.0 112.0 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 mp -63.24 -34.37 77.51 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 117.276 -1.345 . . . . 0.0 112.423 170.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.71 -32.57 67.53 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 121.173 1.806 . . . . 0.0 111.339 169.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.0 m -75.08 -35.08 61.84 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 170.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.1 mm -70.57 -36.48 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 119.929 1.24 . . . . 0.0 110.709 176.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.8 t -66.99 -46.43 84.83 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.419 0 C-N-CA 125.681 1.592 . . . . 0.0 110.402 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -52.53 -42.54 64.47 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.742 1.61 . . . . 0.0 111.847 170.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.7 m -61.0 -29.31 69.62 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 175.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -83.22 -33.9 26.0 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.862 1.665 . . . . 0.0 113.679 171.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.8 mt -66.06 -35.81 81.52 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 120.033 1.288 . . . . 0.0 111.568 173.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 88.6 mt -73.19 -35.42 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.502 1.121 . . . . 0.0 110.662 169.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.14 -38.6 54.57 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 125.596 1.57 . . . . 0.0 114.752 -172.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.1 t -154.48 -26.99 0.12 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.17 4.03 38.48 Favored Glycine 0 N--CA 1.479 1.556 0 N-CA-C 116.721 1.448 . . . . 0.0 116.721 175.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.9 p -158.21 140.5 14.27 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.42 1.488 . . . . 0.0 111.488 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 81.0 t -94.43 143.69 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.29 1.436 . . . . 0.0 110.556 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -124.43 157.46 35.13 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.018 1.327 . . . . 0.0 110.427 171.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -53.87 -38.35 64.63 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.394 -0.816 . . . . 0.0 112.734 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -66.97 -22.44 65.93 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.169 1.388 . . . . 0.0 113.676 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -78.12 -37.64 45.72 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.288 0.495 . . . . 0.0 111.943 171.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.2 mt -88.04 -27.73 21.82 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 -173.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.0 ptt85 -58.16 -27.53 63.9 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -88.81 5.91 41.43 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 173.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -128.08 -8.97 5.38 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 120.572 -1.33 . . . . 0.0 113.966 -170.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.474 0.773 0 C-N-CA 124.784 1.233 . . . . 0.0 112.091 174.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.466 0.352 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -130.27 127.33 39.33 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.195 0.598 . . . . 0.0 111.812 -170.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -103.45 145.95 29.23 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.182 -0.949 . . . . 0.0 109.864 169.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.6 t -139.61 139.27 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 O-C-N 121.085 -1.009 . . . . 0.0 111.505 -170.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.2 mm -111.81 132.28 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.468 1.507 . . . . 0.0 113.519 -172.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.5 tpt85 -140.8 46.49 1.77 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.324 1.849 . . . . 0.0 110.423 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.2 mt -66.67 127.46 93.42 Favored Pre-proline 0 N--CA 1.481 1.083 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.054 170.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -58.63 135.41 67.19 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.978 2.452 . . . . 0.0 112.741 173.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.93 1.25 88.92 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-O 118.506 -1.163 . . . . 0.0 115.506 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -135.62 162.43 57.13 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 119.461 1.63 . . . . 0.0 113.921 173.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -61.92 142.85 94.53 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.603 2.869 . . . . 0.0 114.596 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.1 p -68.45 130.4 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.685 0.794 . . . . 0.0 110.285 169.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.8 p -123.39 147.31 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.036 1.334 . . . . 0.0 110.972 171.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -135.86 119.37 16.97 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.938 1.695 . . . . 0.0 108.948 -170.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 50.7 t -90.25 155.28 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 126.05 1.74 . . . . 0.0 111.701 -173.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.58 -88.95 1.03 Allowed Glycine 0 CA--C 1.533 1.192 0 O-C-N 121.429 -0.794 . . . . 0.0 112.761 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 85.3 m -154.25 154.2 33.04 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.164 1.386 . . . . 0.0 109.479 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -73.37 125.24 90.89 Favored Pre-proline 0 CA--C 1.547 0.839 0 O-C-N 120.561 -1.337 . . . . 0.0 110.779 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.84 155.19 43.68 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 124.036 3.157 . . . . 0.0 114.529 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.4 t -83.84 -27.98 28.35 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -169.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.73 -34.64 2.82 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 125.27 1.414 . . . . 0.0 113.36 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -79.1 60.48 2.99 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.877 1.671 . . . . 0.0 111.185 169.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.7 m -136.87 156.45 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.736 1.614 . . . . 0.0 112.525 -171.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 29.2 mt -94.36 133.55 37.81 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.309 2.243 . . . . 0.0 109.481 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -118.03 113.47 21.69 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -173.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -88.79 148.91 20.63 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.174 1.369 . . . . 0.0 110.616 169.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 68.5 mtt85 -145.92 159.38 43.3 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 119.23 1.515 . . . . 0.0 112.408 -175.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -164.82 167.23 19.01 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.499 1.12 . . . . 0.0 113.657 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.2 m -119.59 134.12 55.36 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.079 1.752 . . . . 0.0 108.002 169.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -97.49 177.73 32.25 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-O 122.025 0.792 . . . . 0.0 114.966 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -81.33 -12.13 59.12 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -169.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -101.78 4.98 40.97 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.656 1.571 . . . . 0.0 112.099 169.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.03 17.13 33.23 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 126.214 1.864 . . . . 0.0 114.384 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.1 pm0 -78.61 173.14 12.74 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.704 1.602 . . . . 0.0 113.726 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 95.5 m -130.75 135.14 47.5 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.453 1.101 . . . . 0.0 109.366 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 74.5 t -120.17 143.79 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.491 1.516 . . . . 0.0 110.822 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.6 tp -134.08 151.15 51.27 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.853 1.661 . . . . 0.0 109.151 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.2 t -140.86 139.38 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.884 1.673 . . . . 0.0 108.154 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -134.11 134.89 42.78 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.69 0.757 . . . . 0.0 112.304 -176.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -129.81 147.23 64.59 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 126.033 1.733 . . . . 0.0 111.194 -176.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -61.06 133.07 45.05 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.428 2.085 . . . . 0.0 111.394 171.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 . . . . . 0 C--O 1.253 1.263 0 C-N-CA 124.741 1.217 . . . . 0.0 112.358 -179.962 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.416 HH21 ' CD ' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -62.06 -36.9 83.03 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 120.91 -1.119 . . . . 0.0 112.787 -174.095 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.4 m -60.57 -24.37 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.434 0.693 . . . . 0.0 112.832 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -70.99 -38.7 72.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.122 0.874 . . . . 0.0 111.383 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.1 mt -71.63 -42.12 67.99 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.014 0.926 . . . . 0.0 111.717 -172.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.416 ' CD ' HH21 ' A' ' 14' ' ' ARG . 4.1 pt-20 -66.31 -32.61 74.12 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.091 0.956 . . . . 0.0 112.506 169.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.8 -37.78 88.76 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.749 -1.219 . . . . 0.0 112.299 170.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.8 t -69.63 -36.34 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.368 1.067 . . . . 0.0 111.748 172.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -60.37 -44.88 95.19 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.784 -1.197 . . . . 0.0 111.132 170.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.7 mp -67.55 -34.06 76.31 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-O 117.469 -1.253 . . . . 0.0 112.624 173.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.83 -34.56 69.81 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 121.167 1.803 . . . . 0.0 110.808 169.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.0 m -72.3 -38.32 68.76 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.177 0.991 . . . . 0.0 113.253 170.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.1 mm -72.91 -35.73 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 120.88 1.673 . . . . 0.0 111.112 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.0 t -66.73 -48.5 79.85 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.519 0 CA-C-O 117.387 -1.292 . . . . 0.0 109.221 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -53.25 -42.98 66.99 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 120.997 1.726 . . . . 0.0 112.273 171.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.6 m -60.52 -33.01 72.01 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.713 -0.617 . . . . 0.0 112.291 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -78.88 -35.11 44.18 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.669 1.587 . . . . 0.0 113.323 172.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.3 mt -66.46 -32.4 73.74 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.713 1.142 . . . . 0.0 111.723 174.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 92.2 mt -76.41 -35.92 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.908 1.283 . . . . 0.0 111.054 169.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.14 -38.57 46.92 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 125.474 1.511 . . . . 0.0 114.875 -172.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.5 t -151.34 -28.32 0.19 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 177.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.67 8.53 34.68 Favored Glycine 0 N--CA 1.475 1.278 0 N-CA-C 116.748 1.459 . . . . 0.0 116.748 174.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.2 m -157.14 145.25 19.31 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.55 1.54 . . . . 0.0 110.234 171.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.6 p -112.45 144.36 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.794 1.238 . . . . 0.0 110.634 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -129.68 159.9 35.03 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.023 1.329 . . . . 0.0 110.325 -173.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -52.97 -38.4 62.11 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -174.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -73.4 -15.73 61.35 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -87.33 -18.82 29.23 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.162 0.892 . . . . 0.0 112.617 171.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 76.5 mt -99.29 -32.49 11.16 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.91 1.684 . . . . 0.0 113.789 -176.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -61.19 -21.06 63.46 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 119.721 1.146 . . . . 0.0 114.082 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -83.77 -1.44 54.24 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.087 1.355 . . . . 0.0 113.558 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -118.41 -21.63 7.97 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.688 1.195 . . . . 0.0 113.611 -169.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.475 0.823 0 C-N-CA 124.09 0.956 . . . . 0.0 112.576 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.2 tpt85 . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -130.69 135.31 47.71 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.919 1.688 . . . . 0.0 111.314 -174.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -113.77 142.47 46.01 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 119.201 0.91 . . . . 0.0 109.928 168.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.9 t -140.25 138.32 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.536 1.134 . . . . 0.0 110.009 -169.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 53' ' ' ILE . 0.4 OUTLIER -124.24 136.68 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -172.44 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -131.16 89.23 2.7 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.955 1.702 . . . . 0.0 109.084 169.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.8 mt -101.35 134.88 20.03 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 124.696 1.198 . . . . 0.0 109.507 173.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.19 132.15 32.98 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.172 1.914 . . . . 0.0 111.671 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.01 -0.93 79.75 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.8 1.191 . . . . 0.0 115.79 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -137.55 155.82 75.15 Favored Pre-proline 0 N--CA 1.476 0.827 0 CA-C-N 119.336 1.568 . . . . 0.0 112.276 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.27 148.62 68.62 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.724 2.283 . . . . 0.0 112.618 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.2 p -55.66 135.92 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.282 1.033 . . . . 0.0 111.243 170.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.69 145.81 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.781 1.232 . . . . 0.0 110.904 170.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -132.92 125.54 30.09 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.294 1.437 . . . . 0.0 110.059 -174.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.6 t -95.96 149.17 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.818 1.647 . . . . 0.0 110.382 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.03 -98.94 1.36 Allowed Glycine 0 CA--C 1.532 1.113 0 O-C-N 121.486 -0.759 . . . . 0.0 112.116 175.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.4 m -153.83 146.07 23.84 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.665 1.232 . . . . 0.0 110.832 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -68.31 125.22 91.36 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 121.049 -1.032 . . . . 0.0 111.444 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.511 ' HB2' HG11 ' A' ' 71' ' ' VAL . 95.8 Cg_endo -81.72 162.8 18.83 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.122 3.214 . . . . 0.0 115.053 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.6 t -102.85 -31.8 10.1 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 116.793 2.146 . . . . 0.0 116.793 -168.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.49 -29.93 1.17 Allowed Glycine 0 N--CA 1.478 1.464 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.0 p30 -85.46 55.97 3.75 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 122.557 1.17 . . . . 0.0 110.157 169.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.511 HG11 ' HB2' ' A' ' 67' ' ' PRO . 27.9 m -133.74 157.12 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.561 1.544 . . . . 0.0 111.195 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 67.9 mt -87.88 153.08 21.6 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.707 2.003 . . . . 0.0 109.005 169.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -128.84 115.01 17.25 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.124 0.42 . . . . 0.0 111.26 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.83 141.27 15.46 Favored Glycine 0 N--CA 1.468 0.786 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 169.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -149.36 145.26 26.91 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 119.768 1.784 . . . . 0.0 112.953 -169.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.03 160.88 43.03 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.172 0.989 . . . . 0.0 113.521 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.6 m -113.36 125.95 54.83 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.099 1.36 . . . . 0.0 109.063 171.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.58 178.58 45.79 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.215 0.912 . . . . 0.0 115.001 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -84.21 -11.91 55.72 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 -169.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -96.93 3.39 52.11 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 120.573 1.533 . . . . 0.0 111.803 169.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.65 18.83 29.04 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 126.418 1.961 . . . . 0.0 114.379 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.8 pm0 -84.28 171.86 12.35 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.642 1.577 . . . . 0.0 114.558 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 90.9 m -125.7 133.27 52.19 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.962 1.305 . . . . 0.0 110.198 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.1 t -117.26 142.13 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.705 1.602 . . . . 0.0 109.805 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.5 tp -134.03 148.17 51.05 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.066 1.346 . . . . 0.0 110.878 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.4 t -134.12 135.76 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.92 2.088 . . . . 0.0 108.029 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -138.52 137.81 37.44 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.988 0.813 . . . . 0.0 112.958 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -153.17 153.96 30.22 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.215 1.006 . . . . 0.0 113.344 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -63.77 141.87 80.52 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.102 2.535 . . . . 0.0 114.452 -171.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 . . . . . 0 C--O 1.253 1.263 0 C-N-CA 127.109 2.163 . . . . 0.0 113.45 -173.755 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 . . . . . 0 CA--C 1.543 0.706 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.46 -38.26 77.16 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 121.273 -0.892 . . . . 0.0 112.689 -173.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.7 m -61.19 -22.33 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 123.864 0.727 . . . . 0.0 112.711 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -68.85 -43.65 75.01 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 119.258 0.935 . . . . 0.0 112.369 175.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.66 -41.55 71.94 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.335 -0.853 . . . . 0.0 111.466 -171.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -64.34 -32.51 74.15 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.531 1.133 . . . . 0.0 112.519 171.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.19 -39.33 82.51 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.707 -1.246 . . . . 0.0 112.468 171.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.1 t -65.32 -41.12 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.783 0.833 . . . . 0.0 111.116 172.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -57.85 -42.01 83.55 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.42 -0.8 . . . . 0.0 111.844 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.46 -33.8 73.44 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 117.583 -1.198 . . . . 0.0 113.31 173.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.97 -33.87 65.18 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 120.856 1.662 . . . . 0.0 111.24 169.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.6 m -73.06 -37.64 66.75 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 170.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.6 mm -72.05 -33.71 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 120.975 1.716 . . . . 0.0 110.792 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.406 HG21 HD11 ' A' ' 53' ' ' ILE . 93.4 t -69.25 -46.73 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.599 1.16 . . . . 0.0 109.748 175.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -53.44 -42.99 67.69 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.693 1.588 . . . . 0.0 112.044 170.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.8 m -60.43 -29.81 69.23 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.779 -0.576 . . . . 0.0 112.27 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -82.2 -35.17 28.57 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.81 1.644 . . . . 0.0 113.514 172.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.7 mt -65.87 -34.92 79.26 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.897 1.226 . . . . 0.0 111.578 174.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 91.8 mt -73.75 -36.32 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.731 1.212 . . . . 0.0 110.828 169.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.08 -37.73 55.68 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 125.557 1.551 . . . . 0.0 114.682 -172.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.5 t -154.23 -26.96 0.13 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.4 9.46 35.95 Favored Glycine 0 N--CA 1.478 1.463 0 N-CA-C 116.565 1.386 . . . . 0.0 116.565 175.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.3 m -158.79 142.73 15.35 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.788 1.635 . . . . 0.0 110.095 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -107.38 146.73 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.733 1.213 . . . . 0.0 110.676 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -130.1 160.2 34.46 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.473 1.509 . . . . 0.0 109.965 -177.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -54.61 -37.5 65.66 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.647 -0.658 . . . . 0.0 112.724 -175.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -66.21 -21.87 66.32 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.706 1.202 . . . . 0.0 113.561 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -92.66 5.92 49.28 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.751 1.22 . . . . 0.0 112.964 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.5 mt -127.65 -26.49 2.97 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.7 ptt85 -62.83 -23.09 67.11 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 120.219 -1.55 . . . . 0.0 114.565 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.94 -5.09 57.09 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.686 1.594 . . . . 0.0 112.611 173.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -107.72 -22.89 12.31 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.263 1.825 . . . . 0.0 111.561 -169.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.47 0.531 0 C-N-CA 124.691 1.197 . . . . 0.0 111.36 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.467 0.388 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.557 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -131.69 133.26 44.67 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.195 0.598 . . . . 0.0 112.07 -170.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.46 141.72 39.9 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.535 -0.728 . . . . 0.0 109.587 169.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.9 t -137.55 141.68 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.655 1.182 . . . . 0.0 110.191 -171.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.406 HD11 HG21 ' A' ' 26' ' ' VAL . 0.8 OUTLIER -119.91 132.01 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -169.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -130.93 77.3 1.78 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.906 1.682 . . . . 0.0 109.857 171.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.4 mt -95.49 127.98 39.89 Favored Pre-proline 0 N--CA 1.478 0.97 0 O-C-N 121.262 -0.899 . . . . 0.0 109.159 171.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.91 134.17 58.45 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.46 2.107 . . . . 0.0 112.682 173.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.07 0.12 87.29 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 124.838 1.209 . . . . 0.0 116.017 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -137.1 157.21 74.93 Favored Pre-proline 0 CA--C 1.548 0.883 0 CA-C-N 119.232 1.516 . . . . 0.0 112.154 173.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -70.12 151.03 66.82 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.783 2.322 . . . . 0.0 113.057 -174.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.9 p -58.29 132.48 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.296 1.038 . . . . 0.0 111.467 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 86.6 t -110.94 142.01 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.593 1.557 . . . . 0.0 109.096 170.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -135.63 118.0 15.7 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.12 1.368 . . . . 0.0 109.115 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.7 t -92.57 153.7 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.286 1.834 . . . . 0.0 111.169 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.48 -101.71 1.42 Allowed Glycine 0 CA--C 1.533 1.157 0 O-C-N 121.321 -0.862 . . . . 0.0 112.472 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.4 m -144.29 147.89 34.11 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.388 1.075 . . . . 0.0 109.946 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -70.37 125.64 92.06 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 120.687 -1.258 . . . . 0.0 111.031 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.419 ' CB ' HG11 ' A' ' 71' ' ' VAL . 62.2 Cg_endo -77.42 155.15 32.11 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 124.052 3.168 . . . . 0.0 114.824 -174.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.5 t -85.19 -31.35 23.26 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -169.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 133.51 -36.74 2.09 Favored Glycine 0 N--CA 1.478 1.467 0 C-N-CA 125.05 1.309 . . . . 0.0 112.321 -173.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -78.8 63.13 3.47 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.464 1.506 . . . . 0.0 110.101 169.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.419 HG11 ' CB ' ' A' ' 67' ' ' PRO . 27.7 m -138.98 151.83 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.506 1.523 . . . . 0.0 111.976 -176.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.9 mt -85.78 141.39 29.71 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.952 2.101 . . . . 0.0 109.122 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -121.43 110.35 15.96 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.366 0.53 . . . . 0.0 112.129 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.14 143.16 17.25 Favored Glycine 0 N--CA 1.467 0.755 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 169.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -153.68 134.83 14.02 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.886 1.843 . . . . 0.0 113.003 -169.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -142.63 161.44 38.08 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.503 1.121 . . . . 0.0 113.704 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.5 m -112.45 127.98 56.19 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.853 1.261 . . . . 0.0 108.72 171.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.18 174.51 40.42 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.206 0.908 . . . . 0.0 114.986 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -79.88 -11.41 59.81 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 -169.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -101.07 4.88 42.65 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 120.744 1.611 . . . . 0.0 112.355 169.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.67 17.4 30.9 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 126.031 1.777 . . . . 0.0 114.355 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.2 pm0 -83.79 172.98 11.67 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.792 1.637 . . . . 0.0 113.791 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.6 m -126.86 131.43 51.19 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.27 1.428 . . . . 0.0 109.681 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.1 t -113.68 141.02 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.624 1.57 . . . . 0.0 110.067 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.6 tp -129.89 148.23 51.74 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.087 1.355 . . . . 0.0 109.864 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.8 t -133.37 136.79 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.08 1.752 . . . . 0.0 108.317 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -131.68 131.99 43.57 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.783 0.801 . . . . 0.0 111.934 -176.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -131.84 148.31 69.41 Favored Pre-proline 0 N--CA 1.473 0.691 0 C-N-CA 126.163 1.785 . . . . 0.0 111.065 -173.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -61.39 134.91 54.38 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.87 2.38 . . . . 0.0 112.529 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 125.744 1.618 . . . . 0.0 112.438 177.479 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 . . . . . 0 N--CA 1.473 0.687 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -31.34 71.84 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -173.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.6 m -68.07 -21.46 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 172.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -71.17 -42.9 68.49 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 120.699 -1.251 . . . . 0.0 112.209 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.88 -39.1 76.49 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.386 -0.821 . . . . 0.0 111.301 -171.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.07 -28.83 65.75 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.721 1.208 . . . . 0.0 112.818 173.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.98 -39.76 87.26 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.764 -1.21 . . . . 0.0 111.381 169.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.4 t -67.92 -36.1 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.107 0.963 . . . . 0.0 111.538 174.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -59.26 -46.28 88.94 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.224 -0.923 . . . . 0.0 111.095 170.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.2 mp -69.07 -35.44 76.52 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 117.093 -1.432 . . . . 0.0 113.099 175.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.07 -38.69 68.38 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 121.066 1.757 . . . . 0.0 110.235 169.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.7 m -67.95 -38.82 83.26 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.152 0.981 . . . . 0.0 113.523 172.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.9 mm -72.35 -35.11 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 120.72 1.6 . . . . 0.0 110.748 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.2 t -68.82 -43.82 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.374 1.469 . . . . 0.0 110.235 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -56.54 -40.03 74.43 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 121.126 1.784 . . . . 0.0 112.34 169.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -62.79 -23.96 67.5 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 174.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -85.84 -36.86 19.75 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.295 1.838 . . . . 0.0 112.987 171.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.5 mt -68.92 -40.29 79.15 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 120.093 1.315 . . . . 0.0 111.984 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 86.2 mt -69.37 -32.18 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.457 1.503 . . . . 0.0 110.958 174.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.95 -75.34 0.77 Allowed Glycine 0 C--N 1.338 0.694 0 C-N-CA 125.36 1.457 . . . . 0.0 111.359 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.6 t -118.5 -26.73 6.12 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -170.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.61 0.74 46.41 Favored Glycine 0 N--CA 1.475 1.252 0 N-CA-C 116.972 1.549 . . . . 0.0 116.972 171.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.7 m -147.79 134.64 20.11 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.097 1.759 . . . . 0.0 109.956 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.5 p -104.86 147.92 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.04 1.336 . . . . 0.0 110.918 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -133.05 160.74 36.28 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.302 1.441 . . . . 0.0 110.702 -175.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -58.0 -37.7 74.74 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.745 -0.597 . . . . 0.0 111.899 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.73 -23.5 63.4 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.069 0.948 . . . . 0.0 113.187 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -77.79 -27.39 50.16 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.799 0.727 . . . . 0.0 112.16 174.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 72.3 mt -97.7 -28.1 14.05 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.587 1.555 . . . . 0.0 114.687 -173.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.2 ptt85 -62.03 -23.36 66.41 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 119.974 1.261 . . . . 0.0 113.702 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -88.23 5.97 39.08 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.314 1.446 . . . . 0.0 114.456 171.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -119.09 -15.04 9.29 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.947 1.249 . . . . 0.0 113.061 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.472 0.669 0 C-N-CA 123.74 0.816 . . . . 0.0 112.202 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 . . . . . 0 N--CA 1.475 0.79 0 CA-C-O 119.548 -0.263 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -132.58 131.72 41.77 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.008 1.323 . . . . 0.0 111.742 -176.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -104.81 144.6 31.54 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 119.784 1.174 . . . . 0.0 110.659 169.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 37.4 t -140.8 141.18 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.445 1.098 . . . . 0.0 111.821 -169.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 mm -118.06 140.16 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.801 1.24 . . . . 0.0 114.13 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -139.89 72.69 1.4 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 128.098 2.559 . . . . 0.0 109.537 169.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.0 mt -91.73 127.77 48.83 Favored Pre-proline 0 N--CA 1.484 1.241 0 O-C-N 121.009 -1.057 . . . . 0.0 109.898 172.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -60.77 136.41 66.22 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.995 2.463 . . . . 0.0 112.9 171.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.23 2.11 89.34 Favored Glycine 0 CA--C 1.536 1.367 0 N-CA-C 115.912 1.125 . . . . 0.0 115.912 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -139.79 157.35 69.95 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 118.901 1.351 . . . . 0.0 111.877 174.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.01 143.78 73.62 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.426 2.084 . . . . 0.0 112.956 -176.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.57 135.5 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.256 1.422 . . . . 0.0 110.945 172.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.2 p -129.37 142.65 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.798 0.839 . . . . 0.0 111.891 171.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -140.11 123.47 16.98 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.409 1.083 . . . . 0.0 110.099 -173.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.5 t -95.5 155.2 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 127.015 2.126 . . . . 0.0 111.128 -172.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.26 -96.56 1.12 Allowed Glycine 0 CA--C 1.53 1.009 0 O-C-N 121.087 -1.008 . . . . 0.0 112.536 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.0 m -155.97 155.39 32.68 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.174 0.99 . . . . 0.0 110.211 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -68.96 132.17 90.55 Favored Pre-proline 0 CA--C 1.546 0.803 0 O-C-N 120.93 -1.106 . . . . 0.0 110.425 171.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.65 160.76 34.51 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 124.18 3.253 . . . . 0.0 114.121 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.6 t -85.7 -28.36 24.72 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -173.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.68 -32.83 3.24 Favored Glycine 0 N--CA 1.478 1.44 0 C-N-CA 125.644 1.592 . . . . 0.0 112.709 -176.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -77.44 60.2 2.02 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.403 1.881 . . . . 0.0 111.114 169.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.0 m -138.51 155.05 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.273 1.429 . . . . 0.0 113.177 -172.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.5 mt -91.03 142.4 27.81 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 128.029 2.532 . . . . 0.0 109.092 171.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -126.42 112.62 15.83 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.753 0.706 . . . . 0.0 111.311 -176.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.53 149.88 19.44 Favored Glycine 0 N--CA 1.469 0.871 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 169.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -147.19 148.56 31.63 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 118.656 1.228 . . . . 0.0 112.099 -169.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.3 166.33 33.76 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.412 1.085 . . . . 0.0 112.865 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.6 m -132.49 123.11 25.97 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.325 1.45 . . . . 0.0 109.634 172.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.62 176.43 42.44 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.0 1.286 . . . . 0.0 113.651 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -49.13 -45.0 42.97 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 126.347 1.859 . . . . 0.0 111.775 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -83.39 3.58 31.22 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 -170.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.65 25.38 13.6 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.666 0.651 . . . . 0.0 113.298 173.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.39 -166.01 1.49 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.656 1.182 . . . . 0.0 113.914 -174.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 16.6 m -147.39 120.27 8.72 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.318 -1.489 . . . . 0.0 111.611 173.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 37.1 t -96.64 142.25 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 126.246 1.819 . . . . 0.0 108.998 169.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.5 tp -129.91 146.74 51.62 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.356 1.463 . . . . 0.0 108.975 169.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 p -133.86 142.07 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.02 1.328 . . . . 0.0 109.663 172.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -137.08 134.39 36.44 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.162 0.506 . . . . 0.0 111.825 -170.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -131.72 152.8 81.0 Favored Pre-proline 0 N--CA 1.473 0.714 0 C-N-CA 124.954 1.301 . . . . 0.0 112.524 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -56.91 137.56 82.26 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 122.641 2.227 . . . . 0.0 112.933 170.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 . . . . . 0 C--O 1.252 1.223 0 C-N-CA 125.798 1.639 . . . . 0.0 112.279 177.522 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -59.9 -32.44 70.76 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -172.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.3 m -64.94 -21.81 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 174.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -67.94 -43.22 79.6 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 120.878 -1.139 . . . . 0.0 112.837 176.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mp -70.62 -41.68 71.92 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.444 -0.785 . . . . 0.0 111.816 -171.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.15 -30.92 71.97 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.364 1.066 . . . . 0.0 112.64 172.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.41 -36.97 79.88 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.925 -1.109 . . . . 0.0 112.447 171.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.4 t -69.87 -36.23 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 124.175 0.99 . . . . 0.0 111.376 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -58.37 -46.07 87.02 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.314 -0.866 . . . . 0.0 111.23 171.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.1 mp -70.05 -34.13 72.83 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-O 117.321 -1.323 . . . . 0.0 113.195 173.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.18 -34.86 68.9 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 121.365 1.893 . . . . 0.0 110.586 169.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.1 m -71.23 -41.53 70.03 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.301 1.04 . . . . 0.0 112.806 171.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.4 mm -70.66 -35.08 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 120.623 1.556 . . . . 0.0 111.201 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.3 t -65.11 -47.44 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.026 1.33 . . . . 0.0 109.99 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -52.97 -42.64 65.71 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.607 1.549 . . . . 0.0 112.124 171.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.3 t -59.33 -38.12 79.51 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.788 -0.57 . . . . 0.0 111.95 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.404 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . 18.2 tpt180 -72.47 -37.25 68.52 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.47 1.108 . . . . 0.0 113.367 172.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.6 mt -67.31 -32.35 73.27 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.877 1.217 . . . . 0.0 112.182 176.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 89.8 mt -74.15 -37.86 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 124.523 1.129 . . . . 0.0 110.826 169.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.1 -38.58 54.89 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 125.862 1.696 . . . . 0.0 114.52 -172.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.1 t -150.17 -30.52 0.21 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.29 4.47 35.24 Favored Glycine 0 N--CA 1.475 1.283 0 N-CA-C 117.105 1.602 . . . . 0.0 117.105 176.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.8 p -152.92 141.57 20.92 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.45 1.5 . . . . 0.0 111.34 177.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.5 t -99.67 139.19 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.124 1.37 . . . . 0.0 110.383 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -123.07 155.08 37.62 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.918 1.287 . . . . 0.0 109.806 174.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -54.76 -38.3 67.04 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.296 -0.878 . . . . 0.0 113.317 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -67.38 -17.69 64.83 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.404 ' CE2' ' HB2' ' A' ' 29' ' ' ARG . 91.3 t80 -85.11 -22.26 28.96 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 118.539 -0.743 . . . . 0.0 112.648 171.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.1 mt -97.6 -31.37 12.34 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.34 1.427 . . . . 0.0 114.439 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -58.88 -24.28 62.01 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -93.76 7.54 44.48 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.101 1.361 . . . . 0.0 113.456 174.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -127.62 -16.05 4.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.681 1.592 . . . . 0.0 113.246 -174.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.479 0.978 0 CA-C-N 119.125 0.875 . . . . 0.0 110.906 169.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.537 0 CA-C-O 119.245 -0.407 . . . . 0.0 111.77 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -130.64 126.89 37.77 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.296 0.638 . . . . 0.0 111.107 -170.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.71 148.69 27.15 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.98 -1.075 . . . . 0.0 110.127 169.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.2 t -141.0 140.81 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.897 1.279 . . . . 0.0 110.717 -171.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 53' ' ' ILE . 0.6 OUTLIER -118.55 133.44 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.986 1.314 . . . . 0.0 113.576 -170.051 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -131.88 79.61 1.88 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.738 1.615 . . . . 0.0 109.381 169.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.5 mt -96.91 123.65 52.78 Favored Pre-proline 0 N--CA 1.479 0.991 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 173.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.86 132.51 50.22 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.407 2.071 . . . . 0.0 112.501 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.53 2.57 87.09 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.906 1.241 . . . . 0.0 115.776 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -135.92 162.11 58.71 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-N 119.806 1.803 . . . . 0.0 114.084 171.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -62.94 143.64 91.64 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.481 2.787 . . . . 0.0 114.136 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 p -58.0 133.84 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.775 0.83 . . . . 0.0 110.631 169.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 71.4 t -114.01 141.71 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.765 1.226 . . . . 0.0 109.313 172.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -134.87 119.55 18.22 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.988 1.315 . . . . 0.0 109.554 177.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.4 t -90.39 152.51 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.366 1.466 . . . . 0.0 111.085 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.08 -105.48 2.24 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 121.368 -0.833 . . . . 0.0 112.621 170.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.8 m -145.02 148.87 34.21 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.544 1.137 . . . . 0.0 110.052 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -67.95 128.62 93.34 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 120.598 -1.314 . . . . 0.0 111.298 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.447 ' CB ' HG11 ' A' ' 71' ' ' VAL . 73.7 Cg_endo -80.18 152.94 21.42 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.264 3.309 . . . . 0.0 114.922 -177.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.7 t -82.9 -31.36 27.89 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -169.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.31 -35.03 2.42 Favored Glycine 0 N--CA 1.479 1.544 0 C-N-CA 125.246 1.403 . . . . 0.0 112.458 -174.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -79.44 61.14 3.4 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.306 1.442 . . . . 0.0 109.922 169.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.447 HG11 ' CB ' ' A' ' 67' ' ' PRO . 32.2 m -138.84 156.33 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.934 1.693 . . . . 0.0 111.398 -175.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.5 mt -91.72 138.61 31.42 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 127.734 2.414 . . . . 0.0 108.869 173.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -119.19 113.25 20.59 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.271 0.487 . . . . 0.0 111.741 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.68 144.68 17.47 Favored Glycine 0 N--CA 1.467 0.722 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 169.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -152.99 138.9 18.06 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.07 1.935 . . . . 0.0 112.853 -169.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.91 164.72 30.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.675 1.19 . . . . 0.0 114.043 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.3 m -119.74 125.21 48.07 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.223 1.409 . . . . 0.0 109.273 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.05 173.95 43.5 Favored Glycine 0 CA--C 1.54 1.653 0 C-N-CA 124.488 1.042 . . . . 0.0 115.26 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -81.59 -12.28 58.81 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -169.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -95.04 2.52 55.28 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 120.333 1.424 . . . . 0.0 112.161 169.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.93 15.03 46.99 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 126.783 2.135 . . . . 0.0 115.077 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 20.4 pm0 -78.68 172.4 13.76 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.992 1.717 . . . . 0.0 113.253 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.6 m -129.49 138.27 51.29 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.597 1.559 . . . . 0.0 110.342 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 88.6 t -122.52 140.27 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.471 1.508 . . . . 0.0 109.957 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.5 tp -128.79 148.35 50.86 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.181 1.392 . . . . 0.0 109.674 173.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.7 t -134.25 136.77 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.79 1.636 . . . . 0.0 108.275 176.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -131.01 129.98 42.75 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 122.031 0.919 . . . . 0.0 111.907 -176.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -130.44 142.25 44.79 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 126.661 1.984 . . . . 0.0 110.501 -171.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -61.89 133.67 45.91 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.435 2.09 . . . . 0.0 112.004 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 70.0 ttp85 . . . . . 0 C--O 1.252 1.211 0 C-N-CA 125.133 1.373 . . . . 0.0 112.33 -179.902 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 . . . . . 0 CA--C 1.546 0.805 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -59.48 -37.9 79.44 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.755 0.822 . . . . 0.0 112.889 -172.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.9 m -60.46 -22.65 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.666 0.786 . . . . 0.0 112.027 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -65.39 -42.94 92.11 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.251 0.932 . . . . 0.0 112.13 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.1 mp -73.86 -41.15 62.63 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.315 -0.866 . . . . 0.0 111.404 -170.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -67.73 -29.19 68.37 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.202 1.001 . . . . 0.0 112.799 171.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.06 -37.76 84.6 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 120.607 -1.308 . . . . 0.0 112.292 169.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.6 t -69.01 -36.15 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.002 0.921 . . . . 0.0 111.417 172.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -60.24 -44.57 95.12 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.12 -0.987 . . . . 0.0 111.421 171.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.0 mp -69.97 -34.18 73.04 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-O 117.343 -1.313 . . . . 0.0 112.673 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.434 ' HA ' HG21 ' A' ' 84' ' ' VAL . . . -57.95 -33.44 68.83 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 121.144 1.793 . . . . 0.0 110.883 169.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.1 m -72.25 -38.66 68.85 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.27 1.028 . . . . 0.0 113.432 171.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -74.11 -34.86 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 120.99 1.723 . . . . 0.0 111.073 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.471 HG21 HD11 ' A' ' 53' ' ' ILE . 97.5 t -64.86 -48.3 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.83 1.252 . . . . 0.0 109.62 173.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -54.12 -43.49 70.53 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.764 1.62 . . . . 0.0 112.086 172.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.2 m -59.45 -31.48 69.35 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.636 -0.665 . . . . 0.0 112.407 175.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -80.19 -35.19 36.74 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.715 1.606 . . . . 0.0 113.381 172.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 67.1 mt -66.59 -33.5 75.79 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 120.058 1.299 . . . . 0.0 111.643 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 91.1 mt -73.82 -36.46 46.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.904 1.281 . . . . 0.0 110.777 169.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.99 -38.72 55.62 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 125.632 1.587 . . . . 0.0 114.826 -173.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.2 t -152.5 -26.39 0.17 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.51 11.19 39.15 Favored Glycine 0 N--CA 1.48 1.581 0 N-CA-C 116.234 1.254 . . . . 0.0 116.234 175.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.8 m -157.69 143.4 17.27 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.886 1.674 . . . . 0.0 109.492 173.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.83 145.74 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.135 1.374 . . . . 0.0 109.858 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -130.49 158.77 39.01 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.723 1.209 . . . . 0.0 110.754 -172.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -56.11 -38.72 71.15 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.776 -0.577 . . . . 0.0 112.313 -177.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -70.96 -18.32 62.63 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -78.46 -38.28 41.52 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.211 0.914 . . . . 0.0 111.088 169.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 58.4 mt -87.35 -28.5 22.18 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -169.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -59.73 -21.14 60.28 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 172.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -83.56 -7.68 59.47 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.829 1.251 . . . . 0.0 114.032 174.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -115.46 -14.2 11.57 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.785 1.234 . . . . 0.0 113.302 -169.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.471 0.577 0 C-N-CA 123.486 0.714 . . . . 0.0 111.812 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -130.34 133.98 46.84 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.533 1.533 . . . . 0.0 110.877 -174.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.78 141.75 40.33 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.137 -0.977 . . . . 0.0 109.79 169.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.6 t -136.62 142.39 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.526 1.13 . . . . 0.0 111.024 -173.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.471 HD11 HG21 ' A' ' 26' ' ' VAL . 0.6 OUTLIER -124.15 134.68 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.89 1.276 . . . . 0.0 114.226 -169.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -138.75 77.99 1.65 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.109 1.764 . . . . 0.0 109.679 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.0 mt -95.89 132.32 27.35 Favored Pre-proline 0 N--CA 1.478 0.947 0 C-N-CA 124.982 1.313 . . . . 0.0 109.523 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.1 134.66 37.58 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.196 1.931 . . . . 0.0 111.545 174.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.82 1.26 85.28 Favored Glycine 0 CA--C 1.536 1.36 0 N-CA-C 116.043 1.177 . . . . 0.0 116.043 177.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -138.78 156.9 72.64 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-N 119.073 1.437 . . . . 0.0 111.954 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.39 150.33 75.79 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.705 2.27 . . . . 0.0 112.969 -174.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 50.7 t -60.44 131.88 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.278 1.031 . . . . 0.0 110.358 173.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 72.4 t -112.62 140.25 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.454 1.502 . . . . 0.0 109.469 173.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -135.07 118.15 16.44 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.037 1.335 . . . . 0.0 109.421 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.7 t -94.62 151.77 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.881 1.672 . . . . 0.0 111.032 -177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.66 -93.5 1.03 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 121.283 -0.886 . . . . 0.0 112.317 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 m -154.74 152.58 30.06 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.669 -0.901 . . . . 0.0 110.463 175.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -69.17 129.4 92.02 Favored Pre-proline 0 CA--C 1.547 0.863 0 O-C-N 120.928 -1.108 . . . . 0.0 110.722 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.43 ' CB ' HG11 ' A' ' 71' ' ' VAL . 75.3 Cg_endo -78.6 158.71 28.63 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 124.3 3.333 . . . . 0.0 114.602 -176.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.3 t -83.29 -25.19 31.8 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -171.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.59 -34.17 3.71 Favored Glycine 0 N--CA 1.478 1.442 0 C-N-CA 125.713 1.625 . . . . 0.0 112.804 -175.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -79.03 61.36 3.18 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.738 1.615 . . . . 0.0 111.261 169.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.43 HG11 ' CB ' ' A' ' 67' ' ' PRO . 29.9 m -136.93 158.95 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 126.343 1.857 . . . . 0.0 112.526 -173.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 27.9 mt -92.77 139.41 30.58 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.826 2.051 . . . . 0.0 108.799 172.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -127.55 113.56 16.28 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.101 0.961 . . . . 0.0 110.506 -175.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -97.75 145.4 17.79 Favored Glycine 0 N--CA 1.467 0.727 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -148.01 139.31 23.52 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.763 1.282 . . . . 0.0 112.682 -169.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.24 162.39 36.48 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.609 1.164 . . . . 0.0 113.181 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 74.5 m -114.16 124.65 52.59 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.19 1.396 . . . . 0.0 108.423 172.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.54 173.31 45.63 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-O 122.166 0.87 . . . . 0.0 114.424 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -79.63 -17.35 54.0 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -169.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -92.84 4.81 53.17 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.646 1.566 . . . . 0.0 112.543 169.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.37 16.96 32.93 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 126.136 1.827 . . . . 0.0 114.308 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.9 pm0 -82.92 171.55 13.75 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.471 1.508 . . . . 0.0 114.206 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.5 m -123.14 132.99 54.29 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.66 1.584 . . . . 0.0 109.203 175.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.434 HG21 ' HA ' ' A' ' 23' ' ' ALA . 17.4 t -127.51 140.68 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.629 1.171 . . . . 0.0 110.155 -176.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.5 tp -133.42 147.66 51.74 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.293 1.037 . . . . 0.0 110.76 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.09 143.28 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.816 1.246 . . . . 0.0 109.565 170.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -137.37 137.5 38.93 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -173.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -132.13 151.27 78.11 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 125.793 1.637 . . . . 0.0 112.432 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -58.68 135.86 70.09 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.405 2.07 . . . . 0.0 111.996 169.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 . . . . . 0 C--O 1.253 1.285 0 C-N-CA 124.938 1.295 . . . . 0.0 112.179 178.614 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 . . . . . 0 CA--C 1.545 0.75 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -37.98 77.68 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 121.294 -0.879 . . . . 0.0 112.732 -173.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 m -62.52 -21.74 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -70.44 -44.06 68.63 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 119.132 0.878 . . . . 0.0 112.146 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.57 -42.26 71.33 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.083 -1.011 . . . . 0.0 111.367 -172.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -63.27 -32.73 74.22 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.395 1.078 . . . . 0.0 112.449 171.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.09 84.04 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.752 -1.217 . . . . 0.0 112.308 171.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.6 t -64.79 -40.33 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.802 0.841 . . . . 0.0 111.071 174.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -57.07 -44.72 83.34 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.536 -0.728 . . . . 0.0 112.145 171.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.9 mp -68.45 -33.91 75.02 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 116.871 -1.538 . . . . 0.0 112.943 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.11 -39.53 69.46 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 121.252 1.842 . . . . 0.0 110.308 169.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.6 m -70.09 -38.25 75.64 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 172.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.9 mm -70.42 -34.21 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 121.181 1.81 . . . . 0.0 110.813 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.2 t -66.57 -48.51 80.17 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 C-N-CA 124.945 1.298 . . . . 0.0 110.092 173.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -54.86 -39.52 68.72 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 121.408 1.913 . . . . 0.0 112.802 171.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.4 m -61.84 -29.08 69.93 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.984 0.514 . . . . 0.0 112.066 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -82.68 -36.78 25.61 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.063 1.745 . . . . 0.0 113.438 171.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.61 -34.2 77.35 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.055 1.298 . . . . 0.0 111.566 175.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 92.0 mt -76.56 -36.7 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 124.618 1.167 . . . . 0.0 110.714 169.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.36 -37.85 53.63 Favored Glycine 0 C--N 1.341 0.849 0 C-N-CA 125.822 1.677 . . . . 0.0 114.698 -171.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.2 t -148.66 -30.44 0.27 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 175.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.78 12.07 27.05 Favored Glycine 0 N--CA 1.473 1.141 0 N-CA-C 116.703 1.441 . . . . 0.0 116.703 174.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.4 m -157.84 143.2 16.93 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.364 1.466 . . . . 0.0 109.736 170.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.2 p -112.36 141.45 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.384 1.474 . . . . 0.0 110.616 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -131.74 159.79 37.42 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.535 1.534 . . . . 0.0 110.45 -172.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -56.2 -38.54 71.14 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.38 -0.825 . . . . 0.0 113.056 -175.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -69.87 -21.77 63.3 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -77.23 -35.52 55.42 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.476 0.58 . . . . 0.0 111.78 169.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 58.8 mt -86.61 -29.19 22.76 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -174.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -61.15 -22.72 64.96 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -91.97 -0.19 57.48 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.271 1.029 . . . . 0.0 113.457 172.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -117.03 -17.37 10.36 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.178 1.391 . . . . 0.0 113.496 -173.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 123.892 0.877 . . . . 0.0 111.08 170.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.468 0.437 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.328 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -129.9 132.97 46.58 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.955 0.502 . . . . 0.0 112.324 -170.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -111.52 141.24 45.35 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.636 -0.665 . . . . 0.0 109.555 168.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.0 t -138.89 138.23 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.681 1.192 . . . . 0.0 109.339 -169.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 53' ' ' ILE . 0.3 OUTLIER -120.62 132.83 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -169.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -129.75 84.11 2.19 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.263 1.825 . . . . 0.0 109.254 173.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.1 mt -99.06 134.37 21.44 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 124.208 1.003 . . . . 0.0 108.85 173.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.36 136.35 43.13 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.238 1.959 . . . . 0.0 111.514 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.76 0.28 83.98 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.638 1.113 . . . . 0.0 115.702 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -136.15 157.99 74.58 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 118.95 1.375 . . . . 0.0 112.564 175.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.59 151.75 64.54 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.676 2.251 . . . . 0.0 113.285 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.3 p -54.86 140.87 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.408 1.483 . . . . 0.0 112.328 172.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 85.0 t -116.18 140.81 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 125.864 1.666 . . . . 0.0 108.76 170.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -134.67 119.5 18.38 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.721 1.208 . . . . 0.0 110.12 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.1 t -93.77 154.99 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.716 2.006 . . . . 0.0 110.963 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.81 -105.13 1.67 Allowed Glycine 0 CA--C 1.533 1.203 0 O-C-N 121.216 -0.927 . . . . 0.0 111.521 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.2 t -153.87 161.04 42.35 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.033 0.917 . . . . 0.0 112.089 169.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -71.89 126.38 91.39 Favored Pre-proline 0 CA--C 1.548 0.878 0 O-C-N 120.902 -1.123 . . . . 0.0 111.85 -171.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.444 ' CB ' HG11 ' A' ' 71' ' ' VAL . 73.6 Cg_endo -79.54 155.68 24.6 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 124.069 3.18 . . . . 0.0 114.856 -175.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.431 HG23 ' H ' ' A' ' 70' ' ' ASP . 7.2 t -83.51 -20.46 33.89 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 115.81 1.781 . . . . 0.0 115.81 -169.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.39 -30.5 6.2 Favored Glycine 0 N--CA 1.479 1.559 0 C-N-CA 125.361 1.457 . . . . 0.0 113.12 -173.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.431 ' H ' HG23 ' A' ' 68' ' ' THR . 20.6 m-20 -82.13 60.11 4.75 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.424 1.489 . . . . 0.0 109.351 168.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.444 HG11 ' CB ' ' A' ' 67' ' ' PRO . 34.4 m -140.94 152.98 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 126.458 1.903 . . . . 0.0 110.381 -175.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.7 mt -79.59 146.43 32.57 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.023 1.729 . . . . 0.0 108.942 169.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -126.75 106.39 9.34 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.877 0.762 . . . . 0.0 109.979 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -88.82 149.4 20.93 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 169.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 33.2 ttt-85 -148.07 143.69 27.36 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.217 1.509 . . . . 0.0 112.013 -170.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -152.66 167.72 27.98 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.373 1.069 . . . . 0.0 113.251 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.0 m -134.09 128.1 33.51 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.708 1.603 . . . . 0.0 109.601 171.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.42 -175.09 49.87 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.6 1.572 . . . . 0.0 114.934 177.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -58.74 -45.38 89.8 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.256 1.422 . . . . 0.0 112.107 177.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -77.71 2.57 16.43 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -172.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.26 23.0 28.11 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.0 1.286 . . . . 0.0 113.465 172.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.11 -163.15 0.95 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.266 1.426 . . . . 0.0 114.111 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.1 m -146.15 128.68 16.03 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.336 -1.478 . . . . 0.0 111.361 175.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.3 t -105.2 142.51 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 126.195 1.798 . . . . 0.0 109.208 169.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.8 tp -129.15 141.49 51.16 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.083 1.353 . . . . 0.0 109.382 169.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.18 136.81 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.524 1.53 . . . . 0.0 108.461 173.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -131.67 130.97 42.74 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.682 0.753 . . . . 0.0 112.048 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -133.54 142.36 43.66 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 125.066 1.346 . . . . 0.0 112.058 -169.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -59.24 130.41 35.96 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.184 2.59 . . . . 0.0 112.533 177.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 67.9 ttp85 . . . . . 0 C--O 1.253 1.258 0 C-N-CA 125.231 1.412 . . . . 0.0 112.356 178.458 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.406 HH21 ' CD ' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -62.75 -35.93 81.37 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 117.556 -1.211 . . . . 0.0 113.068 -174.583 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.8 m -59.9 -25.66 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 119.002 0.819 . . . . 0.0 112.756 172.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -77.45 -35.56 53.83 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.554 0.615 . . . . 0.0 112.56 176.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.8 mt -69.25 -39.87 78.19 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.405 -0.809 . . . . 0.0 110.976 -175.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.406 ' CD ' HH21 ' A' ' 14' ' ' ARG . 6.0 pt-20 -68.23 -30.47 69.53 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.041 0.936 . . . . 0.0 112.688 169.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.65 -38.64 89.92 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 120.227 1.376 . . . . 0.0 112.098 170.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.4 t -67.95 -39.74 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.182 0.993 . . . . 0.0 111.429 172.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -58.79 -44.91 90.85 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.211 -0.931 . . . . 0.0 111.277 172.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.2 mp -68.79 -34.9 76.32 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-O 117.13 -1.414 . . . . 0.0 112.678 174.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.38 -34.17 68.58 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 121.504 1.956 . . . . 0.0 110.511 169.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.3 m -72.72 -40.21 66.33 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.256 1.022 . . . . 0.0 113.736 170.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.1 mm -67.8 -37.38 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 120.983 1.719 . . . . 0.0 110.799 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.443 HG13 HG21 ' A' ' 36' ' ' VAL . 57.2 t -64.46 -45.58 95.36 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.376 0 C-N-CA 125.326 1.45 . . . . 0.0 110.241 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -51.97 -42.72 63.15 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 120.683 1.583 . . . . 0.0 112.345 171.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 56.5 m -62.05 -31.33 71.73 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.416 -0.803 . . . . 0.0 112.541 175.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -77.92 -37.08 48.58 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.877 1.271 . . . . 0.0 113.181 172.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.8 mt -67.42 -32.84 73.99 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.833 1.197 . . . . 0.0 111.916 176.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.8 mt -73.6 -36.93 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.585 1.154 . . . . 0.0 110.708 169.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.98 -39.17 55.02 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 125.689 1.614 . . . . 0.0 114.689 -172.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.0 t -151.48 -27.05 0.19 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.92 3.86 54.64 Favored Glycine 0 N--CA 1.479 1.54 0 N-CA-C 116.127 1.211 . . . . 0.0 116.127 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.6 m -142.26 132.9 25.38 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.756 1.622 . . . . 0.0 109.874 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.443 HG21 HG13 ' A' ' 26' ' ' VAL . 89.9 t -97.21 140.34 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.5 0.72 . . . . 0.0 109.423 170.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -127.11 156.68 41.35 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.76 1.224 . . . . 0.0 110.611 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -55.74 -36.89 67.76 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 121.303 -0.873 . . . . 0.0 112.557 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -67.55 -21.91 65.43 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.152 1.381 . . . . 0.0 113.73 177.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -78.44 -37.49 43.58 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.395 0.543 . . . . 0.0 111.863 171.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 18.9 mt -88.92 -30.29 18.95 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -172.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -55.89 -27.82 53.78 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -89.3 2.95 53.61 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.928 1.291 . . . . 0.0 114.382 176.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -121.6 -13.81 8.29 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.782 1.233 . . . . 0.0 113.446 -172.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -174.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 111.341 0.126 . . . . 0.0 111.341 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -130.97 120.95 24.27 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.121 1.768 . . . . 0.0 109.262 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.32 143.68 27.84 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.05 -1.032 . . . . 0.0 109.037 168.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.0 t -139.01 139.41 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.15 0.98 . . . . 0.0 110.774 -169.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 mm -114.02 134.03 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.541 1.536 . . . . 0.0 113.815 -169.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -133.67 70.96 1.45 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.232 1.813 . . . . 0.0 109.547 169.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.9 mt -88.08 128.93 51.91 Favored Pre-proline 0 N--CA 1.478 0.97 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.36 134.13 35.0 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.193 1.929 . . . . 0.0 111.287 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.92 3.3 85.68 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 118.533 -1.148 . . . . 0.0 115.962 176.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -137.49 162.9 52.29 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 119.539 1.669 . . . . 0.0 113.944 173.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -59.38 141.52 97.73 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.524 2.816 . . . . 0.0 114.454 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.59 130.18 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.182 0.993 . . . . 0.0 110.311 170.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.6 t -109.94 139.57 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.929 1.292 . . . . 0.0 109.275 172.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -134.41 112.72 11.19 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.838 1.255 . . . . 0.0 108.86 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.6 t -86.56 151.89 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.373 1.469 . . . . 0.0 110.947 -177.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.2 -96.91 1.38 Allowed Glycine 0 CA--C 1.531 1.059 0 O-C-N 121.608 -0.682 . . . . 0.0 112.025 175.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.1 m -150.0 157.41 43.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.52 1.128 . . . . 0.0 110.025 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -69.75 133.99 88.32 Favored Pre-proline 0 CA--C 1.546 0.796 0 O-C-N 120.791 -1.193 . . . . 0.0 110.654 169.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.63 156.01 31.68 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 124.194 3.263 . . . . 0.0 114.342 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.1 t -82.78 -26.32 31.93 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -175.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.02 -35.01 3.38 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 125.629 1.585 . . . . 0.0 113.055 -177.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -77.95 58.59 1.96 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.05 1.74 . . . . 0.0 111.404 169.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.1 m -131.5 159.93 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.549 1.54 . . . . 0.0 113.013 -172.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.1 mt -99.91 119.64 38.53 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 127.562 2.345 . . . . 0.0 110.335 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -106.09 108.3 19.74 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -170.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.55 145.54 17.79 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 169.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.1 ttt-85 -156.93 125.45 5.73 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 120.762 2.281 . . . . 0.0 113.967 -169.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.81 167.39 21.25 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.8 1.24 . . . . 0.0 114.044 -173.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 63.2 m -119.47 132.28 55.76 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.563 1.545 . . . . 0.0 108.15 174.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.59 -179.64 42.08 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 121.881 0.712 . . . . 0.0 114.634 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -86.99 -18.35 30.88 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -169.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -93.11 5.19 52.36 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.398 1.454 . . . . 0.0 112.163 169.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.89 16.12 49.46 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 126.661 2.077 . . . . 0.0 114.113 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.6 pm0 -76.98 178.24 7.11 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.955 1.702 . . . . 0.0 113.087 175.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.8 m -141.19 142.24 34.02 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.417 -1.427 . . . . 0.0 109.93 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 76.9 t -127.54 139.36 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.706 1.602 . . . . 0.0 109.721 -174.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.2 tp -129.1 148.22 51.03 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.154 1.382 . . . . 0.0 109.476 175.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.5 t -127.49 134.72 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.979 2.112 . . . . 0.0 107.414 175.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -135.78 137.21 41.4 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.2 0.6 . . . . 0.0 111.373 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -153.25 155.13 31.59 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 123.827 0.851 . . . . 0.0 112.796 174.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -58.85 134.72 62.14 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.795 2.33 . . . . 0.0 113.53 -176.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 . . . . . 0 C--O 1.253 1.27 0 C-N-CA 125.995 1.718 . . . . 0.0 112.265 176.492 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 . . . . . 0 N--CA 1.475 0.784 0 CA-C-O 120.733 0.301 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.64 -35.15 70.13 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.629 1.172 . . . . 0.0 113.007 -175.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.64 -21.4 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -70.56 -43.23 69.9 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 120.905 -1.122 . . . . 0.0 112.446 177.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.03 -42.08 76.85 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.446 -0.784 . . . . 0.0 111.599 -171.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -62.45 -32.97 73.93 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.719 1.208 . . . . 0.0 112.397 172.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.69 -39.17 80.67 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.6 -1.312 . . . . 0.0 112.412 172.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.74 -38.16 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 O-C-N 121.327 -0.858 . . . . 0.0 111.295 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -58.01 -46.76 84.74 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.39 -0.819 . . . . 0.0 111.195 171.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.1 mp -69.71 -33.59 72.73 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 117.387 -1.292 . . . . 0.0 113.057 175.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.34 -34.17 68.49 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 121.301 1.864 . . . . 0.0 110.455 169.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.2 m -73.56 -39.05 64.99 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.598 1.159 . . . . 0.0 113.535 171.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.7 mm -73.74 -34.2 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 120.724 1.602 . . . . 0.0 111.02 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.4 t -64.79 -48.86 82.73 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-O 117.544 -1.217 . . . . 0.0 109.411 172.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -53.49 -44.21 68.85 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 120.931 1.696 . . . . 0.0 112.177 171.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.8 m -58.74 -35.22 72.38 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.676 -0.64 . . . . 0.0 112.021 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -75.41 -37.05 60.68 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.483 1.513 . . . . 0.0 113.414 171.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.0 mt -66.21 -31.94 73.07 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 120.033 1.288 . . . . 0.0 111.966 175.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 93.1 mt -75.68 -39.45 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 124.685 1.194 . . . . 0.0 110.803 169.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.63 -38.08 61.56 Favored Glycine 0 C--N 1.34 0.775 0 C-N-CA 125.437 1.494 . . . . 0.0 114.114 -171.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.3 t -148.6 -29.69 0.28 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.3 12.18 31.85 Favored Glycine 0 N--CA 1.477 1.386 0 N-CA-C 116.425 1.33 . . . . 0.0 116.425 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.5 m -157.98 146.87 19.32 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.959 1.704 . . . . 0.0 109.611 171.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.4 p -119.34 142.17 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.635 1.574 . . . . 0.0 110.43 -175.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -133.02 157.44 45.22 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.3 1.04 . . . . 0.0 111.032 -169.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -54.98 -39.32 68.88 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -70.95 -19.73 62.53 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.526 1.131 . . . . 0.0 113.318 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -78.98 -43.44 24.43 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.162 0.892 . . . . 0.0 109.908 169.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.7 mt -79.87 -27.16 40.11 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -169.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -57.6 -24.21 55.12 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 170.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -84.14 -3.75 58.33 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.507 1.123 . . . . 0.0 113.882 173.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.2 mm-40 -115.97 -16.02 11.14 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.795 1.238 . . . . 0.0 113.167 -173.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt . . . . . 0 N--CA 1.472 0.666 0 CA-C-N 118.888 0.767 . . . . 0.0 110.937 173.469 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.471 0.62 0 CA-C-O 119.177 -0.44 . . . . 0.0 111.815 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -127.56 128.95 46.47 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.022 0.529 . . . . 0.0 111.932 -169.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -104.04 143.47 32.85 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.353 -0.842 . . . . 0.0 109.965 169.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.5 t -140.06 140.11 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.093 0.957 . . . . 0.0 110.625 -171.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 53' ' ' ILE . 0.7 OUTLIER -115.14 132.03 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.067 1.347 . . . . 0.0 113.63 -169.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.6 mmt85 -130.86 74.93 1.63 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.594 1.557 . . . . 0.0 109.673 171.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.5 mt -93.12 131.22 33.58 Favored Pre-proline 0 N--CA 1.479 1.003 0 O-C-N 121.396 -0.815 . . . . 0.0 108.856 172.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.46 136.7 44.08 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.231 1.954 . . . . 0.0 111.459 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.07 -0.13 83.68 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.746 1.165 . . . . 0.0 115.587 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -137.06 157.55 74.35 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 119.015 1.407 . . . . 0.0 112.218 173.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.2 153.02 62.28 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.848 2.366 . . . . 0.0 112.852 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.6 p -55.95 136.95 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.672 1.189 . . . . 0.0 111.935 172.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 99.2 t -115.8 141.13 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.888 1.675 . . . . 0.0 108.082 169.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -139.93 123.13 16.89 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.442 1.097 . . . . 0.0 110.646 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.7 t -95.97 154.97 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 126.596 1.959 . . . . 0.0 111.149 -172.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.36 -95.11 1.3 Allowed Glycine 0 CA--C 1.532 1.115 0 O-C-N 121.327 -0.858 . . . . 0.0 112.485 174.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 60.5 m -152.36 149.84 29.06 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.478 1.111 . . . . 0.0 110.057 174.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -69.38 125.28 91.86 Favored Pre-proline 0 CA--C 1.546 0.822 0 O-C-N 120.636 -1.29 . . . . 0.0 111.262 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.415 ' HB2' HG11 ' A' ' 71' ' ' VAL . 61.1 Cg_endo -77.37 153.74 31.36 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.969 3.112 . . . . 0.0 114.623 -175.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 t -83.14 -31.08 27.39 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -169.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.26 -33.77 2.73 Favored Glycine 0 N--CA 1.478 1.466 0 C-N-CA 125.193 1.377 . . . . 0.0 112.978 -174.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -78.09 57.51 1.82 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.97 1.708 . . . . 0.0 110.511 169.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.415 HG11 ' HB2' ' A' ' 67' ' ' PRO . 35.8 m -137.4 154.43 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.274 1.83 . . . . 0.0 111.526 -172.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.7 mt -87.98 140.19 29.75 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 127.097 2.159 . . . . 0.0 109.187 173.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -121.36 112.58 18.75 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.424 0.556 . . . . 0.0 111.785 -176.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.6 143.14 16.41 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 169.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -151.66 131.46 13.25 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.646 1.723 . . . . 0.0 112.339 -170.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -143.58 168.18 20.48 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.729 1.211 . . . . 0.0 113.655 -174.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.7 m -120.03 131.85 55.27 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.422 1.489 . . . . 0.0 108.882 176.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.56 173.2 32.21 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.616 1.103 . . . . 0.0 114.688 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -81.43 -12.59 58.88 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -169.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -95.81 5.11 52.11 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 120.76 1.618 . . . . 0.0 111.58 169.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.36 17.32 40.05 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 126.766 2.127 . . . . 0.0 114.213 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.6 pm0 -82.93 175.26 10.2 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.911 1.684 . . . . 0.0 113.869 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.5 m -128.26 138.38 52.4 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.084 1.353 . . . . 0.0 109.956 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.2 t -120.98 141.13 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.365 1.466 . . . . 0.0 110.355 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.0 tp -128.56 147.18 50.69 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.219 1.407 . . . . 0.0 109.812 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.4 t -131.59 137.39 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.339 1.456 . . . . 0.0 108.426 173.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -130.22 127.39 39.52 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.989 0.9 . . . . 0.0 111.76 -176.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -125.35 143.77 45.6 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.44 1.896 . . . . 0.0 110.694 -173.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -61.22 132.55 41.96 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.426 2.084 . . . . 0.0 111.609 174.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 . . . . . 0 C--O 1.254 1.314 0 C-N-CA 124.688 1.195 . . . . 0.0 112.522 -178.539 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -57.33 -37.0 71.85 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.714 -0.616 . . . . 0.0 112.455 -173.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.2 m -68.48 -24.06 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.817 1.247 . . . . 0.0 112.968 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.17 -43.93 73.23 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.336 0.971 . . . . 0.0 112.115 177.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.26 -39.9 71.31 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.516 -0.74 . . . . 0.0 111.294 -169.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -69.84 -31.14 68.84 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.709 1.203 . . . . 0.0 112.686 173.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.95 -38.98 83.46 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.908 -1.12 . . . . 0.0 112.18 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.0 t -67.15 -39.42 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 O-C-N 121.29 -0.881 . . . . 0.0 111.414 172.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -57.24 -44.87 84.23 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.589 -0.694 . . . . 0.0 111.023 171.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -71.38 -36.24 71.36 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 116.176 -1.869 . . . . 0.0 113.257 175.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.3 -39.76 67.28 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 121.976 2.171 . . . . 0.0 109.8 169.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.0 m -64.83 -40.36 95.06 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 118.051 -0.976 . . . . 0.0 113.334 173.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.8 mm -75.49 -28.63 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 120.584 1.538 . . . . 0.0 111.552 178.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.3 t -65.14 -49.21 80.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 O-C-N 120.926 -1.109 . . . . 0.0 108.978 170.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -56.77 -42.28 79.13 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 120.444 1.475 . . . . 0.0 113.191 174.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.0 p -64.94 -23.42 67.22 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.998 0.817 . . . . 0.0 112.29 177.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -83.79 -35.15 24.52 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.471 1.908 . . . . 0.0 113.411 169.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.5 mt -64.38 -38.68 91.89 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 120.527 1.512 . . . . 0.0 111.386 172.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 89.3 mt -72.42 -35.58 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 124.491 1.117 . . . . 0.0 110.891 170.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.5 -38.48 51.92 Favored Glycine 0 C--N 1.34 0.75 0 C-N-CA 125.657 1.599 . . . . 0.0 114.473 -171.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.0 t -152.18 -26.87 0.17 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 177.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.35 6.59 33.46 Favored Glycine 0 N--CA 1.477 1.381 0 N-CA-C 116.954 1.542 . . . . 0.0 116.954 173.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 t -161.07 150.0 16.46 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.546 1.538 . . . . 0.0 109.881 170.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -115.9 147.15 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 126.046 1.738 . . . . 0.0 110.826 -178.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -126.27 159.02 34.22 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.498 1.519 . . . . 0.0 110.352 -173.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -54.75 -38.48 67.24 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.862 -0.524 . . . . 0.0 112.413 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -69.36 -21.72 63.79 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -79.91 -31.92 40.16 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.769 0.713 . . . . 0.0 111.756 172.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 89.4 mt -86.54 -33.91 20.13 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.988 1.315 . . . . 0.0 114.19 -174.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -58.55 -20.88 50.33 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 175.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -80.38 -14.97 57.89 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 175.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -100.84 -44.36 5.8 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.921 0.888 . . . . 0.0 112.674 -169.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt . . . . . 0 N--CA 1.487 1.406 0 N-CA-C 117.832 2.53 . . . . 0.0 117.832 174.996 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.468 0.461 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -131.77 127.43 36.7 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.786 0.434 . . . . 0.0 111.17 -170.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -104.69 145.67 30.02 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.368 0.985 . . . . 0.0 109.675 169.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.2 t -139.99 141.4 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.331 1.052 . . . . 0.0 110.738 -170.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 mm -111.42 126.38 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.614 1.566 . . . . 0.0 112.669 -172.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -125.94 63.3 1.23 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.518 1.927 . . . . 0.0 109.703 170.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.9 mt -79.74 126.83 79.55 Favored Pre-proline 0 N--CA 1.481 1.084 0 CA-C-O 118.34 -0.838 . . . . 0.0 108.989 169.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -58.38 139.43 90.56 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.947 2.431 . . . . 0.0 113.082 173.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.78 0.0 87.22 Favored Glycine 0 CA--C 1.537 1.409 0 N-CA-C 116.042 1.177 . . . . 0.0 116.042 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -138.13 158.71 70.56 Favored Pre-proline 0 CA--C 1.549 0.935 0 CA-C-N 119.23 1.515 . . . . 0.0 112.685 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.98 149.85 59.83 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.846 2.364 . . . . 0.0 113.481 -174.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 81.3 t -64.09 130.82 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.5 1.52 . . . . 0.0 111.172 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.5 t -106.09 142.43 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.569 1.548 . . . . 0.0 108.202 170.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -135.57 113.97 11.59 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.797 1.239 . . . . 0.0 109.208 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.0 t -84.22 151.63 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.715 1.606 . . . . 0.0 110.975 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.51 -99.23 1.2 Allowed Glycine 0 CA--C 1.534 1.232 0 O-C-N 121.321 -0.862 . . . . 0.0 112.985 175.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -148.74 158.12 43.92 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.73 1.212 . . . . 0.0 109.979 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -71.27 130.28 88.03 Favored Pre-proline 0 CA--C 1.549 0.938 0 O-C-N 120.627 -1.295 . . . . 0.0 110.636 170.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.9 157.07 34.87 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.272 3.315 . . . . 0.0 114.103 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.7 t -83.63 -32.25 25.79 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -171.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.96 -33.19 2.64 Favored Glycine 0 N--CA 1.476 1.336 0 C-N-CA 125.41 1.481 . . . . 0.0 113.261 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -78.3 58.99 2.21 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.096 1.758 . . . . 0.0 111.229 169.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.0 m -136.94 155.23 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.372 1.469 . . . . 0.0 112.706 -171.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.8 mt -91.7 138.88 31.2 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 128.284 2.633 . . . . 0.0 109.546 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -121.62 103.8 9.17 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.787 0.721 . . . . 0.0 111.877 -175.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -83.75 150.97 27.21 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 169.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.8 ttt-85 -148.88 153.84 38.61 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 118.845 1.322 . . . . 0.0 111.478 -172.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -161.76 167.26 25.28 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.554 1.142 . . . . 0.0 112.922 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 97.2 m -131.51 110.98 11.37 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.507 1.523 . . . . 0.0 109.572 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.45 163.27 54.39 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.162 0.887 . . . . 0.0 114.88 -177.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -68.35 -8.22 38.11 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.632 1.973 . . . . 0.0 115.34 -174.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -102.9 4.05 37.17 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.258 1.39 . . . . 0.0 113.084 169.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.68 20.79 15.91 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.902 1.239 . . . . 0.0 114.484 172.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.64 -170.54 3.06 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.912 1.285 . . . . 0.0 113.874 -177.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.0 m -147.24 123.21 10.71 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 120.705 -1.247 . . . . 0.0 111.883 172.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.7 t -94.27 146.03 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.448 1.499 . . . . 0.0 110.866 171.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.6 tp -130.18 145.27 51.71 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.689 1.596 . . . . 0.0 108.364 169.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.16 139.4 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.179 1.392 . . . . 0.0 108.576 171.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -132.18 129.37 39.67 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.914 0.886 . . . . 0.0 111.014 -175.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -131.8 140.26 37.69 Favored Pre-proline 0 N--CA 1.473 0.677 0 C-N-CA 126.138 1.775 . . . . 0.0 111.042 -170.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -62.17 136.53 60.92 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.176 1.917 . . . . 0.0 112.099 174.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 . . . . . 0 C--O 1.253 1.252 0 C-N-CA 124.458 1.103 . . . . 0.0 111.8 173.225 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 . . . . . 0 N--CA 1.469 0.516 0 CA-C-O 119.753 -0.165 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.403 HH21 ' CD ' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -58.86 -39.95 82.84 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 118.383 -0.818 . . . . 0.0 111.751 -178.026 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.5 t -56.65 -31.61 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.201 1.4 . . . . 0.0 112.512 174.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -77.26 -33.67 55.91 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 176.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.4 mp -74.11 -38.92 63.7 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 120.929 -1.107 . . . . 0.0 111.24 -178.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.403 ' CD ' HH21 ' A' ' 14' ' ' ARG . 6.7 pt-20 -65.21 -27.25 68.55 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 170.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.39 -36.68 83.47 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 120.69 -1.256 . . . . 0.0 112.308 169.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.1 t -70.81 -36.28 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 124.445 1.098 . . . . 0.0 111.342 172.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -60.49 -45.0 95.36 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.112 -0.992 . . . . 0.0 111.449 171.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.1 mp -70.28 -33.38 71.5 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-O 117.147 -1.406 . . . . 0.0 112.494 174.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.29 -33.93 69.99 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 121.475 1.943 . . . . 0.0 110.805 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.7 m -72.05 -38.88 69.42 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.101 0.96 . . . . 0.0 113.236 171.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.0 mm -73.82 -34.85 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 120.721 1.6 . . . . 0.0 110.933 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.1 t -62.67 -48.2 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 117.452 -1.261 . . . . 0.0 110.033 172.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -54.1 -42.36 69.31 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 120.994 1.725 . . . . 0.0 112.173 171.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.2 m -60.28 -33.04 71.77 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.702 -0.624 . . . . 0.0 112.142 175.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -76.71 -37.22 56.45 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.065 1.346 . . . . 0.0 113.31 171.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.1 mt -65.06 -31.19 72.29 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.674 1.125 . . . . 0.0 112.133 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 89.7 mt -76.52 -36.78 28.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 125.156 1.382 . . . . 0.0 111.248 169.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.18 -39.43 31.92 Favored Glycine 0 N--CA 1.469 0.845 0 C-N-CA 126.08 1.8 . . . . 0.0 115.547 -171.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.9 t -151.08 -23.95 0.21 Allowed 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.0 6.04 54.34 Favored Glycine 0 N--CA 1.468 0.828 0 N-CA-C 117.271 1.668 . . . . 0.0 117.271 169.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.0 m -158.5 149.88 20.91 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.418 1.487 . . . . 0.0 110.343 170.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 p -103.51 145.11 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.448 1.099 . . . . 0.0 113.0 -173.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -116.6 152.9 33.23 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.675 1.59 . . . . 0.0 110.792 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -57.4 -35.67 70.33 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.888 -1.133 . . . . 0.0 111.885 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -70.42 -19.18 63.01 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.93 1.292 . . . . 0.0 112.738 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -83.62 -32.95 25.43 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.904 0.775 . . . . 0.0 112.179 169.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.3 mt -86.63 -34.65 19.76 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.451 1.5 . . . . 0.0 114.005 -172.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -60.48 -20.51 60.26 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -84.82 -3.41 58.63 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.23 1.412 . . . . 0.0 113.591 175.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -114.35 -26.49 7.96 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.942 1.297 . . . . 0.0 113.202 -172.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt . . . . . 0 N--CA 1.472 0.666 0 C-N-CA 124.017 0.927 . . . . 0.0 112.829 -178.265 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 111.143 0.053 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -133.83 129.88 37.14 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.246 1.419 . . . . 0.0 110.932 -175.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.12 136.17 47.42 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 120.195 1.361 . . . . 0.0 109.302 168.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.3 t -126.45 143.08 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.054 1.341 . . . . 0.0 110.767 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.471 ' HB ' ' H ' ' A' ' 61' ' ' VAL . 20.3 mm -120.57 134.07 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.542 1.537 . . . . 0.0 113.418 -169.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -113.53 3.49 15.76 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 116.277 1.955 . . . . 0.0 116.277 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.6 mt -40.04 124.72 1.64 Allowed Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 125.739 1.616 . . . . 0.0 113.544 -172.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -60.7 140.64 91.92 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.147 2.564 . . . . 0.0 113.742 173.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.0 -1.38 86.85 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.811 1.196 . . . . 0.0 115.476 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -131.49 160.84 65.49 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 125.001 1.32 . . . . 0.0 111.298 172.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -62.26 161.89 25.38 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.461 2.107 . . . . 0.0 112.145 176.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.1 t -72.11 142.9 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 169.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.471 ' H ' ' HB ' ' A' ' 53' ' ' ILE . 87.6 t -113.94 138.52 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 169.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -124.51 118.55 26.86 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.036 1.334 . . . . 0.0 108.708 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.3 t -94.22 154.34 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.043 1.337 . . . . 0.0 110.811 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.36 -109.14 2.7 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.0 t -154.69 162.14 41.25 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.736 0.768 . . . . 0.0 111.332 169.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.5 tttp -61.63 141.86 94.67 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.74 1.216 . . . . 0.0 111.565 -176.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -65.36 -167.48 0.1 Allowed 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 124.342 3.361 . . . . 0.0 115.89 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 t -119.61 -24.58 6.2 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 117.571 2.434 . . . . 0.0 117.571 -169.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.57 -10.04 21.76 Favored Glycine 0 N--CA 1.484 1.862 0 CA-C-N 119.472 1.033 . . . . 0.0 114.556 -173.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -134.45 83.8 2.06 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.829 2.452 . . . . 0.0 110.278 170.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.3 m -139.54 147.15 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.896 1.278 . . . . 0.0 111.621 -176.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.5 mt -72.33 148.95 44.86 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.05 1.34 . . . . 0.0 107.55 169.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -133.15 113.7 13.02 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.588 0.755 . . . . 0.0 109.201 -178.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -99.42 147.82 18.48 Favored Glycine 0 N--CA 1.468 0.788 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 169.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 74.2 ttt-85 -150.05 146.51 27.0 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 118.466 1.133 . . . . 0.0 112.84 -169.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.53 155.59 33.67 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.793 0.837 . . . . 0.0 112.955 -178.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.1 m -113.72 129.9 56.51 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.276 1.43 . . . . 0.0 109.475 169.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.03 -160.51 36.12 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 124.182 0.896 . . . . 0.0 115.055 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -99.51 -15.15 18.77 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -169.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -91.57 -1.82 57.36 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 120.338 1.426 . . . . 0.0 111.998 168.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.01 20.07 26.97 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 126.303 1.906 . . . . 0.0 113.651 -174.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.0 pm0 -80.66 163.5 23.55 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.841 1.656 . . . . 0.0 113.988 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.9 m -128.51 140.37 51.84 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.125 0.97 . . . . 0.0 110.507 173.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.8 t -131.79 143.2 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.157 1.783 . . . . 0.0 109.363 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.3 tp -130.15 147.58 51.9 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.46 1.504 . . . . 0.0 111.569 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 76.2 t -122.44 138.34 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 126.887 2.075 . . . . 0.0 108.401 171.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -137.06 134.51 36.6 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.741 0.701 . . . . 0.0 112.652 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.0 152.27 33.72 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 176.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -58.27 128.02 27.02 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.548 2.832 . . . . 0.0 113.431 -175.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 125.156 1.382 . . . . 0.0 112.131 179.396 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 . . . . . 0 CA--C 1.541 0.605 0 CA-C-O 119.695 -0.193 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.4 HH21 ' CD ' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -58.39 -36.1 73.04 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 118.365 -0.826 . . . . 0.0 112.042 176.744 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.8 t -57.25 -28.47 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.911 1.684 . . . . 0.0 113.408 171.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -76.85 -38.51 53.6 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.181 -0.949 . . . . 0.0 112.278 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.5 mp -70.6 -36.75 73.71 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.324 -0.86 . . . . 0.0 111.349 -174.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.4 ' CD ' HH21 ' A' ' 14' ' ' ARG . 8.3 pt-20 -67.08 -32.07 72.99 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.7 0.8 . . . . 0.0 112.581 170.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.06 -40.74 87.14 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.637 -1.289 . . . . 0.0 112.125 171.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.5 t -63.45 -43.55 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.822 0.849 . . . . 0.0 110.932 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -57.27 -41.13 79.1 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.741 -0.599 . . . . 0.0 111.51 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 mp -67.63 -34.84 77.76 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 117.315 -1.326 . . . . 0.0 113.326 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.74 -33.92 67.03 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 120.991 1.723 . . . . 0.0 111.249 169.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 m -73.92 -37.56 64.58 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 170.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.3 mm -69.58 -36.57 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 120.618 1.554 . . . . 0.0 110.4 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.13 -46.93 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.915 1.286 . . . . 0.0 109.624 176.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -52.89 -43.63 66.32 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 120.62 1.555 . . . . 0.0 111.963 170.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.9 m -59.96 -32.41 70.79 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.791 0.436 . . . . 0.0 111.986 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -79.07 -36.62 40.59 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.594 1.558 . . . . 0.0 113.712 172.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.0 mt -66.34 -34.26 77.57 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 120.195 1.361 . . . . 0.0 111.43 175.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.3 mt -73.06 -36.74 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.386 1.074 . . . . 0.0 110.491 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.75 -38.81 60.75 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 125.695 1.617 . . . . 0.0 114.428 -173.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.5 t -152.24 -26.52 0.17 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 178.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.51 3.35 53.24 Favored Glycine 0 N--CA 1.481 1.694 0 N-CA-C 116.156 1.223 . . . . 0.0 116.156 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.5 m -143.66 135.3 26.25 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.214 1.806 . . . . 0.0 108.974 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 p -107.01 145.5 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.668 0.787 . . . . 0.0 109.634 172.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -133.59 156.91 46.98 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.666 1.186 . . . . 0.0 110.187 -175.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -56.3 -37.58 70.08 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.804 -0.56 . . . . 0.0 111.907 -177.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -70.03 -22.06 63.13 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -77.6 -37.89 49.38 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.497 0.59 . . . . 0.0 111.738 170.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 60.6 mt -87.71 -27.05 22.63 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 -173.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -56.49 -27.74 57.94 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 175.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -90.5 4.34 51.41 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.623 1.169 . . . . 0.0 114.12 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -123.09 -10.57 8.12 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 119.814 1.188 . . . . 0.0 113.943 -170.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.829 0 C-N-CA 125.274 1.429 . . . . 0.0 114.547 -175.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 119.974 -0.06 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -131.74 116.93 17.92 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.733 1.613 . . . . 0.0 109.457 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.15 145.08 25.66 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.012 -1.055 . . . . 0.0 108.69 168.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.2 t -139.89 134.76 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 120.682 -1.261 . . . . 0.0 110.931 -169.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mm -116.07 139.16 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.087 1.355 . . . . 0.0 114.641 -170.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -144.87 73.3 1.36 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.076 1.75 . . . . 0.0 109.628 169.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.0 mt -83.35 121.76 76.91 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-N 114.386 -1.279 . . . . 0.0 107.682 169.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.22 132.68 50.48 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.073 1.849 . . . . 0.0 112.214 174.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.05 0.18 83.41 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.869 1.223 . . . . 0.0 116.016 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -139.87 165.57 30.01 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 119.79 1.795 . . . . 0.0 113.872 173.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -60.74 140.95 93.48 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.609 2.873 . . . . 0.0 115.644 -173.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.6 t -69.98 116.03 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.509 1.124 . . . . 0.0 108.946 169.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.87 143.98 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.195 1.398 . . . . 0.0 109.765 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -139.16 110.91 7.16 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.792 1.237 . . . . 0.0 108.881 -170.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.1 t -80.93 153.8 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.745 1.618 . . . . 0.0 111.466 -172.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.42 -87.54 1.12 Allowed Glycine 0 CA--C 1.533 1.157 0 O-C-N 121.487 -0.758 . . . . 0.0 113.263 172.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.1 m -157.68 160.76 38.31 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.014 1.326 . . . . 0.0 109.889 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.8 tptt -73.94 131.9 80.82 Favored Pre-proline 0 CA--C 1.548 0.879 0 O-C-N 120.778 -1.201 . . . . 0.0 110.581 171.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.65 156.49 40.13 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 124.223 3.282 . . . . 0.0 114.349 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.6 t -83.91 -33.24 24.77 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -173.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.62 -40.82 1.45 Allowed Glycine 0 N--CA 1.474 1.209 0 C-N-CA 124.983 1.278 . . . . 0.0 113.472 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -78.44 58.8 2.24 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.527 1.531 . . . . 0.0 111.767 171.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.8 m -127.13 156.76 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.244 1.418 . . . . 0.0 113.298 -173.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.0 mt -97.25 112.94 24.52 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 127.761 2.424 . . . . 0.0 110.789 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -98.45 100.57 11.84 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.172 0.989 . . . . 0.0 113.034 -171.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -85.68 152.83 26.62 Favored Glycine 0 N--CA 1.473 1.134 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 169.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -149.66 154.77 39.13 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.544 1.672 . . . . 0.0 112.211 -169.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -163.35 167.94 21.1 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.298 1.039 . . . . 0.0 113.372 176.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 62.3 m -124.75 132.93 53.32 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.121 1.768 . . . . 0.0 107.814 171.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.84 -179.31 38.96 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 123.52 0.581 . . . . 0.0 114.432 -178.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -88.51 -10.02 50.41 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -169.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -99.73 7.09 45.37 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.791 1.632 . . . . 0.0 111.138 169.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.43 18.04 40.22 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 127.033 2.254 . . . . 0.0 114.099 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.9 pm0 -79.14 176.05 10.03 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.525 1.53 . . . . 0.0 113.584 178.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.6 m -136.48 139.53 42.39 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.491 1.116 . . . . 0.0 109.534 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.4 t -129.68 143.42 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.539 1.536 . . . . 0.0 110.541 -174.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.0 tp -134.25 150.42 51.02 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.564 1.546 . . . . 0.0 109.136 173.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 37.7 t -126.42 138.39 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 126.194 1.798 . . . . 0.0 108.574 171.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -135.98 138.69 42.53 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.487 0.715 . . . . 0.0 111.438 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -154.5 156.62 31.79 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.289 1.436 . . . . 0.0 112.521 173.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -59.13 138.64 86.34 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.415 2.076 . . . . 0.0 113.828 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 . . . . . 0 C--O 1.255 1.344 0 C-N-CA 125.801 1.64 . . . . 0.0 112.19 172.87 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 . . . . . 0 CA--C 1.543 0.692 0 CA-C-O 120.303 0.097 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -35.0 77.11 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 118.38 -0.819 . . . . 0.0 113.006 -175.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.0 m -63.99 -19.82 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 174.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.96 -44.82 68.71 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.672 1.124 . . . . 0.0 112.326 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -69.52 -41.33 76.16 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.278 -0.889 . . . . 0.0 111.491 -171.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -64.64 -33.6 76.31 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.65 1.18 . . . . 0.0 112.635 171.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.52 -37.76 85.73 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.736 -1.228 . . . . 0.0 112.384 172.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.0 t -68.85 -37.64 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 124.023 0.929 . . . . 0.0 111.37 172.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -59.4 -43.9 92.91 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.175 -0.953 . . . . 0.0 111.744 170.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.7 mp -68.98 -34.95 76.15 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 120.382 1.446 . . . . 0.0 112.806 173.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.26 -34.43 68.63 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 121.158 1.799 . . . . 0.0 110.584 169.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.5 m -71.52 -40.16 70.28 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.084 0.954 . . . . 0.0 113.177 172.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.8 mm -72.04 -35.48 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 120.69 1.587 . . . . 0.0 111.108 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.21 -45.69 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.696 1.198 . . . . 0.0 109.547 174.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -53.75 -43.11 68.88 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 120.78 1.627 . . . . 0.0 112.12 171.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.6 t -59.15 -39.55 82.79 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.964 -0.46 . . . . 0.0 111.826 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -68.55 -38.34 80.7 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.666 1.186 . . . . 0.0 113.088 171.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.0 mt -67.72 -38.46 83.61 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.747 1.158 . . . . 0.0 112.084 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.09 -37.36 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.49 1.116 . . . . 0.0 111.348 172.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.39 -64.19 3.08 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 124.837 1.208 . . . . 0.0 111.083 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.1 t -126.81 -27.6 3.05 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -174.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.48 3.05 53.51 Favored Glycine 0 N--CA 1.475 1.267 0 N-CA-C 116.81 1.484 . . . . 0.0 116.81 172.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.4 m -146.73 136.94 23.6 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.633 1.573 . . . . 0.0 109.713 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 p -104.76 146.69 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.505 1.122 . . . . 0.0 110.688 176.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -133.65 159.18 41.28 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.877 1.271 . . . . 0.0 110.352 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -55.79 -38.58 70.11 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -71.04 -17.18 62.63 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -80.62 -32.14 36.37 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.349 0.977 . . . . 0.0 112.041 170.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.3 mt -90.98 -30.45 16.82 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.237 1.415 . . . . 0.0 114.489 -172.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.9 ptt85 -59.0 -23.93 62.32 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 119.398 0.999 . . . . 0.0 113.491 174.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -82.02 -6.95 59.55 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 175.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -113.4 -20.11 11.45 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -169.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 N--CA 1.467 0.414 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -172.851 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -133.63 123.14 24.52 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.582 1.553 . . . . 0.0 109.193 -176.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.4 138.57 35.44 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.229 0.922 . . . . 0.0 109.166 169.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.8 t -132.89 140.36 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.033 1.333 . . . . 0.0 109.692 -173.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.24 131.9 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -169.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -128.77 78.43 1.85 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.5 1.92 . . . . 0.0 109.848 170.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.8 mt -96.9 125.59 45.8 Favored Pre-proline 0 N--CA 1.481 1.104 0 O-C-N 121.128 -0.982 . . . . 0.0 109.047 170.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.91 134.86 62.91 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.549 2.166 . . . . 0.0 112.484 172.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.9 0.31 85.81 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 124.711 1.148 . . . . 0.0 115.942 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -139.74 156.39 70.98 Favored Pre-proline 0 N--CA 1.476 0.827 0 CA-C-N 119.407 1.604 . . . . 0.0 112.506 174.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -69.75 149.79 67.39 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.699 2.266 . . . . 0.0 112.983 -173.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.0 t -57.02 132.8 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.934 1.294 . . . . 0.0 110.783 175.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.1 t -111.74 141.92 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.154 1.382 . . . . 0.0 109.41 170.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -136.5 117.77 14.57 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.132 1.373 . . . . 0.0 109.223 176.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.8 t -91.94 159.55 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.02 1.728 . . . . 0.0 111.156 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.41 -104.64 1.62 Allowed Glycine 0 CA--C 1.531 1.067 0 O-C-N 120.959 -1.088 . . . . 0.0 112.026 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.5 t -154.74 160.58 41.42 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.553 0.692 . . . . 0.0 111.516 169.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -74.16 125.94 89.6 Favored Pre-proline 0 CA--C 1.546 0.807 0 O-C-N 120.698 -1.251 . . . . 0.0 111.703 -170.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.402 ' HB2' HG11 ' A' ' 71' ' ' VAL . 71.1 Cg_endo -76.65 154.19 34.7 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.834 3.023 . . . . 0.0 114.728 -177.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.1 t -84.4 -30.13 25.62 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -171.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.29 -35.38 2.44 Favored Glycine 0 N--CA 1.479 1.534 0 C-N-CA 124.738 1.161 . . . . 0.0 113.816 -175.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -78.18 58.64 2.08 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.922 1.689 . . . . 0.0 110.816 169.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.402 HG11 ' HB2' ' A' ' 67' ' ' PRO . 33.6 m -138.95 155.33 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 125.946 1.698 . . . . 0.0 111.863 -171.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.1 mt -74.44 164.79 26.18 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.881 1.672 . . . . 0.0 109.873 169.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -149.32 93.14 2.03 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.729 0.812 . . . . 0.0 110.223 -173.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -85.58 148.56 22.88 Favored Glycine 0 N--CA 1.471 1.007 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 169.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -151.44 150.14 30.08 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.636 1.718 . . . . 0.0 113.207 -169.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -157.51 157.18 33.34 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.316 1.046 . . . . 0.0 113.638 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 85.5 m -109.52 125.86 52.93 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.107 1.363 . . . . 0.0 107.871 169.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.18 173.42 42.74 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 122.385 0.991 . . . . 0.0 114.807 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -80.47 -8.03 59.39 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 -169.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -103.39 6.38 37.72 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.935 1.698 . . . . 0.0 111.648 168.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.1 18.71 30.7 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.264 1.887 . . . . 0.0 114.273 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.7 pm0 -85.28 176.18 8.48 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.613 1.565 . . . . 0.0 113.759 177.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.8 m -132.59 134.18 44.59 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.124 1.37 . . . . 0.0 110.444 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.7 t -118.89 144.28 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.066 1.746 . . . . 0.0 110.115 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.6 tp -133.6 143.75 48.83 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.469 1.108 . . . . 0.0 110.557 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.7 t -114.76 135.66 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 127.797 2.439 . . . . 0.0 108.207 171.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -136.71 144.18 43.76 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.839 0.828 . . . . 0.0 111.145 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.2 152.45 20.18 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 176.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -58.11 142.36 96.97 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.678 2.919 . . . . 0.0 114.316 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 . . . . . 0 C--O 1.253 1.284 0 C-N-CA 125.715 1.606 . . . . 0.0 112.68 172.47 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 . . . . . 0 N--CA 1.475 0.817 0 CA-C-O 120.813 0.339 . . . . 0.0 111.737 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -31.47 71.49 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 121.008 -1.057 . . . . 0.0 113.795 -174.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.2 m -65.79 -21.4 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 172.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -69.97 -43.03 72.34 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 120.905 -1.122 . . . . 0.0 112.5 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.26 -40.82 77.6 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.387 -0.821 . . . . 0.0 111.523 -171.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.4 -30.23 70.56 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.538 1.135 . . . . 0.0 112.62 173.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.43 -37.64 80.45 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.881 -1.137 . . . . 0.0 111.918 171.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.0 t -68.71 -37.0 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 O-C-N 121.43 -0.794 . . . . 0.0 111.302 172.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -59.36 -46.48 88.51 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.2 -0.937 . . . . 0.0 111.602 171.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -69.18 -34.14 74.47 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 117.398 -1.287 . . . . 0.0 112.844 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.16 -34.08 68.07 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 121.079 1.763 . . . . 0.0 110.578 169.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.9 m -73.0 -38.46 66.61 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.552 1.141 . . . . 0.0 113.642 171.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.6 mm -70.89 -37.04 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 120.701 1.591 . . . . 0.0 110.814 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.3 t -66.42 -48.31 81.17 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 C-N-CA 124.792 1.237 . . . . 0.0 109.609 175.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -53.61 -43.06 68.35 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 120.593 1.542 . . . . 0.0 112.154 171.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.2 m -59.64 -32.47 70.47 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.807 -0.558 . . . . 0.0 112.107 176.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -79.72 -36.39 37.49 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.634 1.574 . . . . 0.0 113.555 172.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 78.5 mt -65.62 -33.22 75.38 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 120.063 1.301 . . . . 0.0 111.707 174.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.32 -37.57 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.312 1.045 . . . . 0.0 110.894 169.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.39 -37.53 62.75 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 125.637 1.589 . . . . 0.0 114.272 -172.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.3 t -151.46 -27.45 0.19 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 177.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.15 8.69 33.3 Favored Glycine 0 N--CA 1.477 1.411 0 N-CA-C 116.703 1.441 . . . . 0.0 116.703 175.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.7 p -158.82 136.94 10.58 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.517 1.527 . . . . 0.0 109.985 176.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.45 145.95 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.272 1.029 . . . . 0.0 110.327 176.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -127.56 159.41 34.71 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.598 1.559 . . . . 0.0 109.666 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -53.44 -38.95 64.02 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -175.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -70.24 -15.96 62.98 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -89.27 -3.71 58.42 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.785 0.834 . . . . 0.0 112.494 170.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.1 mt -116.19 -33.88 4.86 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.022 1.329 . . . . 0.0 113.634 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.3 ptt85 -64.42 -21.66 66.71 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 119.66 1.118 . . . . 0.0 113.471 178.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -89.02 2.8 53.47 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.209 1.404 . . . . 0.0 113.984 171.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -121.33 -13.38 8.47 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.357 1.463 . . . . 0.0 112.742 -174.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 N--CA 1.472 0.629 0 CA-C-N 118.715 0.689 . . . . 0.0 110.938 171.319 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -136.45 144.89 44.66 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.177 1.391 . . . . 0.0 112.246 -173.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -120.58 149.45 42.43 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.907 0.883 . . . . 0.0 110.87 169.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.9 t -141.16 140.77 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 120.838 -1.163 . . . . 0.0 110.582 -173.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -113.97 136.17 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -170.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -138.72 74.54 1.48 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.218 1.807 . . . . 0.0 109.469 175.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.8 mt -91.69 126.44 53.95 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-N 114.392 -1.277 . . . . 0.0 109.331 171.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -57.87 137.15 79.58 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.027 2.485 . . . . 0.0 112.932 173.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.61 -1.1 88.32 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.604 1.097 . . . . 0.0 115.413 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -136.25 158.27 73.93 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 119.009 1.404 . . . . 0.0 112.164 175.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.46 152.42 60.27 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.72 2.28 . . . . 0.0 112.774 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.1 p -62.44 135.89 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.693 1.197 . . . . 0.0 111.822 171.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.1 p -122.24 147.17 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.818 1.247 . . . . 0.0 110.752 169.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -127.07 124.34 39.04 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.313 1.445 . . . . 0.0 109.727 -173.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.2 t -103.8 149.1 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 127.81 2.444 . . . . 0.0 109.792 -169.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.96 -94.53 1.0 Allowed Glycine 0 CA--C 1.532 1.114 0 O-C-N 120.727 -1.233 . . . . 0.0 111.678 -175.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 m -155.4 157.64 37.37 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.551 1.14 . . . . 0.0 109.879 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -71.51 128.48 89.88 Favored Pre-proline 0 CA--C 1.55 0.943 0 O-C-N 120.569 -1.332 . . . . 0.0 112.19 177.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -77.94 155.53 30.3 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 124.397 3.398 . . . . 0.0 114.736 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.0 t -84.45 -20.3 31.98 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -170.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.21 -31.6 5.76 Favored Glycine 0 N--CA 1.478 1.458 0 C-N-CA 125.782 1.658 . . . . 0.0 113.413 -176.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -78.46 60.1 2.54 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.033 1.733 . . . . 0.0 110.365 169.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.57 154.08 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 126.19 1.796 . . . . 0.0 111.502 -170.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 25.0 mt -86.93 138.23 31.71 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.946 2.098 . . . . 0.0 108.963 173.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -121.57 111.15 16.88 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.151 0.887 . . . . 0.0 111.619 -174.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.56 144.28 16.99 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 169.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -151.35 135.76 16.92 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 119.247 1.523 . . . . 0.0 112.548 -169.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.1 165.01 29.5 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.392 1.077 . . . . 0.0 113.779 -176.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.7 m -117.44 129.76 56.04 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.401 1.481 . . . . 0.0 108.613 173.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.11 173.52 36.21 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.2 0.905 . . . . 0.0 114.603 -178.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -81.86 -9.25 59.66 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 -169.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -99.01 5.02 47.32 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 120.752 1.614 . . . . 0.0 111.506 168.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.38 16.77 36.23 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.562 2.029 . . . . 0.0 114.157 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.7 pm0 -83.58 173.29 11.54 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.66 1.584 . . . . 0.0 113.837 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.1 m -126.75 137.48 53.24 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.452 1.501 . . . . 0.0 110.14 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.7 t -124.17 141.4 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.606 1.562 . . . . 0.0 110.303 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.6 tp -130.49 146.02 51.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.798 1.239 . . . . 0.0 110.209 175.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.9 t -130.63 138.85 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.039 1.736 . . . . 0.0 108.789 176.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -134.53 131.52 38.08 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.394 0.616 . . . . 0.0 112.576 -175.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -123.33 148.68 55.86 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 125.031 1.332 . . . . 0.0 112.446 175.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -57.42 134.27 62.47 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.545 2.163 . . . . 0.0 112.101 170.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 . . . . . 0 C--O 1.254 1.315 0 C-N-CA 124.957 1.303 . . . . 0.0 112.63 -178.776 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 . . . . . 0 CA--C 1.542 0.651 0 CA-C-O 118.821 -0.609 . . . . 0.0 111.791 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -57.75 -41.34 81.71 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.259 0.936 . . . . 0.0 111.134 175.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.1 t -59.94 -29.02 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.34 1.856 . . . . 0.0 112.667 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -70.52 -40.52 73.45 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.31 -0.868 . . . . 0.0 112.674 173.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.7 mp -75.6 -36.96 60.16 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.026 -1.046 . . . . 0.0 111.818 -171.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -64.54 -27.48 68.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.548 0.739 . . . . 0.0 112.784 169.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.2 -37.75 78.27 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.713 -1.242 . . . . 0.0 112.076 169.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.6 t -68.12 -36.4 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 O-C-N 121.267 -0.895 . . . . 0.0 111.315 173.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -58.71 -44.49 90.38 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.321 -0.862 . . . . 0.0 111.526 170.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.6 mp -69.62 -35.8 75.59 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-O 116.597 -1.668 . . . . 0.0 113.101 173.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.64 -37.11 67.79 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 121.8 2.091 . . . . 0.0 110.391 169.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.6 m -69.16 -39.57 78.68 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.162 0.985 . . . . 0.0 113.334 172.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.9 mm -71.1 -34.76 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 120.606 1.548 . . . . 0.0 110.549 176.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.83 -51.04 76.9 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 C-N-CA 125.667 1.587 . . . . 0.0 110.328 174.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -54.66 -40.12 68.73 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 121.086 1.766 . . . . 0.0 112.745 172.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.1 m -62.68 -28.97 70.3 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.883 0.473 . . . . 0.0 112.103 175.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -83.23 -37.06 24.08 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.123 1.769 . . . . 0.0 113.482 172.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.7 mt -66.39 -35.98 81.7 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.989 1.268 . . . . 0.0 111.807 175.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.7 mt -74.33 -36.34 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 124.845 1.258 . . . . 0.0 110.879 169.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.87 -39.0 40.14 Favored Glycine 0 C--N 1.34 0.786 0 C-N-CA 125.523 1.535 . . . . 0.0 114.775 -170.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.8 t -150.07 -27.31 0.25 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 176.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.94 11.83 36.16 Favored Glycine 0 N--CA 1.475 1.25 0 N-CA-C 116.515 1.366 . . . . 0.0 116.515 174.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.9 m -155.29 140.05 17.11 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.256 1.422 . . . . 0.0 110.871 172.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 80.5 t -99.84 143.68 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.037 1.735 . . . . 0.0 109.212 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -127.77 156.69 42.06 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.549 1.14 . . . . 0.0 111.2 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -54.85 -38.23 67.2 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.211 -0.93 . . . . 0.0 112.241 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.29 -20.58 64.77 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.199 1.4 . . . . 0.0 113.692 177.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -82.99 -35.3 25.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.565 0.62 . . . . 0.0 112.345 172.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.4 mt -84.11 -32.23 24.83 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -175.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -58.66 -21.87 55.41 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 175.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -82.54 -5.19 58.61 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 174.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -109.16 -44.54 3.93 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.678 1.191 . . . . 0.0 112.452 -174.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 pt . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 117.354 2.353 . . . . 0.0 117.354 175.165 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.47 0.541 0 CA-C-O 119.039 -0.505 . . . . 0.0 112.058 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -130.86 129.6 42.52 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 122.995 0.518 . . . . 0.0 111.367 -170.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.47 144.24 32.51 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 118.902 0.773 . . . . 0.0 109.607 169.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.3 t -140.53 140.58 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.841 1.257 . . . . 0.0 110.328 -169.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -128.95 141.1 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -169.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -138.75 88.22 2.28 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.376 1.87 . . . . 0.0 108.314 169.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.1 mt -104.65 126.75 30.49 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 124.132 0.973 . . . . 0.0 109.364 173.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.15 133.83 57.96 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.542 2.162 . . . . 0.0 113.235 174.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.0 1.11 89.79 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.043 1.306 . . . . 0.0 116.207 175.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -134.12 158.17 75.95 Favored Pre-proline 0 N--CA 1.476 0.829 0 CA-C-N 119.247 1.523 . . . . 0.0 112.19 173.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.65 143.19 61.24 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.518 2.145 . . . . 0.0 112.702 -177.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 p -52.34 137.41 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.857 1.663 . . . . 0.0 112.451 171.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.7 t -119.78 134.03 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.287 1.835 . . . . 0.0 109.352 172.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -141.16 115.9 9.67 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.594 1.158 . . . . 0.0 109.283 176.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.7 t -93.23 155.1 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.682 1.993 . . . . 0.0 111.494 -169.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.74 -97.17 1.21 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 121.269 -0.895 . . . . 0.0 113.409 172.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.8 m -153.71 154.86 34.88 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.471 1.109 . . . . 0.0 110.346 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -70.67 127.99 91.38 Favored Pre-proline 0 CA--C 1.548 0.882 0 O-C-N 120.69 -1.256 . . . . 0.0 110.951 175.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.426 ' CB ' HG11 ' A' ' 71' ' ' VAL . 73.8 Cg_endo -78.55 158.76 28.79 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 124.283 3.322 . . . . 0.0 114.664 -178.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.8 t -85.57 -29.77 23.88 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -169.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.48 -35.48 2.33 Favored Glycine 0 N--CA 1.476 1.365 0 C-N-CA 125.484 1.516 . . . . 0.0 112.449 -175.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -78.9 61.86 3.22 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.489 1.515 . . . . 0.0 110.589 169.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.426 HG11 ' CB ' ' A' ' 67' ' ' PRO . 30.3 m -137.47 155.48 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.53 1.532 . . . . 0.0 112.535 -177.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.0 mt -91.99 127.93 37.65 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 128.417 2.687 . . . . 0.0 109.243 176.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -114.52 108.13 16.44 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.766 0.712 . . . . 0.0 111.649 -173.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.51 146.78 18.73 Favored Glycine 0 N--CA 1.469 0.856 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 169.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -152.37 132.92 13.85 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 119.377 1.589 . . . . 0.0 112.644 -169.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.28 168.45 21.04 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 42.6 m -135.43 118.01 15.93 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.927 1.691 . . . . 0.0 109.417 -177.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.48 172.15 52.57 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.454 1.026 . . . . 0.0 113.055 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -49.19 -43.96 42.68 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 126.324 1.85 . . . . 0.0 111.472 175.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -81.06 2.17 28.33 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -172.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.39 22.97 27.85 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.387 0.994 . . . . 0.0 113.139 172.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.42 -166.78 1.54 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.322 1.449 . . . . 0.0 113.285 -178.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.7 m -146.85 123.55 11.19 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 120.377 -1.452 . . . . 0.0 111.904 172.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.2 t -97.69 143.0 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.708 2.003 . . . . 0.0 109.988 170.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.1 tp -131.28 144.9 51.63 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.395 1.478 . . . . 0.0 109.134 169.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.7 t -125.76 137.42 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.318 1.447 . . . . 0.0 108.544 172.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -131.67 126.36 34.41 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.689 0.757 . . . . 0.0 111.284 -175.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -129.49 144.59 53.47 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 126.564 1.946 . . . . 0.0 110.813 -170.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.92 133.42 38.67 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.377 2.051 . . . . 0.0 112.188 178.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.2 ttp85 . . . . . 0 C--O 1.253 1.265 0 C-N-CA 125.138 1.375 . . . . 0.0 112.231 178.479 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 . . . . . 0 CA--C 1.545 0.787 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.97 -31.66 72.04 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 121.011 -1.056 . . . . 0.0 113.724 -172.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.6 m -60.57 -20.58 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 172.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -70.24 -45.13 67.12 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.181 0.901 . . . . 0.0 112.454 174.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -70.9 -41.33 71.42 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.209 -0.932 . . . . 0.0 111.303 -170.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -63.62 -33.13 74.94 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.909 0.883 . . . . 0.0 112.562 170.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.24 -37.02 84.51 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.72 -1.238 . . . . 0.0 111.829 172.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.7 t -69.27 -38.58 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 O-C-N 121.236 -0.915 . . . . 0.0 111.529 172.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.9 tpp85 -58.11 -46.14 86.06 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.156 -0.965 . . . . 0.0 111.009 171.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -69.95 -34.79 73.87 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 116.759 -1.591 . . . . 0.0 112.616 175.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.78 -37.99 69.31 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 121.589 1.995 . . . . 0.0 109.735 169.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.8 m -70.23 -38.26 75.18 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.115 0.966 . . . . 0.0 113.483 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.0 mm -71.55 -34.86 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 120.854 1.661 . . . . 0.0 110.489 176.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.1 t -63.21 -50.5 78.84 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 C-N-CA 125.4 1.48 . . . . 0.0 109.59 172.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -55.08 -40.51 70.45 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 121.307 1.867 . . . . 0.0 113.34 172.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.4 m -59.32 -34.01 71.81 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.085 -0.384 . . . . 0.0 111.682 174.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -79.41 -35.7 40.19 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.825 1.65 . . . . 0.0 113.937 172.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.96 -33.71 76.43 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 120.161 1.346 . . . . 0.0 111.576 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 87.6 mt -75.04 -37.4 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 124.849 1.259 . . . . 0.0 110.585 169.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.23 -39.48 62.3 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 125.637 1.589 . . . . 0.0 114.181 -173.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.3 t -151.49 -27.75 0.19 Allowed 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.22 0.27 38.14 Favored Glycine 0 N--CA 1.481 1.655 0 N-CA-C 116.757 1.463 . . . . 0.0 116.757 175.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.1 m -144.09 136.01 26.26 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.35 1.86 . . . . 0.0 109.01 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.9 p -114.41 143.18 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.335 1.054 . . . . 0.0 110.224 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -128.41 158.46 38.25 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.748 1.219 . . . . 0.0 110.872 -170.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -51.9 -37.95 54.38 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.722 0.809 . . . . 0.0 113.07 -177.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -70.31 -20.05 63.03 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.637 1.575 . . . . 0.0 114.236 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -80.55 -36.96 32.29 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.997 0.817 . . . . 0.0 111.491 171.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.5 mt -87.48 -33.06 19.14 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.74 1.616 . . . . 0.0 113.951 -170.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.6 ptt85 -55.15 -22.37 16.81 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 172.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -84.35 -12.25 54.87 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 176.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -110.55 -21.63 12.05 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 119.957 1.253 . . . . 0.0 114.038 -170.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -132.52 130.08 39.93 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.042 1.337 . . . . 0.0 111.498 -174.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.405 ' H ' ' HB ' ' A' ' 63' ' ' VAL . . . -105.71 142.76 34.89 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 168.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.5 t -138.33 140.5 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 O-C-N 121.085 -1.009 . . . . 0.0 110.975 -169.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 mm -114.17 134.28 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.748 1.619 . . . . 0.0 113.628 -172.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -136.64 69.13 1.42 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.594 1.958 . . . . 0.0 109.589 170.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 30.8 mt -89.93 128.18 51.0 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 123.971 0.909 . . . . 0.0 109.383 171.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -61.46 132.56 41.38 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.35 2.033 . . . . 0.0 112.713 173.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.35 2.89 87.33 Favored Glycine 0 CA--C 1.537 1.412 0 N-CA-C 116.079 1.192 . . . . 0.0 116.079 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -136.13 155.12 77.72 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-N 119.152 1.476 . . . . 0.0 112.008 172.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.05 147.45 67.49 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.722 2.281 . . . . 0.0 113.14 -171.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 p -58.33 130.2 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.641 1.176 . . . . 0.0 111.651 174.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.1 t -109.88 139.28 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.753 1.621 . . . . 0.0 108.937 171.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -135.47 108.5 7.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.767 1.227 . . . . 0.0 108.511 177.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.405 ' HB ' ' H ' ' A' ' 51' ' ' ALA . 27.6 t -80.8 149.3 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.111 1.364 . . . . 0.0 110.985 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.14 -93.59 1.43 Allowed Glycine 0 CA--C 1.533 1.196 0 O-C-N 121.654 -0.654 . . . . 0.0 112.128 174.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.1 m -149.35 158.4 44.14 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.048 1.339 . . . . 0.0 109.146 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -76.69 128.27 82.25 Favored Pre-proline 0 CA--C 1.548 0.892 0 O-C-N 120.548 -1.345 . . . . 0.0 110.896 173.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -75.83 155.45 39.16 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.285 3.323 . . . . 0.0 114.89 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.7 t -86.18 -31.79 21.58 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -169.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.36 -41.17 1.42 Allowed Glycine 0 N--CA 1.474 1.201 0 C-N-CA 124.991 1.282 . . . . 0.0 112.583 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -78.49 64.13 3.48 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.059 1.343 . . . . 0.0 111.047 169.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.0 158.17 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.443 1.497 . . . . 0.0 112.406 -178.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.4 mt -99.83 126.7 45.97 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.612 2.365 . . . . 0.0 110.056 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -109.2 109.58 20.56 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -170.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.26 146.7 18.24 Favored Glycine 0 N--CA 1.475 1.24 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 169.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 68.8 ttt-85 -154.2 132.84 12.16 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 120.812 2.306 . . . . 0.0 114.101 -169.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -143.32 173.59 11.47 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.196 1.398 . . . . 0.0 113.597 -177.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -143.73 119.26 10.35 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.597 1.559 . . . . 0.0 110.409 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.26 175.14 54.62 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.521 1.534 . . . . 0.0 115.513 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -68.02 -9.92 49.58 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.11 2.164 . . . . 0.0 115.373 -174.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -97.47 3.81 50.69 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 120.309 1.413 . . . . 0.0 113.452 169.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.57 23.47 26.13 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.971 1.272 . . . . 0.0 114.238 173.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.14 -164.4 1.11 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.297 1.439 . . . . 0.0 114.527 -172.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.4 m -146.91 121.57 9.83 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.334 -1.479 . . . . 0.0 111.833 173.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.7 t -98.14 139.55 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.841 1.656 . . . . 0.0 109.456 169.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.6 tp -129.01 146.9 50.86 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.216 1.406 . . . . 0.0 109.302 171.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.9 t -125.6 134.81 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.005 1.322 . . . . 0.0 108.268 171.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -132.94 131.33 40.7 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.278 1.031 . . . . 0.0 111.359 -176.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -148.51 152.98 39.44 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.352 1.061 . . . . 0.0 112.398 177.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -62.65 135.93 55.43 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.893 2.395 . . . . 0.0 113.86 -170.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 . . . . . 0 C--O 1.254 1.324 0 C-N-CA 127.369 2.268 . . . . 0.0 112.34 179.82 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.808 0 CA-C-O 121.114 0.286 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.0 m -66.0 157.96 29.51 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.869 1.268 . . . . 0.0 113.67 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -141.11 155.17 46.16 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.212 1.405 . . . . 0.0 112.991 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.9 m -107.83 157.1 18.45 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.157 1.783 . . . . 0.0 110.442 174.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.9 mmt-85 -144.65 165.04 29.17 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 127.681 2.392 . . . . 0.0 110.177 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.4 m -109.91 102.94 11.66 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.484 1.114 . . . . 0.0 111.067 -174.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.2 mm -73.73 160.54 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 125.592 1.557 . . . . 0.0 110.894 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.6 t -111.94 141.91 44.99 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.937 1.295 . . . . 0.0 112.3 177.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.1 m -127.78 26.94 5.81 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.428 1.891 . . . . 0.0 110.475 169.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.1 p -136.27 -70.95 0.46 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.85 1.66 . . . . 0.0 109.292 -172.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.97 -43.58 78.68 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.211 1.404 . . . . 0.0 111.936 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -73.54 -25.27 60.32 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.836 -0.54 . . . . 0.0 112.44 174.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -74.19 -47.93 32.4 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.966 -1.084 . . . . 0.0 111.837 174.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -36.4 78.01 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.347 -0.846 . . . . 0.0 112.588 -174.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.2 m -61.76 -21.41 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -68.72 -43.54 75.77 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.465 1.029 . . . . 0.0 112.231 174.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.74 -42.56 73.77 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.395 -0.815 . . . . 0.0 111.263 -171.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -65.7 -29.54 70.1 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.705 1.202 . . . . 0.0 112.81 171.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.59 -38.77 77.46 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.678 -1.264 . . . . 0.0 112.421 170.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.56 -36.28 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 O-C-N 121.289 -0.882 . . . . 0.0 111.305 172.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -58.83 -44.74 90.96 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.315 -0.865 . . . . 0.0 111.293 171.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.3 mp -70.01 -35.88 74.7 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-O 117.225 -1.369 . . . . 0.0 113.293 173.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.19 -34.73 66.53 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 121.284 1.856 . . . . 0.0 110.602 169.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.5 m -70.17 -38.89 75.53 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.709 0.803 . . . . 0.0 112.927 172.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.4 mm -74.42 -33.96 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 120.563 1.528 . . . . 0.0 111.507 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.9 t -66.13 -43.77 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 117.577 -1.201 . . . . 0.0 110.323 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -52.59 -43.01 65.05 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.666 1.575 . . . . 0.0 112.034 170.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.8 t -61.75 -31.08 71.24 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.317 0.647 . . . . 0.0 112.301 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -79.91 -36.49 36.35 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.993 1.317 . . . . 0.0 113.306 172.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 71.0 mt -66.27 -35.17 79.7 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.69 1.132 . . . . 0.0 111.685 175.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.4 mt -74.56 -35.21 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.417 1.087 . . . . 0.0 111.04 169.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.69 -38.33 50.69 Favored Glycine 0 C--N 1.339 0.724 0 C-N-CA 125.798 1.666 . . . . 0.0 114.99 -172.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.5 t -152.84 -26.52 0.15 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.82 4.66 42.21 Favored Glycine 0 N--CA 1.476 1.358 0 N-CA-C 116.512 1.365 . . . . 0.0 116.512 174.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.8 p -155.85 141.38 17.78 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.241 1.416 . . . . 0.0 111.131 176.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 80.4 t -93.74 144.09 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.247 1.419 . . . . 0.0 109.64 175.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -125.07 158.09 34.64 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.622 1.169 . . . . 0.0 110.302 171.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -56.9 -37.17 71.05 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.223 -0.923 . . . . 0.0 112.632 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -69.88 -19.07 63.44 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -77.11 -39.88 47.9 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.783 0.72 . . . . 0.0 111.91 171.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.2 mt -85.64 -27.45 25.4 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -173.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -57.82 -24.18 56.15 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 119.812 1.187 . . . . 0.0 113.58 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -83.58 -3.28 57.54 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.087 1.355 . . . . 0.0 114.122 175.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -118.6 -19.31 8.79 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.449 1.1 . . . . 0.0 113.561 -169.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -50.64 -64.09 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.062 0.945 . . . . 0.0 110.995 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 62.58 -13.4 0.07 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 128.265 2.626 . . . . 0.0 116.953 170.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -142.89 -31.47 0.5 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.707 1.603 . . . . 0.0 112.502 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.28 158.65 15.48 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.62 -53.49 13.52 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.218 1.407 . . . . 0.0 110.65 169.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -131.47 132.03 43.96 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.438 0.695 . . . . 0.0 111.495 -170.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.08 147.41 31.24 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.212 -0.93 . . . . 0.0 110.924 169.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.3 t -138.43 141.18 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.266 1.427 . . . . 0.0 110.848 -171.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.35 131.18 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.998 1.319 . . . . 0.0 113.828 -171.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -130.72 76.43 1.72 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.967 1.707 . . . . 0.0 109.481 169.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.4 mt -94.31 131.0 32.21 Favored Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 123.715 0.806 . . . . 0.0 108.985 172.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -64.64 136.78 51.41 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.195 1.93 . . . . 0.0 111.544 175.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.97 -0.99 87.9 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.704 1.145 . . . . 0.0 115.851 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -138.32 156.56 73.53 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-N 119.322 1.561 . . . . 0.0 112.582 175.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.19 153.57 66.83 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.811 2.341 . . . . 0.0 113.064 -174.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.1 p -59.2 132.93 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.254 1.022 . . . . 0.0 111.531 172.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 95.5 t -111.32 141.64 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.492 1.517 . . . . 0.0 109.194 170.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -134.84 119.67 18.4 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.215 1.406 . . . . 0.0 109.428 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.2 t -94.87 155.24 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.287 1.835 . . . . 0.0 111.353 -174.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.67 -95.22 0.99 Allowed Glycine 0 CA--C 1.53 1.023 0 O-C-N 121.151 -0.968 . . . . 0.0 112.836 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.6 m -153.0 152.81 31.81 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.537 -0.978 . . . . 0.0 110.26 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -67.19 130.07 93.73 Favored Pre-proline 0 CA--C 1.547 0.865 0 O-C-N 120.72 -1.238 . . . . 0.0 110.883 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.458 ' CB ' HG11 ' A' ' 71' ' ' VAL . 73.1 Cg_endo -79.54 158.77 25.46 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.179 3.253 . . . . 0.0 114.621 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.7 t -88.49 -34.02 17.6 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -169.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.15 -36.57 1.86 Allowed Glycine 0 N--CA 1.477 1.411 0 C-N-CA 125.153 1.358 . . . . 0.0 112.355 -174.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -78.43 63.07 3.2 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.236 1.414 . . . . 0.0 110.522 169.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.458 HG11 ' CB ' ' A' ' 67' ' ' PRO . 30.4 m -139.84 154.36 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.648 1.579 . . . . 0.0 112.351 -176.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.4 mt -89.04 147.5 24.23 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 127.677 2.391 . . . . 0.0 109.128 170.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -127.09 116.95 21.48 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 118.672 0.669 . . . . 0.0 112.206 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.89 150.78 19.98 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.12 1.343 . . . . 0.0 110.001 169.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -156.11 137.04 13.54 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.573 1.686 . . . . 0.0 113.137 -171.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.61 161.98 37.8 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.033 1.333 . . . . 0.0 113.6 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 74.9 m -114.42 128.26 56.25 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.155 1.382 . . . . 0.0 108.319 172.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.08 176.91 44.2 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 122.033 0.796 . . . . 0.0 114.64 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -83.51 -9.56 58.89 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -169.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -102.3 5.91 40.19 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 120.733 1.606 . . . . 0.0 112.194 169.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.12 17.48 34.56 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.247 1.879 . . . . 0.0 114.362 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -83.93 173.22 11.38 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.19 1.796 . . . . 0.0 113.357 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.4 m -129.23 136.55 50.26 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.97 1.308 . . . . 0.0 110.25 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.2 t -119.29 139.7 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.023 1.729 . . . . 0.0 109.575 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.4 tt -132.84 149.11 52.29 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.467 1.107 . . . . 0.0 109.817 175.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 86.0 t -133.23 139.87 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.509 1.523 . . . . 0.0 109.397 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -131.74 137.73 48.34 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.988 0.899 . . . . 0.0 112.825 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -137.04 150.48 69.62 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 126.564 1.946 . . . . 0.0 111.031 -173.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -64.17 137.93 59.08 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.801 2.334 . . . . 0.0 112.582 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 125.92 1.688 . . . . 0.0 112.409 177.605 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.736 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.9 m -71.26 -29.63 65.32 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -174.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -44.43 132.31 6.1 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.757 1.623 . . . . 0.0 113.985 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.4 t -160.82 148.55 15.82 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.139 1.775 . . . . 0.0 110.531 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -144.2 156.61 44.38 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.987 2.115 . . . . 0.0 110.761 -174.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.9 t -144.49 144.3 31.29 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.668 1.187 . . . . 0.0 111.671 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 55.0 mt -81.38 138.82 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.909 0.884 . . . . 0.0 111.368 -170.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.3 m -76.34 42.62 0.28 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.045 1.738 . . . . 0.0 113.754 178.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.9 m -62.59 42.34 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 130.273 3.429 . . . . 0.0 117.213 -169.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.4 p -137.01 -64.6 0.57 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 127.372 2.269 . . . . 0.0 107.335 169.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.87 -47.26 60.23 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.045 1.338 . . . . 0.0 112.411 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -69.94 -26.43 64.12 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.475 0.71 . . . . 0.0 111.654 174.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -71.18 -54.09 12.22 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.059 -1.026 . . . . 0.0 111.554 173.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -28.46 69.31 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -171.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.3 m -60.4 -21.1 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 170.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -69.2 -45.56 69.62 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 119.466 1.03 . . . . 0.0 112.391 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 mp -70.0 -40.17 75.43 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.552 -0.718 . . . . 0.0 111.617 -170.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -65.02 -34.2 77.87 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.722 1.209 . . . . 0.0 112.519 170.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.92 -38.92 89.94 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 120.604 -1.31 . . . . 0.0 112.361 171.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 94.3 t -68.11 -37.82 78.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 O-C-N 121.294 -0.879 . . . . 0.0 111.533 172.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -59.53 -44.59 93.15 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.318 -0.864 . . . . 0.0 111.057 172.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.5 mp -69.52 -34.32 74.1 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 117.448 -1.263 . . . . 0.0 113.044 174.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.16 -34.44 68.44 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 121.172 1.805 . . . . 0.0 110.534 169.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.3 m -72.63 -38.65 67.66 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.353 1.061 . . . . 0.0 113.636 171.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.1 mm -72.79 -34.2 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 120.915 1.689 . . . . 0.0 110.97 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.2 t -67.18 -47.19 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.795 1.238 . . . . 0.0 109.63 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -53.11 -44.0 67.32 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 120.821 1.646 . . . . 0.0 111.976 170.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.2 m -59.97 -30.43 69.1 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.744 -0.598 . . . . 0.0 112.486 175.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.2 tpt180 -80.92 -35.22 32.7 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.685 1.594 . . . . 0.0 113.526 171.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.7 mt -66.11 -33.8 76.61 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.988 1.267 . . . . 0.0 111.588 174.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 90.7 mt -75.08 -35.69 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.791 1.236 . . . . 0.0 110.811 169.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.89 -38.05 49.7 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 125.5 1.524 . . . . 0.0 114.807 -172.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.1 t -152.58 -26.97 0.16 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.93 1.06 39.2 Favored Glycine 0 N--CA 1.477 1.43 0 N-CA-C 116.774 1.47 . . . . 0.0 116.774 174.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.9 m -147.8 139.0 23.52 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.098 1.759 . . . . 0.0 109.33 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.46 147.05 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.737 1.215 . . . . 0.0 109.955 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -132.32 157.42 44.5 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.782 1.233 . . . . 0.0 110.472 -174.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -55.66 -38.28 69.38 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.758 -0.589 . . . . 0.0 112.268 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -70.45 -20.18 62.91 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.794 1.238 . . . . 0.0 113.721 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -78.99 -41.81 28.11 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.833 0.742 . . . . 0.0 111.067 169.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.3 mt -81.67 -30.34 32.74 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -170.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -56.3 -26.91 53.75 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 173.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -84.18 -3.35 58.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.325 1.05 . . . . 0.0 113.723 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.6 mm-40 -120.71 -13.73 8.67 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.617 1.167 . . . . 0.0 113.535 -169.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.82 -60.81 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.405 0.682 . . . . 0.0 112.66 -176.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.259 21.7 mmt85 62.71 -19.33 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 128.148 2.579 . . . . 0.0 117.869 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -148.97 -33.9 0.21 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.843 1.257 . . . . 0.0 113.121 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.23 151.47 45.31 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.458 1.103 . . . . 0.0 111.582 174.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.06 -45.53 13.91 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.849 -0.532 . . . . 0.0 110.3 172.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -132.71 124.34 27.98 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.55 1.54 . . . . 0.0 109.169 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.13 142.63 29.57 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.443 1.02 . . . . 0.0 109.579 169.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 63.1 t -137.84 141.16 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.646 1.178 . . . . 0.0 109.476 -171.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -122.97 134.07 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -169.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -129.67 81.79 2.04 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.467 1.907 . . . . 0.0 109.631 170.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.5 mt -98.34 125.18 44.22 Favored Pre-proline 0 N--CA 1.48 1.063 0 C-N-CA 123.775 0.83 . . . . 0.0 108.979 169.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.87 133.4 53.51 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.384 2.056 . . . . 0.0 112.291 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.25 3.42 87.2 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-O 118.273 -1.293 . . . . 0.0 115.977 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -138.8 163.39 46.95 Favored Pre-proline 0 N--CA 1.475 0.78 0 CA-C-N 119.717 1.759 . . . . 0.0 114.075 173.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -60.62 140.78 92.86 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.579 2.853 . . . . 0.0 114.204 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.2 t -60.23 131.31 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.332 1.053 . . . . 0.0 110.024 169.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 70.1 t -110.38 141.41 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.095 1.358 . . . . 0.0 109.562 172.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -138.17 114.42 10.23 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.999 1.319 . . . . 0.0 109.191 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.3 t -89.97 155.53 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.941 1.696 . . . . 0.0 111.312 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.83 -102.83 1.58 Allowed Glycine 0 CA--C 1.532 1.107 0 O-C-N 121.343 -0.848 . . . . 0.0 112.736 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.3 m -146.12 150.05 35.18 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.516 1.126 . . . . 0.0 110.17 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -67.59 129.74 93.39 Favored Pre-proline 0 CA--C 1.548 0.898 0 O-C-N 120.861 -1.15 . . . . 0.0 111.002 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.413 ' CB ' HG11 ' A' ' 71' ' ' VAL . 73.8 Cg_endo -79.86 155.0 23.32 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.952 3.102 . . . . 0.0 114.314 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.4 HG23 ' H ' ' A' ' 70' ' ' ASP . 13.9 t -83.66 -26.95 29.44 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -171.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.25 -33.9 3.36 Favored Glycine 0 N--CA 1.476 1.32 0 C-N-CA 125.572 1.558 . . . . 0.0 112.64 -175.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.4 ' H ' HG23 ' A' ' 68' ' ' THR . 23.8 m-20 -79.18 60.23 2.98 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.775 1.63 . . . . 0.0 111.216 169.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.413 HG11 ' CB ' ' A' ' 67' ' ' PRO . 34.3 m -136.68 158.99 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 126.078 1.751 . . . . 0.0 112.29 -173.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.9 mt -99.77 126.96 45.93 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.854 2.462 . . . . 0.0 110.382 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -111.33 110.1 20.41 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -169.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.38 145.88 18.29 Favored Glycine 0 N--CA 1.471 0.998 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 169.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -154.46 137.4 15.44 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 120.145 1.972 . . . . 0.0 113.654 -169.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.26 163.65 34.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.56 1.144 . . . . 0.0 113.95 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 62.1 m -117.11 130.52 56.69 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.411 1.485 . . . . 0.0 108.578 172.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.31 174.7 37.08 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.092 0.853 . . . . 0.0 114.638 -177.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -81.45 -10.82 59.42 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 -169.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -99.61 5.49 45.91 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.714 1.597 . . . . 0.0 111.983 169.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.37 17.62 33.49 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 126.259 1.885 . . . . 0.0 114.268 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.3 pm0 -84.08 175.51 9.46 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.839 1.656 . . . . 0.0 113.459 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.5 m -133.2 133.88 43.34 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.073 1.349 . . . . 0.0 110.41 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 67.3 t -114.26 141.18 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.168 1.787 . . . . 0.0 110.029 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.7 tp -129.23 146.77 51.07 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.388 1.475 . . . . 0.0 109.524 174.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.6 t -124.4 137.7 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 127.596 2.358 . . . . 0.0 107.719 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -135.35 138.13 43.06 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.017 0.527 . . . . 0.0 111.724 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -148.83 154.25 39.97 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 172.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -59.82 137.64 77.84 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.779 2.319 . . . . 0.0 113.404 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 . . . . . 0 C--O 1.255 1.354 0 C-N-CA 125.888 1.675 . . . . 0.0 112.241 178.542 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 112.325 -0.31 . . . . 0.0 112.325 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.4 m -153.74 157.42 39.44 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.264 1.426 . . . . 0.0 112.076 174.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -64.38 159.23 21.66 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -174.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.4 m -59.54 145.09 45.48 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.822 1.649 . . . . 0.0 112.724 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 -77.2 127.81 33.27 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.162 0.985 . . . . 0.0 112.305 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.9 m -56.27 140.13 45.84 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.909 1.284 . . . . 0.0 111.888 176.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.1 mt -58.4 138.52 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.486 1.115 . . . . 0.0 109.959 178.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 t -83.69 37.33 0.58 Allowed 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 -169.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.0 m -66.58 47.25 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.839 2.456 . . . . 0.0 113.675 171.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.6 p -138.34 -64.15 0.53 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 128.896 2.878 . . . . 0.0 107.024 171.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.85 -47.77 50.68 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.974 1.31 . . . . 0.0 112.504 174.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.6 tp60 -68.81 -28.26 66.59 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.9 -1.125 . . . . 0.0 111.286 174.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -71.46 -51.28 24.63 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.738 -0.601 . . . . 0.0 111.325 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -37.15 79.78 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.057 -1.027 . . . . 0.0 111.822 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.9 t -58.24 -31.43 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.337 1.455 . . . . 0.0 113.085 173.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -71.12 -39.64 71.92 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.235 -0.916 . . . . 0.0 112.957 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -77.86 -36.31 50.01 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.271 -0.893 . . . . 0.0 111.918 -172.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -64.34 -28.0 69.4 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.337 -0.852 . . . . 0.0 112.705 170.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.68 -36.6 84.11 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.608 -1.307 . . . . 0.0 111.981 170.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.3 t -71.33 -35.79 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.567 1.147 . . . . 0.0 111.174 173.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.2 tpp85 -60.82 -46.36 90.82 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.011 -1.055 . . . . 0.0 111.473 171.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.3 mp -69.76 -33.25 72.16 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 117.352 -1.308 . . . . 0.0 112.418 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.58 -33.05 69.53 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 121.269 1.849 . . . . 0.0 110.785 169.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.3 m -73.79 -38.61 64.58 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.303 1.041 . . . . 0.0 113.33 171.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.7 mm -73.31 -36.7 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 121.072 1.76 . . . . 0.0 110.84 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.6 t -62.2 -49.93 82.03 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 CA-C-O 117.558 -1.21 . . . . 0.0 109.466 173.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -54.05 -43.52 70.28 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 120.803 1.638 . . . . 0.0 112.377 173.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.0 m -59.33 -36.84 76.41 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.756 -0.59 . . . . 0.0 111.912 176.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -74.55 -36.49 63.11 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.36 1.464 . . . . 0.0 113.271 172.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.2 mt -67.27 -30.57 70.48 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.864 1.211 . . . . 0.0 112.034 175.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.4 mt -76.05 -37.31 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.869 1.268 . . . . 0.0 110.936 169.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.58 -39.52 55.95 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.383 1.468 . . . . 0.0 114.456 -173.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.8 t -148.83 -27.61 0.3 Allowed 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.69 14.23 35.3 Favored Glycine 0 N--CA 1.479 1.535 0 N-CA-C 116.061 1.184 . . . . 0.0 116.061 175.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.1 m -156.67 145.83 20.36 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.945 1.698 . . . . 0.0 109.694 172.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.0 p -120.69 143.64 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.521 1.528 . . . . 0.0 110.359 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -128.8 156.25 43.88 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.371 1.068 . . . . 0.0 111.395 -169.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -54.2 -39.09 66.36 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.671 -0.643 . . . . 0.0 112.299 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -71.1 -21.07 62.27 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.246 1.418 . . . . 0.0 113.638 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -80.98 -37.23 29.62 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.869 0.759 . . . . 0.0 111.39 169.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.6 mt -82.16 -32.3 30.06 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.984 1.314 . . . . 0.0 113.733 -171.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -58.31 -22.94 54.93 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 173.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -85.11 -1.14 56.53 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.556 1.142 . . . . 0.0 113.913 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -116.56 -21.28 9.24 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.841 1.257 . . . . 0.0 112.998 -174.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -53.53 -62.0 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.623 0.769 . . . . 0.0 111.781 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 64.42 -12.4 0.11 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.648 2.379 . . . . 0.0 117.114 170.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -151.94 -31.37 0.15 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.278 1.031 . . . . 0.0 112.491 171.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.37 154.89 32.32 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.6 -56.57 5.61 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.023 1.329 . . . . 0.0 111.571 171.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -126.99 131.36 51.06 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.147 0.579 . . . . 0.0 112.501 -169.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.29 144.47 37.38 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.394 -0.816 . . . . 0.0 109.637 169.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.0 t -139.85 138.72 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.264 1.026 . . . . 0.0 110.389 -169.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.448 HD13 ' HA ' ' A' ' 53' ' ' ILE . 0.4 OUTLIER -119.29 132.93 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -169.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -130.02 83.31 2.12 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.977 1.711 . . . . 0.0 109.45 172.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.5 mt -100.18 132.12 23.13 Favored Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 124.048 0.939 . . . . 0.0 109.271 173.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.52 134.18 37.43 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.352 2.035 . . . . 0.0 111.658 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.48 0.24 82.41 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.774 1.178 . . . . 0.0 115.565 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -135.31 158.12 75.23 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 119.027 1.414 . . . . 0.0 112.087 172.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.2 155.74 66.88 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.621 2.214 . . . . 0.0 112.786 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.2 p -57.66 139.82 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.637 1.175 . . . . 0.0 111.588 171.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 85.1 t -119.24 139.26 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.466 1.507 . . . . 0.0 108.806 172.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -133.5 121.82 22.73 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.001 1.32 . . . . 0.0 109.564 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.8 t -95.02 151.93 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.618 1.567 . . . . 0.0 111.116 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.17 -102.62 2.3 Favored Glycine 0 CA--C 1.533 1.213 0 O-C-N 121.462 -0.773 . . . . 0.0 112.522 172.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 94.5 m -143.97 141.65 30.3 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.599 1.159 . . . . 0.0 109.896 174.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -65.45 125.9 90.45 Favored Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 120.73 -1.231 . . . . 0.0 111.127 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.437 ' CB ' HG11 ' A' ' 71' ' ' VAL . 60.5 Cg_endo -76.63 153.57 34.34 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.712 2.942 . . . . 0.0 114.911 -172.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 70' ' ' ASP . 11.3 t -82.22 -24.0 35.1 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -169.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.64 -35.05 3.71 Favored Glycine 0 N--CA 1.478 1.487 0 C-N-CA 125.394 1.473 . . . . 0.0 112.618 -174.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.411 ' H ' HG23 ' A' ' 68' ' ' THR . 18.9 m-20 -77.9 59.56 2.13 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.027 1.731 . . . . 0.0 110.672 169.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.437 HG11 ' CB ' ' A' ' 67' ' ' PRO . 28.0 m -135.55 157.29 39.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 126.292 1.837 . . . . 0.0 112.046 -173.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.6 mt -90.78 144.65 25.5 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.704 1.602 . . . . 0.0 109.125 170.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -125.49 122.13 35.73 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.532 0.733 . . . . 0.0 112.102 -177.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.42 148.08 16.44 Favored Glycine 0 N--CA 1.47 0.942 0 C-N-CA 126.033 1.778 . . . . 0.0 109.563 169.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -152.42 141.55 21.34 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.094 1.447 . . . . 0.0 112.876 -169.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.75 162.03 40.03 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.015 1.326 . . . . 0.0 113.228 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 70.1 m -113.11 127.44 56.2 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.951 1.301 . . . . 0.0 108.697 171.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.19 172.35 43.37 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.379 0.99 . . . . 0.0 114.06 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -82.93 -11.78 57.88 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 -169.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -92.94 2.91 56.55 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.837 1.653 . . . . 0.0 111.848 169.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.86 14.68 39.14 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 126.735 2.112 . . . . 0.0 114.369 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.5 pm0 -81.89 173.76 11.94 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.861 1.665 . . . . 0.0 113.794 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.0 m -127.84 138.92 52.87 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.452 1.501 . . . . 0.0 110.348 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.4 t -121.52 139.29 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.425 1.49 . . . . 0.0 109.487 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.2 tp -126.78 148.08 49.95 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.48 1.512 . . . . 0.0 109.935 174.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.38 136.17 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.462 1.505 . . . . 0.0 108.203 174.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -130.19 131.74 45.73 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.845 0.831 . . . . 0.0 112.142 -177.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -126.14 151.54 72.05 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 126.264 1.825 . . . . 0.0 111.552 -178.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -61.11 136.15 63.18 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 122.655 2.237 . . . . 0.0 112.023 170.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 . . . . . 0 C--O 1.252 1.213 0 C-N-CA 125.211 1.404 . . . . 0.0 113.252 -177.597 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.762 0 N-CA-C 112.115 -0.394 . . . . 0.0 112.115 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.6 p -98.7 18.14 17.6 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.066 1.746 . . . . 0.0 114.106 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -152.92 167.64 28.45 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.08 1.752 . . . . 0.0 111.069 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.5 m -103.02 130.65 50.2 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.217 1.007 . . . . 0.0 110.9 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -56.5 -33.21 65.79 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.752 1.221 . . . . 0.0 114.047 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.3 t -113.33 175.53 5.41 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.002 1.721 . . . . 0.0 111.908 171.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.0 mt -117.05 136.67 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.668 1.587 . . . . 0.0 107.69 176.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 64.1 p -86.8 30.32 0.75 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -169.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 p -68.72 51.59 0.08 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 128.571 2.749 . . . . 0.0 114.163 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.7 p -137.55 -66.48 0.5 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 130.007 3.323 . . . . 0.0 106.561 169.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.15 -46.48 61.41 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.428 1.491 . . . . 0.0 113.048 174.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.6 tp60 -74.16 -19.23 60.63 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.687 0.795 . . . . 0.0 111.703 175.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -77.78 -49.05 15.14 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 120.79 -1.194 . . . . 0.0 112.162 172.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.62 -36.43 80.71 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 121.118 -0.989 . . . . 0.0 112.839 -174.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.9 m -60.07 -23.06 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 174.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -71.16 -39.95 71.59 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.217 0.917 . . . . 0.0 111.735 175.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.0 mt -71.84 -41.63 67.91 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.053 0.941 . . . . 0.0 111.541 -172.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -66.68 -33.24 75.2 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.88 0.872 . . . . 0.0 112.516 169.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.8 -37.88 89.02 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 120.28 1.4 . . . . 0.0 112.161 171.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.9 t -69.1 -37.78 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.193 0.997 . . . . 0.0 111.712 172.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -60.87 -43.44 98.42 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.004 -1.06 . . . . 0.0 111.336 172.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -69.79 -34.43 73.71 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 117.468 -1.254 . . . . 0.0 112.585 173.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.27 -33.05 68.99 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 121.175 1.807 . . . . 0.0 110.486 169.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.8 m -73.61 -38.89 64.94 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.401 1.08 . . . . 0.0 113.74 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.1 mm -72.47 -36.12 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 121.221 1.828 . . . . 0.0 110.626 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.413 HG21 HD11 ' A' ' 53' ' ' ILE . 94.7 t -64.66 -48.4 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 117.549 -1.215 . . . . 0.0 109.664 174.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -53.62 -44.27 69.37 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.836 1.653 . . . . 0.0 112.1 172.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.2 m -58.85 -34.48 71.62 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.786 -0.571 . . . . 0.0 112.113 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -77.78 -35.67 51.34 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.482 1.513 . . . . 0.0 113.63 172.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 56.0 mt -66.77 -33.05 74.77 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 120.127 1.33 . . . . 0.0 111.56 175.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 90.8 mt -72.75 -36.98 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 124.821 1.248 . . . . 0.0 110.672 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.2 -39.7 51.88 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.506 1.527 . . . . 0.0 114.673 -173.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.6 t -151.45 -27.25 0.19 Allowed 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.86 2.42 49.24 Favored Glycine 0 N--CA 1.48 1.629 0 N-CA-C 116.436 1.334 . . . . 0.0 116.436 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.9 m -143.81 136.5 27.19 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.254 1.821 . . . . 0.0 109.115 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 p -113.31 145.9 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.597 1.159 . . . . 0.0 110.216 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -132.92 157.4 45.2 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.634 1.174 . . . . 0.0 111.073 -170.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.55 -40.75 65.79 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.797 -0.565 . . . . 0.0 112.368 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.95 -17.82 62.05 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.394 1.078 . . . . 0.0 113.756 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -81.67 -36.86 28.29 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.032 0.833 . . . . 0.0 111.52 169.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 64.3 mt -85.68 -31.75 22.34 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.742 1.617 . . . . 0.0 114.374 -171.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -60.66 -19.17 57.61 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -85.62 -5.29 59.29 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.06 1.344 . . . . 0.0 114.131 173.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -116.1 -18.2 10.67 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.719 1.208 . . . . 0.0 113.482 -169.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -51.01 -57.05 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.004 0.922 . . . . 0.0 113.008 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.28 20.9 mmt85 62.6 -15.02 0.06 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 118.824 2.898 . . . . 0.0 118.824 175.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -155.52 -28.15 0.1 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.787 0.835 . . . . 0.0 113.023 173.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.61 159.44 29.21 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -82.13 -49.69 9.88 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.967 0.907 . . . . 0.0 111.853 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -129.04 130.89 47.16 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.649 1.58 . . . . 0.0 111.44 -173.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -106.02 142.73 35.23 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.48 -0.762 . . . . 0.0 109.442 169.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.5 t -138.14 139.54 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.492 1.117 . . . . 0.0 110.354 -170.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.413 HD11 HG21 ' A' ' 26' ' ' VAL . 0.8 OUTLIER -120.58 133.24 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -169.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.6 mmt85 -132.58 79.06 1.83 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.884 1.674 . . . . 0.0 109.664 171.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.5 mt -96.37 132.16 27.11 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 124.188 0.995 . . . . 0.0 109.329 172.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.59 131.02 26.49 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.174 1.916 . . . . 0.0 111.499 175.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.2 2.6 80.11 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 116.201 1.241 . . . . 0.0 116.201 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -137.99 155.83 74.4 Favored Pre-proline 0 N--CA 1.475 0.81 0 CA-C-N 119.246 1.523 . . . . 0.0 111.907 172.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.91 151.41 78.14 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.682 2.255 . . . . 0.0 113.044 -173.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 p -59.15 131.67 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.403 1.081 . . . . 0.0 111.249 172.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.3 t -109.53 138.25 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.313 1.445 . . . . 0.0 109.099 170.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -132.72 116.3 16.43 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.247 1.419 . . . . 0.0 108.804 176.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.6 t -93.12 152.02 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.439 1.495 . . . . 0.0 111.186 -175.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.25 -97.44 1.42 Allowed Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.694 -0.629 . . . . 0.0 111.558 176.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.2 m -146.53 149.7 34.11 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.42 1.088 . . . . 0.0 109.604 177.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.2 tttp -70.47 127.33 92.15 Favored Pre-proline 0 CA--C 1.547 0.84 0 O-C-N 120.628 -1.295 . . . . 0.0 110.485 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.64 154.83 39.82 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 124.026 3.151 . . . . 0.0 114.739 -173.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.1 t -83.19 -23.25 32.93 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -169.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.37 -35.45 3.61 Favored Glycine 0 N--CA 1.475 1.261 0 C-N-CA 125.545 1.545 . . . . 0.0 113.026 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -78.43 59.25 2.33 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.87 1.668 . . . . 0.0 111.267 169.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.0 m -132.93 158.2 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.949 1.7 . . . . 0.0 112.299 -174.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.4 mt -89.73 144.04 26.31 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 126.505 1.922 . . . . 0.0 109.425 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -123.29 114.03 19.68 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.074 0.549 . . . . 0.0 112.376 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.31 144.16 17.13 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 169.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -153.73 138.31 16.88 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 120.504 2.152 . . . . 0.0 113.559 -169.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.05 166.26 26.63 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.022 1.329 . . . . 0.0 113.782 -176.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.0 m -120.03 130.56 54.77 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.62 1.568 . . . . 0.0 108.454 173.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.93 177.29 39.94 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.11 0.862 . . . . 0.0 114.346 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -84.36 -14.09 50.49 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -169.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -93.76 4.52 53.81 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.871 1.669 . . . . 0.0 112.124 169.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.92 15.98 43.37 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.583 2.039 . . . . 0.0 114.106 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.9 pm0 -79.8 172.64 13.51 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.522 1.529 . . . . 0.0 113.573 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.5 m -130.22 137.36 50.0 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.37 1.468 . . . . 0.0 109.834 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.3 t -120.28 138.01 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.731 1.612 . . . . 0.0 109.605 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 15.6 tp -128.35 149.47 50.5 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.33 1.452 . . . . 0.0 109.539 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 75.2 t -132.09 133.73 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.246 1.818 . . . . 0.0 107.871 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -133.69 137.46 45.32 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.226 0.536 . . . . 0.0 112.395 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -151.95 155.03 33.41 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 123.835 0.854 . . . . 0.0 112.624 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -60.14 138.82 84.0 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.118 2.546 . . . . 0.0 113.906 -173.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 . . . . . 0 C--O 1.252 1.204 0 C-N-CA 126.162 1.785 . . . . 0.0 112.746 -178.598 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.4 t -150.07 149.61 30.55 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.184 1.393 . . . . 0.0 111.398 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -135.64 146.78 48.2 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.557 1.543 . . . . 0.0 111.656 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.2 m -52.11 136.86 28.93 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.089 1.356 . . . . 0.0 112.743 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -67.14 165.48 15.88 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.828 1.651 . . . . 0.0 114.251 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.6 m -66.02 148.74 51.34 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.763 1.225 . . . . 0.0 109.443 169.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.6 mt -133.19 140.14 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.495 1.118 . . . . 0.0 108.225 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.9 m -90.84 38.39 0.95 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -169.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 m -63.1 34.05 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 129.24 3.016 . . . . 0.0 117.512 -170.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.0 p -134.35 -63.66 0.71 Allowed 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 127.448 2.299 . . . . 0.0 107.719 169.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.95 -43.43 71.61 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.531 1.532 . . . . 0.0 112.934 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -77.84 -24.54 48.61 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.51 0.724 . . . . 0.0 111.799 173.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -71.79 -50.44 29.82 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 121.095 -1.003 . . . . 0.0 111.35 174.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -35.2 73.49 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 121.228 -0.92 . . . . 0.0 113.006 -174.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.6 m -62.96 -20.71 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -69.73 -45.4 68.24 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 119.196 0.907 . . . . 0.0 112.07 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.92 -42.68 72.98 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.319 -0.863 . . . . 0.0 111.623 -170.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -60.74 -35.8 77.29 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.504 1.122 . . . . 0.0 112.168 171.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.2 -39.94 74.89 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 120.887 -1.133 . . . . 0.0 112.67 174.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.3 t -63.85 -40.79 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.961 0.905 . . . . 0.0 110.946 172.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.4 tmm_? -63.41 -40.17 96.49 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.245 -0.91 . . . . 0.0 112.0 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 mp -63.24 -34.37 77.51 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 117.276 -1.345 . . . . 0.0 112.423 170.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.71 -32.57 67.53 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 121.173 1.806 . . . . 0.0 111.339 169.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.0 m -75.08 -35.08 61.84 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 170.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.1 mm -70.57 -36.48 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 119.929 1.24 . . . . 0.0 110.709 176.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.8 t -66.99 -46.43 84.83 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.419 0 C-N-CA 125.681 1.592 . . . . 0.0 110.402 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -52.53 -42.54 64.47 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.742 1.61 . . . . 0.0 111.847 170.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.7 m -61.0 -29.31 69.62 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 175.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -83.22 -33.9 26.0 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.862 1.665 . . . . 0.0 113.679 171.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.8 mt -66.06 -35.81 81.52 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 120.033 1.288 . . . . 0.0 111.568 173.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 88.6 mt -73.19 -35.42 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.502 1.121 . . . . 0.0 110.662 169.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.14 -38.6 54.57 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 125.596 1.57 . . . . 0.0 114.752 -172.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.1 t -154.48 -26.99 0.12 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.17 4.03 38.48 Favored Glycine 0 N--CA 1.479 1.556 0 N-CA-C 116.721 1.448 . . . . 0.0 116.721 175.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.9 p -158.21 140.5 14.27 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.42 1.488 . . . . 0.0 111.488 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 81.0 t -94.43 143.69 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.29 1.436 . . . . 0.0 110.556 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -124.43 157.46 35.13 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.018 1.327 . . . . 0.0 110.427 171.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -53.87 -38.35 64.63 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.394 -0.816 . . . . 0.0 112.734 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -66.97 -22.44 65.93 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.169 1.388 . . . . 0.0 113.676 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -78.12 -37.64 45.72 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.288 0.495 . . . . 0.0 111.943 171.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.2 mt -88.04 -27.73 21.82 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 -173.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.0 ptt85 -58.16 -27.53 63.9 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -88.81 5.91 41.43 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 173.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -128.08 -8.97 5.38 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 120.572 -1.33 . . . . 0.0 113.966 -170.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -53.01 -61.66 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.784 1.233 . . . . 0.0 112.091 174.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.269 23.7 mmt85 64.92 -17.22 0.09 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 117.82 2.526 . . . . 0.0 117.82 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -143.45 -28.23 0.54 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.591 1.157 . . . . 0.0 113.974 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.3 153.9 17.76 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.429 1.092 . . . . 0.0 113.805 -171.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.72 -53.55 21.43 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.271 1.028 . . . . 0.0 109.64 169.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -130.27 127.33 39.33 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.195 0.598 . . . . 0.0 111.812 -170.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -103.45 145.95 29.23 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.182 -0.949 . . . . 0.0 109.864 169.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.6 t -139.61 139.27 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 O-C-N 121.085 -1.009 . . . . 0.0 111.505 -170.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.2 mm -111.81 132.28 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.468 1.507 . . . . 0.0 113.519 -172.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.5 tpt85 -140.8 46.49 1.77 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.324 1.849 . . . . 0.0 110.423 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.2 mt -66.67 127.46 93.42 Favored Pre-proline 0 N--CA 1.481 1.083 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.054 170.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -58.63 135.41 67.19 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.978 2.452 . . . . 0.0 112.741 173.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.93 1.25 88.92 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-O 118.506 -1.163 . . . . 0.0 115.506 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -135.62 162.43 57.13 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 119.461 1.63 . . . . 0.0 113.921 173.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -61.92 142.85 94.53 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.603 2.869 . . . . 0.0 114.596 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.1 p -68.45 130.4 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.685 0.794 . . . . 0.0 110.285 169.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.8 p -123.39 147.31 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.036 1.334 . . . . 0.0 110.972 171.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -135.86 119.37 16.97 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.938 1.695 . . . . 0.0 108.948 -170.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 50.7 t -90.25 155.28 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 126.05 1.74 . . . . 0.0 111.701 -173.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.58 -88.95 1.03 Allowed Glycine 0 CA--C 1.533 1.192 0 O-C-N 121.429 -0.794 . . . . 0.0 112.761 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 85.3 m -154.25 154.2 33.04 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.164 1.386 . . . . 0.0 109.479 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -73.37 125.24 90.89 Favored Pre-proline 0 CA--C 1.547 0.839 0 O-C-N 120.561 -1.337 . . . . 0.0 110.779 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.84 155.19 43.68 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 124.036 3.157 . . . . 0.0 114.529 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.4 t -83.84 -27.98 28.35 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -169.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.73 -34.64 2.82 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 125.27 1.414 . . . . 0.0 113.36 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -79.1 60.48 2.99 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.877 1.671 . . . . 0.0 111.185 169.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.7 m -136.87 156.45 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.736 1.614 . . . . 0.0 112.525 -171.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 29.2 mt -94.36 133.55 37.81 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.309 2.243 . . . . 0.0 109.481 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -118.03 113.47 21.69 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -173.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -88.79 148.91 20.63 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.174 1.369 . . . . 0.0 110.616 169.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 68.5 mtt85 -145.92 159.38 43.3 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 119.23 1.515 . . . . 0.0 112.408 -175.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -164.82 167.23 19.01 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.499 1.12 . . . . 0.0 113.657 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.2 m -119.59 134.12 55.36 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.079 1.752 . . . . 0.0 108.002 169.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -97.49 177.73 32.25 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-O 122.025 0.792 . . . . 0.0 114.966 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -81.33 -12.13 59.12 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 -169.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -101.78 4.98 40.97 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 120.656 1.571 . . . . 0.0 112.099 169.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.03 17.13 33.23 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 126.214 1.864 . . . . 0.0 114.384 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.1 pm0 -78.61 173.14 12.74 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.704 1.602 . . . . 0.0 113.726 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 95.5 m -130.75 135.14 47.5 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.453 1.101 . . . . 0.0 109.366 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 74.5 t -120.17 143.79 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.491 1.516 . . . . 0.0 110.822 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.6 tp -134.08 151.15 51.27 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.853 1.661 . . . . 0.0 109.151 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.2 t -140.86 139.38 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.884 1.673 . . . . 0.0 108.154 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -134.11 134.89 42.78 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.69 0.757 . . . . 0.0 112.304 -176.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -129.81 147.23 64.59 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 126.033 1.733 . . . . 0.0 111.194 -176.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -61.06 133.07 45.05 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.428 2.085 . . . . 0.0 111.394 171.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 . . . . . 0 C--O 1.253 1.263 0 C-N-CA 124.741 1.217 . . . . 0.0 112.358 -179.962 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.767 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -77.56 165.44 24.31 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.929 1.292 . . . . 0.0 113.208 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.62 173.48 7.07 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.673 1.189 . . . . 0.0 113.687 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.8 p -65.37 152.4 43.94 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.311 1.044 . . . . 0.0 113.669 -175.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -114.41 -25.91 8.19 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.508 1.523 . . . . 0.0 113.696 177.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.2 t -93.5 -176.6 4.15 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.358 1.463 . . . . 0.0 112.24 175.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.7 mp -108.54 141.04 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.975 2.11 . . . . 0.0 108.916 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.4 t -52.89 145.95 11.69 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.478 0.711 . . . . 0.0 112.475 173.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.7 m -107.44 4.17 25.95 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.627 1.171 . . . . 0.0 113.462 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.6 p -120.1 -72.99 0.66 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.617 1.567 . . . . 0.0 110.524 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.12 -36.83 72.27 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.764 0.826 . . . . 0.0 112.511 -171.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.3 tp60 -85.8 -18.03 34.09 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.555 0.742 . . . . 0.0 112.029 175.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -80.94 -48.82 11.79 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.884 -1.135 . . . . 0.0 112.049 174.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.416 HH21 ' CD ' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -62.06 -36.9 83.03 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 120.91 -1.119 . . . . 0.0 112.787 -174.095 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.4 m -60.57 -24.37 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.434 0.693 . . . . 0.0 112.832 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -70.99 -38.7 72.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.122 0.874 . . . . 0.0 111.383 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.1 mt -71.63 -42.12 67.99 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.014 0.926 . . . . 0.0 111.717 -172.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.416 ' CD ' HH21 ' A' ' 14' ' ' ARG . 4.1 pt-20 -66.31 -32.61 74.12 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.091 0.956 . . . . 0.0 112.506 169.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.8 -37.78 88.76 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.749 -1.219 . . . . 0.0 112.299 170.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.8 t -69.63 -36.34 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.368 1.067 . . . . 0.0 111.748 172.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -60.37 -44.88 95.19 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.784 -1.197 . . . . 0.0 111.132 170.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.7 mp -67.55 -34.06 76.31 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-O 117.469 -1.253 . . . . 0.0 112.624 173.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.83 -34.56 69.81 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 121.167 1.803 . . . . 0.0 110.808 169.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.0 m -72.3 -38.32 68.76 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.177 0.991 . . . . 0.0 113.253 170.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.1 mm -72.91 -35.73 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 120.88 1.673 . . . . 0.0 111.112 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.0 t -66.73 -48.5 79.85 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.519 0 CA-C-O 117.387 -1.292 . . . . 0.0 109.221 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -53.25 -42.98 66.99 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 120.997 1.726 . . . . 0.0 112.273 171.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.6 m -60.52 -33.01 72.01 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.713 -0.617 . . . . 0.0 112.291 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -78.88 -35.11 44.18 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.669 1.587 . . . . 0.0 113.323 172.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.3 mt -66.46 -32.4 73.74 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.713 1.142 . . . . 0.0 111.723 174.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 92.2 mt -76.41 -35.92 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.908 1.283 . . . . 0.0 111.054 169.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.14 -38.57 46.92 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 125.474 1.511 . . . . 0.0 114.875 -172.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.5 t -151.34 -28.32 0.19 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 177.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.67 8.53 34.68 Favored Glycine 0 N--CA 1.475 1.278 0 N-CA-C 116.748 1.459 . . . . 0.0 116.748 174.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.2 m -157.14 145.25 19.31 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.55 1.54 . . . . 0.0 110.234 171.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.6 p -112.45 144.36 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.794 1.238 . . . . 0.0 110.634 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -129.68 159.9 35.03 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.023 1.329 . . . . 0.0 110.325 -173.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -52.97 -38.4 62.11 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -174.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -73.4 -15.73 61.35 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -87.33 -18.82 29.23 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.162 0.892 . . . . 0.0 112.617 171.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 76.5 mt -99.29 -32.49 11.16 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.91 1.684 . . . . 0.0 113.789 -176.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -61.19 -21.06 63.46 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 119.721 1.146 . . . . 0.0 114.082 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -83.77 -1.44 54.24 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.087 1.355 . . . . 0.0 113.558 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -118.41 -21.63 7.97 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.688 1.195 . . . . 0.0 113.611 -169.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -51.06 -59.65 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.09 0.956 . . . . 0.0 112.576 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 63.25 -19.7 0.05 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 118.098 2.629 . . . . 0.0 118.098 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -155.54 -26.07 0.11 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.66 160.81 23.64 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.866 0.867 . . . . 0.0 113.235 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.2 tpt85 -83.86 -48.35 10.12 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.768 0.827 . . . . 0.0 112.534 -177.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -130.69 135.31 47.71 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.919 1.688 . . . . 0.0 111.314 -174.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -113.77 142.47 46.01 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 119.201 0.91 . . . . 0.0 109.928 168.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.9 t -140.25 138.32 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.536 1.134 . . . . 0.0 110.009 -169.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 53' ' ' ILE . 0.4 OUTLIER -124.24 136.68 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -172.44 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -131.16 89.23 2.7 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.955 1.702 . . . . 0.0 109.084 169.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.8 mt -101.35 134.88 20.03 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 124.696 1.198 . . . . 0.0 109.507 173.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.19 132.15 32.98 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.172 1.914 . . . . 0.0 111.671 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.01 -0.93 79.75 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.8 1.191 . . . . 0.0 115.79 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -137.55 155.82 75.15 Favored Pre-proline 0 N--CA 1.476 0.827 0 CA-C-N 119.336 1.568 . . . . 0.0 112.276 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.27 148.62 68.62 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.724 2.283 . . . . 0.0 112.618 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.2 p -55.66 135.92 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.282 1.033 . . . . 0.0 111.243 170.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.69 145.81 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.781 1.232 . . . . 0.0 110.904 170.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -132.92 125.54 30.09 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.294 1.437 . . . . 0.0 110.059 -174.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.6 t -95.96 149.17 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.818 1.647 . . . . 0.0 110.382 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.03 -98.94 1.36 Allowed Glycine 0 CA--C 1.532 1.113 0 O-C-N 121.486 -0.759 . . . . 0.0 112.116 175.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.4 m -153.83 146.07 23.84 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.665 1.232 . . . . 0.0 110.832 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -68.31 125.22 91.36 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 121.049 -1.032 . . . . 0.0 111.444 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.511 ' HB2' HG11 ' A' ' 71' ' ' VAL . 95.8 Cg_endo -81.72 162.8 18.83 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.122 3.214 . . . . 0.0 115.053 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.6 t -102.85 -31.8 10.1 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 116.793 2.146 . . . . 0.0 116.793 -168.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.49 -29.93 1.17 Allowed Glycine 0 N--CA 1.478 1.464 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.0 p30 -85.46 55.97 3.75 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 122.557 1.17 . . . . 0.0 110.157 169.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.511 HG11 ' HB2' ' A' ' 67' ' ' PRO . 27.9 m -133.74 157.12 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.561 1.544 . . . . 0.0 111.195 -177.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 67.9 mt -87.88 153.08 21.6 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.707 2.003 . . . . 0.0 109.005 169.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -128.84 115.01 17.25 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.124 0.42 . . . . 0.0 111.26 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.83 141.27 15.46 Favored Glycine 0 N--CA 1.468 0.786 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 169.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -149.36 145.26 26.91 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 119.768 1.784 . . . . 0.0 112.953 -169.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.03 160.88 43.03 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.172 0.989 . . . . 0.0 113.521 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.6 m -113.36 125.95 54.83 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.099 1.36 . . . . 0.0 109.063 171.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.58 178.58 45.79 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.215 0.912 . . . . 0.0 115.001 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -84.21 -11.91 55.72 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 -169.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -96.93 3.39 52.11 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 120.573 1.533 . . . . 0.0 111.803 169.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.65 18.83 29.04 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 126.418 1.961 . . . . 0.0 114.379 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.8 pm0 -84.28 171.86 12.35 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.642 1.577 . . . . 0.0 114.558 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 90.9 m -125.7 133.27 52.19 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.962 1.305 . . . . 0.0 110.198 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.1 t -117.26 142.13 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.705 1.602 . . . . 0.0 109.805 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.5 tp -134.03 148.17 51.05 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.066 1.346 . . . . 0.0 110.878 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.4 t -134.12 135.76 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.92 2.088 . . . . 0.0 108.029 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -138.52 137.81 37.44 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.988 0.813 . . . . 0.0 112.958 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -153.17 153.96 30.22 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.215 1.006 . . . . 0.0 113.344 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -63.77 141.87 80.52 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.102 2.535 . . . . 0.0 114.452 -171.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 . . . . . 0 C--O 1.253 1.263 0 C-N-CA 127.109 2.163 . . . . 0.0 113.45 -173.755 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.897 0 N-CA-C 111.614 -0.595 . . . . 0.0 111.614 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.0 m 61.38 0.04 0.41 Allowed 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 118.37 2.73 . . . . 0.0 118.37 171.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -144.66 128.87 17.72 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.745 1.218 . . . . 0.0 111.594 -177.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.5 p -71.06 160.12 33.47 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.846 1.258 . . . . 0.0 113.36 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -115.82 -9.57 11.84 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -170.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.8 m 55.0 64.1 1.91 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.327 1.451 . . . . 0.0 112.085 -175.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.8 mt -129.02 140.52 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 126.733 2.013 . . . . 0.0 107.641 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.6 p -81.58 31.94 0.35 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 116.288 1.958 . . . . 0.0 116.288 -169.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.3 m -68.04 49.22 0.06 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 128.626 2.77 . . . . 0.0 114.89 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.4 p -139.19 -66.2 0.47 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 128.562 2.745 . . . . 0.0 106.965 169.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.48 -44.94 66.67 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.53 1.532 . . . . 0.0 112.942 175.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -76.78 -21.43 55.17 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.565 -0.709 . . . . 0.0 112.171 174.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -73.51 -50.52 21.06 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.01 -1.056 . . . . 0.0 111.662 173.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.46 -38.26 77.16 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 121.273 -0.892 . . . . 0.0 112.689 -173.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.7 m -61.19 -22.33 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 123.864 0.727 . . . . 0.0 112.711 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -68.85 -43.65 75.01 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 119.258 0.935 . . . . 0.0 112.369 175.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.66 -41.55 71.94 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.335 -0.853 . . . . 0.0 111.466 -171.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -64.34 -32.51 74.15 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.531 1.133 . . . . 0.0 112.519 171.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.19 -39.33 82.51 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.707 -1.246 . . . . 0.0 112.468 171.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.1 t -65.32 -41.12 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.783 0.833 . . . . 0.0 111.116 172.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -57.85 -42.01 83.55 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.42 -0.8 . . . . 0.0 111.844 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.46 -33.8 73.44 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 117.583 -1.198 . . . . 0.0 113.31 173.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.97 -33.87 65.18 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 120.856 1.662 . . . . 0.0 111.24 169.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.6 m -73.06 -37.64 66.75 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 170.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.6 mm -72.05 -33.71 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 120.975 1.716 . . . . 0.0 110.792 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.406 HG21 HD11 ' A' ' 53' ' ' ILE . 93.4 t -69.25 -46.73 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.599 1.16 . . . . 0.0 109.748 175.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -53.44 -42.99 67.69 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.693 1.588 . . . . 0.0 112.044 170.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.8 m -60.43 -29.81 69.23 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.779 -0.576 . . . . 0.0 112.27 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -82.2 -35.17 28.57 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.81 1.644 . . . . 0.0 113.514 172.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.7 mt -65.87 -34.92 79.26 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.897 1.226 . . . . 0.0 111.578 174.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 91.8 mt -73.75 -36.32 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.731 1.212 . . . . 0.0 110.828 169.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.08 -37.73 55.68 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 125.557 1.551 . . . . 0.0 114.682 -172.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.5 t -154.23 -26.96 0.13 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.4 9.46 35.95 Favored Glycine 0 N--CA 1.478 1.463 0 N-CA-C 116.565 1.386 . . . . 0.0 116.565 175.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.3 m -158.79 142.73 15.35 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.788 1.635 . . . . 0.0 110.095 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -107.38 146.73 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.733 1.213 . . . . 0.0 110.676 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -130.1 160.2 34.46 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.473 1.509 . . . . 0.0 109.965 -177.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -54.61 -37.5 65.66 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.647 -0.658 . . . . 0.0 112.724 -175.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -66.21 -21.87 66.32 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.706 1.202 . . . . 0.0 113.561 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -92.66 5.92 49.28 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.751 1.22 . . . . 0.0 112.964 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.5 mt -127.65 -26.49 2.97 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.7 ptt85 -62.83 -23.09 67.11 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 120.219 -1.55 . . . . 0.0 114.565 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.94 -5.09 57.09 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.686 1.594 . . . . 0.0 112.611 173.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -107.72 -22.89 12.31 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.263 1.825 . . . . 0.0 111.561 -169.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -53.15 -64.91 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.691 1.197 . . . . 0.0 111.36 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 64.8 -12.62 0.12 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.566 2.346 . . . . 0.0 116.686 171.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -153.15 -28.06 0.14 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.96 0.904 . . . . 0.0 112.977 176.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.61 154.27 23.84 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 175.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.02 -54.84 13.0 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.839 1.256 . . . . 0.0 110.557 169.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -131.69 133.26 44.67 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.195 0.598 . . . . 0.0 112.07 -170.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.46 141.72 39.9 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.535 -0.728 . . . . 0.0 109.587 169.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.9 t -137.55 141.68 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.655 1.182 . . . . 0.0 110.191 -171.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.406 HD11 HG21 ' A' ' 26' ' ' VAL . 0.8 OUTLIER -119.91 132.01 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -169.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -130.93 77.3 1.78 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.906 1.682 . . . . 0.0 109.857 171.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.4 mt -95.49 127.98 39.89 Favored Pre-proline 0 N--CA 1.478 0.97 0 O-C-N 121.262 -0.899 . . . . 0.0 109.159 171.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.91 134.17 58.45 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.46 2.107 . . . . 0.0 112.682 173.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.07 0.12 87.29 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 124.838 1.209 . . . . 0.0 116.017 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -137.1 157.21 74.93 Favored Pre-proline 0 CA--C 1.548 0.883 0 CA-C-N 119.232 1.516 . . . . 0.0 112.154 173.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -70.12 151.03 66.82 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.783 2.322 . . . . 0.0 113.057 -174.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.9 p -58.29 132.48 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.296 1.038 . . . . 0.0 111.467 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 86.6 t -110.94 142.01 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.593 1.557 . . . . 0.0 109.096 170.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -135.63 118.0 15.7 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.12 1.368 . . . . 0.0 109.115 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.7 t -92.57 153.7 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.286 1.834 . . . . 0.0 111.169 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.48 -101.71 1.42 Allowed Glycine 0 CA--C 1.533 1.157 0 O-C-N 121.321 -0.862 . . . . 0.0 112.472 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.4 m -144.29 147.89 34.11 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.388 1.075 . . . . 0.0 109.946 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -70.37 125.64 92.06 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 120.687 -1.258 . . . . 0.0 111.031 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.419 ' CB ' HG11 ' A' ' 71' ' ' VAL . 62.2 Cg_endo -77.42 155.15 32.11 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 124.052 3.168 . . . . 0.0 114.824 -174.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.5 t -85.19 -31.35 23.26 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -169.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 133.51 -36.74 2.09 Favored Glycine 0 N--CA 1.478 1.467 0 C-N-CA 125.05 1.309 . . . . 0.0 112.321 -173.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -78.8 63.13 3.47 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.464 1.506 . . . . 0.0 110.101 169.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.419 HG11 ' CB ' ' A' ' 67' ' ' PRO . 27.7 m -138.98 151.83 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.506 1.523 . . . . 0.0 111.976 -176.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.9 mt -85.78 141.39 29.71 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.952 2.101 . . . . 0.0 109.122 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -121.43 110.35 15.96 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.366 0.53 . . . . 0.0 112.129 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.14 143.16 17.25 Favored Glycine 0 N--CA 1.467 0.755 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 169.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -153.68 134.83 14.02 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.886 1.843 . . . . 0.0 113.003 -169.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -142.63 161.44 38.08 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.503 1.121 . . . . 0.0 113.704 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.5 m -112.45 127.98 56.19 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.853 1.261 . . . . 0.0 108.72 171.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.18 174.51 40.42 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.206 0.908 . . . . 0.0 114.986 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -79.88 -11.41 59.81 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 -169.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -101.07 4.88 42.65 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 120.744 1.611 . . . . 0.0 112.355 169.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.67 17.4 30.9 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 126.031 1.777 . . . . 0.0 114.355 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.2 pm0 -83.79 172.98 11.67 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.792 1.637 . . . . 0.0 113.791 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.6 m -126.86 131.43 51.19 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.27 1.428 . . . . 0.0 109.681 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.1 t -113.68 141.02 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.624 1.57 . . . . 0.0 110.067 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.6 tp -129.89 148.23 51.74 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.087 1.355 . . . . 0.0 109.864 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.8 t -133.37 136.79 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.08 1.752 . . . . 0.0 108.317 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -131.68 131.99 43.57 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.783 0.801 . . . . 0.0 111.934 -176.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -131.84 148.31 69.41 Favored Pre-proline 0 N--CA 1.473 0.691 0 C-N-CA 126.163 1.785 . . . . 0.0 111.065 -173.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -61.39 134.91 54.38 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.87 2.38 . . . . 0.0 112.529 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 125.744 1.618 . . . . 0.0 112.438 177.479 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.686 0 N-CA-C 112.205 -0.358 . . . . 0.0 112.205 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.9 t -84.22 166.91 17.14 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.499 1.119 . . . . 0.0 112.966 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.97 156.13 25.41 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.562 1.145 . . . . 0.0 112.75 173.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.1 m -163.71 119.98 1.7 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.407 1.483 . . . . 0.0 109.466 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -49.6 129.25 19.11 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.99 1.316 . . . . 0.0 113.753 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.1 t -80.52 170.34 16.48 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.716 1.206 . . . . 0.0 113.549 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 68.3 mt -126.09 135.08 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 126.727 2.011 . . . . 0.0 108.583 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -124.3 138.36 54.39 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -169.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.1 m -62.43 24.52 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 128.628 2.771 . . . . 0.0 116.796 174.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.7 p -117.04 -64.53 1.3 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 127.821 2.448 . . . . 0.0 109.634 169.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.09 -35.03 66.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.447 1.099 . . . . 0.0 113.213 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -87.72 -16.99 32.71 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.692 -0.63 . . . . 0.0 112.246 174.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -79.75 -45.41 18.92 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.844 -1.16 . . . . 0.0 112.055 173.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -31.34 71.84 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -173.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.6 m -68.07 -21.46 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 172.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -71.17 -42.9 68.49 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 120.699 -1.251 . . . . 0.0 112.209 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.88 -39.1 76.49 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.386 -0.821 . . . . 0.0 111.301 -171.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.07 -28.83 65.75 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.721 1.208 . . . . 0.0 112.818 173.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.98 -39.76 87.26 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.764 -1.21 . . . . 0.0 111.381 169.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.4 t -67.92 -36.1 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.107 0.963 . . . . 0.0 111.538 174.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -59.26 -46.28 88.94 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.224 -0.923 . . . . 0.0 111.095 170.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.2 mp -69.07 -35.44 76.52 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 117.093 -1.432 . . . . 0.0 113.099 175.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.07 -38.69 68.38 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 121.066 1.757 . . . . 0.0 110.235 169.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.7 m -67.95 -38.82 83.26 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.152 0.981 . . . . 0.0 113.523 172.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.9 mm -72.35 -35.11 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 120.72 1.6 . . . . 0.0 110.748 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.2 t -68.82 -43.82 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.374 1.469 . . . . 0.0 110.235 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -56.54 -40.03 74.43 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 121.126 1.784 . . . . 0.0 112.34 169.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -62.79 -23.96 67.5 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 174.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -85.84 -36.86 19.75 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.295 1.838 . . . . 0.0 112.987 171.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.5 mt -68.92 -40.29 79.15 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 120.093 1.315 . . . . 0.0 111.984 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 86.2 mt -69.37 -32.18 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.457 1.503 . . . . 0.0 110.958 174.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.95 -75.34 0.77 Allowed Glycine 0 C--N 1.338 0.694 0 C-N-CA 125.36 1.457 . . . . 0.0 111.359 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.6 t -118.5 -26.73 6.12 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -170.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.61 0.74 46.41 Favored Glycine 0 N--CA 1.475 1.252 0 N-CA-C 116.972 1.549 . . . . 0.0 116.972 171.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.7 m -147.79 134.64 20.11 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.097 1.759 . . . . 0.0 109.956 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.5 p -104.86 147.92 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.04 1.336 . . . . 0.0 110.918 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -133.05 160.74 36.28 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.302 1.441 . . . . 0.0 110.702 -175.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -58.0 -37.7 74.74 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.745 -0.597 . . . . 0.0 111.899 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.73 -23.5 63.4 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.069 0.948 . . . . 0.0 113.187 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -77.79 -27.39 50.16 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.799 0.727 . . . . 0.0 112.16 174.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 72.3 mt -97.7 -28.1 14.05 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.587 1.555 . . . . 0.0 114.687 -173.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.2 ptt85 -62.03 -23.36 66.41 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 119.974 1.261 . . . . 0.0 113.702 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -88.23 5.97 39.08 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.314 1.446 . . . . 0.0 114.456 171.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -119.09 -15.04 9.29 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.947 1.249 . . . . 0.0 113.061 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -54.29 -59.01 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.74 0.816 . . . . 0.0 112.202 177.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.255 20.9 mmt85 65.53 -12.53 0.15 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 117.832 2.53 . . . . 0.0 117.832 174.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -164.56 -29.35 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.898 1.279 . . . . 0.0 112.602 169.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.22 153.09 43.43 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.057 0.943 . . . . 0.0 112.824 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -76.04 -53.36 8.47 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.159 0.583 . . . . 0.0 111.703 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -132.58 131.72 41.77 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.008 1.323 . . . . 0.0 111.742 -176.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -104.81 144.6 31.54 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 119.784 1.174 . . . . 0.0 110.659 169.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 37.4 t -140.8 141.18 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.445 1.098 . . . . 0.0 111.821 -169.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 mm -118.06 140.16 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.801 1.24 . . . . 0.0 114.13 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -139.89 72.69 1.4 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 128.098 2.559 . . . . 0.0 109.537 169.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.0 mt -91.73 127.77 48.83 Favored Pre-proline 0 N--CA 1.484 1.241 0 O-C-N 121.009 -1.057 . . . . 0.0 109.898 172.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -60.77 136.41 66.22 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.995 2.463 . . . . 0.0 112.9 171.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.23 2.11 89.34 Favored Glycine 0 CA--C 1.536 1.367 0 N-CA-C 115.912 1.125 . . . . 0.0 115.912 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -139.79 157.35 69.95 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 118.901 1.351 . . . . 0.0 111.877 174.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.01 143.78 73.62 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.426 2.084 . . . . 0.0 112.956 -176.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.57 135.5 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.256 1.422 . . . . 0.0 110.945 172.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.2 p -129.37 142.65 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.798 0.839 . . . . 0.0 111.891 171.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -140.11 123.47 16.98 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.409 1.083 . . . . 0.0 110.099 -173.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.5 t -95.5 155.2 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 127.015 2.126 . . . . 0.0 111.128 -172.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.26 -96.56 1.12 Allowed Glycine 0 CA--C 1.53 1.009 0 O-C-N 121.087 -1.008 . . . . 0.0 112.536 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.0 m -155.97 155.39 32.68 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.174 0.99 . . . . 0.0 110.211 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -68.96 132.17 90.55 Favored Pre-proline 0 CA--C 1.546 0.803 0 O-C-N 120.93 -1.106 . . . . 0.0 110.425 171.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.65 160.76 34.51 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 124.18 3.253 . . . . 0.0 114.121 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.6 t -85.7 -28.36 24.72 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -173.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.68 -32.83 3.24 Favored Glycine 0 N--CA 1.478 1.44 0 C-N-CA 125.644 1.592 . . . . 0.0 112.709 -176.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -77.44 60.2 2.02 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.403 1.881 . . . . 0.0 111.114 169.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.0 m -138.51 155.05 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.273 1.429 . . . . 0.0 113.177 -172.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.5 mt -91.03 142.4 27.81 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 128.029 2.532 . . . . 0.0 109.092 171.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -126.42 112.62 15.83 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.753 0.706 . . . . 0.0 111.311 -176.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.53 149.88 19.44 Favored Glycine 0 N--CA 1.469 0.871 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 169.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -147.19 148.56 31.63 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 118.656 1.228 . . . . 0.0 112.099 -169.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.3 166.33 33.76 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.412 1.085 . . . . 0.0 112.865 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.6 m -132.49 123.11 25.97 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.325 1.45 . . . . 0.0 109.634 172.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.62 176.43 42.44 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.0 1.286 . . . . 0.0 113.651 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -49.13 -45.0 42.97 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 126.347 1.859 . . . . 0.0 111.775 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -83.39 3.58 31.22 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 -170.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.65 25.38 13.6 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.666 0.651 . . . . 0.0 113.298 173.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.39 -166.01 1.49 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.656 1.182 . . . . 0.0 113.914 -174.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 16.6 m -147.39 120.27 8.72 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.318 -1.489 . . . . 0.0 111.611 173.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 37.1 t -96.64 142.25 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 126.246 1.819 . . . . 0.0 108.998 169.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.5 tp -129.91 146.74 51.62 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.356 1.463 . . . . 0.0 108.975 169.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 p -133.86 142.07 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.02 1.328 . . . . 0.0 109.663 172.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -137.08 134.39 36.44 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.162 0.506 . . . . 0.0 111.825 -170.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -131.72 152.8 81.0 Favored Pre-proline 0 N--CA 1.473 0.714 0 C-N-CA 124.954 1.301 . . . . 0.0 112.524 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -56.91 137.56 82.26 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 122.641 2.227 . . . . 0.0 112.933 170.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 . . . . . 0 C--O 1.252 1.223 0 C-N-CA 125.798 1.639 . . . . 0.0 112.279 177.522 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.799 0 N-CA-C 111.984 -0.446 . . . . 0.0 111.984 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.7 m -59.66 142.59 52.65 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.912 1.285 . . . . 0.0 113.902 -175.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.23 159.87 28.2 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -177.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.2 m -66.73 136.57 55.7 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.013 1.325 . . . . 0.0 112.271 -176.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -59.15 112.02 1.55 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.01 1.324 . . . . 0.0 110.495 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.8 m -143.82 135.82 26.52 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.618 1.567 . . . . 0.0 110.164 -169.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.6 mt -114.35 128.2 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.644 1.177 . . . . 0.0 110.697 176.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 27.0 m -54.52 140.39 34.78 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.641 1.976 . . . . 0.0 115.307 -173.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 m -70.92 56.38 0.19 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.678 1.991 . . . . 0.0 112.769 170.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -141.6 -59.51 0.48 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 128.432 2.693 . . . . 0.0 108.281 172.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.97 -41.4 51.5 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.663 1.585 . . . . 0.0 112.303 171.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -83.29 -15.49 49.95 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -77.99 -50.5 12.01 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.72 -1.237 . . . . 0.0 112.107 173.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -59.9 -32.44 70.76 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -172.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.3 m -64.94 -21.81 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 174.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -67.94 -43.22 79.6 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 120.878 -1.139 . . . . 0.0 112.837 176.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mp -70.62 -41.68 71.92 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.444 -0.785 . . . . 0.0 111.816 -171.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.15 -30.92 71.97 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.364 1.066 . . . . 0.0 112.64 172.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.41 -36.97 79.88 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.925 -1.109 . . . . 0.0 112.447 171.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.4 t -69.87 -36.23 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 124.175 0.99 . . . . 0.0 111.376 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -58.37 -46.07 87.02 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.314 -0.866 . . . . 0.0 111.23 171.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.1 mp -70.05 -34.13 72.83 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-O 117.321 -1.323 . . . . 0.0 113.195 173.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.18 -34.86 68.9 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 121.365 1.893 . . . . 0.0 110.586 169.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.1 m -71.23 -41.53 70.03 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.301 1.04 . . . . 0.0 112.806 171.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.4 mm -70.66 -35.08 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 120.623 1.556 . . . . 0.0 111.201 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.3 t -65.11 -47.44 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.026 1.33 . . . . 0.0 109.99 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -52.97 -42.64 65.71 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.607 1.549 . . . . 0.0 112.124 171.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.3 t -59.33 -38.12 79.51 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.788 -0.57 . . . . 0.0 111.95 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.404 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . 18.2 tpt180 -72.47 -37.25 68.52 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.47 1.108 . . . . 0.0 113.367 172.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.6 mt -67.31 -32.35 73.27 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.877 1.217 . . . . 0.0 112.182 176.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 89.8 mt -74.15 -37.86 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 124.523 1.129 . . . . 0.0 110.826 169.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.1 -38.58 54.89 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 125.862 1.696 . . . . 0.0 114.52 -172.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.1 t -150.17 -30.52 0.21 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.29 4.47 35.24 Favored Glycine 0 N--CA 1.475 1.283 0 N-CA-C 117.105 1.602 . . . . 0.0 117.105 176.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.8 p -152.92 141.57 20.92 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.45 1.5 . . . . 0.0 111.34 177.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.5 t -99.67 139.19 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.124 1.37 . . . . 0.0 110.383 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -123.07 155.08 37.62 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.918 1.287 . . . . 0.0 109.806 174.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -54.76 -38.3 67.04 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.296 -0.878 . . . . 0.0 113.317 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -67.38 -17.69 64.83 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.404 ' CE2' ' HB2' ' A' ' 29' ' ' ARG . 91.3 t80 -85.11 -22.26 28.96 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 118.539 -0.743 . . . . 0.0 112.648 171.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.1 mt -97.6 -31.37 12.34 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.34 1.427 . . . . 0.0 114.439 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -58.88 -24.28 62.01 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -93.76 7.54 44.48 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.101 1.361 . . . . 0.0 113.456 174.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -127.62 -16.05 4.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.681 1.592 . . . . 0.0 113.246 -174.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -50.27 -66.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.125 0.875 . . . . 0.0 110.906 169.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 64.19 -16.25 0.08 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 128.255 2.622 . . . . 0.0 117.025 174.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -147.24 1.98 0.75 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.632 1.173 . . . . 0.0 114.042 -174.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -136.41 150.6 48.86 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.457 1.503 . . . . 0.0 113.094 -172.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.66 -56.15 10.49 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.017 1.327 . . . . 0.0 111.77 174.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -130.64 126.89 37.77 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.296 0.638 . . . . 0.0 111.107 -170.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.71 148.69 27.15 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.98 -1.075 . . . . 0.0 110.127 169.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.2 t -141.0 140.81 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.897 1.279 . . . . 0.0 110.717 -171.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 53' ' ' ILE . 0.6 OUTLIER -118.55 133.44 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.986 1.314 . . . . 0.0 113.576 -170.051 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -131.88 79.61 1.88 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.738 1.615 . . . . 0.0 109.381 169.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.5 mt -96.91 123.65 52.78 Favored Pre-proline 0 N--CA 1.479 0.991 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 173.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.86 132.51 50.22 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.407 2.071 . . . . 0.0 112.501 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.53 2.57 87.09 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.906 1.241 . . . . 0.0 115.776 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -135.92 162.11 58.71 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-N 119.806 1.803 . . . . 0.0 114.084 171.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -62.94 143.64 91.64 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.481 2.787 . . . . 0.0 114.136 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 p -58.0 133.84 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.775 0.83 . . . . 0.0 110.631 169.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 71.4 t -114.01 141.71 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.765 1.226 . . . . 0.0 109.313 172.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -134.87 119.55 18.22 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.988 1.315 . . . . 0.0 109.554 177.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.4 t -90.39 152.51 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.366 1.466 . . . . 0.0 111.085 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.08 -105.48 2.24 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 121.368 -0.833 . . . . 0.0 112.621 170.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.8 m -145.02 148.87 34.21 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.544 1.137 . . . . 0.0 110.052 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -67.95 128.62 93.34 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 120.598 -1.314 . . . . 0.0 111.298 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.447 ' CB ' HG11 ' A' ' 71' ' ' VAL . 73.7 Cg_endo -80.18 152.94 21.42 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.264 3.309 . . . . 0.0 114.922 -177.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.7 t -82.9 -31.36 27.89 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -169.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.31 -35.03 2.42 Favored Glycine 0 N--CA 1.479 1.544 0 C-N-CA 125.246 1.403 . . . . 0.0 112.458 -174.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -79.44 61.14 3.4 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.306 1.442 . . . . 0.0 109.922 169.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.447 HG11 ' CB ' ' A' ' 67' ' ' PRO . 32.2 m -138.84 156.33 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.934 1.693 . . . . 0.0 111.398 -175.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.5 mt -91.72 138.61 31.42 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 127.734 2.414 . . . . 0.0 108.869 173.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -119.19 113.25 20.59 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.271 0.487 . . . . 0.0 111.741 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.68 144.68 17.47 Favored Glycine 0 N--CA 1.467 0.722 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 169.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -152.99 138.9 18.06 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.07 1.935 . . . . 0.0 112.853 -169.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.91 164.72 30.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.675 1.19 . . . . 0.0 114.043 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.3 m -119.74 125.21 48.07 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.223 1.409 . . . . 0.0 109.273 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.05 173.95 43.5 Favored Glycine 0 CA--C 1.54 1.653 0 C-N-CA 124.488 1.042 . . . . 0.0 115.26 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -81.59 -12.28 58.81 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -169.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -95.04 2.52 55.28 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 120.333 1.424 . . . . 0.0 112.161 169.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.93 15.03 46.99 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 126.783 2.135 . . . . 0.0 115.077 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 20.4 pm0 -78.68 172.4 13.76 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.992 1.717 . . . . 0.0 113.253 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.6 m -129.49 138.27 51.29 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.597 1.559 . . . . 0.0 110.342 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 88.6 t -122.52 140.27 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.471 1.508 . . . . 0.0 109.957 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.5 tp -128.79 148.35 50.86 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.181 1.392 . . . . 0.0 109.674 173.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.7 t -134.25 136.77 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.79 1.636 . . . . 0.0 108.275 176.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -131.01 129.98 42.75 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 122.031 0.919 . . . . 0.0 111.907 -176.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -130.44 142.25 44.79 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 126.661 1.984 . . . . 0.0 110.501 -171.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -61.89 133.67 45.91 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.435 2.09 . . . . 0.0 112.004 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 70.0 ttp85 . . . . . 0 C--O 1.252 1.211 0 C-N-CA 125.133 1.373 . . . . 0.0 112.33 -179.902 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.761 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.1 p -69.05 161.02 29.91 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.787 1.235 . . . . 0.0 114.295 -178.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -128.86 153.1 47.79 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.719 1.608 . . . . 0.0 112.238 -178.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 90.6 m -154.19 146.03 23.45 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.151 1.381 . . . . 0.0 110.669 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.51 136.55 38.34 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.812 1.245 . . . . 0.0 111.554 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.4 m -69.8 117.93 12.02 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.94 0.896 . . . . 0.0 110.328 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.5 mt -75.51 135.61 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-O 122.011 0.91 . . . . 0.0 111.516 -169.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.1 m -89.07 41.84 1.05 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.096 1.759 . . . . 0.0 113.668 -175.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.1 m -62.42 32.64 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 129.472 3.109 . . . . 0.0 117.636 -170.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.3 p -132.16 -64.5 0.77 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.28 2.232 . . . . 0.0 107.633 169.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.28 -43.43 70.46 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.473 1.509 . . . . 0.0 113.291 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -77.63 -22.9 50.01 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.026 0.93 . . . . 0.0 112.129 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -71.8 -50.62 28.12 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.299 -0.876 . . . . 0.0 111.632 173.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -59.48 -37.9 79.44 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.755 0.822 . . . . 0.0 112.889 -172.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.9 m -60.46 -22.65 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.666 0.786 . . . . 0.0 112.027 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -65.39 -42.94 92.11 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.251 0.932 . . . . 0.0 112.13 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.1 mp -73.86 -41.15 62.63 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.315 -0.866 . . . . 0.0 111.404 -170.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -67.73 -29.19 68.37 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.202 1.001 . . . . 0.0 112.799 171.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.06 -37.76 84.6 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 120.607 -1.308 . . . . 0.0 112.292 169.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.6 t -69.01 -36.15 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.002 0.921 . . . . 0.0 111.417 172.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -60.24 -44.57 95.12 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.12 -0.987 . . . . 0.0 111.421 171.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.0 mp -69.97 -34.18 73.04 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-O 117.343 -1.313 . . . . 0.0 112.673 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.434 ' HA ' HG21 ' A' ' 84' ' ' VAL . . . -57.95 -33.44 68.83 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 121.144 1.793 . . . . 0.0 110.883 169.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.1 m -72.25 -38.66 68.85 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.27 1.028 . . . . 0.0 113.432 171.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -74.11 -34.86 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 120.99 1.723 . . . . 0.0 111.073 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.471 HG21 HD11 ' A' ' 53' ' ' ILE . 97.5 t -64.86 -48.3 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.83 1.252 . . . . 0.0 109.62 173.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -54.12 -43.49 70.53 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.764 1.62 . . . . 0.0 112.086 172.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.2 m -59.45 -31.48 69.35 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.636 -0.665 . . . . 0.0 112.407 175.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -80.19 -35.19 36.74 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.715 1.606 . . . . 0.0 113.381 172.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 67.1 mt -66.59 -33.5 75.79 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 120.058 1.299 . . . . 0.0 111.643 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 91.1 mt -73.82 -36.46 46.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.904 1.281 . . . . 0.0 110.777 169.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.99 -38.72 55.62 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 125.632 1.587 . . . . 0.0 114.826 -173.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.2 t -152.5 -26.39 0.17 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.51 11.19 39.15 Favored Glycine 0 N--CA 1.48 1.581 0 N-CA-C 116.234 1.254 . . . . 0.0 116.234 175.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.8 m -157.69 143.4 17.27 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.886 1.674 . . . . 0.0 109.492 173.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.83 145.74 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.135 1.374 . . . . 0.0 109.858 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -130.49 158.77 39.01 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.723 1.209 . . . . 0.0 110.754 -172.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -56.11 -38.72 71.15 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.776 -0.577 . . . . 0.0 112.313 -177.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -70.96 -18.32 62.63 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -78.46 -38.28 41.52 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.211 0.914 . . . . 0.0 111.088 169.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 58.4 mt -87.35 -28.5 22.18 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -169.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -59.73 -21.14 60.28 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 172.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -83.56 -7.68 59.47 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.829 1.251 . . . . 0.0 114.032 174.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -115.46 -14.2 11.57 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.785 1.234 . . . . 0.0 113.302 -169.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -55.06 -58.73 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.486 0.714 . . . . 0.0 111.812 175.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.261 26.6 mmm180 64.2 -13.53 0.1 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 127.902 2.481 . . . . 0.0 117.659 172.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -159.89 -29.31 0.06 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.968 1.307 . . . . 0.0 113.168 169.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.38 159.17 33.7 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.325 1.05 . . . . 0.0 113.343 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -80.7 -54.04 5.98 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.535 0.734 . . . . 0.0 112.649 -176.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -130.34 133.98 46.84 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.533 1.533 . . . . 0.0 110.877 -174.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.78 141.75 40.33 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.137 -0.977 . . . . 0.0 109.79 169.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.6 t -136.62 142.39 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.526 1.13 . . . . 0.0 111.024 -173.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.471 HD11 HG21 ' A' ' 26' ' ' VAL . 0.6 OUTLIER -124.15 134.68 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.89 1.276 . . . . 0.0 114.226 -169.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -138.75 77.99 1.65 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.109 1.764 . . . . 0.0 109.679 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.0 mt -95.89 132.32 27.35 Favored Pre-proline 0 N--CA 1.478 0.947 0 C-N-CA 124.982 1.313 . . . . 0.0 109.523 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.1 134.66 37.58 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.196 1.931 . . . . 0.0 111.545 174.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.82 1.26 85.28 Favored Glycine 0 CA--C 1.536 1.36 0 N-CA-C 116.043 1.177 . . . . 0.0 116.043 177.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -138.78 156.9 72.64 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-N 119.073 1.437 . . . . 0.0 111.954 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.39 150.33 75.79 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.705 2.27 . . . . 0.0 112.969 -174.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 50.7 t -60.44 131.88 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.278 1.031 . . . . 0.0 110.358 173.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 72.4 t -112.62 140.25 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.454 1.502 . . . . 0.0 109.469 173.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -135.07 118.15 16.44 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.037 1.335 . . . . 0.0 109.421 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.7 t -94.62 151.77 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.881 1.672 . . . . 0.0 111.032 -177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.66 -93.5 1.03 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 121.283 -0.886 . . . . 0.0 112.317 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 m -154.74 152.58 30.06 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.669 -0.901 . . . . 0.0 110.463 175.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -69.17 129.4 92.02 Favored Pre-proline 0 CA--C 1.547 0.863 0 O-C-N 120.928 -1.108 . . . . 0.0 110.722 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.43 ' CB ' HG11 ' A' ' 71' ' ' VAL . 75.3 Cg_endo -78.6 158.71 28.63 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 124.3 3.333 . . . . 0.0 114.602 -176.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.3 t -83.29 -25.19 31.8 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -171.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.59 -34.17 3.71 Favored Glycine 0 N--CA 1.478 1.442 0 C-N-CA 125.713 1.625 . . . . 0.0 112.804 -175.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -79.03 61.36 3.18 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.738 1.615 . . . . 0.0 111.261 169.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.43 HG11 ' CB ' ' A' ' 67' ' ' PRO . 29.9 m -136.93 158.95 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 126.343 1.857 . . . . 0.0 112.526 -173.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 27.9 mt -92.77 139.41 30.58 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.826 2.051 . . . . 0.0 108.799 172.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -127.55 113.56 16.28 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.101 0.961 . . . . 0.0 110.506 -175.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -97.75 145.4 17.79 Favored Glycine 0 N--CA 1.467 0.727 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -148.01 139.31 23.52 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.763 1.282 . . . . 0.0 112.682 -169.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.24 162.39 36.48 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.609 1.164 . . . . 0.0 113.181 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 74.5 m -114.16 124.65 52.59 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.19 1.396 . . . . 0.0 108.423 172.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.54 173.31 45.63 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-O 122.166 0.87 . . . . 0.0 114.424 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -79.63 -17.35 54.0 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -169.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -92.84 4.81 53.17 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.646 1.566 . . . . 0.0 112.543 169.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.37 16.96 32.93 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 126.136 1.827 . . . . 0.0 114.308 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.9 pm0 -82.92 171.55 13.75 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.471 1.508 . . . . 0.0 114.206 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.5 m -123.14 132.99 54.29 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.66 1.584 . . . . 0.0 109.203 175.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.434 HG21 ' HA ' ' A' ' 23' ' ' ALA . 17.4 t -127.51 140.68 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.629 1.171 . . . . 0.0 110.155 -176.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.5 tp -133.42 147.66 51.74 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.293 1.037 . . . . 0.0 110.76 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.09 143.28 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.816 1.246 . . . . 0.0 109.565 170.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -137.37 137.5 38.93 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -173.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -132.13 151.27 78.11 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 125.793 1.637 . . . . 0.0 112.432 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -58.68 135.86 70.09 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.405 2.07 . . . . 0.0 111.996 169.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 . . . . . 0 C--O 1.253 1.285 0 C-N-CA 124.938 1.295 . . . . 0.0 112.179 178.614 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.734 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.1 p -76.05 159.85 30.38 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.689 1.196 . . . . 0.0 113.103 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -147.74 149.07 31.71 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.954 1.302 . . . . 0.0 111.845 -177.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.7 m -59.4 150.63 25.87 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.518 1.527 . . . . 0.0 112.834 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -101.21 -28.2 12.79 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -176.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.9 m -78.85 128.2 33.03 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.978 1.311 . . . . 0.0 110.958 -176.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.3 mm -93.72 146.8 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.582 1.153 . . . . 0.0 110.504 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.5 m -75.75 34.83 0.12 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.004 1.722 . . . . 0.0 115.625 -172.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.4 m -70.17 51.71 0.12 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 128.269 2.628 . . . . 0.0 115.009 -173.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -140.09 -68.67 0.41 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 128.437 2.695 . . . . 0.0 106.939 169.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.75 -43.74 68.22 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.623 1.569 . . . . 0.0 112.677 176.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -77.41 -21.11 53.61 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.637 -0.665 . . . . 0.0 112.33 175.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -73.72 -51.12 17.62 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 121.166 -0.959 . . . . 0.0 111.583 173.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -37.98 77.68 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 121.294 -0.879 . . . . 0.0 112.732 -173.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 m -62.52 -21.74 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -70.44 -44.06 68.63 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 119.132 0.878 . . . . 0.0 112.146 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.57 -42.26 71.33 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.083 -1.011 . . . . 0.0 111.367 -172.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -63.27 -32.73 74.22 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.395 1.078 . . . . 0.0 112.449 171.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.09 84.04 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.752 -1.217 . . . . 0.0 112.308 171.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.6 t -64.79 -40.33 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.802 0.841 . . . . 0.0 111.071 174.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -57.07 -44.72 83.34 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.536 -0.728 . . . . 0.0 112.145 171.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.9 mp -68.45 -33.91 75.02 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 116.871 -1.538 . . . . 0.0 112.943 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.11 -39.53 69.46 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 121.252 1.842 . . . . 0.0 110.308 169.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.6 m -70.09 -38.25 75.64 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 172.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.9 mm -70.42 -34.21 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 121.181 1.81 . . . . 0.0 110.813 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.2 t -66.57 -48.51 80.17 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 C-N-CA 124.945 1.298 . . . . 0.0 110.092 173.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -54.86 -39.52 68.72 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 121.408 1.913 . . . . 0.0 112.802 171.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.4 m -61.84 -29.08 69.93 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.984 0.514 . . . . 0.0 112.066 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -82.68 -36.78 25.61 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.063 1.745 . . . . 0.0 113.438 171.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.61 -34.2 77.35 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.055 1.298 . . . . 0.0 111.566 175.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 92.0 mt -76.56 -36.7 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 124.618 1.167 . . . . 0.0 110.714 169.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.36 -37.85 53.63 Favored Glycine 0 C--N 1.341 0.849 0 C-N-CA 125.822 1.677 . . . . 0.0 114.698 -171.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.2 t -148.66 -30.44 0.27 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 175.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.78 12.07 27.05 Favored Glycine 0 N--CA 1.473 1.141 0 N-CA-C 116.703 1.441 . . . . 0.0 116.703 174.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.4 m -157.84 143.2 16.93 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.364 1.466 . . . . 0.0 109.736 170.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.2 p -112.36 141.45 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.384 1.474 . . . . 0.0 110.616 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -131.74 159.79 37.42 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.535 1.534 . . . . 0.0 110.45 -172.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -56.2 -38.54 71.14 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.38 -0.825 . . . . 0.0 113.056 -175.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -69.87 -21.77 63.3 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -77.23 -35.52 55.42 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.476 0.58 . . . . 0.0 111.78 169.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 58.8 mt -86.61 -29.19 22.76 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -174.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -61.15 -22.72 64.96 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -91.97 -0.19 57.48 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.271 1.029 . . . . 0.0 113.457 172.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -117.03 -17.37 10.36 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.178 1.391 . . . . 0.0 113.496 -173.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -48.75 -57.33 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.892 0.877 . . . . 0.0 111.08 170.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 63.26 -15.22 0.07 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 128.053 2.541 . . . . 0.0 117.499 173.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -155.73 -25.4 0.11 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.27 156.34 23.16 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.345 1.058 . . . . 0.0 112.937 177.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.78 -57.81 5.08 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.857 1.263 . . . . 0.0 111.328 170.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -129.9 132.97 46.58 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.955 0.502 . . . . 0.0 112.324 -170.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -111.52 141.24 45.35 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.636 -0.665 . . . . 0.0 109.555 168.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.0 t -138.89 138.23 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.681 1.192 . . . . 0.0 109.339 -169.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 53' ' ' ILE . 0.3 OUTLIER -120.62 132.83 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -169.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -129.75 84.11 2.19 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.263 1.825 . . . . 0.0 109.254 173.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.1 mt -99.06 134.37 21.44 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 124.208 1.003 . . . . 0.0 108.85 173.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.36 136.35 43.13 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.238 1.959 . . . . 0.0 111.514 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.76 0.28 83.98 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.638 1.113 . . . . 0.0 115.702 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -136.15 157.99 74.58 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 118.95 1.375 . . . . 0.0 112.564 175.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.59 151.75 64.54 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.676 2.251 . . . . 0.0 113.285 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.3 p -54.86 140.87 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.408 1.483 . . . . 0.0 112.328 172.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 85.0 t -116.18 140.81 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 125.864 1.666 . . . . 0.0 108.76 170.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -134.67 119.5 18.38 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.721 1.208 . . . . 0.0 110.12 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.1 t -93.77 154.99 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.716 2.006 . . . . 0.0 110.963 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.81 -105.13 1.67 Allowed Glycine 0 CA--C 1.533 1.203 0 O-C-N 121.216 -0.927 . . . . 0.0 111.521 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.2 t -153.87 161.04 42.35 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.033 0.917 . . . . 0.0 112.089 169.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -71.89 126.38 91.39 Favored Pre-proline 0 CA--C 1.548 0.878 0 O-C-N 120.902 -1.123 . . . . 0.0 111.85 -171.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.444 ' CB ' HG11 ' A' ' 71' ' ' VAL . 73.6 Cg_endo -79.54 155.68 24.6 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 124.069 3.18 . . . . 0.0 114.856 -175.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.431 HG23 ' H ' ' A' ' 70' ' ' ASP . 7.2 t -83.51 -20.46 33.89 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 115.81 1.781 . . . . 0.0 115.81 -169.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.39 -30.5 6.2 Favored Glycine 0 N--CA 1.479 1.559 0 C-N-CA 125.361 1.457 . . . . 0.0 113.12 -173.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.431 ' H ' HG23 ' A' ' 68' ' ' THR . 20.6 m-20 -82.13 60.11 4.75 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.424 1.489 . . . . 0.0 109.351 168.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.444 HG11 ' CB ' ' A' ' 67' ' ' PRO . 34.4 m -140.94 152.98 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 126.458 1.903 . . . . 0.0 110.381 -175.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.7 mt -79.59 146.43 32.57 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.023 1.729 . . . . 0.0 108.942 169.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -126.75 106.39 9.34 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.877 0.762 . . . . 0.0 109.979 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -88.82 149.4 20.93 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 169.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 33.2 ttt-85 -148.07 143.69 27.36 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.217 1.509 . . . . 0.0 112.013 -170.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -152.66 167.72 27.98 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.373 1.069 . . . . 0.0 113.251 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.0 m -134.09 128.1 33.51 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.708 1.603 . . . . 0.0 109.601 171.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.42 -175.09 49.87 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.6 1.572 . . . . 0.0 114.934 177.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -58.74 -45.38 89.8 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.256 1.422 . . . . 0.0 112.107 177.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -77.71 2.57 16.43 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -172.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.26 23.0 28.11 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.0 1.286 . . . . 0.0 113.465 172.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.11 -163.15 0.95 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.266 1.426 . . . . 0.0 114.111 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.1 m -146.15 128.68 16.03 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.336 -1.478 . . . . 0.0 111.361 175.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.3 t -105.2 142.51 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 126.195 1.798 . . . . 0.0 109.208 169.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.8 tp -129.15 141.49 51.16 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.083 1.353 . . . . 0.0 109.382 169.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.18 136.81 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.524 1.53 . . . . 0.0 108.461 173.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -131.67 130.97 42.74 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.682 0.753 . . . . 0.0 112.048 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -133.54 142.36 43.66 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 125.066 1.346 . . . . 0.0 112.058 -169.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -59.24 130.41 35.96 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.184 2.59 . . . . 0.0 112.533 177.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 67.9 ttp85 . . . . . 0 C--O 1.253 1.258 0 C-N-CA 125.231 1.412 . . . . 0.0 112.356 178.458 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.775 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.6 m 52.18 63.42 2.25 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.777 1.631 . . . . 0.0 113.17 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -136.27 144.49 44.81 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.322 1.449 . . . . 0.0 112.331 -177.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.8 m -61.82 143.2 56.68 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.968 1.307 . . . . 0.0 113.39 -173.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -45.6 151.78 0.38 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.603 2.361 . . . . 0.0 114.618 173.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.8 t -143.24 150.0 38.71 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.36 1.464 . . . . 0.0 111.389 174.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.8 mt -133.64 139.28 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.375 1.87 . . . . 0.0 108.742 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 94.7 p -64.21 166.63 7.65 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -176.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.7 m -127.51 30.12 5.4 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.823 1.649 . . . . 0.0 111.234 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.2 p -133.61 -74.43 0.49 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.582 1.553 . . . . 0.0 109.325 -175.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.64 -46.19 66.76 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.333 1.053 . . . . 0.0 112.018 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -72.58 -23.03 60.9 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.852 -0.53 . . . . 0.0 112.324 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -74.92 -50.47 16.72 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.966 -1.084 . . . . 0.0 111.564 172.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.406 HH21 ' CD ' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -62.75 -35.93 81.37 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 117.556 -1.211 . . . . 0.0 113.068 -174.583 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.8 m -59.9 -25.66 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 119.002 0.819 . . . . 0.0 112.756 172.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -77.45 -35.56 53.83 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.554 0.615 . . . . 0.0 112.56 176.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.8 mt -69.25 -39.87 78.19 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.405 -0.809 . . . . 0.0 110.976 -175.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.406 ' CD ' HH21 ' A' ' 14' ' ' ARG . 6.0 pt-20 -68.23 -30.47 69.53 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.041 0.936 . . . . 0.0 112.688 169.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.65 -38.64 89.92 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 120.227 1.376 . . . . 0.0 112.098 170.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.4 t -67.95 -39.74 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.182 0.993 . . . . 0.0 111.429 172.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -58.79 -44.91 90.85 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.211 -0.931 . . . . 0.0 111.277 172.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.2 mp -68.79 -34.9 76.32 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-O 117.13 -1.414 . . . . 0.0 112.678 174.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.38 -34.17 68.58 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 121.504 1.956 . . . . 0.0 110.511 169.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.3 m -72.72 -40.21 66.33 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.256 1.022 . . . . 0.0 113.736 170.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.1 mm -67.8 -37.38 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 120.983 1.719 . . . . 0.0 110.799 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.443 HG13 HG21 ' A' ' 36' ' ' VAL . 57.2 t -64.46 -45.58 95.36 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.376 0 C-N-CA 125.326 1.45 . . . . 0.0 110.241 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -51.97 -42.72 63.15 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 120.683 1.583 . . . . 0.0 112.345 171.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 56.5 m -62.05 -31.33 71.73 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.416 -0.803 . . . . 0.0 112.541 175.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -77.92 -37.08 48.58 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.877 1.271 . . . . 0.0 113.181 172.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.8 mt -67.42 -32.84 73.99 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.833 1.197 . . . . 0.0 111.916 176.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.8 mt -73.6 -36.93 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.585 1.154 . . . . 0.0 110.708 169.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.98 -39.17 55.02 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 125.689 1.614 . . . . 0.0 114.689 -172.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.0 t -151.48 -27.05 0.19 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.92 3.86 54.64 Favored Glycine 0 N--CA 1.479 1.54 0 N-CA-C 116.127 1.211 . . . . 0.0 116.127 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.6 m -142.26 132.9 25.38 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.756 1.622 . . . . 0.0 109.874 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.443 HG21 HG13 ' A' ' 26' ' ' VAL . 89.9 t -97.21 140.34 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.5 0.72 . . . . 0.0 109.423 170.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -127.11 156.68 41.35 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.76 1.224 . . . . 0.0 110.611 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -55.74 -36.89 67.76 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 121.303 -0.873 . . . . 0.0 112.557 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -67.55 -21.91 65.43 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.152 1.381 . . . . 0.0 113.73 177.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -78.44 -37.49 43.58 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.395 0.543 . . . . 0.0 111.863 171.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 18.9 mt -88.92 -30.29 18.95 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -172.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -55.89 -27.82 53.78 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -89.3 2.95 53.61 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.928 1.291 . . . . 0.0 114.382 176.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -121.6 -13.81 8.29 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.782 1.233 . . . . 0.0 113.446 -172.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -56.0 -49.29 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -174.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.499 0.0 OUTLIER 67.18 -18.54 0.13 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 129.535 3.134 . . . . 0.0 118.216 178.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -160.0 -43.66 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.022 1.329 . . . . 0.0 110.226 169.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.501 ' HB1' HG13 ' A' ' 86' ' ' VAL . . . -41.45 112.63 0.33 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.287 2.235 . . . . 0.0 111.579 177.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -63.56 -42.18 98.36 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 121.712 -0.617 . . . . 0.0 111.341 -172.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -130.97 120.95 24.27 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.121 1.768 . . . . 0.0 109.262 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.32 143.68 27.84 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.05 -1.032 . . . . 0.0 109.037 168.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.0 t -139.01 139.41 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.15 0.98 . . . . 0.0 110.774 -169.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 mm -114.02 134.03 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.541 1.536 . . . . 0.0 113.815 -169.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -133.67 70.96 1.45 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.232 1.813 . . . . 0.0 109.547 169.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 33.9 mt -88.08 128.93 51.91 Favored Pre-proline 0 N--CA 1.478 0.97 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.36 134.13 35.0 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.193 1.929 . . . . 0.0 111.287 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.92 3.3 85.68 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 118.533 -1.148 . . . . 0.0 115.962 176.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -137.49 162.9 52.29 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 119.539 1.669 . . . . 0.0 113.944 173.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -59.38 141.52 97.73 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.524 2.816 . . . . 0.0 114.454 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.59 130.18 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.182 0.993 . . . . 0.0 110.311 170.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.6 t -109.94 139.57 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.929 1.292 . . . . 0.0 109.275 172.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -134.41 112.72 11.19 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.838 1.255 . . . . 0.0 108.86 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.6 t -86.56 151.89 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.373 1.469 . . . . 0.0 110.947 -177.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.2 -96.91 1.38 Allowed Glycine 0 CA--C 1.531 1.059 0 O-C-N 121.608 -0.682 . . . . 0.0 112.025 175.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.1 m -150.0 157.41 43.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.52 1.128 . . . . 0.0 110.025 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -69.75 133.99 88.32 Favored Pre-proline 0 CA--C 1.546 0.796 0 O-C-N 120.791 -1.193 . . . . 0.0 110.654 169.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.63 156.01 31.68 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 124.194 3.263 . . . . 0.0 114.342 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.1 t -82.78 -26.32 31.93 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -175.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.02 -35.01 3.38 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 125.629 1.585 . . . . 0.0 113.055 -177.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -77.95 58.59 1.96 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.05 1.74 . . . . 0.0 111.404 169.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.1 m -131.5 159.93 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.549 1.54 . . . . 0.0 113.013 -172.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.1 mt -99.91 119.64 38.53 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 127.562 2.345 . . . . 0.0 110.335 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -106.09 108.3 19.74 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -170.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.55 145.54 17.79 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 169.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.1 ttt-85 -156.93 125.45 5.73 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 120.762 2.281 . . . . 0.0 113.967 -169.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.81 167.39 21.25 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.8 1.24 . . . . 0.0 114.044 -173.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 63.2 m -119.47 132.28 55.76 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.563 1.545 . . . . 0.0 108.15 174.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.59 -179.64 42.08 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 121.881 0.712 . . . . 0.0 114.634 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -86.99 -18.35 30.88 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -169.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -93.11 5.19 52.36 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.398 1.454 . . . . 0.0 112.163 169.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.89 16.12 49.46 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 126.661 2.077 . . . . 0.0 114.113 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.6 pm0 -76.98 178.24 7.11 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.955 1.702 . . . . 0.0 113.087 175.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.8 m -141.19 142.24 34.02 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.417 -1.427 . . . . 0.0 109.93 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 76.9 t -127.54 139.36 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.706 1.602 . . . . 0.0 109.721 -174.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.2 tp -129.1 148.22 51.03 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.154 1.382 . . . . 0.0 109.476 175.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.501 HG13 ' HB1' ' A' ' 48' ' ' ALA . 34.5 t -127.49 134.72 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.979 2.112 . . . . 0.0 107.414 175.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -135.78 137.21 41.4 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.2 0.6 . . . . 0.0 111.373 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -153.25 155.13 31.59 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 123.827 0.851 . . . . 0.0 112.796 174.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -58.85 134.72 62.14 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.795 2.33 . . . . 0.0 113.53 -176.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 . . . . . 0 C--O 1.253 1.27 0 C-N-CA 125.995 1.718 . . . . 0.0 112.265 176.492 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.784 0 CA-C-O 121.149 0.305 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.8 m -86.02 165.19 16.88 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.828 1.251 . . . . 0.0 112.727 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -111.37 143.29 42.41 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.488 1.515 . . . . 0.0 109.888 169.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.0 p -83.41 170.55 14.38 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.59 -1.319 . . . . 0.0 113.57 -174.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -110.77 -2.67 16.1 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -169.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . 0.276 3.6 t 49.42 -174.6 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 127.917 2.487 . . . . 0.0 114.417 -170.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.7 mm -66.78 154.27 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 O-C-N 120.419 -1.426 . . . . 0.0 111.189 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.1 m -70.33 105.92 3.18 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.156 0.982 . . . . 0.0 112.275 -177.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.6 p -68.39 55.01 0.08 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 127.357 2.263 . . . . 0.0 113.933 170.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.7 p -141.48 -64.55 0.44 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 129.435 3.094 . . . . 0.0 107.182 170.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.7 -39.48 70.16 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.455 1.502 . . . . 0.0 113.129 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -86.11 -17.75 34.2 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.623 -0.673 . . . . 0.0 112.596 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -76.5 -49.0 17.63 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 120.855 -1.153 . . . . 0.0 111.776 173.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.64 -35.15 70.13 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.629 1.172 . . . . 0.0 113.007 -175.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.64 -21.4 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -70.56 -43.23 69.9 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 120.905 -1.122 . . . . 0.0 112.446 177.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.03 -42.08 76.85 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.446 -0.784 . . . . 0.0 111.599 -171.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -62.45 -32.97 73.93 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.719 1.208 . . . . 0.0 112.397 172.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.69 -39.17 80.67 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.6 -1.312 . . . . 0.0 112.412 172.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.74 -38.16 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 O-C-N 121.327 -0.858 . . . . 0.0 111.295 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -58.01 -46.76 84.74 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.39 -0.819 . . . . 0.0 111.195 171.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.1 mp -69.71 -33.59 72.73 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 117.387 -1.292 . . . . 0.0 113.057 175.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.34 -34.17 68.49 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 121.301 1.864 . . . . 0.0 110.455 169.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.2 m -73.56 -39.05 64.99 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.598 1.159 . . . . 0.0 113.535 171.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.7 mm -73.74 -34.2 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 120.724 1.602 . . . . 0.0 111.02 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.4 t -64.79 -48.86 82.73 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-O 117.544 -1.217 . . . . 0.0 109.411 172.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -53.49 -44.21 68.85 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 120.931 1.696 . . . . 0.0 112.177 171.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.8 m -58.74 -35.22 72.38 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.676 -0.64 . . . . 0.0 112.021 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -75.41 -37.05 60.68 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.483 1.513 . . . . 0.0 113.414 171.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.0 mt -66.21 -31.94 73.07 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 120.033 1.288 . . . . 0.0 111.966 175.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 93.1 mt -75.68 -39.45 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 124.685 1.194 . . . . 0.0 110.803 169.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.63 -38.08 61.56 Favored Glycine 0 C--N 1.34 0.775 0 C-N-CA 125.437 1.494 . . . . 0.0 114.114 -171.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.3 t -148.6 -29.69 0.28 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.3 12.18 31.85 Favored Glycine 0 N--CA 1.477 1.386 0 N-CA-C 116.425 1.33 . . . . 0.0 116.425 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.5 m -157.98 146.87 19.32 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.959 1.704 . . . . 0.0 109.611 171.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.4 p -119.34 142.17 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.635 1.574 . . . . 0.0 110.43 -175.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -133.02 157.44 45.22 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.3 1.04 . . . . 0.0 111.032 -169.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -54.98 -39.32 68.88 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -70.95 -19.73 62.53 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.526 1.131 . . . . 0.0 113.318 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -78.98 -43.44 24.43 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.162 0.892 . . . . 0.0 109.908 169.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.7 mt -79.87 -27.16 40.11 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -169.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -57.6 -24.21 55.12 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 170.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -84.14 -3.75 58.33 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.507 1.123 . . . . 0.0 113.882 173.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.2 mm-40 -115.97 -16.02 11.14 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.795 1.238 . . . . 0.0 113.167 -173.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt -58.17 -66.22 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 118.888 0.767 . . . . 0.0 110.937 173.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 66.15 -15.08 0.13 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 127.462 2.305 . . . . 0.0 116.521 172.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -156.16 -26.73 0.1 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.759 1.224 . . . . 0.0 114.079 175.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.97 154.0 25.95 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.007 0.923 . . . . 0.0 111.974 174.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.04 -60.29 2.46 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.412 1.085 . . . . 0.0 111.815 175.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -127.56 128.95 46.47 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.022 0.529 . . . . 0.0 111.932 -169.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -104.04 143.47 32.85 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.353 -0.842 . . . . 0.0 109.965 169.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.5 t -140.06 140.11 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.093 0.957 . . . . 0.0 110.625 -171.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 53' ' ' ILE . 0.7 OUTLIER -115.14 132.03 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.067 1.347 . . . . 0.0 113.63 -169.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.6 mmt85 -130.86 74.93 1.63 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.594 1.557 . . . . 0.0 109.673 171.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.5 mt -93.12 131.22 33.58 Favored Pre-proline 0 N--CA 1.479 1.003 0 O-C-N 121.396 -0.815 . . . . 0.0 108.856 172.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.46 136.7 44.08 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.231 1.954 . . . . 0.0 111.459 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.07 -0.13 83.68 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.746 1.165 . . . . 0.0 115.587 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -137.06 157.55 74.35 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 119.015 1.407 . . . . 0.0 112.218 173.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.2 153.02 62.28 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.848 2.366 . . . . 0.0 112.852 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.6 p -55.95 136.95 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.672 1.189 . . . . 0.0 111.935 172.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 99.2 t -115.8 141.13 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.888 1.675 . . . . 0.0 108.082 169.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -139.93 123.13 16.89 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.442 1.097 . . . . 0.0 110.646 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.7 t -95.97 154.97 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 126.596 1.959 . . . . 0.0 111.149 -172.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.36 -95.11 1.3 Allowed Glycine 0 CA--C 1.532 1.115 0 O-C-N 121.327 -0.858 . . . . 0.0 112.485 174.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 60.5 m -152.36 149.84 29.06 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.478 1.111 . . . . 0.0 110.057 174.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -69.38 125.28 91.86 Favored Pre-proline 0 CA--C 1.546 0.822 0 O-C-N 120.636 -1.29 . . . . 0.0 111.262 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.415 ' HB2' HG11 ' A' ' 71' ' ' VAL . 61.1 Cg_endo -77.37 153.74 31.36 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.969 3.112 . . . . 0.0 114.623 -175.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 t -83.14 -31.08 27.39 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -169.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.26 -33.77 2.73 Favored Glycine 0 N--CA 1.478 1.466 0 C-N-CA 125.193 1.377 . . . . 0.0 112.978 -174.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -78.09 57.51 1.82 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.97 1.708 . . . . 0.0 110.511 169.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.415 HG11 ' HB2' ' A' ' 67' ' ' PRO . 35.8 m -137.4 154.43 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.274 1.83 . . . . 0.0 111.526 -172.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.7 mt -87.98 140.19 29.75 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 127.097 2.159 . . . . 0.0 109.187 173.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -121.36 112.58 18.75 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.424 0.556 . . . . 0.0 111.785 -176.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.6 143.14 16.41 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 169.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -151.66 131.46 13.25 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.646 1.723 . . . . 0.0 112.339 -170.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -143.58 168.18 20.48 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.729 1.211 . . . . 0.0 113.655 -174.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.7 m -120.03 131.85 55.27 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.422 1.489 . . . . 0.0 108.882 176.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.56 173.2 32.21 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.616 1.103 . . . . 0.0 114.688 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -81.43 -12.59 58.88 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -169.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -95.81 5.11 52.11 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 120.76 1.618 . . . . 0.0 111.58 169.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.36 17.32 40.05 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 126.766 2.127 . . . . 0.0 114.213 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.6 pm0 -82.93 175.26 10.2 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.911 1.684 . . . . 0.0 113.869 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.5 m -128.26 138.38 52.4 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.084 1.353 . . . . 0.0 109.956 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.2 t -120.98 141.13 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.365 1.466 . . . . 0.0 110.355 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.0 tp -128.56 147.18 50.69 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.219 1.407 . . . . 0.0 109.812 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.4 t -131.59 137.39 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.339 1.456 . . . . 0.0 108.426 173.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -130.22 127.39 39.52 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.989 0.9 . . . . 0.0 111.76 -176.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -125.35 143.77 45.6 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.44 1.896 . . . . 0.0 110.694 -173.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -61.22 132.55 41.96 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.426 2.084 . . . . 0.0 111.609 174.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 . . . . . 0 C--O 1.254 1.314 0 C-N-CA 124.688 1.195 . . . . 0.0 112.522 -178.539 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 112.069 -0.412 . . . . 0.0 112.069 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.3 m -94.45 -13.48 26.16 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -175.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.76 149.68 48.8 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.541 1.136 . . . . 0.0 112.875 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.7 m -153.95 154.77 34.4 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.913 1.685 . . . . 0.0 110.381 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -86.43 121.76 29.43 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.987 0.915 . . . . 0.0 111.581 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.9 m -65.6 145.8 55.61 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.4 1.08 . . . . 0.0 111.142 171.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 55.1 mt -128.14 133.35 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.574 1.55 . . . . 0.0 108.536 175.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.2 m -122.46 129.72 52.32 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.824 0.85 . . . . 0.0 112.869 -170.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.1 p -70.57 58.62 0.19 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.522 1.929 . . . . 0.0 114.063 173.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.3 p -141.82 -64.75 0.43 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 129.128 2.971 . . . . 0.0 107.273 169.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.4 -43.04 67.57 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.359 1.464 . . . . 0.0 112.836 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -79.51 -21.62 45.05 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.547 -0.721 . . . . 0.0 112.603 174.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -72.82 -45.2 59.73 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.722 -1.236 . . . . 0.0 111.734 173.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -57.33 -37.0 71.85 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.714 -0.616 . . . . 0.0 112.455 -173.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.2 m -68.48 -24.06 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.817 1.247 . . . . 0.0 112.968 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.17 -43.93 73.23 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.336 0.971 . . . . 0.0 112.115 177.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.26 -39.9 71.31 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.516 -0.74 . . . . 0.0 111.294 -169.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -69.84 -31.14 68.84 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.709 1.203 . . . . 0.0 112.686 173.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.95 -38.98 83.46 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.908 -1.12 . . . . 0.0 112.18 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.0 t -67.15 -39.42 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 O-C-N 121.29 -0.881 . . . . 0.0 111.414 172.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -57.24 -44.87 84.23 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.589 -0.694 . . . . 0.0 111.023 171.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -71.38 -36.24 71.36 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 116.176 -1.869 . . . . 0.0 113.257 175.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.3 -39.76 67.28 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 121.976 2.171 . . . . 0.0 109.8 169.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.0 m -64.83 -40.36 95.06 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 118.051 -0.976 . . . . 0.0 113.334 173.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.8 mm -75.49 -28.63 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 120.584 1.538 . . . . 0.0 111.552 178.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.3 t -65.14 -49.21 80.4 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 O-C-N 120.926 -1.109 . . . . 0.0 108.978 170.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -56.77 -42.28 79.13 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 120.444 1.475 . . . . 0.0 113.191 174.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.0 p -64.94 -23.42 67.22 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.998 0.817 . . . . 0.0 112.29 177.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -83.79 -35.15 24.52 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.471 1.908 . . . . 0.0 113.411 169.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.5 mt -64.38 -38.68 91.89 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 120.527 1.512 . . . . 0.0 111.386 172.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 89.3 mt -72.42 -35.58 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 124.491 1.117 . . . . 0.0 110.891 170.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.5 -38.48 51.92 Favored Glycine 0 C--N 1.34 0.75 0 C-N-CA 125.657 1.599 . . . . 0.0 114.473 -171.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.0 t -152.18 -26.87 0.17 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 177.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.35 6.59 33.46 Favored Glycine 0 N--CA 1.477 1.381 0 N-CA-C 116.954 1.542 . . . . 0.0 116.954 173.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 t -161.07 150.0 16.46 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.546 1.538 . . . . 0.0 109.881 170.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -115.9 147.15 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 126.046 1.738 . . . . 0.0 110.826 -178.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -126.27 159.02 34.22 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.498 1.519 . . . . 0.0 110.352 -173.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -54.75 -38.48 67.24 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.862 -0.524 . . . . 0.0 112.413 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -69.36 -21.72 63.79 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -79.91 -31.92 40.16 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.769 0.713 . . . . 0.0 111.756 172.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 89.4 mt -86.54 -33.91 20.13 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.988 1.315 . . . . 0.0 114.19 -174.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -58.55 -20.88 50.33 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 175.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -80.38 -14.97 57.89 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 175.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -100.84 -44.36 5.8 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.921 0.888 . . . . 0.0 112.674 -169.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt -40.03 -36.9 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 117.832 2.53 . . . . 0.0 117.832 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.36 -3.11 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.293 1 C-N-CA 132.021 4.128 . . . . 0.0 119.112 175.677 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -179.95 -35.38 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 128.242 2.617 . . . . 0.0 111.988 -169.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.85 139.56 55.2 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.315 0.646 . . . . 0.0 109.928 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.22 -58.62 5.51 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.628 0.771 . . . . 0.0 112.706 -171.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -131.77 127.43 36.7 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 122.786 0.434 . . . . 0.0 111.17 -170.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -104.69 145.67 30.02 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.368 0.985 . . . . 0.0 109.675 169.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.2 t -139.99 141.4 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.331 1.052 . . . . 0.0 110.738 -170.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 mm -111.42 126.38 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.614 1.566 . . . . 0.0 112.669 -172.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -125.94 63.3 1.23 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.518 1.927 . . . . 0.0 109.703 170.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.9 mt -79.74 126.83 79.55 Favored Pre-proline 0 N--CA 1.481 1.084 0 CA-C-O 118.34 -0.838 . . . . 0.0 108.989 169.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -58.38 139.43 90.56 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.947 2.431 . . . . 0.0 113.082 173.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.78 0.0 87.22 Favored Glycine 0 CA--C 1.537 1.409 0 N-CA-C 116.042 1.177 . . . . 0.0 116.042 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -138.13 158.71 70.56 Favored Pre-proline 0 CA--C 1.549 0.935 0 CA-C-N 119.23 1.515 . . . . 0.0 112.685 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.98 149.85 59.83 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.846 2.364 . . . . 0.0 113.481 -174.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 81.3 t -64.09 130.82 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.5 1.52 . . . . 0.0 111.172 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.5 t -106.09 142.43 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.569 1.548 . . . . 0.0 108.202 170.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -135.57 113.97 11.59 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.797 1.239 . . . . 0.0 109.208 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.0 t -84.22 151.63 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.715 1.606 . . . . 0.0 110.975 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.51 -99.23 1.2 Allowed Glycine 0 CA--C 1.534 1.232 0 O-C-N 121.321 -0.862 . . . . 0.0 112.985 175.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -148.74 158.12 43.92 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.73 1.212 . . . . 0.0 109.979 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -71.27 130.28 88.03 Favored Pre-proline 0 CA--C 1.549 0.938 0 O-C-N 120.627 -1.295 . . . . 0.0 110.636 170.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.9 157.07 34.87 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 124.272 3.315 . . . . 0.0 114.103 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.7 t -83.63 -32.25 25.79 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -171.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.96 -33.19 2.64 Favored Glycine 0 N--CA 1.476 1.336 0 C-N-CA 125.41 1.481 . . . . 0.0 113.261 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -78.3 58.99 2.21 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.096 1.758 . . . . 0.0 111.229 169.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.0 m -136.94 155.23 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.372 1.469 . . . . 0.0 112.706 -171.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.8 mt -91.7 138.88 31.2 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 128.284 2.633 . . . . 0.0 109.546 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -121.62 103.8 9.17 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.787 0.721 . . . . 0.0 111.877 -175.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -83.75 150.97 27.21 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 169.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.8 ttt-85 -148.88 153.84 38.61 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 118.845 1.322 . . . . 0.0 111.478 -172.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -161.76 167.26 25.28 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.554 1.142 . . . . 0.0 112.922 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 97.2 m -131.51 110.98 11.37 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.507 1.523 . . . . 0.0 109.572 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.45 163.27 54.39 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.162 0.887 . . . . 0.0 114.88 -177.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -68.35 -8.22 38.11 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.632 1.973 . . . . 0.0 115.34 -174.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -102.9 4.05 37.17 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.258 1.39 . . . . 0.0 113.084 169.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.68 20.79 15.91 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.902 1.239 . . . . 0.0 114.484 172.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.64 -170.54 3.06 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.912 1.285 . . . . 0.0 113.874 -177.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.0 m -147.24 123.21 10.71 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 120.705 -1.247 . . . . 0.0 111.883 172.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.7 t -94.27 146.03 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.448 1.499 . . . . 0.0 110.866 171.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.6 tp -130.18 145.27 51.71 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.689 1.596 . . . . 0.0 108.364 169.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.16 139.4 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.179 1.392 . . . . 0.0 108.576 171.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -132.18 129.37 39.67 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.914 0.886 . . . . 0.0 111.014 -175.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -131.8 140.26 37.69 Favored Pre-proline 0 N--CA 1.473 0.677 0 C-N-CA 126.138 1.775 . . . . 0.0 111.042 -170.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -62.17 136.53 60.92 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.176 1.917 . . . . 0.0 112.099 174.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 . . . . . 0 C--O 1.253 1.252 0 C-N-CA 124.458 1.103 . . . . 0.0 111.8 173.225 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.747 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m 57.73 37.94 27.34 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.795 1.638 . . . . 0.0 114.461 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -92.52 44.66 1.17 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.595 1.558 . . . . 0.0 112.588 -175.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.8 m -59.53 143.47 50.07 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.514 1.926 . . . . 0.0 113.303 -174.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.19 156.8 43.66 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.471 1.509 . . . . 0.0 113.01 175.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.1 t -152.09 158.62 43.24 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.704 1.602 . . . . 0.0 110.972 174.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.2 mt -79.8 120.89 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 O-C-N 121.498 -0.751 . . . . 0.0 109.85 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.1 m -47.56 125.55 8.55 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.28 1.832 . . . . 0.0 115.44 -171.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.8 m -70.77 63.04 0.28 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.635 1.574 . . . . 0.0 112.47 170.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.6 p -142.18 -83.16 0.19 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.95 2.5 . . . . 0.0 108.419 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.92 -46.83 67.29 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.595 1.158 . . . . 0.0 111.967 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -66.65 -28.25 68.33 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.578 -0.701 . . . . 0.0 112.155 175.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -71.02 -56.7 5.61 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.345 0.658 . . . . 0.0 111.191 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.403 HH21 ' CD ' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -58.86 -39.95 82.84 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 118.383 -0.818 . . . . 0.0 111.751 -178.026 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.5 t -56.65 -31.61 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.201 1.4 . . . . 0.0 112.512 174.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -77.26 -33.67 55.91 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 176.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.4 mp -74.11 -38.92 63.7 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 120.929 -1.107 . . . . 0.0 111.24 -178.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.403 ' CD ' HH21 ' A' ' 14' ' ' ARG . 6.7 pt-20 -65.21 -27.25 68.55 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 170.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.39 -36.68 83.47 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 120.69 -1.256 . . . . 0.0 112.308 169.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.1 t -70.81 -36.28 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 124.445 1.098 . . . . 0.0 111.342 172.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -60.49 -45.0 95.36 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.112 -0.992 . . . . 0.0 111.449 171.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.1 mp -70.28 -33.38 71.5 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-O 117.147 -1.406 . . . . 0.0 112.494 174.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.29 -33.93 69.99 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 121.475 1.943 . . . . 0.0 110.805 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.7 m -72.05 -38.88 69.42 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.101 0.96 . . . . 0.0 113.236 171.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.0 mm -73.82 -34.85 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 120.721 1.6 . . . . 0.0 110.933 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.1 t -62.67 -48.2 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 117.452 -1.261 . . . . 0.0 110.033 172.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -54.1 -42.36 69.31 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 120.994 1.725 . . . . 0.0 112.173 171.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.2 m -60.28 -33.04 71.77 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.702 -0.624 . . . . 0.0 112.142 175.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -76.71 -37.22 56.45 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.065 1.346 . . . . 0.0 113.31 171.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.1 mt -65.06 -31.19 72.29 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.674 1.125 . . . . 0.0 112.133 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 89.7 mt -76.52 -36.78 28.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 125.156 1.382 . . . . 0.0 111.248 169.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.18 -39.43 31.92 Favored Glycine 0 N--CA 1.469 0.845 0 C-N-CA 126.08 1.8 . . . . 0.0 115.547 -171.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.9 t -151.08 -23.95 0.21 Allowed 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.0 6.04 54.34 Favored Glycine 0 N--CA 1.468 0.828 0 N-CA-C 117.271 1.668 . . . . 0.0 117.271 169.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.0 m -158.5 149.88 20.91 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.418 1.487 . . . . 0.0 110.343 170.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 p -103.51 145.11 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.448 1.099 . . . . 0.0 113.0 -173.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -116.6 152.9 33.23 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.675 1.59 . . . . 0.0 110.792 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -57.4 -35.67 70.33 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.888 -1.133 . . . . 0.0 111.885 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -70.42 -19.18 63.01 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.93 1.292 . . . . 0.0 112.738 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -83.62 -32.95 25.43 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.904 0.775 . . . . 0.0 112.179 169.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.3 mt -86.63 -34.65 19.76 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.451 1.5 . . . . 0.0 114.005 -172.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -60.48 -20.51 60.26 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -84.82 -3.41 58.63 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.23 1.412 . . . . 0.0 113.591 175.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -114.35 -26.49 7.96 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.942 1.297 . . . . 0.0 113.202 -172.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.49 HG22 ' HB3' ' A' ' 48' ' ' ALA . 1.2 pt -52.5 -60.5 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.017 0.927 . . . . 0.0 112.829 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 62.53 -23.29 0.05 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 128.086 2.554 . . . . 0.0 117.556 -177.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -153.38 -27.77 0.14 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -172.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.49 ' HB3' HG22 ' A' ' 45' ' ' ILE . . . -69.53 146.43 51.85 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.51 1.124 . . . . 0.0 111.156 169.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -77.94 -48.39 16.4 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.594 0.358 . . . . 0.0 111.143 176.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -133.83 129.88 37.14 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.246 1.419 . . . . 0.0 110.932 -175.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.12 136.17 47.42 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 120.195 1.361 . . . . 0.0 109.302 168.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.3 t -126.45 143.08 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.054 1.341 . . . . 0.0 110.767 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.471 ' HB ' ' H ' ' A' ' 61' ' ' VAL . 20.3 mm -120.57 134.07 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.542 1.537 . . . . 0.0 113.418 -169.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -113.53 3.49 15.76 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 116.277 1.955 . . . . 0.0 116.277 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.6 mt -40.04 124.72 1.64 Allowed Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 125.739 1.616 . . . . 0.0 113.544 -172.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -60.7 140.64 91.92 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.147 2.564 . . . . 0.0 113.742 173.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.0 -1.38 86.85 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.811 1.196 . . . . 0.0 115.476 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -131.49 160.84 65.49 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 125.001 1.32 . . . . 0.0 111.298 172.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -62.26 161.89 25.38 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.461 2.107 . . . . 0.0 112.145 176.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.1 t -72.11 142.9 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 169.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.471 ' H ' ' HB ' ' A' ' 53' ' ' ILE . 87.6 t -113.94 138.52 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 169.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -124.51 118.55 26.86 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.036 1.334 . . . . 0.0 108.708 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.3 t -94.22 154.34 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.043 1.337 . . . . 0.0 110.811 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.36 -109.14 2.7 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.0 t -154.69 162.14 41.25 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.736 0.768 . . . . 0.0 111.332 169.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.5 tttp -61.63 141.86 94.67 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.74 1.216 . . . . 0.0 111.565 -176.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -65.36 -167.48 0.1 Allowed 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 124.342 3.361 . . . . 0.0 115.89 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 t -119.61 -24.58 6.2 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 117.571 2.434 . . . . 0.0 117.571 -169.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.57 -10.04 21.76 Favored Glycine 0 N--CA 1.484 1.862 0 CA-C-N 119.472 1.033 . . . . 0.0 114.556 -173.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -134.45 83.8 2.06 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.829 2.452 . . . . 0.0 110.278 170.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.3 m -139.54 147.15 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.896 1.278 . . . . 0.0 111.621 -176.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.5 mt -72.33 148.95 44.86 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.05 1.34 . . . . 0.0 107.55 169.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -133.15 113.7 13.02 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.588 0.755 . . . . 0.0 109.201 -178.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -99.42 147.82 18.48 Favored Glycine 0 N--CA 1.468 0.788 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 169.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 74.2 ttt-85 -150.05 146.51 27.0 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 118.466 1.133 . . . . 0.0 112.84 -169.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.53 155.59 33.67 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.793 0.837 . . . . 0.0 112.955 -178.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.1 m -113.72 129.9 56.51 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.276 1.43 . . . . 0.0 109.475 169.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.03 -160.51 36.12 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 124.182 0.896 . . . . 0.0 115.055 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -99.51 -15.15 18.77 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -169.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -91.57 -1.82 57.36 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 120.338 1.426 . . . . 0.0 111.998 168.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.01 20.07 26.97 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 126.303 1.906 . . . . 0.0 113.651 -174.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.0 pm0 -80.66 163.5 23.55 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.841 1.656 . . . . 0.0 113.988 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.9 m -128.51 140.37 51.84 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.125 0.97 . . . . 0.0 110.507 173.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.8 t -131.79 143.2 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.157 1.783 . . . . 0.0 109.363 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.3 tp -130.15 147.58 51.9 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.46 1.504 . . . . 0.0 111.569 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.484 HG13 ' HB1' ' A' ' 48' ' ' ALA . 76.2 t -122.44 138.34 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 126.887 2.075 . . . . 0.0 108.401 171.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -137.06 134.51 36.6 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.741 0.701 . . . . 0.0 112.652 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -150.0 152.27 33.72 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 176.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -58.27 128.02 27.02 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.548 2.832 . . . . 0.0 113.431 -175.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 125.156 1.382 . . . . 0.0 112.131 179.396 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.855 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.5 p -75.0 -38.77 61.52 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -174.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -77.76 167.22 21.9 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -172.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.4 t -146.44 159.71 43.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.676 1.59 . . . . 0.0 111.081 169.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 68.7 mmt-85 -112.92 -152.9 0.51 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.864 1.666 . . . . 0.0 112.002 -175.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.1 t -169.18 111.62 0.5 Allowed 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 123.057 1.408 . . . . 0.0 111.845 170.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mp -85.87 144.77 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 124.556 1.142 . . . . 0.0 109.917 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 64.5 m -94.24 49.52 1.31 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.39 1.476 . . . . 0.0 112.121 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.4 m -56.11 18.96 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 130.326 3.45 . . . . 0.0 118.831 -169.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.4 p -124.29 -62.71 1.25 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.822 2.049 . . . . 0.0 108.714 169.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.13 -45.45 73.58 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.289 1.436 . . . . 0.0 112.288 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.4 tp60 -68.54 -34.78 76.46 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.634 -0.666 . . . . 0.0 111.101 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -70.51 -52.71 19.97 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.608 0.363 . . . . 0.0 110.807 -176.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.4 HH21 ' CD ' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -58.39 -36.1 73.04 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 118.365 -0.826 . . . . 0.0 112.042 176.744 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.8 t -57.25 -28.47 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.911 1.684 . . . . 0.0 113.408 171.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -76.85 -38.51 53.6 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.181 -0.949 . . . . 0.0 112.278 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.5 mp -70.6 -36.75 73.71 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.324 -0.86 . . . . 0.0 111.349 -174.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.4 ' CD ' HH21 ' A' ' 14' ' ' ARG . 8.3 pt-20 -67.08 -32.07 72.99 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.7 0.8 . . . . 0.0 112.581 170.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.06 -40.74 87.14 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.637 -1.289 . . . . 0.0 112.125 171.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.5 t -63.45 -43.55 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.822 0.849 . . . . 0.0 110.932 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -57.27 -41.13 79.1 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.741 -0.599 . . . . 0.0 111.51 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 mp -67.63 -34.84 77.76 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 117.315 -1.326 . . . . 0.0 113.326 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.74 -33.92 67.03 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 120.991 1.723 . . . . 0.0 111.249 169.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 m -73.92 -37.56 64.58 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 170.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.3 mm -69.58 -36.57 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 120.618 1.554 . . . . 0.0 110.4 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.13 -46.93 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.915 1.286 . . . . 0.0 109.624 176.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -52.89 -43.63 66.32 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 120.62 1.555 . . . . 0.0 111.963 170.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.9 m -59.96 -32.41 70.79 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.791 0.436 . . . . 0.0 111.986 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -79.07 -36.62 40.59 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.594 1.558 . . . . 0.0 113.712 172.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.0 mt -66.34 -34.26 77.57 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 120.195 1.361 . . . . 0.0 111.43 175.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.3 mt -73.06 -36.74 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.386 1.074 . . . . 0.0 110.491 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.75 -38.81 60.75 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 125.695 1.617 . . . . 0.0 114.428 -173.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.5 t -152.24 -26.52 0.17 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 178.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.51 3.35 53.24 Favored Glycine 0 N--CA 1.481 1.694 0 N-CA-C 116.156 1.223 . . . . 0.0 116.156 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.5 m -143.66 135.3 26.25 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.214 1.806 . . . . 0.0 108.974 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 p -107.01 145.5 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.668 0.787 . . . . 0.0 109.634 172.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -133.59 156.91 46.98 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.666 1.186 . . . . 0.0 110.187 -175.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -56.3 -37.58 70.08 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.804 -0.56 . . . . 0.0 111.907 -177.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -70.03 -22.06 63.13 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -77.6 -37.89 49.38 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.497 0.59 . . . . 0.0 111.738 170.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 60.6 mt -87.71 -27.05 22.63 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 -173.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -56.49 -27.74 57.94 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 175.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -90.5 4.34 51.41 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.623 1.169 . . . . 0.0 114.12 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -123.09 -10.57 8.12 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 119.814 1.188 . . . . 0.0 113.943 -170.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.27 -45.18 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.274 1.429 . . . . 0.0 114.547 -175.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . 0.3 73.4 mtt85 75.15 -24.84 0.21 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 129.056 2.942 . . . . 0.0 117.273 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -160.1 -42.72 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.628 1.571 . . . . 0.0 109.487 169.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.437 ' HB1' HG13 ' A' ' 86' ' ' VAL . . . -38.69 130.13 1.42 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 128.34 2.656 . . . . 0.0 112.905 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -47.65 60.08 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.596 -0.69 . . . . 0.0 110.867 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -131.74 116.93 17.92 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.733 1.613 . . . . 0.0 109.457 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.15 145.08 25.66 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.012 -1.055 . . . . 0.0 108.69 168.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.2 t -139.89 134.76 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 120.682 -1.261 . . . . 0.0 110.931 -169.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mm -116.07 139.16 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.087 1.355 . . . . 0.0 114.641 -170.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -144.87 73.3 1.36 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.076 1.75 . . . . 0.0 109.628 169.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.0 mt -83.35 121.76 76.91 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-N 114.386 -1.279 . . . . 0.0 107.682 169.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.22 132.68 50.48 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.073 1.849 . . . . 0.0 112.214 174.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.05 0.18 83.41 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.869 1.223 . . . . 0.0 116.016 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -139.87 165.57 30.01 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 119.79 1.795 . . . . 0.0 113.872 173.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -60.74 140.95 93.48 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.609 2.873 . . . . 0.0 115.644 -173.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.6 t -69.98 116.03 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.509 1.124 . . . . 0.0 108.946 169.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.87 143.98 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.195 1.398 . . . . 0.0 109.765 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -139.16 110.91 7.16 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.792 1.237 . . . . 0.0 108.881 -170.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.1 t -80.93 153.8 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.745 1.618 . . . . 0.0 111.466 -172.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.42 -87.54 1.12 Allowed Glycine 0 CA--C 1.533 1.157 0 O-C-N 121.487 -0.758 . . . . 0.0 113.263 172.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.1 m -157.68 160.76 38.31 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.014 1.326 . . . . 0.0 109.889 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.8 tptt -73.94 131.9 80.82 Favored Pre-proline 0 CA--C 1.548 0.879 0 O-C-N 120.778 -1.201 . . . . 0.0 110.581 171.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.65 156.49 40.13 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 124.223 3.282 . . . . 0.0 114.349 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.6 t -83.91 -33.24 24.77 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -173.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.62 -40.82 1.45 Allowed Glycine 0 N--CA 1.474 1.209 0 C-N-CA 124.983 1.278 . . . . 0.0 113.472 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -78.44 58.8 2.24 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.527 1.531 . . . . 0.0 111.767 171.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.8 m -127.13 156.76 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.244 1.418 . . . . 0.0 113.298 -173.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.0 mt -97.25 112.94 24.52 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 127.761 2.424 . . . . 0.0 110.789 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -98.45 100.57 11.84 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.172 0.989 . . . . 0.0 113.034 -171.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -85.68 152.83 26.62 Favored Glycine 0 N--CA 1.473 1.134 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 169.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -149.66 154.77 39.13 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.544 1.672 . . . . 0.0 112.211 -169.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -163.35 167.94 21.1 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.298 1.039 . . . . 0.0 113.372 176.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 62.3 m -124.75 132.93 53.32 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.121 1.768 . . . . 0.0 107.814 171.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.84 -179.31 38.96 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 123.52 0.581 . . . . 0.0 114.432 -178.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -88.51 -10.02 50.41 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -169.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -99.73 7.09 45.37 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.791 1.632 . . . . 0.0 111.138 169.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.43 18.04 40.22 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 127.033 2.254 . . . . 0.0 114.099 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.9 pm0 -79.14 176.05 10.03 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.525 1.53 . . . . 0.0 113.584 178.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.6 m -136.48 139.53 42.39 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.491 1.116 . . . . 0.0 109.534 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.4 t -129.68 143.42 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.539 1.536 . . . . 0.0 110.541 -174.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.0 tp -134.25 150.42 51.02 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.564 1.546 . . . . 0.0 109.136 173.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.437 HG13 ' HB1' ' A' ' 48' ' ' ALA . 37.7 t -126.42 138.39 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 126.194 1.798 . . . . 0.0 108.574 171.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -135.98 138.69 42.53 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.487 0.715 . . . . 0.0 111.438 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -154.5 156.62 31.79 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.289 1.436 . . . . 0.0 112.521 173.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -59.13 138.64 86.34 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.415 2.076 . . . . 0.0 113.828 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 . . . . . 0 C--O 1.255 1.344 0 C-N-CA 125.801 1.64 . . . . 0.0 112.19 172.87 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.68 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m -137.13 160.36 39.22 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.204 1.401 . . . . 0.0 112.576 -174.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -60.75 163.36 5.67 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.409 1.084 . . . . 0.0 113.17 174.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.1 m -158.49 162.74 37.51 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.42 1.888 . . . . 0.0 109.025 -173.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -98.91 128.6 45.13 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.807 0.843 . . . . 0.0 111.526 172.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.8 m -82.47 135.21 35.18 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 171.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.7 mt -143.92 159.98 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 125.962 1.705 . . . . 0.0 108.098 -176.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.8 m -96.39 118.87 33.81 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.156 -0.965 . . . . 0.0 112.342 -178.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.7 m -67.79 57.68 0.06 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.497 2.319 . . . . 0.0 113.419 172.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.8 p -141.17 -64.11 0.45 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 129.265 3.026 . . . . 0.0 106.444 169.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.58 -44.44 64.47 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.493 1.517 . . . . 0.0 112.389 172.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -72.34 -27.73 62.6 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.431 -0.793 . . . . 0.0 112.356 174.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -70.68 -48.96 52.09 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.337 -0.852 . . . . 0.0 110.862 176.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -35.0 77.11 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 118.38 -0.819 . . . . 0.0 113.006 -175.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.0 m -63.99 -19.82 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 174.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.96 -44.82 68.71 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.672 1.124 . . . . 0.0 112.326 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -69.52 -41.33 76.16 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.278 -0.889 . . . . 0.0 111.491 -171.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -64.64 -33.6 76.31 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.65 1.18 . . . . 0.0 112.635 171.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.52 -37.76 85.73 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.736 -1.228 . . . . 0.0 112.384 172.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.0 t -68.85 -37.64 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 124.023 0.929 . . . . 0.0 111.37 172.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -59.4 -43.9 92.91 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.175 -0.953 . . . . 0.0 111.744 170.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.7 mp -68.98 -34.95 76.15 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 120.382 1.446 . . . . 0.0 112.806 173.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.26 -34.43 68.63 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 121.158 1.799 . . . . 0.0 110.584 169.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.5 m -71.52 -40.16 70.28 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.084 0.954 . . . . 0.0 113.177 172.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.8 mm -72.04 -35.48 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 120.69 1.587 . . . . 0.0 111.108 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.21 -45.69 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.696 1.198 . . . . 0.0 109.547 174.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -53.75 -43.11 68.88 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 120.78 1.627 . . . . 0.0 112.12 171.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.6 t -59.15 -39.55 82.79 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.964 -0.46 . . . . 0.0 111.826 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -68.55 -38.34 80.7 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.666 1.186 . . . . 0.0 113.088 171.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.0 mt -67.72 -38.46 83.61 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.747 1.158 . . . . 0.0 112.084 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.09 -37.36 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.49 1.116 . . . . 0.0 111.348 172.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.39 -64.19 3.08 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 124.837 1.208 . . . . 0.0 111.083 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.1 t -126.81 -27.6 3.05 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -174.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.48 3.05 53.51 Favored Glycine 0 N--CA 1.475 1.267 0 N-CA-C 116.81 1.484 . . . . 0.0 116.81 172.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.4 m -146.73 136.94 23.6 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.633 1.573 . . . . 0.0 109.713 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 p -104.76 146.69 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.505 1.122 . . . . 0.0 110.688 176.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -133.65 159.18 41.28 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.877 1.271 . . . . 0.0 110.352 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -55.79 -38.58 70.11 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -71.04 -17.18 62.63 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -80.62 -32.14 36.37 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.349 0.977 . . . . 0.0 112.041 170.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.3 mt -90.98 -30.45 16.82 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.237 1.415 . . . . 0.0 114.489 -172.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.9 ptt85 -59.0 -23.93 62.32 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 119.398 0.999 . . . . 0.0 113.491 174.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -82.02 -6.95 59.55 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 175.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -113.4 -20.11 11.45 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -169.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.449 HG22 ' HB3' ' A' ' 48' ' ' ALA . 1.1 pt -56.92 -63.11 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -172.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 63.9 -19.56 0.06 Allowed 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 117.696 2.48 . . . . 0.0 117.696 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -148.25 -35.47 0.21 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.216 1.406 . . . . 0.0 112.803 -178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HB3' HG22 ' A' ' 45' ' ' ILE . . . -68.35 145.66 53.97 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.867 1.267 . . . . 0.0 110.585 172.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.52 -42.83 16.41 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.561 0.345 . . . . 0.0 111.51 176.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -133.63 123.14 24.52 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.582 1.553 . . . . 0.0 109.193 -176.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.4 138.57 35.44 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.229 0.922 . . . . 0.0 109.166 169.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.8 t -132.89 140.36 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.033 1.333 . . . . 0.0 109.692 -173.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.24 131.9 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -169.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -128.77 78.43 1.85 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.5 1.92 . . . . 0.0 109.848 170.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.8 mt -96.9 125.59 45.8 Favored Pre-proline 0 N--CA 1.481 1.104 0 O-C-N 121.128 -0.982 . . . . 0.0 109.047 170.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.91 134.86 62.91 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.549 2.166 . . . . 0.0 112.484 172.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.9 0.31 85.81 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 124.711 1.148 . . . . 0.0 115.942 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -139.74 156.39 70.98 Favored Pre-proline 0 N--CA 1.476 0.827 0 CA-C-N 119.407 1.604 . . . . 0.0 112.506 174.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -69.75 149.79 67.39 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.699 2.266 . . . . 0.0 112.983 -173.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.0 t -57.02 132.8 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.934 1.294 . . . . 0.0 110.783 175.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.1 t -111.74 141.92 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.154 1.382 . . . . 0.0 109.41 170.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -136.5 117.77 14.57 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.132 1.373 . . . . 0.0 109.223 176.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.8 t -91.94 159.55 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.02 1.728 . . . . 0.0 111.156 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.41 -104.64 1.62 Allowed Glycine 0 CA--C 1.531 1.067 0 O-C-N 120.959 -1.088 . . . . 0.0 112.026 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.5 t -154.74 160.58 41.42 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.553 0.692 . . . . 0.0 111.516 169.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -74.16 125.94 89.6 Favored Pre-proline 0 CA--C 1.546 0.807 0 O-C-N 120.698 -1.251 . . . . 0.0 111.703 -170.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.402 ' HB2' HG11 ' A' ' 71' ' ' VAL . 71.1 Cg_endo -76.65 154.19 34.7 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.834 3.023 . . . . 0.0 114.728 -177.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.1 t -84.4 -30.13 25.62 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -171.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.29 -35.38 2.44 Favored Glycine 0 N--CA 1.479 1.534 0 C-N-CA 124.738 1.161 . . . . 0.0 113.816 -175.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -78.18 58.64 2.08 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.922 1.689 . . . . 0.0 110.816 169.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.402 HG11 ' HB2' ' A' ' 67' ' ' PRO . 33.6 m -138.95 155.33 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 125.946 1.698 . . . . 0.0 111.863 -171.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.1 mt -74.44 164.79 26.18 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.881 1.672 . . . . 0.0 109.873 169.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -149.32 93.14 2.03 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.729 0.812 . . . . 0.0 110.223 -173.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -85.58 148.56 22.88 Favored Glycine 0 N--CA 1.471 1.007 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 169.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -151.44 150.14 30.08 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.636 1.718 . . . . 0.0 113.207 -169.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -157.51 157.18 33.34 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.316 1.046 . . . . 0.0 113.638 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 85.5 m -109.52 125.86 52.93 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.107 1.363 . . . . 0.0 107.871 169.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.18 173.42 42.74 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 122.385 0.991 . . . . 0.0 114.807 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -80.47 -8.03 59.39 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 -169.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -103.39 6.38 37.72 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.935 1.698 . . . . 0.0 111.648 168.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.1 18.71 30.7 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.264 1.887 . . . . 0.0 114.273 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.7 pm0 -85.28 176.18 8.48 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.613 1.565 . . . . 0.0 113.759 177.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.8 m -132.59 134.18 44.59 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.124 1.37 . . . . 0.0 110.444 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.7 t -118.89 144.28 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.066 1.746 . . . . 0.0 110.115 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.6 tp -133.6 143.75 48.83 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.469 1.108 . . . . 0.0 110.557 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.7 t -114.76 135.66 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 127.797 2.439 . . . . 0.0 108.207 171.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -136.71 144.18 43.76 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.839 0.828 . . . . 0.0 111.145 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.2 152.45 20.18 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 176.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -58.11 142.36 96.97 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.678 2.919 . . . . 0.0 114.316 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 . . . . . 0 C--O 1.253 1.284 0 C-N-CA 125.715 1.606 . . . . 0.0 112.68 172.47 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.85 0 N-CA-C 112.354 -0.299 . . . . 0.0 112.354 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.0 m 56.4 49.98 14.0 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.466 1.507 . . . . 0.0 112.913 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -81.57 142.72 32.56 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.076 0.951 . . . . 0.0 111.26 177.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.7 m 53.14 56.83 6.96 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.811 1.244 . . . . 0.0 112.121 -172.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.5 mmm-85 -133.89 150.14 51.34 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 127.164 2.186 . . . . 0.0 110.386 176.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 73.4 m -136.32 132.34 35.53 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.932 1.293 . . . . 0.0 110.684 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.0 mm -124.62 140.53 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.919 1.688 . . . . 0.0 109.266 173.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 27.9 t -52.38 146.17 10.0 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.645 1.178 . . . . 0.0 113.751 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 m -118.58 25.71 10.07 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.126 1.77 . . . . 0.0 111.106 171.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.7 p -139.14 -72.35 0.39 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.902 1.681 . . . . 0.0 108.798 -175.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.65 -38.68 73.86 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.432 1.493 . . . . 0.0 113.009 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -84.44 -20.0 32.5 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.679 -0.638 . . . . 0.0 112.698 174.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -77.14 -48.04 18.77 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.876 -1.14 . . . . 0.0 111.737 172.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -31.47 71.49 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 121.008 -1.057 . . . . 0.0 113.795 -174.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.2 m -65.79 -21.4 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 172.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -69.97 -43.03 72.34 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 120.905 -1.122 . . . . 0.0 112.5 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.26 -40.82 77.6 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.387 -0.821 . . . . 0.0 111.523 -171.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.4 -30.23 70.56 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.538 1.135 . . . . 0.0 112.62 173.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.43 -37.64 80.45 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.881 -1.137 . . . . 0.0 111.918 171.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.0 t -68.71 -37.0 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 O-C-N 121.43 -0.794 . . . . 0.0 111.302 172.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -59.36 -46.48 88.51 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.2 -0.937 . . . . 0.0 111.602 171.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -69.18 -34.14 74.47 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 117.398 -1.287 . . . . 0.0 112.844 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.16 -34.08 68.07 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 121.079 1.763 . . . . 0.0 110.578 169.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.9 m -73.0 -38.46 66.61 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.552 1.141 . . . . 0.0 113.642 171.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.6 mm -70.89 -37.04 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 120.701 1.591 . . . . 0.0 110.814 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.3 t -66.42 -48.31 81.17 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 C-N-CA 124.792 1.237 . . . . 0.0 109.609 175.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -53.61 -43.06 68.35 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 120.593 1.542 . . . . 0.0 112.154 171.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.2 m -59.64 -32.47 70.47 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.807 -0.558 . . . . 0.0 112.107 176.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -79.72 -36.39 37.49 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.634 1.574 . . . . 0.0 113.555 172.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 78.5 mt -65.62 -33.22 75.38 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 120.063 1.301 . . . . 0.0 111.707 174.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.32 -37.57 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.312 1.045 . . . . 0.0 110.894 169.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.39 -37.53 62.75 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 125.637 1.589 . . . . 0.0 114.272 -172.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.3 t -151.46 -27.45 0.19 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 177.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.15 8.69 33.3 Favored Glycine 0 N--CA 1.477 1.411 0 N-CA-C 116.703 1.441 . . . . 0.0 116.703 175.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.7 p -158.82 136.94 10.58 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.517 1.527 . . . . 0.0 109.985 176.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.45 145.95 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.272 1.029 . . . . 0.0 110.327 176.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -127.56 159.41 34.71 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.598 1.559 . . . . 0.0 109.666 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -53.44 -38.95 64.02 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -175.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -70.24 -15.96 62.98 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -89.27 -3.71 58.42 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.785 0.834 . . . . 0.0 112.494 170.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.1 mt -116.19 -33.88 4.86 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.022 1.329 . . . . 0.0 113.634 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.3 ptt85 -64.42 -21.66 66.71 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 119.66 1.118 . . . . 0.0 113.471 178.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -89.02 2.8 53.47 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.209 1.404 . . . . 0.0 113.984 171.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -121.33 -13.38 8.47 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.357 1.463 . . . . 0.0 112.742 -174.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.1 pt -56.49 -63.36 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 118.715 0.689 . . . . 0.0 110.938 171.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 66.07 -13.47 0.16 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 127.907 2.483 . . . . 0.0 116.7 170.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -154.88 -31.84 0.1 Allowed 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 169.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.14 155.85 39.81 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.608 0.763 . . . . 0.0 111.291 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -76.66 -49.61 15.74 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.957 -0.464 . . . . 0.0 111.589 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -136.45 144.89 44.66 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.177 1.391 . . . . 0.0 112.246 -173.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -120.58 149.45 42.43 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.907 0.883 . . . . 0.0 110.87 169.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.9 t -141.16 140.77 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 120.838 -1.163 . . . . 0.0 110.582 -173.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -113.97 136.17 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -170.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -138.72 74.54 1.48 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.218 1.807 . . . . 0.0 109.469 175.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.8 mt -91.69 126.44 53.95 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-N 114.392 -1.277 . . . . 0.0 109.331 171.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -57.87 137.15 79.58 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.027 2.485 . . . . 0.0 112.932 173.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.61 -1.1 88.32 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.604 1.097 . . . . 0.0 115.413 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -136.25 158.27 73.93 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 119.009 1.404 . . . . 0.0 112.164 175.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.46 152.42 60.27 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.72 2.28 . . . . 0.0 112.774 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.1 p -62.44 135.89 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.693 1.197 . . . . 0.0 111.822 171.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.1 p -122.24 147.17 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.818 1.247 . . . . 0.0 110.752 169.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -127.07 124.34 39.04 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.313 1.445 . . . . 0.0 109.727 -173.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.2 t -103.8 149.1 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 127.81 2.444 . . . . 0.0 109.792 -169.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.96 -94.53 1.0 Allowed Glycine 0 CA--C 1.532 1.114 0 O-C-N 120.727 -1.233 . . . . 0.0 111.678 -175.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 m -155.4 157.64 37.37 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.551 1.14 . . . . 0.0 109.879 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -71.51 128.48 89.88 Favored Pre-proline 0 CA--C 1.55 0.943 0 O-C-N 120.569 -1.332 . . . . 0.0 112.19 177.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -77.94 155.53 30.3 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 124.397 3.398 . . . . 0.0 114.736 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.0 t -84.45 -20.3 31.98 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -170.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.21 -31.6 5.76 Favored Glycine 0 N--CA 1.478 1.458 0 C-N-CA 125.782 1.658 . . . . 0.0 113.413 -176.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -78.46 60.1 2.54 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.033 1.733 . . . . 0.0 110.365 169.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.57 154.08 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 126.19 1.796 . . . . 0.0 111.502 -170.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 25.0 mt -86.93 138.23 31.71 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.946 2.098 . . . . 0.0 108.963 173.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -121.57 111.15 16.88 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.151 0.887 . . . . 0.0 111.619 -174.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.56 144.28 16.99 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 169.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -151.35 135.76 16.92 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 119.247 1.523 . . . . 0.0 112.548 -169.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.1 165.01 29.5 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.392 1.077 . . . . 0.0 113.779 -176.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.7 m -117.44 129.76 56.04 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.401 1.481 . . . . 0.0 108.613 173.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.11 173.52 36.21 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.2 0.905 . . . . 0.0 114.603 -178.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -81.86 -9.25 59.66 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 -169.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -99.01 5.02 47.32 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 120.752 1.614 . . . . 0.0 111.506 168.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.38 16.77 36.23 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.562 2.029 . . . . 0.0 114.157 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.7 pm0 -83.58 173.29 11.54 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.66 1.584 . . . . 0.0 113.837 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.1 m -126.75 137.48 53.24 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.452 1.501 . . . . 0.0 110.14 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.7 t -124.17 141.4 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.606 1.562 . . . . 0.0 110.303 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.6 tp -130.49 146.02 51.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.798 1.239 . . . . 0.0 110.209 175.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.9 t -130.63 138.85 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.039 1.736 . . . . 0.0 108.789 176.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -134.53 131.52 38.08 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.394 0.616 . . . . 0.0 112.576 -175.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -123.33 148.68 55.86 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 125.031 1.332 . . . . 0.0 112.446 175.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -57.42 134.27 62.47 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.545 2.163 . . . . 0.0 112.101 170.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 . . . . . 0 C--O 1.254 1.315 0 C-N-CA 124.957 1.303 . . . . 0.0 112.63 -178.776 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.699 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.9 p -151.73 162.6 40.75 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.591 1.557 . . . . 0.0 111.854 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -57.9 107.57 0.48 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.183 1.393 . . . . 0.0 111.795 -176.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.1 m -135.63 137.12 41.55 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.971 1.308 . . . . 0.0 111.407 -169.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.73 156.63 37.92 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.151 1.38 . . . . 0.0 112.167 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.6 t -156.28 166.23 34.05 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.542 1.537 . . . . 0.0 110.716 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.9 mm -100.57 129.46 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.324 1.049 . . . . 0.0 110.577 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.5 t -58.08 142.53 46.63 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.664 1.186 . . . . 0.0 113.918 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.0 m -127.38 31.95 5.12 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.791 2.037 . . . . 0.0 109.861 169.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.8 p -141.3 -75.03 0.31 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.234 1.813 . . . . 0.0 109.47 -171.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.69 -45.53 82.44 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.292 1.437 . . . . 0.0 111.732 173.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.2 tp60 -67.85 -32.7 73.41 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.652 -0.655 . . . . 0.0 112.175 173.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -72.2 -47.28 51.77 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.515 -0.741 . . . . 0.0 111.791 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -57.75 -41.34 81.71 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.259 0.936 . . . . 0.0 111.134 175.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.1 t -59.94 -29.02 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.34 1.856 . . . . 0.0 112.667 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -70.52 -40.52 73.45 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.31 -0.868 . . . . 0.0 112.674 173.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.7 mp -75.6 -36.96 60.16 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.026 -1.046 . . . . 0.0 111.818 -171.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -64.54 -27.48 68.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.548 0.739 . . . . 0.0 112.784 169.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.2 -37.75 78.27 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.713 -1.242 . . . . 0.0 112.076 169.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.6 t -68.12 -36.4 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 O-C-N 121.267 -0.895 . . . . 0.0 111.315 173.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -58.71 -44.49 90.38 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.321 -0.862 . . . . 0.0 111.526 170.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.6 mp -69.62 -35.8 75.59 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-O 116.597 -1.668 . . . . 0.0 113.101 173.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.64 -37.11 67.79 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 121.8 2.091 . . . . 0.0 110.391 169.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.6 m -69.16 -39.57 78.68 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.162 0.985 . . . . 0.0 113.334 172.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.9 mm -71.1 -34.76 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 120.606 1.548 . . . . 0.0 110.549 176.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.83 -51.04 76.9 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 C-N-CA 125.667 1.587 . . . . 0.0 110.328 174.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -54.66 -40.12 68.73 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 121.086 1.766 . . . . 0.0 112.745 172.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.1 m -62.68 -28.97 70.3 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.883 0.473 . . . . 0.0 112.103 175.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -83.23 -37.06 24.08 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.123 1.769 . . . . 0.0 113.482 172.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.7 mt -66.39 -35.98 81.7 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.989 1.268 . . . . 0.0 111.807 175.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.7 mt -74.33 -36.34 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 124.845 1.258 . . . . 0.0 110.879 169.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.87 -39.0 40.14 Favored Glycine 0 C--N 1.34 0.786 0 C-N-CA 125.523 1.535 . . . . 0.0 114.775 -170.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.8 t -150.07 -27.31 0.25 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 176.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.94 11.83 36.16 Favored Glycine 0 N--CA 1.475 1.25 0 N-CA-C 116.515 1.366 . . . . 0.0 116.515 174.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.9 m -155.29 140.05 17.11 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.256 1.422 . . . . 0.0 110.871 172.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 80.5 t -99.84 143.68 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.037 1.735 . . . . 0.0 109.212 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -127.77 156.69 42.06 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.549 1.14 . . . . 0.0 111.2 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -54.85 -38.23 67.2 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.211 -0.93 . . . . 0.0 112.241 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.29 -20.58 64.77 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.199 1.4 . . . . 0.0 113.692 177.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -82.99 -35.3 25.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.565 0.62 . . . . 0.0 112.345 172.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.4 mt -84.11 -32.23 24.83 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -175.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -58.66 -21.87 55.41 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 175.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -82.54 -5.19 58.61 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 174.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -109.16 -44.54 3.93 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.678 1.191 . . . . 0.0 112.452 -174.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 pt -39.74 -42.59 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 117.354 2.353 . . . . 0.0 117.354 175.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 38.19 -3.83 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 1 C-N-CA 133.88 4.872 . . . . 0.0 118.794 178.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -169.05 -33.86 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 128.531 2.732 . . . . 0.0 112.716 -170.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.41 145.74 43.48 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.808 0.843 . . . . 0.0 110.7 172.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.08 -59.8 3.16 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.263 1.025 . . . . 0.0 112.058 -176.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -130.86 129.6 42.52 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 122.995 0.518 . . . . 0.0 111.367 -170.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.47 144.24 32.51 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 118.902 0.773 . . . . 0.0 109.607 169.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.3 t -140.53 140.58 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.841 1.257 . . . . 0.0 110.328 -169.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -128.95 141.1 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -169.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -138.75 88.22 2.28 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.376 1.87 . . . . 0.0 108.314 169.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.1 mt -104.65 126.75 30.49 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 124.132 0.973 . . . . 0.0 109.364 173.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.15 133.83 57.96 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.542 2.162 . . . . 0.0 113.235 174.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.0 1.11 89.79 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.043 1.306 . . . . 0.0 116.207 175.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -134.12 158.17 75.95 Favored Pre-proline 0 N--CA 1.476 0.829 0 CA-C-N 119.247 1.523 . . . . 0.0 112.19 173.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.65 143.19 61.24 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.518 2.145 . . . . 0.0 112.702 -177.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 p -52.34 137.41 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.857 1.663 . . . . 0.0 112.451 171.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.7 t -119.78 134.03 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.287 1.835 . . . . 0.0 109.352 172.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -141.16 115.9 9.67 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.594 1.158 . . . . 0.0 109.283 176.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.7 t -93.23 155.1 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.682 1.993 . . . . 0.0 111.494 -169.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.74 -97.17 1.21 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 121.269 -0.895 . . . . 0.0 113.409 172.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.8 m -153.71 154.86 34.88 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.471 1.109 . . . . 0.0 110.346 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -70.67 127.99 91.38 Favored Pre-proline 0 CA--C 1.548 0.882 0 O-C-N 120.69 -1.256 . . . . 0.0 110.951 175.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.426 ' CB ' HG11 ' A' ' 71' ' ' VAL . 73.8 Cg_endo -78.55 158.76 28.79 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 124.283 3.322 . . . . 0.0 114.664 -178.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.8 t -85.57 -29.77 23.88 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -169.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.48 -35.48 2.33 Favored Glycine 0 N--CA 1.476 1.365 0 C-N-CA 125.484 1.516 . . . . 0.0 112.449 -175.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -78.9 61.86 3.22 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.489 1.515 . . . . 0.0 110.589 169.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.426 HG11 ' CB ' ' A' ' 67' ' ' PRO . 30.3 m -137.47 155.48 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.53 1.532 . . . . 0.0 112.535 -177.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.0 mt -91.99 127.93 37.65 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 128.417 2.687 . . . . 0.0 109.243 176.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -114.52 108.13 16.44 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.766 0.712 . . . . 0.0 111.649 -173.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.51 146.78 18.73 Favored Glycine 0 N--CA 1.469 0.856 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 169.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -152.37 132.92 13.85 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 119.377 1.589 . . . . 0.0 112.644 -169.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.28 168.45 21.04 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 42.6 m -135.43 118.01 15.93 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.927 1.691 . . . . 0.0 109.417 -177.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.48 172.15 52.57 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.454 1.026 . . . . 0.0 113.055 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -49.19 -43.96 42.68 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 126.324 1.85 . . . . 0.0 111.472 175.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -81.06 2.17 28.33 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -172.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.39 22.97 27.85 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.387 0.994 . . . . 0.0 113.139 172.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.42 -166.78 1.54 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.322 1.449 . . . . 0.0 113.285 -178.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.7 m -146.85 123.55 11.19 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 120.377 -1.452 . . . . 0.0 111.904 172.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.2 t -97.69 143.0 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.708 2.003 . . . . 0.0 109.988 170.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.1 tp -131.28 144.9 51.63 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.395 1.478 . . . . 0.0 109.134 169.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.7 t -125.76 137.42 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.318 1.447 . . . . 0.0 108.544 172.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -131.67 126.36 34.41 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.689 0.757 . . . . 0.0 111.284 -175.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -129.49 144.59 53.47 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 126.564 1.946 . . . . 0.0 110.813 -170.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.92 133.42 38.67 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.377 2.051 . . . . 0.0 112.188 178.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.2 ttp85 . . . . . 0 C--O 1.253 1.265 0 C-N-CA 125.138 1.375 . . . . 0.0 112.231 178.479 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.772 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.1 p -77.01 168.85 19.39 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.991 1.316 . . . . 0.0 112.631 174.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -149.06 144.34 26.63 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.339 1.055 . . . . 0.0 111.397 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.1 p -78.95 118.28 20.81 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.365 1.066 . . . . 0.0 112.174 177.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.86 166.68 32.06 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 126.429 1.892 . . . . 0.0 112.532 178.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.3 m -68.55 143.65 54.84 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.516 1.127 . . . . 0.0 110.74 171.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 68.3 mt -134.38 145.67 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.274 1.429 . . . . 0.0 108.242 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.1 p -82.32 34.19 0.42 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 -172.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.2 m -63.58 32.23 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 130.02 3.328 . . . . 0.0 117.315 -172.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 27.2 p -129.42 -65.42 0.85 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.219 2.208 . . . . 0.0 107.92 169.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.05 -44.28 76.75 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.339 1.456 . . . . 0.0 112.76 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -78.03 -22.09 49.72 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.76 0.824 . . . . 0.0 111.839 174.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -74.17 -53.22 10.31 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 120.803 -1.186 . . . . 0.0 111.68 173.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.97 -31.66 72.04 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 121.011 -1.056 . . . . 0.0 113.724 -172.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.6 m -60.57 -20.58 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 172.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -70.24 -45.13 67.12 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.181 0.901 . . . . 0.0 112.454 174.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -70.9 -41.33 71.42 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.209 -0.932 . . . . 0.0 111.303 -170.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -63.62 -33.13 74.94 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.909 0.883 . . . . 0.0 112.562 170.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.24 -37.02 84.51 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.72 -1.238 . . . . 0.0 111.829 172.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.7 t -69.27 -38.58 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 O-C-N 121.236 -0.915 . . . . 0.0 111.529 172.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.9 tpp85 -58.11 -46.14 86.06 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.156 -0.965 . . . . 0.0 111.009 171.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.9 mp -69.95 -34.79 73.87 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 116.759 -1.591 . . . . 0.0 112.616 175.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.78 -37.99 69.31 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 121.589 1.995 . . . . 0.0 109.735 169.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.8 m -70.23 -38.26 75.18 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.115 0.966 . . . . 0.0 113.483 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.0 mm -71.55 -34.86 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 120.854 1.661 . . . . 0.0 110.489 176.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.1 t -63.21 -50.5 78.84 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 C-N-CA 125.4 1.48 . . . . 0.0 109.59 172.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -55.08 -40.51 70.45 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 121.307 1.867 . . . . 0.0 113.34 172.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.4 m -59.32 -34.01 71.81 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.085 -0.384 . . . . 0.0 111.682 174.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -79.41 -35.7 40.19 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.825 1.65 . . . . 0.0 113.937 172.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.96 -33.71 76.43 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 120.161 1.346 . . . . 0.0 111.576 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 87.6 mt -75.04 -37.4 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 124.849 1.259 . . . . 0.0 110.585 169.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.23 -39.48 62.3 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 125.637 1.589 . . . . 0.0 114.181 -173.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.3 t -151.49 -27.75 0.19 Allowed 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.22 0.27 38.14 Favored Glycine 0 N--CA 1.481 1.655 0 N-CA-C 116.757 1.463 . . . . 0.0 116.757 175.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.1 m -144.09 136.01 26.26 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.35 1.86 . . . . 0.0 109.01 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.9 p -114.41 143.18 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.335 1.054 . . . . 0.0 110.224 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -128.41 158.46 38.25 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.748 1.219 . . . . 0.0 110.872 -170.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -51.9 -37.95 54.38 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.722 0.809 . . . . 0.0 113.07 -177.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -70.31 -20.05 63.03 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.637 1.575 . . . . 0.0 114.236 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -80.55 -36.96 32.29 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.997 0.817 . . . . 0.0 111.491 171.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.5 mt -87.48 -33.06 19.14 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.74 1.616 . . . . 0.0 113.951 -170.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.6 ptt85 -55.15 -22.37 16.81 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 172.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -84.35 -12.25 54.87 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 176.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -110.55 -21.63 12.05 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 119.957 1.253 . . . . 0.0 114.038 -170.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -60.44 -31.64 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.15 -5.61 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.209 1 C-N-CA 132.424 4.29 . . . . 0.0 117.806 177.629 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -173.92 -47.04 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 128.851 2.86 . . . . 0.0 109.398 -174.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.99 130.69 30.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.813 1.245 . . . . 0.0 110.977 -176.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -59.05 -54.69 44.21 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -169.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -132.52 130.08 39.93 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.042 1.337 . . . . 0.0 111.498 -174.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.405 ' H ' ' HB ' ' A' ' 63' ' ' VAL . . . -105.71 142.76 34.89 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 168.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.5 t -138.33 140.5 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 O-C-N 121.085 -1.009 . . . . 0.0 110.975 -169.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 mm -114.17 134.28 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.748 1.619 . . . . 0.0 113.628 -172.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -136.64 69.13 1.42 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.594 1.958 . . . . 0.0 109.589 170.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 30.8 mt -89.93 128.18 51.0 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 123.971 0.909 . . . . 0.0 109.383 171.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -61.46 132.56 41.38 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.35 2.033 . . . . 0.0 112.713 173.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.35 2.89 87.33 Favored Glycine 0 CA--C 1.537 1.412 0 N-CA-C 116.079 1.192 . . . . 0.0 116.079 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -136.13 155.12 77.72 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-N 119.152 1.476 . . . . 0.0 112.008 172.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.05 147.45 67.49 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.722 2.281 . . . . 0.0 113.14 -171.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 p -58.33 130.2 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.641 1.176 . . . . 0.0 111.651 174.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.1 t -109.88 139.28 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.753 1.621 . . . . 0.0 108.937 171.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -135.47 108.5 7.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.767 1.227 . . . . 0.0 108.511 177.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.405 ' HB ' ' H ' ' A' ' 51' ' ' ALA . 27.6 t -80.8 149.3 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.111 1.364 . . . . 0.0 110.985 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.14 -93.59 1.43 Allowed Glycine 0 CA--C 1.533 1.196 0 O-C-N 121.654 -0.654 . . . . 0.0 112.128 174.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.1 m -149.35 158.4 44.14 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.048 1.339 . . . . 0.0 109.146 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -76.69 128.27 82.25 Favored Pre-proline 0 CA--C 1.548 0.892 0 O-C-N 120.548 -1.345 . . . . 0.0 110.896 173.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -75.83 155.45 39.16 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.285 3.323 . . . . 0.0 114.89 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.7 t -86.18 -31.79 21.58 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -169.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.36 -41.17 1.42 Allowed Glycine 0 N--CA 1.474 1.201 0 C-N-CA 124.991 1.282 . . . . 0.0 112.583 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -78.49 64.13 3.48 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.059 1.343 . . . . 0.0 111.047 169.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.0 158.17 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.443 1.497 . . . . 0.0 112.406 -178.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.4 mt -99.83 126.7 45.97 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.612 2.365 . . . . 0.0 110.056 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -109.2 109.58 20.56 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -170.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.26 146.7 18.24 Favored Glycine 0 N--CA 1.475 1.24 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 169.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 68.8 ttt-85 -154.2 132.84 12.16 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 120.812 2.306 . . . . 0.0 114.101 -169.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -143.32 173.59 11.47 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.196 1.398 . . . . 0.0 113.597 -177.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 m -143.73 119.26 10.35 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.597 1.559 . . . . 0.0 110.409 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.26 175.14 54.62 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.521 1.534 . . . . 0.0 115.513 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -68.02 -9.92 49.58 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.11 2.164 . . . . 0.0 115.373 -174.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -97.47 3.81 50.69 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 120.309 1.413 . . . . 0.0 113.452 169.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.57 23.47 26.13 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.971 1.272 . . . . 0.0 114.238 173.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.14 -164.4 1.11 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.297 1.439 . . . . 0.0 114.527 -172.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.4 m -146.91 121.57 9.83 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.334 -1.479 . . . . 0.0 111.833 173.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.7 t -98.14 139.55 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.841 1.656 . . . . 0.0 109.456 169.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.6 tp -129.01 146.9 50.86 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.216 1.406 . . . . 0.0 109.302 171.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.9 t -125.6 134.81 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.005 1.322 . . . . 0.0 108.268 171.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -132.94 131.33 40.7 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.278 1.031 . . . . 0.0 111.359 -176.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -148.51 152.98 39.44 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.352 1.061 . . . . 0.0 112.398 177.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -62.65 135.93 55.43 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.893 2.395 . . . . 0.0 113.86 -170.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 . . . . . 0 C--O 1.254 1.324 0 C-N-CA 127.369 2.268 . . . . 0.0 112.34 179.82 . . . . . . . . 0 0 . 1 stop_ save_